data_1lmz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1lmz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.7 m 46.96 -162.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.65 -27.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -73.72 -16.69 61.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 0.0 109.447 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.02 130.17 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.552 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLN . 33.4 t -162.68 137.19 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.51 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' SER . 93.2 mt-30 50.53 179.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.535 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' LEU . 5.1 m-20 48.31 77.12 0.48 Allowed Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.251 -0.905 . . . . 0.0 109.409 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -47.69 -10.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.886 2.391 . . . . 0.0 112.073 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' ASP . 13.5 mt -62.78 -33.81 75.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 47' ' ' ILE . 54.0 m-85 -63.03 -58.13 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.67 -47.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.66 69.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -72.26 -43.51 64.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.489 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 60.5 t-80 -60.85 -43.53 98.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.62 -41.25 79.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.54 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -60.24 -48.11 83.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' HIS . 80.0 mm-40 -141.97 -131.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.489 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 5.7 t90 56.56 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.16 0.63 65.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 169' ' ' CYS . 10.0 t -118.08 96.61 49.91 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.217 -1.167 . . . . 0.0 109.416 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.25 122.59 5.65 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.778 2.318 . . . . 0.0 111.871 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 27.6 tp10 -110.67 139.31 46.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.885 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.4 p -115.56 3.96 14.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 93.6 m-20 -77.77 123.54 26.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.33 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.446 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 12.9 t -64.48 -37.81 88.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HZ2' ' CB ' ' A' ' 29' ' ' LYS . 9.5 mtmp? -62.88 -55.06 29.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -65.87 -43.91 86.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.803 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.6 -34.79 76.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.103 -0.998 . . . . 0.0 109.924 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.51 -39.45 83.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.885 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 3.6 mp0 -73.77 -31.05 63.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.885 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.571 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 55.9 ttm -59.06 -54.05 51.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.798 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.55 -33.16 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.983 . . . . 0.0 110.034 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 t -71.81 -45.88 60.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.4 mt -64.23 -44.26 92.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 41' ' ' GLN . 97.2 mt-10 -63.1 -33.28 75.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 109.829 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.27 -36.38 7.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 19.3 mp0 -75.47 -14.7 60.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -1.221 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLU . 4.0 pp0? -55.27 -23.77 24.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.62 108.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.92 -34.09 3.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.2 mm? -86.14 178.06 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -1.186 . . . . 0.0 109.489 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.6 m -108.69 149.93 28.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.348 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 p90 -53.79 -36.28 62.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -62.54 -40.51 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 93.4 m -64.31 -37.25 86.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.9 t -60.09 -39.42 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.44 -46.8 83.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -62.03 -50.99 69.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 109.349 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -66.96 -28.74 68.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' VAL . 64.6 ttt180 -53.37 -44.55 68.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.156 -0.965 . . . . 0.0 108.973 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.66 -43.58 79.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -66.15 -37.53 85.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 14.3 t80 -59.65 -49.06 79.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 21.9 mmm180 -61.24 -29.55 69.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.735 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.64 98.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.875 . . . . 0.0 110.241 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.0 m -93.9 -41.91 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 110.232 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 32.4 m-85 -70.73 -52.09 23.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.218 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 49.7 t60 -51.55 -38.07 52.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.055 -1.028 . . . . 0.0 109.865 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.03 -37.13 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.769 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 64' ' ' ASP . 70.2 m-85 -88.06 -9.0 54.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.007 . . . . 0.0 109.856 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 63' ' ' PHE . 7.2 t70 61.75 129.83 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.74 -31.76 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.841 2.36 . . . . 0.0 112.69 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.62 -50.66 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.632 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 71' ' ' MET . 40.7 mtpt -66.82 -34.5 77.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 109.797 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.16 -28.9 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.6 -18.39 29.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.57 25.98 5.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.1 ptp -75.22 -160.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -129.58 160.56 32.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 49.2 mp0 -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -70.73 -24.34 62.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.443 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -67.0 -47.65 70.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 0.0 109.386 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 m -64.91 -38.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.57 -32.61 73.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.583 HH11 ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.93 -41.99 81.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.775 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.93 -30.68 70.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.4 t -49.55 -33.8 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.952 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -91.36 -63.45 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -101.55 115.75 31.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.49 -46.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.64 15.07 64.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 pt -123.58 167.39 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -1.131 . . . . 0.0 109.304 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.9 mt -49.07 128.64 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -108.29 128.08 54.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.693 ' O ' ' N ' ' A' ' 90' ' ' GLY . 58.4 t-80 -158.21 1.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.147 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 59.48 -60.65 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.07 -46.73 93.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -42.54 96.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -1.151 . . . . 0.0 109.499 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.6 mt -63.37 -49.41 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -54.47 -33.14 59.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.401 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.368 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 94.8 mt -58.41 -41.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 96' ' ' ILE . 16.9 mm -55.49 -47.28 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.82 93.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.27 -45.22 91.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.137 . . . . 0.0 109.386 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -70.04 -47.63 61.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.72 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.446 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 84.5 t80 -68.06 -46.17 71.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.73 -38.95 84.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.62 -44.98 85.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.85 -41.19 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -71.7 -27.01 62.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -51.25 -32.1 23.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.31 1.81 39.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.9 9.38 86.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -79.04 129.23 73.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.11 -1.229 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.51 122.16 8.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.673 2.249 . . . . 0.0 111.692 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -76.44 -44.89 33.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.472 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.43 -49.69 76.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.792 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 85.4 m-20 -54.64 -35.1 63.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.949 . . . . 0.0 111.005 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 75.7 t80 -73.54 -48.42 33.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.032 -1.042 . . . . 0.0 111.219 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 117' ' ' TRP . 3.1 m -55.95 -50.34 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.052 -1.03 . . . . 0.0 111.655 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.462 ' H ' HG23 ' A' ' 116' ' ' VAL . 25.2 p-90 -86.66 -22.42 26.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.84 -1.162 . . . . 0.0 111.087 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 120' ' ' VAL . 8.0 t -59.48 -27.95 66.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.821 -1.175 . . . . 0.0 109.658 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.12 -15.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.075 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 118' ' ' SER . 14.8 m -83.22 22.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 109.979 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.612 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 29.4 t30 61.05 48.27 6.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.046 . . . . 0.0 109.765 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 32.4 p80 41.91 32.99 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 8.6 tt0 -142.84 90.86 7.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -47.16 155.19 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.724 2.282 . . . . 0.0 111.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 16.7 mp0 -105.66 158.92 16.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 109.688 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.9 mtt -135.98 156.9 48.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.134 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 t -122.57 160.38 25.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.482 ' OE1' ' N ' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -141.28 43.72 1.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.73 169.72 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 m -87.69 -33.24 18.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.59 ' HG1' ' H ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -137.68 169.43 17.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.2 mt -67.85 -27.69 66.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.577 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.59 ' H ' ' HG1' ' A' ' 131' ' ' THR . 20.7 t -59.08 -41.22 87.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -64.19 -29.86 70.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.395 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.37 131.76 93.25 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.409 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 98.4 Cg_endo -80.03 141.45 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.141 2.561 . . . . 0.0 112.571 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 6.26 42.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 109.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.1 t -136.37 92.69 2.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.887 . . . . 0.0 109.35 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -98.06 154.53 37.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.74 -40.18 24.25 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.797 2.331 . . . . 0.0 112.061 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.86 70.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.0 m -62.39 -45.58 92.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.05 -43.77 86.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.59 73.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 109.513 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 8.2 tt -66.88 -46.73 74.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 87.7 p -58.9 -39.03 80.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.962 . . . . 0.0 109.548 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -63.59 -34.68 78.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.4 -50.28 60.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.22 -32.49 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -57.92 -38.11 75.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.33 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.676 ' HZ1' ' NH1' ' A' ' 152' ' ' ARG . 7.0 ttpm? -61.55 -38.94 89.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.452 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.676 ' NH1' ' HZ1' ' A' ' 151' ' ' LYS . 12.7 mpt_? -63.55 -20.22 65.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.28 24.65 10.09 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -89.84 131.92 35.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -1.121 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.34 177.69 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 54.07 57.19 6.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.9 m -121.78 25.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.412 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.49 166.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 p -66.36 -24.53 66.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.397 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.456 ' CG2' ' N ' ' A' ' 161' ' ' ILE . 15.0 t -72.04 -42.66 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.456 ' N ' ' CG2' ' A' ' 160' ' ' THR . 81.5 mt -65.65 -41.45 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 50.1 t -63.22 -40.43 97.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.299 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CE1' ' O ' ' A' ' 136' ' ' PRO . 68.0 t80 -60.75 -46.85 88.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.395 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -45.55 84.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.888 . . . . 0.0 109.354 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -62.66 -34.45 77.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 178.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 30.7 ttm -63.28 -45.0 93.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.645 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -70.08 -37.17 75.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.668 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.76 -46.98 79.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 14.4 m -64.66 -61.14 2.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.0 7.54 3.25 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.5 mp -50.07 -43.55 51.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 109.38 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -100.61 134.54 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.487 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -87.19 103.41 15.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -91.92 121.99 34.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.593 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -160.9 100.28 1.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.96 148.17 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.68 129.9 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.23 7.98 63.35 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 52.3 t -79.65 94.2 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.507 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.2 t 65.63 -57.18 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 37.6 t -173.07 60.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.414 ' OH ' ' CB ' ' A' ' 128' ' ' GLN . 21.8 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 109.608 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.588 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' C ' ' H ' ' A' ' 6' ' ' TRP . 14.1 m -150.91 26.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.407 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.98 -44.19 0.16 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.523 ' H ' ' C ' ' A' ' 4' ' ' CYS . 94.1 m95 -54.63 -35.06 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 m -73.49 63.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -149.94 48.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -152.96 -125.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.1 150.17 98.07 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.859 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.63 -19.84 41.46 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.899 2.4 . . . . 0.0 112.095 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.29 -41.36 98.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.392 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -65.24 -49.6 69.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.443 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.0 -45.12 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.84 88.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -57.57 -42.39 83.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.536 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 48.7 t-80 -62.32 -41.76 98.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.8 -40.03 94.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -58.77 -53.04 62.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 21' ' ' TRP . 76.3 mm-40 -142.48 -131.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.536 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 24.2 t90 58.76 138.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.535 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.28 -29.0 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 169' ' ' CYS . 11.0 p -75.49 131.59 77.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.11 120.51 6.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.817 2.345 . . . . 0.0 111.885 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -111.5 137.19 49.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.845 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -132.61 4.87 3.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 28' ' ' SER . 63.3 t0 -94.22 142.96 26.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.284 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 60.3 p -64.33 -34.63 78.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.4 -47.64 75.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.91 -48.89 27.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.61 -35.37 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.845 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.505 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 48.9 t80 -60.63 -46.97 88.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.864 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.14 -30.11 62.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.83 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -58.47 -53.28 60.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.793 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.462 ' O ' ' CD ' ' A' ' 38' ' ' GLU . 4.1 tp -69.77 -31.62 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 110.017 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 69.2 m -73.31 -46.58 48.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.902 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 16.5 pt-20 -49.8 -43.5 48.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.778 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . 77.2 171.31 35.19 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.744 ' C ' ' H ' ' A' ' 42' ' ' ALA . 4.5 tt0 -66.35 -43.77 85.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.247 . . . . 0.0 109.737 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 58.34 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 109.704 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.744 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -70.84 117.88 12.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.11 -15.25 63.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -116.87 -135.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -1.176 . . . . 0.0 109.461 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -153.27 154.8 35.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.434 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -52.31 -35.64 51.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.4 tp -52.91 -40.99 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 73.5 m -66.83 -35.65 80.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 0.0 109.701 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.9 t -60.97 -39.91 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.414 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 mt -59.95 -47.48 85.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.666 ' NZ ' ' HZ3' ' A' ' 52' ' ' LYS . 9.8 mtmp? -64.63 -53.06 53.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.262 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.666 ' HZ3' ' NZ ' ' A' ' 51' ' ' LYS . 13.0 mptt -64.51 -34.36 78.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 49' ' ' VAL . 7.9 tmm_? -50.45 -45.94 56.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.2 -0.938 . . . . 0.0 108.95 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.38 -42.24 98.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -66.51 -36.33 82.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.223 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -61.95 -45.66 92.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.3 mtm180 -57.15 -42.1 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.828 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.6 66.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 m -92.34 -12.61 31.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 0.0 110.363 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.84 -43.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.906 -1.121 . . . . 0.0 110.239 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -51.41 -43.76 62.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.113 -0.992 . . . . 0.0 109.885 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -67.11 -39.98 86.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 93.5 m-85 -71.58 -24.17 61.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.854 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.4 t70 69.62 131.48 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.996 -1.065 . . . . 0.0 109.563 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -39.9 -37.24 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.834 2.356 . . . . 0.0 112.679 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.03 -48.38 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.14 -0.975 . . . . 0.0 109.647 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 71' ' ' MET . 60.5 mttp -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.15 -43.4 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 109.626 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.3 -30.3 54.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.68 58.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.407 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.8 mtp -65.08 136.65 56.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -94.37 171.98 8.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.93 -33.28 70.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -59.18 -42.57 91.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -59.26 -38.45 80.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.85 -44.99 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.571 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.538 ' OE1' ' NH1' ' A' ' 89' ' ' ARG . 41.8 tp10 -56.44 -37.79 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -65.4 -43.74 89.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.718 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.01 -36.21 79.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.619 ' CG1' HH21 ' A' ' 87' ' ' ARG . 52.7 t -50.64 -35.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.723 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.15 -60.04 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 109.518 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -99.91 115.92 30.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.72 -45.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.11 33.38 40.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.42 172.17 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -1.111 . . . . 0.0 109.336 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.0 mt -48.53 135.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.619 HH21 ' CG1' ' A' ' 80' ' ' VAL . 1.3 tpt180 -75.46 122.62 24.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.44 91.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 109.141 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 77' ' ' GLU . 38.3 ttm-85 -48.57 -32.54 8.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.932 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.44 -38.48 93.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.693 ' HZ1' ' H ' ' A' ' 40' ' ' GLN . 14.1 mmmt -60.04 -47.34 86.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.499 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 92' ' ' ILE . 76.5 mt -60.26 -41.39 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -58.08 -39.08 77.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.0 81.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.505 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 33.3 mm -59.6 -43.74 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.434 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 96' ' ' ILE . 96.6 mt -61.28 -28.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.548 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.05 -45.65 80.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.679 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -63.12 -35.48 80.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -1.148 . . . . 0.0 109.416 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.679 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -62.78 -46.79 86.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 109.521 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -71.43 -45.77 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.93 81.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.529 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.41 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 64.8 t80 -63.6 -49.2 74.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.94 -42.71 80.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.483 ' NE2' ' OE1' ' A' ' 107' ' ' GLN . 69.7 tp60 -65.53 -41.64 92.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.6 ttt -65.31 -41.82 93.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.471 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.68 -27.33 65.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.483 ' OE1' ' NE2' ' A' ' 104' ' ' GLN . 61.4 tt0 -51.8 -31.13 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -76.74 -12.7 60.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.45 0.46 76.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.83 132.54 64.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.2 -1.177 . . . . 0.0 109.712 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.49 118.58 5.73 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.6 2.2 . . . . 0.0 111.7 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -77.22 -38.57 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.795 . . . . 0.0 110.455 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.14 -49.72 76.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 110.77 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 118' ' ' SER . 93.0 m-20 -61.27 -44.43 97.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.228 -0.92 . . . . 0.0 111.102 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.77 -53.47 57.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.94 -1.1 . . . . 0.0 111.224 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.406 HG21 ' N ' ' A' ' 117' ' ' TRP . 12.2 m -57.96 -49.71 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.934 -1.104 . . . . 0.0 111.666 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.511 ' O ' ' CE3' ' A' ' 117' ' ' TRP . 2.4 p-90 -86.89 -21.55 26.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.712 -1.242 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 120' ' ' VAL . 17.0 p -58.84 -33.84 70.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.799 -1.188 . . . . 0.0 109.721 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.07 -12.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.915 . . . . 0.0 110.076 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 118' ' ' SER . 43.1 t -82.32 23.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.073 -1.017 . . . . 0.0 109.939 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 35.1 t30 68.95 18.75 8.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 53.58 50.08 18.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.0 tt0 -159.7 121.41 1.82 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.34 151.89 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.716 2.278 . . . . 0.0 111.794 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 87.9 mm-40 -118.44 146.96 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.975 . . . . 0.0 109.72 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -135.91 156.49 48.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.79 . . . . 0.0 109.097 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.7 t -119.4 163.22 17.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.86 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -149.06 43.41 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.26 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.05 -150.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 109.676 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.445 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 14.4 m -138.72 -33.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -121.9 154.34 37.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.13 -33.84 75.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.893 . . . . 0.0 109.618 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -63.03 -33.38 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 130' ' ' THR . 95.6 mt-10 -62.92 -30.87 71.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.52 117.04 43.44 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.699 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.06 125.65 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.079 2.519 . . . . 0.0 112.537 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 10.2 t -76.65 -18.15 58.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 109.322 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.0 t -102.72 99.19 9.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.11 155.45 37.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -46.89 -40.67 25.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.749 2.299 . . . . 0.0 111.963 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.85 -35.18 67.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.389 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.8 m -60.66 -41.86 95.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -64.8 -45.82 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.49 81.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.489 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 7.4 tt -66.52 -46.35 76.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -56.33 -47.54 78.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.93 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.59 -45.0 73.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.17 -33.85 72.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.606 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -57.37 -40.89 79.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.86 -37.07 85.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.43 -17.81 65.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.19 20.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 136.27 33.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.14 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -105.24 -179.22 3.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.541 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 54.37 56.92 6.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.49 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 m -122.56 26.59 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.87 161.39 0.16 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.1 t -55.66 -32.61 63.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.158 . . . . 0.0 109.425 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 46.7 m -68.57 -46.83 68.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.04 -33.82 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.42 -41.77 79.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.299 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 137' ' ' THR . 43.4 t80 -62.23 -45.38 93.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.3 t -59.15 -36.9 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.54 -43.36 97.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.418 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.94 -39.74 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.638 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -61.63 -47.12 86.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.859 . . . . 0.0 109.689 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.65 -37.86 80.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.75 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' VAL . 15.6 m -59.59 -28.81 67.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.457 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.06 9.92 55.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.81 -40.65 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 109.483 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 t -96.36 129.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.691 ' ND2' ' HE2' ' A' ' 175' ' ' HIS . 45.7 t-20 -100.04 117.53 34.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.378 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -75.42 137.04 40.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.457 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.691 ' HE2' ' ND2' ' A' ' 173' ' ' ASN . 75.6 m-70 -146.22 48.68 1.2 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.95 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.54 144.88 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.9 t -81.69 134.19 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.952 . . . . 0.0 109.503 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.27 25.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.567 ' HG ' ' H ' ' A' ' 182' ' ' TYR . 13.8 p -86.94 -160.53 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.527 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.9 t -84.41 -54.16 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 t -64.94 -11.17 35.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.567 ' H ' ' HG ' ' A' ' 179' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.609 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' CYS . 32.8 ptt180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' ARG . 20.2 m 53.94 171.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.07 12.69 1.44 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 2.9 p-90 -148.3 46.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 109.429 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.42 130.36 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.527 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 m -73.81 146.41 44.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 27.6 mp0 -65.29 -29.35 70.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.515 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -53.52 142.65 40.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.85 -23.81 18.54 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.874 2.383 . . . . 0.0 112.163 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.85 -39.79 95.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -79.45 -47.38 15.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.39 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.7 mt -55.41 -49.05 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.416 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -46.08 78.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -62.23 -40.41 96.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t-80 -58.68 -45.86 88.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.38 -46.23 12.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -57.98 -37.66 74.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 21' ' ' TRP . 93.7 mt-10 -144.54 -156.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.464 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.483 ' O ' ' O ' ' A' ' 20' ' ' GLU . 34.6 t90 59.76 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.64 -28.51 10.01 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.56 119.63 68.48 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.33 -1.1 . . . . 0.0 109.409 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.95 129.13 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.868 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -115.58 137.95 51.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.9 p -126.46 4.99 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.888 . . . . 0.0 109.104 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -72.18 119.47 16.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.6 p -60.55 -36.89 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -62.71 -46.98 85.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.828 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.16 -50.74 62.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 8.8 mp -64.55 -39.0 92.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.119 -0.988 . . . . 0.0 109.887 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 90.4 t80 -61.6 -52.91 62.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 109.864 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -33.11 75.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -56.72 -50.81 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.82 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.32 -40.16 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.995 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -72.24 -39.96 68.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.123 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.44 -40.64 66.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 109.848 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -53.63 -35.88 61.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' C ' ' HZ3' ' A' ' 91' ' ' LYS . . . -51.15 -31.56 26.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.409 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 26.8 mt-30 -71.06 -29.83 65.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -1.202 . . . . 0.0 109.742 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' LEU . 6.0 pt20 -51.28 -31.26 20.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.695 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.43 109.75 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.656 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.82 -31.88 5.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLN . 27.1 mt -96.23 -179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.484 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.0 m -105.78 163.15 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.972 . . . . 0.0 109.415 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.2 -46.43 75.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.3 tp -56.57 -34.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.9 m -64.54 -33.99 77.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.8 t -63.18 -40.76 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -53.66 -51.38 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -56.91 -39.68 74.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -80.75 -17.87 49.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.375 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.454 ' NH1' ' HG3' ' A' ' 53' ' ' ARG . 39.8 ttm-85 -60.99 -49.25 78.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.157 -0.964 . . . . 0.0 108.992 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -73.95 -42.84 59.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.456 -0.778 . . . . 0.0 109.347 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -66.64 -43.11 85.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 60' ' ' PHE . 35.9 t80 -60.42 -46.14 91.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.364 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' HIS . 76.6 mtm180 -59.48 -37.13 77.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 15.1 p -94.14 -12.33 28.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.301 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.635 ' CD2' ' CZ ' ' A' ' 56' ' ' TYR . 52.4 m-85 -120.95 -54.22 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.967 -1.083 . . . . 0.0 110.2 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 57' ' ' ARG . 44.7 t-80 -55.6 -41.79 73.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -55.77 -32.93 63.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 81.5 m-85 -94.96 3.81 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.856 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 57.7 162.58 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 109.555 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 68' ' ' VAL . 60.7 Cg_endo -74.48 -14.49 22.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.876 2.384 . . . . 0.0 112.694 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.678 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.81 -46.61 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.908 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 6.3 m -56.69 -41.9 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.007 . . . . 0.0 109.641 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.465 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -58.9 -40.93 85.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.96 27.98 2.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.6 ttm -71.21 147.83 47.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.689 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -100.08 149.23 23.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 55.7 mp0 -52.34 -31.81 35.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.99 -45.64 88.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.45 -39.13 79.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.428 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.5 t -55.29 -46.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.33 -34.14 70.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.58 -49.27 71.84 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.337 -0.852 . . . . 0.0 109.78 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 mt -63.88 -38.39 90.9 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.97 -30.72 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -89.42 -58.54 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -99.52 124.85 45.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.415 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -170.27 -61.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.442 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.98 75.12 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.1 pt -100.3 -169.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.337 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.11 138.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.28 122.27 31.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.468 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -177.6 81.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -48.37 -28.59 3.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.16 98.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.476 ' HZ3' ' C ' ' A' ' 39' ' ' GLY . 14.1 mtpt -69.13 -42.48 75.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -1.205 . . . . 0.0 109.571 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.95 -50.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -57.13 -33.48 67.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.443 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.21 -43.58 98.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 95' ' ' ILE . 20.2 mm -55.75 -44.3 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -55.36 -50.15 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.69 -29.21 65.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.659 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.31 -40.3 85.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -1.195 . . . . 0.0 109.422 -178.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.659 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -67.8 -38.96 83.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -55.39 -44.83 76.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 109.541 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.33 69.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.442 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 37.0 t80 -60.75 -44.64 96.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.69 -36.31 83.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -57.68 -43.18 84.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.69 -43.86 71.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.62 -28.06 66.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -51.87 -33.04 34.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.5 -12.48 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.19 10.99 83.0 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -93.5 149.16 36.78 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.215 -1.168 . . . . 0.0 109.735 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.66 120.09 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.722 2.282 . . . . 0.0 111.697 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -66.46 -43.25 86.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 0.0 110.408 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.11 72.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.183 -0.948 . . . . 0.0 110.713 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' O ' ' CB ' ' A' ' 118' ' ' SER . 18.2 t70 -55.11 -51.18 67.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 111.046 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.426 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 69.7 t80 -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 111.261 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -58.37 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 111.706 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.415 ' NE1' ' HA ' ' A' ' 114' ' ' ASP . 45.0 p-90 -88.19 -20.69 25.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.786 -1.196 . . . . 0.0 111.162 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 120' ' ' VAL . 71.7 p -61.23 -24.29 66.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.159 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.13 -11.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.052 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.6 m -90.23 24.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 109.987 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 0.2 OUTLIER 77.51 -50.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 109.719 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.3 p-80 162.48 -19.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.38 148.96 35.92 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.15 154.7 47.05 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.707 2.272 . . . . 0.0 111.779 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -87.44 153.01 21.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 126' ' ' MET . 2.4 mpp? -136.57 150.46 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.431 ' OG1' ' CD1' ' A' ' 135' ' ' ILE . 15.1 t -99.35 171.55 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.864 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -160.17 67.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.31 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.49 -121.46 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 109.676 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 m -158.72 -33.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 t -124.0 170.27 10.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -73.79 -28.57 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.0 m -67.0 -38.1 85.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -67.25 -15.04 63.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.186 -0.946 . . . . 0.0 109.445 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.446 HG22 HD13 ' A' ' 135' ' ' ILE . 44.3 mm -65.68 116.69 34.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -42.53 136.23 4.35 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.071 2.514 . . . . 0.0 112.552 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -4.01 35.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -143.98 83.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.2 p -74.86 153.11 86.94 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.18 -29.97 68.91 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.76 2.307 . . . . 0.0 112.059 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.5 -33.44 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.386 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.5 p -64.27 -40.42 95.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.88 -50.12 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 109.527 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.62 82.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.03 -43.79 91.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.473 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.0 p -55.35 -43.86 75.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -62.58 -32.03 72.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.479 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.04 36.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.488 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 3.8 mm? -62.36 -37.88 87.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.635 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -59.23 -37.44 77.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.09 -39.89 91.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.509 HH11 ' HG2' ' A' ' 152' ' ' ARG . 38.7 mtt-85 -64.65 -19.57 65.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.23 21.91 21.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.06 138.42 36.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -103.53 170.42 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 59.08 47.08 12.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 158' ' ' GLY . 17.2 m -118.92 25.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.71 168.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.3 m -55.8 -32.61 63.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.46 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.1 m -62.28 -48.6 79.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -65.7 -34.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.94 -47.07 69.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -64.95 -40.78 95.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 109.347 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -59.57 -36.72 76.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.24 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.595 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 81.8 t80 -61.61 -43.09 99.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.5 mtp -70.43 -36.85 74.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -64.59 -54.79 26.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.698 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.32 83.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.595 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 22.9 m -53.88 -38.3 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.6 5.97 47.62 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.69 -33.1 73.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.75 132.32 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -94.57 105.33 17.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -96.02 96.13 8.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.168 -0.957 . . . . 0.0 109.494 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' A' ' 176' ' ' VAL . 21.2 m80 -108.9 -6.88 15.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.524 ' O ' ' O ' ' A' ' 175' ' ' HIS . 87.6 t 54.29 163.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.453 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 81.8 t -108.08 133.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.83 61.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 181' ' ' CYS . 39.2 m -144.41 168.35 20.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.163 . . . . 0.0 109.525 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 98.5 m 50.09 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 179' ' ' CYS . 38.6 t -155.8 14.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 109.513 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.492 ' HG3' HH11 ' A' ' 3' ' ' ARG . 32.0 mtm-85 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.323 0.583 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -141.39 -142.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.44 -11.99 0.1 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . 44.5 m95 -67.14 -9.48 40.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 6' ' ' TRP . 20.1 m 35.76 -154.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 8' ' ' SER . 10.3 t -178.08 47.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 10' ' ' ASP . 6.6 pt20 -130.63 -105.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 9' ' ' GLN . 58.2 m-20 -43.6 107.09 0.54 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -48.71 -34.84 28.55 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.799 2.333 . . . . 0.0 112.173 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.44 -44.22 95.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.473 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.46 ' CE1' ' CE1' ' A' ' 17' ' ' HIS . 40.0 t80 -68.15 -42.6 79.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.2 mt -59.36 -42.61 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.424 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' ASN . . . -61.72 -39.12 90.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.88 -41.27 77.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CE1' ' CE1' ' A' ' 13' ' ' TYR . 3.5 m80 -77.39 -20.87 54.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.912 . . . . 0.0 109.461 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -104.15 -2.04 26.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.523 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . 13.0 m120 -77.27 -74.83 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -147.89 23.43 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -79.85 132.89 36.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.95 -28.35 13.03 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 169' ' ' CYS . 4.0 t -91.39 112.95 56.77 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.212 -1.169 . . . . 0.0 109.41 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.68 137.85 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.759 2.306 . . . . 0.0 111.865 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.7 141.34 51.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.809 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.9 p -90.44 12.4 18.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.376 -0.827 . . . . 0.0 109.107 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -81.36 129.51 34.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 109.317 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.424 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 95.2 p -71.28 -31.03 66.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -58.64 -42.57 88.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.681 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.88 -48.56 65.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.89 -42.07 81.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 109.82 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 31.8 t80 -61.5 -52.68 63.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.48 -30.65 71.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -67.97 -55.39 12.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.805 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.3 mt -65.75 -43.84 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -58.23 -49.26 77.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 0.0 110.105 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 4.2 mm? -76.86 -41.68 43.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.857 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -53.93 -37.97 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.792 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.63 -29.73 25.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.624 ' NE2' ' CZ ' ' A' ' 56' ' ' TYR . 72.3 mt-30 -66.79 -30.03 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.187 . . . . 0.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.678 HE22 ' N ' ' A' ' 46' ' ' TRP . 35.6 tp60 -45.79 -39.05 7.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.935 . . . . 0.0 109.702 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.84 107.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.63 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.28 -32.72 4.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.5 mt -89.19 -165.11 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -1.126 . . . . 0.0 109.512 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.7 t -121.73 149.88 42.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.678 ' N ' HE22 ' A' ' 41' ' ' GLN . 36.2 p90 -57.61 -49.13 77.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 9.4 tp -48.34 -37.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.672 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.0 m -71.71 -34.2 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.727 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.63 -48.35 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -60.45 -47.22 87.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -61.9 -51.49 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.982 . . . . 0.0 109.305 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.65 -36.2 83.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 109.403 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -48.26 -46.11 35.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.205 -0.934 . . . . 0.0 108.975 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -65.23 -42.32 93.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.362 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.86 -39.08 90.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.286 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.624 ' CZ ' ' NE2' ' A' ' 40' ' ' GLN . 3.6 m-85 -61.87 -44.13 97.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 109.342 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 53.4 mtp180 -54.77 -43.51 72.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.299 -0.875 . . . . 0.0 109.834 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.38 -23.54 65.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.792 . . . . 0.0 110.328 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 59' ' ' CYS . 3.8 t -92.31 -12.64 31.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.271 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -133.16 -46.68 0.84 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.892 -1.13 . . . . 0.0 110.231 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 53.3 t-80 -53.47 -41.55 66.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.037 -1.039 . . . . 0.0 109.901 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.08 -34.87 68.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.792 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' ASP . 88.1 m-85 -91.04 4.41 52.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.874 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.61 160.67 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.601 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.73 -24.22 25.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.856 2.371 . . . . 0.0 112.728 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.85 -48.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.1 mttm -66.09 -33.78 76.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.403 -0.811 . . . . 0.0 109.866 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 71' ' ' MET . 61.0 t -57.43 -43.14 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.058 -1.026 . . . . 0.0 109.576 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.17 -24.35 61.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.63 14.13 28.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.356 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 11.8 ptm -77.61 152.55 33.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -100.62 163.29 12.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.558 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.38 -28.71 60.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.459 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -57.07 -37.42 71.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.13 -38.37 86.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -61.5 -38.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.612 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.83 -39.4 90.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.391 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 78' ' ' ARG . 53.5 mtm-85 -75.35 -47.85 25.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.318 -0.863 . . . . 0.0 109.767 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.73 -41.85 99.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.0 t -54.24 -34.28 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.713 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.62 -54.86 3.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.543 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -98.86 109.01 21.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 109.404 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.29 -38.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.87 36.84 46.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -124.5 173.42 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -1.139 . . . . 0.0 109.377 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 87.2 mt -47.71 138.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.568 HH11 ' HG2' ' A' ' 87' ' ' ARG . 9.9 ttt-85 -89.53 126.28 35.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 109.5 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.89 84.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -48.12 -32.09 6.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.935 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.88 93.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -65.13 -40.5 94.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mm -57.82 -47.46 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.49 -38.31 63.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.28 75.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.398 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.514 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 63.2 mt -59.9 -40.74 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.573 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 41.2 mm -54.19 -43.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.96 64.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -65.61 -45.73 82.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.14 . . . . 0.0 109.407 -178.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.516 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.71 -44.97 84.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.71 -41.28 98.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -46.54 38.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.424 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 49.8 t80 -55.45 -44.74 76.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.516 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.19 -32.99 74.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -54.85 -49.83 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.1 mtp -66.53 -38.55 87.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.73 -27.21 67.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -51.6 -34.03 35.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -81.11 -4.69 56.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.9 10.69 80.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -84.74 149.12 53.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.03 119.62 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.626 2.217 . . . . 0.0 111.704 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -73.85 -46.85 42.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.36 82.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.716 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.527 ' O ' ' OG ' ' A' ' 118' ' ' SER . 19.6 t70 -55.27 -39.1 69.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.907 . . . . 0.0 111.017 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.449 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 92.2 t80 -66.5 -49.43 66.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 111.192 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 m -60.46 -46.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 111.67 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.1 p-90 -85.97 -33.72 21.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.726 -1.233 . . . . 0.0 111.163 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 120' ' ' VAL . 74.4 m -57.12 -27.5 61.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 109.754 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.4 m -83.78 26.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.056 -1.027 . . . . 0.0 109.988 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.0 m120 74.36 21.57 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 56.51 42.2 27.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.93 . . . . 0.0 109.487 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -138.8 146.09 48.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.519 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.67 154.76 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.683 2.255 . . . . 0.0 111.836 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -120.27 147.46 44.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.965 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.7 ptp -135.58 157.31 47.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.838 . . . . 0.0 109.104 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 t -127.49 161.2 29.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -147.12 57.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.91 -151.18 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.705 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.3 m -114.31 -28.16 7.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 0.0 109.382 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.3 m -139.18 154.11 48.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.453 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.439 ' H ' HD12 ' A' ' 132' ' ' LEU . 1.0 OUTLIER -62.13 -30.86 71.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -67.2 -32.63 73.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.953 . . . . 0.0 109.513 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.08 -26.27 64.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.421 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 1.7 mp -67.34 121.58 79.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.25 133.94 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.125 2.55 . . . . 0.0 112.504 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.67 -17.32 48.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.373 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 138' ' ' SER . 24.1 p -73.05 102.4 3.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -134.8 151.65 76.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.36 -31.39 92.7 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.761 2.307 . . . . 0.0 112.049 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.85 73.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -63.57 -43.63 96.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.31 -44.5 97.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.83 60.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.438 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 6.8 tt -65.05 -49.05 71.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -57.84 -39.64 78.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.907 . . . . 0.0 109.539 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -62.31 -35.3 78.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.8 -51.57 57.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.2 mt -59.17 -35.02 72.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -58.16 -37.18 74.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -62.48 -40.6 97.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.5 mpt_? -64.51 -20.01 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.79 20.82 20.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -84.51 128.04 34.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 156' ' ' PHE . 22.9 tptt -97.41 176.99 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.457 ' H ' ' HG3' ' A' ' 155' ' ' LYS . 67.9 m-85 55.05 47.38 22.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 158' ' ' GLY . 2.6 m -121.71 25.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.69 171.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 p -58.31 -32.36 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.455 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 164' ' ' SER . 32.9 m -64.75 -48.46 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.37 -39.8 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 109.521 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 31.9 t -68.93 -50.13 52.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.29 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.492 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 53.1 t80 -63.93 -35.63 81.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 109.35 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 160' ' ' THR . 68.3 m -59.41 -41.47 89.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.256 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -65.05 -42.33 94.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.6 mtp -57.38 -40.9 79.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.521 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 24.1 mm100 -77.1 -36.4 55.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.41 -54.17 27.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.699 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.558 ' O ' ' O ' ' A' ' 23' ' ' VAL . 11.4 p -57.78 -61.14 2.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 144.22 2.76 0.81 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mp -48.5 -41.81 31.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.419 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.74 128.54 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -81.12 101.29 9.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 109.404 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.526 ' O ' ' ND1' ' A' ' 175' ' ' HIS . 78.6 m-20 -83.87 121.35 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 174' ' ' ASP . 28.4 m-70 -158.57 127.36 5.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.53 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.41 132.96 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.49 -20.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.78 -3.47 79.82 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.55 ' HG ' ' H ' ' A' ' 181' ' ' CYS . 6.9 t -90.17 143.49 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -1.151 . . . . 0.0 109.555 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.9 -36.73 80.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.55 ' H ' ' HG ' ' A' ' 179' ' ' CYS . 61.2 m -59.11 -39.33 81.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.591 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.9 t80 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.607 -179.908 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 m -48.11 137.73 10.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.39 -11.87 55.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -67.59 -1.86 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -1.154 . . . . 0.0 109.422 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -62.32 137.1 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -58.06 144.9 38.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.26 -32.81 73.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 109.533 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 143.1 78.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.06 -15.34 25.96 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.871 2.381 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.0 -43.06 99.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.22 -47.86 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.6 -46.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.29 92.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.11 -39.19 92.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.514 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 54.4 t-80 -55.27 -47.04 76.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.425 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.09 -42.36 38.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -58.88 -43.36 90.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 21' ' ' TRP . 87.9 mt-10 -146.55 -143.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' O ' ' A' ' 20' ' ' GLU . 35.3 t90 60.06 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.77 67.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -118.38 94.19 46.68 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.272 -1.134 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.04 131.27 21.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.766 2.311 . . . . 0.0 111.834 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.4 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.862 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.1 p -106.28 0.32 25.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.38 134.76 36.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -72.93 -31.72 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -64.7 -54.78 26.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -73.36 -49.75 25.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 109.893 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.2 -44.62 75.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.02 -42.41 98.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.954 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.515 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 36.5 tp10 -58.29 -31.51 67.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 109.78 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 tpp -63.67 -46.36 85.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.834 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.53 -47.21 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 110.01 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 14.2 p -60.04 -38.55 83.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.522 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 43.6 mt -66.08 -36.81 84.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.13 -0.981 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 65.3 mm-40 -60.18 -37.9 81.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.704 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.2 -36.05 7.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -66.09 -31.31 72.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -1.186 . . . . 0.0 109.794 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.533 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 7.9 tt0 -56.8 -31.73 64.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.736 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.72 109.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.98 -31.89 5.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.6 mp -104.73 -160.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -1.187 . . . . 0.0 109.422 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.2 m -125.44 152.96 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.542 ' CZ3' ' OE2' ' A' ' 38' ' ' GLU . 72.5 t-105 -54.19 -42.52 69.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.366 -0.833 . . . . 0.0 109.493 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -48.99 -39.74 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.68 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.52 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 52.9 m -71.92 -31.5 66.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 109.686 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ARG . 67.6 t -57.82 -30.8 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 109.438 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 4.1 mm? -52.87 -54.68 30.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.419 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.09 -45.89 89.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.351 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.85 -24.62 65.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' VAL . 33.2 ttt-85 -62.23 -47.33 84.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.22 -0.925 . . . . 0.0 109.032 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -44.51 84.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 109.337 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.49 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 12.5 m120 -70.28 -43.95 69.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 22.9 t80 -63.4 -37.31 86.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.474 -0.766 . . . . 0.0 109.332 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.77 -41.95 92.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.383 -0.823 . . . . 0.0 109.783 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 -21.43 59.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 55' ' ' ASN . 25.8 m -89.46 -11.97 41.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 110.266 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 83.3 m-85 -133.51 -50.91 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.113 . . . . 0.0 110.2 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -49.91 -42.83 48.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.913 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -59.32 -28.52 66.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 64' ' ' ASP . 90.8 m-85 -85.52 17.55 3.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.052 -1.03 . . . . 0.0 109.901 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 55.52 162.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 109.576 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.52 -54.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.884 2.389 . . . . 0.0 112.755 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 9.9 p -48.48 -44.61 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.703 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.512 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 80.6 tttt -58.12 -37.99 75.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.46 -38.96 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.083 -1.01 . . . . 0.0 109.63 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.06 -24.45 62.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.83 12.83 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.384 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.5 mtp -61.94 135.98 57.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -95.47 162.95 13.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CD ' HE22 ' A' ' 93' ' ' GLN . 75.6 mm-40 -57.86 -27.75 63.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -71.82 -29.02 63.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.11 -49.4 70.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 14.9 m -60.68 -37.64 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.58 -37.1 70.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' CG ' HH11 ' A' ' 78' ' ' ARG . 2.9 ttt-85 -65.25 -42.32 93.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.402 -0.811 . . . . 0.0 109.775 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.9 mt -67.12 -27.15 67.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.631 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.93 -28.42 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.712 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.79 -56.72 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 109.519 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 79' ' ' LEU . 53.1 t0 -99.07 169.89 9.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 73.77 73.59 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 109.416 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -77.95 33.18 1.7 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.501 ' O ' ' O ' ' A' ' 84' ' ' GLY . 16.0 pt -55.87 -159.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -1.12 . . . . 0.0 109.372 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.751 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 2.9 tt -55.86 -165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 109.515 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.751 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 8.0 mtt-85 -47.65 153.3 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -142.65 -156.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.176 -179.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 57.88 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.933 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -66.13 -44.19 91.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -61.59 -42.58 99.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -1.227 . . . . 0.0 109.5 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 mt -57.06 -47.29 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.555 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.534 HE22 ' CD ' ' A' ' 73' ' ' GLU . 15.5 mm100 -53.22 -36.99 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.35 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.355 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.586 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 81.4 mt -59.47 -50.0 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.91 -38.5 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.518 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.33 99.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 97.4 m-20 -69.44 -44.68 70.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.423 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.06 95.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.546 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -63.63 -43.93 95.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 109.531 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.99 -34.18 66.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.895 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.64 -51.29 63.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.31 -39.01 91.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -60.13 -42.84 95.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -61.98 -41.43 98.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.65 -27.01 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.127 -0.983 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -51.67 -20.38 2.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.506 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 110' ' ' GLU . 64.3 t30 -75.53 -18.45 59.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.83 65.16 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.517 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 12.0 mp0 -103.48 151.07 38.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.163 -1.198 . . . . 0.0 109.653 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.97 119.65 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.67 2.247 . . . . 0.0 111.676 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -74.88 -45.74 40.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 0.0 110.467 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -62.09 -47.95 82.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 110.734 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' O ' ' OG ' ' A' ' 118' ' ' SER . 18.4 t70 -55.8 -40.36 72.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.937 . . . . 0.0 111.036 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -64.72 -51.22 63.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.029 -1.045 . . . . 0.0 111.225 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.3 m -56.78 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.98 -1.075 . . . . 0.0 111.716 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.477 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -86.99 -32.82 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.775 -1.203 . . . . 0.0 111.134 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 120' ' ' VAL . 57.1 p -55.65 -21.03 16.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -44.04 -15.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.007 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.9 m -91.77 24.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.044 -1.035 . . . . 0.0 109.982 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.525 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 1.3 m120 72.56 -48.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 3.0 p-80 165.13 -20.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -106.31 149.3 38.06 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.6 149.17 67.58 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.696 2.264 . . . . 0.0 111.805 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -75.38 146.81 40.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.745 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 88.1 mtp -126.44 144.93 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.117 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.09 175.49 6.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -164.86 71.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.279 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.12 -132.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.734 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.9 m -154.22 -35.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -113.13 155.21 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.76 -30.27 70.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.501 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.0 p -70.74 -33.37 70.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.5 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.69 -24.89 67.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.5 mm -66.33 116.77 37.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.686 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.85 126.3 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.187 2.592 . . . . 0.0 112.538 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.453 ' OG1' ' CB ' ' A' ' 163' ' ' TYR . 2.0 t -77.2 -18.26 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.266 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.4 p -89.25 66.61 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.356 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -77.27 152.31 81.59 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.37 -36.02 16.92 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.8 2.333 . . . . 0.0 112.035 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.46 -41.51 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.1 m -59.65 -39.82 85.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -62.17 -48.32 80.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.82 78.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.528 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.7 p -63.26 -39.43 94.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.918 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.54 43.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.71 -33.44 75.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.564 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.44 -39.67 84.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.422 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -61.16 -39.93 91.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 152' ' ' ARG . 7.3 mtt-85 -64.43 -21.51 66.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.85 36.99 5.87 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.448 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 1.4 m-85 -84.79 133.51 34.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -1.112 . . . . 0.0 109.517 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.61 159.87 14.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.448 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 56.12 48.38 17.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 158' ' ' GLY . 10.7 p -121.82 26.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.457 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.51 156.3 0.07 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -59.88 -14.02 13.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -1.133 . . . . 0.0 109.448 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.6 p -70.86 -44.97 65.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.0 mt -65.07 -36.34 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.526 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 68.3 m -55.81 -40.81 73.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.321 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.453 ' CB ' ' OG1' ' A' ' 137' ' ' THR . 37.6 t80 -66.78 -47.26 72.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.405 -0.809 . . . . 0.0 109.314 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.7 m -66.05 -40.68 91.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.317 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.77 -49.38 77.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 92.6 mtp -68.94 -39.55 79.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.666 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.47 -41.89 99.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.734 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.58 97.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.678 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.4 m -66.06 -60.82 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 138.8 1.69 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.29 -33.34 72.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -1.167 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -99.74 130.1 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -98.76 105.06 17.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.29 114.23 26.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -135.51 143.18 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.44 142.5 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.441 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.435 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 89.05 15.63 58.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 178' ' ' GLY . 7.7 m -149.8 176.16 10.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 75.3 m 50.75 -97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.488 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 52.7 t -156.17 15.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.8 t80 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.641 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.338 0.59 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -48.13 167.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.99 9.23 1.54 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 21.6 m95 -83.13 -1.22 52.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.94 132.8 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' GLN . 68.4 m -79.64 177.94 8.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.4 mm-40 -61.03 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 51.54 85.06 0.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.01 -25.76 4.32 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.852 2.368 . . . . 0.0 112.1 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.91 -39.31 93.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.481 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -71.16 -48.11 53.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.12 -44.84 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.376 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.92 81.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -61.64 -43.96 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.18 -49.45 77.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.48 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.483 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -56.95 -56.36 22.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -175.25 131.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -159.64 123.05 3.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 109.516 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.98 -5.29 75.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' CYS . 19.3 t -63.4 132.09 95.02 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.209 -1.171 . . . . 0.0 109.343 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.03 120.47 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.777 2.318 . . . . 0.0 111.849 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.46 132.79 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.854 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -115.08 3.5 14.43 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 109.083 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.1 126.02 32.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 m -64.52 -40.44 95.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -60.93 -45.28 95.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.61 -45.01 69.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.895 . . . . 0.0 109.846 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.2 -43.93 96.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.118 -0.989 . . . . 0.0 109.808 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.49 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 44.9 t80 -60.52 -37.03 79.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.919 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.93 -30.55 63.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.878 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.9 tpp -64.45 -54.98 24.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.794 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -64.46 -33.32 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 110.045 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.5 m -64.44 -49.9 69.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 110.106 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.19 -28.38 59.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 109.805 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -52.82 -35.26 56.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 109.772 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.61 -33.88 74.03 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -59.05 -32.54 69.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -1.207 . . . . 0.0 109.763 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -52.87 -39.7 62.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.05 120.41 3.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -35.27 4.2 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.02 -138.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.137 . . . . 0.0 109.445 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -142.41 158.92 43.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -56.14 -39.36 72.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.474 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -59.12 -34.46 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.687 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.437 ' N ' HG21 ' A' ' 47' ' ' ILE . 61.1 m -69.39 -33.47 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.0 t -57.63 -43.16 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.442 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mp -56.7 -52.15 66.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.57 -44.69 93.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 109.307 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -73.25 -21.61 60.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.193 -0.942 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.8 ttm-85 -60.35 -46.05 91.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -71.13 -45.95 62.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.403 -0.811 . . . . 0.0 109.439 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.99 -35.0 79.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.609 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 25.3 t80 -62.78 -44.61 95.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.546 HH11 ' HG2' ' A' ' 57' ' ' ARG . 27.9 mtt-85 -57.0 -41.81 79.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.828 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -29.9 71.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.258 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 97.9 m -93.49 -12.6 29.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.262 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 61.8 m-85 -125.68 -43.27 1.88 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 0.0 110.181 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 29.9 t-80 -49.89 -40.14 42.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -61.85 -31.73 72.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.739 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.7 m-85 -91.34 -0.85 57.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.077 -1.014 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.05 161.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.107 -0.995 . . . . 0.0 109.623 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.47 -27.11 16.17 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.867 2.378 . . . . 0.0 112.713 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.5 -47.87 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.13 -35.35 80.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.11 -35.71 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 109.598 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.81 66.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.466 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 23.08 9.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 tpp -61.22 156.45 18.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.671 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -110.47 156.83 20.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.6 mt-10 -55.75 -35.06 65.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.94 -37.59 85.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.71 -49.5 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.3 mp0 -64.25 -32.74 74.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.28 -49.2 67.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.806 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.0 -41.18 67.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.605 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.9 t -51.1 -33.08 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.702 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -80.95 -59.79 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -98.96 117.11 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 77.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -22.91 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 84' ' ' GLY . 24.0 pt -62.29 -134.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.321 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.05 136.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -101.29 117.98 36.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.467 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -172.4 94.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.183 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -45.27 -35.43 3.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 109.967 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.33 -47.66 85.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -66.16 -38.12 87.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.25 -50.22 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.12 -32.99 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.326 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.26 99.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.388 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 95' ' ' ILE . 96.1 mt -60.06 -46.17 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.375 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 96' ' ' ILE . 95.6 mt -62.61 -36.45 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.63 94.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.623 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 13.9 m120 -60.17 -42.52 95.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.66 89.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.512 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -61.23 -44.33 97.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.29 72.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 30.1 t80 -66.93 -43.72 82.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.93 -50.51 62.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -59.9 -35.0 73.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ttt -59.16 -40.96 87.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.29 -27.75 66.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.482 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -51.66 -34.05 36.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -83.4 -1.19 52.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.39 35.92 40.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -116.84 82.16 12.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.657 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -41.67 131.31 3.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.634 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.06 -47.74 83.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -45.45 80.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 110.718 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -59.22 -33.21 70.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 111.034 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.3 t80 -65.26 -53.43 44.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.023 -1.048 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 m -58.02 -40.99 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.719 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -68.56 -31.12 70.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.719 -1.238 . . . . 0.0 111.104 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -65.15 -34.78 79.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 109.676 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -58.72 -44.2 90.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.084 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.71 20.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.079 -1.013 . . . . 0.0 110.006 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.62 30.48 18.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 55.45 22.88 5.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -123.39 100.98 38.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.626 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -47.38 139.45 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.728 2.286 . . . . 0.0 111.855 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -85.5 157.38 20.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -131.85 151.3 51.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 109.183 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -131.58 152.52 50.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -133.96 45.67 2.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.324 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.52 147.06 52.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.2 m -74.08 -36.26 64.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.4 m -132.56 157.58 44.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.555 ' H ' ' CD1' ' A' ' 132' ' ' LEU . 6.0 mp -54.29 -32.34 56.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.2 t -64.93 -33.83 76.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.34 -19.12 63.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 109.367 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -66.85 124.2 88.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 109.676 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.36 127.24 5.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.143 2.562 . . . . 0.0 112.552 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 -13.79 47.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.304 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -109.15 100.64 9.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 109.374 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -105.51 150.75 39.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.917 . . . . 0.0 109.462 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.96 -41.1 26.01 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.789 2.326 . . . . 0.0 111.982 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.65 -36.91 60.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.3 m -60.9 -43.24 98.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -61.96 -48.07 82.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.21 89.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.22 -41.39 99.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.2 p -57.88 -43.36 85.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.7 -27.68 68.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.502 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.48 -51.33 29.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.42 -36.17 73.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.567 ' HZ1' ' CB ' ' A' ' 150' ' ' LYS . 3.1 ttmp? -57.62 -36.6 72.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.34 -40.1 92.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -67.51 -19.74 65.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.413 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.92 22.25 16.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.623 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 8.0 m-85 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -1.107 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -101.79 168.52 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.501 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 54.05 53.13 11.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.28 25.16 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.419 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.41 167.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -55.47 -32.18 62.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.436 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 65.9 p -64.38 -47.78 77.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -65.7 -35.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 5.9 t -68.7 -44.13 74.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.259 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -62.23 -44.97 95.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.7 m -57.99 -37.18 73.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.222 -0.924 . . . . 0.0 109.248 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.617 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 72.4 t80 -59.73 -41.36 90.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.398 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.12 -38.57 72.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.504 HE22 ' CG ' ' A' ' 174' ' ' ASP . 98.1 mm-40 -63.34 -46.45 86.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.7 -44.63 49.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.617 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 98.3 m -62.44 -36.13 81.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.462 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.28 8.8 56.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.8 mp -53.41 -26.82 21.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -1.152 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.06 138.61 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.449 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -82.12 102.37 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.504 ' CG ' HE22 ' A' ' 167' ' ' GLN . 34.4 m-20 -91.56 118.17 30.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.56 166.0 28.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.621 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.27 150.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.29 130.23 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 91.2 4.71 68.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 181' ' ' CYS . 53.5 t -76.34 28.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.542 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.484 ' H ' ' C ' ' A' ' 178' ' ' GLY . 3.2 m 63.04 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 179' ' ' CYS . 73.3 m -59.47 -35.35 73.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 7.0 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.613 ' HG2' HH11 ' A' ' 3' ' ' ARG . 10.2 mtt-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' A' ' 6' ' ' TRP . 26.6 p -47.23 127.29 10.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.94 -6.27 3.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.455 ' H ' ' C ' ' A' ' 4' ' ' CYS . 16.9 m95 -54.53 -37.0 64.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.423 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -88.76 127.15 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.564 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' GLN . 75.2 m -165.86 146.46 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.0 mm100 60.32 133.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.552 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' GLN . 1.1 m-20 63.0 125.11 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.26 -7.71 19.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.845 2.364 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.49 -32.86 72.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.55 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 30.8 m-85 -49.47 -44.23 45.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.78 -28.42 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.424 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -58.97 -48.23 82.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.429 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.559 ' CG ' ' N ' ' A' ' 17' ' ' HIS . 2.2 p90 -75.52 -39.09 58.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.559 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 48.3 t-80 -60.85 -48.21 82.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.42 -44.86 67.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 98.4 m-20 -55.28 -45.45 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.3 pt-20 -173.52 -143.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.595 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 11.0 t-105 60.6 125.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.03 -20.28 46.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 169' ' ' CYS . 26.3 m -84.66 141.36 38.64 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.17 -1.194 . . . . 0.0 109.33 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.87 122.85 4.48 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.758 2.306 . . . . 0.0 111.905 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -119.6 131.98 55.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.02 . . . . 0.0 109.857 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -123.21 5.5 9.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.88 135.01 33.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -69.63 -39.36 77.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.603 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.47 -43.59 88.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 109.717 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -65.94 -49.64 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.86 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.9 mt -72.91 -29.96 63.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.873 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' ' N ' ' A' ' 33' ' ' GLU . 9.2 t80 -59.98 -56.39 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.0 pp20? -68.58 -29.72 68.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.595 ' SD ' ' CH2' ' A' ' 21' ' ' TRP . 55.2 tpp -63.61 -53.36 52.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.88 -46.78 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 110.05 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.9 t -70.34 -39.17 74.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.4 tp -73.34 -38.37 65.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.438 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 35.0 mm-40 -52.76 -34.54 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.24 -23.66 41.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.2 -38.01 86.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.176 . . . . 0.0 109.783 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -48.75 -38.93 23.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.786 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.53 106.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.662 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -31.26 6.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.4 mm? -86.03 -165.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -1.192 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' ' 48' ' ' THR . 15.6 p -117.36 150.64 38.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -56.21 -36.65 68.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -30.77 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.707 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.686 ' H ' ' HG ' ' A' ' 45' ' ' SER . 52.4 m -67.64 -40.46 84.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.679 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' ARG . 70.4 t -68.91 -40.89 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -57.05 -47.25 81.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -60.79 -51.45 69.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 109.297 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.48 -26.31 67.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.7 tmm_? -54.47 -46.63 73.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.38 -34.48 76.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.259 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -63.76 -45.8 88.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -0.789 . . . . 0.0 109.327 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 79.3 mtm180 -62.29 -30.63 71.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.864 . . . . 0.0 109.732 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.66 82.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.881 . . . . 0.0 110.276 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -93.77 -13.33 27.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.27 -178.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -113.76 -52.33 2.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.913 -1.117 . . . . 0.0 110.175 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.424 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.9 t-80 -51.94 -40.0 60.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 109.91 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -56.55 -32.5 65.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-85 -88.67 -2.83 58.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 109.883 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER 56.2 158.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.08 -24.04 20.85 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.893 2.396 . . . . 0.0 112.728 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.39 -48.24 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' MET . 12.2 mptt -67.88 -33.7 75.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.1 t -56.16 -41.22 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.029 . . . . 0.0 109.551 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.11 68.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.46 17.7 20.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.399 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ttp -75.81 155.43 35.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.68 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -105.48 162.53 13.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.96 -30.07 70.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.32 -41.32 84.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -60.93 -39.83 90.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.36 -42.51 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -60.15 -34.06 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.622 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.41 -44.55 82.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 13.9 mt -65.04 -33.4 75.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.932 . . . . 0.0 109.626 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.79 -31.99 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -84.88 -60.89 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.552 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.23 123.73 43.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.371 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -166.11 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.78 27.18 57.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ARG . 9.9 pt -133.0 167.38 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.138 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.71 58.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.623 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -106.69 139.79 40.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.471 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' GLY . 14.3 p80 -128.8 44.19 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.146 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.546 HH11 ' HG2' ' A' ' 89' ' ' ARG . 3.9 ttt-85 65.67 -58.54 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -60.82 -35.35 89.94 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -61.27 -50.98 70.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -1.167 . . . . 0.0 109.461 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -52.39 -39.51 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.691 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.53 -36.63 76.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.0 109.32 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.14 95.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.7 mp -55.54 -47.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -58.46 -30.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.551 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.23 94.83 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.728 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 29.0 p30 -68.63 -33.35 73.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 109.358 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.728 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -67.4 -42.25 83.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -65.23 -45.95 82.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.585 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.72 63.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 29.8 t80 -68.83 -43.44 75.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -47.96 71.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.474 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -57.97 -39.58 78.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 17.2 ttt -66.74 -41.24 88.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.85 -25.94 68.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -51.28 -29.28 14.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 51.0 p30 -80.16 -1.48 40.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.489 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.66 79.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 108' ' ' ASN . 32.4 tt0 -80.76 132.98 56.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.158 -1.201 . . . . 0.0 109.627 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.47 121.27 8.03 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.614 2.21 . . . . 0.0 111.726 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -74.72 -43.86 52.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.393 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.405 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -56.06 -49.99 72.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -0.967 . . . . 0.0 110.708 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 86.5 m-20 -61.23 -42.7 99.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 27.5 t80 -55.31 -48.62 73.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 111.213 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 117' ' ' TRP . 4.7 m -63.82 -48.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 0.0 111.721 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.488 ' CD2' ' N ' ' A' ' 118' ' ' SER . 4.3 p-90 -89.32 -37.49 14.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.769 -1.207 . . . . 0.0 111.117 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.4 m -56.18 -26.88 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.781 -1.199 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -13.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.04 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 118' ' ' SER . 18.7 m -82.8 21.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t30 60.36 36.22 20.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.061 -1.024 . . . . 0.0 109.703 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.2 m80 53.54 27.08 6.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.47 87.91 21.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.72 151.78 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.695 2.263 . . . . 0.0 111.842 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -93.44 155.16 17.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.719 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 71.6 mtm -137.15 147.17 45.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.198 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.5 t -142.18 155.82 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.801 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -123.61 45.61 2.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.289 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.2 139.5 35.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.2 m -74.56 -35.52 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.702 ' HG1' ' H ' ' A' ' 132' ' ' LEU . 1.8 t -139.45 178.92 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.397 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.702 ' H ' ' HG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -68.84 -33.4 73.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.543 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m -63.12 -36.42 83.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.81 -24.44 64.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.161 -0.962 . . . . 0.0 109.404 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.411 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 87.4 mt -67.28 119.95 68.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.728 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.76 129.22 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.088 2.526 . . . . 0.0 112.487 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.401 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 1.2 t -80.62 -19.19 45.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.4 m -98.05 98.54 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.858 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.446 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 4.5 p -106.23 154.61 39.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.32 -40.12 52.85 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.839 2.36 . . . . 0.0 111.999 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.16 -36.48 58.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.407 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.446 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 73.8 m -61.19 -41.3 96.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 -53.13 57.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.27 -35.26 79.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.435 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.01 -50.19 74.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 80.5 p -58.5 -37.69 76.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.91 -36.08 82.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.549 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.31 -50.56 45.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.467 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.603 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.88 -38.82 79.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.355 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -61.92 -39.37 91.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -63.84 -20.54 65.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.92 31.01 8.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.47 137.95 32.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.132 . . . . 0.0 109.454 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -101.19 173.58 6.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.485 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 52.82 50.79 17.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 158' ' ' GLY . 11.3 p -123.68 28.79 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.21 159.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.8 t -52.46 -29.81 26.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.373 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.5 m -65.9 -36.84 84.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.446 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.9 mm -62.24 -44.09 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.22 -48.7 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.411 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 42.9 t80 -60.21 -47.01 87.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.811 . . . . 0.0 109.352 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.438 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 22.6 t -61.64 -43.35 99.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.857 . . . . 0.0 109.27 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.411 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -63.08 -32.63 74.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.47 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 31.5 ttm -64.29 -45.13 89.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.609 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.81 -34.1 77.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.672 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.659 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.2 m -77.2 -42.5 37.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.65 28.77 5.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.72 -34.33 77.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.41 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.69 132.15 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -84.64 100.95 11.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 45.6 p-10 -120.64 92.62 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 176' ' ' VAL . 75.5 m80 -132.99 36.35 3.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' ' 177' ' ' VAL . 86.3 t 54.39 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.452 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.52 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 8.1 p -110.61 136.23 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.75 24.13 75.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 181' ' ' CYS . 66.4 m -143.73 169.9 16.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 109.523 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 84.5 m 48.3 -93.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 179' ' ' CYS . 50.0 m -157.92 33.09 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 7.9 p -47.39 146.02 2.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.66 2.87 46.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -54.22 -36.56 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -1.135 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 m -97.01 131.14 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 13.0 t -177.31 -168.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.547 ' N ' ' OG ' ' A' ' 8' ' ' SER . 94.9 mt-30 49.38 -117.93 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.85 153.44 91.17 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.352 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.46 -6.14 18.28 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.804 2.336 . . . . 0.0 112.139 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.82 -39.52 85.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -56.47 -43.73 79.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.408 HD11 HG23 ' A' ' 14' ' ' ILE . 89.0 mt -67.43 -43.95 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.51 76.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.39 -40.15 93.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -63.42 -37.42 87.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -88.41 -4.41 58.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.513 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.522 HD21 HH22 ' A' ' 53' ' ' ARG . 48.0 t30 -74.09 -73.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -150.93 38.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.479 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -92.77 138.83 31.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.02 -21.39 44.18 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.58 132.44 72.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.247 -1.149 . . . . 0.0 109.366 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.48 119.69 6.28 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.724 2.282 . . . . 0.0 111.87 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.67 137.25 41.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -134.54 2.59 3.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.071 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -89.66 135.19 33.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.375 -0.828 . . . . 0.0 109.303 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.58 ' HG ' ' HH ' ' A' ' 102' ' ' TYR . 96.2 p -59.94 -38.28 81.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.632 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -57.02 -43.82 82.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.766 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.37 -53.31 24.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.03 -27.89 66.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.783 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 56.1 t80 -60.36 -50.53 73.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.928 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -74.44 -31.11 62.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.813 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.89 -54.39 22.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -64.4 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.032 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.489 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 36.1 t -73.36 -46.6 48.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.16 -0.962 . . . . 0.0 110.088 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.1 -41.67 97.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.877 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.22 -28.59 64.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.296 -0.878 . . . . 0.0 109.788 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.75 -37.07 27.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -66.07 -29.0 69.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -1.184 . . . . 0.0 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.4 tt0 -48.11 -34.22 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.72 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.42 111.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -33.12 5.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.0 mt -96.06 -145.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -1.14 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 m -144.68 155.97 43.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -51.17 -38.95 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.374 -0.829 . . . . 0.0 109.461 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 48' ' ' THR . 9.7 tp -61.94 -40.44 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 109.672 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 96.1 m -63.91 -35.87 82.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 53' ' ' ARG . 72.9 t -62.06 -42.82 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.473 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.43 -51.06 69.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -60.37 -44.08 95.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 109.348 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -75.78 -19.35 59.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.975 . . . . 0.0 109.361 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.522 HH22 HD21 ' A' ' 19' ' ' ASN . 43.8 ttp180 -61.22 -45.65 93.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 108.994 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 10.2 pt-20 -72.15 -43.0 65.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.34 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.95 -35.29 79.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.229 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 52.7 t80 -57.39 -49.27 76.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.427 -0.795 . . . . 0.0 109.308 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.4 mtp180 -58.42 -43.12 88.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.741 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.97 -39.81 42.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.793 . . . . 0.0 110.305 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -96.78 -28.63 14.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 35.4 m-85 -95.71 -27.75 15.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.977 -1.077 . . . . 0.0 110.231 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.7 t60 -48.77 -21.66 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -90.87 -25.61 19.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.81 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.459 ' O ' ' C ' ' A' ' 64' ' ' ASP . 61.9 m-85 -92.03 66.09 4.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 109.925 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' PHE . 3.7 m-20 -41.33 153.77 0.24 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 109.604 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -35.92 -53.66 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.852 2.368 . . . . 0.0 112.722 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.31 -45.11 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.64 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -67.35 -31.67 72.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.853 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.9 t -56.45 -46.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.572 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.81 58.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.48 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 -3.58 58.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 mtp -70.97 141.1 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.459 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 31.1 tp60 -99.85 169.15 9.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 78.7 mm-40 -61.84 -33.87 74.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 46.7 mp0 -60.84 -40.89 94.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.437 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -62.74 -37.76 87.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.41 -43.29 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.48 -33.47 75.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.97 -44.76 91.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.314 -0.866 . . . . 0.0 109.792 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -70.07 -35.48 74.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 109.591 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.1 t -51.19 -34.94 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.739 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -87.83 -60.13 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.614 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -100.17 109.23 21.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.903 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.47 -60.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.47 4.61 70.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.9 pt -90.02 -155.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.32 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.2 mt -68.62 136.79 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.478 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 87' ' ' ARG . 19.7 mmm-85 -88.6 95.89 10.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -172.41 88.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.13 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -49.96 -29.12 7.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.04 96.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -63.05 -48.19 79.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -1.186 . . . . 0.0 109.479 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.83 -44.13 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.598 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -54.51 -38.62 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.327 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.02 79.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.1 mm -57.69 -46.66 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.432 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.7 mp -55.18 -43.74 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.06 -36.23 85.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.602 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 16.5 t30 -56.87 -48.16 78.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.72 93.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.428 ' HG3' ' NH1' ' A' ' 100' ' ' ARG . 46.2 ttm-85 -66.56 -45.16 80.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.525 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.73 -36.06 67.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.58 ' HH ' ' HG ' ' A' ' 28' ' ' SER . 43.0 t80 -71.08 -47.6 57.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.61 -37.79 85.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.865 . . . . 0.0 109.534 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.53 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.601 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 28.2 ttt -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.529 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.35 -27.19 67.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -52.11 -24.08 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.49 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -75.54 -18.12 59.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.8 7.43 68.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.59 150.28 38.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.205 -1.174 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.99 119.17 6.18 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.621 2.214 . . . . 0.0 111.693 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -74.57 -44.91 48.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.803 . . . . 0.0 110.404 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.58 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.201 -0.937 . . . . 0.0 110.732 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 83.2 m-20 -56.23 -43.59 78.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.204 -0.935 . . . . 0.0 111.081 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -61.93 -51.31 68.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 111.227 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.406 HG21 ' N ' ' A' ' 117' ' ' TRP . 6.7 m -57.97 -47.37 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 111.722 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -87.6 -28.04 22.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.696 -1.253 . . . . 0.0 111.178 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -59.61 -23.9 63.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 109.709 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -43.85 -19.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.08 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.7 m -82.9 22.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.087 -1.008 . . . . 0.0 109.954 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 58.22 36.92 26.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.0 109.67 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.1 m80 60.27 15.23 5.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.531 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -111.83 128.1 25.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.628 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.57 147.89 41.42 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.672 2.248 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -98.5 144.5 27.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 109.751 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.4 ttp -132.07 135.06 46.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.784 . . . . 0.0 109.097 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 t -85.5 156.08 20.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.897 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -151.06 48.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.855 . . . . 0.0 109.3 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.82 -155.81 0.53 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.662 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.521 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.2 m -130.88 -54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.541 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.0 m -98.04 161.11 13.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.429 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.53 -11.16 59.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 t -89.72 -39.04 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 131' ' ' THR . 11.2 pt-20 -68.66 -13.31 62.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 79.1 mt -67.43 118.41 56.44 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.52 131.29 5.49 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.047 2.498 . . . . 0.0 112.536 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -91.39 -11.85 36.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.9 t -92.88 99.04 11.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.3 p -110.18 151.56 42.63 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -45.71 -40.79 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.815 2.343 . . . . 0.0 112.011 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.24 76.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -61.66 -42.2 98.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.863 . . . . 0.0 109.494 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -61.06 -44.46 97.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.65 -43.61 68.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.4 -49.56 77.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.7 m -54.12 -43.61 70.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.76 -38.14 84.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.11 -49.87 66.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.5 -34.94 74.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.878 . . . . 0.0 109.564 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -60.55 -36.79 79.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -60.76 -37.88 83.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.24 -21.32 63.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.283 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.77 4.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -97.51 129.92 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -92.97 167.16 11.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 51.54 48.31 23.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.7 p -121.63 25.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.45 165.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.8 t -56.87 -29.88 63.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -1.156 . . . . 0.0 109.442 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 m -59.77 -47.56 85.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 73.3 m -61.04 -42.89 99.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -60.31 -44.58 95.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.46 -0.775 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.512 ' HG ' ' N ' ' A' ' 165' ' ' PHE . 82.5 p -61.98 -36.71 82.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.512 ' N ' ' HG ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.39 -42.45 83.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 56.8 mtp -61.36 -39.24 89.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -61.69 -47.12 86.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.17 -38.98 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.98 -14.18 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.42 0.04 77.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.3 mp -63.04 -39.92 96.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.07 131.56 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.501 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -95.66 117.98 31.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.443 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.15 105.15 17.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -145.89 144.5 30.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.67 137.08 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.13 134.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.22 3.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.533 ' C ' ' H ' ' A' ' 181' ' ' CYS . 34.8 m -98.66 173.72 6.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -1.152 . . . . 0.0 109.534 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 54.1 m 54.45 5.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.443 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.533 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.3 m 62.8 50.19 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.602 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 23.9 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' A' ' 3' ' ' ARG . 45.1 mtm-85 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.544 ' C ' ' H ' ' A' ' 6' ' ' TRP . 16.3 p -96.39 -176.14 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.39 -24.83 0.9 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 11.4 m0 53.13 55.68 8.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -59.84 -5.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 6' ' ' TRP . 52.6 m -47.22 114.33 0.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 109.418 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -167.84 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -151.55 150.89 27.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.0 -36.97 16.75 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.896 2.397 . . . . 0.0 112.145 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.44 -51.25 66.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.443 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -70.08 -45.12 67.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 109.379 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.9 mt -59.81 -42.37 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.347 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.94 -47.1 69.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -59.85 -44.7 93.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CE1' ' CE3' ' A' ' 21' ' ' TRP . 19.9 t60 -62.6 -45.54 92.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.27 -22.25 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.19 -75.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -145.15 113.8 6.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.873 . . . . 0.0 109.52 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CE3' ' CE1' ' A' ' 17' ' ' HIS . 62.3 t90 -172.99 139.61 0.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -29.84 3.1 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 169' ' ' CYS . 3.7 m -68.02 149.19 98.27 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.232 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.99 128.25 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.805 2.337 . . . . 0.0 111.891 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 78.5 mm-40 -124.99 130.67 52.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -123.13 12.21 9.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.072 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.3 136.8 35.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.0 p -73.16 -33.61 65.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.07 -51.57 60.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 25' ' ' GLU . 8.9 mtpm? -62.79 -46.39 88.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 109.861 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.42 -37.21 80.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 109.834 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -65.15 -51.32 61.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.12 -32.55 73.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.1 tpt -59.36 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.806 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.29 -39.06 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.7 m -65.7 -45.29 83.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.54 -41.23 66.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.13 -34.17 73.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.38 -36.18 88.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.83 -26.63 64.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -1.191 . . . . 0.0 109.748 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -51.47 -26.07 7.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.698 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.09 109.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.95 -33.42 5.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 mt -97.36 175.18 6.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -1.175 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.8 m -100.94 161.79 13.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 45.2 p90 -55.48 -41.29 72.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.862 . . . . 0.0 109.446 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 8.7 tp -57.97 -38.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.724 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.3 m -64.69 -37.95 89.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.694 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.43 -42.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.466 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.99 -42.49 85.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -61.72 -51.5 68.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 11.5 mptt -65.75 -36.58 83.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -47.15 -42.65 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.194 -0.941 . . . . 0.0 109.006 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -70.17 -42.48 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -63.43 -47.46 81.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.266 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CD2' ' CE1' ' A' ' 60' ' ' PHE . 12.3 m-85 -58.68 -49.27 78.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 17.9 mmm180 -53.3 -27.75 24.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.35 -29.43 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 56' ' ' TYR . 16.7 m-85 -81.73 -51.75 7.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.945 -1.097 . . . . 0.0 110.205 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 53.1 t60 -51.62 -42.3 61.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.829 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -73.67 -14.58 61.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CE2' ' SD ' ' A' ' 71' ' ' MET . 16.3 t80 -93.3 2.83 56.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.007 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.93 159.2 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.024 . . . . 0.0 109.598 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.2 -53.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.886 2.391 . . . . 0.0 112.707 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.1 t -48.17 -41.95 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.717 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -64.74 -34.57 78.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.382 -0.824 . . . . 0.0 109.883 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.93 -40.55 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.614 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -70.68 -32.94 70.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 109.452 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.04 18.57 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.603 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -75.36 155.2 36.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.689 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.442 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.8 tp60 -102.63 167.54 9.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 96.4 mt-10 -70.05 -25.92 63.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.2 -30.99 67.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.465 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.27 -49.7 68.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 8.5 m -59.65 -37.88 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.9 mt-10 -58.99 -35.98 74.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.3 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -65.72 -40.2 91.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.16 -34.28 77.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.9 -35.49 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -87.06 -62.03 1.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -101.34 107.08 18.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.61 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.85 14.38 65.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 pt -104.09 178.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.391 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.51 140.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.455 ' HG3' HH11 ' A' ' 87' ' ' ARG . 44.0 mtm-85 -87.81 101.81 14.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.52 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.723 ' HD1' ' H ' ' A' ' 91' ' ' LYS . 49.2 t-80 -171.54 82.04 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.218 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 15.3 ptm180 -46.84 -30.46 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.83 93.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.723 ' H ' ' HD1' ' A' ' 88' ' ' HIS . 62.3 mttp -66.11 -42.62 88.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.6 mt -63.64 -49.55 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.37 -35.6 67.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.375 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.3 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.98 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 96' ' ' ILE . 77.8 mt -55.06 -39.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.539 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.69 95.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.481 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 3.0 m120 -63.26 -43.83 96.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -1.204 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.06 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 47.6 ttm-85 -58.46 -41.75 85.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.21 70.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.87 -48.46 81.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -61.75 -44.72 96.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.6 -44.26 93.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.604 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 23.7 ttt -67.11 -32.54 73.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.48 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.91 -29.25 69.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -52.29 -24.75 7.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.15 -18.7 59.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.492 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.8 55.11 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -116.85 150.8 46.46 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -1.181 . . . . 0.0 109.691 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.21 130.86 26.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.618 2.212 . . . . 0.0 111.659 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -79.25 -49.21 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.475 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -55.77 -48.92 74.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.533 ' O ' ' OG ' ' A' ' 118' ' ' SER . 85.3 m-20 -60.0 -43.63 95.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 111.053 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.59 -50.92 70.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.067 -1.021 . . . . 0.0 111.188 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 117' ' ' TRP . 4.6 m -59.31 -48.45 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.096 -1.003 . . . . 0.0 111.64 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.474 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.0 p-90 -88.88 -33.38 17.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 0.0 111.147 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 120' ' ' VAL . 66.8 m -55.08 -26.44 37.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.793 -1.192 . . . . 0.0 109.752 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.32 -14.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 118' ' ' SER . 12.9 m -85.07 27.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.046 -1.034 . . . . 0.0 109.983 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 75.78 19.0 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.747 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 58.72 39.65 24.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -146.05 146.77 29.56 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.636 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.86 147.56 44.35 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.691 2.261 . . . . 0.0 111.814 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -111.21 153.72 25.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 58.2 ttm -133.26 148.83 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -122.52 164.84 17.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.437 ' CG ' ' HH ' ' A' ' 182' ' ' TYR . 90.7 mt-30 -133.41 49.68 2.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.308 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.52 -158.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.521 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 11.7 m -145.34 -27.48 0.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.545 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 8.9 m -127.73 157.98 38.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.556 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -75.22 -12.79 60.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.2 m -93.0 -32.53 14.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 131' ' ' THR . 5.6 pt-20 -74.11 -1.42 20.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.925 . . . . 0.0 109.428 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 135' ' ' ILE . 28.9 mm -66.9 130.85 93.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.77 126.24 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.096 2.531 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.418 ' O ' ' CG2' ' A' ' 137' ' ' THR . 3.1 m -89.77 -10.57 45.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.9 . . . . 0.0 109.342 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 72.2 p -94.13 102.26 14.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 p -119.11 149.9 47.92 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.53 -31.84 87.67 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.17 58.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.45 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 42.9 t -62.08 -46.33 89.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.469 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -61.67 -46.23 90.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.57 84.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.67 -47.11 82.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.0 t -54.5 -45.09 73.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -60.62 -33.33 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.547 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.24 16.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.7 mp -60.15 -34.75 73.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.575 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -58.15 -34.97 70.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.43 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -62.66 -36.31 82.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.627 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -72.14 -19.88 61.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.357 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.56 30.11 7.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.481 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 5.1 m-85 -86.29 132.67 33.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -1.108 . . . . 0.0 109.474 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -104.79 177.86 4.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 52.8 47.94 23.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 158' ' ' GLY . 26.9 m -116.32 25.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.58 166.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.0 m -54.01 -32.54 54.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.3 p -65.09 -48.04 75.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -66.31 -39.29 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.45 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 7.9 t -68.58 -44.31 74.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.5 -42.03 98.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -59.27 -33.47 71.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.245 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.598 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 79.4 t80 -65.77 -35.45 80.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.397 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.2 mmm -63.32 -52.2 62.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.85 -38.0 85.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.45 -54.19 49.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.675 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.598 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 8.7 m -66.29 -33.23 75.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.01 35.38 6.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -74.05 -41.39 61.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.425 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.0 m -96.56 134.27 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.491 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -88.66 110.04 20.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -84.57 122.42 29.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -142.38 165.55 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.601 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 4.8 m -122.65 164.11 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 0.0 109.414 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.21 133.38 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.502 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 72.2 29.48 66.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 178' ' ' GLY . 3.3 m -164.64 178.74 7.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.46 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 43.6 t 51.03 -98.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 7.7 m -162.91 27.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.645 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.605 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.332 0.587 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 m -140.94 71.37 1.36 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -139.88 -5.67 1.19 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 19.8 m95 49.53 11.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.411 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 5' ' ' GLY . 28.8 m -62.25 140.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -168.32 36.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.349 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 70.0 tp60 -142.76 110.03 5.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 6.3 t70 61.71 134.51 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.28 -10.17 23.87 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.819 2.346 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.34 -41.58 98.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -69.65 -41.57 75.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 14' ' ' ILE . 1.8 mp -60.8 -51.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.424 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -46.97 65.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.429 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' OH ' ' CZ3' ' A' ' 21' ' ' TRP . 60.5 t80 -61.55 -43.83 98.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.0 -39.96 94.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -88.16 -0.11 56.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -75.19 -78.91 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.835 . . . . 0.0 109.407 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -147.06 40.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CZ3' ' OH ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -103.89 145.47 30.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.57 62.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' CYS . 1.2 m -84.67 152.26 59.72 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.226 -1.161 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 121.13 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.727 2.285 . . . . 0.0 111.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 78.4 mm-40 -123.8 135.92 54.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.9 p -126.75 12.33 7.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.281 -0.887 . . . . 0.0 109.055 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.88 134.44 47.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.385 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 83.4 p -72.44 -37.9 68.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -67.8 -34.57 77.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 0.0 109.804 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 25' ' ' GLU . 30.6 ttmt -75.23 -54.29 7.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 8.5 mp -66.57 -37.28 84.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.856 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 51.0 t80 -61.17 -42.73 99.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.938 . . . . 0.0 109.904 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.2 -29.51 64.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.599 ' SD ' ' CH2' ' A' ' 46' ' ' TRP . 49.9 tpp -74.46 -54.28 7.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.783 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.18 -37.74 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.043 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 15.0 p -73.16 -46.28 51.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 61.9 tp -73.28 -34.99 66.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -0.99 . . . . 0.0 109.932 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.439 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 43.2 tp10 -52.13 -28.66 18.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.69 51.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -62.36 -32.41 73.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 109.754 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.493 HE22 ' HG ' ' A' ' 164' ' ' SER . 50.2 tt0 -50.21 -35.07 24.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.705 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.43 116.84 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.42 -20.2 49.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.48 -144.34 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -1.205 . . . . 0.0 109.414 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.7 t -146.4 151.22 37.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 72.6 t-105 -55.35 -28.47 54.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -54.05 -37.89 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.727 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 18.8 m -85.26 -33.84 22.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 109.657 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -61.06 -36.99 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.63 -54.05 46.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.1 -49.96 75.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.262 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -65.51 -33.33 75.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 53' ' ' ARG . 28.0 ttt-85 -48.97 -43.71 40.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.14 -40.62 86.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -66.36 -40.84 90.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.288 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' OH ' ' CG2' ' A' ' 86' ' ' ILE . 4.5 m-85 -56.22 -48.61 76.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 84.7 mtm180 -64.74 -27.08 68.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 0.0 109.81 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.1 94.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.9 m -94.45 -40.79 9.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.3 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.74 -52.01 16.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 0.0 110.224 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 39.2 t60 -50.94 -38.28 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.899 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -54.32 -36.98 64.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.12 -0.988 . . . . 0.0 109.811 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' ASP . 86.9 m-85 -97.54 3.71 50.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.883 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.92 161.44 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.096 -1.003 . . . . 0.0 109.569 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.12 -26.37 21.42 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.885 2.39 . . . . 0.0 112.694 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.6 t -62.68 -48.81 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.734 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' MET . 89.2 mttt -67.17 -31.79 72.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.32 -41.37 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 109.606 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.96 62.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.507 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.24 3.06 51.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.3 mtp -66.2 136.67 56.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.617 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -92.12 168.12 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 57.4 mp0 -59.23 -29.7 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.462 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.4 -44.35 88.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.5 -37.52 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.82 -44.02 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -35.72 76.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -60.56 -41.5 94.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 109.736 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 82' ' ' ASP . 92.1 mt -72.73 -31.92 65.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.175 -0.953 . . . . 0.0 109.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.83 -31.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.938 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -84.29 -59.27 2.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.978 . . . . 0.0 109.568 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 79' ' ' LEU . 21.3 t70 -96.33 148.27 22.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.897 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 74.09 71.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.406 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -89.24 30.59 5.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' O ' ' A' ' 86' ' ' ILE . 4.9 pt -45.75 117.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.31 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.749 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 3.5 tt 38.63 -168.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.504 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.749 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -52.16 152.56 3.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -141.91 -162.9 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 109.184 -178.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.634 ' H ' ' CD1' ' A' ' 92' ' ' ILE . 56.7 ttt180 62.37 -77.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 109.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -71.86 -48.07 29.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.21 -38.6 87.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.634 ' CD1' ' H ' ' A' ' 89' ' ' ARG . 52.5 mt -55.07 -46.64 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 109.648 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.428 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.57 82.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 95' ' ' ILE . 96.8 mt -67.8 -38.79 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.5 mt -54.22 -46.59 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.18 -36.1 92.49 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.541 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -60.96 -49.08 78.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -1.23 . . . . 0.0 109.422 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.89 89.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -64.62 -46.83 80.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.25 69.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.421 ' CD1' ' CE1' ' A' ' 32' ' ' PHE . 77.2 t80 -64.64 -46.81 80.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 109.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.05 -40.65 98.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -57.45 -42.51 82.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 25.5 ttt -71.09 -33.26 70.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.548 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.69 -30.77 71.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -51.4 -25.91 6.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 109.548 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -76.47 -16.65 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.01 41.65 47.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -129.79 151.11 77.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.186 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.2 125.7 15.06 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.592 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 23.9 t80 -72.99 -44.1 61.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.42 -0.8 . . . . 0.0 110.417 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.98 -48.85 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.742 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 118' ' ' SER . 87.2 m-20 -52.16 -38.38 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 111.102 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -72.7 -49.87 28.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 111.244 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.425 HG13 ' H ' ' A' ' 117' ' ' TRP . 1.4 p -55.45 -49.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.01 -1.056 . . . . 0.0 111.696 -175.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.425 ' H ' HG13 ' A' ' 116' ' ' VAL . 15.8 p-90 -87.01 -24.38 24.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.709 -1.244 . . . . 0.0 111.147 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' VAL . 7.7 t -57.63 -32.99 67.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.61 -12.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 7.3 p -83.09 23.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 12.0 t-20 79.33 16.63 0.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 7.1 m80 57.74 43.54 21.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -155.31 148.44 18.29 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.0 151.34 73.42 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.655 2.237 . . . . 0.0 111.833 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -120.35 146.49 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 109.801 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.6 mtp -129.59 156.26 44.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 109.184 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 t -128.9 147.59 50.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.908 . . . . 0.0 109.797 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -113.24 43.02 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 109.302 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.58 152.1 37.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 m -92.48 -34.41 14.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.79 30.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.481 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -74.06 -9.11 58.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.6 p -83.4 -31.53 26.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.19 -18.47 55.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.51 116.88 41.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.765 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.11 136.83 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.146 2.564 . . . . 0.0 112.5 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 t -85.05 -4.25 59.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.2 t -98.39 103.66 15.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.367 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -126.89 152.68 75.69 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.13 -42.53 26.34 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.758 2.305 . . . . 0.0 112.043 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.36 -37.85 63.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.516 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 1.0 OUTLIER -57.77 -49.73 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 109.506 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.32 -39.41 93.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.04 77.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.68 -44.25 96.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.549 ' HG ' ' N ' ' A' ' 147' ' ' LYS . 86.4 p -62.16 -38.07 87.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.52 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.549 ' N ' ' HG ' ' A' ' 146' ' ' SER . 15.4 mtpp -65.05 -36.47 84.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.86 -50.51 56.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.75 -34.32 76.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -60.24 -41.69 93.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -63.89 -38.19 90.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.546 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 11.7 tpp180 -64.4 -21.47 66.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.34 24.18 6.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -95.39 130.65 42.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -1.111 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 63.2 mttp -98.06 -167.12 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 19.0 p90 40.31 38.86 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.5 OUTLIER -102.34 25.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -45.38 163.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 2.5 t -63.43 -23.99 67.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -1.161 . . . . 0.0 109.478 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.5 p -70.07 -38.45 75.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -69.74 -41.24 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 159' ' ' THR . 14.3 p -64.88 -33.72 76.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.457 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 51.9 t80 -65.61 -50.97 63.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.374 -0.829 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.493 ' HG ' HE22 ' A' ' 41' ' ' GLN . 18.9 t -58.69 -33.11 69.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 109.28 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.84 -42.18 88.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.444 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 52.0 mtt -62.96 -37.43 87.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -55.07 -40.26 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.76 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.91 11.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.546 ' HG ' ' CD1' ' A' ' 171' ' ' LEU . 10.5 t -59.29 -37.27 77.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.94 14.28 52.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.546 ' CD1' ' HG ' ' A' ' 169' ' ' CYS . 4.4 mp -54.83 -56.81 15.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.16 134.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.457 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.824 HD22 ' NE2' ' A' ' 175' ' ' HIS . 17.2 t-20 -100.56 103.78 15.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.435 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 32.4 p30 -103.47 91.47 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.536 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.824 ' NE2' HD22 ' A' ' 173' ' ' ASN . 44.6 m170 -102.81 0.3 32.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.592 ' O ' ' O ' ' A' ' 175' ' ' HIS . 6.2 t 56.61 139.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.55 123.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.98 -50.15 0.71 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 7.8 t -150.46 -132.67 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -1.157 . . . . 0.0 109.519 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 8.5 t 52.95 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 35.9 t -162.49 32.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.3 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.643 -179.47 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.463 ' HG3' HH11 ' A' ' 3' ' ' ARG . 44.3 mtm-85 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 180' ' ' CYS . 8.0 m -59.8 151.83 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.419 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.22 -20.68 16.27 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -52.64 -34.96 53.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.436 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.34 128.81 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.555 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 9' ' ' GLN . 22.6 t -169.68 129.97 1.02 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 8' ' ' SER . 92.8 mm-40 44.8 -156.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 109.526 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 52.38 64.09 7.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -45.64 -34.94 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.771 2.314 . . . . 0.0 112.185 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.542 ' CD2' ' HZ3' ' A' ' 51' ' ' LYS . 60.1 tp -63.87 -38.63 91.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 17' ' ' HIS . 86.6 t80 -66.65 -43.61 84.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.44 -43.65 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.23 83.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -59.94 -42.83 94.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.365 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 13' ' ' TYR . 2.4 m-70 -62.24 -39.47 92.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -60.63 -27.45 67.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.61 -77.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.506 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -143.64 116.24 8.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -172.17 140.09 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.59 -28.22 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -67.9 154.4 93.69 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.184 -1.186 . . . . 0.0 109.412 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.07 120.09 4.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.762 2.308 . . . . 0.0 111.959 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' OE1' ' O ' ' A' ' 23' ' ' VAL . 18.8 mp0 -103.15 133.86 47.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.812 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -134.77 4.1 3.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.93 133.2 35.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 p -61.35 -34.44 75.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.86 -52.3 57.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -68.74 -45.9 70.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.884 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -46.55 89.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.868 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.475 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 93.8 t80 -68.05 -47.29 68.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.489 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 14.1 tm-20 -64.08 -30.72 71.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.854 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.7 ttm -64.71 -51.83 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -58.28 -47.41 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 12.4 p -62.55 -37.89 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.052 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.525 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 6.2 tp -66.69 -39.81 88.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.12 -27.81 69.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.5 -36.51 11.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 40' ' ' GLN . 1.7 mp0 -59.9 -33.79 72.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.2 tt0 -57.18 -29.74 63.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.715 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.03 109.83 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.626 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.67 -32.3 5.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.0 mt -103.67 -155.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -1.153 . . . . 0.0 109.464 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 m -121.97 149.67 43.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 47' ' ' ILE . 23.7 p90 -49.05 -36.51 18.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.473 HD13 HG23 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -60.9 -37.2 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.659 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.463 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 57.2 m -64.46 -33.69 76.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.95 -38.96 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 50' ' ' LEU . 10.1 mp -54.3 -52.06 62.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.542 ' HZ3' ' CD2' ' A' ' 12' ' ' LEU . 61.0 mttm -59.67 -49.21 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.325 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.22 -34.13 77.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.602 ' NH1' HH21 ' A' ' 57' ' ' ARG . 3.1 ttt-85 -49.5 -45.44 47.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.118 -0.989 . . . . 0.0 108.937 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -66.84 -40.6 88.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.376 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.539 HD22 ' C ' ' A' ' 84' ' ' GLY . 36.5 t-20 -64.51 -40.98 96.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.851 . . . . 0.0 109.249 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' PHE . 4.4 m-85 -56.59 -43.34 79.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 109.304 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.602 HH21 ' NH1' ' A' ' 53' ' ' ARG . 96.7 mtt180 -58.61 -36.22 73.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -49.29 76.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.198 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.535 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 3.2 p -94.68 -13.2 26.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.285 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.535 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 63.6 m-85 -133.27 32.16 3.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.913 -1.117 . . . . 0.0 110.192 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 p80 -46.91 -42.94 18.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.536 ' N ' ' HD1' ' A' ' 61' ' ' HIS . 40.6 tt0 -79.64 -42.9 23.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.806 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 69.5 t80 44.07 36.64 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -56.57 113.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 109.558 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.07 -45.12 7.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.944 2.429 . . . . 0.0 112.678 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 9.8 p -66.27 -45.33 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.534 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 55.3 tttp -61.94 -45.24 94.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.82 -39.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.095 . . . . 0.0 109.628 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.31 64.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.494 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 12.77 23.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.6 tpp -50.41 161.05 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.625 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.82 156.99 19.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.81 -33.38 74.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.5 -39.22 86.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.3 t -71.84 -28.54 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -68.34 -43.57 77.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.341 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 30.9 ptt180 -76.42 -34.63 58.8 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.838 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 mt -61.84 -39.05 90.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.678 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.56 -28.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.988 . . . . 0.0 109.736 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.55 -53.79 3.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 78' ' ' ARG . 1.9 p30 -99.77 106.52 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.72 -64.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.539 ' C ' HD22 ' A' ' 55' ' ' ASN . . . 91.34 -1.48 76.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.5 pt -77.11 -159.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.42 136.56 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 96.6 mtt180 -79.35 95.68 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.6 m-70 -166.47 82.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 109.214 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -46.56 -35.25 5.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.984 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.83 -34.37 82.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -72.45 -41.69 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.509 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.6 -56.29 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.29 -30.95 63.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.7 99.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.39 -43.11 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 96' ' ' ILE . 25.6 mm -54.59 -48.1 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.28 -34.28 89.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 32' ' ' PHE . 15.8 t-20 -56.65 -45.8 81.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.184 . . . . 0.0 109.337 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.76 73.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.542 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.29 -43.4 98.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.38 75.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.34 -46.42 83.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.21 -42.65 99.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -59.12 -53.87 53.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.543 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 26.0 ttt -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.73 -27.41 65.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -52.05 -26.42 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -75.69 -19.09 59.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.44 18.86 65.46 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.34 151.65 37.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.9 119.18 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.618 2.212 . . . . 0.0 111.668 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -75.42 -43.33 50.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -59.79 -47.62 84.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 118' ' ' SER . 92.2 m-20 -51.1 -54.93 20.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 0.0 111.029 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.25 -43.35 82.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.39 -60.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.679 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.541 ' CD1' ' O ' ' A' ' 113' ' ' ALA . 67.8 p-90 -86.03 -17.86 34.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.727 -1.233 . . . . 0.0 111.153 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.508 ' OG ' ' NE2' ' A' ' 122' ' ' HIS . 9.2 t -54.98 -30.61 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.872 -1.142 . . . . 0.0 109.744 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -43.43 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 178.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 118' ' ' SER . 13.9 m -82.84 24.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.945 . . . . 0.0 110.004 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.87 29.28 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.508 ' NE2' ' OG ' ' A' ' 118' ' ' SER . 26.1 m80 55.62 34.48 23.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -141.91 114.53 6.52 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.45 154.49 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.648 2.232 . . . . 0.0 111.861 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.459 HE22 ' CB ' ' A' ' 141' ' ' ALA . 94.4 mt-30 -106.59 144.4 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.549 ' CE ' HD21 ' A' ' 173' ' ' ASN . 80.1 mtp -137.61 151.73 48.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.797 . . . . 0.0 109.187 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 t -129.65 160.09 34.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.904 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.04 46.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 0.0 109.26 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.45 -135.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.73 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 m -143.34 -33.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.378 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 t -137.96 170.77 15.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.437 HD11 ' H ' ' A' ' 132' ' ' LEU . 5.5 mp -68.31 -32.29 72.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.4 m -54.21 -37.3 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.184 -0.947 . . . . 0.0 109.478 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.7 -35.04 78.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.917 . . . . 0.0 109.427 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.56 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 1.8 mp -81.36 117.82 69.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.697 ' C ' ' H ' ' A' ' 138' ' ' SER . 89.0 Cg_endo -82.59 2.49 8.47 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.133 2.556 . . . . 0.0 112.555 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 56.08 -4.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.697 ' H ' ' C ' ' A' ' 136' ' ' PRO . 65.2 p -123.41 80.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.319 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -83.74 153.78 64.53 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.49 -37.01 19.22 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.773 2.315 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.459 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -71.97 -36.83 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.311 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.2 m -61.38 -49.07 78.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.462 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 49.8 t0 -62.93 -45.91 90.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.42 86.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.0 -43.52 87.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 23.3 t -54.64 -44.99 73.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.462 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 61.1 mttp -63.81 -30.74 71.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.573 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.56 -52.03 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 3.8 mm? -62.91 -39.09 93.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.78 -37.54 87.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -60.8 -38.14 84.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.359 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.583 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -63.8 -22.7 67.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.378 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 116.53 9.51 11.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -82.53 133.74 35.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -1.143 . . . . 0.0 109.494 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 60.6 mttp -99.97 -169.39 1.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 14.5 p90 39.43 40.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 158' ' ' GLY . 0.3 OUTLIER -110.57 25.44 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.364 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.49 170.7 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.5 t -62.77 -28.13 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -1.097 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 68.3 p -64.59 -48.17 75.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.459 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -63.92 -35.9 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.88 -48.54 73.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.312 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.54 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 58.3 t80 -60.11 -43.21 95.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -59.63 -39.19 83.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -68.03 -41.01 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.437 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 35.4 mmm -59.74 -41.2 90.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.0 109.573 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 163' ' ' TYR . 49.4 mt-30 -69.8 -46.14 66.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.34 77.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 169' ' ' CYS . 17.2 t -81.41 -4.35 55.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 65.77 24.13 71.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.8 tp -68.8 -47.16 66.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 109.422 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.45 131.98 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.549 HD21 ' CE ' ' A' ' 126' ' ' MET . 79.9 m-20 -90.54 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -98.27 119.05 36.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.498 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.652 ' ND1' ' CD2' ' A' ' 182' ' ' TYR . 2.5 p80 -164.33 127.28 2.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.55 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.81 150.98 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.413 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 140.72 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.131 -0.981 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 91.75 1.62 70.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.516 ' C ' ' H ' ' A' ' 181' ' ' CYS . 49.9 m -155.01 179.5 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 5.2 t 60.4 1.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.516 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.4 t 65.82 50.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.902 . . . . 0.0 109.614 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.652 ' CD2' ' ND1' ' A' ' 175' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -46.52 159.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -109.87 -21.76 6.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -66.08 -11.83 51.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.633 ' CG1' ' H ' ' A' ' 8' ' ' SER . 43.6 t -82.39 -123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.633 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 23.8 t 53.5 170.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 8' ' ' SER . 52.3 tt0 59.5 135.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' LEU . 13.4 m-20 50.45 82.05 0.25 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.3 -10.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.828 2.352 . . . . 0.0 112.108 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' ASP . 18.3 tp -62.7 -34.01 76.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 33.2 m-85 -54.26 -41.97 69.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 109.504 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.8 mt -80.0 -33.14 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.435 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.32 -48.19 71.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 109.509 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 13' ' ' TYR . 1.5 p90 -76.51 -34.27 58.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.482 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 57.3 t-80 -55.77 -50.01 71.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.26 -38.44 65.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.419 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -56.02 -46.59 78.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.9 pt-20 -173.28 -146.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' A' ' 20' ' ' GLU . 27.9 t-105 58.94 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.14 -9.0 59.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.2 154.43 37.68 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.94 119.9 7.02 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.786 2.324 . . . . 0.0 111.899 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -127.47 136.69 52.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.975 . . . . 0.0 109.826 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.0 p -131.55 9.46 4.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 0.0 109.075 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -90.68 135.17 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 0.0 109.299 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 89.4 p -61.67 -39.31 90.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.9 -41.09 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 0.0 109.774 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -77.23 -53.89 7.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.905 . . . . 0.0 109.863 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.9 mp -64.6 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 80.0 t80 -62.33 -56.45 18.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 109.854 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.84 -31.14 70.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.902 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.407 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.56 -51.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.866 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -62.43 -43.3 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -60.86 -48.38 82.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 110.086 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 8.2 mp -73.69 -44.68 55.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.929 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.89 -37.13 75.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.69 -25.1 34.88 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -82.64 -18.39 41.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.234 . . . . 0.0 109.773 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.6 pp0? -61.95 -21.44 64.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.71 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.07 110.22 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.695 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.03 -32.9 5.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.05 164.37 12.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -1.142 . . . . 0.0 109.448 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -86.26 167.06 15.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' VAL . 5.4 p90 -61.07 -43.78 98.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.4 tp -43.52 -42.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.451 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 95.1 m -61.13 -34.21 74.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 46' ' ' TRP . 16.4 t -66.56 -46.7 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.33 -53.06 61.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -61.64 -46.21 90.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.351 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' TYR . 43.6 tttm -65.44 -30.18 70.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.383 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.2 ttm180 -55.72 -48.37 75.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.267 -0.895 . . . . 0.0 108.952 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.47 -46.64 87.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.45 -0.781 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 94.4 m-20 -69.07 -32.42 71.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.251 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.7 t80 -62.28 -44.61 96.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.405 -0.809 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 61' ' ' HIS . 14.5 mtm180 -60.08 -42.22 94.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 109.764 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.52 69.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -0.815 . . . . 0.0 110.301 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.6 m -92.98 -12.1 31.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 110.281 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 65.6 m-85 -129.47 -48.11 1.17 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.882 -1.137 . . . . 0.0 110.155 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' ARG . 62.3 t60 -50.14 -43.46 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.085 -1.009 . . . . 0.0 109.904 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -66.56 -25.92 66.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 64' ' ' ASP . 93.4 m-85 -91.88 16.48 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 109.889 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 55.12 167.05 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.94 -55.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.832 2.355 . . . . 0.0 112.68 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 7.2 p -48.93 -44.29 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 48.3 tttp -58.28 -36.91 74.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.845 . . . . 0.0 109.82 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -57.18 -37.92 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 109.575 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.53 -29.82 68.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.81 22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.342 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.42 ' SD ' ' CB ' ' A' ' 75' ' ' ASP . 3.4 mmm -60.48 173.76 0.66 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.638 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 71' ' ' MET . 13.9 mm100 -131.8 158.29 41.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.35 -29.76 71.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -72.57 -31.55 65.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.478 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' CB ' ' SD ' ' A' ' 71' ' ' MET . 85.6 m-20 -65.06 -48.14 74.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.75 -40.19 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.537 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -62.28 -30.62 71.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.309 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.21 -46.42 77.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.379 -0.826 . . . . 0.0 109.803 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.452 ' CD1' ' C ' ' A' ' 79' ' ' LEU . 1.3 pp -78.58 -22.78 46.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 109.572 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 t -51.17 -36.71 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.801 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -50.61 -42.41 56.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 84' ' ' GLY . 93.8 m-20 -89.86 115.02 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -80.28 26.12 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.432 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.439 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . -45.06 -23.49 0.65 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.3 pt -124.19 177.19 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -1.136 . . . . 0.0 109.322 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.4 mt -45.28 137.31 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 59.8 mtp180 -80.05 95.36 6.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 11.7 m-70 -168.37 83.66 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.134 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.301 -0.874 . . . . 0.0 109.97 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.16 97.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -62.19 -38.47 89.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -1.215 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 mt -57.23 -48.66 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.45 -38.72 69.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 0.0 109.402 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -36.66 71.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.26 -40.43 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.368 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.4 mt -56.16 -50.29 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.534 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.79 -36.68 92.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.598 ' ND2' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -56.67 -41.84 77.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -1.157 . . . . 0.0 109.38 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.3 74.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.08 -41.83 93.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 -29.92 70.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 35.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.0 -36.37 83.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.41 -38.71 84.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.577 ' SD ' ' NH2' ' A' ' 152' ' ' ARG . 2.0 tpt -67.79 -38.79 83.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -61.67 -30.09 70.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.437 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -52.52 -31.51 35.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.475 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -87.0 -5.59 59.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.77 69.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -105.28 119.42 53.02 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -1.183 . . . . 0.0 109.654 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.72 119.43 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.548 2.166 . . . . 0.0 111.714 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.48 -35.98 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.828 . . . . 0.0 110.427 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.443 ' O ' HG21 ' A' ' 116' ' ' VAL . . . -67.95 -50.07 58.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.182 -0.949 . . . . 0.0 110.707 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 118' ' ' SER . 40.8 t0 -60.5 -46.76 88.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -56.92 -52.77 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.089 -1.007 . . . . 0.0 111.209 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 113' ' ' ALA . 15.4 m -56.74 -48.94 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.03 -1.044 . . . . 0.0 111.677 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.471 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 3.4 p-90 -88.35 -27.7 21.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.819 -1.176 . . . . 0.0 111.121 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 120' ' ' VAL . 28.3 t -55.92 -27.21 51.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.717 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.57 -14.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 118' ' ' SER . 59.9 t -83.9 23.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.06 -1.025 . . . . 0.0 109.911 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 14.6 t-20 72.82 22.66 3.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.2 t60 60.26 49.65 6.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.94 149.13 22.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.03 155.16 29.79 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.676 2.251 . . . . 0.0 111.816 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -119.2 145.51 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.744 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.9 ttm -136.34 149.81 48.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.16 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 t -134.81 156.76 48.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.37 48.53 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.81 128.98 38.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.636 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.413 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.4 m -71.07 -33.43 70.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 t -136.84 174.5 10.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.27 -31.05 71.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -60.36 -39.34 86.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.413 ' OE1' ' N ' ' A' ' 130' ' ' THR . 95.1 mt-10 -65.39 -29.44 70.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.44 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.25 116.18 33.78 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.693 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -86.95 117.49 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.14 2.56 . . . . 0.0 112.511 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.8 m -74.04 -17.66 60.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 138' ' ' SER . 24.6 p -94.72 100.67 12.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.89 151.54 44.86 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 -32.1 92.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.854 2.369 . . . . 0.0 112.036 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.83 -38.69 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 m -56.52 -44.41 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.83 -45.58 88.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.14 81.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.46 -43.91 95.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -56.83 -44.45 82.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.21 -36.2 81.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.77 73.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.8 mt -60.77 -40.57 93.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.393 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -60.93 -40.59 93.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.577 ' NH2' ' SD ' ' A' ' 105' ' ' MET . 5.8 tpp180 -65.72 -22.63 66.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.335 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.33 9.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.84 133.15 34.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -1.165 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -97.68 175.5 6.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 54.3 51.81 13.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 158' ' ' GLY . 15.4 m -119.89 26.2 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.24 167.62 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.9 t -59.58 -28.28 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -1.147 . . . . 0.0 109.477 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 p -63.56 -43.08 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.519 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -66.21 -39.77 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.73 -40.25 96.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.286 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -60.57 -48.93 79.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 m -61.97 -37.97 86.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.28 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.68 -46.01 91.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 75.2 mtp -65.78 -39.7 91.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.0 109.594 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.76 -41.24 97.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.407 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -74.16 -54.7 7.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.609 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.1 t -47.84 -24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.24 7.46 67.61 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.0 mp -54.68 -52.0 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 109.39 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 25.6 m -98.81 130.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.568 ' ND2' ' HD1' ' A' ' 175' ' ' HIS . 19.6 t30 -94.26 101.95 13.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 90.5 m-20 -94.09 119.88 33.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.568 ' HD1' ' ND2' ' A' ' 173' ' ' ASN . 73.0 m80 -157.72 128.9 6.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.27 144.41 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.83 -38.33 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.86 -23.97 47.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.94 139.16 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.505 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.95 -37.17 83.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.461 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.84 -28.82 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.568 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.9 t80 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.951 . . . . 0.0 109.574 -179.864 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.265 0.555 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.67 132.3 53.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.884 . . . . 0.0 109.408 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -74.44 -39.13 43.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -63.27 1.75 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 109.449 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 5' ' ' GLY . 8.3 p -59.01 -14.89 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.505 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.0 m 60.79 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 10' ' ' ASP . 23.5 pt20 -82.78 -17.49 43.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLN . 9.5 m-20 -43.34 106.39 0.49 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.384 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.5 -38.24 35.1 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.824 2.35 . . . . 0.0 112.156 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.4 tp -62.89 -41.2 99.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.466 ' CE2' ' CE1' ' A' ' 17' ' ' HIS . 40.9 t80 -68.13 -42.57 79.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.83 -44.25 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.06 89.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -59.27 -43.54 92.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.466 ' CE1' ' CE2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.64 -49.35 68.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.65 -39.94 95.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.31 -54.56 44.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -177.37 124.93 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 59.1 t90 -171.22 124.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.457 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.7 1.04 83.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.96 120.16 71.43 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -45.98 120.83 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -128.17 135.62 49.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.962 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.9 p -115.41 9.05 15.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.076 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.65 132.47 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.302 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.5 p -73.7 -38.13 64.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.605 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.58 -42.64 98.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -70.37 -51.94 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 109.869 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 7.8 mp -66.77 -38.37 86.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.798 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 67.2 t80 -61.55 -38.96 89.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.76 -30.63 64.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.9 tpp -73.21 -54.45 8.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.853 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.31 -32.72 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 110.007 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 91.6 m -72.13 -49.99 31.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.139 -0.976 . . . . 0.0 110.057 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mt -75.2 -28.99 60.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 109.888 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 39.0 tp10 -52.08 -31.94 32.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.792 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.47 -21.81 69.02 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.43 -27.42 62.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -1.204 . . . . 0.0 109.733 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -60.27 -33.06 71.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.771 -178.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 41' ' ' GLN . . . -46.02 110.85 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.47 -6.71 68.27 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.16 -169.94 2.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -1.183 . . . . 0.0 109.406 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -108.97 153.0 24.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.539 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 6.0 t-105 -54.86 -46.22 74.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -56.96 -38.97 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.692 -178.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 98.4 m -63.02 -35.22 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.714 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.5 t -60.19 -44.74 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -55.13 -44.29 74.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.487 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.43 -52.84 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.354 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 10.9 mptt -69.55 -25.79 64.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 49' ' ' VAL . 37.0 ttp180 -54.23 -44.6 71.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 109.004 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -72.74 -43.97 62.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -64.08 -49.61 71.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.239 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 21.7 t80 -58.48 -39.94 81.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.309 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -55.76 -37.91 69.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.844 . . . . 0.0 109.77 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.0 -23.46 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.256 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.7 m -91.77 -12.14 34.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.146 -0.971 . . . . 0.0 110.251 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 43.9 m-85 -125.46 -51.68 1.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.135 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -53.44 -41.68 66.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 109.835 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.06 -38.85 73.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 96.9 m-85 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 130.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.002 . . . . 0.0 109.611 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -40.6 -36.05 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.68 -49.29 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.9 mttm -72.25 -31.2 65.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.869 . . . . 0.0 109.862 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.93 -44.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 109.605 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.54 -34.21 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.539 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.01 18.18 17.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.309 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.7 tpp -63.69 157.6 23.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -103.63 167.36 9.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.47 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 96.7 mt-10 -71.19 -24.17 62.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -72.04 -31.82 66.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.59 -47.14 79.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.418 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 14.4 m -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 76' ' ' VAL . 97.9 mt-10 -59.12 -33.66 71.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 78' ' ' ARG . 42.0 ttm-85 -66.67 -46.08 76.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.774 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.4 mt -66.47 -34.38 77.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.1 t -51.79 -35.82 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -81.26 -60.33 2.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 62.7 t0 -100.06 139.69 35.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 73.72 76.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -74.22 -31.99 58.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.613 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.3 pt 28.96 41.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.348 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 84' ' ' GLY . 54.9 mt 52.12 4.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.607 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -97.85 109.49 22.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.483 ' CG ' ' H ' ' A' ' 89' ' ' ARG . 84.0 t60 -96.99 172.17 8.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.165 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.483 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 38.4 ttm180 -48.63 -41.91 32.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.74 -47.39 61.6 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -64.72 -51.81 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 109.524 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 91.6 mt -54.77 -47.39 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.625 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -53.02 -33.45 51.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.09 98.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.354 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.8 mp -60.77 -48.13 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.383 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.11 -50.0 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.43 84.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.66 -36.98 79.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -1.194 . . . . 0.0 109.465 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -65.97 -37.41 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.38 -45.19 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.541 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.84 -31.25 66.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 16.7 t80 -69.29 -50.53 45.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.73 -37.53 86.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.29 -42.02 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.8 ttt -64.22 -41.3 97.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.54 -27.41 69.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -51.97 -29.15 19.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.552 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -76.26 -17.23 59.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.08 3.55 67.67 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.75 115.6 65.34 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.65 124.64 7.01 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.619 2.213 . . . . 0.0 111.714 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.63 ' CZ ' ' NH1' ' A' ' 152' ' ' ARG . 49.6 t80 -61.1 -37.47 82.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.492 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -68.11 -49.83 58.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.126 -0.984 . . . . 0.0 110.745 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.505 ' O ' ' OG ' ' A' ' 118' ' ' SER . 56.5 t0 -52.07 -35.39 47.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 111.032 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.577 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 14.7 t80 -76.41 -46.24 28.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 2.6 p -56.49 -45.87 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.974 -1.079 . . . . 0.0 111.729 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 18.2 p-90 -88.92 -26.9 21.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.735 -1.228 . . . . 0.0 111.114 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.7 m -58.06 -27.52 63.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.875 -1.141 . . . . 0.0 109.719 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.76 -13.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.084 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.9 m -82.51 22.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.025 . . . . 0.0 109.947 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 59.64 35.0 22.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -0.942 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.4 m80 54.84 26.88 8.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -137.07 89.63 16.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.558 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.03 155.03 1.96 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.673 2.248 . . . . 0.0 111.779 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.5 156.15 16.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.729 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 48.3 ttp -127.62 136.15 51.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 173' ' ' ASN . 1.4 t -95.57 169.14 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.906 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -168.99 44.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.9 -174.23 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.587 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.5 m -114.34 -29.81 6.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -128.63 157.86 40.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.7 mt -74.66 -10.97 60.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.8 m -87.64 -31.49 19.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.9 pt-20 -80.14 -7.81 59.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.72 118.38 57.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.718 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.68 130.27 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.095 2.53 . . . . 0.0 112.544 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.0 t -86.91 -15.11 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.267 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.5 t -85.52 102.18 13.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.648 ' H ' ' HG ' ' A' ' 142' ' ' SER . 9.4 p -118.71 152.69 51.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.93 . . . . 0.0 109.508 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.66 -35.15 92.47 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.093 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -41.13 52.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' A' ' 139' ' ' THR . 83.2 p -61.4 -37.46 83.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.23 -46.46 86.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 0.0 109.568 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.89 -30.42 65.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.09 -46.68 76.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -63.19 -42.63 99.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -61.28 -35.41 77.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.562 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.79 42.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.68 -32.42 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.858 . . . . 0.0 109.583 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -60.48 -40.73 92.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.429 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -61.0 -37.02 81.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.63 ' NH1' ' CZ ' ' A' ' 112' ' ' PHE . 98.8 mtt180 -64.87 -20.03 66.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.49 22.92 13.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -84.65 141.03 30.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -1.107 . . . . 0.0 109.535 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -109.1 175.29 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 53.91 44.18 29.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.5 p -122.66 26.02 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.82 166.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.1 m -54.58 -33.6 60.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.3 m -61.02 -46.49 90.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.4 mp -64.67 -41.57 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 83.1 m -64.37 -40.4 95.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 109.264 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.26 -47.63 85.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.271 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.539 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 29.7 t -59.63 -37.15 77.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.288 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.69 -37.66 79.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.8 mtp -65.25 -47.29 77.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.617 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.41 -35.88 80.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.713 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.74 -44.18 93.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.7 m -83.02 -59.13 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.45 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.85 18.04 1.01 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 mt -58.95 -32.82 69.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -1.095 . . . . 0.0 109.427 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.09 141.83 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.41 ' O ' ' CG2' ' A' ' 127' ' ' THR . 23.5 t30 -76.02 102.56 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 22.9 t70 -94.03 101.35 13.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 81.7 m-70 -160.05 123.39 3.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.79 134.5 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.3 p -54.99 -25.76 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.423 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -64.08 -24.27 68.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 3.7 m -77.67 140.86 39.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.193 . . . . 0.0 109.535 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.555 ' C ' ' H ' ' A' ' 182' ' ' TYR . 83.3 m -62.9 -38.61 91.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.91 . . . . 0.0 109.438 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 95.1 m -51.29 -7.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.555 ' H ' ' C ' ' A' ' 180' ' ' CYS . 20.9 t80 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.411 ' H ' ' HD3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -92.82 -153.52 0.35 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.427 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.2 -5.11 56.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 28.6 m95 45.73 38.41 4.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.99 131.19 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -171.47 29.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.81 -130.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.91 153.08 45.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.48 -27.51 3.44 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.862 2.375 . . . . 0.0 112.184 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.33 -39.68 95.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.404 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -66.11 -45.36 81.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.425 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.92 -39.82 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.72 92.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -66.87 -40.12 87.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' GLU . 59.1 t-80 -56.38 -48.53 76.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.77 -39.11 70.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -44.49 91.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.502 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 39.9 mt-10 -149.1 -137.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.496 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.482 ' O ' ' O ' ' A' ' 20' ' ' GLU . 23.5 t90 59.82 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.547 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.41 82.94 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.9 t -119.71 94.74 48.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 0.0 109.34 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -46.87 121.96 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.764 2.309 . . . . 0.0 111.878 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.48 140.71 37.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -128.28 -2.02 5.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.0 109.109 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -81.33 130.7 35.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.436 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 9.4 t -57.17 -34.42 68.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.204 -0.935 . . . . 0.0 109.608 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -67.21 -55.55 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.763 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -66.92 -43.73 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.923 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -44.14 95.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.835 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.96 -36.71 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 109.903 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.25 -32.05 71.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.3 tpp -63.84 -53.31 52.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.785 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 3.2 tp -72.11 -32.12 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.75 -50.35 30.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.132 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 6.7 mp -74.08 -16.38 61.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -52.24 -42.1 63.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.953 . . . . 0.0 109.841 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.583 ' N ' ' OE1' ' A' ' 38' ' ' GLU . . . 61.69 171.97 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.7 ' C ' ' H ' ' A' ' 42' ' ' ALA . 31.4 tp60 -60.07 -45.15 93.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -1.193 . . . . 0.0 109.77 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.614 HE21 ' N ' ' A' ' 46' ' ' TRP . 52.9 tt0 60.13 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.671 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.7 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -58.28 143.27 45.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 -24.03 0.62 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.547 ' H ' ' C ' ' A' ' 42' ' ' ALA . 17.4 mt -104.04 -141.23 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 109.476 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -153.43 155.0 35.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.614 ' N ' HE21 ' A' ' 41' ' ' GLN . 76.0 t-105 -48.08 -39.05 19.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.41 -40.59 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.5 m -63.83 -38.73 92.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.735 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.18 -40.75 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.422 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.26 -44.78 92.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -65.64 -49.49 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.394 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -52.39 -45.39 65.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.158 -0.964 . . . . 0.0 109.038 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.4 -44.87 96.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 24.0 m120 -66.2 -38.45 88.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.254 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CG ' ' A' ' 60' ' ' PHE . 25.3 t80 -62.8 -50.43 71.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.348 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 20.7 mmm180 -60.8 -21.37 63.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.798 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -48.58 62.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.6 m -95.65 -43.34 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 110.254 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CG ' ' CE2' ' A' ' 56' ' ' TYR . 53.9 m-85 -66.91 -50.79 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 57.5 t60 -48.78 -41.67 33.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -61.6 -37.37 83.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.734 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.573 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 48.0 m-85 -78.5 -48.24 15.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 109.832 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.1 t70 79.87 136.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.534 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -40.05 -22.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.909 2.406 . . . . 0.0 112.745 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' ASP . 91.9 t -75.97 -44.55 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.653 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' LYS . 3.2 mptp? -72.61 -45.07 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.845 . . . . 0.0 109.895 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.514 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 3.1 m -56.05 -42.84 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.612 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -62.19 -38.0 87.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.53 13.13 32.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.373 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.502 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 27.3 ttp -83.26 158.14 22.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -103.98 160.52 14.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.5 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.56 -30.29 69.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.69 -43.72 72.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 55.1 t0 -61.58 -38.33 87.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.444 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.08 -44.13 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -56.2 -37.18 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.44 -38.66 90.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.341 -0.849 . . . . 0.0 109.782 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.2 mt -70.99 -29.32 65.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.77 -36.38 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.04 -62.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.0 109.514 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -100.01 116.13 31.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.431 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.66 -46.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 55' ' ' ASN . . . 78.74 26.36 58.85 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 pt -116.43 171.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 86' ' ' ILE . 97.0 mt -47.22 135.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.601 HH11 ' HG2' ' A' ' 87' ' ' ARG . 9.0 mtt-85 -74.9 102.49 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.42 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -171.73 80.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.208 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 89' ' ' ARG . 11.9 ptt-85 -47.67 -32.97 6.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.908 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.75 95.47 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.08 -45.24 95.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.52 -41.56 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -60.67 -37.63 82.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.26 96.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.355 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.99 -46.41 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.5 mt -54.66 -39.23 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.74 -33.39 87.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 88.1 m-20 -61.6 -41.83 98.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 109.423 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.74 86.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 109.51 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -57.71 -45.03 86.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.71 -33.5 68.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.436 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 70.5 t80 -64.5 -45.5 87.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.78 -39.18 84.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -60.54 -37.01 79.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.525 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.5 mmm -63.35 -37.08 85.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.73 -29.42 69.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -51.72 -35.35 42.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -91.8 -1.34 57.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.8 66.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -97.05 149.15 35.38 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.154 -1.203 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.82 124.57 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.662 2.241 . . . . 0.0 111.698 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.409 ' CE1' ' NH1' ' A' ' 152' ' ' ARG . 72.3 t80 -79.11 -45.47 19.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.49 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.711 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.513 ' O ' ' OG ' ' A' ' 118' ' ' SER . 20.0 t70 -52.65 -36.5 56.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 111.043 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.66 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 48.3 t80 -73.09 -49.6 27.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.081 -1.012 . . . . 0.0 111.221 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.437 HG21 ' H ' ' A' ' 117' ' ' TRP . 3.0 m -56.12 -49.35 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.023 -1.048 . . . . 0.0 111.675 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.437 ' H ' HG21 ' A' ' 116' ' ' VAL . 20.0 p-90 -86.88 -28.06 23.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.742 -1.224 . . . . 0.0 111.09 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 21.7 p -56.75 -28.41 61.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.874 -1.142 . . . . 0.0 109.725 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -46.63 -11.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' SER . 18.5 m -84.7 24.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 123' ' ' GLN . 3.5 m-20 72.51 17.62 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.023 . . . . 0.0 109.701 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 16.8 t60 73.58 -23.14 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.544 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 121' ' ' ASN . 2.3 pt20 -86.52 145.76 40.28 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.532 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 154.06 72.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.666 2.244 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.609 HE22 ' CB ' ' A' ' 141' ' ' ALA . 94.4 mt-30 -104.68 149.0 25.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.771 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.575 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 71.2 mmm -135.78 145.95 47.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 109.172 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.2 t -115.7 164.79 13.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.929 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -139.15 47.12 1.91 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.299 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.57 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.7 m -72.15 -37.8 69.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.1 t -133.95 177.93 7.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.454 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.09 -34.11 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.604 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -59.11 -35.23 73.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.55 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -72.72 -23.25 60.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.483 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 5.7 mm -65.57 120.47 68.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.749 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.473 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 85.1 Cg_endo -83.72 135.72 6.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.072 2.514 . . . . 0.0 112.525 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 t -91.52 6.72 44.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.33 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.9 m -138.81 90.23 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.28 160.61 29.38 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -47.88 -41.78 31.89 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.874 2.382 . . . . 0.0 112.035 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.609 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -71.38 -38.45 71.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -58.45 -43.92 88.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -61.84 -45.16 95.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.511 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.04 73.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.05 -48.68 80.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.486 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.6 t -61.23 -37.18 82.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.665 ' HZ2' ' HZ2' ' A' ' 151' ' ' LYS . 63.4 tttm -62.0 -42.04 98.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.18 71.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.7 -34.53 74.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.593 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -59.78 -40.91 89.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 109.4 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.665 ' HZ2' ' HZ2' ' A' ' 147' ' ' LYS . 38.7 mmtm -61.17 -40.38 93.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.447 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.66 ' NH2' ' CD1' ' A' ' 115' ' ' PHE . 98.6 mtt180 -67.98 -19.89 64.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.23 13.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.482 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 2.1 m-85 -86.29 127.34 34.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -1.118 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -97.23 -176.85 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 40' ' ' GLN . 76.4 m-85 53.2 48.32 22.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.73 24.17 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.1 162.67 0.21 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -31.49 62.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -1.167 . . . . 0.0 109.446 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.6 m -66.77 -47.77 71.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.81 -44.42 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.1 m -60.29 -43.9 95.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.325 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.483 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 73.4 t80 -60.53 -43.26 97.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 0.0 109.334 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -57.08 -38.97 74.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -61.75 -31.18 71.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 63.0 mmm -68.12 -54.18 19.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.623 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.19 -42.49 65.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.708 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.7 75.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 26.2 t -83.31 -61.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.424 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.04 14.43 1.83 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.7 mt -65.55 -34.23 77.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.56 140.59 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.575 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 1.7 m-80 -88.88 115.09 26.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -98.63 113.02 24.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -152.18 143.06 23.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.522 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 m -97.04 145.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.1 m -54.75 142.82 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.09 -83.01 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 73.8 m -74.25 -171.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -1.158 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.609 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 33.3 m 52.4 17.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.468 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.609 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 13.7 p 42.46 43.63 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 30.4 t80 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 109.621 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.48 ' C ' ' H ' ' A' ' 6' ' ' TRP . 63.5 m 45.91 31.25 1.04 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.97 -46.01 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.664 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -149.84 -91.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -1.201 . . . . 0.0 109.452 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 38.6 t 54.39 -0.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.633 ' H ' ' C ' ' A' ' 6' ' ' TRP . 72.1 m -79.87 28.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.424 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' SER . 35.1 tt0 -61.27 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 5.6 p30 -94.77 152.23 39.62 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.35 -34.09 13.53 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.819 2.346 . . . . 0.0 112.098 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.68 -43.3 99.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.476 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.55 -46.61 75.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 109.393 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.0 mt -62.14 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.373 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.12 98.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -62.01 -40.77 96.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 20.6 t60 -60.65 -48.9 79.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.81 -39.31 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.551 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.85 -47.33 83.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 89.5 mt-10 -151.82 -125.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.497 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.523 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 37.7 t90 57.99 114.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.52 -6.31 67.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 169' ' ' CYS . 8.3 p -105.78 109.92 63.65 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.183 -1.186 . . . . 0.0 109.429 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.1 121.12 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.742 2.294 . . . . 0.0 111.896 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -92.94 134.73 34.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.141 -0.974 . . . . 0.0 109.887 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -132.59 -2.25 3.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 109.042 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.14 147.53 46.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.543 ' O ' ' CZ ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -71.0 -60.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -178.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.86 -37.02 82.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.72 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.04 -42.81 84.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.871 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -40.8 88.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.215 -0.928 . . . . 0.0 109.862 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.3 m-30 -60.51 -41.42 94.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.896 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 37' ' ' LEU . 98.6 mt-10 -64.4 -32.81 74.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 ttm -68.42 -53.7 21.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.801 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.6 -39.18 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 110.027 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 77.0 m -71.31 -47.19 58.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.114 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 17.2 tp -64.84 -41.5 95.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 109.811 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 44.2 tp10 -56.22 -29.74 61.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.85 -38.38 59.64 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 40' ' ' GLN . 18.9 mp0 -60.3 -30.75 69.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -1.233 . . . . 0.0 109.724 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.7 tt0 -48.09 -29.7 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 109.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.66 109.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.23 -32.11 5.36 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.9 mp -98.21 -160.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -1.209 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.9 m -131.99 152.55 51.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.362 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 43.6 p90 -55.63 -33.49 64.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -57.99 -40.68 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 54.6 m -73.5 -32.52 64.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.692 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 73.0 t -57.4 -36.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -54.38 -54.93 33.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.57 -45.97 90.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.123 -0.986 . . . . 0.0 109.35 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HZ2' ' CG2' ' A' ' 48' ' ' THR . 45.5 mmtm -68.86 -28.47 66.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG2' HH11 ' A' ' 53' ' ' ARG . 6.4 ttt-85 -52.82 -45.95 67.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -0.986 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -70.47 -43.77 69.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -65.48 -38.16 88.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.325 -0.859 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.13 -49.75 76.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' HIS . 73.8 mtm180 -54.75 -43.39 72.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.41 71.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.29 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.86 -20.19 19.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.201 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -104.33 -38.96 6.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.849 -1.157 . . . . 0.0 110.238 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.5 t60 -49.77 -41.91 45.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 109.898 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.44 -31.39 72.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.722 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 53.7 m-85 -91.31 62.79 4.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -39.31 153.6 0.18 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.618 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -35.34 -53.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.856 2.371 . . . . 0.0 112.757 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -54.44 -44.93 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.647 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 71' ' ' MET . 20.3 tptp -65.73 -37.1 85.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.388 -0.82 . . . . 0.0 109.876 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.98 -49.89 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.076 -1.015 . . . . 0.0 109.594 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.63 70.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.511 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.06 -0.83 57.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.398 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 63' ' ' PHE . 8.9 ttp -71.52 158.35 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -104.67 156.8 17.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.57 -31.28 69.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.51 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -60.49 -39.2 86.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.86 -40.85 94.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.05 -44.03 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.579 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.79 -36.67 81.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.308 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HG3' HH11 ' A' ' 78' ' ' ARG . 33.2 ttm-85 -63.22 -42.29 99.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -36.13 82.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.2 t -51.29 -33.44 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -93.64 -60.28 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.523 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -101.3 108.1 19.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.92 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.418 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.94 27.94 57.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 pt -121.03 171.78 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -1.15 . . . . 0.0 109.38 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -46.69 141.62 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -94.0 97.6 10.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.431 -179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 15.6 m-70 -162.71 86.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.176 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 89' ' ' ARG . 24.9 ttt-85 -48.65 -29.88 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.38 -47.05 92.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -63.85 -48.81 75.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.27 -41.08 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.9 -36.63 72.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.399 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.318 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 98.9 mt -57.59 -41.66 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 mm -56.29 -50.76 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.12 95.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.614 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 17.9 m120 -57.85 -35.94 71.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.14 68.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.88 -42.61 99.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.47 -35.12 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 10.3 t80 -63.98 -48.13 77.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 tp -63.29 -39.27 94.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -60.75 -38.3 84.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -64.13 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.242 -0.912 . . . . 0.0 109.468 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.75 -29.12 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -52.39 -24.45 7.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.514 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.92 -16.88 59.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.512 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.77 9.6 74.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.58 114.42 63.1 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.246 -1.15 . . . . 0.0 109.677 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.02 120.53 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.578 2.185 . . . . 0.0 111.692 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -58.47 -35.03 71.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 0.0 110.504 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.424 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -63.21 -50.87 68.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.0 110.742 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 118' ' ' SER . 90.2 m-20 -62.67 -43.56 98.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 111.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.88 -49.33 73.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.991 -1.068 . . . . 0.0 111.155 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.436 HG11 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -63.8 -48.9 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.034 -1.041 . . . . 0.0 111.632 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.509 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 2.7 p-90 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.775 -1.203 . . . . 0.0 111.207 -177.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 33.1 m -55.41 -28.57 55.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.861 -1.149 . . . . 0.0 109.766 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.23 -14.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' SER . 7.1 p -83.24 26.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.901 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 120' ' ' VAL . 2.4 m-80 76.03 17.61 2.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.706 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 59.94 39.34 20.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.492 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -151.13 144.84 17.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.59 146.95 50.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.694 2.262 . . . . 0.0 111.872 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.2 134.58 46.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.982 . . . . 0.0 109.741 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 38.7 ttp -109.36 125.41 52.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 t -94.28 166.56 12.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 109.868 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -147.43 53.3 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.403 -0.811 . . . . 0.0 109.252 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.21 142.88 27.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -80.48 -33.47 36.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.0 m -128.91 159.29 36.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.417 ' CD1' ' NE1' ' A' ' 6' ' ' TRP . 31.5 mt -55.94 -35.56 66.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.9 p -66.85 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.92 -23.1 66.55 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.142 -0.974 . . . . 0.0 109.411 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.26 116.98 42.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -84.18 132.1 5.19 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.132 2.555 . . . . 0.0 112.516 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.1 t -92.44 -12.46 32.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.309 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 80.0 p -92.57 100.93 13.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.36 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.413 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 9.1 p -116.74 151.45 47.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.07 -31.87 93.99 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.844 2.362 . . . . 0.0 111.966 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.92 -41.47 51.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.413 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 39.1 m -60.74 -41.15 94.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.56 -48.93 77.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.522 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.41 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.432 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 7.5 tt -59.56 -48.29 82.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.47 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -59.97 -41.77 92.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.21 -33.15 74.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.76 -51.38 49.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.548 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.89 -34.63 74.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -58.03 -40.33 80.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.382 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.6 -37.13 82.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -63.91 -20.11 65.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.09 19.39 19.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.614 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 6.0 m-85 -88.51 133.6 34.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.52 177.75 5.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 55.05 53.67 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.86 24.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.45 167.51 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 p -66.05 -25.27 66.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 109.37 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.9 p -70.9 -46.17 63.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.01 -34.52 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 43.1 t -68.12 -46.0 72.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.317 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.07 -42.49 99.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.1 m -57.57 -32.6 67.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.28 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -31.25 69.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.446 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 25.5 mtt -68.5 -53.95 19.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.523 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 1.9 pp0? -62.39 -36.46 82.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.704 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.478 ' N ' ' CD ' ' A' ' 167' ' ' GLN . . . -74.71 -38.96 62.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.744 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.487 ' HG ' ' CD1' ' A' ' 171' ' ' LEU . 10.3 t -74.54 -29.05 61.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.444 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.14 56.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.487 ' CD1' ' HG ' ' A' ' 169' ' ' CYS . 1.1 mp -52.69 -52.88 54.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 0.0 109.39 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.1 m -91.9 135.84 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -82.67 105.03 13.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -93.71 123.92 37.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CD2' ' CD2' ' A' ' 182' ' ' TYR . 1.9 p-80 -164.06 159.23 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -111.39 122.73 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' A' ' 178' ' ' GLY . 8.6 p -70.19 -40.02 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 177' ' ' VAL . . . -60.03 -18.94 49.6 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 96.5 m -86.37 -176.67 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.503 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.6 t -106.12 -21.77 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.523 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.7 t -54.27 -33.92 59.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 1.1 t80 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 3' ' ' ARG . 23.9 ptt-85 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.555 ' C ' ' H ' ' A' ' 6' ' ' TRP . 4.1 m -96.87 -155.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.88 -16.18 0.86 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.555 ' H ' ' C ' ' A' ' 4' ' ' CYS . 26.6 m95 44.46 37.8 2.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.183 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 ' CG2' HH21 ' A' ' 3' ' ' ARG . 11.5 m -64.91 126.74 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' GLN . 29.4 t -164.08 156.84 17.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' SER . 41.3 tt0 56.94 159.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 109.561 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.2 72.74 0.82 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.9 -28.78 13.83 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.844 2.363 . . . . 0.0 112.147 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.36 -39.32 94.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.72 -46.54 78.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.56 -48.78 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.383 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.77 -36.77 76.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.52 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -59.89 -44.11 94.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.484 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.15 -49.05 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -64.53 -40.28 95.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -64.42 -64.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.519 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.9 mm-40 -140.13 -151.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 20' ' ' GLU . 27.1 t-105 62.19 130.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.475 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.62 -17.69 58.51 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.8 m -78.11 149.69 76.72 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.416 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.01 119.41 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.858 2.372 . . . . 0.0 111.785 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.6 133.41 56.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.985 . . . . 0.0 109.809 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 p -134.46 9.09 3.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.033 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.73 141.49 31.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.501 ' HG ' ' H ' ' A' ' 113' ' ' ALA . 14.9 m -68.63 -36.38 78.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -58.97 -52.43 65.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -40.29 96.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.66 -39.38 80.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.11 -0.994 . . . . 0.0 109.871 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -67.1 -54.24 23.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.873 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -71.11 -31.46 67.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.4 tpp -60.04 -53.75 54.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 109.676 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 18.3 tt -82.76 -42.99 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.062 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 33.7 t -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.944 . . . . 0.0 110.044 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.6 -40.42 76.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.867 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -59.91 -24.35 64.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.802 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.43 -28.72 3.5 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.18 -31.64 72.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.24 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -47.98 -34.41 9.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.78 111.33 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.727 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.61 -39.24 2.84 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -105.78 -138.15 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.7 t -141.73 155.26 45.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 22.7 p90 -55.54 -31.85 62.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -58.57 -39.64 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.7 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -73.28 -32.26 64.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.9 t -58.69 -37.68 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.7 mt -53.83 -55.49 26.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -59.27 -42.19 90.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -21.59 60.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.376 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 49' ' ' VAL . 7.9 ttt-85 -58.62 -47.64 83.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.209 -0.932 . . . . 0.0 108.99 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.63 -41.02 76.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -66.05 -50.72 63.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.269 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 28.0 t80 -60.45 -37.51 81.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.379 -0.826 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 40.8 ttp180 -55.83 -38.12 69.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.859 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.25 53.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.07 -11.69 35.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 110.286 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 56.4 m-85 -130.04 -51.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.97 -1.082 . . . . 0.0 110.193 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.2 t-80 -49.25 -38.3 26.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.083 -1.01 . . . . 0.0 109.909 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -55.45 -37.44 67.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.781 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.09 -16.79 52.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.866 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 63.99 132.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.064 -1.022 . . . . 0.0 109.578 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.33 -34.5 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.904 2.402 . . . . 0.0 112.688 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.2 t -55.16 -49.35 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mtpt -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -58.09 -42.17 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.595 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.83 -42.24 67.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.25 23.91 8.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.1 ttm -62.36 163.04 9.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -109.9 154.22 23.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -34.92 69.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.28 -37.38 85.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.456 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -60.13 -44.11 95.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.5 t -56.41 -43.18 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.596 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.15 -33.46 74.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.315 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -58.89 -44.23 91.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.799 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.32 -32.6 64.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.3 t -51.78 -36.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.763 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -75.57 -62.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -99.89 107.84 19.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.423 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -175.62 75.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.397 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.66 10.4 1.51 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.518 ' H ' ' C ' ' A' ' 83' ' ' ALA . 5.1 pt -79.59 -175.92 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -1.146 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 67.6 mt -83.34 -2.33 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -66.88 145.58 55.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.427 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' O ' ' N ' ' A' ' 90' ' ' GLY . 53.0 m80 -141.96 70.52 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.133 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.427 ' HG3' HH11 ' A' ' 89' ' ' ARG . 27.2 ttm-85 59.02 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.397 -0.814 . . . . 0.0 109.927 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -56.57 -37.48 75.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -59.59 -45.47 91.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 92' ' ' ILE . 74.8 mt -56.73 -44.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.629 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.332 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.21 -36.31 79.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.419 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.9 mm -69.03 -44.52 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 96' ' ' ILE . 28.8 mm -54.96 -47.93 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 109.543 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.42 -42.92 99.88 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 23.9 m120 -58.86 -43.77 90.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -1.207 . . . . 0.0 109.42 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.71 92.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.57 -44.28 91.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.4 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.11 -53.74 7.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -56.99 -44.71 83.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -61.04 -33.87 73.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -62.33 -35.87 80.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' N ' ' A' ' 108' ' ' ASN . 84.3 tt0 -70.82 -30.77 67.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -51.89 -14.38 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.561 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 106' ' ' GLU . 77.7 m-20 -75.97 -14.98 60.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 36.6 18.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -138.75 152.17 70.09 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.76 119.12 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.612 2.208 . . . . 0.0 111.685 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -74.57 -43.51 55.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.0 110.465 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' H ' ' HG ' ' A' ' 28' ' ' SER . . . -63.42 -47.21 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.168 -0.958 . . . . 0.0 110.772 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.564 ' O ' ' OG ' ' A' ' 118' ' ' SER . 53.6 t0 -54.9 -37.7 66.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 111.056 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 -48.35 39.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.088 -1.008 . . . . 0.0 111.221 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 3.6 m -53.96 -49.35 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.058 -1.026 . . . . 0.0 111.679 -175.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.431 ' H ' HG22 ' A' ' 116' ' ' VAL . 21.9 p-90 -87.69 -24.94 23.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.729 -1.232 . . . . 0.0 111.09 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 6.8 m -56.02 -23.95 36.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.783 -1.198 . . . . 0.0 109.708 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -44.46 -15.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.166 -0.958 . . . . 0.0 110.076 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.3 m -88.15 24.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.001 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 1.6 m120 72.14 38.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 109.641 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 51.4 p-80 41.96 40.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.579 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -147.52 148.09 30.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.542 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.42 135.58 36.99 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.671 2.247 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.448 HE22 ' CB ' ' A' ' 141' ' ' ALA . 86.3 mt-30 -100.08 148.41 24.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.776 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.6 ptm -133.27 156.68 47.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.447 -0.783 . . . . 0.0 109.155 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 t -124.03 163.3 21.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.921 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -137.69 54.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.99 -158.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.663 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.536 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 6.4 m -140.9 -29.6 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.34 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 m -135.06 161.17 36.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.469 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.4 mt -73.58 -16.73 61.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.84 -41.21 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.8 pt-20 -71.93 -26.04 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.174 -0.954 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.0 117.45 48.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.03 131.28 5.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.096 2.53 . . . . 0.0 112.563 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -13.38 59.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.259 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.2 m -94.73 101.87 13.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.91 154.62 49.64 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.05 -42.68 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.843 2.362 . . . . 0.0 112.009 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.448 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -75.73 -41.38 53.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -62.05 -42.53 99.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.412 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 44.1 t0 -62.87 -45.24 93.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.17 80.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.6 tp -57.96 -50.9 71.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.3 p -58.6 -39.36 80.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.55 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 60.7 mttp -60.69 -32.72 71.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.06 -55.11 10.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 9.5 mp -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.626 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.63 -41.38 85.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.419 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.01 -35.45 80.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.494 HH11 ' HG3' ' A' ' 152' ' ' ARG . 26.6 ttm-85 -63.86 -21.75 66.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.8 21.47 8.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.69 136.76 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -1.112 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 1.8 mptm? -97.67 -169.64 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 16.5 p90 39.47 41.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -96.38 25.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.54 154.58 1.21 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.7 m -55.87 -28.03 54.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.423 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -48.33 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.9 mp -58.74 -44.24 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 109.438 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 2.2 t -62.64 -49.04 76.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -62.74 -40.0 95.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.364 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -60.71 -38.65 85.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 165' ' ' PHE . 0.8 OUTLIER -61.12 -43.63 98.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.529 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.3 mtp -59.33 -40.2 85.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.75 -34.16 77.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.31 -63.2 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.685 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.8 t -63.26 -40.31 97.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.98 21.64 15.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.8 mt -54.17 -35.1 61.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.395 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.18 133.95 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.546 ' OD1' ' ND1' ' A' ' 175' ' ' HIS . 5.8 t-20 -81.48 100.96 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.45 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -86.26 118.46 25.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.546 ' ND1' ' OD1' ' A' ' 173' ' ' ASN . 15.0 m170 -147.62 162.22 39.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.519 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.82 132.71 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 83.3 t -71.88 -39.25 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.495 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.91 28.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 29.7 t -91.03 167.29 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -1.138 . . . . 0.0 109.49 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.3 p -90.84 -37.87 13.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.503 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 182' ' ' TYR . 17.0 p -53.31 -35.9 60.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.464 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 39.8 t80 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HG3' HH11 ' A' ' 3' ' ' ARG . 50.7 mtm-85 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.08 -164.83 1.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.387 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.12 3.24 63.71 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.608 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 1.4 m0 47.83 42.89 16.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.477 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 8' ' ' SER . 33.2 m -66.29 127.99 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER 166.6 178.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.497 ' N ' ' OG ' ' A' ' 8' ' ' SER . 49.4 tp60 59.41 -127.86 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.12 150.74 91.66 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 -11.63 26.29 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.159 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.75 -33.08 74.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.555 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 42.3 m-85 -54.16 -46.47 72.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.444 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.93 -28.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.4 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -56.84 -47.14 81.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CD1' ' C ' ' A' ' 16' ' ' TYR . 1.3 p90 -75.76 -38.73 58.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.502 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.552 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 83.9 t60 -54.16 -46.27 72.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.498 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -71.38 -34.51 70.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.514 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 3.1 m120 -61.81 -62.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.545 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TRP . 10.3 pt-20 -174.04 -115.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.487 ' O ' ' O ' ' A' ' 20' ' ' GLU . 34.5 t-105 60.07 130.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.524 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.81 60.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.7 OUTLIER -76.89 152.74 82.77 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.264 -1.139 . . . . 0.0 109.376 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 123.01 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.752 2.301 . . . . 0.0 111.857 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -108.57 135.22 50.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.858 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -134.94 5.32 3.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 109.038 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.91 128.45 35.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.277 -0.889 . . . . 0.0 109.296 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.536 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -61.71 -55.89 25.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.581 -178.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' CB ' ' HZ3' ' A' ' 29' ' ' LYS . 9.6 mtpm? -62.73 -43.63 98.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.708 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.619 ' NZ ' ' NH2' ' A' ' 53' ' ' ARG . 15.9 tptp -64.63 -44.35 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.85 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.3 tp -60.87 -42.07 97.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.85 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.9 m-30 -60.34 -35.89 76.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 0.0 109.892 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.76 -30.06 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.819 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.0 tpp -74.34 -56.23 5.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.837 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 tp -61.69 -36.7 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.59 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 75.9 m -71.72 -44.72 63.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.6 tp -73.53 -39.8 64.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.977 . . . . 0.0 109.876 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 50.1 mm-40 -53.71 -34.56 59.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.775 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.72 -34.27 56.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -64.22 -29.14 70.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.161 . . . . 0.0 109.778 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.1 tt0 -49.04 -31.01 6.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.759 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.99 110.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -31.84 6.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 41' ' ' GLN . 19.4 mt -99.47 -150.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.8 m -145.98 161.34 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -52.39 -41.25 62.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -51.9 -40.99 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -75.65 -34.63 60.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.71 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' ARG . 93.3 t -59.65 -44.21 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' HZ1' ' CD1' ' A' ' 47' ' ' ILE . 46.5 mttp -59.36 -49.39 78.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' TYR . 45.4 mmtm -72.51 -22.5 61.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.334 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.619 ' NH2' ' NZ ' ' A' ' 30' ' ' LYS . 3.8 ttt-85 -57.57 -44.29 85.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.111 -0.993 . . . . 0.0 108.975 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.11 -44.56 65.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -66.38 -35.03 79.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.242 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 29.4 t80 -57.06 -49.25 76.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.468 -0.77 . . . . 0.0 109.379 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 80.4 mtm180 -59.67 -41.37 90.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.06 39.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.213 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.9 m -95.9 -33.97 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 30.1 m-85 -86.05 -32.85 21.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.047 -1.033 . . . . 0.0 110.233 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 85.5 t60 -47.47 -16.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 60' ' ' PHE . 7.2 pt20 -100.35 -22.07 15.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.818 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 64' ' ' ASP . 60.0 m-85 -99.94 68.79 1.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.077 -1.015 . . . . 0.0 109.871 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 63' ' ' PHE . 4.9 m-20 -41.42 154.3 0.24 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.995 . . . . 0.0 109.607 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -34.46 -53.97 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.948 2.432 . . . . 0.0 112.627 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.82 -44.76 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.125 -0.984 . . . . 0.0 109.632 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.7 -32.78 74.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.34 -43.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.617 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.497 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.41 -3.1 58.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.6 mtp -55.74 146.68 20.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.2 tp60 -105.97 166.46 10.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 97.2 mt-10 -63.25 -29.31 70.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.442 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.41 -37.16 84.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 109.441 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.63 -39.28 80.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.421 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.82 -44.14 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -56.98 -37.25 71.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.377 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -61.05 -44.09 97.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.416 -0.803 . . . . 0.0 109.81 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.8 mt -73.78 -33.07 64.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.9 t -50.55 -35.63 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.953 . . . . 0.0 109.788 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -88.93 -50.19 6.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.089 -1.007 . . . . 0.0 109.568 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.5 m-20 -71.33 153.27 42.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.38 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.12 26.65 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -47.33 -34.74 9.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.3 pt -148.61 -174.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.343 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.47 138.04 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -89.92 106.88 18.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 109.445 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CD2' ' H ' ' A' ' 90' ' ' GLY . 20.2 t-160 -176.34 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -45.02 -34.72 2.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.894 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.49 ' H ' ' CD2' ' A' ' 88' ' ' HIS . . . -66.86 -44.52 88.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -66.44 -43.12 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.491 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.94 -46.67 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -59.71 -33.22 71.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.42 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.99 90.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.13 -44.79 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.05 -45.82 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.22 -38.06 95.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 6.9 t30 -57.64 -40.87 80.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.356 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.71 95.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.57 -40.81 75.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.77 -31.97 73.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.486 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.557 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 22.6 t80 -62.1 -48.4 80.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.3 mm? -58.35 -37.4 75.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 109.488 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -61.28 -51.71 67.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.606 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 27.3 ttt -69.97 -39.45 75.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.36 -26.78 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 109.443 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -51.7 -25.11 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.14 -19.0 58.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.496 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.58 17.47 68.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.11 152.74 38.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.151 -1.205 . . . . 0.0 109.741 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.83 122.92 10.63 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.641 2.228 . . . . 0.0 111.669 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.606 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 26.3 t80 -76.73 -42.16 42.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.68 39.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 118' ' ' SER . 43.8 t0 -53.01 -33.32 51.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.012 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 16.2 t80 -76.24 -52.28 10.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.036 -1.04 . . . . 0.0 111.223 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.56 -50.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.972 -1.08 . . . . 0.0 111.683 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 7.6 p-90 -82.05 -31.12 31.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.709 -1.244 . . . . 0.0 111.163 -176.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 18.0 t -56.28 -24.01 40.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.871 -1.143 . . . . 0.0 109.785 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -43.11 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.279 -0.888 . . . . 0.0 110.083 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 118' ' ' SER . 19.5 m -83.11 24.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.973 -1.079 . . . . 0.0 110.003 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 67.35 36.23 4.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 118' ' ' SER . 74.0 m-70 53.82 26.16 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -142.89 103.67 5.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.75 147.61 4.46 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.685 2.257 . . . . 0.0 111.808 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -95.83 157.97 15.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.727 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -121.95 142.49 50.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 173' ' ' ASN . 2.7 t -86.14 160.19 19.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.938 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -141.73 46.83 1.67 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.79 135.75 42.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.8 m -76.8 -30.22 56.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.353 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -133.39 175.75 9.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.6 mt -67.79 -31.92 72.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.556 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.1 p -63.51 -34.86 78.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -73.51 -21.6 60.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.125 -0.985 . . . . 0.0 109.435 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.96 120.02 68.55 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.758 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.28 136.53 7.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.11 2.54 . . . . 0.0 112.561 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.15 4.78 53.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.325 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.9 t -137.14 90.74 2.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.59 156.27 39.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.74 -40.08 24.18 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.777 2.318 . . . . 0.0 112.03 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.96 -38.38 66.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.307 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.6 t -62.54 -47.38 84.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.03 -45.45 92.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.88 75.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.53 -46.64 78.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.537 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.3 t -56.09 -43.73 78.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.547 ' CB ' ' HZ2' ' A' ' 147' ' ' LYS . 2.9 ttmp? -61.22 -35.96 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.08 -52.41 35.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 mp -66.29 -37.13 84.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.38 -0.825 . . . . 0.0 109.546 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -62.45 -37.23 85.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.333 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.62 -37.58 86.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 0.0 109.441 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.608 ' NH2' ' CE1' ' A' ' 115' ' ' PHE . 99.3 mtt180 -63.77 -23.41 67.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.46 12.21 9.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -78.41 135.01 37.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -1.108 . . . . 0.0 109.51 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 19.9 tptt -101.35 -166.19 1.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 14.6 p90 37.83 33.95 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.407 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -101.77 24.89 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.388 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.62 157.0 1.67 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.7 m -53.61 -31.01 45.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.0 m -63.53 -47.18 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.493 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -64.98 -40.53 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.4 -41.05 96.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.319 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.5 -46.41 90.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.288 -0.883 . . . . 0.0 109.306 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.469 ' HG ' ' N ' ' A' ' 165' ' ' PHE . 95.5 p -60.74 -36.8 79.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.469 ' N ' ' HG ' ' A' ' 164' ' ' SER . 5.6 t80 -62.02 -49.42 76.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.8 mtp -59.95 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.97 -46.05 90.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.429 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . . . -72.62 -43.61 63.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.671 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' VAL . 13.6 t -58.13 -29.56 65.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.986 . . . . 0.0 109.425 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 0.33 61.3 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.7 mp -55.07 -43.29 73.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -1.17 . . . . 0.0 109.428 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.99 135.97 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 173' ' ' ASN . 1.8 m120 -86.43 117.89 25.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 42.1 p-10 -91.86 93.43 8.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -149.23 130.98 15.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.55 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 26.3 m -100.02 139.75 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.23 -33.77 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.11 65.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 176' ' ' VAL . 12.6 p -79.09 129.63 34.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.548 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 71.2 m -63.1 -29.67 70.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.9 t -48.73 -28.74 3.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 1.2 t80 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.619 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.7 p -43.35 159.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -125.98 -17.93 2.44 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -65.58 5.16 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 5' ' ' GLY . 4.6 t -63.32 140.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 p -61.8 151.29 34.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 109.475 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.81 -31.69 68.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -49.14 143.49 9.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.444 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.08 -28.5 12.8 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.898 2.399 . . . . 0.0 112.161 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.4 tp -62.13 -39.97 94.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.71 -49.13 67.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.91 . . . . 0.0 109.427 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 14' ' ' ILE . 80.8 mt -67.59 -40.9 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.69 -36.66 84.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -62.12 -43.09 99.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -60.92 -42.89 98.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.463 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.99 -39.45 85.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -63.63 -55.37 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -175.84 130.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.95 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -173.92 122.14 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.75 -0.03 79.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 169' ' ' CYS . 6.6 m -80.42 148.62 66.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.291 -1.123 . . . . 0.0 109.33 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 119.7 6.68 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.754 2.303 . . . . 0.0 111.857 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.26 130.86 53.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.832 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -117.05 4.09 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.865 . . . . 0.0 109.006 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -78.53 116.84 19.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 76.1 p -61.58 -33.52 74.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.599 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -58.04 -47.15 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -70.28 -48.8 55.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.09 -39.77 93.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 61.5 t80 -60.3 -45.0 94.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.893 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.59 -31.67 72.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 109.88 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.52 -53.22 57.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.805 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.84 -42.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.025 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.589 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 12.1 m -62.27 -51.74 66.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 mt -76.07 -42.4 47.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 161' ' ' ILE . 44.2 tt0 -54.25 -36.49 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.797 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.46 -32.97 61.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.54 -27.56 69.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -1.22 . . . . 0.0 109.718 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -48.53 -36.9 16.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 109.624 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.47 114.71 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.659 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.59 -33.36 5.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 mt -97.44 -141.83 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -1.17 . . . . 0.0 109.43 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.0 p -147.3 154.49 41.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -50.88 -45.03 59.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.219 -0.925 . . . . 0.0 109.494 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.8 tp -55.35 -34.77 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.684 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.1 m -72.02 -35.08 69.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.0 t -59.19 -49.06 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.49 -50.84 70.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -59.37 -48.45 81.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.304 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -69.36 -30.57 68.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HG2' HH11 ' A' ' 53' ' ' ARG . 20.2 ttt-85 -50.99 -46.27 61.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 108.943 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.33 -44.22 72.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.355 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.58 -41.51 98.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.479 ' CD2' ' CE2' ' A' ' 60' ' ' PHE . 3.3 m-85 -55.87 -49.68 72.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.393 -0.817 . . . . 0.0 109.369 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' HIS . 58.8 mtp180 -51.72 -45.04 63.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.782 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.75 -43.14 47.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.1 m -96.4 -27.55 14.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.278 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.479 ' CE2' ' CD2' ' A' ' 56' ' ' TYR . 38.9 m-85 -92.36 -34.38 14.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.093 . . . . 0.0 110.133 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 86.5 t60 -48.29 -38.92 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -68.4 -34.12 75.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.716 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 64' ' ' ASP . 40.2 m-85 -88.9 62.97 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.85 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -39.77 159.0 0.13 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 109.558 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -38.61 -53.45 1.82 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.923 2.415 . . . . 0.0 112.651 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.9 t -53.36 -44.63 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -66.71 -34.39 77.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.23 -48.77 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 109.661 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.32 63.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.49 7.07 43.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.426 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 41.9 ttm -57.06 146.97 25.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' OE1' ' OE2' ' A' ' 74' ' ' GLU . 95.3 mt-30 -107.44 162.02 14.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.07 -28.51 70.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' OE1' ' A' ' 72' ' ' GLN . 24.9 pt-20 -72.29 -27.76 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.81 -47.71 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 m -64.05 -36.85 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.521 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -54.82 -37.97 66.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -70.05 -43.74 70.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.367 -0.833 . . . . 0.0 109.803 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.04 -41.45 74.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.99 . . . . 0.0 109.692 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -50.86 -36.3 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.31 -62.41 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -99.84 114.14 27.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.92 79.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -25.95 7.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' GLY . 22.1 pt -57.85 -160.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.249 -1.147 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.98 132.67 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.52 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.0 ptm180 -102.48 136.33 42.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.16 100.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.152 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -47.51 -30.28 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.923 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.8 -48.82 15.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.61 -43.39 98.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -1.145 . . . . 0.0 109.489 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.47 -55.33 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.628 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -58.17 -31.58 67.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.72 93.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 109.39 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.5 -41.7 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.426 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 70.9 mt -55.4 -54.3 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.82 94.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.589 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -58.03 -40.29 80.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -70.75 -37.05 73.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.04 -43.42 98.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.0 -33.85 72.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 19.4 t80 -69.84 -46.66 65.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 109.527 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.87 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 28.1 ttt -61.71 -41.53 97.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.485 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.1 -27.09 63.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -52.07 -21.82 3.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.513 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.46 -13.71 60.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.7 4.55 72.74 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.46 167.25 16.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -1.213 . . . . 0.0 109.696 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.76 118.55 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.546 2.164 . . . . 0.0 111.704 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 36.4 t80 -66.35 -44.23 83.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.467 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.47 89.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.774 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 24.7 t70 -53.41 -54.43 36.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 111.082 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -39.06 68.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.998 -1.064 . . . . 0.0 111.313 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.02 -60.4 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.997 -1.064 . . . . 0.0 111.676 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -87.99 -20.99 25.1 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.759 -1.213 . . . . 0.0 111.151 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 58.3 m -56.93 -32.25 65.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.838 -1.164 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -45.89 -14.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 118' ' ' SER . 13.5 m -82.23 24.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.1 -1.0 . . . . 0.0 109.949 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 71.95 29.65 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 109.764 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.1 t60 53.9 31.98 14.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 0.0 109.59 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.461 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 39.1 mt-30 -150.32 121.52 3.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.97 153.26 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.732 2.288 . . . . 0.0 111.809 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 91.9 mm-40 -110.89 148.22 32.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.731 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.595 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 31.5 tpp -120.85 135.06 55.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.103 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -85.94 164.17 17.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.449 ' NE2' ' OH ' ' A' ' 182' ' ' TYR . 76.1 mm-40 -142.91 43.08 1.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.835 . . . . 0.0 109.364 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.18 -164.6 1.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.478 ' N ' ' OE2' ' A' ' 134' ' ' GLU . 40.3 m -158.91 -26.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.573 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.3 m -115.36 158.13 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.92 -13.78 60.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -92.87 -32.87 14.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 131' ' ' THR . 6.5 pt-20 -77.36 3.56 12.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -0.964 . . . . 0.0 109.409 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 135' ' ' ILE . 46.6 mm -65.89 126.09 91.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.695 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.12 128.24 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.159 2.573 . . . . 0.0 112.512 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.0 t -101.07 7.86 43.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 t -144.34 88.98 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.396 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.95 160.98 32.71 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.43 -40.29 28.93 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.801 2.334 . . . . 0.0 112.01 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.85 75.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.347 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 t -61.39 -46.95 88.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 147' ' ' LYS . 24.4 t70 -61.49 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.88 83.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.3 tt -65.82 -39.79 91.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 109.537 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -55.66 -48.95 74.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' NZ ' ' OD2' ' A' ' 143' ' ' ASP . 61.0 mttp -62.96 -28.8 70.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.52 -47.51 69.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -57.45 -37.88 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -61.33 -40.06 92.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.402 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -68.06 -19.99 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 109.377 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.05 26.25 19.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.23 135.87 33.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -101.73 175.0 5.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 55.66 46.92 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' GLY . 25.8 m -120.18 25.93 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.62 164.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.2 m -53.84 -31.27 48.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -1.089 . . . . 0.0 109.386 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 -47.3 76.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.497 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -63.83 -36.32 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.5 m -67.99 -48.82 64.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.287 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.92 -41.56 98.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.416 -0.803 . . . . 0.0 109.316 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.0 m -59.13 -38.5 79.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -60.68 -45.68 93.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mmm -58.91 -41.83 88.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.611 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.02 -31.34 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' VAL . 2.5 p -80.74 -63.98 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 109.472 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.722 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 158.04 -98.78 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mt 61.52 -22.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.722 ' H ' ' C ' ' A' ' 170' ' ' GLY . 12.9 m -132.39 143.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.595 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 6.1 m-20 -92.53 102.18 14.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.407 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.39 97.34 11.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.496 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.53 141.08 32.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 m -94.63 136.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.77 138.19 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.62 2.95 62.95 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 180' ' ' CYS . 7.6 m -153.24 155.06 35.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -1.163 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 1.7 t 71.01 3.87 4.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 3.2 m 62.71 56.36 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.538 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.458 HH21 ' CD1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.261 0.553 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 m -52.59 166.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.62 -17.53 61.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.506 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -76.51 6.91 5.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.427 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.83 133.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -71.47 162.56 29.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.935 . . . . 0.0 109.447 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.57 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 0.7 OUTLIER -84.07 1.23 44.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.92 144.87 73.12 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.74 -17.15 26.17 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.893 2.395 . . . . 0.0 112.102 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.81 -46.71 14.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -66.42 -44.58 82.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.434 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 15' ' ' ALA . 15.2 tt -59.78 -42.17 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 14' ' ' ILE . . . -72.43 -41.59 66.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.504 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' OH ' ' NE1' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -59.62 -37.53 78.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.47 -43.45 85.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.7 p30 -91.63 1.09 57.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ALA . 31.5 t30 -63.59 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -153.08 -16.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.573 ' NE1' ' OH ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -50.13 145.89 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.32 -5.51 62.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.61 119.06 65.75 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.243 -1.151 . . . . 0.0 109.335 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.15 121.01 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.806 2.337 . . . . 0.0 111.855 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -103.72 138.92 39.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -134.63 0.31 2.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.033 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -81.26 118.7 22.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -53.81 -37.85 63.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.22 -42.09 94.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -70.98 -48.81 51.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.49 -36.69 85.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.817 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -61.42 -50.81 71.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 109.917 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.11 -28.97 65.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.421 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 47.5 tpp -57.28 -52.6 64.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.795 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 2.8 tp -65.83 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.971 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 78.4 m -74.48 -38.87 62.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.096 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.07 -50.08 51.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 109.887 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -62.82 -27.89 69.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.8 -33.97 28.62 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.79 -27.54 69.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.263 . . . . 0.0 109.776 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 7.1 tt0 -50.37 -41.3 51.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.93 112.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.669 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.17 -37.16 3.63 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.88 -140.4 0.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.172 . . . . 0.0 109.41 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 p -141.59 159.92 41.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.512 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 74.9 t-105 -57.08 -44.62 83.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.484 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 tp -56.87 -34.61 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.722 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.4 m -70.63 -34.62 72.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.96 . . . . 0.0 109.723 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.3 t -70.16 -44.3 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.1 mt -53.26 -53.97 43.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.8 -45.6 82.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.097 -1.002 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' NZ ' ' O ' ' A' ' 85' ' ' ILE . 63.5 mttm -79.79 -11.55 59.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 49' ' ' VAL . 27.5 ttt-85 -64.65 -48.54 74.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.189 -0.944 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -72.61 -39.25 67.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.809 . . . . 0.0 109.307 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -70.07 -41.55 73.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.294 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 32.2 t80 -60.2 -44.75 94.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.407 -0.808 . . . . 0.0 109.375 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' HIS . 52.2 mtp180 -58.57 -38.49 78.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.849 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.06 80.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 1.9 p -93.4 -12.83 28.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 37.6 m-85 -117.0 -54.21 2.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.941 -1.1 . . . . 0.0 110.173 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ARG . 74.8 t60 -54.87 -42.15 71.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.112 -0.992 . . . . 0.0 109.882 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -57.37 -35.26 69.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 46.8 m-85 -72.57 -22.7 60.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 131.44 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.005 . . . . 0.0 109.608 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -40.52 -34.29 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.93 2.42 . . . . 0.0 112.701 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.7 t -56.34 -49.77 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' MET . 53.6 mtpt -73.24 -30.27 63.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.848 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.519 ' O ' ' SD ' ' A' ' 71' ' ' MET . 62.1 t -56.02 -44.15 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.41 42.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.65 34.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 9.6 ptm -61.64 144.91 53.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.701 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -95.22 171.36 8.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.578 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.67 -33.53 68.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.451 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 74' ' ' GLU . 49.3 mp0 -56.07 -36.91 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.86 -38.28 90.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.3 t -59.47 -44.51 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.1 -34.94 79.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.187 -0.945 . . . . 0.0 109.338 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -58.8 -43.86 90.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.338 -0.852 . . . . 0.0 109.783 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.8 mt -69.58 -32.63 71.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.97 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.15 -32.95 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -92.93 -51.96 4.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 87.4 m-20 -90.89 155.65 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.361 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 74.73 84.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -70.42 25.99 0.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.594 ' H ' ' C ' ' A' ' 83' ' ' ALA . 2.5 pt -47.18 -97.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -1.176 . . . . 0.0 109.312 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.408 ' H ' ' CG1' ' A' ' 85' ' ' ILE . 14.4 tt -114.55 131.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.619 HH11 ' HG2' ' A' ' 87' ' ' ARG . 8.9 mtt-85 -86.36 94.11 9.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -173.44 80.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -47.16 -33.8 5.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.938 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.01 -42.7 97.06 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -63.5 -44.53 94.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -1.193 . . . . 0.0 109.489 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.85 -43.71 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -57.16 -37.24 71.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.91 88.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.384 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.421 HG21 HD11 ' A' ' 95' ' ' ILE . 27.2 mm -57.56 -42.71 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.83 . . . . 0.0 109.44 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.561 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 26.9 mm -54.1 -50.17 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.91 -32.2 80.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 24.4 m120 -62.86 -46.91 85.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -1.177 . . . . 0.0 109.414 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.77 83.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -64.57 -39.59 94.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.4 61.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.535 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -68.8 -48.39 63.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.55 -41.48 90.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.59 -38.87 91.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.543 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -35.39 80.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.44 -29.46 68.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -51.77 -19.88 1.87 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.496 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -75.73 -17.85 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.54 63.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.39 151.13 42.48 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -1.154 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -68.43 119.35 6.35 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.636 2.224 . . . . 0.0 111.675 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -74.32 -40.19 62.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.504 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.93 -49.99 73.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 118' ' ' SER . 89.5 m-20 -57.84 -54.3 48.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 111.064 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 57.8 t80 -53.69 -42.46 68.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 111.256 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.38 -59.56 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.974 -1.079 . . . . 0.0 111.662 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 113' ' ' ALA . 59.2 p-90 -88.22 -21.28 24.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.735 -1.228 . . . . 0.0 111.122 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' VAL . 72.7 p -58.94 -28.59 66.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.825 -1.172 . . . . 0.0 109.77 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.01 -14.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.01 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 118' ' ' SER . 13.4 m -84.17 24.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.041 -1.037 . . . . 0.0 109.974 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.3 t-20 72.52 31.35 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.682 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 81.9 t60 53.05 33.47 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.539 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -142.52 106.5 5.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.558 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -46.61 151.58 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.611 2.207 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.79 143.53 29.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.723 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.3 ttm -126.76 130.38 50.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.843 . . . . 0.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.18 164.75 12.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.875 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -164.03 41.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 109.3 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.37 -176.72 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 109.67 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -76.53 -41.48 46.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.398 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 t -147.44 175.0 11.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.11 -32.18 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.4 p -57.46 -38.03 73.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.444 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.54 -32.01 72.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.47 131.96 89.73 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.78 138.59 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.152 2.568 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -84.59 4.25 33.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -140.96 88.47 2.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.4 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -94.9 174.8 3.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 139' ' ' THR . 35.9 Cg_exo -56.9 -42.24 66.66 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.07 74.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 t -60.97 -48.84 79.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.14 -41.36 94.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.04 89.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.2 tp -60.45 -48.27 82.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 21.3 t -55.33 -43.67 75.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -59.29 -37.87 78.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.544 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.24 -51.67 28.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 109.593 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -59.12 -41.68 88.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.09 -37.38 86.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.542 ' NH2' ' CE1' ' A' ' 115' ' ' PHE . 28.2 mtt-85 -64.15 -21.4 66.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.342 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.02 6.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 10.0 m-85 -96.1 137.08 35.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -1.116 . . . . 0.0 109.475 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -94.59 -166.98 1.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 31.6 p90 40.03 37.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 146' ' ' SER . 0.8 OUTLIER -100.52 24.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.423 179.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.21 158.93 3.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -57.82 -29.82 65.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.1 m -66.94 -44.85 79.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -63.28 -37.79 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.15 -41.14 92.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.56 -44.01 97.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.431 -0.793 . . . . 0.0 109.337 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 22.9 t -57.71 -38.02 74.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -59.25 -41.77 89.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.399 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 57.6 mtt -63.91 -38.39 90.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.632 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -59.19 -38.94 81.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.687 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -80.44 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.542 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 37.3 t -49.96 -43.38 50.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.495 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.83 15.66 26.0 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.542 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.0 mp -51.71 -51.1 58.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.4 m -90.88 136.31 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -85.6 103.39 14.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.932 . . . . 0.0 109.447 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 63.6 t0 -96.52 115.43 27.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.526 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 51.2 m80 -159.82 15.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 175' ' ' HIS . 9.4 t 52.49 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.428 ' H ' ' CG1' ' A' ' 176' ' ' VAL . 10.4 p -94.94 -8.86 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.03 47.6 0.71 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 181' ' ' CYS . 4.8 t -146.49 170.11 17.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 109.516 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 72.1 m 53.55 -86.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.539 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.1 p -166.05 36.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.596 179.913 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.598 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.01 161.35 30.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.56 -5.79 86.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -54.39 -33.64 59.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.483 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.03 137.08 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.591 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 17.4 p -157.53 -136.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.505 ' N ' ' OG ' ' A' ' 8' ' ' SER . 51.7 mt-30 -61.22 -147.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.533 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 53.61 74.62 0.73 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.36 -27.62 13.89 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.9 2.4 . . . . 0.0 112.108 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.17 -39.1 65.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.465 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -65.82 -53.75 35.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 pt -63.79 -33.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.355 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.28 -43.71 83.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -72.87 -44.57 61.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 109.478 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.599 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 30.0 t-80 -64.0 -49.42 72.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.84 -34.06 74.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -65.38 -69.62 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.526 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.83 119.13 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.599 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 77.7 t90 -172.65 128.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.42 83.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.2 114.91 64.83 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.4 120.48 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.75 2.3 . . . . 0.0 111.896 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -101.65 128.91 47.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.85 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.6 p -103.09 -4.4 24.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -79.71 117.81 20.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 0.0 109.367 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.0 m -59.64 -34.08 72.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 109.628 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.02 -46.23 85.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.87 -44.17 73.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.67 -47.18 82.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.835 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -60.7 -42.17 96.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.837 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -73.46 -30.46 63.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.6 tpp -63.0 -54.63 35.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 109.803 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.01 -35.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.998 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.0 m -71.92 -44.21 64.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.072 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.7 -43.32 72.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -0.994 . . . . 0.0 109.845 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.31 -31.18 70.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.788 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.3 -32.94 22.8 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.2 -29.34 70.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -1.215 . . . . 0.0 109.7 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.5 pp0? -51.92 -23.4 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.662 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.14 109.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 0.0 109.684 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.05 -32.23 5.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 23.2 mt -105.79 160.98 14.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 p -89.06 157.09 18.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.425 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -56.32 -29.6 61.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -56.16 -38.05 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.686 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.5 m -74.46 -33.14 62.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -58.27 -35.01 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.44 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.2 mt -54.69 -51.4 65.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.34 -46.32 89.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 56' ' ' TYR . 68.0 mmtt -71.18 -22.74 61.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.37 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.593 HH11 ' CG ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -59.17 -47.59 84.74 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 109.001 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 57' ' ' ARG . 78.0 mm-40 -66.6 -44.35 82.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.398 -0.814 . . . . 0.0 109.394 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.6 -32.72 71.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.245 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.643 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 60.4 t80 -64.27 -45.96 85.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.464 -0.773 . . . . 0.0 109.403 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 54' ' ' GLU . 58.4 mtm180 -58.27 -42.3 86.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.75 73.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 110.303 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.504 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 10.7 m -94.92 -12.38 26.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.065 -1.022 . . . . 0.0 110.232 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 54.6 m-85 -123.83 -43.18 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.877 -1.139 . . . . 0.0 110.218 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 57' ' ' ARG . 36.4 t-80 -49.39 -43.12 43.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -67.78 -34.43 76.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.735 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 38.5 m-85 -71.29 -44.95 64.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 5.0 t70 73.85 136.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.066 -1.021 . . . . 0.0 109.613 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -41.16 -25.67 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.864 2.376 . . . . 0.0 112.739 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.97 -47.78 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -67.25 -49.65 63.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.841 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 8.3 m -55.16 -44.32 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 109.541 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -66.48 -21.49 66.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.95 . . . . 0.0 109.445 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.74 1.28 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.369 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.4 mtm -78.83 159.4 27.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.34 168.83 8.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.54 -34.04 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 109.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.52 -37.45 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.902 . . . . 0.0 109.469 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.64 -38.33 90.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.466 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.6 t -56.73 -42.97 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.625 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.97 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.336 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' CG ' HH11 ' A' ' 78' ' ' ARG . 2.7 ttt-85 -60.91 -47.04 88.25 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.458 ' O ' ' CA ' ' A' ' 84' ' ' GLY . 96.0 mt -69.68 -39.07 77.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.7 t -50.71 -33.1 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.722 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -91.69 -56.87 2.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -95.06 122.4 37.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 55.49 47.0 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.425 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -86.87 31.89 4.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.72 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 20.01 -116.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -1.13 . . . . 0.0 109.32 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.89 140.54 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -77.14 94.56 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.7 m170 -164.22 88.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.157 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -51.24 -28.71 12.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.828 . . . . 0.0 109.852 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.96 -42.5 77.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -60.88 -52.44 65.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -1.135 . . . . 0.0 109.577 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 89.3 mt -57.49 -50.73 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -57.33 -32.69 66.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.407 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.97 -40.14 94.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.6 mm -58.41 -50.95 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 109.352 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.0 mt -53.99 -48.22 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.578 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.35 -33.94 83.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 24.7 m120 -62.67 -40.43 97.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.428 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.13 -40.76 86.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HG3' ' NH1' ' A' ' 100' ' ' ARG . 48.1 ttm-85 -59.17 -41.44 88.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -37.05 67.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.594 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 17.8 t80 -73.52 -48.61 31.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 25.5 tp -58.36 -45.91 87.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.895 . . . . 0.0 109.472 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -63.33 -36.12 82.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.8 ttt -61.17 -43.17 99.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.132 -0.98 . . . . 0.0 109.459 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -71.9 -27.3 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.19 -31.93 33.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.04 0.84 34.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.21 40.1 34.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.82 82.37 49.42 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -1.182 . . . . 0.0 109.634 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -37.29 127.99 0.63 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.626 2.218 . . . . 0.0 111.732 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -63.98 -48.18 77.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.09 -41.3 71.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 110.678 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -62.42 -33.72 75.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 111.008 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.541 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 84.1 t80 -63.92 -52.55 59.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.064 -1.022 . . . . 0.0 111.241 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.4 m -58.1 -41.42 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.0 111.692 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.512 ' O ' ' N ' ' A' ' 122' ' ' HIS . 59.6 m95 -63.88 -33.55 75.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.775 -1.203 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.4 t -66.03 -34.61 78.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.81 -1.181 . . . . 0.0 109.746 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.83 -43.01 99.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.101 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.76 24.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.947 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.51 22.05 7.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.641 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 117' ' ' TRP . 84.7 t60 49.27 45.68 23.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -151.37 114.91 3.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 138.72 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.716 2.277 . . . . 0.0 111.836 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -97.58 149.7 21.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 109.762 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -135.68 148.11 48.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.121 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 13.5 t -133.51 154.93 50.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 109.82 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -110.8 44.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.86 163.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.643 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.0 m -116.23 -28.58 6.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 109.361 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 132' ' ' LEU . 1.7 t -142.06 -179.9 6.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.412 ' N ' ' OG1' ' A' ' 131' ' ' THR . 39.5 mt -64.23 -35.95 82.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -67.27 -29.57 69.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -63.15 -20.14 65.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.445 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 1.6 mp -67.04 119.83 67.25 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 109.698 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.19 130.68 5.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.065 2.51 . . . . 0.0 112.472 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.24 11.12 40.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 109.324 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 138' ' ' SER . 55.1 p -138.52 88.41 2.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.86 154.8 37.21 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.09 -32.11 94.27 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.813 2.342 . . . . 0.0 112.08 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.51 -40.89 48.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.4 p -62.51 -41.25 98.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.86 -48.08 75.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.41 82.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -47.41 84.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.85 . . . . 0.0 109.51 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.5 m -55.92 -43.62 77.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.47 -35.9 78.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.513 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.65 -52.59 36.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.952 . . . . 0.0 109.531 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.8 mp -63.58 -38.11 89.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -61.35 -39.69 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.406 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.4 -37.05 85.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.504 HH11 ' HG2' ' A' ' 152' ' ' ARG . 44.9 mtt-85 -64.32 -23.24 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.404 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.74 10.51 16.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -74.68 137.74 42.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -1.115 . . . . 0.0 109.523 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.597 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -97.97 -168.4 1.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 21.8 p90 39.53 38.32 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.509 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.1 m -97.68 24.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.52 155.18 3.98 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 57.0 m -54.91 -30.4 58.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.451 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.1 m -67.03 -47.91 69.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -64.95 -37.08 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.53 -42.16 92.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.31 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.99 -43.51 98.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.3 m -57.4 -37.32 72.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 109.265 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.92 -39.94 91.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.3 mmm -66.11 -49.24 68.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.656 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.536 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 96.0 mm-40 -69.24 -41.93 76.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.715 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.54 84.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.98 -45.28 71.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.09 12.3 22.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.0 mt -58.64 -31.31 68.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 109.424 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.7 p -122.66 139.95 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.434 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -97.28 105.25 17.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.536 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 97.8 m-20 -94.76 97.58 10.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.506 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -139.7 150.23 44.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 m -68.75 -160.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.43 139.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.43 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 81.1 29.32 41.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.2 m -149.82 162.02 41.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.465 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 80.8 m 52.52 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.553 ' N ' ' O ' ' A' ' 179' ' ' CYS . 22.4 p -169.96 24.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.478 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 74.0 t80 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.685 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 p -46.13 160.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.71 -0.78 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -78.26 8.69 4.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.14 130.87 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.922 . . . . 0.0 109.455 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.506 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 12.0 p -173.95 54.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 8' ' ' SER . 89.7 mm-40 -137.58 -135.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.34 153.91 4.75 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.335 -0.853 . . . . 0.0 109.448 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.7 -11.44 31.91 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.791 2.328 . . . . 0.0 112.174 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.48 -36.4 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.442 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 87.4 m-85 -73.67 -54.72 7.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.46 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.24 -48.9 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.342 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.96 87.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.59 -41.22 94.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 13' ' ' TYR . 28.1 m80 -62.99 -45.9 90.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.5 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.51 -37.26 51.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.479 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -57.94 -60.47 3.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -153.69 104.98 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.534 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -171.28 116.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.38 6.18 71.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' CYS . 2.3 t -110.68 104.12 55.5 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.245 -1.15 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.65 132.03 16.29 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.765 2.31 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.22 136.26 52.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.779 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.4 p -104.91 0.72 28.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.096 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -77.79 123.48 26.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.795 . . . . 0.0 109.35 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.44 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 83.3 p -66.84 -33.26 75.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 109.638 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -59.06 -43.54 91.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.152 -0.967 . . . . 0.0 109.771 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.57 -50.61 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.47 -38.51 77.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.16 -41.47 92.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 109.841 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.81 -31.06 63.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 109.84 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.48 -52.96 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 10.0 tp -55.1 -42.58 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.0 109.989 -178.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 30.7 p -72.81 -48.83 34.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.141 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 84.8 mt -65.75 -29.93 70.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.075 -1.016 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -51.77 -36.87 49.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.77 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.65 -29.29 61.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -59.04 -34.51 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.4 tt0 -57.68 -32.86 67.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.0 109.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 109.645 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.52 3.37 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.5 mm? -85.94 -160.01 0.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -1.192 . . . . 0.0 109.455 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 m -118.53 152.32 36.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -56.07 -33.24 64.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 0.0 109.513 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -29.56 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 109.611 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.2 m -64.78 -39.61 93.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.5 t -61.99 -38.91 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 mt -55.69 -55.13 35.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 51' ' ' LYS . 9.4 mtmp? -60.38 -45.12 94.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.325 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.599 ' HZ2' ' CG1' ' A' ' 86' ' ' ILE . 1.0 OUTLIER -68.91 -29.45 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.351 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 53' ' ' ARG . 2.5 ttt-85 -54.27 -43.08 70.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.15 -0.968 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.99 -43.78 70.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.435 -0.791 . . . . 0.0 109.376 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -43.87 88.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t80 -60.88 -44.72 96.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.389 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 42.9 ttp180 -59.68 -27.31 66.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 109.77 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.44 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.425 -0.797 . . . . 0.0 110.265 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.0 m -92.89 -20.85 20.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.133 -0.979 . . . . 0.0 110.262 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 27.9 m-85 -102.75 -52.43 3.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.976 -1.077 . . . . 0.0 110.16 -178.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t60 -54.0 -39.14 65.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.972 -1.08 . . . . 0.0 109.88 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -56.32 -37.92 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' ASP . 54.9 m-85 -91.36 3.85 53.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 0.0 109.956 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.45 162.57 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.604 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.52 -28.49 8.31 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.904 2.403 . . . . 0.0 112.746 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -62.95 -48.96 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.681 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 71' ' ' MET . 91.1 mttt -65.51 -34.58 78.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.846 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.09 -39.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -72.05 -34.31 68.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.1 16.53 22.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.361 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' LYS . 20.7 ttp -79.65 159.87 26.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.7 159.86 16.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.79 -25.17 62.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.48 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -55.68 -44.02 76.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -61.83 -38.37 87.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.08 -41.44 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.58 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.18 -38.76 84.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -68.94 -39.93 79.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.392 -0.817 . . . . 0.0 109.799 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.57 -46.45 69.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.3 t -51.78 -31.59 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.751 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.01 -57.61 3.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.515 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.79 126.37 44.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 51.89 47.05 25.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -75.85 15.56 4.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.615 ' C ' ' O ' ' A' ' 84' ' ' GLY . 3.9 pt 28.88 90.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.107 . . . . 0.0 109.346 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.599 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 79.0 mt 58.02 151.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.541 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 53.8 mtm-85 -89.01 105.39 17.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 16.8 m-70 -163.47 61.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.219 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -47.56 -35.86 9.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.33 88.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -73.41 -41.93 62.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -1.173 . . . . 0.0 109.549 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.67 -53.53 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.609 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -56.36 -33.32 65.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.977 . . . . 0.0 109.323 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.55 -37.79 79.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.38 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.19 -40.49 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.4 mt -54.41 -45.68 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.8 -37.93 93.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 4.0 m120 -58.53 -42.73 88.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -1.187 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.8 77.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 43.0 ttm-85 -59.1 -39.56 82.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.73 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.579 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.44 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 20.5 t80 -59.39 -48.32 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.39 -41.5 98.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.432 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.2 -44.19 96.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 109.563 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.85 -43.18 75.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.943 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.64 -26.66 65.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -52.49 -27.34 15.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.546 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -75.95 -14.04 60.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.472 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.95 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -94.9 114.71 64.26 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.713 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -46.27 125.48 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.614 2.209 . . . . 0.0 111.698 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.89 -34.44 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.87 -49.31 59.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.176 -0.952 . . . . 0.0 110.685 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 118' ' ' SER . 86.2 m-20 -56.06 -55.63 30.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 111.079 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -56.11 -38.23 70.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 111.21 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 2.4 t -55.93 -59.64 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 111.66 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -88.97 -20.48 24.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.806 -1.184 . . . . 0.0 111.173 -178.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -60.41 -28.04 67.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.754 -1.216 . . . . 0.0 109.72 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.015 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 5.4 m -92.15 24.6 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 109.964 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 5.3 t-20 79.23 19.49 0.75 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 59.94 48.16 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.533 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.9 pt20 -154.15 147.97 18.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.92 154.78 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.652 2.234 . . . . 0.0 111.815 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 19.9 mp0 -122.83 152.85 40.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 0.0 109.725 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 61.1 mtt -136.49 155.01 50.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -135.25 158.81 43.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.924 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 128' ' ' GLN . 7.6 mp0 -117.27 47.35 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.324 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.15 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 m -83.98 -41.25 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.6 m -131.85 164.55 25.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.5 mp -69.62 -11.0 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.1 m -85.12 -35.75 21.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -12.5 61.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -178.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.414 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 85.2 mt -68.52 118.0 55.69 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.767 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.01 128.63 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.63 -19.55 48.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.336 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 m -87.42 102.65 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.328 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.426 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 26.9 p -121.34 150.31 53.99 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.96 -40.71 33.16 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.746 2.297 . . . . 0.0 112.042 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.16 -38.75 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.426 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 31.4 m -61.33 -45.46 94.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.39 -44.57 94.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -41.3 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.515 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.31 -44.36 88.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.7 t -57.48 -42.32 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -62.62 -35.24 78.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.33 -51.91 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.03 -34.35 74.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -58.37 -36.43 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -62.1 -39.28 91.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.408 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.421 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.7 mpt_? -63.79 -21.26 66.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.26 22.23 10.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.48 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 11.8 m-85 -83.27 133.4 34.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -101.67 170.33 8.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 53.35 47.88 23.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 158' ' ' GLY . 10.7 p -122.32 26.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.417 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.76 170.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.9 t -59.0 -31.63 68.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -1.169 . . . . 0.0 109.427 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -47.21 84.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.96 -39.95 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.499 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 79.9 m -67.21 -41.71 85.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.414 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 75.9 t80 -60.25 -45.39 93.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.467 -0.771 . . . . 0.0 109.348 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 m -58.85 -39.17 80.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.304 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -41.96 96.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.0 mtp -56.54 -41.7 77.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.81 -36.41 83.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.677 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.04 75.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.546 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 9.1 t -71.15 -62.89 1.23 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.466 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.17 15.32 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.546 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.4 mp -52.79 -52.36 57.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.39 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -102.24 135.66 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.94 101.73 14.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 11.3 p30 -91.76 115.63 28.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -142.23 162.15 36.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.494 ' CG2' ' HG ' ' A' ' 179' ' ' CYS . 19.5 m -115.74 144.19 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.05 -34.54 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.76 -29.1 57.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.494 ' HG ' ' CG2' ' A' ' 176' ' ' VAL . 52.7 m -82.29 146.82 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -1.216 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.2 t -65.53 -29.29 69.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 182' ' ' TYR . 30.0 p -49.74 -45.0 48.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.62 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 22.9 t80 . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HG2' ' NH1' ' A' ' 3' ' ' ARG . 7.4 tpt180 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.3 m -47.07 138.25 6.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.15 22.49 12.24 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 6' ' ' TRP . 40.6 p-90 -147.09 52.85 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.0 109.475 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 p -152.07 -16.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.6 p -84.32 14.1 4.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -54.67 -39.97 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.39 159.59 1.38 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.35 -35.04 43.12 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.79 2.327 . . . . 0.0 112.14 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.7 tp -61.04 -37.8 83.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.813 . . . . 0.0 109.48 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.47 -44.5 90.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.52 -43.96 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 109.383 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.39 98.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.34 -40.82 98.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -63.59 -48.0 79.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.58 -33.14 72.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -51.53 -51.11 57.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.22 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CD2' ' N ' ' A' ' 22' ' ' GLY . 46.4 t90 -144.77 147.92 33.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.518 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 21' ' ' TRP . . . 86.39 -29.28 4.88 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 169' ' ' CYS . 32.8 m -72.15 145.64 88.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.26 120.04 6.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.778 2.319 . . . . 0.0 111.893 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.495 ' OE1' ' SG ' ' A' ' 169' ' ' CYS . 74.3 mt-10 -95.33 128.04 41.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.952 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -133.98 -3.08 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.058 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -81.44 137.08 35.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.495 ' HG ' ' N ' ' A' ' 29' ' ' LYS . 54.7 p -61.91 -38.12 87.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.585 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' N ' ' HG ' ' A' ' 28' ' ' SER . 69.0 mttm -67.94 -49.37 62.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -64.61 -38.68 91.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.845 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -33.97 65.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -65.17 -48.13 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.878 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -65.61 -30.41 71.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.821 -178.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.5 tpt -70.72 -53.37 15.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.19 -34.11 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.994 -178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -72.18 -49.52 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 110.123 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.3 -39.5 78.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 50.4 mm-40 -57.08 -35.87 69.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.66 -31.25 57.55 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -63.75 -31.52 72.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.237 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 38' ' ' GLU . 5.1 pt20 -52.64 -23.44 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 -179.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.19 108.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.965 . . . . 0.0 109.665 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.9 -33.3 2.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.4 mm? -87.69 169.52 12.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.5 p -82.11 165.01 20.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -67.81 -35.29 78.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.506 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.19 -39.1 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.639 -179.7 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.427 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 92.5 m -49.92 -35.76 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.645 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.45 -29.81 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.49 -56.47 9.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -60.92 -37.29 81.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.152 -0.967 . . . . 0.0 109.265 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' TYR . 53.1 tttm -73.91 -26.69 60.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -57.7 -48.9 78.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.242 -0.911 . . . . 0.0 108.989 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.32 -47.69 69.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.841 . . . . 0.0 109.284 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.61 -34.54 78.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 29.7 t80 -59.47 -47.43 85.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.321 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -57.1 -30.85 64.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.779 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.04 93.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.7 m -94.32 -13.1 26.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.072 -1.017 . . . . 0.0 110.262 -178.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 43.2 m-85 -111.26 -52.78 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.937 -1.102 . . . . 0.0 110.201 -178.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -52.94 -36.96 60.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 109.87 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -55.55 -33.7 64.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.3 m-85 -97.08 4.9 51.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 0.0 109.864 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.22 164.52 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.04 -1.038 . . . . 0.0 109.609 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.37 -34.06 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.869 2.379 . . . . 0.0 112.713 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.93 -49.12 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' MET . 46.4 mtpt -65.1 -35.17 80.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.84 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.81 -40.3 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 109.557 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -35.49 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.913 . . . . 0.0 109.462 179.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.39 15.31 26.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.1 tmm? -83.86 149.64 26.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.406 ' O ' ' SD ' ' A' ' 71' ' ' MET . 14.9 pt20 -102.97 167.04 10.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.42 -28.12 69.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -56.54 -44.36 80.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.497 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.57 -38.72 81.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.98 -45.64 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.02 -31.63 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -68.0 -48.47 65.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.336 -0.853 . . . . 0.0 109.795 -178.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' CD1' ' C ' ' A' ' 79' ' ' LEU . 1.3 pp -80.5 -20.13 44.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.635 -178.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.0 t -54.35 -45.14 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.908 . . . . 0.0 109.774 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -58.04 -50.54 73.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.498 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -99.67 107.05 19.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 178.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.09 74.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.41 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.41 -23.89 4.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' GLY . 21.2 pt -56.46 -164.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 109.352 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.28 136.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -92.44 96.52 10.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CD2' ' HZ2' ' A' ' 91' ' ' LYS . 29.4 m-70 -165.69 87.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.571 HH11 ' HG2' ' A' ' 89' ' ' ARG . 1.4 ptt-85 -47.31 -29.34 2.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.992 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.03 97.89 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' HZ2' ' CD2' ' A' ' 88' ' ' HIS . 62.3 mttp -62.61 -45.07 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.451 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 98.3 mt -56.8 -42.2 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.576 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -60.27 -37.82 81.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.12 78.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mm -62.57 -40.92 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -57.04 -40.67 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.8 -40.68 99.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -57.38 -47.65 81.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.458 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.71 -42.84 85.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -63.88 -43.71 95.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.88 -38.1 58.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -66.63 -48.6 68.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.43 -42.49 87.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.46 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.55 -41.97 87.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.576 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -40.4 96.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.68 -27.07 64.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -51.99 -17.73 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.487 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 78.5 m-20 -74.88 -16.25 60.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.04 19.2 65.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.3 mp0 -115.87 151.93 46.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.188 -1.184 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.06 123.53 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.535 2.156 . . . . 0.0 111.696 179.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -76.18 -43.48 42.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 110.43 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -60.69 -49.85 75.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.095 -1.003 . . . . 0.0 110.704 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -51.56 -36.36 44.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 111.019 -178.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.39 -47.92 21.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 111.207 -177.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 2.9 p -56.34 -46.52 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.017 . . . . 0.0 111.653 -175.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.553 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 16.9 p-90 -88.18 -27.85 21.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.745 -1.222 . . . . 0.0 111.131 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 120' ' ' VAL . 10.2 t -56.08 -29.26 60.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.871 -1.143 . . . . 0.0 109.772 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.25 -13.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' SER . 14.1 m -82.54 24.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.051 -1.03 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.599 ' C ' ' H ' ' A' ' 123' ' ' GLN . 13.6 t-20 74.17 17.21 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 109.68 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER 66.68 -13.35 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' A' ' 121' ' ' ASN . 23.2 mt-30 -86.37 150.61 52.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.72 149.59 73.4 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.631 2.221 . . . . 0.0 111.849 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -110.27 145.66 37.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.3 mtt -135.84 152.55 51.18 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.173 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.6 t -94.73 160.65 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.29 49.63 1.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 109.317 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.99 135.05 42.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.682 -179.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.8 m -76.05 -34.29 59.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.32 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.3 m -127.34 159.22 35.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.7 mt -56.26 -30.89 63.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' A' ' 134' ' ' GLU . 85.7 p -71.81 -29.94 64.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.43 ' N ' ' HG ' ' A' ' 133' ' ' SER . 95.8 mt-10 -75.82 1.12 15.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.11 119.81 67.29 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.766 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.92 130.05 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.144 2.562 . . . . 0.0 112.544 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 t -104.63 12.58 32.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.268 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -139.0 92.41 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 161.64 22.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.9 -39.55 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.829 2.352 . . . . 0.0 111.975 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.59 73.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.2 m -59.95 -45.97 90.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.26 -42.2 99.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.38 -43.2 67.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -60.55 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -53.84 -43.27 69.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -62.45 -33.74 75.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.49 -51.19 38.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -33.16 72.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.589 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -58.36 -39.23 79.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.356 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.99 -40.48 97.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 109.443 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.45 -20.46 66.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.18 32.42 7.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.43 132.11 37.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.94 174.85 6.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 53.24 48.03 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLY . 5.4 m -115.2 26.22 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.07 167.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.35 -28.31 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -1.158 . . . . 0.0 109.417 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -70.32 -41.26 73.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.425 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.6 mp -65.43 -47.82 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.0 p -64.28 -38.81 92.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.263 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.542 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 53.7 t80 -62.26 -46.5 88.54 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -61.6 -37.86 85.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.275 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.71 -55.07 34.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 179.692 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.455 ' N ' ' CG ' ' A' ' 165' ' ' PHE . 48.0 mtm -63.72 -41.31 98.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.646 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -66.41 -42.92 87.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 -42.32 75.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 109.697 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' ' OE1' ' A' ' 25' ' ' GLU . 3.5 m -60.91 -61.1 2.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.413 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 144.31 1.78 0.89 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' A' ' 171' ' ' LEU . 4.3 mm? -57.43 -43.12 83.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 109.396 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.75 136.57 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -87.95 112.58 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.429 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 80.7 m-20 -86.82 110.02 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.532 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 58.8 m-70 -153.8 126.69 8.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.558 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.26 137.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.75 135.68 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.43 5.71 60.22 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 16.4 p -77.15 -150.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.491 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.53 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 71.9 m -57.85 -39.6 78.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 0.9 OUTLIER 173.15 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.979 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 182' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' ARG . 14.2 m 55.76 167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.0 109.397 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.93 -29.13 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -72.85 -0.0 12.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' SER . 7.1 p -108.88 134.72 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 167.27 0.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -79.26 -130.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.877 . . . . 0.0 109.484 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 152.08 14.28 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.96 -11.47 32.33 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.863 2.376 . . . . 0.0 112.137 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.28 -38.72 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.497 ' HH ' ' CB ' ' A' ' 47' ' ' ILE . 87.9 m-85 -59.82 -47.93 83.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.7 mt -66.64 -41.6 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.359 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -46.84 87.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -66.97 -41.46 86.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -59.97 -42.18 93.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.87 -10.71 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -78.29 -76.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.433 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.44 101.53 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -170.04 126.47 0.83 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.69 -29.15 8.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.5 m -72.17 149.33 91.85 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.23 -1.159 . . . . 0.0 109.32 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.43 119.29 6.3 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.776 2.317 . . . . 0.0 111.89 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -112.67 132.87 54.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.804 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 p -134.87 3.06 3.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.029 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -80.72 122.37 27.04 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.364 -0.835 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 t -58.69 -39.81 81.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.25 -43.22 82.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.723 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.35 -50.77 50.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.81 -35.72 79.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.881 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.88 -45.59 93.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -74.61 -31.27 61.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.77 -179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.7 ttm -71.67 -54.59 9.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.723 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 2.9 tp -59.37 -40.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 0.0 110.035 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 76.7 m -72.76 -46.43 53.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.123 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD2' ' NH1' ' A' ' 53' ' ' ARG . 9.6 tp -69.8 -33.71 72.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.01 . . . . 0.0 109.863 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -52.15 -34.94 46.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.803 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.53 ' C ' ' HZ3' ' A' ' 91' ' ' LYS . . . -52.23 -27.0 22.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.15 -31.94 72.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -1.22 . . . . 0.0 109.777 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.62 -26.34 63.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.965 . . . . 0.0 109.728 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.59 109.08 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.694 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.91 -29.95 4.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.3 mt -100.45 163.73 12.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.429 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -87.39 164.86 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.384 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -59.38 -40.95 88.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 109.505 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.497 ' CB ' ' HH ' ' A' ' 13' ' ' TYR . 9.0 tp -54.53 -39.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.653 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.8 m -61.37 -36.27 79.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -69.75 -40.1 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.2 mt -57.12 -54.92 41.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -57.62 -47.41 82.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -68.66 -29.86 68.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttm-85 -50.74 -47.11 59.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 108.987 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.35 -43.68 73.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.515 -0.741 . . . . 0.0 109.406 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -67.12 -37.3 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 0.0 109.229 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 7.5 t80 -63.19 -43.89 96.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.374 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 61' ' ' HIS . 43.7 mtt-85 -58.41 -39.2 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.31 77.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.47 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 85.6 m -92.39 -12.92 30.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 110.244 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 5.9 m-85 -115.97 -49.09 2.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.932 -1.105 . . . . 0.0 110.153 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.4 t60 -49.86 -42.48 47.72 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.066 -1.021 . . . . 0.0 109.877 -178.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -65.15 -30.14 71.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.789 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.434 ' O ' ' O ' ' A' ' 64' ' ' ASP . 50.2 m-85 -88.13 -0.2 56.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.833 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 56.14 165.65 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.049 -1.032 . . . . 0.0 109.596 -179.747 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 68' ' ' VAL . 72.6 Cg_endo -78.72 -54.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.832 2.355 . . . . 0.0 112.709 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 t -47.22 -33.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -68.7 -44.11 74.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.341 -0.849 . . . . 0.0 109.827 -177.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 65' ' ' PRO . 1.4 m -56.99 -39.92 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.616 -178.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -64.18 -39.37 93.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.473 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.93 23.54 7.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 109.373 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' A' ' 72' ' ' GLN . 11.5 ttp -93.53 160.37 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 109.626 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' H ' ' HG3' ' A' ' 71' ' ' MET . 95.2 mt-30 -101.46 166.5 10.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.3 mt-10 -70.52 -21.93 62.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.13 -31.15 65.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.94 . . . . 0.0 109.468 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.05 -38.23 87.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.424 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 10.5 m -73.57 -29.32 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -67.11 -36.38 81.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 -178.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 13.3 ptm180 -77.87 -41.9 35.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.491 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 1.2 pp -81.46 -7.13 59.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.953 . . . . 0.0 109.637 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 9.3 p -49.37 -42.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.688 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.494 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 2.8 pp0? -90.42 20.91 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.006 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.1 t0 -74.94 121.39 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.378 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.54 0.34 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 65.65 43.3 94.6 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -58.55 -165.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.9 tt -56.02 127.89 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -73.24 95.41 2.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.478 ' ND1' ' H ' ' A' ' 91' ' ' LYS . 1.9 t-80 -171.83 69.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -45.02 -36.15 3.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.904 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.03 98.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.53 ' HZ3' ' C ' ' A' ' 39' ' ' GLY . 33.8 tptt -62.43 -43.23 99.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.478 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 mt -54.64 -50.56 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.62 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.89 -30.61 69.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.985 . . . . 0.0 109.384 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -58.78 -44.47 90.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.467 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.9 mp -56.28 -39.8 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.81 -29.23 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.77 -45.13 77.4 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -64.86 -38.02 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -1.185 . . . . 0.0 109.428 -178.548 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.59 80.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -59.53 -43.87 93.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.36 -30.41 66.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.93 -47.25 87.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.28 -44.77 86.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.94 -44.68 94.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.482 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.42 ' SD ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.61 -41.61 79.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -71.45 -27.4 63.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.485 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -52.56 -23.26 6.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.425 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -75.35 -13.11 60.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.84 48.8 6.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -135.34 150.93 73.9 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.187 -1.184 . . . . 0.0 109.653 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.23 119.14 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.571 2.181 . . . . 0.0 111.677 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -75.28 -40.76 58.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.439 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 -48.17 69.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 110.725 -178.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 118' ' ' SER . 44.3 t0 -55.1 -55.28 32.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 111.096 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -55.66 -38.59 69.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 111.249 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.97 -59.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 0.0 111.646 -178.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -87.79 -28.1 21.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.663 -1.273 . . . . 0.0 111.125 -177.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 120' ' ' VAL . 94.1 p -56.34 -26.03 51.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.816 -1.178 . . . . 0.0 109.769 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.47 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.056 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 118' ' ' SER . 10.7 m -89.56 25.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 23.8 t30 80.01 22.06 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.696 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 59.46 49.75 8.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.499 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -154.61 146.46 17.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.37 143.36 43.1 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.642 2.228 . . . . 0.0 111.778 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -100.25 151.35 21.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 109.746 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -136.03 156.89 48.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.176 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 t -129.82 164.12 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.856 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -133.16 50.88 2.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.23 142.2 27.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.704 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 m -92.43 -27.69 17.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 109.361 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -126.15 156.73 39.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -57.88 -34.76 70.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 m -62.35 -36.67 82.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.67 -28.84 70.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.1 mt -67.08 116.55 37.06 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.11 130.19 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.11 2.54 . . . . 0.0 112.503 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.75 -8.15 58.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.5 p -101.05 101.84 12.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.378 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.513 ' HG1' ' H ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -119.82 151.78 52.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.588 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.31 -33.84 97.81 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.75 2.3 . . . . 0.0 112.009 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.89 -35.2 57.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.359 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.513 ' H ' ' HG1' ' A' ' 139' ' ' THR . 82.9 p -62.8 -34.62 77.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.92 -51.01 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.43 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.429 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 0.3 OUTLIER -55.68 -50.14 71.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.6 t -63.81 -42.49 97.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -60.7 -36.98 80.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.03 -51.63 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -32.94 74.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.512 ' HZ1' ' CG1' ' A' ' 157' ' ' VAL . 14.9 mmtm -59.84 -38.37 81.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.397 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -61.72 -36.93 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -69.04 -19.81 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.24 27.16 9.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -1.121 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -112.43 169.37 8.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 51.6 50.78 18.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.512 ' CG1' ' HZ1' ' A' ' 150' ' ' LYS . 9.0 p -120.14 27.05 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.414 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.95 159.46 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 33.5 m -53.2 -29.63 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -1.195 . . . . 0.0 109.492 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.2 p -62.42 -42.26 99.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.5 mp -63.95 -47.61 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.84 -42.61 99.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.306 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.15 -45.13 91.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.461 -0.774 . . . . 0.0 109.357 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.5 m -62.72 -40.25 96.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.306 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.441 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -61.6 -35.13 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 179.342 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -65.39 -52.47 53.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -38.22 84.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.31 -0.869 . . . . 0.0 109.681 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.96 85.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.694 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.522 ' O ' ' O ' ' A' ' 23' ' ' VAL . 64.5 m -81.45 -62.44 1.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.373 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.52 2.74 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.88 -47.51 43.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.26 136.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.404 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -100.76 108.14 19.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 38.5 p30 -116.95 92.22 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -108.72 9.37 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 179' ' ' CYS . 4.2 t 56.59 101.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.3 p -54.99 -34.84 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.38 -44.1 97.34 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.531 ' C ' ' H ' ' A' ' 181' ' ' CYS . 12.4 t -105.37 -178.85 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.55 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 12.1 t 55.09 5.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.875 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 8.7 p 42.22 25.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 180' ' ' CYS . 1.4 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 109.572 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 3' ' ' ARG . 4.4 ptm180 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.287 0.565 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.8 m -47.93 112.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -71.39 -29.34 68.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -53.41 -7.97 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.466 -179.647 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 5' ' ' GLY . 12.7 p -56.66 134.43 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 t -65.66 140.84 58.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -64.83 -31.45 72.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.38 143.82 6.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -32.3 9.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.829 2.353 . . . . 0.0 112.14 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.01 -41.95 99.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.23 -45.62 76.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.413 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.69 -43.97 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 19' ' ' ASN . . . -62.84 -43.92 97.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.447 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 74.0 t80 -62.41 -41.64 98.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.8 t-80 -61.92 -45.32 94.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -79.95 -47.43 15.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' ALA . 17.0 t-20 -56.55 -42.73 79.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.527 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' HIS . 77.4 mm-40 -138.62 -150.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.463 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 20' ' ' GLU . 11.0 t90 59.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.32 72.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.89 115.39 64.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.215 -1.168 . . . . 0.0 109.423 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.99 121.69 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.758 2.305 . . . . 0.0 111.851 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -117.95 136.17 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.854 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 p -121.26 6.47 10.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.9 . . . . 0.0 109.042 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.287 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 32' ' ' PHE . 15.1 m -74.61 -32.61 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -59.11 -52.4 65.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 109.753 -178.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -64.17 -43.42 95.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.872 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.32 -31.88 62.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.816 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 28' ' ' SER . 47.7 t80 -62.81 -47.78 81.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.95 . . . . 0.0 109.854 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.1 pp20? -75.2 -30.19 60.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 8.1 tpt -66.78 -53.12 36.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -63.06 -33.21 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 83.5 m -71.2 -49.49 42.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.31 -35.93 66.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 32.3 mm-40 -53.93 -33.05 55.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.786 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.81 97.7 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 36' ' ' CYS . 2.8 mp0 -70.0 -24.79 63.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.807 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -45.28 -27.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -178.894 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.77 123.86 7.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.31 -29.77 4.68 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.34 -166.46 1.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -123.83 152.25 42.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -53.78 -39.88 65.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -63.58 -39.4 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.684 -179.182 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.511 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 88.2 m -66.46 -36.74 83.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.719 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.13 -44.85 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.395 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.5 mt -60.61 -46.62 89.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.62 -50.72 71.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.306 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HZ3' ' CG2' ' A' ' 48' ' ' THR . 1.4 mptm? -68.1 -32.65 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.337 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' NH1' ' CE1' ' A' ' 16' ' ' TYR . 43.3 ttm180 -50.42 -44.32 55.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 108.94 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.29 -43.63 63.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 109.394 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -64.69 -40.71 95.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.404 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 2.6 m-85 -55.85 -47.15 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.366 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 4.0 mmp_? -59.78 -34.7 73.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.416 -0.802 . . . . 0.0 109.82 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.94 -35.66 73.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 30.2 p -94.1 -36.16 12.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.005 . . . . 0.0 110.266 -179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 -48.03 9.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.926 -1.109 . . . . 0.0 110.2 -178.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 56.9 t60 -50.23 -39.12 43.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.0 . . . . 0.0 109.848 -178.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -56.53 -35.09 67.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' ASP . 62.8 m-85 -95.78 1.89 53.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.913 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.12 162.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 0.0 109.632 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.06 -27.6 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.88 2.386 . . . . 0.0 112.64 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -49.25 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' MET . 7.2 mtpm? -67.29 -33.11 74.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.78 -41.81 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -71.02 -34.64 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.61 17.62 20.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 16.2 ttp -77.79 157.75 29.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.654 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.72 159.96 15.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 48.0 mp0 -60.36 -25.87 66.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.493 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.53 -43.2 93.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 15.9 t70 -61.01 -38.69 86.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.36 -42.99 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.47 -38.35 80.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -63.29 -41.96 99.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.806 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 82' ' ' ASP . 96.4 mt -67.35 -34.34 77.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.69 -33.12 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -86.94 -57.24 3.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.522 ' O ' ' O ' ' A' ' 79' ' ' LEU . 84.1 m-20 -80.04 170.62 16.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 74.14 87.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -61.42 8.64 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.624 ' H ' ' C ' ' A' ' 83' ' ' ALA . 14.0 pt -57.57 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -1.184 . . . . 0.0 109.362 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 76.0 mt -68.02 133.58 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 109.457 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.556 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 38.6 ttm180 -97.79 108.9 21.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.8 m-70 -164.55 85.37 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.515 HH11 ' HG2' ' A' ' 89' ' ' ARG . 19.5 ttt-85 -48.71 -30.51 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.783 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.69 -47.37 68.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.95 -45.09 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -1.212 . . . . 0.0 109.526 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.7 mt -55.88 -44.79 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -58.29 -37.77 75.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.398 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.92 84.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -44.77 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 96' ' ' ILE . 95.8 mt -56.81 -42.34 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.525 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.45 -37.43 94.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.476 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 2.9 m120 -61.4 -43.07 99.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.84 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG3' ' NH1' ' A' ' 100' ' ' ARG . 47.9 ttm-85 -63.9 -46.64 83.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.22 77.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.555 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 24.9 t80 -62.95 -41.71 99.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.24 -39.63 87.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.75 -41.3 86.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 51.9 mmm -63.69 -39.56 94.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.11 -27.05 64.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.412 ' O ' ' OE1' ' A' ' 107' ' ' GLN . 1.1 tm0? -51.42 -35.31 38.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -83.46 -3.51 57.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.08 74.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.5 146.88 40.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.144 -1.21 . . . . 0.0 109.644 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.72 124.81 11.47 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.63 2.22 . . . . 0.0 111.713 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -78.33 -45.31 22.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.456 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -55.44 -44.4 76.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.74 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.511 ' O ' ' OG ' ' A' ' 118' ' ' SER . 91.2 m-20 -57.65 -45.55 85.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 111.055 -178.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -60.16 -49.33 78.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.014 -1.053 . . . . 0.0 111.23 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 7.0 m -60.37 -46.65 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 111.731 -176.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.492 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 3.3 p-90 -88.7 -37.26 15.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.733 -1.23 . . . . 0.0 111.1 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 120' ' ' VAL . 41.4 m -56.96 -25.29 57.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.807 -1.183 . . . . 0.0 109.698 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.18 -14.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.022 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.8 m -85.04 23.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m120 58.27 40.27 24.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.752 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.24 14.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -114.65 120.52 37.5 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.59 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.22 153.32 31.6 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.648 2.232 . . . . 0.0 111.86 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -102.53 149.89 23.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.8 mtt -136.61 156.6 48.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 t -117.12 159.57 22.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.885 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.46 53.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.78 -143.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 m -141.76 -30.2 0.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.922 . . . . 0.0 109.353 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -123.48 156.31 35.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.16 -32.57 74.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.1 p -66.66 -33.18 75.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.41 -25.12 67.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 135' ' ' ILE . 32.3 mm -66.51 116.99 39.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.728 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.25 133.54 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.068 2.512 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.59 -9.68 53.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.9 p -96.95 102.21 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.384 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -117.67 152.91 50.37 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.387 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.01 -41.82 25.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.741 2.294 . . . . 0.0 112.041 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.65 61.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.06 -43.3 92.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.61 -38.8 80.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.63 -45.63 93.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.202 -0.936 . . . . 0.0 109.498 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.3 t -58.14 -41.75 84.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -61.79 -39.15 90.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.549 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -48.31 71.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.0 mt -59.68 -35.22 74.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.07 -41.1 82.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.396 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -64.38 -37.81 88.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.593 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 24.4 mmt180 -65.23 -20.62 66.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.346 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.76 29.2 10.97 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 4.0 m-85 -92.16 130.59 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 156' ' ' PHE . 72.9 tttt -93.43 170.33 9.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.45 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 55.2 m-85 57.64 50.86 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.09 28.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.13 159.77 0.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.4 m -52.43 -32.41 39.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -1.172 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.5 m -66.37 -36.54 83.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.36 -44.14 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.513 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 85.7 m -61.04 -41.64 96.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.618 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 42.9 t80 -60.12 -50.59 73.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.306 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.8 m -60.99 -39.25 88.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -64.36 -44.83 90.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.469 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 40.1 mmm -64.69 -41.83 95.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.632 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CE2' ' A' ' 163' ' ' TYR . 42.0 mt-30 -63.47 -43.67 96.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 -179.424 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.46 -45.0 92.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.674 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.7 t -61.65 -23.24 65.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.26 7.88 58.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.1 mp -63.24 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.411 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.21 130.79 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.431 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -94.03 108.54 20.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -88.28 112.06 22.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -138.18 134.93 35.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.88 136.91 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.15 134.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.21 -0.85 72.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.52 ' C ' ' H ' ' A' ' 181' ' ' CYS . 65.9 m -151.74 -178.14 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.565 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.5 t 54.3 6.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 179' ' ' CYS . 2.2 m 69.52 37.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.609 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 16.2 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.58 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.374 0.606 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 p -47.63 163.5 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.43 -7.24 88.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -55.59 -29.13 58.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -1.12 . . . . 0.0 109.392 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 8' ' ' SER . 6.3 p -98.66 126.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER 166.28 72.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -156.36 -128.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.523 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -84.61 152.19 59.81 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.9 -26.72 3.54 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.8 2.333 . . . . 0.0 112.132 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.1 tp -63.18 -44.74 94.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.78 -46.76 71.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.7 -43.96 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.39 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.11 99.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -63.13 -37.46 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLU . 83.7 t60 -58.0 -51.24 70.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.71 -37.93 85.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.527 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.455 ' N ' HD21 ' A' ' 19' ' ' ASN . 2.6 m120 -60.22 -51.86 67.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.469 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.1 mm-40 -142.96 -132.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.478 ' CH2' ' OD2' ' A' ' 174' ' ' ASP . 27.8 t90 58.92 116.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.17 5.59 67.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -120.04 96.01 49.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.293 -1.122 . . . . 0.0 109.412 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.71 120.02 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.738 2.292 . . . . 0.0 111.853 -179.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -95.58 134.53 38.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.863 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.4 p -112.7 0.16 15.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.83 121.0 24.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.647 ' HG ' ' H ' ' A' ' 113' ' ' ALA . 52.0 m -61.57 -38.64 88.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.907 . . . . 0.0 109.627 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -59.93 -55.38 34.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -69.39 -43.51 73.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.935 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.95 -39.28 94.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.842 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.412 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 62.2 t80 -63.0 -34.92 78.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.911 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -74.17 -30.22 62.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.955 . . . . 0.0 109.874 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.552 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 55.0 ttm -64.94 -53.99 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.965 . . . . 0.0 109.785 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 3.3 tp -65.19 -39.29 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.032 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 5.7 t -72.89 -40.89 65.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.67 -40.07 94.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 109.822 -178.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.44 ' OE2' ' N ' ' A' ' 165' ' ' PHE . 82.5 mt-10 -54.21 -28.7 42.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.772 -179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.15 -39.1 19.43 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -67.79 -30.87 70.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -1.211 . . . . 0.0 109.711 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.9 tt0 -52.64 -35.94 55.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 109.721 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.54 116.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -31.4 6.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.81 -145.0 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -1.189 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 t -148.23 155.41 41.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -50.4 -41.91 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.908 . . . . 0.0 109.514 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 48' ' ' THR . 9.6 tp -52.1 -43.06 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.645 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.451 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 63.1 m -71.64 -33.78 69.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.4 t -58.8 -39.37 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.47 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -53.92 -54.37 39.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.511 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.64 -40.14 82.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -77.28 -19.26 56.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.624 ' NH1' ' NH2' ' A' ' 57' ' ' ARG . 1.2 ttt-85 -60.97 -46.96 88.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.171 -0.956 . . . . 0.0 109.013 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -74.02 -41.33 62.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.363 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -67.44 -45.03 77.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.25 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 42.6 t80 -62.87 -38.13 89.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.42 -0.8 . . . . 0.0 109.284 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.624 ' NH2' ' NH1' ' A' ' 53' ' ' ARG . 48.6 ttm-85 -57.27 -38.49 73.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.31 -22.47 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.26 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.507 ' SG ' ' CB ' ' A' ' 83' ' ' ALA . 63.9 m -92.45 -13.55 29.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.222 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 55.8 m-85 -127.21 -53.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.935 -1.103 . . . . 0.0 110.173 -178.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -57.71 -42.46 83.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -178.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -53.8 -35.14 61.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' ASP . 92.7 m-85 -91.43 8.98 33.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.0 109.908 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER 56.42 156.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 -179.45 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.4 -28.15 39.41 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.853 2.369 . . . . 0.0 112.68 -178.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.35 -49.19 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -67.98 -31.46 71.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.61 -41.12 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.586 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.27 64.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.62 14.63 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.426 ' O ' ' OE1' ' A' ' 72' ' ' GLN . 7.7 mmm -54.83 -176.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.668 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 71' ' ' MET . 15.8 mm100 -136.74 159.15 42.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.2 mt-10 -61.39 -34.97 76.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -72.1 -28.37 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.44 -47.96 65.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 -179.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 6.9 m -60.35 -38.08 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.32 -36.99 81.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -65.38 -39.66 92.53 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 109.769 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.35 -31.84 72.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.603 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.5 t -56.25 -34.9 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.71 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -96.38 -33.94 11.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 84' ' ' GLY . 93.1 m-20 -86.75 138.49 31.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.368 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.507 ' CB ' ' SG ' ' A' ' 59' ' ' CYS . . . 70.03 -21.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 47.07 27.49 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 86' ' ' ILE . 6.2 pt -56.35 83.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.334 179.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 85' ' ' ILE . 85.1 mt 57.04 145.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.489 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.1 OUTLIER -101.64 111.64 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.535 ' N ' ' HD1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.58 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.165 179.753 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 89' ' ' ARG . 35.0 ttt-85 -46.87 -36.81 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.39 95.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -67.3 -44.49 79.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.5 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.1 mt -58.52 -49.44 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.551 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -53.57 -34.82 59.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.419 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.4 mm -60.39 -45.37 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mm -55.55 -51.99 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.84 72.67 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.655 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.35 -37.34 77.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -1.188 . . . . 0.0 109.378 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.655 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -71.08 -35.68 71.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.65 -42.49 92.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.2 -32.11 68.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.412 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 32.4 t80 -66.24 -44.03 84.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.86 -40.25 96.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -60.5 -37.84 82.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.519 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.55 -34.25 77.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -68.76 -27.52 65.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -52.17 -27.84 15.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.16 -15.15 60.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.2 17.25 78.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -96.63 149.7 36.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.247 -1.149 . . . . 0.0 109.634 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.14 119.16 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.623 2.216 . . . . 0.0 111.69 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -71.29 -39.94 71.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.822 . . . . 0.0 110.446 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.647 ' H ' ' HG ' ' A' ' 28' ' ' SER . . . -61.72 -50.31 72.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.976 . . . . 0.0 110.771 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' O ' ' OG ' ' A' ' 118' ' ' SER . 29.1 t0 -55.57 -54.13 47.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -0.918 . . . . 0.0 111.081 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -53.85 -43.06 69.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 111.217 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.57 -60.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.097 . . . . 0.0 111.638 -177.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' O ' ' A' ' 113' ' ' ALA . 67.1 p-90 -88.24 -19.28 27.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.787 -1.196 . . . . 0.0 111.141 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 120' ' ' VAL . 34.0 m -56.09 -30.09 61.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.763 -1.21 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.43 -11.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 110.049 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.2 m -86.02 24.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 109.991 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 17.3 t30 77.1 20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 62.38 29.64 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.903 . . . . 0.0 109.568 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -148.01 143.38 17.58 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.593 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.03 142.24 61.03 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.585 2.19 . . . . 0.0 111.833 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.93 155.66 22.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.0 ptp -135.28 156.49 48.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.155 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 t -118.36 155.67 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 109.872 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -115.95 45.04 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.304 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.15 135.12 47.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.872 . . . . 0.0 109.653 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.673 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 9.1 m -88.29 -32.98 18.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.57 166.31 22.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.7 mt -74.27 -8.73 57.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.567 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -87.81 -31.98 19.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.527 -177.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.673 ' CD ' ' H ' ' A' ' 130' ' ' THR . 8.5 pt-20 -86.93 9.96 17.75 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -178.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.16 119.85 62.33 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.756 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.04 120.95 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.179 2.586 . . . . 0.0 112.482 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 t -97.29 21.65 9.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.318 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.6 p -129.61 66.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.375 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.62 153.39 52.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.463 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.85 -30.74 92.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.754 2.303 . . . . 0.0 112.04 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.26 -38.11 51.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.37 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -62.42 -48.6 78.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -64.96 -41.1 95.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.57 86.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.2 tp -59.14 -48.63 80.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.511 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -54.67 -45.61 73.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -60.3 -35.04 74.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.88 -50.55 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.451 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.92 -38.63 91.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.81 -26.5 68.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.78 -40.03 86.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -74.07 -20.17 60.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.22 29.46 7.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.34 137.54 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.519 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -102.1 175.36 5.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 53.4 47.3 24.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 158' ' ' GLY . 7.7 p -122.66 26.54 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.1 167.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.521 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 55.4 m -58.19 -30.41 66.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 0.0 109.435 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 62.9 p -62.26 -42.07 99.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.5 mp -65.64 -46.81 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.53 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 12.3 p -63.01 -39.61 95.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.282 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 34.1 t80 -62.67 -47.83 81.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.5 p -59.5 -41.85 90.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.286 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.594 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 1.1 t80 -61.83 -27.04 68.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 178.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -53.56 27.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.682 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -67.89 -36.28 79.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.686 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.649 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 41.7 m -78.59 -64.34 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.37 9.12 2.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mp -50.96 -52.62 40.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -1.134 . . . . 0.0 109.414 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.3 m -98.2 134.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 175' ' ' HIS . 11.5 t-20 -81.15 105.13 12.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.478 ' OD2' ' CH2' ' A' ' 21' ' ' TRP . 11.7 p30 -91.62 107.33 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 109.484 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.864 ' HD1' ' N ' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -156.69 171.03 21.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.527 179.653 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.07 164.7 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.7 t -80.29 140.05 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.467 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.7 -17.46 58.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 15.4 t -91.27 165.95 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -1.119 . . . . 0.0 109.466 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.0 p -76.06 92.63 3.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 180' ' ' CYS . 0.1 OUTLIER 160.6 -39.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 28.9 t80 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.725 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.561 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 1.8 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -129.34 144.93 51.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -144.93 140.07 28.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.7 m 46.96 -162.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.65 -27.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -73.72 -16.69 61.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 0.0 109.447 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.02 130.17 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.552 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLN . 33.4 t -162.68 137.19 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.51 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' SER . 93.2 mt-30 50.53 179.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.535 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' LEU . 5.1 m-20 48.31 77.12 0.48 Allowed Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.251 -0.905 . . . . 0.0 109.409 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -47.69 -10.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.886 2.391 . . . . 0.0 112.073 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' ASP . 13.5 mt -62.78 -33.81 75.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 47' ' ' ILE . 54.0 m-85 -63.03 -58.13 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.67 -47.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.66 69.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -72.26 -43.51 64.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.489 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 60.5 t-80 -60.85 -43.53 98.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.62 -41.25 79.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.54 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -60.24 -48.11 83.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' HIS . 80.0 mm-40 -141.97 -131.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.489 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 5.7 t90 56.56 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.16 0.63 65.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 169' ' ' CYS . 10.0 t -118.08 96.61 49.91 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.217 -1.167 . . . . 0.0 109.416 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.25 122.59 5.65 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.778 2.318 . . . . 0.0 111.871 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 27.6 tp10 -110.67 139.31 46.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.885 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.4 p -115.56 3.96 14.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 93.6 m-20 -77.77 123.54 26.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.33 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.446 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 12.9 t -64.48 -37.81 88.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HZ2' ' CB ' ' A' ' 29' ' ' LYS . 9.5 mtmp? -62.88 -55.06 29.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -65.87 -43.91 86.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.803 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.6 -34.79 76.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.103 -0.998 . . . . 0.0 109.924 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.51 -39.45 83.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.885 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 3.6 mp0 -73.77 -31.05 63.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.885 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.571 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 55.9 ttm -59.06 -54.05 51.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.798 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.55 -33.16 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.983 . . . . 0.0 110.034 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 t -71.81 -45.88 60.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.4 mt -64.23 -44.26 92.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 41' ' ' GLN . 97.2 mt-10 -63.1 -33.28 75.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 109.829 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.27 -36.38 7.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 19.3 mp0 -75.47 -14.7 60.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -1.221 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLU . 4.0 pp0? -55.27 -23.77 24.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.62 108.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.92 -34.09 3.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.2 mm? -86.14 178.06 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -1.186 . . . . 0.0 109.489 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.6 m -108.69 149.93 28.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.348 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 p90 -53.79 -36.28 62.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -62.54 -40.51 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 93.4 m -64.31 -37.25 86.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.9 t -60.09 -39.42 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.44 -46.8 83.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -62.03 -50.99 69.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 109.349 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -66.96 -28.74 68.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' VAL . 64.6 ttt180 -53.37 -44.55 68.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.156 -0.965 . . . . 0.0 108.973 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.66 -43.58 79.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -66.15 -37.53 85.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 14.3 t80 -59.65 -49.06 79.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 21.9 mmm180 -61.24 -29.55 69.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.735 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.64 98.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.875 . . . . 0.0 110.241 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.0 m -93.9 -41.91 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 110.232 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 32.4 m-85 -70.73 -52.09 23.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.218 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 49.7 t60 -51.55 -38.07 52.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.055 -1.028 . . . . 0.0 109.865 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.03 -37.13 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.769 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 64' ' ' ASP . 70.2 m-85 -88.06 -9.0 54.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.007 . . . . 0.0 109.856 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 63' ' ' PHE . 7.2 t70 61.75 129.83 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.74 -31.76 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.841 2.36 . . . . 0.0 112.69 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.62 -50.66 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.632 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 71' ' ' MET . 40.7 mtpt -66.82 -34.5 77.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 109.797 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.16 -28.9 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.6 -18.39 29.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.57 25.98 5.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.1 ptp -75.22 -160.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -129.58 160.56 32.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 49.2 mp0 -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -70.73 -24.34 62.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.443 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -67.0 -47.65 70.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 0.0 109.386 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 m -64.91 -38.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.57 -32.61 73.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.583 HH11 ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.93 -41.99 81.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.775 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.93 -30.68 70.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.4 t -49.55 -33.8 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.952 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -91.36 -63.45 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -101.55 115.75 31.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.49 -46.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.64 15.07 64.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 pt -123.58 167.39 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -1.131 . . . . 0.0 109.304 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.9 mt -49.07 128.64 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -108.29 128.08 54.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.693 ' O ' ' N ' ' A' ' 90' ' ' GLY . 58.4 t-80 -158.21 1.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.147 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 59.48 -60.65 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.07 -46.73 93.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -42.54 96.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -1.151 . . . . 0.0 109.499 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.6 mt -63.37 -49.41 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -54.47 -33.14 59.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.401 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.368 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 94.8 mt -58.41 -41.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 96' ' ' ILE . 16.9 mm -55.49 -47.28 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.82 93.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.27 -45.22 91.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.137 . . . . 0.0 109.386 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -70.04 -47.63 61.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.72 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.446 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 84.5 t80 -68.06 -46.17 71.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.73 -38.95 84.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.62 -44.98 85.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.85 -41.19 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -71.7 -27.01 62.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -51.25 -32.1 23.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.31 1.81 39.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.9 9.38 86.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -79.04 129.23 73.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.11 -1.229 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.51 122.16 8.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.673 2.249 . . . . 0.0 111.692 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -76.44 -44.89 33.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.472 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.43 -49.69 76.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.792 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 85.4 m-20 -54.64 -35.1 63.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.949 . . . . 0.0 111.005 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 75.7 t80 -73.54 -48.42 33.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.032 -1.042 . . . . 0.0 111.219 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 117' ' ' TRP . 3.1 m -55.95 -50.34 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.052 -1.03 . . . . 0.0 111.655 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.462 ' H ' HG23 ' A' ' 116' ' ' VAL . 25.2 p-90 -86.66 -22.42 26.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.84 -1.162 . . . . 0.0 111.087 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 120' ' ' VAL . 8.0 t -59.48 -27.95 66.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.821 -1.175 . . . . 0.0 109.658 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.12 -15.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.075 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 118' ' ' SER . 14.8 m -83.22 22.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 109.979 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.612 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 29.4 t30 61.05 48.27 6.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.046 . . . . 0.0 109.765 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 32.4 p80 41.91 32.99 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 8.6 tt0 -142.84 90.86 7.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -47.16 155.19 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.724 2.282 . . . . 0.0 111.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 16.7 mp0 -105.66 158.92 16.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 109.688 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.9 mtt -135.98 156.9 48.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.134 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 t -122.57 160.38 25.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.482 ' OE1' ' N ' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -141.28 43.72 1.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.73 169.72 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 m -87.69 -33.24 18.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.59 ' HG1' ' H ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -137.68 169.43 17.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.2 mt -67.85 -27.69 66.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.577 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.59 ' H ' ' HG1' ' A' ' 131' ' ' THR . 20.7 t -59.08 -41.22 87.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -64.19 -29.86 70.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.395 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.37 131.76 93.25 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.409 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 98.4 Cg_endo -80.03 141.45 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.141 2.561 . . . . 0.0 112.571 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 6.26 42.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 109.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.1 t -136.37 92.69 2.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.887 . . . . 0.0 109.35 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -98.06 154.53 37.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.74 -40.18 24.25 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.797 2.331 . . . . 0.0 112.061 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.86 70.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.0 m -62.39 -45.58 92.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.05 -43.77 86.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.59 73.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 109.513 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 8.2 tt -66.88 -46.73 74.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 87.7 p -58.9 -39.03 80.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.962 . . . . 0.0 109.548 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -63.59 -34.68 78.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.4 -50.28 60.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.22 -32.49 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -57.92 -38.11 75.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.33 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.676 ' HZ1' ' NH1' ' A' ' 152' ' ' ARG . 7.0 ttpm? -61.55 -38.94 89.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.452 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.676 ' NH1' ' HZ1' ' A' ' 151' ' ' LYS . 12.7 mpt_? -63.55 -20.22 65.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.28 24.65 10.09 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -89.84 131.92 35.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -1.121 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.34 177.69 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 54.07 57.19 6.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.9 m -121.78 25.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.412 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.49 166.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 p -66.36 -24.53 66.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.397 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.456 ' CG2' ' N ' ' A' ' 161' ' ' ILE . 15.0 t -72.04 -42.66 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.456 ' N ' ' CG2' ' A' ' 160' ' ' THR . 81.5 mt -65.65 -41.45 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 50.1 t -63.22 -40.43 97.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.299 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CE1' ' O ' ' A' ' 136' ' ' PRO . 68.0 t80 -60.75 -46.85 88.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.395 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -45.55 84.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.888 . . . . 0.0 109.354 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -62.66 -34.45 77.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 178.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 30.7 ttm -63.28 -45.0 93.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.645 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -70.08 -37.17 75.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.668 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.76 -46.98 79.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 14.4 m -64.66 -61.14 2.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.0 7.54 3.25 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.5 mp -50.07 -43.55 51.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 109.38 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -100.61 134.54 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.487 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -87.19 103.41 15.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -91.92 121.99 34.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.593 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -160.9 100.28 1.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.96 148.17 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.68 129.9 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.23 7.98 63.35 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 52.3 t -79.65 94.2 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.507 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.561 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 3.2 t 65.63 -57.18 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 37.6 t -173.07 60.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 21.8 t80 -83.27 118.41 71.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.528 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 88.0 Cg_endo -85.72 176.26 5.54 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.017 2.478 . . . . 0.0 112.331 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.71 -10.92 64.68 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -90.12 18.38 5.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -1.122 . . . . 0.0 109.668 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -83.42 151.32 62.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.306 -1.673 0 C-N-CA 123.086 2.524 . . . . 0.0 112.216 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.295 0.569 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -141.29 157.52 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.588 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -137.18 140.0 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' C ' ' H ' ' A' ' 6' ' ' TRP . 14.1 m -150.91 26.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.407 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.98 -44.19 0.16 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.523 ' H ' ' C ' ' A' ' 4' ' ' CYS . 94.1 m95 -54.63 -35.06 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 m -73.49 63.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -149.94 48.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -152.96 -125.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.1 150.17 98.07 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.859 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.63 -19.84 41.46 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.899 2.4 . . . . 0.0 112.095 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.29 -41.36 98.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.392 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -65.24 -49.6 69.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.443 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.0 -45.12 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.84 88.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -57.57 -42.39 83.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.536 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 48.7 t-80 -62.32 -41.76 98.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.8 -40.03 94.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -58.77 -53.04 62.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 21' ' ' TRP . 76.3 mm-40 -142.48 -131.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.536 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 24.2 t90 58.76 138.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.535 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.28 -29.0 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 169' ' ' CYS . 11.0 p -75.49 131.59 77.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.11 120.51 6.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.817 2.345 . . . . 0.0 111.885 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -111.5 137.19 49.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.845 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -132.61 4.87 3.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 28' ' ' SER . 63.3 t0 -94.22 142.96 26.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.284 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 60.3 p -64.33 -34.63 78.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.4 -47.64 75.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.91 -48.89 27.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.61 -35.37 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.845 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.505 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 48.9 t80 -60.63 -46.97 88.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.864 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.14 -30.11 62.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.83 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -58.47 -53.28 60.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.793 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.462 ' O ' ' CD ' ' A' ' 38' ' ' GLU . 4.1 tp -69.77 -31.62 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 110.017 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 69.2 m -73.31 -46.58 48.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.902 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 16.5 pt-20 -49.8 -43.5 48.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.778 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . 77.2 171.31 35.19 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.744 ' C ' ' H ' ' A' ' 42' ' ' ALA . 4.5 tt0 -66.35 -43.77 85.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.247 . . . . 0.0 109.737 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 58.34 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 109.704 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.744 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -70.84 117.88 12.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.11 -15.25 63.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -116.87 -135.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -1.176 . . . . 0.0 109.461 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -153.27 154.8 35.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.434 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -52.31 -35.64 51.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.4 tp -52.91 -40.99 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 73.5 m -66.83 -35.65 80.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 0.0 109.701 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.9 t -60.97 -39.91 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.414 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 mt -59.95 -47.48 85.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.666 ' NZ ' ' HZ3' ' A' ' 52' ' ' LYS . 9.8 mtmp? -64.63 -53.06 53.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.262 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.666 ' HZ3' ' NZ ' ' A' ' 51' ' ' LYS . 13.0 mptt -64.51 -34.36 78.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 49' ' ' VAL . 7.9 tmm_? -50.45 -45.94 56.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.2 -0.938 . . . . 0.0 108.95 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.38 -42.24 98.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -66.51 -36.33 82.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.223 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -61.95 -45.66 92.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.3 mtm180 -57.15 -42.1 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.828 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.6 66.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 m -92.34 -12.61 31.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 0.0 110.363 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.84 -43.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.906 -1.121 . . . . 0.0 110.239 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -51.41 -43.76 62.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.113 -0.992 . . . . 0.0 109.885 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -67.11 -39.98 86.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 93.5 m-85 -71.58 -24.17 61.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.854 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.4 t70 69.62 131.48 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.996 -1.065 . . . . 0.0 109.563 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -39.9 -37.24 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.834 2.356 . . . . 0.0 112.679 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.03 -48.38 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.14 -0.975 . . . . 0.0 109.647 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 71' ' ' MET . 60.5 mttp -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.15 -43.4 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 109.626 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.3 -30.3 54.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.68 58.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.407 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.8 mtp -65.08 136.65 56.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -94.37 171.98 8.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.93 -33.28 70.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -59.18 -42.57 91.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -59.26 -38.45 80.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.85 -44.99 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.571 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.538 ' OE1' ' NH1' ' A' ' 89' ' ' ARG . 41.8 tp10 -56.44 -37.79 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -65.4 -43.74 89.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.718 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.01 -36.21 79.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.619 ' CG1' HH21 ' A' ' 87' ' ' ARG . 52.7 t -50.64 -35.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.723 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.15 -60.04 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 109.518 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -99.91 115.92 30.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.72 -45.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.11 33.38 40.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.42 172.17 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -1.111 . . . . 0.0 109.336 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.0 mt -48.53 135.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.619 HH21 ' CG1' ' A' ' 80' ' ' VAL . 1.3 tpt180 -75.46 122.62 24.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.44 91.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 109.141 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 77' ' ' GLU . 38.3 ttm-85 -48.57 -32.54 8.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.932 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.44 -38.48 93.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.693 ' HZ1' ' H ' ' A' ' 40' ' ' GLN . 14.1 mmmt -60.04 -47.34 86.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.499 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 92' ' ' ILE . 76.5 mt -60.26 -41.39 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -58.08 -39.08 77.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.0 81.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.505 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 33.3 mm -59.6 -43.74 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.434 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 96' ' ' ILE . 96.6 mt -61.28 -28.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.548 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.05 -45.65 80.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.679 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -63.12 -35.48 80.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -1.148 . . . . 0.0 109.416 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.679 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -62.78 -46.79 86.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 109.521 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -71.43 -45.77 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.93 81.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.529 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.41 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 64.8 t80 -63.6 -49.2 74.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.94 -42.71 80.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.483 ' NE2' ' OE1' ' A' ' 107' ' ' GLN . 69.7 tp60 -65.53 -41.64 92.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.6 ttt -65.31 -41.82 93.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.471 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.68 -27.33 65.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.483 ' OE1' ' NE2' ' A' ' 104' ' ' GLN . 61.4 tt0 -51.8 -31.13 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -76.74 -12.7 60.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.45 0.46 76.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.83 132.54 64.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.2 -1.177 . . . . 0.0 109.712 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.49 118.58 5.73 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.6 2.2 . . . . 0.0 111.7 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -77.22 -38.57 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.795 . . . . 0.0 110.455 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.14 -49.72 76.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 110.77 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 118' ' ' SER . 93.0 m-20 -61.27 -44.43 97.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.228 -0.92 . . . . 0.0 111.102 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.77 -53.47 57.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.94 -1.1 . . . . 0.0 111.224 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.406 HG21 ' N ' ' A' ' 117' ' ' TRP . 12.2 m -57.96 -49.71 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.934 -1.104 . . . . 0.0 111.666 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.511 ' O ' ' CE3' ' A' ' 117' ' ' TRP . 2.4 p-90 -86.89 -21.55 26.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.712 -1.242 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 120' ' ' VAL . 17.0 p -58.84 -33.84 70.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.799 -1.188 . . . . 0.0 109.721 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.07 -12.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.915 . . . . 0.0 110.076 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 118' ' ' SER . 43.1 t -82.32 23.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.073 -1.017 . . . . 0.0 109.939 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 35.1 t30 68.95 18.75 8.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 53.58 50.08 18.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.0 tt0 -159.7 121.41 1.82 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.34 151.89 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.716 2.278 . . . . 0.0 111.794 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 87.9 mm-40 -118.44 146.96 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.975 . . . . 0.0 109.72 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -135.91 156.49 48.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.79 . . . . 0.0 109.097 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.7 t -119.4 163.22 17.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.86 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -149.06 43.41 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.26 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.05 -150.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 109.676 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.445 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 14.4 m -138.72 -33.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -121.9 154.34 37.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.13 -33.84 75.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.893 . . . . 0.0 109.618 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -63.03 -33.38 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 130' ' ' THR . 95.6 mt-10 -62.92 -30.87 71.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.52 117.04 43.44 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.699 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.06 125.65 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.079 2.519 . . . . 0.0 112.537 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 10.2 t -76.65 -18.15 58.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 109.322 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.0 t -102.72 99.19 9.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.11 155.45 37.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -46.89 -40.67 25.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.749 2.299 . . . . 0.0 111.963 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.85 -35.18 67.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.389 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.8 m -60.66 -41.86 95.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -64.8 -45.82 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.49 81.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.489 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 7.4 tt -66.52 -46.35 76.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -56.33 -47.54 78.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.93 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.59 -45.0 73.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.17 -33.85 72.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.606 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -57.37 -40.89 79.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.86 -37.07 85.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.43 -17.81 65.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.19 20.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 136.27 33.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.14 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -105.24 -179.22 3.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.541 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 54.37 56.92 6.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.49 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 m -122.56 26.59 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.87 161.39 0.16 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.1 t -55.66 -32.61 63.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.158 . . . . 0.0 109.425 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 46.7 m -68.57 -46.83 68.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.04 -33.82 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.42 -41.77 79.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.299 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 137' ' ' THR . 43.4 t80 -62.23 -45.38 93.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.3 t -59.15 -36.9 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.54 -43.36 97.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.418 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.94 -39.74 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.638 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -61.63 -47.12 86.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.859 . . . . 0.0 109.689 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.65 -37.86 80.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.75 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' VAL . 15.6 m -59.59 -28.81 67.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.457 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.06 9.92 55.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.81 -40.65 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 109.483 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 t -96.36 129.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.691 ' ND2' ' HE2' ' A' ' 175' ' ' HIS . 45.7 t-20 -100.04 117.53 34.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.378 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -75.42 137.04 40.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.457 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.691 ' HE2' ' ND2' ' A' ' 173' ' ' ASN . 75.6 m-70 -146.22 48.68 1.2 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.95 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.54 144.88 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.9 t -81.69 134.19 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.952 . . . . 0.0 109.503 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.27 25.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.567 ' HG ' ' H ' ' A' ' 182' ' ' TYR . 13.8 p -86.94 -160.53 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.527 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.9 t -84.41 -54.16 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 t -64.94 -11.17 35.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.567 ' H ' ' HG ' ' A' ' 179' ' ' CYS . 0.7 OUTLIER -122.53 83.01 47.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.609 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.58 41.43 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 123.142 2.561 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.68 25.72 66.84 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.34 43.38 20.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -1.147 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -129.45 79.63 73.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 109.563 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 C--N 1.306 -1.698 0 C-N-CA 123.072 2.515 . . . . 0.0 112.173 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -98.78 158.87 15.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.59 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' CYS . 32.8 ptt180 -146.66 158.96 44.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' ARG . 20.2 m 53.94 171.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.07 12.69 1.44 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 2.9 p-90 -148.3 46.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 109.429 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.42 130.36 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.527 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 m -73.81 146.41 44.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 9' ' ' GLN . 27.6 mp0 -65.29 -29.35 70.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.515 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -53.52 142.65 40.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.85 -23.81 18.54 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.874 2.383 . . . . 0.0 112.163 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.85 -39.79 95.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -79.45 -47.38 15.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.39 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.7 mt -55.41 -49.05 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.416 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -46.08 78.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -62.23 -40.41 96.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t-80 -58.68 -45.86 88.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.38 -46.23 12.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -57.98 -37.66 74.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 21' ' ' TRP . 93.7 mt-10 -144.54 -156.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.464 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.483 ' O ' ' O ' ' A' ' 20' ' ' GLU . 34.6 t90 59.76 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.64 -28.51 10.01 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.56 119.63 68.48 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.33 -1.1 . . . . 0.0 109.409 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.95 129.13 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.868 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -115.58 137.95 51.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.9 p -126.46 4.99 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.888 . . . . 0.0 109.104 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -72.18 119.47 16.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.6 p -60.55 -36.89 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -62.71 -46.98 85.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.828 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.16 -50.74 62.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 8.8 mp -64.55 -39.0 92.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.119 -0.988 . . . . 0.0 109.887 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 90.4 t80 -61.6 -52.91 62.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 109.864 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -33.11 75.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -56.72 -50.81 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.82 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.32 -40.16 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.995 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -72.24 -39.96 68.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.123 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.44 -40.64 66.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 109.848 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -53.63 -35.88 61.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' C ' ' HZ3' ' A' ' 91' ' ' LYS . . . -51.15 -31.56 26.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.409 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 26.8 mt-30 -71.06 -29.83 65.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -1.202 . . . . 0.0 109.742 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' LEU . 6.0 pt20 -51.28 -31.26 20.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.695 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.43 109.75 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.656 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.82 -31.88 5.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLN . 27.1 mt -96.23 -179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.484 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.0 m -105.78 163.15 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.972 . . . . 0.0 109.415 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.2 -46.43 75.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.3 tp -56.57 -34.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.9 m -64.54 -33.99 77.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.8 t -63.18 -40.76 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -53.66 -51.38 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -56.91 -39.68 74.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -80.75 -17.87 49.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.375 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.454 ' NH1' ' HG3' ' A' ' 53' ' ' ARG . 39.8 ttm-85 -60.99 -49.25 78.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.157 -0.964 . . . . 0.0 108.992 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -73.95 -42.84 59.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.456 -0.778 . . . . 0.0 109.347 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -66.64 -43.11 85.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 60' ' ' PHE . 35.9 t80 -60.42 -46.14 91.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.364 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' HIS . 76.6 mtm180 -59.48 -37.13 77.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 15.1 p -94.14 -12.33 28.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.301 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.635 ' CD2' ' CZ ' ' A' ' 56' ' ' TYR . 52.4 m-85 -120.95 -54.22 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.967 -1.083 . . . . 0.0 110.2 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 57' ' ' ARG . 44.7 t-80 -55.6 -41.79 73.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -55.77 -32.93 63.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 81.5 m-85 -94.96 3.81 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.856 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 57.7 162.58 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 109.555 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 68' ' ' VAL . 60.7 Cg_endo -74.48 -14.49 22.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.876 2.384 . . . . 0.0 112.694 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.678 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.81 -46.61 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.908 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 6.3 m -56.69 -41.9 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.007 . . . . 0.0 109.641 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.465 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -58.9 -40.93 85.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.96 27.98 2.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.6 ttm -71.21 147.83 47.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.689 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -100.08 149.23 23.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 55.7 mp0 -52.34 -31.81 35.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.99 -45.64 88.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.45 -39.13 79.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.428 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.5 t -55.29 -46.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.33 -34.14 70.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.58 -49.27 71.84 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.337 -0.852 . . . . 0.0 109.78 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 mt -63.88 -38.39 90.9 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.97 -30.72 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -89.42 -58.54 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -99.52 124.85 45.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.415 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -170.27 -61.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.442 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.98 75.12 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.1 pt -100.3 -169.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.337 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.11 138.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.28 122.27 31.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.468 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -177.6 81.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -48.37 -28.59 3.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.16 98.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.476 ' HZ3' ' C ' ' A' ' 39' ' ' GLY . 14.1 mtpt -69.13 -42.48 75.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -1.205 . . . . 0.0 109.571 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.95 -50.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -57.13 -33.48 67.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.443 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.21 -43.58 98.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 95' ' ' ILE . 20.2 mm -55.75 -44.3 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -55.36 -50.15 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.69 -29.21 65.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.659 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.31 -40.3 85.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -1.195 . . . . 0.0 109.422 -178.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.659 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -67.8 -38.96 83.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -55.39 -44.83 76.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 109.541 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.33 69.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.442 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 37.0 t80 -60.75 -44.64 96.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.69 -36.31 83.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -57.68 -43.18 84.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.69 -43.86 71.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.62 -28.06 66.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -51.87 -33.04 34.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.5 -12.48 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.19 10.99 83.0 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -93.5 149.16 36.78 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.215 -1.168 . . . . 0.0 109.735 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.66 120.09 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.722 2.282 . . . . 0.0 111.697 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -66.46 -43.25 86.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 0.0 110.408 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.11 72.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.183 -0.948 . . . . 0.0 110.713 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' O ' ' CB ' ' A' ' 118' ' ' SER . 18.2 t70 -55.11 -51.18 67.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 111.046 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.426 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 69.7 t80 -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 111.261 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -58.37 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 111.706 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.415 ' NE1' ' HA ' ' A' ' 114' ' ' ASP . 45.0 p-90 -88.19 -20.69 25.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.786 -1.196 . . . . 0.0 111.162 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 120' ' ' VAL . 71.7 p -61.23 -24.29 66.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.159 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.13 -11.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.052 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.6 m -90.23 24.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 109.987 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 0.2 OUTLIER 77.51 -50.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 109.719 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.3 p-80 162.48 -19.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.38 148.96 35.92 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.15 154.7 47.05 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.707 2.272 . . . . 0.0 111.779 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -87.44 153.01 21.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 126' ' ' MET . 2.4 mpp? -136.57 150.46 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.431 ' OG1' ' CD1' ' A' ' 135' ' ' ILE . 15.1 t -99.35 171.55 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.864 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -160.17 67.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.31 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.49 -121.46 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 109.676 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 m -158.72 -33.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 t -124.0 170.27 10.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -73.79 -28.57 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.0 m -67.0 -38.1 85.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -67.25 -15.04 63.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.186 -0.946 . . . . 0.0 109.445 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.446 HG22 HD13 ' A' ' 135' ' ' ILE . 44.3 mm -65.68 116.69 34.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -42.53 136.23 4.35 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.071 2.514 . . . . 0.0 112.552 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -4.01 35.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -143.98 83.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.2 p -74.86 153.11 86.94 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.18 -29.97 68.91 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.76 2.307 . . . . 0.0 112.059 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.5 -33.44 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.386 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.5 p -64.27 -40.42 95.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.88 -50.12 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 109.527 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.62 82.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.03 -43.79 91.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.473 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.0 p -55.35 -43.86 75.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -62.58 -32.03 72.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.479 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.04 36.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.488 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 3.8 mm? -62.36 -37.88 87.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.635 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -59.23 -37.44 77.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.09 -39.89 91.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.509 HH11 ' HG2' ' A' ' 152' ' ' ARG . 38.7 mtt-85 -64.65 -19.57 65.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.23 21.91 21.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.06 138.42 36.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -103.53 170.42 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 59.08 47.08 12.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 158' ' ' GLY . 17.2 m -118.92 25.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.71 168.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.3 m -55.8 -32.61 63.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.46 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.1 m -62.28 -48.6 79.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -65.7 -34.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.94 -47.07 69.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -64.95 -40.78 95.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 109.347 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -59.57 -36.72 76.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.24 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.595 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 81.8 t80 -61.61 -43.09 99.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.5 mtp -70.43 -36.85 74.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -64.59 -54.79 26.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.698 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.32 83.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.595 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 22.9 m -53.88 -38.3 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.6 5.97 47.62 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.69 -33.1 73.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.75 132.32 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -94.57 105.33 17.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -96.02 96.13 8.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.168 -0.957 . . . . 0.0 109.494 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' A' ' 176' ' ' VAL . 21.2 m80 -108.9 -6.88 15.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.524 ' O ' ' O ' ' A' ' 175' ' ' HIS . 87.6 t 54.29 163.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.453 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 81.8 t -108.08 133.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.83 61.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 181' ' ' CYS . 39.2 m -144.41 168.35 20.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.163 . . . . 0.0 109.525 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 98.5 m 50.09 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 179' ' ' CYS . 38.6 t -155.8 14.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.623 ' O ' ' O ' ' A' ' 183' ' ' PRO . 30.0 t80 -71.42 139.46 84.17 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 109.513 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.623 ' O ' ' O ' ' A' ' 182' ' ' TYR . 89.8 Cg_exo -40.07 -175.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.156 2.571 . . . . 0.0 112.375 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.21 -14.1 63.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.37 21.92 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.099 . . . . 0.0 109.593 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.13 80.15 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 109.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--N 1.305 -1.736 0 C-N-CA 123.065 2.51 . . . . 0.0 112.288 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.37 151.83 25.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' HG3' HH11 ' A' ' 3' ' ' ARG . 32.0 mtm-85 -139.88 -174.05 3.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.442 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -141.39 -142.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.44 -11.99 0.1 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . 44.5 m95 -67.14 -9.48 40.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 6' ' ' TRP . 20.1 m 35.76 -154.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 8' ' ' SER . 10.3 t -178.08 47.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 10' ' ' ASP . 6.6 pt20 -130.63 -105.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 9' ' ' GLN . 58.2 m-20 -43.6 107.09 0.54 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -48.71 -34.84 28.55 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.799 2.333 . . . . 0.0 112.173 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.44 -44.22 95.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.473 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.46 ' CE1' ' CE1' ' A' ' 17' ' ' HIS . 40.0 t80 -68.15 -42.6 79.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.2 mt -59.36 -42.61 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.424 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' ASN . . . -61.72 -39.12 90.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.88 -41.27 77.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CE1' ' CE1' ' A' ' 13' ' ' TYR . 3.5 m80 -77.39 -20.87 54.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.912 . . . . 0.0 109.461 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -104.15 -2.04 26.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.523 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . 13.0 m120 -77.27 -74.83 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -147.89 23.43 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -79.85 132.89 36.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.95 -28.35 13.03 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 169' ' ' CYS . 4.0 t -91.39 112.95 56.77 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.212 -1.169 . . . . 0.0 109.41 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.68 137.85 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.759 2.306 . . . . 0.0 111.865 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.7 141.34 51.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.809 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.9 p -90.44 12.4 18.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.376 -0.827 . . . . 0.0 109.107 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -81.36 129.51 34.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 109.317 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.424 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 95.2 p -71.28 -31.03 66.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -58.64 -42.57 88.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.681 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.88 -48.56 65.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.89 -42.07 81.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 109.82 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 31.8 t80 -61.5 -52.68 63.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.48 -30.65 71.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -67.97 -55.39 12.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.805 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.3 mt -65.75 -43.84 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -58.23 -49.26 77.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 0.0 110.105 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 4.2 mm? -76.86 -41.68 43.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.857 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -53.93 -37.97 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.792 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.63 -29.73 25.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.624 ' NE2' ' CZ ' ' A' ' 56' ' ' TYR . 72.3 mt-30 -66.79 -30.03 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.187 . . . . 0.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.678 HE22 ' N ' ' A' ' 46' ' ' TRP . 35.6 tp60 -45.79 -39.05 7.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.935 . . . . 0.0 109.702 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.84 107.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.63 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.28 -32.72 4.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.5 mt -89.19 -165.11 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -1.126 . . . . 0.0 109.512 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.7 t -121.73 149.88 42.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.678 ' N ' HE22 ' A' ' 41' ' ' GLN . 36.2 p90 -57.61 -49.13 77.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 9.4 tp -48.34 -37.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.672 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.0 m -71.71 -34.2 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.727 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.63 -48.35 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -60.45 -47.22 87.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -61.9 -51.49 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.982 . . . . 0.0 109.305 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.65 -36.2 83.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 109.403 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -48.26 -46.11 35.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.205 -0.934 . . . . 0.0 108.975 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -65.23 -42.32 93.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.362 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.86 -39.08 90.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.286 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.624 ' CZ ' ' NE2' ' A' ' 40' ' ' GLN . 3.6 m-85 -61.87 -44.13 97.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 109.342 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 53.4 mtp180 -54.77 -43.51 72.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.299 -0.875 . . . . 0.0 109.834 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.38 -23.54 65.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.792 . . . . 0.0 110.328 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 59' ' ' CYS . 3.8 t -92.31 -12.64 31.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.271 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -133.16 -46.68 0.84 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.892 -1.13 . . . . 0.0 110.231 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 53.3 t-80 -53.47 -41.55 66.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.037 -1.039 . . . . 0.0 109.901 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.08 -34.87 68.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.792 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' ASP . 88.1 m-85 -91.04 4.41 52.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.874 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.61 160.67 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.601 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.73 -24.22 25.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.856 2.371 . . . . 0.0 112.728 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.85 -48.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.1 mttm -66.09 -33.78 76.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.403 -0.811 . . . . 0.0 109.866 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 71' ' ' MET . 61.0 t -57.43 -43.14 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.058 -1.026 . . . . 0.0 109.576 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.17 -24.35 61.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.63 14.13 28.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.356 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 11.8 ptm -77.61 152.55 33.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -100.62 163.29 12.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.558 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.38 -28.71 60.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.459 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -57.07 -37.42 71.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.13 -38.37 86.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.0 t -61.5 -38.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.612 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.83 -39.4 90.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.391 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 78' ' ' ARG . 53.5 mtm-85 -75.35 -47.85 25.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.318 -0.863 . . . . 0.0 109.767 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.73 -41.85 99.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.0 t -54.24 -34.28 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.713 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.62 -54.86 3.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.543 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -98.86 109.01 21.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 109.404 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.29 -38.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.87 36.84 46.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -124.5 173.42 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -1.139 . . . . 0.0 109.377 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 87.2 mt -47.71 138.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.568 HH11 ' HG2' ' A' ' 87' ' ' ARG . 9.9 ttt-85 -89.53 126.28 35.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 109.5 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.89 84.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -48.12 -32.09 6.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.935 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.88 93.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -65.13 -40.5 94.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mm -57.82 -47.46 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.49 -38.31 63.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.28 75.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.398 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.514 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 63.2 mt -59.9 -40.74 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.573 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 41.2 mm -54.19 -43.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.96 64.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -65.61 -45.73 82.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.14 . . . . 0.0 109.407 -178.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.516 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.71 -44.97 84.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.71 -41.28 98.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -46.54 38.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.424 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 49.8 t80 -55.45 -44.74 76.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.516 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.19 -32.99 74.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -54.85 -49.83 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.1 mtp -66.53 -38.55 87.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.73 -27.21 67.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -51.6 -34.03 35.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -81.11 -4.69 56.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.9 10.69 80.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -84.74 149.12 53.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.03 119.62 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.626 2.217 . . . . 0.0 111.704 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -73.85 -46.85 42.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.36 82.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.716 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.527 ' O ' ' OG ' ' A' ' 118' ' ' SER . 19.6 t70 -55.27 -39.1 69.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.907 . . . . 0.0 111.017 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.449 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 92.2 t80 -66.5 -49.43 66.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 111.192 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 m -60.46 -46.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 111.67 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.1 p-90 -85.97 -33.72 21.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.726 -1.233 . . . . 0.0 111.163 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 120' ' ' VAL . 74.4 m -57.12 -27.5 61.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 109.754 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.4 m -83.78 26.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.056 -1.027 . . . . 0.0 109.988 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.0 m120 74.36 21.57 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 56.51 42.2 27.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.93 . . . . 0.0 109.487 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -138.8 146.09 48.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.519 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.67 154.76 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.683 2.255 . . . . 0.0 111.836 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -120.27 147.46 44.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.965 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.7 ptp -135.58 157.31 47.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.838 . . . . 0.0 109.104 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 t -127.49 161.2 29.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -147.12 57.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.91 -151.18 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.705 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.3 m -114.31 -28.16 7.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 0.0 109.382 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.3 m -139.18 154.11 48.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.453 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.439 ' H ' HD12 ' A' ' 132' ' ' LEU . 1.0 OUTLIER -62.13 -30.86 71.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -67.2 -32.63 73.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.953 . . . . 0.0 109.513 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.08 -26.27 64.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.421 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 1.7 mp -67.34 121.58 79.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.25 133.94 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.125 2.55 . . . . 0.0 112.504 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.67 -17.32 48.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.373 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 138' ' ' SER . 24.1 p -73.05 102.4 3.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -134.8 151.65 76.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.36 -31.39 92.7 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.761 2.307 . . . . 0.0 112.049 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.85 73.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -63.57 -43.63 96.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.31 -44.5 97.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.83 60.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.438 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 6.8 tt -65.05 -49.05 71.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -57.84 -39.64 78.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.907 . . . . 0.0 109.539 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -62.31 -35.3 78.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.8 -51.57 57.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.2 mt -59.17 -35.02 72.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -58.16 -37.18 74.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -62.48 -40.6 97.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.5 mpt_? -64.51 -20.01 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.79 20.82 20.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -84.51 128.04 34.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 156' ' ' PHE . 22.9 tptt -97.41 176.99 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.457 ' H ' ' HG3' ' A' ' 155' ' ' LYS . 67.9 m-85 55.05 47.38 22.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 158' ' ' GLY . 2.6 m -121.71 25.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.69 171.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 p -58.31 -32.36 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.455 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 164' ' ' SER . 32.9 m -64.75 -48.46 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.37 -39.8 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 109.521 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 31.9 t -68.93 -50.13 52.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.29 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.492 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 53.1 t80 -63.93 -35.63 81.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 109.35 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 160' ' ' THR . 68.3 m -59.41 -41.47 89.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.256 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -65.05 -42.33 94.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.6 mtp -57.38 -40.9 79.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.521 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 24.1 mm100 -77.1 -36.4 55.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.41 -54.17 27.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.699 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.558 ' O ' ' O ' ' A' ' 23' ' ' VAL . 11.4 p -57.78 -61.14 2.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 144.22 2.76 0.81 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mp -48.5 -41.81 31.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.419 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.74 128.54 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -81.12 101.29 9.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 109.404 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.526 ' O ' ' ND1' ' A' ' 175' ' ' HIS . 78.6 m-20 -83.87 121.35 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 174' ' ' ASP . 28.4 m-70 -158.57 127.36 5.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.53 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.41 132.96 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.49 -20.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.78 -3.47 79.82 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.55 ' HG ' ' H ' ' A' ' 181' ' ' CYS . 6.9 t -90.17 143.49 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -1.151 . . . . 0.0 109.555 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.9 -36.73 80.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.55 ' H ' ' HG ' ' A' ' 179' ' ' CYS . 61.2 m -59.11 -39.33 81.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.591 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -124.69 81.12 61.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.607 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -86.16 28.62 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.086 2.524 . . . . 0.0 112.332 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.03 23.46 76.12 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.3 t30 56.74 40.09 29.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.091 . . . . 0.0 109.605 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -100.91 131.86 22.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo . . . . . 0 C--N 1.306 -1.702 0 C-N-CA 123.021 2.481 . . . . 0.0 112.308 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.254 0.549 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -75.1 147.32 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -148.52 164.74 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 m -48.11 137.73 10.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.39 -11.87 55.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -67.59 -1.86 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -1.154 . . . . 0.0 109.422 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -62.32 137.1 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -58.06 144.9 38.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.26 -32.81 73.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 109.533 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 143.1 78.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.06 -15.34 25.96 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.871 2.381 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.0 -43.06 99.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.22 -47.86 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.6 -46.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.29 92.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.11 -39.19 92.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.514 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 54.4 t-80 -55.27 -47.04 76.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.425 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.09 -42.36 38.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -58.88 -43.36 90.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 21' ' ' TRP . 87.9 mt-10 -146.55 -143.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' O ' ' A' ' 20' ' ' GLU . 35.3 t90 60.06 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.77 67.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -118.38 94.19 46.68 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.272 -1.134 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.04 131.27 21.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.766 2.311 . . . . 0.0 111.834 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.4 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.862 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.1 p -106.28 0.32 25.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.38 134.76 36.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -72.93 -31.72 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -64.7 -54.78 26.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -73.36 -49.75 25.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 109.893 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.2 -44.62 75.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.02 -42.41 98.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.954 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.515 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 36.5 tp10 -58.29 -31.51 67.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 109.78 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 tpp -63.67 -46.36 85.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.834 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.53 -47.21 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 110.01 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 14.2 p -60.04 -38.55 83.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.522 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 43.6 mt -66.08 -36.81 84.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.13 -0.981 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 65.3 mm-40 -60.18 -37.9 81.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.704 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.2 -36.05 7.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -66.09 -31.31 72.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -1.186 . . . . 0.0 109.794 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.533 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 7.9 tt0 -56.8 -31.73 64.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.736 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.72 109.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.98 -31.89 5.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.6 mp -104.73 -160.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -1.187 . . . . 0.0 109.422 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.2 m -125.44 152.96 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.542 ' CZ3' ' OE2' ' A' ' 38' ' ' GLU . 72.5 t-105 -54.19 -42.52 69.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.366 -0.833 . . . . 0.0 109.493 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -48.99 -39.74 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.68 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.52 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 52.9 m -71.92 -31.5 66.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 109.686 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ARG . 67.6 t -57.82 -30.8 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 109.438 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 4.1 mm? -52.87 -54.68 30.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.419 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.09 -45.89 89.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.351 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.85 -24.62 65.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' VAL . 33.2 ttt-85 -62.23 -47.33 84.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.22 -0.925 . . . . 0.0 109.032 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -44.51 84.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 109.337 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 12.5 m120 -70.28 -43.95 69.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 22.9 t80 -63.4 -37.31 86.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.474 -0.766 . . . . 0.0 109.332 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.77 -41.95 92.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.383 -0.823 . . . . 0.0 109.783 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 -21.43 59.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 55' ' ' ASN . 25.8 m -89.46 -11.97 41.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 110.266 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 83.3 m-85 -133.51 -50.91 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.113 . . . . 0.0 110.2 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -49.91 -42.83 48.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.913 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -59.32 -28.52 66.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 64' ' ' ASP . 90.8 m-85 -85.52 17.55 3.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.052 -1.03 . . . . 0.0 109.901 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 55.52 162.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 109.576 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.52 -54.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.884 2.389 . . . . 0.0 112.755 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 9.9 p -48.48 -44.61 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.703 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 80.6 tttt -58.12 -37.99 75.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.46 -38.96 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.083 -1.01 . . . . 0.0 109.63 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.06 -24.45 62.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.83 12.83 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.384 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.5 mtp -61.94 135.98 57.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -95.47 162.95 13.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CD ' HE22 ' A' ' 93' ' ' GLN . 75.6 mm-40 -57.86 -27.75 63.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -71.82 -29.02 63.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.11 -49.4 70.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 14.9 m -60.68 -37.64 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.58 -37.1 70.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' CG ' HH11 ' A' ' 78' ' ' ARG . 2.9 ttt-85 -65.25 -42.32 93.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.402 -0.811 . . . . 0.0 109.775 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.9 mt -67.12 -27.15 67.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.631 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.93 -28.42 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.712 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.79 -56.72 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 109.519 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 79' ' ' LEU . 53.1 t0 -99.07 169.89 9.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 73.77 73.59 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 109.416 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -77.95 33.18 1.7 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.501 ' O ' ' O ' ' A' ' 84' ' ' GLY . 16.0 pt -55.87 -159.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -1.12 . . . . 0.0 109.372 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.751 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 2.9 tt -55.86 -165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 109.515 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.751 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 8.0 mtt-85 -47.65 153.3 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -142.65 -156.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.176 -179.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 57.88 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.933 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -66.13 -44.19 91.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -61.59 -42.58 99.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -1.227 . . . . 0.0 109.5 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 mt -57.06 -47.29 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.555 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.534 HE22 ' CD ' ' A' ' 73' ' ' GLU . 15.5 mm100 -53.22 -36.99 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.35 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.355 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.586 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 81.4 mt -59.47 -50.0 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.91 -38.5 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.518 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.33 99.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 97.4 m-20 -69.44 -44.68 70.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.423 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.06 95.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.546 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -63.63 -43.93 95.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 109.531 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.99 -34.18 66.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.895 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.64 -51.29 63.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.31 -39.01 91.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -60.13 -42.84 95.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -61.98 -41.43 98.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.65 -27.01 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.127 -0.983 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -51.67 -20.38 2.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.506 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 110' ' ' GLU . 64.3 t30 -75.53 -18.45 59.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.83 65.16 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.517 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 12.0 mp0 -103.48 151.07 38.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.163 -1.198 . . . . 0.0 109.653 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.97 119.65 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.67 2.247 . . . . 0.0 111.676 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -74.88 -45.74 40.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 0.0 110.467 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -62.09 -47.95 82.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 110.734 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' O ' ' OG ' ' A' ' 118' ' ' SER . 18.4 t70 -55.8 -40.36 72.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.937 . . . . 0.0 111.036 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -64.72 -51.22 63.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.029 -1.045 . . . . 0.0 111.225 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.3 m -56.78 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.98 -1.075 . . . . 0.0 111.716 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.477 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -86.99 -32.82 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.775 -1.203 . . . . 0.0 111.134 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 120' ' ' VAL . 57.1 p -55.65 -21.03 16.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -44.04 -15.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.007 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.9 m -91.77 24.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.044 -1.035 . . . . 0.0 109.982 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.525 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 1.3 m120 72.56 -48.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 3.0 p-80 165.13 -20.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -106.31 149.3 38.06 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.6 149.17 67.58 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.696 2.264 . . . . 0.0 111.805 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -75.38 146.81 40.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.745 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 88.1 mtp -126.44 144.93 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.117 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.09 175.49 6.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -164.86 71.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.279 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.12 -132.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.734 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.9 m -154.22 -35.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -113.13 155.21 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.76 -30.27 70.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.501 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.0 p -70.74 -33.37 70.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.5 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.69 -24.89 67.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.5 mm -66.33 116.77 37.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.686 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.85 126.3 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.187 2.592 . . . . 0.0 112.538 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.453 ' OG1' ' CB ' ' A' ' 163' ' ' TYR . 2.0 t -77.2 -18.26 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.266 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.4 p -89.25 66.61 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.356 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -77.27 152.31 81.59 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.37 -36.02 16.92 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.8 2.333 . . . . 0.0 112.035 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.46 -41.51 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.1 m -59.65 -39.82 85.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -62.17 -48.32 80.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.82 78.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.528 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.7 p -63.26 -39.43 94.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.918 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.54 43.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.71 -33.44 75.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.564 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.44 -39.67 84.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.422 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -61.16 -39.93 91.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 152' ' ' ARG . 7.3 mtt-85 -64.43 -21.51 66.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.85 36.99 5.87 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.448 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 1.4 m-85 -84.79 133.51 34.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -1.112 . . . . 0.0 109.517 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.61 159.87 14.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.448 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 56.12 48.38 17.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 158' ' ' GLY . 10.7 p -121.82 26.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.457 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.51 156.3 0.07 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -59.88 -14.02 13.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -1.133 . . . . 0.0 109.448 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.6 p -70.86 -44.97 65.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.0 mt -65.07 -36.34 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.526 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 68.3 m -55.81 -40.81 73.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.321 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.453 ' CB ' ' OG1' ' A' ' 137' ' ' THR . 37.6 t80 -66.78 -47.26 72.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.405 -0.809 . . . . 0.0 109.314 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.7 m -66.05 -40.68 91.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.317 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.77 -49.38 77.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 92.6 mtp -68.94 -39.55 79.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.666 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.47 -41.89 99.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.734 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.58 97.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.678 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.4 m -66.06 -60.82 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 138.8 1.69 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.29 -33.34 72.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -1.167 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -99.74 130.1 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -98.76 105.06 17.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.29 114.23 26.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -135.51 143.18 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.44 142.5 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.441 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.435 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 89.05 15.63 58.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 178' ' ' GLY . 7.7 m -149.8 176.16 10.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 75.3 m 50.75 -97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.488 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 52.7 t -156.17 15.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 29.8 t80 -66.46 117.09 40.56 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.641 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.569 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 84.9 Cg_endo -83.55 -163.74 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.074 2.516 . . . . 0.0 112.397 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.23 67.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.46 40.74 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -1.155 . . . . 0.0 109.605 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -130.8 79.63 71.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.144 -0.973 . . . . 0.0 109.491 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.307 -1.648 0 C-N-CA 123.004 2.469 . . . . 0.0 112.259 -179.916 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.5 tpp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.492 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 13.8 pt-20 -87.35 143.53 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -149.45 174.16 12.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -48.13 167.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.99 9.23 1.54 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 21.6 m95 -83.13 -1.22 52.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.94 132.8 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' GLN . 68.4 m -79.64 177.94 8.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.4 mm-40 -61.03 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 51.54 85.06 0.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.01 -25.76 4.32 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.852 2.368 . . . . 0.0 112.1 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.91 -39.31 93.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.481 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -71.16 -48.11 53.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.12 -44.84 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.376 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.92 81.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -61.64 -43.96 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.18 -49.45 77.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.48 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.483 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -56.95 -56.36 22.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -175.25 131.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -159.64 123.05 3.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 109.516 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.98 -5.29 75.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' CYS . 19.3 t -63.4 132.09 95.02 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.209 -1.171 . . . . 0.0 109.343 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.03 120.47 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.777 2.318 . . . . 0.0 111.849 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.46 132.79 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.854 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -115.08 3.5 14.43 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 109.083 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.1 126.02 32.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 m -64.52 -40.44 95.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -60.93 -45.28 95.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.61 -45.01 69.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.895 . . . . 0.0 109.846 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.2 -43.93 96.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.118 -0.989 . . . . 0.0 109.808 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.49 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 44.9 t80 -60.52 -37.03 79.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.919 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.93 -30.55 63.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.878 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.9 tpp -64.45 -54.98 24.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.794 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -64.46 -33.32 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 110.045 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.5 m -64.44 -49.9 69.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 110.106 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.19 -28.38 59.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 109.805 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -52.82 -35.26 56.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 109.772 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.61 -33.88 74.03 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -59.05 -32.54 69.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -1.207 . . . . 0.0 109.763 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -52.87 -39.7 62.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.05 120.41 3.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -35.27 4.2 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.02 -138.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.137 . . . . 0.0 109.445 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -142.41 158.92 43.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -56.14 -39.36 72.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.474 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -59.12 -34.46 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.687 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.437 ' N ' HG21 ' A' ' 47' ' ' ILE . 61.1 m -69.39 -33.47 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.0 t -57.63 -43.16 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.442 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mp -56.7 -52.15 66.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.57 -44.69 93.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 109.307 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -73.25 -21.61 60.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.193 -0.942 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.8 ttm-85 -60.35 -46.05 91.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -71.13 -45.95 62.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.403 -0.811 . . . . 0.0 109.439 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.99 -35.0 79.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.609 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 25.3 t80 -62.78 -44.61 95.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.546 HH11 ' HG2' ' A' ' 57' ' ' ARG . 27.9 mtt-85 -57.0 -41.81 79.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.828 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -29.9 71.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.258 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 97.9 m -93.49 -12.6 29.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.262 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 61.8 m-85 -125.68 -43.27 1.88 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 0.0 110.181 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 29.9 t-80 -49.89 -40.14 42.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -61.85 -31.73 72.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.739 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.7 m-85 -91.34 -0.85 57.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.077 -1.014 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.05 161.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.107 -0.995 . . . . 0.0 109.623 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.47 -27.11 16.17 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.867 2.378 . . . . 0.0 112.713 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.5 -47.87 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.13 -35.35 80.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.11 -35.71 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 109.598 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.81 66.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.466 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 23.08 9.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 tpp -61.22 156.45 18.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.671 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -110.47 156.83 20.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.6 mt-10 -55.75 -35.06 65.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.94 -37.59 85.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.71 -49.5 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.3 mp0 -64.25 -32.74 74.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.28 -49.2 67.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.806 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.0 -41.18 67.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.605 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.9 t -51.1 -33.08 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.702 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -80.95 -59.79 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -98.96 117.11 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 77.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -22.91 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 84' ' ' GLY . 24.0 pt -62.29 -134.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.321 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.05 136.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -101.29 117.98 36.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.467 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -172.4 94.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.183 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -45.27 -35.43 3.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 109.967 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.33 -47.66 85.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -66.16 -38.12 87.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.25 -50.22 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.12 -32.99 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.326 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.26 99.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.388 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 95' ' ' ILE . 96.1 mt -60.06 -46.17 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.375 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 96' ' ' ILE . 95.6 mt -62.61 -36.45 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.63 94.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.623 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 13.9 m120 -60.17 -42.52 95.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.66 89.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.512 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -61.23 -44.33 97.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.29 72.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 30.1 t80 -66.93 -43.72 82.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.93 -50.51 62.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -59.9 -35.0 73.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ttt -59.16 -40.96 87.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.29 -27.75 66.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.482 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -51.66 -34.05 36.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -83.4 -1.19 52.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.39 35.92 40.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -116.84 82.16 12.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.657 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -41.67 131.31 3.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.634 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.06 -47.74 83.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -45.45 80.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 110.718 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -59.22 -33.21 70.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 111.034 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.3 t80 -65.26 -53.43 44.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.023 -1.048 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 m -58.02 -40.99 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.719 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -68.56 -31.12 70.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.719 -1.238 . . . . 0.0 111.104 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -65.15 -34.78 79.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 109.676 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -58.72 -44.2 90.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.084 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.71 20.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.079 -1.013 . . . . 0.0 110.006 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.62 30.48 18.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 55.45 22.88 5.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -123.39 100.98 38.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.626 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -47.38 139.45 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.728 2.286 . . . . 0.0 111.855 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -85.5 157.38 20.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -131.85 151.3 51.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 109.183 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -131.58 152.52 50.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -133.96 45.67 2.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.324 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.52 147.06 52.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.2 m -74.08 -36.26 64.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.4 m -132.56 157.58 44.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.555 ' H ' ' CD1' ' A' ' 132' ' ' LEU . 6.0 mp -54.29 -32.34 56.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.2 t -64.93 -33.83 76.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.34 -19.12 63.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 109.367 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -66.85 124.2 88.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 109.676 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.36 127.24 5.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.143 2.562 . . . . 0.0 112.552 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 -13.79 47.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.304 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -109.15 100.64 9.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 109.374 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -105.51 150.75 39.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.917 . . . . 0.0 109.462 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.96 -41.1 26.01 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.789 2.326 . . . . 0.0 111.982 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.65 -36.91 60.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.3 m -60.9 -43.24 98.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -61.96 -48.07 82.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.21 89.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.22 -41.39 99.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.2 p -57.88 -43.36 85.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.7 -27.68 68.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.502 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.48 -51.33 29.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.42 -36.17 73.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.567 ' HZ1' ' CB ' ' A' ' 150' ' ' LYS . 3.1 ttmp? -57.62 -36.6 72.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.34 -40.1 92.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -67.51 -19.74 65.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.413 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.92 22.25 16.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.623 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 8.0 m-85 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -1.107 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -101.79 168.52 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.501 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 54.05 53.13 11.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.28 25.16 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.419 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.41 167.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -55.47 -32.18 62.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.436 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 65.9 p -64.38 -47.78 77.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -65.7 -35.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 5.9 t -68.7 -44.13 74.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.259 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -62.23 -44.97 95.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.7 m -57.99 -37.18 73.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.222 -0.924 . . . . 0.0 109.248 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.617 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 72.4 t80 -59.73 -41.36 90.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.398 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.12 -38.57 72.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.504 HE22 ' CG ' ' A' ' 174' ' ' ASP . 98.1 mm-40 -63.34 -46.45 86.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.7 -44.63 49.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.617 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 98.3 m -62.44 -36.13 81.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.462 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.28 8.8 56.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.8 mp -53.41 -26.82 21.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -1.152 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.06 138.61 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.449 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -82.12 102.37 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.504 ' CG ' HE22 ' A' ' 167' ' ' GLN . 34.4 m-20 -91.56 118.17 30.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.56 166.0 28.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.621 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.27 150.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.29 130.23 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 91.2 4.71 68.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 181' ' ' CYS . 53.5 t -76.34 28.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.542 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 3.2 m 63.04 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 179' ' ' CYS . 73.3 m -59.47 -35.35 73.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 7.0 t80 -125.47 80.67 65.43 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.405 ' HA ' ' H ' ' A' ' 178' ' ' GLY . 85.3 Cg_endo -85.88 47.97 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.028 2.485 . . . . 0.0 112.359 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.07 64.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 57.87 42.79 22.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 109.535 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -134.78 78.72 54.31 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.518 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 C--N 1.306 -1.702 0 C-N-CA 123.097 2.531 . . . . 0.0 112.211 -179.89 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.318 0.58 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' OE2' ' SG ' ' A' ' 179' ' ' CYS . 22.3 pt-20 -83.71 145.58 28.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.613 ' HG2' HH11 ' A' ' 3' ' ' ARG . 10.2 mtt-85 -108.32 160.53 15.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' A' ' 6' ' ' TRP . 26.6 p -47.23 127.29 10.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.94 -6.27 3.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.455 ' H ' ' C ' ' A' ' 4' ' ' CYS . 16.9 m95 -54.53 -37.0 64.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.423 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -88.76 127.15 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.564 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' GLN . 75.2 m -165.86 146.46 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.0 mm100 60.32 133.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.552 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' GLN . 1.1 m-20 63.0 125.11 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.26 -7.71 19.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.845 2.364 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.49 -32.86 72.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.55 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 30.8 m-85 -49.47 -44.23 45.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.78 -28.42 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.424 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -58.97 -48.23 82.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.429 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.559 ' CG ' ' N ' ' A' ' 17' ' ' HIS . 2.2 p90 -75.52 -39.09 58.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.559 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 48.3 t-80 -60.85 -48.21 82.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.42 -44.86 67.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 98.4 m-20 -55.28 -45.45 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.3 pt-20 -173.52 -143.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.595 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 11.0 t-105 60.6 125.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.03 -20.28 46.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 169' ' ' CYS . 26.3 m -84.66 141.36 38.64 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.17 -1.194 . . . . 0.0 109.33 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.87 122.85 4.48 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.758 2.306 . . . . 0.0 111.905 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -119.6 131.98 55.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.02 . . . . 0.0 109.857 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -123.21 5.5 9.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.88 135.01 33.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -69.63 -39.36 77.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.603 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.47 -43.59 88.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 109.717 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -65.94 -49.64 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.86 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.9 mt -72.91 -29.96 63.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.873 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' ' N ' ' A' ' 33' ' ' GLU . 9.2 t80 -59.98 -56.39 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.0 pp20? -68.58 -29.72 68.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.595 ' SD ' ' CH2' ' A' ' 21' ' ' TRP . 55.2 tpp -63.61 -53.36 52.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.88 -46.78 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 110.05 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.9 t -70.34 -39.17 74.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.4 tp -73.34 -38.37 65.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 35.0 mm-40 -52.76 -34.54 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.24 -23.66 41.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.2 -38.01 86.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.176 . . . . 0.0 109.783 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -48.75 -38.93 23.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.786 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.53 106.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.662 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -31.26 6.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.4 mm? -86.03 -165.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -1.192 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' ' 48' ' ' THR . 15.6 p -117.36 150.64 38.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -56.21 -36.65 68.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -30.77 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.707 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.686 ' H ' ' HG ' ' A' ' 45' ' ' SER . 52.4 m -67.64 -40.46 84.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.679 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' ARG . 70.4 t -68.91 -40.89 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -57.05 -47.25 81.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -60.79 -51.45 69.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 109.297 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.48 -26.31 67.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.7 tmm_? -54.47 -46.63 73.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.38 -34.48 76.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.259 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -63.76 -45.8 88.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -0.789 . . . . 0.0 109.327 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 79.3 mtm180 -62.29 -30.63 71.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.864 . . . . 0.0 109.732 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.66 82.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.881 . . . . 0.0 110.276 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -93.77 -13.33 27.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.27 -178.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -113.76 -52.33 2.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.913 -1.117 . . . . 0.0 110.175 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.424 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.9 t-80 -51.94 -40.0 60.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 109.91 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -56.55 -32.5 65.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-85 -88.67 -2.83 58.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 109.883 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER 56.2 158.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.08 -24.04 20.85 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.893 2.396 . . . . 0.0 112.728 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.39 -48.24 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' MET . 12.2 mptt -67.88 -33.7 75.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.1 t -56.16 -41.22 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.029 . . . . 0.0 109.551 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.11 68.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.46 17.7 20.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.399 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ttp -75.81 155.43 35.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.68 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -105.48 162.53 13.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.96 -30.07 70.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.32 -41.32 84.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -60.93 -39.83 90.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.36 -42.51 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -60.15 -34.06 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.622 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.41 -44.55 82.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 13.9 mt -65.04 -33.4 75.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.932 . . . . 0.0 109.626 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.79 -31.99 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -84.88 -60.89 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.552 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.23 123.73 43.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.371 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -166.11 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.78 27.18 57.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ARG . 9.9 pt -133.0 167.38 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.138 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.71 58.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.623 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -106.69 139.79 40.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.471 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' GLY . 14.3 p80 -128.8 44.19 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.146 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.546 HH11 ' HG2' ' A' ' 89' ' ' ARG . 3.9 ttt-85 65.67 -58.54 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -60.82 -35.35 89.94 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -61.27 -50.98 70.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -1.167 . . . . 0.0 109.461 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -52.39 -39.51 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.691 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.53 -36.63 76.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.0 109.32 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.14 95.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.7 mp -55.54 -47.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -58.46 -30.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.551 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.23 94.83 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.728 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 29.0 p30 -68.63 -33.35 73.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 109.358 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.728 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -67.4 -42.25 83.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -65.23 -45.95 82.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.585 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.72 63.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 29.8 t80 -68.83 -43.44 75.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -47.96 71.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.474 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -57.97 -39.58 78.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 17.2 ttt -66.74 -41.24 88.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.85 -25.94 68.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -51.28 -29.28 14.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 51.0 p30 -80.16 -1.48 40.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.489 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.66 79.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 108' ' ' ASN . 32.4 tt0 -80.76 132.98 56.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.158 -1.201 . . . . 0.0 109.627 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.47 121.27 8.03 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.614 2.21 . . . . 0.0 111.726 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -74.72 -43.86 52.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.393 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.405 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -56.06 -49.99 72.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -0.967 . . . . 0.0 110.708 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 86.5 m-20 -61.23 -42.7 99.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 27.5 t80 -55.31 -48.62 73.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 111.213 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 117' ' ' TRP . 4.7 m -63.82 -48.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 0.0 111.721 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.488 ' CD2' ' N ' ' A' ' 118' ' ' SER . 4.3 p-90 -89.32 -37.49 14.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.769 -1.207 . . . . 0.0 111.117 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.4 m -56.18 -26.88 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.781 -1.199 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -13.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.04 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 118' ' ' SER . 18.7 m -82.8 21.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t30 60.36 36.22 20.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.061 -1.024 . . . . 0.0 109.703 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.2 m80 53.54 27.08 6.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.47 87.91 21.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.72 151.78 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.695 2.263 . . . . 0.0 111.842 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -93.44 155.16 17.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.719 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 71.6 mtm -137.15 147.17 45.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.198 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.5 t -142.18 155.82 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.801 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -123.61 45.61 2.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.289 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.2 139.5 35.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.2 m -74.56 -35.52 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.702 ' HG1' ' H ' ' A' ' 132' ' ' LEU . 1.8 t -139.45 178.92 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.397 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.702 ' H ' ' HG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -68.84 -33.4 73.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.543 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m -63.12 -36.42 83.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.81 -24.44 64.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.161 -0.962 . . . . 0.0 109.404 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.411 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 87.4 mt -67.28 119.95 68.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.728 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.76 129.22 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.088 2.526 . . . . 0.0 112.487 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.401 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 1.2 t -80.62 -19.19 45.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.4 m -98.05 98.54 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.858 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.446 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 4.5 p -106.23 154.61 39.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.32 -40.12 52.85 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.839 2.36 . . . . 0.0 111.999 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.16 -36.48 58.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.407 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.446 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 73.8 m -61.19 -41.3 96.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 -53.13 57.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.27 -35.26 79.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.435 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.01 -50.19 74.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 80.5 p -58.5 -37.69 76.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.91 -36.08 82.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.549 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.31 -50.56 45.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.467 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.603 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.88 -38.82 79.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.355 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -61.92 -39.37 91.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -63.84 -20.54 65.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.92 31.01 8.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.47 137.95 32.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.132 . . . . 0.0 109.454 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -101.19 173.58 6.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.485 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 52.82 50.79 17.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 158' ' ' GLY . 11.3 p -123.68 28.79 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.21 159.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.8 t -52.46 -29.81 26.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.373 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.5 m -65.9 -36.84 84.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.446 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.9 mm -62.24 -44.09 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.22 -48.7 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.411 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 42.9 t80 -60.21 -47.01 87.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.811 . . . . 0.0 109.352 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.438 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 22.6 t -61.64 -43.35 99.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.857 . . . . 0.0 109.27 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.411 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -63.08 -32.63 74.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.47 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 31.5 ttm -64.29 -45.13 89.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.609 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.81 -34.1 77.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.672 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.659 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.2 m -77.2 -42.5 37.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.65 28.77 5.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.72 -34.33 77.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.41 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.69 132.15 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -84.64 100.95 11.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 45.6 p-10 -120.64 92.62 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 176' ' ' VAL . 75.5 m80 -132.99 36.35 3.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' ' 177' ' ' VAL . 86.3 t 54.39 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.452 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.52 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 8.1 p -110.61 136.23 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.75 24.13 75.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 181' ' ' CYS . 66.4 m -143.73 169.9 16.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 109.523 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 84.5 m 48.3 -93.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 179' ' ' CYS . 50.0 m -157.92 33.09 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 30.8 t80 -88.27 117.06 67.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.552 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 87.8 Cg_endo -84.1 -159.61 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.15 2.567 . . . . 0.0 112.374 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.53 7.87 66.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -143.67 33.64 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -127.34 80.15 72.15 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 123.077 2.518 . . . . 0.0 112.226 -179.836 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.493 ' OE2' ' SG ' ' A' ' 179' ' ' CYS . 22.3 pt-20 -147.4 161.85 40.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.517 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -88.55 148.64 24.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.965 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 7.9 p -47.39 146.02 2.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.66 2.87 46.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -54.22 -36.56 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -1.135 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 m -97.01 131.14 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 13.0 t -177.31 -168.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.547 ' N ' ' OG ' ' A' ' 8' ' ' SER . 94.9 mt-30 49.38 -117.93 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.85 153.44 91.17 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.352 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.46 -6.14 18.28 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.804 2.336 . . . . 0.0 112.139 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.82 -39.52 85.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -56.47 -43.73 79.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.408 HD11 HG23 ' A' ' 14' ' ' ILE . 89.0 mt -67.43 -43.95 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.51 76.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.39 -40.15 93.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -63.42 -37.42 87.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -88.41 -4.41 58.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.513 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.522 HD21 HH22 ' A' ' 53' ' ' ARG . 48.0 t30 -74.09 -73.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -150.93 38.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.479 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -92.77 138.83 31.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.02 -21.39 44.18 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.58 132.44 72.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.247 -1.149 . . . . 0.0 109.366 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.48 119.69 6.28 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.724 2.282 . . . . 0.0 111.87 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.67 137.25 41.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -134.54 2.59 3.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.071 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -89.66 135.19 33.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.375 -0.828 . . . . 0.0 109.303 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.58 ' HG ' ' HH ' ' A' ' 102' ' ' TYR . 96.2 p -59.94 -38.28 81.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.632 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -57.02 -43.82 82.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.766 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.37 -53.31 24.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.03 -27.89 66.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.783 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 56.1 t80 -60.36 -50.53 73.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.928 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -74.44 -31.11 62.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.813 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.89 -54.39 22.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -64.4 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.032 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.489 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 36.1 t -73.36 -46.6 48.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.16 -0.962 . . . . 0.0 110.088 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.1 -41.67 97.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.877 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.22 -28.59 64.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.296 -0.878 . . . . 0.0 109.788 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.75 -37.07 27.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -66.07 -29.0 69.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -1.184 . . . . 0.0 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.4 tt0 -48.11 -34.22 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.72 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.42 111.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -33.12 5.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.0 mt -96.06 -145.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -1.14 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 m -144.68 155.97 43.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -51.17 -38.95 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.374 -0.829 . . . . 0.0 109.461 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 48' ' ' THR . 9.7 tp -61.94 -40.44 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 109.672 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 96.1 m -63.91 -35.87 82.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 53' ' ' ARG . 72.9 t -62.06 -42.82 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.473 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.43 -51.06 69.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -60.37 -44.08 95.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 109.348 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -75.78 -19.35 59.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.975 . . . . 0.0 109.361 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.522 HH22 HD21 ' A' ' 19' ' ' ASN . 43.8 ttp180 -61.22 -45.65 93.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 108.994 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 10.2 pt-20 -72.15 -43.0 65.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.34 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.95 -35.29 79.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.229 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 52.7 t80 -57.39 -49.27 76.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.427 -0.795 . . . . 0.0 109.308 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.4 mtp180 -58.42 -43.12 88.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.741 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.97 -39.81 42.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.793 . . . . 0.0 110.305 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -96.78 -28.63 14.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 35.4 m-85 -95.71 -27.75 15.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.977 -1.077 . . . . 0.0 110.231 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.7 t60 -48.77 -21.66 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -90.87 -25.61 19.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.81 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.459 ' O ' ' C ' ' A' ' 64' ' ' ASP . 61.9 m-85 -92.03 66.09 4.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 109.925 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' PHE . 3.7 m-20 -41.33 153.77 0.24 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 109.604 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -35.92 -53.66 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.852 2.368 . . . . 0.0 112.722 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.31 -45.11 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.64 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -67.35 -31.67 72.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.853 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.9 t -56.45 -46.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.572 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.81 58.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.48 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 -3.58 58.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 mtp -70.97 141.1 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.459 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 31.1 tp60 -99.85 169.15 9.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 78.7 mm-40 -61.84 -33.87 74.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 46.7 mp0 -60.84 -40.89 94.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.437 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -62.74 -37.76 87.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.41 -43.29 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.48 -33.47 75.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.97 -44.76 91.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.314 -0.866 . . . . 0.0 109.792 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -70.07 -35.48 74.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 109.591 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.1 t -51.19 -34.94 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.739 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -87.83 -60.13 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.614 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -100.17 109.23 21.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.903 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.47 -60.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.47 4.61 70.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.9 pt -90.02 -155.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.32 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.2 mt -68.62 136.79 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.478 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 87' ' ' ARG . 19.7 mmm-85 -88.6 95.89 10.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -172.41 88.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.13 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -49.96 -29.12 7.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.04 96.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -63.05 -48.19 79.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -1.186 . . . . 0.0 109.479 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.83 -44.13 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.598 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -54.51 -38.62 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.327 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.02 79.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.1 mm -57.69 -46.66 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.432 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.7 mp -55.18 -43.74 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.06 -36.23 85.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.602 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 16.5 t30 -56.87 -48.16 78.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.72 93.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.428 ' HG3' ' NH1' ' A' ' 100' ' ' ARG . 46.2 ttm-85 -66.56 -45.16 80.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.525 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.73 -36.06 67.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.58 ' HH ' ' HG ' ' A' ' 28' ' ' SER . 43.0 t80 -71.08 -47.6 57.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.61 -37.79 85.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.865 . . . . 0.0 109.534 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.53 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.601 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 28.2 ttt -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.529 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.35 -27.19 67.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -52.11 -24.08 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.49 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -75.54 -18.12 59.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.8 7.43 68.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.59 150.28 38.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.205 -1.174 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.99 119.17 6.18 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.621 2.214 . . . . 0.0 111.693 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -74.57 -44.91 48.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.803 . . . . 0.0 110.404 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.58 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.201 -0.937 . . . . 0.0 110.732 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 83.2 m-20 -56.23 -43.59 78.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.204 -0.935 . . . . 0.0 111.081 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -61.93 -51.31 68.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 111.227 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.406 HG21 ' N ' ' A' ' 117' ' ' TRP . 6.7 m -57.97 -47.37 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 111.722 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -87.6 -28.04 22.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.696 -1.253 . . . . 0.0 111.178 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -59.61 -23.9 63.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 109.709 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -43.85 -19.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.08 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.7 m -82.9 22.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.087 -1.008 . . . . 0.0 109.954 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 58.22 36.92 26.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.0 109.67 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.1 m80 60.27 15.23 5.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.531 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -111.83 128.1 25.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.628 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.57 147.89 41.42 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.672 2.248 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -98.5 144.5 27.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 109.751 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.4 ttp -132.07 135.06 46.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.784 . . . . 0.0 109.097 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 t -85.5 156.08 20.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.897 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -151.06 48.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.855 . . . . 0.0 109.3 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.82 -155.81 0.53 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.662 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.521 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.2 m -130.88 -54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.541 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.0 m -98.04 161.11 13.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.429 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.53 -11.16 59.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 t -89.72 -39.04 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 131' ' ' THR . 11.2 pt-20 -68.66 -13.31 62.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 79.1 mt -67.43 118.41 56.44 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.52 131.29 5.49 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.047 2.498 . . . . 0.0 112.536 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -91.39 -11.85 36.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.9 t -92.88 99.04 11.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.3 p -110.18 151.56 42.63 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -45.71 -40.79 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.815 2.343 . . . . 0.0 112.011 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.24 76.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -61.66 -42.2 98.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.863 . . . . 0.0 109.494 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -61.06 -44.46 97.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.65 -43.61 68.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.4 -49.56 77.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.7 m -54.12 -43.61 70.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.76 -38.14 84.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.11 -49.87 66.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.5 -34.94 74.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.878 . . . . 0.0 109.564 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -60.55 -36.79 79.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -60.76 -37.88 83.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.24 -21.32 63.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.283 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.77 4.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -97.51 129.92 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -92.97 167.16 11.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 51.54 48.31 23.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.7 p -121.63 25.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.45 165.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.8 t -56.87 -29.88 63.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -1.156 . . . . 0.0 109.442 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 m -59.77 -47.56 85.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 73.3 m -61.04 -42.89 99.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -60.31 -44.58 95.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.46 -0.775 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.512 ' HG ' ' N ' ' A' ' 165' ' ' PHE . 82.5 p -61.98 -36.71 82.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.512 ' N ' ' HG ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.39 -42.45 83.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 56.8 mtp -61.36 -39.24 89.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -61.69 -47.12 86.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.17 -38.98 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.98 -14.18 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.42 0.04 77.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.3 mp -63.04 -39.92 96.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.07 131.56 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.501 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -95.66 117.98 31.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.443 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.15 105.15 17.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -145.89 144.5 30.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.67 137.08 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.13 134.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.22 3.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.533 ' C ' ' H ' ' A' ' 181' ' ' CYS . 34.8 m -98.66 173.72 6.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -1.152 . . . . 0.0 109.534 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 54.1 m 54.45 5.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.443 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.533 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.3 m 62.8 50.19 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.602 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 23.9 t80 -124.6 80.33 61.45 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.59 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -84.99 30.79 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.067 2.511 . . . . 0.0 112.358 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.21 20.28 79.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 53.48 39.97 30.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -1.131 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 187' ' ' PRO . 16.6 pttp -83.16 147.42 53.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 186' ' ' LYS . 88.8 Cg_exo . . . . . 0 C--N 1.306 -1.659 0 C-N-CA 123.017 2.478 . . . . 0.0 112.238 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 2.3 pm0 -98.7 149.37 22.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' A' ' 3' ' ' ARG . 45.1 mtm-85 -107.98 149.84 27.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.487 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' C ' ' H ' ' A' ' 6' ' ' TRP . 16.3 p -96.39 -176.14 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.39 -24.83 0.9 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 11.4 m0 53.13 55.68 8.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -59.84 -5.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 6' ' ' TRP . 52.6 m -47.22 114.33 0.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 109.418 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -167.84 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -151.55 150.89 27.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.0 -36.97 16.75 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.896 2.397 . . . . 0.0 112.145 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.44 -51.25 66.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.443 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -70.08 -45.12 67.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 109.379 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.9 mt -59.81 -42.37 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.347 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.94 -47.1 69.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -59.85 -44.7 93.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CE1' ' CE3' ' A' ' 21' ' ' TRP . 19.9 t60 -62.6 -45.54 92.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.27 -22.25 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.19 -75.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -145.15 113.8 6.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.873 . . . . 0.0 109.52 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CE3' ' CE1' ' A' ' 17' ' ' HIS . 62.3 t90 -172.99 139.61 0.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -29.84 3.1 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 169' ' ' CYS . 3.7 m -68.02 149.19 98.27 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.232 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.99 128.25 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.805 2.337 . . . . 0.0 111.891 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 78.5 mm-40 -124.99 130.67 52.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -123.13 12.21 9.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.072 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.3 136.8 35.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.0 p -73.16 -33.61 65.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.07 -51.57 60.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 25' ' ' GLU . 8.9 mtpm? -62.79 -46.39 88.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 109.861 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.42 -37.21 80.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 109.834 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -65.15 -51.32 61.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.12 -32.55 73.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.1 tpt -59.36 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.806 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.29 -39.06 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.7 m -65.7 -45.29 83.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.54 -41.23 66.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.13 -34.17 73.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.38 -36.18 88.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.83 -26.63 64.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -1.191 . . . . 0.0 109.748 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -51.47 -26.07 7.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.698 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.09 109.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.95 -33.42 5.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 mt -97.36 175.18 6.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -1.175 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.8 m -100.94 161.79 13.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 45.2 p90 -55.48 -41.29 72.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.862 . . . . 0.0 109.446 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 8.7 tp -57.97 -38.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.724 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.3 m -64.69 -37.95 89.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.694 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.43 -42.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.466 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.99 -42.49 85.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -61.72 -51.5 68.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 11.5 mptt -65.75 -36.58 83.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -47.15 -42.65 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.194 -0.941 . . . . 0.0 109.006 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -70.17 -42.48 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -63.43 -47.46 81.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.266 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CD2' ' CE1' ' A' ' 60' ' ' PHE . 12.3 m-85 -58.68 -49.27 78.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 17.9 mmm180 -53.3 -27.75 24.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.35 -29.43 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 56' ' ' TYR . 16.7 m-85 -81.73 -51.75 7.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.945 -1.097 . . . . 0.0 110.205 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 53.1 t60 -51.62 -42.3 61.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.829 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -73.67 -14.58 61.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CE2' ' SD ' ' A' ' 71' ' ' MET . 16.3 t80 -93.3 2.83 56.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.007 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.93 159.2 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.024 . . . . 0.0 109.598 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.2 -53.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.886 2.391 . . . . 0.0 112.707 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.1 t -48.17 -41.95 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.717 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -64.74 -34.57 78.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.382 -0.824 . . . . 0.0 109.883 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.93 -40.55 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.614 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -70.68 -32.94 70.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 109.452 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.04 18.57 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.603 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -75.36 155.2 36.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.689 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.442 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.8 tp60 -102.63 167.54 9.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 96.4 mt-10 -70.05 -25.92 63.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.2 -30.99 67.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.465 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.27 -49.7 68.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 8.5 m -59.65 -37.88 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.9 mt-10 -58.99 -35.98 74.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.3 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -65.72 -40.2 91.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.16 -34.28 77.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.9 -35.49 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -87.06 -62.03 1.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -101.34 107.08 18.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.61 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.85 14.38 65.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 pt -104.09 178.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.391 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.51 140.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.455 ' HG3' HH11 ' A' ' 87' ' ' ARG . 44.0 mtm-85 -87.81 101.81 14.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.52 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.723 ' HD1' ' H ' ' A' ' 91' ' ' LYS . 49.2 t-80 -171.54 82.04 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.218 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 15.3 ptm180 -46.84 -30.46 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.83 93.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.723 ' H ' ' HD1' ' A' ' 88' ' ' HIS . 62.3 mttp -66.11 -42.62 88.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.6 mt -63.64 -49.55 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.37 -35.6 67.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.375 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.3 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.98 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 96' ' ' ILE . 77.8 mt -55.06 -39.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.539 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.69 95.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.481 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 3.0 m120 -63.26 -43.83 96.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -1.204 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.06 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 47.6 ttm-85 -58.46 -41.75 85.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.21 70.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.87 -48.46 81.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -61.75 -44.72 96.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.6 -44.26 93.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.604 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 23.7 ttt -67.11 -32.54 73.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.48 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.91 -29.25 69.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -52.29 -24.75 7.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.15 -18.7 59.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.492 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.8 55.11 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -116.85 150.8 46.46 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -1.181 . . . . 0.0 109.691 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.21 130.86 26.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.618 2.212 . . . . 0.0 111.659 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -79.25 -49.21 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.475 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -55.77 -48.92 74.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.533 ' O ' ' OG ' ' A' ' 118' ' ' SER . 85.3 m-20 -60.0 -43.63 95.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 111.053 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.59 -50.92 70.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.067 -1.021 . . . . 0.0 111.188 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 117' ' ' TRP . 4.6 m -59.31 -48.45 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.096 -1.003 . . . . 0.0 111.64 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.474 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.0 p-90 -88.88 -33.38 17.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 0.0 111.147 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 120' ' ' VAL . 66.8 m -55.08 -26.44 37.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.793 -1.192 . . . . 0.0 109.752 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.32 -14.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 118' ' ' SER . 12.9 m -85.07 27.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.046 -1.034 . . . . 0.0 109.983 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 75.78 19.0 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.747 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 58.72 39.65 24.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -146.05 146.77 29.56 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.636 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.86 147.56 44.35 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.691 2.261 . . . . 0.0 111.814 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -111.21 153.72 25.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 58.2 ttm -133.26 148.83 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -122.52 164.84 17.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.437 ' CG ' ' HH ' ' A' ' 182' ' ' TYR . 90.7 mt-30 -133.41 49.68 2.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.308 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.52 -158.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.521 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 11.7 m -145.34 -27.48 0.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.545 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 8.9 m -127.73 157.98 38.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.556 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -75.22 -12.79 60.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.2 m -93.0 -32.53 14.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 131' ' ' THR . 5.6 pt-20 -74.11 -1.42 20.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.925 . . . . 0.0 109.428 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 135' ' ' ILE . 28.9 mm -66.9 130.85 93.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.77 126.24 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.096 2.531 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.418 ' O ' ' CG2' ' A' ' 137' ' ' THR . 3.1 m -89.77 -10.57 45.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.9 . . . . 0.0 109.342 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 72.2 p -94.13 102.26 14.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 p -119.11 149.9 47.92 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.53 -31.84 87.67 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.17 58.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.45 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 42.9 t -62.08 -46.33 89.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.469 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -61.67 -46.23 90.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.57 84.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.67 -47.11 82.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.0 t -54.5 -45.09 73.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -60.62 -33.33 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.547 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.24 16.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.7 mp -60.15 -34.75 73.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.575 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -58.15 -34.97 70.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.43 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -62.66 -36.31 82.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.627 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -72.14 -19.88 61.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.357 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.56 30.11 7.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.481 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 5.1 m-85 -86.29 132.67 33.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -1.108 . . . . 0.0 109.474 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -104.79 177.86 4.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 52.8 47.94 23.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 158' ' ' GLY . 26.9 m -116.32 25.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.58 166.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.0 m -54.01 -32.54 54.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.3 p -65.09 -48.04 75.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -66.31 -39.29 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.45 ' SG ' ' OG ' ' A' ' 142' ' ' SER . 7.9 t -68.58 -44.31 74.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.5 -42.03 98.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -59.27 -33.47 71.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.245 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.598 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 79.4 t80 -65.77 -35.45 80.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.397 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.2 mmm -63.32 -52.2 62.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.85 -38.0 85.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.45 -54.19 49.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.675 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.598 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 8.7 m -66.29 -33.23 75.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.01 35.38 6.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -74.05 -41.39 61.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.425 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.0 m -96.56 134.27 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.491 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -88.66 110.04 20.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -84.57 122.42 29.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -142.38 165.55 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.601 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 4.8 m -122.65 164.11 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 0.0 109.414 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.21 133.38 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.502 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 72.2 29.48 66.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 178' ' ' GLY . 3.3 m -164.64 178.74 7.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.46 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.517 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 43.6 t 51.03 -98.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 7.7 m -162.91 27.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.645 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -116.01 97.03 48.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.605 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.543 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 90.7 Cg_endo -86.56 -153.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.02 2.48 . . . . 0.0 112.378 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.82 9.32 37.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -151.67 32.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.54 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -83.68 154.22 65.0 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.555 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 123.034 2.49 . . . . 0.0 112.223 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 tpp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.256 0.55 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.503 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 83.9 tt0 -88.81 146.11 25.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -101.94 174.59 5.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 m -140.94 71.37 1.36 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -139.88 -5.67 1.19 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 19.8 m95 49.53 11.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.411 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 5' ' ' GLY . 28.8 m -62.25 140.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -168.32 36.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.349 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 70.0 tp60 -142.76 110.03 5.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 6.3 t70 61.71 134.51 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.28 -10.17 23.87 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.819 2.346 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.34 -41.58 98.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -69.65 -41.57 75.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 14' ' ' ILE . 1.8 mp -60.8 -51.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.424 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -46.97 65.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.429 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' OH ' ' CZ3' ' A' ' 21' ' ' TRP . 60.5 t80 -61.55 -43.83 98.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.0 -39.96 94.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -88.16 -0.11 56.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -75.19 -78.91 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.835 . . . . 0.0 109.407 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -147.06 40.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CZ3' ' OH ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -103.89 145.47 30.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.57 62.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' CYS . 1.2 m -84.67 152.26 59.72 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.226 -1.161 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 121.13 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.727 2.285 . . . . 0.0 111.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 78.4 mm-40 -123.8 135.92 54.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.9 p -126.75 12.33 7.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.281 -0.887 . . . . 0.0 109.055 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.88 134.44 47.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.385 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 83.4 p -72.44 -37.9 68.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -67.8 -34.57 77.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 0.0 109.804 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 25' ' ' GLU . 30.6 ttmt -75.23 -54.29 7.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 8.5 mp -66.57 -37.28 84.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.856 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 51.0 t80 -61.17 -42.73 99.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.938 . . . . 0.0 109.904 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.2 -29.51 64.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.599 ' SD ' ' CH2' ' A' ' 46' ' ' TRP . 49.9 tpp -74.46 -54.28 7.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.783 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.18 -37.74 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.043 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 15.0 p -73.16 -46.28 51.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 61.9 tp -73.28 -34.99 66.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -0.99 . . . . 0.0 109.932 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 43.2 tp10 -52.13 -28.66 18.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.69 51.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -62.36 -32.41 73.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 109.754 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.493 HE22 ' HG ' ' A' ' 164' ' ' SER . 50.2 tt0 -50.21 -35.07 24.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.705 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.43 116.84 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.42 -20.2 49.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.48 -144.34 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -1.205 . . . . 0.0 109.414 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.7 t -146.4 151.22 37.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 72.6 t-105 -55.35 -28.47 54.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -54.05 -37.89 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.727 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 18.8 m -85.26 -33.84 22.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 109.657 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -61.06 -36.99 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.63 -54.05 46.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.1 -49.96 75.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.262 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -65.51 -33.33 75.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 53' ' ' ARG . 28.0 ttt-85 -48.97 -43.71 40.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.14 -40.62 86.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -66.36 -40.84 90.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.288 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' OH ' ' CG2' ' A' ' 86' ' ' ILE . 4.5 m-85 -56.22 -48.61 76.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 84.7 mtm180 -64.74 -27.08 68.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 0.0 109.81 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.1 94.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.9 m -94.45 -40.79 9.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.3 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.74 -52.01 16.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 0.0 110.224 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 39.2 t60 -50.94 -38.28 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.899 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -54.32 -36.98 64.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.12 -0.988 . . . . 0.0 109.811 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' ASP . 86.9 m-85 -97.54 3.71 50.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.883 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.92 161.44 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.096 -1.003 . . . . 0.0 109.569 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.12 -26.37 21.42 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.885 2.39 . . . . 0.0 112.694 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.6 t -62.68 -48.81 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.734 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' MET . 89.2 mttt -67.17 -31.79 72.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.32 -41.37 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 109.606 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.96 62.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.507 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.24 3.06 51.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.3 mtp -66.2 136.67 56.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.617 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -92.12 168.12 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 57.4 mp0 -59.23 -29.7 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.462 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.4 -44.35 88.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.5 -37.52 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.82 -44.02 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -35.72 76.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -60.56 -41.5 94.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 109.736 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 82' ' ' ASP . 92.1 mt -72.73 -31.92 65.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.175 -0.953 . . . . 0.0 109.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.83 -31.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.938 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -84.29 -59.27 2.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.978 . . . . 0.0 109.568 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 79' ' ' LEU . 21.3 t70 -96.33 148.27 22.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.897 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 74.09 71.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.406 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -89.24 30.59 5.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' O ' ' A' ' 86' ' ' ILE . 4.9 pt -45.75 117.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.31 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.749 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 3.5 tt 38.63 -168.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.504 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.749 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -52.16 152.56 3.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -141.91 -162.9 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 109.184 -178.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.634 ' H ' ' CD1' ' A' ' 92' ' ' ILE . 56.7 ttt180 62.37 -77.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 109.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -71.86 -48.07 29.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.21 -38.6 87.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.634 ' CD1' ' H ' ' A' ' 89' ' ' ARG . 52.5 mt -55.07 -46.64 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 109.648 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.428 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.57 82.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 95' ' ' ILE . 96.8 mt -67.8 -38.79 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.5 mt -54.22 -46.59 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.18 -36.1 92.49 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.541 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -60.96 -49.08 78.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -1.23 . . . . 0.0 109.422 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.89 89.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -64.62 -46.83 80.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.25 69.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.421 ' CD1' ' CE1' ' A' ' 32' ' ' PHE . 77.2 t80 -64.64 -46.81 80.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 109.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.05 -40.65 98.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -57.45 -42.51 82.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 25.5 ttt -71.09 -33.26 70.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.548 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.69 -30.77 71.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -51.4 -25.91 6.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 109.548 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -76.47 -16.65 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.01 41.65 47.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -129.79 151.11 77.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.186 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.2 125.7 15.06 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.592 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 23.9 t80 -72.99 -44.1 61.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.42 -0.8 . . . . 0.0 110.417 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.98 -48.85 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.742 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 118' ' ' SER . 87.2 m-20 -52.16 -38.38 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 111.102 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -72.7 -49.87 28.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 111.244 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.425 HG13 ' H ' ' A' ' 117' ' ' TRP . 1.4 p -55.45 -49.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.01 -1.056 . . . . 0.0 111.696 -175.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.425 ' H ' HG13 ' A' ' 116' ' ' VAL . 15.8 p-90 -87.01 -24.38 24.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.709 -1.244 . . . . 0.0 111.147 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' VAL . 7.7 t -57.63 -32.99 67.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.61 -12.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 7.3 p -83.09 23.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 12.0 t-20 79.33 16.63 0.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 7.1 m80 57.74 43.54 21.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -155.31 148.44 18.29 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.0 151.34 73.42 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.655 2.237 . . . . 0.0 111.833 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -120.35 146.49 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 109.801 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.6 mtp -129.59 156.26 44.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 109.184 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 t -128.9 147.59 50.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.908 . . . . 0.0 109.797 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -113.24 43.02 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 109.302 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.58 152.1 37.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 m -92.48 -34.41 14.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.79 30.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.481 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -74.06 -9.11 58.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.6 p -83.4 -31.53 26.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.19 -18.47 55.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.51 116.88 41.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.765 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.11 136.83 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.146 2.564 . . . . 0.0 112.5 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 t -85.05 -4.25 59.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.2 t -98.39 103.66 15.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.367 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -126.89 152.68 75.69 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.13 -42.53 26.34 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.758 2.305 . . . . 0.0 112.043 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.36 -37.85 63.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.516 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 1.0 OUTLIER -57.77 -49.73 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 109.506 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.32 -39.41 93.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.04 77.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.68 -44.25 96.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.549 ' HG ' ' N ' ' A' ' 147' ' ' LYS . 86.4 p -62.16 -38.07 87.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.52 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.549 ' N ' ' HG ' ' A' ' 146' ' ' SER . 15.4 mtpp -65.05 -36.47 84.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.86 -50.51 56.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.75 -34.32 76.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -60.24 -41.69 93.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -63.89 -38.19 90.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.546 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 11.7 tpp180 -64.4 -21.47 66.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.34 24.18 6.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -95.39 130.65 42.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -1.111 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 63.2 mttp -98.06 -167.12 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 19.0 p90 40.31 38.86 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.5 OUTLIER -102.34 25.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -45.38 163.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 2.5 t -63.43 -23.99 67.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -1.161 . . . . 0.0 109.478 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.5 p -70.07 -38.45 75.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -69.74 -41.24 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 159' ' ' THR . 14.3 p -64.88 -33.72 76.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.457 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 51.9 t80 -65.61 -50.97 63.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.374 -0.829 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.493 ' HG ' HE22 ' A' ' 41' ' ' GLN . 18.9 t -58.69 -33.11 69.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 109.28 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.84 -42.18 88.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.444 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 52.0 mtt -62.96 -37.43 87.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -55.07 -40.26 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.76 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.91 11.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.546 ' HG ' ' CD1' ' A' ' 171' ' ' LEU . 10.5 t -59.29 -37.27 77.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.94 14.28 52.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.546 ' CD1' ' HG ' ' A' ' 169' ' ' CYS . 4.4 mp -54.83 -56.81 15.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.16 134.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.457 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.824 HD22 ' NE2' ' A' ' 175' ' ' HIS . 17.2 t-20 -100.56 103.78 15.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.435 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 32.4 p30 -103.47 91.47 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.536 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.824 ' NE2' HD22 ' A' ' 173' ' ' ASN . 44.6 m170 -102.81 0.3 32.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.592 ' O ' ' O ' ' A' ' 175' ' ' HIS . 6.2 t 56.61 139.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.55 123.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.98 -50.15 0.71 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 7.8 t -150.46 -132.67 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -1.157 . . . . 0.0 109.519 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 8.5 t 52.95 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 35.9 t -162.49 32.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 183' ' ' PRO . 26.3 t80 -124.25 97.76 39.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.643 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 182' ' ' TYR . 68.6 Cg_exo -51.38 -135.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.037 2.491 . . . . 0.0 112.368 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 91.74 3.78 68.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -169.58 37.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.607 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.426 ' NZ ' ' CB ' ' A' ' 186' ' ' LYS . 7.3 ttpm? -140.02 79.5 22.33 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.209 -0.932 . . . . 0.0 109.566 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--N 1.306 -1.662 0 C-N-CA 123.06 2.506 . . . . 0.0 112.264 -179.766 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' OE1' ' SG ' ' A' ' 179' ' ' CYS . 95.1 mt-10 -86.47 148.37 25.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.463 ' HG3' HH11 ' A' ' 3' ' ' ARG . 44.3 mtm-85 -139.39 150.03 44.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 180' ' ' CYS . 8.0 m -59.8 151.83 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.419 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.22 -20.68 16.27 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -52.64 -34.96 53.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.436 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.34 128.81 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.555 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 9' ' ' GLN . 22.6 t -169.68 129.97 1.02 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 8' ' ' SER . 92.8 mm-40 44.8 -156.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 109.526 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 52.38 64.09 7.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -45.64 -34.94 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.771 2.314 . . . . 0.0 112.185 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' CD2' ' HZ3' ' A' ' 51' ' ' LYS . 60.1 tp -63.87 -38.63 91.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 17' ' ' HIS . 86.6 t80 -66.65 -43.61 84.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.44 -43.65 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.23 83.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -59.94 -42.83 94.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.365 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 13' ' ' TYR . 2.4 m-70 -62.24 -39.47 92.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -60.63 -27.45 67.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.61 -77.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.506 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -143.64 116.24 8.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -172.17 140.09 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.59 -28.22 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -67.9 154.4 93.69 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.184 -1.186 . . . . 0.0 109.412 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.07 120.09 4.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.762 2.308 . . . . 0.0 111.959 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' OE1' ' O ' ' A' ' 23' ' ' VAL . 18.8 mp0 -103.15 133.86 47.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.812 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -134.77 4.1 3.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.93 133.2 35.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 p -61.35 -34.44 75.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.86 -52.3 57.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -68.74 -45.9 70.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.884 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -46.55 89.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.868 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.475 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 93.8 t80 -68.05 -47.29 68.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.489 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 14.1 tm-20 -64.08 -30.72 71.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.854 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.7 ttm -64.71 -51.83 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -58.28 -47.41 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 12.4 p -62.55 -37.89 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.052 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.525 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 6.2 tp -66.69 -39.81 88.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.12 -27.81 69.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.5 -36.51 11.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 40' ' ' GLN . 1.7 mp0 -59.9 -33.79 72.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.2 tt0 -57.18 -29.74 63.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.715 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.03 109.83 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.626 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.67 -32.3 5.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.0 mt -103.67 -155.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -1.153 . . . . 0.0 109.464 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 m -121.97 149.67 43.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 47' ' ' ILE . 23.7 p90 -49.05 -36.51 18.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.473 HD13 HG23 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -60.9 -37.2 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.659 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.463 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 57.2 m -64.46 -33.69 76.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.95 -38.96 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 50' ' ' LEU . 10.1 mp -54.3 -52.06 62.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.542 ' HZ3' ' CD2' ' A' ' 12' ' ' LEU . 61.0 mttm -59.67 -49.21 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.325 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.22 -34.13 77.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.602 ' NH1' HH21 ' A' ' 57' ' ' ARG . 3.1 ttt-85 -49.5 -45.44 47.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.118 -0.989 . . . . 0.0 108.937 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -66.84 -40.6 88.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.376 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.539 HD22 ' C ' ' A' ' 84' ' ' GLY . 36.5 t-20 -64.51 -40.98 96.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.851 . . . . 0.0 109.249 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' PHE . 4.4 m-85 -56.59 -43.34 79.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 109.304 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.602 HH21 ' NH1' ' A' ' 53' ' ' ARG . 96.7 mtt180 -58.61 -36.22 73.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -49.29 76.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.198 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.535 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 3.2 p -94.68 -13.2 26.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.285 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.535 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 63.6 m-85 -133.27 32.16 3.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.913 -1.117 . . . . 0.0 110.192 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 p80 -46.91 -42.94 18.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.536 ' N ' ' HD1' ' A' ' 61' ' ' HIS . 40.6 tt0 -79.64 -42.9 23.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.806 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 69.5 t80 44.07 36.64 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -56.57 113.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 109.558 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.07 -45.12 7.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.944 2.429 . . . . 0.0 112.678 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 9.8 p -66.27 -45.33 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.534 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 55.3 tttp -61.94 -45.24 94.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.82 -39.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.095 . . . . 0.0 109.628 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.31 64.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.494 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 12.77 23.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.6 tpp -50.41 161.05 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.625 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.82 156.99 19.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.81 -33.38 74.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.5 -39.22 86.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.3 t -71.84 -28.54 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -68.34 -43.57 77.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.341 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 30.9 ptt180 -76.42 -34.63 58.8 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.838 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 mt -61.84 -39.05 90.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.678 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.56 -28.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.988 . . . . 0.0 109.736 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.55 -53.79 3.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 78' ' ' ARG . 1.9 p30 -99.77 106.52 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.72 -64.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.539 ' C ' HD22 ' A' ' 55' ' ' ASN . . . 91.34 -1.48 76.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.5 pt -77.11 -159.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.42 136.56 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 96.6 mtt180 -79.35 95.68 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.6 m-70 -166.47 82.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 109.214 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -46.56 -35.25 5.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.984 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.83 -34.37 82.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -72.45 -41.69 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.509 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.6 -56.29 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.29 -30.95 63.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.7 99.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.39 -43.11 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 96' ' ' ILE . 25.6 mm -54.59 -48.1 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.28 -34.28 89.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 32' ' ' PHE . 15.8 t-20 -56.65 -45.8 81.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.184 . . . . 0.0 109.337 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.76 73.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.542 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.29 -43.4 98.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.38 75.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.34 -46.42 83.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.21 -42.65 99.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -59.12 -53.87 53.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.543 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 26.0 ttt -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.73 -27.41 65.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -52.05 -26.42 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -75.69 -19.09 59.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.44 18.86 65.46 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.34 151.65 37.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.9 119.18 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.618 2.212 . . . . 0.0 111.668 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -75.42 -43.33 50.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -59.79 -47.62 84.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 118' ' ' SER . 92.2 m-20 -51.1 -54.93 20.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 0.0 111.029 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.25 -43.35 82.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.39 -60.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.679 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.541 ' CD1' ' O ' ' A' ' 113' ' ' ALA . 67.8 p-90 -86.03 -17.86 34.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.727 -1.233 . . . . 0.0 111.153 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.508 ' OG ' ' NE2' ' A' ' 122' ' ' HIS . 9.2 t -54.98 -30.61 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.872 -1.142 . . . . 0.0 109.744 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -43.43 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 178.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 118' ' ' SER . 13.9 m -82.84 24.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.945 . . . . 0.0 110.004 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.87 29.28 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.508 ' NE2' ' OG ' ' A' ' 118' ' ' SER . 26.1 m80 55.62 34.48 23.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -141.91 114.53 6.52 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.45 154.49 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.648 2.232 . . . . 0.0 111.861 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.459 HE22 ' CB ' ' A' ' 141' ' ' ALA . 94.4 mt-30 -106.59 144.4 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.549 ' CE ' HD21 ' A' ' 173' ' ' ASN . 80.1 mtp -137.61 151.73 48.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.797 . . . . 0.0 109.187 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 t -129.65 160.09 34.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.904 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.04 46.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 0.0 109.26 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.45 -135.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.73 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 m -143.34 -33.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.378 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 t -137.96 170.77 15.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.437 HD11 ' H ' ' A' ' 132' ' ' LEU . 5.5 mp -68.31 -32.29 72.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.4 m -54.21 -37.3 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.184 -0.947 . . . . 0.0 109.478 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.7 -35.04 78.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.917 . . . . 0.0 109.427 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.56 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 1.8 mp -81.36 117.82 69.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.697 ' C ' ' H ' ' A' ' 138' ' ' SER . 89.0 Cg_endo -82.59 2.49 8.47 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.133 2.556 . . . . 0.0 112.555 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 56.08 -4.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.697 ' H ' ' C ' ' A' ' 136' ' ' PRO . 65.2 p -123.41 80.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.319 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -83.74 153.78 64.53 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.49 -37.01 19.22 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.773 2.315 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.459 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -71.97 -36.83 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.311 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.2 m -61.38 -49.07 78.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.462 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 49.8 t0 -62.93 -45.91 90.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.42 86.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.0 -43.52 87.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 23.3 t -54.64 -44.99 73.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.462 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 61.1 mttp -63.81 -30.74 71.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.573 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.56 -52.03 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 3.8 mm? -62.91 -39.09 93.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.78 -37.54 87.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -60.8 -38.14 84.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.359 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.583 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -63.8 -22.7 67.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.378 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 116.53 9.51 11.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -82.53 133.74 35.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -1.143 . . . . 0.0 109.494 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 60.6 mttp -99.97 -169.39 1.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 14.5 p90 39.43 40.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 158' ' ' GLY . 0.3 OUTLIER -110.57 25.44 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.364 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.49 170.7 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.5 t -62.77 -28.13 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -1.097 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 68.3 p -64.59 -48.17 75.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.459 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -63.92 -35.9 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.88 -48.54 73.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.312 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.54 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 58.3 t80 -60.11 -43.21 95.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -59.63 -39.19 83.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -68.03 -41.01 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.437 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 35.4 mmm -59.74 -41.2 90.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.0 109.573 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 163' ' ' TYR . 49.4 mt-30 -69.8 -46.14 66.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.34 77.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 169' ' ' CYS . 17.2 t -81.41 -4.35 55.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 65.77 24.13 71.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.8 tp -68.8 -47.16 66.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 109.422 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.45 131.98 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.549 HD21 ' CE ' ' A' ' 126' ' ' MET . 79.9 m-20 -90.54 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -98.27 119.05 36.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.498 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.652 ' ND1' ' CD2' ' A' ' 182' ' ' TYR . 2.5 p80 -164.33 127.28 2.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.55 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.81 150.98 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.413 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 140.72 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.131 -0.981 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 91.75 1.62 70.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.516 ' C ' ' H ' ' A' ' 181' ' ' CYS . 49.9 m -155.01 179.5 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 5.2 t 60.4 1.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.516 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.4 t 65.82 50.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.902 . . . . 0.0 109.614 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.652 ' CD2' ' ND1' ' A' ' 175' ' ' HIS . 0.4 OUTLIER -116.49 95.91 46.8 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.538 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 93.4 Cg_endo -86.91 -168.42 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.101 2.534 . . . . 0.0 112.35 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 94.87 -14.32 65.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.25 19.33 5.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -1.157 . . . . 0.0 109.638 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -83.27 151.47 62.88 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.307 -1.626 0 C-N-CA 122.997 2.465 . . . . 0.0 112.242 179.937 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.607 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.265 0.555 . . . . 0.0 109.525 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.607 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.8 pm0 -134.67 162.58 31.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -143.6 172.52 12.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -46.52 159.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -109.87 -21.76 6.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -66.08 -11.83 51.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.633 ' CG1' ' H ' ' A' ' 8' ' ' SER . 43.6 t -82.39 -123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.633 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 23.8 t 53.5 170.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 8' ' ' SER . 52.3 tt0 59.5 135.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' LEU . 13.4 m-20 50.45 82.05 0.25 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.3 -10.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.828 2.352 . . . . 0.0 112.108 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' ASP . 18.3 tp -62.7 -34.01 76.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 33.2 m-85 -54.26 -41.97 69.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 109.504 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.8 mt -80.0 -33.14 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.435 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.32 -48.19 71.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 109.509 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 13' ' ' TYR . 1.5 p90 -76.51 -34.27 58.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.482 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 57.3 t-80 -55.77 -50.01 71.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.26 -38.44 65.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.419 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -56.02 -46.59 78.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.9 pt-20 -173.28 -146.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' A' ' 20' ' ' GLU . 27.9 t-105 58.94 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.14 -9.0 59.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.2 154.43 37.68 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.94 119.9 7.02 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.786 2.324 . . . . 0.0 111.899 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -127.47 136.69 52.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.975 . . . . 0.0 109.826 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.0 p -131.55 9.46 4.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 0.0 109.075 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -90.68 135.17 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 0.0 109.299 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 89.4 p -61.67 -39.31 90.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.9 -41.09 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 0.0 109.774 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -77.23 -53.89 7.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.905 . . . . 0.0 109.863 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.9 mp -64.6 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 80.0 t80 -62.33 -56.45 18.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 109.854 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.84 -31.14 70.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.902 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.407 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.56 -51.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.866 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -62.43 -43.3 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -60.86 -48.38 82.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 110.086 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 8.2 mp -73.69 -44.68 55.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.929 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.89 -37.13 75.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.69 -25.1 34.88 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -82.64 -18.39 41.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.234 . . . . 0.0 109.773 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.6 pp0? -61.95 -21.44 64.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.71 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.07 110.22 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.695 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.03 -32.9 5.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.05 164.37 12.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -1.142 . . . . 0.0 109.448 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -86.26 167.06 15.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' VAL . 5.4 p90 -61.07 -43.78 98.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 48' ' ' THR . 10.4 tp -43.52 -42.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.451 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 95.1 m -61.13 -34.21 74.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 46' ' ' TRP . 16.4 t -66.56 -46.7 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.33 -53.06 61.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -61.64 -46.21 90.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.351 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' TYR . 43.6 tttm -65.44 -30.18 70.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.383 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.2 ttm180 -55.72 -48.37 75.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.267 -0.895 . . . . 0.0 108.952 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.47 -46.64 87.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.45 -0.781 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 94.4 m-20 -69.07 -32.42 71.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.251 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.7 t80 -62.28 -44.61 96.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.405 -0.809 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 61' ' ' HIS . 14.5 mtm180 -60.08 -42.22 94.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 109.764 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.52 69.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -0.815 . . . . 0.0 110.301 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.6 m -92.98 -12.1 31.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 110.281 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 65.6 m-85 -129.47 -48.11 1.17 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.882 -1.137 . . . . 0.0 110.155 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' ARG . 62.3 t60 -50.14 -43.46 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.085 -1.009 . . . . 0.0 109.904 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -66.56 -25.92 66.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 64' ' ' ASP . 93.4 m-85 -91.88 16.48 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 109.889 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 55.12 167.05 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.94 -55.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.832 2.355 . . . . 0.0 112.68 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 67' ' ' LYS . 7.2 p -48.93 -44.29 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 48.3 tttp -58.28 -36.91 74.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.845 . . . . 0.0 109.82 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -57.18 -37.92 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 109.575 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.53 -29.82 68.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.81 22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.342 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.42 ' SD ' ' CB ' ' A' ' 75' ' ' ASP . 3.4 mmm -60.48 173.76 0.66 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.638 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 71' ' ' MET . 13.9 mm100 -131.8 158.29 41.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.35 -29.76 71.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -72.57 -31.55 65.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.478 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' CB ' ' SD ' ' A' ' 71' ' ' MET . 85.6 m-20 -65.06 -48.14 74.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.75 -40.19 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.537 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -62.28 -30.62 71.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.309 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.21 -46.42 77.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.379 -0.826 . . . . 0.0 109.803 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.452 ' CD1' ' C ' ' A' ' 79' ' ' LEU . 1.3 pp -78.58 -22.78 46.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 109.572 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 t -51.17 -36.71 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.801 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -50.61 -42.41 56.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 84' ' ' GLY . 93.8 m-20 -89.86 115.02 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -80.28 26.12 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.432 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.439 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . -45.06 -23.49 0.65 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.3 pt -124.19 177.19 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -1.136 . . . . 0.0 109.322 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.4 mt -45.28 137.31 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 59.8 mtp180 -80.05 95.36 6.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 11.7 m-70 -168.37 83.66 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.134 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.301 -0.874 . . . . 0.0 109.97 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.16 97.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -62.19 -38.47 89.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -1.215 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 mt -57.23 -48.66 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.45 -38.72 69.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 0.0 109.402 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -36.66 71.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.26 -40.43 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.368 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.4 mt -56.16 -50.29 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.534 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.79 -36.68 92.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.598 ' ND2' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -56.67 -41.84 77.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -1.157 . . . . 0.0 109.38 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.3 74.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.08 -41.83 93.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 -29.92 70.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 35.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.0 -36.37 83.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.41 -38.71 84.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.577 ' SD ' ' NH2' ' A' ' 152' ' ' ARG . 2.0 tpt -67.79 -38.79 83.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -61.67 -30.09 70.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.437 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -52.52 -31.51 35.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.475 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -87.0 -5.59 59.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.77 69.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -105.28 119.42 53.02 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -1.183 . . . . 0.0 109.654 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.72 119.43 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.548 2.166 . . . . 0.0 111.714 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.48 -35.98 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.828 . . . . 0.0 110.427 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.443 ' O ' HG21 ' A' ' 116' ' ' VAL . . . -67.95 -50.07 58.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.182 -0.949 . . . . 0.0 110.707 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 118' ' ' SER . 40.8 t0 -60.5 -46.76 88.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -56.92 -52.77 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.089 -1.007 . . . . 0.0 111.209 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 113' ' ' ALA . 15.4 m -56.74 -48.94 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.03 -1.044 . . . . 0.0 111.677 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.471 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 3.4 p-90 -88.35 -27.7 21.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.819 -1.176 . . . . 0.0 111.121 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 120' ' ' VAL . 28.3 t -55.92 -27.21 51.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.717 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.57 -14.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 118' ' ' SER . 59.9 t -83.9 23.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.06 -1.025 . . . . 0.0 109.911 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 14.6 t-20 72.82 22.66 3.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.2 t60 60.26 49.65 6.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.94 149.13 22.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.03 155.16 29.79 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.676 2.251 . . . . 0.0 111.816 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -119.2 145.51 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.744 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.9 ttm -136.34 149.81 48.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.16 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 t -134.81 156.76 48.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.37 48.53 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.81 128.98 38.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.636 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.413 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.4 m -71.07 -33.43 70.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 t -136.84 174.5 10.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.27 -31.05 71.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -60.36 -39.34 86.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.413 ' OE1' ' N ' ' A' ' 130' ' ' THR . 95.1 mt-10 -65.39 -29.44 70.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.44 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.25 116.18 33.78 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.693 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -86.95 117.49 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.14 2.56 . . . . 0.0 112.511 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.8 m -74.04 -17.66 60.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 138' ' ' SER . 24.6 p -94.72 100.67 12.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.89 151.54 44.86 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 -32.1 92.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.854 2.369 . . . . 0.0 112.036 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.83 -38.69 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 m -56.52 -44.41 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.83 -45.58 88.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.14 81.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.46 -43.91 95.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -56.83 -44.45 82.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.21 -36.2 81.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.77 73.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.8 mt -60.77 -40.57 93.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.393 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -60.93 -40.59 93.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.577 ' NH2' ' SD ' ' A' ' 105' ' ' MET . 5.8 tpp180 -65.72 -22.63 66.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.335 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.33 9.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.84 133.15 34.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -1.165 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -97.68 175.5 6.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 54.3 51.81 13.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 158' ' ' GLY . 15.4 m -119.89 26.2 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.24 167.62 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.9 t -59.58 -28.28 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -1.147 . . . . 0.0 109.477 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 p -63.56 -43.08 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.519 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -66.21 -39.77 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.73 -40.25 96.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.286 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -60.57 -48.93 79.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 m -61.97 -37.97 86.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.28 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.68 -46.01 91.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 75.2 mtp -65.78 -39.7 91.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.0 109.594 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.76 -41.24 97.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.407 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -74.16 -54.7 7.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.609 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.1 t -47.84 -24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.24 7.46 67.61 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.0 mp -54.68 -52.0 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 109.39 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 25.6 m -98.81 130.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.568 ' ND2' ' HD1' ' A' ' 175' ' ' HIS . 19.6 t30 -94.26 101.95 13.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 90.5 m-20 -94.09 119.88 33.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.568 ' HD1' ' ND2' ' A' ' 173' ' ' ASN . 73.0 m80 -157.72 128.9 6.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.27 144.41 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.83 -38.33 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.86 -23.97 47.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.94 139.16 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.505 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.95 -37.17 83.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.461 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.84 -28.82 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.568 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.535 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 30.9 t80 -97.35 115.2 65.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.951 . . . . 0.0 109.574 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.535 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.2 Cg_endo -85.47 177.41 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.111 2.541 . . . . 0.0 112.368 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.44 60.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -149.04 44.32 0.98 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.59 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -83.2 148.88 57.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo . . . . . 0 C--N 1.307 -1.624 0 C-N-CA 123.016 2.478 . . . . 0.0 112.279 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -135.6 150.1 49.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -141.99 158.17 44.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.67 132.3 53.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.884 . . . . 0.0 109.408 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -74.44 -39.13 43.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -63.27 1.75 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 109.449 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 5' ' ' GLY . 8.3 p -59.01 -14.89 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.505 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.0 m 60.79 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 10' ' ' ASP . 23.5 pt20 -82.78 -17.49 43.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLN . 9.5 m-20 -43.34 106.39 0.49 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.384 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.5 -38.24 35.1 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.824 2.35 . . . . 0.0 112.156 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.4 tp -62.89 -41.2 99.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.466 ' CE2' ' CE1' ' A' ' 17' ' ' HIS . 40.9 t80 -68.13 -42.57 79.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.83 -44.25 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.06 89.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -59.27 -43.54 92.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.466 ' CE1' ' CE2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.64 -49.35 68.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.65 -39.94 95.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.31 -54.56 44.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -177.37 124.93 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 59.1 t90 -171.22 124.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.457 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.7 1.04 83.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.96 120.16 71.43 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -45.98 120.83 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -128.17 135.62 49.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.962 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.9 p -115.41 9.05 15.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.076 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.65 132.47 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.302 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.5 p -73.7 -38.13 64.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.605 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.58 -42.64 98.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -70.37 -51.94 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 109.869 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 7.8 mp -66.77 -38.37 86.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.798 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 67.2 t80 -61.55 -38.96 89.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.76 -30.63 64.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.9 tpp -73.21 -54.45 8.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.853 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.31 -32.72 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 110.007 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 91.6 m -72.13 -49.99 31.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.139 -0.976 . . . . 0.0 110.057 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mt -75.2 -28.99 60.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 109.888 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 39.0 tp10 -52.08 -31.94 32.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.792 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.47 -21.81 69.02 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.43 -27.42 62.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -1.204 . . . . 0.0 109.733 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -60.27 -33.06 71.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.771 -178.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 41' ' ' GLN . . . -46.02 110.85 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.47 -6.71 68.27 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.16 -169.94 2.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -1.183 . . . . 0.0 109.406 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -108.97 153.0 24.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.539 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 6.0 t-105 -54.86 -46.22 74.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -56.96 -38.97 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.692 -178.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 98.4 m -63.02 -35.22 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.714 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.5 t -60.19 -44.74 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -55.13 -44.29 74.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.487 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.43 -52.84 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.354 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 10.9 mptt -69.55 -25.79 64.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 49' ' ' VAL . 37.0 ttp180 -54.23 -44.6 71.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 109.004 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -72.74 -43.97 62.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -64.08 -49.61 71.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.239 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 21.7 t80 -58.48 -39.94 81.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.309 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -55.76 -37.91 69.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.844 . . . . 0.0 109.77 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.0 -23.46 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.256 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.7 m -91.77 -12.14 34.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.146 -0.971 . . . . 0.0 110.251 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 43.9 m-85 -125.46 -51.68 1.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.135 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -53.44 -41.68 66.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 109.835 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.06 -38.85 73.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 96.9 m-85 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 130.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.002 . . . . 0.0 109.611 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -40.6 -36.05 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.68 -49.29 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.9 mttm -72.25 -31.2 65.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.869 . . . . 0.0 109.862 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.93 -44.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 109.605 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.54 -34.21 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.539 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.01 18.18 17.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.309 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.7 tpp -63.69 157.6 23.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -103.63 167.36 9.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.47 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 96.7 mt-10 -71.19 -24.17 62.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -72.04 -31.82 66.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.59 -47.14 79.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.418 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 14.4 m -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 76' ' ' VAL . 97.9 mt-10 -59.12 -33.66 71.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 78' ' ' ARG . 42.0 ttm-85 -66.67 -46.08 76.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.774 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.4 mt -66.47 -34.38 77.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.1 t -51.79 -35.82 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -81.26 -60.33 2.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 62.7 t0 -100.06 139.69 35.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 73.72 76.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -74.22 -31.99 58.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.613 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.3 pt 28.96 41.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.348 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 84' ' ' GLY . 54.9 mt 52.12 4.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.607 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -97.85 109.49 22.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.483 ' CG ' ' H ' ' A' ' 89' ' ' ARG . 84.0 t60 -96.99 172.17 8.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.165 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.483 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 38.4 ttm180 -48.63 -41.91 32.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.74 -47.39 61.6 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -64.72 -51.81 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 109.524 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 91.6 mt -54.77 -47.39 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.625 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -53.02 -33.45 51.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.09 98.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.354 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.8 mp -60.77 -48.13 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.383 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.11 -50.0 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.43 84.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.66 -36.98 79.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -1.194 . . . . 0.0 109.465 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -65.97 -37.41 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.38 -45.19 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.541 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.84 -31.25 66.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 16.7 t80 -69.29 -50.53 45.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.73 -37.53 86.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.29 -42.02 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.8 ttt -64.22 -41.3 97.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.54 -27.41 69.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -51.97 -29.15 19.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.552 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -76.26 -17.23 59.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.08 3.55 67.67 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.75 115.6 65.34 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.65 124.64 7.01 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.619 2.213 . . . . 0.0 111.714 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.63 ' CZ ' ' NH1' ' A' ' 152' ' ' ARG . 49.6 t80 -61.1 -37.47 82.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.492 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -68.11 -49.83 58.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.126 -0.984 . . . . 0.0 110.745 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.505 ' O ' ' OG ' ' A' ' 118' ' ' SER . 56.5 t0 -52.07 -35.39 47.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 111.032 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.577 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 14.7 t80 -76.41 -46.24 28.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 2.6 p -56.49 -45.87 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.974 -1.079 . . . . 0.0 111.729 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 18.2 p-90 -88.92 -26.9 21.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.735 -1.228 . . . . 0.0 111.114 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.7 m -58.06 -27.52 63.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.875 -1.141 . . . . 0.0 109.719 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.76 -13.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.084 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.9 m -82.51 22.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.025 . . . . 0.0 109.947 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 59.64 35.0 22.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -0.942 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.4 m80 54.84 26.88 8.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -137.07 89.63 16.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.558 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.03 155.03 1.96 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.673 2.248 . . . . 0.0 111.779 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.5 156.15 16.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.729 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 48.3 ttp -127.62 136.15 51.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 173' ' ' ASN . 1.4 t -95.57 169.14 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.906 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -168.99 44.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.9 -174.23 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.587 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.5 m -114.34 -29.81 6.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -128.63 157.86 40.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.7 mt -74.66 -10.97 60.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.8 m -87.64 -31.49 19.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.9 pt-20 -80.14 -7.81 59.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.72 118.38 57.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.718 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.68 130.27 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.095 2.53 . . . . 0.0 112.544 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.0 t -86.91 -15.11 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.267 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.5 t -85.52 102.18 13.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.648 ' H ' ' HG ' ' A' ' 142' ' ' SER . 9.4 p -118.71 152.69 51.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.93 . . . . 0.0 109.508 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.66 -35.15 92.47 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.093 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -41.13 52.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' A' ' 139' ' ' THR . 83.2 p -61.4 -37.46 83.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.23 -46.46 86.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 0.0 109.568 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.89 -30.42 65.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.09 -46.68 76.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -63.19 -42.63 99.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -61.28 -35.41 77.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.562 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.79 42.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.68 -32.42 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.858 . . . . 0.0 109.583 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -60.48 -40.73 92.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.429 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -61.0 -37.02 81.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.63 ' NH1' ' CZ ' ' A' ' 112' ' ' PHE . 98.8 mtt180 -64.87 -20.03 66.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.49 22.92 13.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -84.65 141.03 30.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -1.107 . . . . 0.0 109.535 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -109.1 175.29 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 53.91 44.18 29.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.5 p -122.66 26.02 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.82 166.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.1 m -54.58 -33.6 60.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.3 m -61.02 -46.49 90.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.4 mp -64.67 -41.57 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 83.1 m -64.37 -40.4 95.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 109.264 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.26 -47.63 85.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.271 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.539 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 29.7 t -59.63 -37.15 77.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.288 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.69 -37.66 79.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.8 mtp -65.25 -47.29 77.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.617 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.41 -35.88 80.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.713 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.74 -44.18 93.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.7 m -83.02 -59.13 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.45 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.85 18.04 1.01 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 mt -58.95 -32.82 69.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -1.095 . . . . 0.0 109.427 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.09 141.83 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.41 ' O ' ' CG2' ' A' ' 127' ' ' THR . 23.5 t30 -76.02 102.56 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 22.9 t70 -94.03 101.35 13.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 81.7 m-70 -160.05 123.39 3.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.79 134.5 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.3 p -54.99 -25.76 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.423 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -64.08 -24.27 68.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 3.7 m -77.67 140.86 39.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.193 . . . . 0.0 109.535 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.555 ' C ' ' H ' ' A' ' 182' ' ' TYR . 83.3 m -62.9 -38.61 91.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.91 . . . . 0.0 109.438 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 95.1 m -51.29 -7.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.586 ' C ' ' H ' ' A' ' 184' ' ' GLY . 20.9 t80 -124.59 80.65 61.06 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 109.576 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -50.43 0.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.044 2.496 . . . . 0.0 112.356 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 182' ' ' TYR . . . 75.08 9.29 83.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 57.5 42.15 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -1.107 . . . . 0.0 109.603 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.55 147.66 53.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 123.043 2.495 . . . . 0.0 112.266 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -125.81 160.69 29.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.411 ' H ' ' HD3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -85.47 138.99 31.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -92.82 -153.52 0.35 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.427 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.2 -5.11 56.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 28.6 m95 45.73 38.41 4.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.99 131.19 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -171.47 29.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.81 -130.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.91 153.08 45.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.48 -27.51 3.44 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.862 2.375 . . . . 0.0 112.184 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.33 -39.68 95.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.404 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -66.11 -45.36 81.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.425 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.92 -39.82 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.72 92.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -66.87 -40.12 87.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' GLU . 59.1 t-80 -56.38 -48.53 76.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.77 -39.11 70.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -44.49 91.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.502 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 39.9 mt-10 -149.1 -137.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.496 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.482 ' O ' ' O ' ' A' ' 20' ' ' GLU . 23.5 t90 59.82 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.547 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.41 82.94 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.9 t -119.71 94.74 48.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 0.0 109.34 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -46.87 121.96 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.764 2.309 . . . . 0.0 111.878 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.48 140.71 37.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -128.28 -2.02 5.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.0 109.109 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -81.33 130.7 35.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.436 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 9.4 t -57.17 -34.42 68.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.204 -0.935 . . . . 0.0 109.608 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -67.21 -55.55 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.763 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -66.92 -43.73 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.923 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -44.14 95.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.835 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.96 -36.71 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 109.903 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.25 -32.05 71.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.3 tpp -63.84 -53.31 52.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.785 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 3.2 tp -72.11 -32.12 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.75 -50.35 30.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.132 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 6.7 mp -74.08 -16.38 61.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -52.24 -42.1 63.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.953 . . . . 0.0 109.841 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.583 ' N ' ' OE1' ' A' ' 38' ' ' GLU . . . 61.69 171.97 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.7 ' C ' ' H ' ' A' ' 42' ' ' ALA . 31.4 tp60 -60.07 -45.15 93.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -1.193 . . . . 0.0 109.77 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.614 HE21 ' N ' ' A' ' 46' ' ' TRP . 52.9 tt0 60.13 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.671 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.7 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -58.28 143.27 45.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 -24.03 0.62 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' H ' ' C ' ' A' ' 42' ' ' ALA . 17.4 mt -104.04 -141.23 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 109.476 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -153.43 155.0 35.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.614 ' N ' HE21 ' A' ' 41' ' ' GLN . 76.0 t-105 -48.08 -39.05 19.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.41 -40.59 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.5 m -63.83 -38.73 92.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.735 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.18 -40.75 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.422 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.26 -44.78 92.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -65.64 -49.49 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.394 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -52.39 -45.39 65.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.158 -0.964 . . . . 0.0 109.038 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.4 -44.87 96.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 24.0 m120 -66.2 -38.45 88.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.254 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CG ' ' A' ' 60' ' ' PHE . 25.3 t80 -62.8 -50.43 71.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.348 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 20.7 mmm180 -60.8 -21.37 63.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.798 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -48.58 62.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.6 m -95.65 -43.34 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 110.254 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CG ' ' CE2' ' A' ' 56' ' ' TYR . 53.9 m-85 -66.91 -50.79 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 57.5 t60 -48.78 -41.67 33.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -61.6 -37.37 83.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.734 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.573 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 48.0 m-85 -78.5 -48.24 15.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 109.832 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.1 t70 79.87 136.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.534 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -40.05 -22.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.909 2.406 . . . . 0.0 112.745 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' ASP . 91.9 t -75.97 -44.55 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.653 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' LYS . 3.2 mptp? -72.61 -45.07 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.845 . . . . 0.0 109.895 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.514 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 3.1 m -56.05 -42.84 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.612 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -62.19 -38.0 87.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.53 13.13 32.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.373 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.502 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 27.3 ttp -83.26 158.14 22.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -103.98 160.52 14.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.5 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.56 -30.29 69.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.69 -43.72 72.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 55.1 t0 -61.58 -38.33 87.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.444 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.08 -44.13 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -56.2 -37.18 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.44 -38.66 90.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.341 -0.849 . . . . 0.0 109.782 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.2 mt -70.99 -29.32 65.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.77 -36.38 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.04 -62.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.0 109.514 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -100.01 116.13 31.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.431 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.66 -46.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 55' ' ' ASN . . . 78.74 26.36 58.85 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 pt -116.43 171.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 86' ' ' ILE . 97.0 mt -47.22 135.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.601 HH11 ' HG2' ' A' ' 87' ' ' ARG . 9.0 mtt-85 -74.9 102.49 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.42 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -171.73 80.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.208 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 89' ' ' ARG . 11.9 ptt-85 -47.67 -32.97 6.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.908 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.75 95.47 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.08 -45.24 95.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.52 -41.56 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -60.67 -37.63 82.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.26 96.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.355 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.99 -46.41 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.5 mt -54.66 -39.23 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.74 -33.39 87.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 88.1 m-20 -61.6 -41.83 98.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 109.423 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.74 86.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 109.51 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -57.71 -45.03 86.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.71 -33.5 68.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.436 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 70.5 t80 -64.5 -45.5 87.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.78 -39.18 84.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -60.54 -37.01 79.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.525 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.5 mmm -63.35 -37.08 85.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.73 -29.42 69.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -51.72 -35.35 42.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -91.8 -1.34 57.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.8 66.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -97.05 149.15 35.38 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.154 -1.203 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.82 124.57 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.662 2.241 . . . . 0.0 111.698 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.409 ' CE1' ' NH1' ' A' ' 152' ' ' ARG . 72.3 t80 -79.11 -45.47 19.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.49 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.711 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.513 ' O ' ' OG ' ' A' ' 118' ' ' SER . 20.0 t70 -52.65 -36.5 56.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 111.043 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.66 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 48.3 t80 -73.09 -49.6 27.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.081 -1.012 . . . . 0.0 111.221 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG21 ' H ' ' A' ' 117' ' ' TRP . 3.0 m -56.12 -49.35 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.023 -1.048 . . . . 0.0 111.675 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.437 ' H ' HG21 ' A' ' 116' ' ' VAL . 20.0 p-90 -86.88 -28.06 23.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.742 -1.224 . . . . 0.0 111.09 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 21.7 p -56.75 -28.41 61.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.874 -1.142 . . . . 0.0 109.725 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -46.63 -11.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' SER . 18.5 m -84.7 24.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 123' ' ' GLN . 3.5 m-20 72.51 17.62 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.023 . . . . 0.0 109.701 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 16.8 t60 73.58 -23.14 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.544 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 121' ' ' ASN . 2.3 pt20 -86.52 145.76 40.28 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.532 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 154.06 72.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.666 2.244 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.609 HE22 ' CB ' ' A' ' 141' ' ' ALA . 94.4 mt-30 -104.68 149.0 25.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.771 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.575 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 71.2 mmm -135.78 145.95 47.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 109.172 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.2 t -115.7 164.79 13.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.929 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -139.15 47.12 1.91 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.299 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.57 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.7 m -72.15 -37.8 69.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.1 t -133.95 177.93 7.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.454 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.09 -34.11 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.604 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -59.11 -35.23 73.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.55 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -72.72 -23.25 60.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.483 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 5.7 mm -65.57 120.47 68.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.749 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.473 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 85.1 Cg_endo -83.72 135.72 6.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.072 2.514 . . . . 0.0 112.525 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.7 t -91.52 6.72 44.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.33 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.9 m -138.81 90.23 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.28 160.61 29.38 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -47.88 -41.78 31.89 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.874 2.382 . . . . 0.0 112.035 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.609 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -71.38 -38.45 71.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -58.45 -43.92 88.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -61.84 -45.16 95.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.511 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.04 73.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.05 -48.68 80.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.486 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.6 t -61.23 -37.18 82.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.665 ' HZ2' ' HZ2' ' A' ' 151' ' ' LYS . 63.4 tttm -62.0 -42.04 98.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.18 71.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.7 -34.53 74.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.593 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -59.78 -40.91 89.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 109.4 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.665 ' HZ2' ' HZ2' ' A' ' 147' ' ' LYS . 38.7 mmtm -61.17 -40.38 93.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.447 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.66 ' NH2' ' CD1' ' A' ' 115' ' ' PHE . 98.6 mtt180 -67.98 -19.89 64.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.23 13.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.482 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 2.1 m-85 -86.29 127.34 34.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -1.118 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -97.23 -176.85 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 40' ' ' GLN . 76.4 m-85 53.2 48.32 22.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.73 24.17 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.1 162.67 0.21 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -31.49 62.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -1.167 . . . . 0.0 109.446 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.6 m -66.77 -47.77 71.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.81 -44.42 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.1 m -60.29 -43.9 95.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.325 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.483 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 73.4 t80 -60.53 -43.26 97.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 0.0 109.334 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -57.08 -38.97 74.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -61.75 -31.18 71.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 63.0 mmm -68.12 -54.18 19.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.623 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.19 -42.49 65.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.708 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.7 75.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 26.2 t -83.31 -61.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.424 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.04 14.43 1.83 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.7 mt -65.55 -34.23 77.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.56 140.59 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.575 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 1.7 m-80 -88.88 115.09 26.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -98.63 113.02 24.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -152.18 143.06 23.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.522 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 m -97.04 145.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.1 m -54.75 142.82 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.09 -83.01 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 73.8 m -74.25 -171.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -1.158 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.609 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 33.3 m 52.4 17.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.468 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.609 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 13.7 p 42.46 43.63 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 30.4 t80 -121.59 82.83 40.96 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 109.621 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.75 36.47 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.131 2.554 . . . . 0.0 112.378 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.46 26.12 66.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.7 t30 57.56 43.27 22.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.546 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -134.77 78.83 54.1 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 122.969 2.446 . . . . 0.0 112.293 -179.794 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.288 0.566 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -84.01 152.54 24.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.594 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -146.44 148.2 32.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.48 ' C ' ' H ' ' A' ' 6' ' ' TRP . 63.5 m 45.91 31.25 1.04 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.97 -46.01 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.664 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -149.84 -91.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -1.201 . . . . 0.0 109.452 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 38.6 t 54.39 -0.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.633 ' H ' ' C ' ' A' ' 6' ' ' TRP . 72.1 m -79.87 28.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.424 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' SER . 35.1 tt0 -61.27 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 5.6 p30 -94.77 152.23 39.62 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.35 -34.09 13.53 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.819 2.346 . . . . 0.0 112.098 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.68 -43.3 99.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.476 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.55 -46.61 75.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 109.393 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.0 mt -62.14 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.373 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.12 98.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -62.01 -40.77 96.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 20.6 t60 -60.65 -48.9 79.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.81 -39.31 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.551 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.85 -47.33 83.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 89.5 mt-10 -151.82 -125.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.497 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.523 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 37.7 t90 57.99 114.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.52 -6.31 67.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 169' ' ' CYS . 8.3 p -105.78 109.92 63.65 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.183 -1.186 . . . . 0.0 109.429 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.1 121.12 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.742 2.294 . . . . 0.0 111.896 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -92.94 134.73 34.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.141 -0.974 . . . . 0.0 109.887 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -132.59 -2.25 3.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 109.042 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.14 147.53 46.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.543 ' O ' ' CZ ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -71.0 -60.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -178.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.86 -37.02 82.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.72 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.04 -42.81 84.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.871 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -40.8 88.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.215 -0.928 . . . . 0.0 109.862 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.3 m-30 -60.51 -41.42 94.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.896 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 37' ' ' LEU . 98.6 mt-10 -64.4 -32.81 74.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 ttm -68.42 -53.7 21.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.801 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.6 -39.18 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 110.027 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 77.0 m -71.31 -47.19 58.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.114 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 17.2 tp -64.84 -41.5 95.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 109.811 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 44.2 tp10 -56.22 -29.74 61.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.85 -38.38 59.64 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 40' ' ' GLN . 18.9 mp0 -60.3 -30.75 69.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -1.233 . . . . 0.0 109.724 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.7 tt0 -48.09 -29.7 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 109.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.66 109.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.23 -32.11 5.36 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.9 mp -98.21 -160.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -1.209 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.9 m -131.99 152.55 51.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.362 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 43.6 p90 -55.63 -33.49 64.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -57.99 -40.68 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 54.6 m -73.5 -32.52 64.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.692 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 73.0 t -57.4 -36.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -54.38 -54.93 33.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.57 -45.97 90.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.123 -0.986 . . . . 0.0 109.35 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HZ2' ' CG2' ' A' ' 48' ' ' THR . 45.5 mmtm -68.86 -28.47 66.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG2' HH11 ' A' ' 53' ' ' ARG . 6.4 ttt-85 -52.82 -45.95 67.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -0.986 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -70.47 -43.77 69.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -65.48 -38.16 88.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.325 -0.859 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.13 -49.75 76.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' HIS . 73.8 mtm180 -54.75 -43.39 72.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.41 71.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.29 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.86 -20.19 19.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.201 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -104.33 -38.96 6.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.849 -1.157 . . . . 0.0 110.238 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.5 t60 -49.77 -41.91 45.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 109.898 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.44 -31.39 72.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.722 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 53.7 m-85 -91.31 62.79 4.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -39.31 153.6 0.18 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.618 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -35.34 -53.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.856 2.371 . . . . 0.0 112.757 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -54.44 -44.93 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.647 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 71' ' ' MET . 20.3 tptp -65.73 -37.1 85.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.388 -0.82 . . . . 0.0 109.876 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.98 -49.89 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.076 -1.015 . . . . 0.0 109.594 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.63 70.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.511 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.06 -0.83 57.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.398 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 63' ' ' PHE . 8.9 ttp -71.52 158.35 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -104.67 156.8 17.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.57 -31.28 69.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.51 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -60.49 -39.2 86.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.86 -40.85 94.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.05 -44.03 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.579 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.79 -36.67 81.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.308 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HG3' HH11 ' A' ' 78' ' ' ARG . 33.2 ttm-85 -63.22 -42.29 99.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -36.13 82.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.2 t -51.29 -33.44 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -93.64 -60.28 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.523 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -101.3 108.1 19.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.92 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.418 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.94 27.94 57.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 pt -121.03 171.78 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -1.15 . . . . 0.0 109.38 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -46.69 141.62 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -94.0 97.6 10.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.431 -179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 15.6 m-70 -162.71 86.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.176 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 89' ' ' ARG . 24.9 ttt-85 -48.65 -29.88 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.38 -47.05 92.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -63.85 -48.81 75.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.27 -41.08 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.9 -36.63 72.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.399 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.318 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 98.9 mt -57.59 -41.66 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 mm -56.29 -50.76 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.12 95.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.614 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 17.9 m120 -57.85 -35.94 71.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.14 68.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.88 -42.61 99.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.47 -35.12 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 10.3 t80 -63.98 -48.13 77.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 tp -63.29 -39.27 94.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -60.75 -38.3 84.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -64.13 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.242 -0.912 . . . . 0.0 109.468 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.75 -29.12 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -52.39 -24.45 7.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.514 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.92 -16.88 59.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.512 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.77 9.6 74.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.58 114.42 63.1 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.246 -1.15 . . . . 0.0 109.677 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.02 120.53 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.578 2.185 . . . . 0.0 111.692 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -58.47 -35.03 71.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 0.0 110.504 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.424 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -63.21 -50.87 68.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.0 110.742 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 118' ' ' SER . 90.2 m-20 -62.67 -43.56 98.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 111.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.88 -49.33 73.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.991 -1.068 . . . . 0.0 111.155 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.436 HG11 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -63.8 -48.9 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.034 -1.041 . . . . 0.0 111.632 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.509 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 2.7 p-90 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.775 -1.203 . . . . 0.0 111.207 -177.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 33.1 m -55.41 -28.57 55.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.861 -1.149 . . . . 0.0 109.766 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.23 -14.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' SER . 7.1 p -83.24 26.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.901 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 120' ' ' VAL . 2.4 m-80 76.03 17.61 2.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.706 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 59.94 39.34 20.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.492 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -151.13 144.84 17.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.59 146.95 50.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.694 2.262 . . . . 0.0 111.872 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.2 134.58 46.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.982 . . . . 0.0 109.741 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 38.7 ttp -109.36 125.41 52.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 t -94.28 166.56 12.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 109.868 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -147.43 53.3 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.403 -0.811 . . . . 0.0 109.252 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.21 142.88 27.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -80.48 -33.47 36.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.0 m -128.91 159.29 36.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.417 ' CD1' ' NE1' ' A' ' 6' ' ' TRP . 31.5 mt -55.94 -35.56 66.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.9 p -66.85 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.92 -23.1 66.55 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.142 -0.974 . . . . 0.0 109.411 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.26 116.98 42.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -84.18 132.1 5.19 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.132 2.555 . . . . 0.0 112.516 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.1 t -92.44 -12.46 32.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.309 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 80.0 p -92.57 100.93 13.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.36 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.413 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 9.1 p -116.74 151.45 47.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.07 -31.87 93.99 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.844 2.362 . . . . 0.0 111.966 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.92 -41.47 51.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.413 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 39.1 m -60.74 -41.15 94.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.56 -48.93 77.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.522 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.41 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.432 ' CD2' ' C ' ' A' ' 145' ' ' LEU . 7.5 tt -59.56 -48.29 82.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.47 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -59.97 -41.77 92.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.21 -33.15 74.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.76 -51.38 49.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.548 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.89 -34.63 74.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -58.03 -40.33 80.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.382 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.6 -37.13 82.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -63.91 -20.11 65.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.09 19.39 19.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.614 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 6.0 m-85 -88.51 133.6 34.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.52 177.75 5.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 55.05 53.67 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.86 24.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.45 167.51 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 p -66.05 -25.27 66.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 109.37 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.9 p -70.9 -46.17 63.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.01 -34.52 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 43.1 t -68.12 -46.0 72.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.317 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.07 -42.49 99.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.1 m -57.57 -32.6 67.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.28 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -31.25 69.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.446 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 25.5 mtt -68.5 -53.95 19.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.523 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 1.9 pp0? -62.39 -36.46 82.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.704 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.478 ' N ' ' CD ' ' A' ' 167' ' ' GLN . . . -74.71 -38.96 62.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.744 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.487 ' HG ' ' CD1' ' A' ' 171' ' ' LEU . 10.3 t -74.54 -29.05 61.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.444 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.14 56.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.487 ' CD1' ' HG ' ' A' ' 169' ' ' CYS . 1.1 mp -52.69 -52.88 54.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 0.0 109.39 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.1 m -91.9 135.84 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -82.67 105.03 13.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -93.71 123.92 37.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CD2' ' CD2' ' A' ' 182' ' ' TYR . 1.9 p-80 -164.06 159.23 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -111.39 122.73 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' A' ' 178' ' ' GLY . 8.6 p -70.19 -40.02 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 177' ' ' VAL . . . -60.03 -18.94 49.6 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 96.5 m -86.37 -176.67 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.503 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.6 t -106.12 -21.77 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.523 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.7 t -54.27 -33.92 59.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 1.1 t80 -125.1 84.44 59.28 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' TYR . 52.0 Cg_exo -52.16 -140.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.111 2.54 . . . . 0.0 112.338 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 94.16 5.68 62.11 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -146.27 30.7 1.02 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -1.145 . . . . 0.0 109.578 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -110.4 149.45 40.22 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 109.588 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.996 2.464 . . . . 0.0 112.256 179.763 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.574 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.275 0.56 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -78.19 162.86 26.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.872 . . . . 0.0 109.537 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 3' ' ' ARG . 23.9 ptt-85 -140.06 170.45 15.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.555 ' C ' ' H ' ' A' ' 6' ' ' TRP . 4.1 m -96.87 -155.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.88 -16.18 0.86 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.555 ' H ' ' C ' ' A' ' 4' ' ' CYS . 26.6 m95 44.46 37.8 2.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.183 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 ' CG2' HH21 ' A' ' 3' ' ' ARG . 11.5 m -64.91 126.74 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' GLN . 29.4 t -164.08 156.84 17.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' SER . 41.3 tt0 56.94 159.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 109.561 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.2 72.74 0.82 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.9 -28.78 13.83 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.844 2.363 . . . . 0.0 112.147 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.36 -39.32 94.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.72 -46.54 78.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.56 -48.78 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.383 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.77 -36.77 76.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.52 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -59.89 -44.11 94.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.484 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.15 -49.05 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -64.53 -40.28 95.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -64.42 -64.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.519 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.9 mm-40 -140.13 -151.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 20' ' ' GLU . 27.1 t-105 62.19 130.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.475 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.62 -17.69 58.51 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.8 m -78.11 149.69 76.72 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.416 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.01 119.41 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.858 2.372 . . . . 0.0 111.785 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.6 133.41 56.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.985 . . . . 0.0 109.809 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 p -134.46 9.09 3.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.033 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.73 141.49 31.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.501 ' HG ' ' H ' ' A' ' 113' ' ' ALA . 14.9 m -68.63 -36.38 78.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -58.97 -52.43 65.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -40.29 96.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.66 -39.38 80.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.11 -0.994 . . . . 0.0 109.871 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -67.1 -54.24 23.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.873 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -71.11 -31.46 67.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.4 tpp -60.04 -53.75 54.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 109.676 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 18.3 tt -82.76 -42.99 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.062 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 33.7 t -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.944 . . . . 0.0 110.044 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.6 -40.42 76.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.867 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -59.91 -24.35 64.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.802 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.43 -28.72 3.5 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.18 -31.64 72.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.24 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -47.98 -34.41 9.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.78 111.33 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.727 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.61 -39.24 2.84 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -105.78 -138.15 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.7 t -141.73 155.26 45.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 22.7 p90 -55.54 -31.85 62.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -58.57 -39.64 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.7 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -73.28 -32.26 64.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.9 t -58.69 -37.68 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.7 mt -53.83 -55.49 26.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -59.27 -42.19 90.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -21.59 60.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.376 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 49' ' ' VAL . 7.9 ttt-85 -58.62 -47.64 83.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.209 -0.932 . . . . 0.0 108.99 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.63 -41.02 76.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -66.05 -50.72 63.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.269 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 28.0 t80 -60.45 -37.51 81.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.379 -0.826 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 40.8 ttp180 -55.83 -38.12 69.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.859 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.25 53.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.07 -11.69 35.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 110.286 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 56.4 m-85 -130.04 -51.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.97 -1.082 . . . . 0.0 110.193 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.2 t-80 -49.25 -38.3 26.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.083 -1.01 . . . . 0.0 109.909 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -55.45 -37.44 67.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.781 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.09 -16.79 52.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.866 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 63.99 132.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.064 -1.022 . . . . 0.0 109.578 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.33 -34.5 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.904 2.402 . . . . 0.0 112.688 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.2 t -55.16 -49.35 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mtpt -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -58.09 -42.17 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.595 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.83 -42.24 67.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.25 23.91 8.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.1 ttm -62.36 163.04 9.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -109.9 154.22 23.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -34.92 69.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.28 -37.38 85.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.456 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -60.13 -44.11 95.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.5 t -56.41 -43.18 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.596 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.15 -33.46 74.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.315 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -58.89 -44.23 91.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.799 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.32 -32.6 64.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.3 t -51.78 -36.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.763 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -75.57 -62.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -99.89 107.84 19.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.423 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -175.62 75.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.397 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.66 10.4 1.51 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.518 ' H ' ' C ' ' A' ' 83' ' ' ALA . 5.1 pt -79.59 -175.92 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -1.146 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 67.6 mt -83.34 -2.33 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -66.88 145.58 55.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.427 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' O ' ' N ' ' A' ' 90' ' ' GLY . 53.0 m80 -141.96 70.52 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.133 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.427 ' HG3' HH11 ' A' ' 89' ' ' ARG . 27.2 ttm-85 59.02 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.397 -0.814 . . . . 0.0 109.927 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -56.57 -37.48 75.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -59.59 -45.47 91.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 92' ' ' ILE . 74.8 mt -56.73 -44.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.629 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.332 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.21 -36.31 79.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.419 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.9 mm -69.03 -44.52 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 96' ' ' ILE . 28.8 mm -54.96 -47.93 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 109.543 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.42 -42.92 99.88 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 23.9 m120 -58.86 -43.77 90.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -1.207 . . . . 0.0 109.42 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.71 92.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.57 -44.28 91.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.4 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.11 -53.74 7.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -56.99 -44.71 83.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -61.04 -33.87 73.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -62.33 -35.87 80.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' N ' ' A' ' 108' ' ' ASN . 84.3 tt0 -70.82 -30.77 67.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -51.89 -14.38 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.561 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 106' ' ' GLU . 77.7 m-20 -75.97 -14.98 60.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 36.6 18.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -138.75 152.17 70.09 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.76 119.12 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.612 2.208 . . . . 0.0 111.685 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -74.57 -43.51 55.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.0 110.465 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' H ' ' HG ' ' A' ' 28' ' ' SER . . . -63.42 -47.21 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.168 -0.958 . . . . 0.0 110.772 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.564 ' O ' ' OG ' ' A' ' 118' ' ' SER . 53.6 t0 -54.9 -37.7 66.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 111.056 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 -48.35 39.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.088 -1.008 . . . . 0.0 111.221 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 3.6 m -53.96 -49.35 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.058 -1.026 . . . . 0.0 111.679 -175.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.431 ' H ' HG22 ' A' ' 116' ' ' VAL . 21.9 p-90 -87.69 -24.94 23.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.729 -1.232 . . . . 0.0 111.09 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 6.8 m -56.02 -23.95 36.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.783 -1.198 . . . . 0.0 109.708 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -44.46 -15.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.166 -0.958 . . . . 0.0 110.076 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.3 m -88.15 24.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.001 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 1.6 m120 72.14 38.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 109.641 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 51.4 p-80 41.96 40.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.579 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -147.52 148.09 30.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.542 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.42 135.58 36.99 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.671 2.247 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.448 HE22 ' CB ' ' A' ' 141' ' ' ALA . 86.3 mt-30 -100.08 148.41 24.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.776 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.6 ptm -133.27 156.68 47.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.447 -0.783 . . . . 0.0 109.155 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 t -124.03 163.3 21.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.921 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -137.69 54.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.99 -158.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.663 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.536 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 6.4 m -140.9 -29.6 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.34 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 m -135.06 161.17 36.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.469 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.4 mt -73.58 -16.73 61.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.84 -41.21 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.8 pt-20 -71.93 -26.04 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.174 -0.954 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.0 117.45 48.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.03 131.28 5.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.096 2.53 . . . . 0.0 112.563 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -13.38 59.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.259 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.2 m -94.73 101.87 13.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.91 154.62 49.64 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.05 -42.68 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.843 2.362 . . . . 0.0 112.009 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.448 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -75.73 -41.38 53.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -62.05 -42.53 99.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.412 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 44.1 t0 -62.87 -45.24 93.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.17 80.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.6 tp -57.96 -50.9 71.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.3 p -58.6 -39.36 80.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.55 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 60.7 mttp -60.69 -32.72 71.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.06 -55.11 10.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 9.5 mp -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.626 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.63 -41.38 85.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.419 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.01 -35.45 80.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.494 HH11 ' HG3' ' A' ' 152' ' ' ARG . 26.6 ttm-85 -63.86 -21.75 66.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.8 21.47 8.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.69 136.76 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -1.112 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 1.8 mptm? -97.67 -169.64 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 16.5 p90 39.47 41.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -96.38 25.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.54 154.58 1.21 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.7 m -55.87 -28.03 54.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.423 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -48.33 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.9 mp -58.74 -44.24 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 109.438 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 2.2 t -62.64 -49.04 76.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -62.74 -40.0 95.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.364 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -60.71 -38.65 85.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 165' ' ' PHE . 0.8 OUTLIER -61.12 -43.63 98.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.529 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.3 mtp -59.33 -40.2 85.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.75 -34.16 77.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.31 -63.2 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.685 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.8 t -63.26 -40.31 97.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.98 21.64 15.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.8 mt -54.17 -35.1 61.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.395 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.18 133.95 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.546 ' OD1' ' ND1' ' A' ' 175' ' ' HIS . 5.8 t-20 -81.48 100.96 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.45 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -86.26 118.46 25.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.546 ' ND1' ' OD1' ' A' ' 173' ' ' ASN . 15.0 m170 -147.62 162.22 39.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.519 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.82 132.71 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 83.3 t -71.88 -39.25 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.495 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.91 28.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 29.7 t -91.03 167.29 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -1.138 . . . . 0.0 109.49 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.3 p -90.84 -37.87 13.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.503 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 182' ' ' TYR . 17.0 p -53.31 -35.9 60.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.464 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 39.8 t80 -125.2 83.59 60.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -85.28 31.55 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.047 2.498 . . . . 0.0 112.441 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.42 14.68 79.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.8 37.82 27.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -1.15 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.63 155.69 59.09 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 C-N-CA 122.998 2.465 . . . . 0.0 112.267 179.894 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -93.63 143.49 26.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HG3' HH11 ' A' ' 3' ' ' ARG . 50.7 mtm-85 -143.75 148.4 35.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.08 -164.83 1.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.387 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.12 3.24 63.71 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.608 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 1.4 m0 47.83 42.89 16.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.477 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 8' ' ' SER . 33.2 m -66.29 127.99 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER 166.6 178.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.497 ' N ' ' OG ' ' A' ' 8' ' ' SER . 49.4 tp60 59.41 -127.86 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.12 150.74 91.66 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 -11.63 26.29 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.159 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.75 -33.08 74.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.555 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 42.3 m-85 -54.16 -46.47 72.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.444 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.93 -28.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.4 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -56.84 -47.14 81.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CD1' ' C ' ' A' ' 16' ' ' TYR . 1.3 p90 -75.76 -38.73 58.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.502 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.552 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 83.9 t60 -54.16 -46.27 72.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.498 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -71.38 -34.51 70.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.514 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 3.1 m120 -61.81 -62.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.545 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TRP . 10.3 pt-20 -174.04 -115.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.487 ' O ' ' O ' ' A' ' 20' ' ' GLU . 34.5 t-105 60.07 130.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.524 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.81 60.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.7 OUTLIER -76.89 152.74 82.77 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.264 -1.139 . . . . 0.0 109.376 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 123.01 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.752 2.301 . . . . 0.0 111.857 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -108.57 135.22 50.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.858 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -134.94 5.32 3.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 109.038 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.91 128.45 35.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.277 -0.889 . . . . 0.0 109.296 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.536 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -61.71 -55.89 25.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.581 -178.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' CB ' ' HZ3' ' A' ' 29' ' ' LYS . 9.6 mtpm? -62.73 -43.63 98.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.708 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.619 ' NZ ' ' NH2' ' A' ' 53' ' ' ARG . 15.9 tptp -64.63 -44.35 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.85 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.3 tp -60.87 -42.07 97.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.85 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.9 m-30 -60.34 -35.89 76.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 0.0 109.892 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.76 -30.06 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.819 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.0 tpp -74.34 -56.23 5.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.837 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 tp -61.69 -36.7 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.59 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 75.9 m -71.72 -44.72 63.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.6 tp -73.53 -39.8 64.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.977 . . . . 0.0 109.876 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 50.1 mm-40 -53.71 -34.56 59.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.775 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.72 -34.27 56.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -64.22 -29.14 70.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.161 . . . . 0.0 109.778 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.1 tt0 -49.04 -31.01 6.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.759 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.99 110.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -31.84 6.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 41' ' ' GLN . 19.4 mt -99.47 -150.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.8 m -145.98 161.34 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -52.39 -41.25 62.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -51.9 -40.99 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -75.65 -34.63 60.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.71 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' ARG . 93.3 t -59.65 -44.21 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' HZ1' ' CD1' ' A' ' 47' ' ' ILE . 46.5 mttp -59.36 -49.39 78.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' TYR . 45.4 mmtm -72.51 -22.5 61.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.334 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.619 ' NH2' ' NZ ' ' A' ' 30' ' ' LYS . 3.8 ttt-85 -57.57 -44.29 85.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.111 -0.993 . . . . 0.0 108.975 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.11 -44.56 65.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -66.38 -35.03 79.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.242 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 29.4 t80 -57.06 -49.25 76.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.468 -0.77 . . . . 0.0 109.379 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 80.4 mtm180 -59.67 -41.37 90.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.06 39.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.213 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.9 m -95.9 -33.97 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 30.1 m-85 -86.05 -32.85 21.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.047 -1.033 . . . . 0.0 110.233 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 85.5 t60 -47.47 -16.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 60' ' ' PHE . 7.2 pt20 -100.35 -22.07 15.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.818 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 64' ' ' ASP . 60.0 m-85 -99.94 68.79 1.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.077 -1.015 . . . . 0.0 109.871 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 63' ' ' PHE . 4.9 m-20 -41.42 154.3 0.24 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.995 . . . . 0.0 109.607 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -34.46 -53.97 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.948 2.432 . . . . 0.0 112.627 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.82 -44.76 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.125 -0.984 . . . . 0.0 109.632 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.7 -32.78 74.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.34 -43.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.617 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.497 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.41 -3.1 58.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.6 mtp -55.74 146.68 20.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.2 tp60 -105.97 166.46 10.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 97.2 mt-10 -63.25 -29.31 70.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.442 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.41 -37.16 84.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 109.441 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.63 -39.28 80.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.421 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.82 -44.14 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -56.98 -37.25 71.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.377 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -61.05 -44.09 97.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.416 -0.803 . . . . 0.0 109.81 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.8 mt -73.78 -33.07 64.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.9 t -50.55 -35.63 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.953 . . . . 0.0 109.788 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -88.93 -50.19 6.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.089 -1.007 . . . . 0.0 109.568 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.5 m-20 -71.33 153.27 42.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.38 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.12 26.65 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -47.33 -34.74 9.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.3 pt -148.61 -174.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.343 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.47 138.04 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -89.92 106.88 18.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 109.445 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CD2' ' H ' ' A' ' 90' ' ' GLY . 20.2 t-160 -176.34 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -45.02 -34.72 2.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.894 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.49 ' H ' ' CD2' ' A' ' 88' ' ' HIS . . . -66.86 -44.52 88.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -66.44 -43.12 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.491 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.94 -46.67 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -59.71 -33.22 71.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.42 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.99 90.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.13 -44.79 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.05 -45.82 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.22 -38.06 95.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 6.9 t30 -57.64 -40.87 80.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.356 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.71 95.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.57 -40.81 75.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.77 -31.97 73.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.486 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.557 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 22.6 t80 -62.1 -48.4 80.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.3 mm? -58.35 -37.4 75.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 109.488 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -61.28 -51.71 67.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.606 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 27.3 ttt -69.97 -39.45 75.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.36 -26.78 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 109.443 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -51.7 -25.11 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.14 -19.0 58.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.496 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.58 17.47 68.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.11 152.74 38.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.151 -1.205 . . . . 0.0 109.741 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.83 122.92 10.63 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.641 2.228 . . . . 0.0 111.669 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.606 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 26.3 t80 -76.73 -42.16 42.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.68 39.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 118' ' ' SER . 43.8 t0 -53.01 -33.32 51.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.012 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 16.2 t80 -76.24 -52.28 10.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.036 -1.04 . . . . 0.0 111.223 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.56 -50.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.972 -1.08 . . . . 0.0 111.683 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 7.6 p-90 -82.05 -31.12 31.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.709 -1.244 . . . . 0.0 111.163 -176.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 18.0 t -56.28 -24.01 40.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.871 -1.143 . . . . 0.0 109.785 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -43.11 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.279 -0.888 . . . . 0.0 110.083 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 118' ' ' SER . 19.5 m -83.11 24.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.973 -1.079 . . . . 0.0 110.003 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 67.35 36.23 4.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 118' ' ' SER . 74.0 m-70 53.82 26.16 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -142.89 103.67 5.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.75 147.61 4.46 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.685 2.257 . . . . 0.0 111.808 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -95.83 157.97 15.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.727 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -121.95 142.49 50.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 173' ' ' ASN . 2.7 t -86.14 160.19 19.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.938 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -141.73 46.83 1.67 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.79 135.75 42.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.8 m -76.8 -30.22 56.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.353 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -133.39 175.75 9.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.6 mt -67.79 -31.92 72.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.556 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.1 p -63.51 -34.86 78.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -73.51 -21.6 60.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.125 -0.985 . . . . 0.0 109.435 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.96 120.02 68.55 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.758 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.28 136.53 7.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.11 2.54 . . . . 0.0 112.561 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.15 4.78 53.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.325 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.9 t -137.14 90.74 2.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.59 156.27 39.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.74 -40.08 24.18 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.777 2.318 . . . . 0.0 112.03 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.96 -38.38 66.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.307 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.6 t -62.54 -47.38 84.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.03 -45.45 92.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.88 75.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.53 -46.64 78.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.537 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.3 t -56.09 -43.73 78.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.547 ' CB ' ' HZ2' ' A' ' 147' ' ' LYS . 2.9 ttmp? -61.22 -35.96 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.08 -52.41 35.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 mp -66.29 -37.13 84.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.38 -0.825 . . . . 0.0 109.546 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -62.45 -37.23 85.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.333 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.62 -37.58 86.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 0.0 109.441 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.608 ' NH2' ' CE1' ' A' ' 115' ' ' PHE . 99.3 mtt180 -63.77 -23.41 67.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.46 12.21 9.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -78.41 135.01 37.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -1.108 . . . . 0.0 109.51 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 19.9 tptt -101.35 -166.19 1.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 14.6 p90 37.83 33.95 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.407 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -101.77 24.89 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.388 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.62 157.0 1.67 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.7 m -53.61 -31.01 45.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.0 m -63.53 -47.18 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.493 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -64.98 -40.53 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.4 -41.05 96.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.319 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.5 -46.41 90.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.288 -0.883 . . . . 0.0 109.306 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.469 ' HG ' ' N ' ' A' ' 165' ' ' PHE . 95.5 p -60.74 -36.8 79.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.469 ' N ' ' HG ' ' A' ' 164' ' ' SER . 5.6 t80 -62.02 -49.42 76.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.8 mtp -59.95 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.97 -46.05 90.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.429 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . . . -72.62 -43.61 63.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.671 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' VAL . 13.6 t -58.13 -29.56 65.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.986 . . . . 0.0 109.425 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 0.33 61.3 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.7 mp -55.07 -43.29 73.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -1.17 . . . . 0.0 109.428 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.99 135.97 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 173' ' ' ASN . 1.8 m120 -86.43 117.89 25.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 42.1 p-10 -91.86 93.43 8.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -149.23 130.98 15.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.55 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 26.3 m -100.02 139.75 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.23 -33.77 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.11 65.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 176' ' ' VAL . 12.6 p -79.09 129.63 34.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.548 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 71.2 m -63.1 -29.67 70.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.9 t -48.73 -28.74 3.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 1.2 t80 -124.63 84.42 57.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.619 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 182' ' ' TYR . 53.6 Cg_exo -51.39 -139.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.115 2.543 . . . . 0.0 112.343 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.5 1.94 58.94 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -153.71 33.42 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.375 -1.074 . . . . 0.0 109.607 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -125.58 79.66 67.19 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.532 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 123.012 2.475 . . . . 0.0 112.322 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.32 0.581 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -131.95 158.18 42.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -149.57 176.72 10.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.7 p -43.35 159.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -125.98 -17.93 2.44 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -65.58 5.16 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 5' ' ' GLY . 4.6 t -63.32 140.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 p -61.8 151.29 34.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 109.475 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.81 -31.69 68.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -49.14 143.49 9.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.444 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.08 -28.5 12.8 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.898 2.399 . . . . 0.0 112.161 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.4 tp -62.13 -39.97 94.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.71 -49.13 67.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.91 . . . . 0.0 109.427 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 14' ' ' ILE . 80.8 mt -67.59 -40.9 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.69 -36.66 84.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -62.12 -43.09 99.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -60.92 -42.89 98.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.463 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.99 -39.45 85.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -63.63 -55.37 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -175.84 130.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.95 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -173.92 122.14 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.75 -0.03 79.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 169' ' ' CYS . 6.6 m -80.42 148.62 66.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.291 -1.123 . . . . 0.0 109.33 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 119.7 6.68 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.754 2.303 . . . . 0.0 111.857 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.26 130.86 53.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.832 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -117.05 4.09 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.865 . . . . 0.0 109.006 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -78.53 116.84 19.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 76.1 p -61.58 -33.52 74.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.599 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -58.04 -47.15 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -70.28 -48.8 55.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.09 -39.77 93.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 61.5 t80 -60.3 -45.0 94.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.893 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.59 -31.67 72.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 109.88 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.52 -53.22 57.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.805 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.84 -42.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.025 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.589 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 12.1 m -62.27 -51.74 66.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 mt -76.07 -42.4 47.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 161' ' ' ILE . 44.2 tt0 -54.25 -36.49 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.797 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.46 -32.97 61.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.54 -27.56 69.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -1.22 . . . . 0.0 109.718 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -48.53 -36.9 16.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 109.624 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.47 114.71 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.659 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.59 -33.36 5.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 mt -97.44 -141.83 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -1.17 . . . . 0.0 109.43 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.0 p -147.3 154.49 41.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -50.88 -45.03 59.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.219 -0.925 . . . . 0.0 109.494 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.8 tp -55.35 -34.77 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.684 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.1 m -72.02 -35.08 69.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.0 t -59.19 -49.06 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.49 -50.84 70.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -59.37 -48.45 81.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.304 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -69.36 -30.57 68.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HG2' HH11 ' A' ' 53' ' ' ARG . 20.2 ttt-85 -50.99 -46.27 61.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 108.943 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.33 -44.22 72.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.355 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.58 -41.51 98.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.479 ' CD2' ' CE2' ' A' ' 60' ' ' PHE . 3.3 m-85 -55.87 -49.68 72.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.393 -0.817 . . . . 0.0 109.369 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' HIS . 58.8 mtp180 -51.72 -45.04 63.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.782 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.75 -43.14 47.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.1 m -96.4 -27.55 14.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.278 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.479 ' CE2' ' CD2' ' A' ' 56' ' ' TYR . 38.9 m-85 -92.36 -34.38 14.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.093 . . . . 0.0 110.133 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 86.5 t60 -48.29 -38.92 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -68.4 -34.12 75.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.716 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 64' ' ' ASP . 40.2 m-85 -88.9 62.97 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.85 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -39.77 159.0 0.13 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 109.558 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -38.61 -53.45 1.82 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.923 2.415 . . . . 0.0 112.651 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.9 t -53.36 -44.63 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -66.71 -34.39 77.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.23 -48.77 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 109.661 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.32 63.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.49 7.07 43.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.426 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 41.9 ttm -57.06 146.97 25.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' OE1' ' OE2' ' A' ' 74' ' ' GLU . 95.3 mt-30 -107.44 162.02 14.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.07 -28.51 70.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' OE1' ' A' ' 72' ' ' GLN . 24.9 pt-20 -72.29 -27.76 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.81 -47.71 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 m -64.05 -36.85 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.521 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -54.82 -37.97 66.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -70.05 -43.74 70.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.367 -0.833 . . . . 0.0 109.803 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.04 -41.45 74.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.99 . . . . 0.0 109.692 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -50.86 -36.3 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.31 -62.41 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -99.84 114.14 27.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.92 79.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -25.95 7.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' GLY . 22.1 pt -57.85 -160.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.249 -1.147 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.98 132.67 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.52 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.0 ptm180 -102.48 136.33 42.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.16 100.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.152 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -47.51 -30.28 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.923 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.8 -48.82 15.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.61 -43.39 98.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -1.145 . . . . 0.0 109.489 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.47 -55.33 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.628 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -58.17 -31.58 67.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.72 93.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 109.39 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.5 -41.7 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.426 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 70.9 mt -55.4 -54.3 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.82 94.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.589 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -58.03 -40.29 80.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -70.75 -37.05 73.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.04 -43.42 98.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.0 -33.85 72.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 19.4 t80 -69.84 -46.66 65.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 109.527 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.87 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 28.1 ttt -61.71 -41.53 97.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.485 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.1 -27.09 63.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -52.07 -21.82 3.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.513 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.46 -13.71 60.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.7 4.55 72.74 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.46 167.25 16.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -1.213 . . . . 0.0 109.696 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.76 118.55 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.546 2.164 . . . . 0.0 111.704 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 36.4 t80 -66.35 -44.23 83.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.467 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.47 89.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.774 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 24.7 t70 -53.41 -54.43 36.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 111.082 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -39.06 68.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.998 -1.064 . . . . 0.0 111.313 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.02 -60.4 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.997 -1.064 . . . . 0.0 111.676 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -87.99 -20.99 25.1 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.759 -1.213 . . . . 0.0 111.151 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 58.3 m -56.93 -32.25 65.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.838 -1.164 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -45.89 -14.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 118' ' ' SER . 13.5 m -82.23 24.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.1 -1.0 . . . . 0.0 109.949 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 71.95 29.65 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 109.764 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.1 t60 53.9 31.98 14.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 0.0 109.59 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.461 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 39.1 mt-30 -150.32 121.52 3.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.97 153.26 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.732 2.288 . . . . 0.0 111.809 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 91.9 mm-40 -110.89 148.22 32.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.731 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.595 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 31.5 tpp -120.85 135.06 55.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.103 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -85.94 164.17 17.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.591 ' NE2' HD22 ' A' ' 185' ' ' ASN . 76.1 mm-40 -142.91 43.08 1.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.835 . . . . 0.0 109.364 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.18 -164.6 1.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.478 ' N ' ' OE2' ' A' ' 134' ' ' GLU . 40.3 m -158.91 -26.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.573 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.3 m -115.36 158.13 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.92 -13.78 60.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -92.87 -32.87 14.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 131' ' ' THR . 6.5 pt-20 -77.36 3.56 12.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -0.964 . . . . 0.0 109.409 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 135' ' ' ILE . 46.6 mm -65.89 126.09 91.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.695 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.12 128.24 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.159 2.573 . . . . 0.0 112.512 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.0 t -101.07 7.86 43.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 t -144.34 88.98 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.396 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.95 160.98 32.71 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.43 -40.29 28.93 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.801 2.334 . . . . 0.0 112.01 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.85 75.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.347 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 t -61.39 -46.95 88.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 147' ' ' LYS . 24.4 t70 -61.49 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.88 83.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.3 tt -65.82 -39.79 91.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 109.537 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -55.66 -48.95 74.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' NZ ' ' OD2' ' A' ' 143' ' ' ASP . 61.0 mttp -62.96 -28.8 70.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.52 -47.51 69.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -57.45 -37.88 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -61.33 -40.06 92.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.402 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -68.06 -19.99 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 109.377 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.05 26.25 19.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.23 135.87 33.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -101.73 175.0 5.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 55.66 46.92 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' GLY . 25.8 m -120.18 25.93 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.62 164.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.2 m -53.84 -31.27 48.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -1.089 . . . . 0.0 109.386 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 -47.3 76.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.497 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -63.83 -36.32 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.5 m -67.99 -48.82 64.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.287 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.92 -41.56 98.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.416 -0.803 . . . . 0.0 109.316 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.0 m -59.13 -38.5 79.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -60.68 -45.68 93.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mmm -58.91 -41.83 88.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.611 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.02 -31.34 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' VAL . 2.5 p -80.74 -63.98 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 109.472 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.722 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 158.04 -98.78 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mt 61.52 -22.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.722 ' H ' ' C ' ' A' ' 170' ' ' GLY . 12.9 m -132.39 143.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.595 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 6.1 m-20 -92.53 102.18 14.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.407 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.39 97.34 11.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.496 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.53 141.08 32.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 m -94.63 136.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.42 ' CG1' ' HZ1' ' A' ' 186' ' ' LYS . 38.4 t -71.77 138.19 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.476 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.62 2.95 62.95 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 180' ' ' CYS . 7.6 m -153.24 155.06 35.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -1.163 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 1.7 t 71.01 3.87 4.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 3.2 m 62.71 56.36 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.538 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.578 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 0.5 OUTLIER -115.53 97.23 48.2 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.578 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 91.5 Cg_endo -86.67 -161.5 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.108 2.539 . . . . 0.0 112.353 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . 94.38 5.42 61.93 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.591 HD22 ' NE2' ' A' ' 128' ' ' GLN . 27.4 m120 -143.41 34.93 1.31 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.563 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.42 ' HZ1' ' CG1' ' A' ' 177' ' ' VAL . 60.0 mttm -135.21 78.74 51.64 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--N 1.306 -1.7 0 C-N-CA 123.011 2.474 . . . . 0.0 112.309 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -94.05 145.62 24.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.458 HH21 ' CD1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -97.81 151.28 20.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 m -52.59 166.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.62 -17.53 61.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.506 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -76.51 6.91 5.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.427 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.83 133.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -71.47 162.56 29.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.935 . . . . 0.0 109.447 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.57 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 0.7 OUTLIER -84.07 1.23 44.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.92 144.87 73.12 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.74 -17.15 26.17 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.893 2.395 . . . . 0.0 112.102 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.81 -46.71 14.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -66.42 -44.58 82.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.434 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 15' ' ' ALA . 15.2 tt -59.78 -42.17 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 14' ' ' ILE . . . -72.43 -41.59 66.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.504 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' OH ' ' NE1' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -59.62 -37.53 78.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.47 -43.45 85.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.7 p30 -91.63 1.09 57.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ALA . 31.5 t30 -63.59 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -153.08 -16.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.573 ' NE1' ' OH ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -50.13 145.89 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.32 -5.51 62.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.61 119.06 65.75 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.243 -1.151 . . . . 0.0 109.335 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.15 121.01 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.806 2.337 . . . . 0.0 111.855 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -103.72 138.92 39.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -134.63 0.31 2.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.033 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -81.26 118.7 22.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -53.81 -37.85 63.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.22 -42.09 94.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -70.98 -48.81 51.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.49 -36.69 85.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.817 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -61.42 -50.81 71.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 109.917 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.11 -28.97 65.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.421 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 47.5 tpp -57.28 -52.6 64.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.795 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 2.8 tp -65.83 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.971 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 78.4 m -74.48 -38.87 62.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.096 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.07 -50.08 51.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 109.887 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -62.82 -27.89 69.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.8 -33.97 28.62 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.79 -27.54 69.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.263 . . . . 0.0 109.776 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 7.1 tt0 -50.37 -41.3 51.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.93 112.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.669 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.17 -37.16 3.63 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.88 -140.4 0.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.172 . . . . 0.0 109.41 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 p -141.59 159.92 41.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.512 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 74.9 t-105 -57.08 -44.62 83.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.484 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 tp -56.87 -34.61 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.722 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.4 m -70.63 -34.62 72.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.96 . . . . 0.0 109.723 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.3 t -70.16 -44.3 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.1 mt -53.26 -53.97 43.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.8 -45.6 82.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.097 -1.002 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' NZ ' ' O ' ' A' ' 85' ' ' ILE . 63.5 mttm -79.79 -11.55 59.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 49' ' ' VAL . 27.5 ttt-85 -64.65 -48.54 74.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.189 -0.944 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -72.61 -39.25 67.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.809 . . . . 0.0 109.307 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -70.07 -41.55 73.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.294 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 32.2 t80 -60.2 -44.75 94.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.407 -0.808 . . . . 0.0 109.375 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' HIS . 52.2 mtp180 -58.57 -38.49 78.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.849 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.06 80.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 1.9 p -93.4 -12.83 28.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 37.6 m-85 -117.0 -54.21 2.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.941 -1.1 . . . . 0.0 110.173 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ARG . 74.8 t60 -54.87 -42.15 71.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.112 -0.992 . . . . 0.0 109.882 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -57.37 -35.26 69.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 46.8 m-85 -72.57 -22.7 60.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 131.44 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.005 . . . . 0.0 109.608 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -40.52 -34.29 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.93 2.42 . . . . 0.0 112.701 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.7 t -56.34 -49.77 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' MET . 53.6 mtpt -73.24 -30.27 63.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.848 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.519 ' O ' ' SD ' ' A' ' 71' ' ' MET . 62.1 t -56.02 -44.15 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.41 42.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.65 34.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 9.6 ptm -61.64 144.91 53.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.701 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -95.22 171.36 8.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.578 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.67 -33.53 68.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.451 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 74' ' ' GLU . 49.3 mp0 -56.07 -36.91 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.86 -38.28 90.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.3 t -59.47 -44.51 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.1 -34.94 79.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.187 -0.945 . . . . 0.0 109.338 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -58.8 -43.86 90.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.338 -0.852 . . . . 0.0 109.783 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.8 mt -69.58 -32.63 71.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.97 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.15 -32.95 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -92.93 -51.96 4.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 87.4 m-20 -90.89 155.65 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.361 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 74.73 84.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -70.42 25.99 0.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.594 ' H ' ' C ' ' A' ' 83' ' ' ALA . 2.5 pt -47.18 -97.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -1.176 . . . . 0.0 109.312 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.408 ' H ' ' CG1' ' A' ' 85' ' ' ILE . 14.4 tt -114.55 131.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.619 HH11 ' HG2' ' A' ' 87' ' ' ARG . 8.9 mtt-85 -86.36 94.11 9.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -173.44 80.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -47.16 -33.8 5.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.938 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.01 -42.7 97.06 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -63.5 -44.53 94.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -1.193 . . . . 0.0 109.489 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.85 -43.71 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -57.16 -37.24 71.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.91 88.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.384 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.421 HG21 HD11 ' A' ' 95' ' ' ILE . 27.2 mm -57.56 -42.71 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.83 . . . . 0.0 109.44 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.561 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 26.9 mm -54.1 -50.17 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.91 -32.2 80.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 24.4 m120 -62.86 -46.91 85.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -1.177 . . . . 0.0 109.414 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.77 83.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -64.57 -39.59 94.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.4 61.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.535 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -68.8 -48.39 63.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.55 -41.48 90.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.59 -38.87 91.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.543 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -35.39 80.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.44 -29.46 68.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -51.77 -19.88 1.87 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.496 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -75.73 -17.85 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.54 63.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.39 151.13 42.48 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -1.154 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -68.43 119.35 6.35 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.636 2.224 . . . . 0.0 111.675 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -74.32 -40.19 62.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.504 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.93 -49.99 73.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 118' ' ' SER . 89.5 m-20 -57.84 -54.3 48.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 111.064 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 57.8 t80 -53.69 -42.46 68.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 111.256 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.38 -59.56 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.974 -1.079 . . . . 0.0 111.662 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 113' ' ' ALA . 59.2 p-90 -88.22 -21.28 24.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.735 -1.228 . . . . 0.0 111.122 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' VAL . 72.7 p -58.94 -28.59 66.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.825 -1.172 . . . . 0.0 109.77 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.01 -14.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.01 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 118' ' ' SER . 13.4 m -84.17 24.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.041 -1.037 . . . . 0.0 109.974 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.3 t-20 72.52 31.35 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.682 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 81.9 t60 53.05 33.47 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.539 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -142.52 106.5 5.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.558 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -46.61 151.58 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.611 2.207 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.79 143.53 29.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.723 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.3 ttm -126.76 130.38 50.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.843 . . . . 0.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.18 164.75 12.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.875 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -164.03 41.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 109.3 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.37 -176.72 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 109.67 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -76.53 -41.48 46.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.398 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.2 t -147.44 175.0 11.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.11 -32.18 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.4 p -57.46 -38.03 73.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.444 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.54 -32.01 72.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.47 131.96 89.73 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.78 138.59 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.152 2.568 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -84.59 4.25 33.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -140.96 88.47 2.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.4 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -94.9 174.8 3.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 139' ' ' THR . 35.9 Cg_exo -56.9 -42.24 66.66 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.07 74.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 t -60.97 -48.84 79.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.14 -41.36 94.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.04 89.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.2 tp -60.45 -48.27 82.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 21.3 t -55.33 -43.67 75.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -59.29 -37.87 78.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.544 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.24 -51.67 28.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 109.593 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -59.12 -41.68 88.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.09 -37.38 86.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.542 ' NH2' ' CE1' ' A' ' 115' ' ' PHE . 28.2 mtt-85 -64.15 -21.4 66.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.342 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.02 6.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 10.0 m-85 -96.1 137.08 35.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -1.116 . . . . 0.0 109.475 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -94.59 -166.98 1.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 31.6 p90 40.03 37.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 146' ' ' SER . 0.8 OUTLIER -100.52 24.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.423 179.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.21 158.93 3.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -57.82 -29.82 65.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.1 m -66.94 -44.85 79.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.7 mp -63.28 -37.79 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.15 -41.14 92.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.56 -44.01 97.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.431 -0.793 . . . . 0.0 109.337 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 22.9 t -57.71 -38.02 74.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -59.25 -41.77 89.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.399 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 57.6 mtt -63.91 -38.39 90.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.632 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -59.19 -38.94 81.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.687 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -80.44 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.542 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 37.3 t -49.96 -43.38 50.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.495 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.83 15.66 26.0 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.542 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.0 mp -51.71 -51.1 58.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.4 m -90.88 136.31 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -85.6 103.39 14.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.932 . . . . 0.0 109.447 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 63.6 t0 -96.52 115.43 27.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.526 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 51.2 m80 -159.82 15.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 175' ' ' HIS . 9.4 t 52.49 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.428 ' H ' ' CG1' ' A' ' 176' ' ' VAL . 10.4 p -94.94 -8.86 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.03 47.6 0.71 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 181' ' ' CYS . 4.8 t -146.49 170.11 17.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 109.516 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 72.1 m 53.55 -86.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.539 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.1 p -166.05 36.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 183' ' ' PRO . 27.5 t80 -90.71 117.3 67.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.545 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 84.5 Cg_endo -84.9 -171.67 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.081 2.52 . . . . 0.0 112.323 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 101.28 -5.71 55.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -107.9 23.38 14.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -1.196 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -142.9 79.89 14.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.947 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.307 -1.643 0 C-N-CA 123.007 2.471 . . . . 0.0 112.289 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mmm . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.307 0.575 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 52.4 mp0 -94.17 154.76 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.598 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.9 OUTLIER -146.71 161.08 41.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.01 161.35 30.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.56 -5.79 86.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -54.39 -33.64 59.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.483 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.03 137.08 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.591 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 17.4 p -157.53 -136.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.505 ' N ' ' OG ' ' A' ' 8' ' ' SER . 51.7 mt-30 -61.22 -147.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.533 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 53.61 74.62 0.73 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.36 -27.62 13.89 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.9 2.4 . . . . 0.0 112.108 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.17 -39.1 65.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.465 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -65.82 -53.75 35.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 pt -63.79 -33.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.355 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.28 -43.71 83.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -72.87 -44.57 61.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 109.478 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.599 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 30.0 t-80 -64.0 -49.42 72.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.84 -34.06 74.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -65.38 -69.62 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.526 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.83 119.13 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.599 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 77.7 t90 -172.65 128.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.42 83.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.2 114.91 64.83 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.4 120.48 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.75 2.3 . . . . 0.0 111.896 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -101.65 128.91 47.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.85 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.6 p -103.09 -4.4 24.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -79.71 117.81 20.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 0.0 109.367 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.0 m -59.64 -34.08 72.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 109.628 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.02 -46.23 85.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.87 -44.17 73.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.67 -47.18 82.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.835 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -60.7 -42.17 96.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.837 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -73.46 -30.46 63.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.6 tpp -63.0 -54.63 35.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 109.803 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.01 -35.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.998 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.0 m -71.92 -44.21 64.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.072 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.7 -43.32 72.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -0.994 . . . . 0.0 109.845 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.31 -31.18 70.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.788 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.3 -32.94 22.8 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.2 -29.34 70.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -1.215 . . . . 0.0 109.7 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.5 pp0? -51.92 -23.4 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.662 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.14 109.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 0.0 109.684 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.05 -32.23 5.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 23.2 mt -105.79 160.98 14.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 p -89.06 157.09 18.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.425 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -56.32 -29.6 61.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -56.16 -38.05 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.686 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.5 m -74.46 -33.14 62.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -58.27 -35.01 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.44 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.2 mt -54.69 -51.4 65.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.34 -46.32 89.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 56' ' ' TYR . 68.0 mmtt -71.18 -22.74 61.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.37 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.593 HH11 ' CG ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -59.17 -47.59 84.74 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 109.001 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 57' ' ' ARG . 78.0 mm-40 -66.6 -44.35 82.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.398 -0.814 . . . . 0.0 109.394 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.6 -32.72 71.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.245 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.643 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 60.4 t80 -64.27 -45.96 85.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.464 -0.773 . . . . 0.0 109.403 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 54' ' ' GLU . 58.4 mtm180 -58.27 -42.3 86.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.75 73.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 110.303 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.504 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 10.7 m -94.92 -12.38 26.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.065 -1.022 . . . . 0.0 110.232 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 54.6 m-85 -123.83 -43.18 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.877 -1.139 . . . . 0.0 110.218 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 57' ' ' ARG . 36.4 t-80 -49.39 -43.12 43.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -67.78 -34.43 76.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.735 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 38.5 m-85 -71.29 -44.95 64.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 5.0 t70 73.85 136.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.066 -1.021 . . . . 0.0 109.613 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -41.16 -25.67 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.864 2.376 . . . . 0.0 112.739 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.97 -47.78 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -67.25 -49.65 63.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.841 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 69' ' ' ALA . 8.3 m -55.16 -44.32 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 109.541 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -66.48 -21.49 66.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.95 . . . . 0.0 109.445 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.74 1.28 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.369 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.4 mtm -78.83 159.4 27.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.34 168.83 8.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.54 -34.04 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 109.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.52 -37.45 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.902 . . . . 0.0 109.469 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.64 -38.33 90.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.466 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.6 t -56.73 -42.97 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.625 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.97 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.336 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' CG ' HH11 ' A' ' 78' ' ' ARG . 2.7 ttt-85 -60.91 -47.04 88.25 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.458 ' O ' ' CA ' ' A' ' 84' ' ' GLY . 96.0 mt -69.68 -39.07 77.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.7 t -50.71 -33.1 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.722 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -91.69 -56.87 2.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -95.06 122.4 37.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 55.49 47.0 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.425 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -86.87 31.89 4.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.72 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 20.01 -116.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -1.13 . . . . 0.0 109.32 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.89 140.54 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -77.14 94.56 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.7 m170 -164.22 88.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.157 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -51.24 -28.71 12.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.828 . . . . 0.0 109.852 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.96 -42.5 77.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -60.88 -52.44 65.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -1.135 . . . . 0.0 109.577 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 89.3 mt -57.49 -50.73 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -57.33 -32.69 66.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.407 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.97 -40.14 94.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.6 mm -58.41 -50.95 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 109.352 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.0 mt -53.99 -48.22 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.578 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.35 -33.94 83.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 24.7 m120 -62.67 -40.43 97.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.428 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.13 -40.76 86.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HG3' ' NH1' ' A' ' 100' ' ' ARG . 48.1 ttm-85 -59.17 -41.44 88.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -37.05 67.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.594 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 17.8 t80 -73.52 -48.61 31.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 25.5 tp -58.36 -45.91 87.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.895 . . . . 0.0 109.472 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -63.33 -36.12 82.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.8 ttt -61.17 -43.17 99.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.132 -0.98 . . . . 0.0 109.459 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -71.9 -27.3 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.19 -31.93 33.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.04 0.84 34.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.21 40.1 34.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.82 82.37 49.42 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -1.182 . . . . 0.0 109.634 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -37.29 127.99 0.63 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.626 2.218 . . . . 0.0 111.732 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -63.98 -48.18 77.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.09 -41.3 71.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 110.678 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -62.42 -33.72 75.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 111.008 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.541 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 84.1 t80 -63.92 -52.55 59.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.064 -1.022 . . . . 0.0 111.241 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.4 m -58.1 -41.42 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.0 111.692 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.512 ' O ' ' N ' ' A' ' 122' ' ' HIS . 59.6 m95 -63.88 -33.55 75.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.775 -1.203 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.4 t -66.03 -34.61 78.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.81 -1.181 . . . . 0.0 109.746 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.83 -43.01 99.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.101 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.76 24.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.947 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.51 22.05 7.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.641 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 117' ' ' TRP . 84.7 t60 49.27 45.68 23.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -151.37 114.91 3.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 138.72 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.716 2.277 . . . . 0.0 111.836 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -97.58 149.7 21.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 109.762 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -135.68 148.11 48.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.121 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 13.5 t -133.51 154.93 50.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 109.82 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -110.8 44.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.86 163.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.643 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.0 m -116.23 -28.58 6.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 109.361 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 132' ' ' LEU . 1.7 t -142.06 -179.9 6.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.412 ' N ' ' OG1' ' A' ' 131' ' ' THR . 39.5 mt -64.23 -35.95 82.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -67.27 -29.57 69.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -63.15 -20.14 65.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.445 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 1.6 mp -67.04 119.83 67.25 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 109.698 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.19 130.68 5.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.065 2.51 . . . . 0.0 112.472 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.24 11.12 40.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 109.324 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 138' ' ' SER . 55.1 p -138.52 88.41 2.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.86 154.8 37.21 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.09 -32.11 94.27 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.813 2.342 . . . . 0.0 112.08 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.51 -40.89 48.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.4 p -62.51 -41.25 98.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.86 -48.08 75.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.41 82.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -47.41 84.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.85 . . . . 0.0 109.51 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.5 m -55.92 -43.62 77.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.47 -35.9 78.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.513 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.65 -52.59 36.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.952 . . . . 0.0 109.531 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.8 mp -63.58 -38.11 89.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -61.35 -39.69 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.406 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.4 -37.05 85.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.504 HH11 ' HG2' ' A' ' 152' ' ' ARG . 44.9 mtt-85 -64.32 -23.24 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.404 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.74 10.51 16.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -74.68 137.74 42.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -1.115 . . . . 0.0 109.523 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.597 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -97.97 -168.4 1.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 21.8 p90 39.53 38.32 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.509 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.1 m -97.68 24.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.52 155.18 3.98 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 57.0 m -54.91 -30.4 58.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.451 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.1 m -67.03 -47.91 69.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 mp -64.95 -37.08 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.53 -42.16 92.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.31 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.99 -43.51 98.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.3 m -57.4 -37.32 72.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 109.265 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.92 -39.94 91.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.3 mmm -66.11 -49.24 68.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.656 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.536 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 96.0 mm-40 -69.24 -41.93 76.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.715 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.54 84.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.98 -45.28 71.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.09 12.3 22.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 83.0 mt -58.64 -31.31 68.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 109.424 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.7 p -122.66 139.95 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.434 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -97.28 105.25 17.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.536 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 97.8 m-20 -94.76 97.58 10.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.506 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -139.7 150.23 44.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 m -68.75 -160.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.43 139.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.43 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 81.1 29.32 41.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.2 m -149.82 162.02 41.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.465 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 80.8 m 52.52 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.553 ' N ' ' O ' ' A' ' 179' ' ' CYS . 22.4 p -169.96 24.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' A' ' 183' ' ' PRO . 74.0 t80 -69.17 131.86 90.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.685 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.545 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 92.6 Cg_endo -80.28 -158.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 123.078 2.518 . . . . 0.0 112.397 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.514 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . 98.98 -9.84 61.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 184' ' ' GLY . 31.0 m120 -155.79 30.38 0.36 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.134 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -99.06 152.4 37.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 C-N-CA 123.123 2.549 . . . . 0.0 112.265 179.656 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.23 0.538 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -74.8 147.95 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.535 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -149.04 171.66 16.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 p -46.13 160.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.71 -0.78 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -78.26 8.69 4.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.14 130.87 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.922 . . . . 0.0 109.455 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.506 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 12.0 p -173.95 54.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 8' ' ' SER . 89.7 mm-40 -137.58 -135.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.34 153.91 4.75 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.335 -0.853 . . . . 0.0 109.448 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.7 -11.44 31.91 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.791 2.328 . . . . 0.0 112.174 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.48 -36.4 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.442 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 87.4 m-85 -73.67 -54.72 7.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.46 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.24 -48.9 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.342 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.96 87.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.59 -41.22 94.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 13' ' ' TYR . 28.1 m80 -62.99 -45.9 90.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.5 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.51 -37.26 51.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.479 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -57.94 -60.47 3.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -153.69 104.98 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.534 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -171.28 116.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.38 6.18 71.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' CYS . 2.3 t -110.68 104.12 55.5 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.245 -1.15 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.65 132.03 16.29 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.765 2.31 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.22 136.26 52.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.779 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.4 p -104.91 0.72 28.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.096 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -77.79 123.48 26.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.795 . . . . 0.0 109.35 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.44 ' OG ' ' OH ' ' A' ' 102' ' ' TYR . 83.3 p -66.84 -33.26 75.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 109.638 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -59.06 -43.54 91.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.152 -0.967 . . . . 0.0 109.771 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.57 -50.61 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.47 -38.51 77.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.16 -41.47 92.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 109.841 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.81 -31.06 63.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 109.84 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.48 -52.96 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 10.0 tp -55.1 -42.58 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.0 109.989 -178.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 30.7 p -72.81 -48.83 34.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.141 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 84.8 mt -65.75 -29.93 70.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.075 -1.016 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -51.77 -36.87 49.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.77 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.65 -29.29 61.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -59.04 -34.51 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.4 tt0 -57.68 -32.86 67.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.0 109.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 109.645 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.52 3.37 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.5 mm? -85.94 -160.01 0.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -1.192 . . . . 0.0 109.455 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 m -118.53 152.32 36.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -56.07 -33.24 64.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 0.0 109.513 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -29.56 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 109.611 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.2 m -64.78 -39.61 93.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.5 t -61.99 -38.91 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 mt -55.69 -55.13 35.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 51' ' ' LYS . 9.4 mtmp? -60.38 -45.12 94.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.325 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.599 ' HZ2' ' CG1' ' A' ' 86' ' ' ILE . 1.0 OUTLIER -68.91 -29.45 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.351 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 53' ' ' ARG . 2.5 ttt-85 -54.27 -43.08 70.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.15 -0.968 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.99 -43.78 70.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.435 -0.791 . . . . 0.0 109.376 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -43.87 88.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t80 -60.88 -44.72 96.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.389 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 42.9 ttp180 -59.68 -27.31 66.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 109.77 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.44 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.425 -0.797 . . . . 0.0 110.265 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.0 m -92.89 -20.85 20.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.133 -0.979 . . . . 0.0 110.262 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 27.9 m-85 -102.75 -52.43 3.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.976 -1.077 . . . . 0.0 110.16 -178.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t60 -54.0 -39.14 65.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.972 -1.08 . . . . 0.0 109.88 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -56.32 -37.92 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' ASP . 54.9 m-85 -91.36 3.85 53.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 0.0 109.956 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.45 162.57 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.604 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.52 -28.49 8.31 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.904 2.403 . . . . 0.0 112.746 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -62.95 -48.96 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.681 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 71' ' ' MET . 91.1 mttt -65.51 -34.58 78.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.846 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.09 -39.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -72.05 -34.31 68.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.1 16.53 22.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.361 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' LYS . 20.7 ttp -79.65 159.87 26.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.7 159.86 16.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.79 -25.17 62.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.48 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -55.68 -44.02 76.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -61.83 -38.37 87.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.08 -41.44 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.58 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.18 -38.76 84.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -68.94 -39.93 79.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.392 -0.817 . . . . 0.0 109.799 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.57 -46.45 69.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.3 t -51.78 -31.59 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.751 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.01 -57.61 3.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.515 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.79 126.37 44.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 51.89 47.05 25.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -75.85 15.56 4.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.615 ' C ' ' O ' ' A' ' 84' ' ' GLY . 3.9 pt 28.88 90.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.107 . . . . 0.0 109.346 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.599 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 79.0 mt 58.02 151.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.541 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 53.8 mtm-85 -89.01 105.39 17.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 16.8 m-70 -163.47 61.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.219 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -47.56 -35.86 9.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.33 88.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -73.41 -41.93 62.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -1.173 . . . . 0.0 109.549 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.67 -53.53 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.609 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -56.36 -33.32 65.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.977 . . . . 0.0 109.323 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.55 -37.79 79.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.38 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.19 -40.49 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.4 mt -54.41 -45.68 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.8 -37.93 93.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 4.0 m120 -58.53 -42.73 88.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -1.187 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.8 77.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 43.0 ttm-85 -59.1 -39.56 82.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.73 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.579 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.44 ' OH ' ' OG ' ' A' ' 28' ' ' SER . 20.5 t80 -59.39 -48.32 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.39 -41.5 98.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.432 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.2 -44.19 96.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 109.563 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.85 -43.18 75.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.943 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.64 -26.66 65.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -52.49 -27.34 15.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.546 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -75.95 -14.04 60.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.472 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.95 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -94.9 114.71 64.26 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.713 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -46.27 125.48 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.614 2.209 . . . . 0.0 111.698 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.89 -34.44 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.87 -49.31 59.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.176 -0.952 . . . . 0.0 110.685 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 118' ' ' SER . 86.2 m-20 -56.06 -55.63 30.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 111.079 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -56.11 -38.23 70.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 111.21 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 2.4 t -55.93 -59.64 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 111.66 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -88.97 -20.48 24.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.806 -1.184 . . . . 0.0 111.173 -178.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -60.41 -28.04 67.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.754 -1.216 . . . . 0.0 109.72 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.015 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 5.4 m -92.15 24.6 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 109.964 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 5.3 t-20 79.23 19.49 0.75 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 59.94 48.16 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.533 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.9 pt20 -154.15 147.97 18.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.92 154.78 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.652 2.234 . . . . 0.0 111.815 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 19.9 mp0 -122.83 152.85 40.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 0.0 109.725 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 61.1 mtt -136.49 155.01 50.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -135.25 158.81 43.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.924 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 128' ' ' GLN . 7.6 mp0 -117.27 47.35 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.324 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.15 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 m -83.98 -41.25 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.6 m -131.85 164.55 25.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.5 mp -69.62 -11.0 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.1 m -85.12 -35.75 21.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -12.5 61.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -178.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.414 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 85.2 mt -68.52 118.0 55.69 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.767 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.01 128.63 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.63 -19.55 48.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.336 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 m -87.42 102.65 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.328 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.426 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 26.9 p -121.34 150.31 53.99 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.96 -40.71 33.16 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.746 2.297 . . . . 0.0 112.042 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.16 -38.75 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.426 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 31.4 m -61.33 -45.46 94.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.39 -44.57 94.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -41.3 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.515 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.31 -44.36 88.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.7 t -57.48 -42.32 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -62.62 -35.24 78.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.33 -51.91 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.03 -34.35 74.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -58.37 -36.43 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -62.1 -39.28 91.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.408 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.421 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.7 mpt_? -63.79 -21.26 66.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.26 22.23 10.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.48 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 11.8 m-85 -83.27 133.4 34.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -101.67 170.33 8.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 53.35 47.88 23.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 158' ' ' GLY . 10.7 p -122.32 26.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.417 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.76 170.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.9 t -59.0 -31.63 68.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -1.169 . . . . 0.0 109.427 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -47.21 84.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.96 -39.95 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.499 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 79.9 m -67.21 -41.71 85.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.414 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 75.9 t80 -60.25 -45.39 93.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.467 -0.771 . . . . 0.0 109.348 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 m -58.85 -39.17 80.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.304 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -41.96 96.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.0 mtp -56.54 -41.7 77.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.81 -36.41 83.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.677 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.04 75.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.546 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 9.1 t -71.15 -62.89 1.23 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.466 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.17 15.32 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.546 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.4 mp -52.79 -52.36 57.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.39 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -102.24 135.66 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.94 101.73 14.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 11.3 p30 -91.76 115.63 28.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -142.23 162.15 36.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.494 ' CG2' ' HG ' ' A' ' 179' ' ' CYS . 19.5 m -115.74 144.19 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.05 -34.54 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.76 -29.1 57.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.494 ' HG ' ' CG2' ' A' ' 176' ' ' VAL . 52.7 m -82.29 146.82 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -1.216 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.2 t -65.53 -29.29 69.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 182' ' ' TYR . 30.0 p -49.74 -45.0 48.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.62 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 183' ' ' PRO . 22.9 t80 -100.89 114.83 65.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 87.9 Cg_endo -86.16 -167.45 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.11 2.54 . . . . 0.0 112.333 178.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.61 63.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -85.78 9.15 17.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -1.133 . . . . 0.0 109.586 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -145.54 78.85 11.74 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.928 . . . . 0.0 109.489 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 123.027 2.485 . . . . 0.0 112.286 -179.77 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 2' ' ' GLU . 19.3 tmm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.252 0.548 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.49 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 79.4 mm-40 -84.32 152.24 24.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.433 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HG2' ' NH1' ' A' ' 3' ' ' ARG . 7.4 tpt180 -132.64 143.68 49.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.3 m -47.07 138.25 6.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.15 22.49 12.24 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 6' ' ' TRP . 40.6 p-90 -147.09 52.85 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.0 109.475 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 p -152.07 -16.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.6 p -84.32 14.1 4.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -54.67 -39.97 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.39 159.59 1.38 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.35 -35.04 43.12 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.79 2.327 . . . . 0.0 112.14 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.7 tp -61.04 -37.8 83.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.813 . . . . 0.0 109.48 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.47 -44.5 90.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.52 -43.96 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 109.383 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.39 98.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.34 -40.82 98.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -63.59 -48.0 79.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.58 -33.14 72.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -51.53 -51.11 57.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.22 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CD2' ' N ' ' A' ' 22' ' ' GLY . 46.4 t90 -144.77 147.92 33.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.518 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 21' ' ' TRP . . . 86.39 -29.28 4.88 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 169' ' ' CYS . 32.8 m -72.15 145.64 88.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.26 120.04 6.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.778 2.319 . . . . 0.0 111.893 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.495 ' OE1' ' SG ' ' A' ' 169' ' ' CYS . 74.3 mt-10 -95.33 128.04 41.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.952 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -133.98 -3.08 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.058 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -81.44 137.08 35.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.495 ' HG ' ' N ' ' A' ' 29' ' ' LYS . 54.7 p -61.91 -38.12 87.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.585 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' N ' ' HG ' ' A' ' 28' ' ' SER . 69.0 mttm -67.94 -49.37 62.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -64.61 -38.68 91.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.845 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -33.97 65.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -65.17 -48.13 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.878 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -65.61 -30.41 71.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.821 -178.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.5 tpt -70.72 -53.37 15.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.19 -34.11 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.994 -178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -72.18 -49.52 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 110.123 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.3 -39.5 78.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 50.4 mm-40 -57.08 -35.87 69.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.66 -31.25 57.55 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -63.75 -31.52 72.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.237 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 38' ' ' GLU . 5.1 pt20 -52.64 -23.44 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 -179.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.19 108.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.965 . . . . 0.0 109.665 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.9 -33.3 2.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.4 mm? -87.69 169.52 12.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.5 p -82.11 165.01 20.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -67.81 -35.29 78.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.506 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.19 -39.1 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.639 -179.7 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.427 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 92.5 m -49.92 -35.76 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.645 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.45 -29.81 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.49 -56.47 9.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -60.92 -37.29 81.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.152 -0.967 . . . . 0.0 109.265 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' TYR . 53.1 tttm -73.91 -26.69 60.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -57.7 -48.9 78.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.242 -0.911 . . . . 0.0 108.989 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.32 -47.69 69.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.841 . . . . 0.0 109.284 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.61 -34.54 78.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 29.7 t80 -59.47 -47.43 85.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.321 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -57.1 -30.85 64.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.779 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.04 93.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.7 m -94.32 -13.1 26.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.072 -1.017 . . . . 0.0 110.262 -178.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 43.2 m-85 -111.26 -52.78 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.937 -1.102 . . . . 0.0 110.201 -178.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -52.94 -36.96 60.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 109.87 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -55.55 -33.7 64.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.3 m-85 -97.08 4.9 51.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 0.0 109.864 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.22 164.52 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.04 -1.038 . . . . 0.0 109.609 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.37 -34.06 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.869 2.379 . . . . 0.0 112.713 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.93 -49.12 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' MET . 46.4 mtpt -65.1 -35.17 80.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.84 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.81 -40.3 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 109.557 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -35.49 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.913 . . . . 0.0 109.462 179.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.39 15.31 26.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.1 tmm? -83.86 149.64 26.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.406 ' O ' ' SD ' ' A' ' 71' ' ' MET . 14.9 pt20 -102.97 167.04 10.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.42 -28.12 69.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -56.54 -44.36 80.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.497 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.57 -38.72 81.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.98 -45.64 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.02 -31.63 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -68.0 -48.47 65.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.336 -0.853 . . . . 0.0 109.795 -178.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' CD1' ' C ' ' A' ' 79' ' ' LEU . 1.3 pp -80.5 -20.13 44.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.635 -178.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.0 t -54.35 -45.14 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.908 . . . . 0.0 109.774 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -58.04 -50.54 73.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.498 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -99.67 107.05 19.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 178.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.09 74.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.41 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.41 -23.89 4.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' GLY . 21.2 pt -56.46 -164.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 109.352 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.28 136.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -92.44 96.52 10.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CD2' ' HZ2' ' A' ' 91' ' ' LYS . 29.4 m-70 -165.69 87.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.571 HH11 ' HG2' ' A' ' 89' ' ' ARG . 1.4 ptt-85 -47.31 -29.34 2.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.992 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.03 97.89 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' HZ2' ' CD2' ' A' ' 88' ' ' HIS . 62.3 mttp -62.61 -45.07 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.451 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 98.3 mt -56.8 -42.2 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.576 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -60.27 -37.82 81.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.12 78.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mm -62.57 -40.92 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -57.04 -40.67 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.8 -40.68 99.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -57.38 -47.65 81.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.458 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.71 -42.84 85.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -63.88 -43.71 95.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.88 -38.1 58.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -66.63 -48.6 68.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.43 -42.49 87.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.46 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.55 -41.97 87.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.576 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -40.4 96.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.68 -27.07 64.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -51.99 -17.73 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.487 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 78.5 m-20 -74.88 -16.25 60.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.04 19.2 65.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.3 mp0 -115.87 151.93 46.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.188 -1.184 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.06 123.53 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.535 2.156 . . . . 0.0 111.696 179.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -76.18 -43.48 42.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 110.43 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -60.69 -49.85 75.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.095 -1.003 . . . . 0.0 110.704 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -51.56 -36.36 44.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 111.019 -178.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.39 -47.92 21.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 111.207 -177.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 2.9 p -56.34 -46.52 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.017 . . . . 0.0 111.653 -175.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.553 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 16.9 p-90 -88.18 -27.85 21.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.745 -1.222 . . . . 0.0 111.131 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 120' ' ' VAL . 10.2 t -56.08 -29.26 60.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.871 -1.143 . . . . 0.0 109.772 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.25 -13.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' SER . 14.1 m -82.54 24.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.051 -1.03 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.599 ' C ' ' H ' ' A' ' 123' ' ' GLN . 13.6 t-20 74.17 17.21 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 109.68 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER 66.68 -13.35 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' A' ' 121' ' ' ASN . 23.2 mt-30 -86.37 150.61 52.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.72 149.59 73.4 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.631 2.221 . . . . 0.0 111.849 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -110.27 145.66 37.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.3 mtt -135.84 152.55 51.18 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.173 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.6 t -94.73 160.65 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.29 49.63 1.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 109.317 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.99 135.05 42.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.682 -179.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.8 m -76.05 -34.29 59.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.32 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.3 m -127.34 159.22 35.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.7 mt -56.26 -30.89 63.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' A' ' 134' ' ' GLU . 85.7 p -71.81 -29.94 64.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.43 ' N ' ' HG ' ' A' ' 133' ' ' SER . 95.8 mt-10 -75.82 1.12 15.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.11 119.81 67.29 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.766 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.92 130.05 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.144 2.562 . . . . 0.0 112.544 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 t -104.63 12.58 32.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.268 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -139.0 92.41 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 161.64 22.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.9 -39.55 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.829 2.352 . . . . 0.0 111.975 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.59 73.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.2 m -59.95 -45.97 90.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.26 -42.2 99.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.38 -43.2 67.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -60.55 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -53.84 -43.27 69.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -62.45 -33.74 75.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.49 -51.19 38.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -33.16 72.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.589 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -58.36 -39.23 79.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.356 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.99 -40.48 97.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 109.443 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.45 -20.46 66.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.18 32.42 7.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.43 132.11 37.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.94 174.85 6.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 53.24 48.03 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLY . 5.4 m -115.2 26.22 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.07 167.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.35 -28.31 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -1.158 . . . . 0.0 109.417 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -70.32 -41.26 73.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.425 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.6 mp -65.43 -47.82 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.0 p -64.28 -38.81 92.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.263 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.542 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 53.7 t80 -62.26 -46.5 88.54 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -61.6 -37.86 85.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.275 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -61.71 -55.07 34.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 179.692 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.455 ' N ' ' CG ' ' A' ' 165' ' ' PHE . 48.0 mtm -63.72 -41.31 98.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.646 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -66.41 -42.92 87.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 -42.32 75.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 109.697 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' ' OE1' ' A' ' 25' ' ' GLU . 3.5 m -60.91 -61.1 2.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.413 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 144.31 1.78 0.89 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' A' ' 171' ' ' LEU . 4.3 mm? -57.43 -43.12 83.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 109.396 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.75 136.57 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -87.95 112.58 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.429 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 80.7 m-20 -86.82 110.02 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.532 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 58.8 m-70 -153.8 126.69 8.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.558 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.26 137.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.75 135.68 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.43 5.71 60.22 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 16.4 p -77.15 -150.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.491 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.53 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 71.9 m -57.85 -39.6 78.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 0.9 OUTLIER 173.15 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.979 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 182' ' ' TYR . 0.3 OUTLIER -118.17 94.93 47.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.519 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 95.4 Cg_endo -87.28 -166.63 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 123.024 2.482 . . . . 0.0 112.416 178.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 93.78 8.23 60.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -142.92 32.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -1.161 . . . . 0.0 109.624 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -138.56 78.8 31.1 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--N 1.306 -1.707 0 C-N-CA 123.071 2.514 . . . . 0.0 112.237 -179.924 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -90.27 145.83 24.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -148.8 154.32 39.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.881 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' ARG . 14.2 m 55.76 167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.0 109.397 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.93 -29.13 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -72.85 -0.0 12.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' SER . 7.1 p -108.88 134.72 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 167.27 0.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -79.26 -130.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.877 . . . . 0.0 109.484 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 152.08 14.28 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.96 -11.47 32.33 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.863 2.376 . . . . 0.0 112.137 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.28 -38.72 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.497 ' HH ' ' CB ' ' A' ' 47' ' ' ILE . 87.9 m-85 -59.82 -47.93 83.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.7 mt -66.64 -41.6 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.359 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -46.84 87.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -66.97 -41.46 86.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -59.97 -42.18 93.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.87 -10.71 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -78.29 -76.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.433 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.44 101.53 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -170.04 126.47 0.83 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.69 -29.15 8.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.5 m -72.17 149.33 91.85 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.23 -1.159 . . . . 0.0 109.32 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.43 119.29 6.3 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.776 2.317 . . . . 0.0 111.89 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -112.67 132.87 54.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.804 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 p -134.87 3.06 3.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.029 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -80.72 122.37 27.04 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.364 -0.835 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 t -58.69 -39.81 81.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.25 -43.22 82.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.723 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.35 -50.77 50.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.81 -35.72 79.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.881 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.88 -45.59 93.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -74.61 -31.27 61.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.77 -179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.7 ttm -71.67 -54.59 9.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.723 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 2.9 tp -59.37 -40.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 0.0 110.035 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 76.7 m -72.76 -46.43 53.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.123 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD2' ' NH1' ' A' ' 53' ' ' ARG . 9.6 tp -69.8 -33.71 72.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.01 . . . . 0.0 109.863 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -52.15 -34.94 46.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.803 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.53 ' C ' ' HZ3' ' A' ' 91' ' ' LYS . . . -52.23 -27.0 22.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.15 -31.94 72.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -1.22 . . . . 0.0 109.777 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.62 -26.34 63.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.965 . . . . 0.0 109.728 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.59 109.08 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.694 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.91 -29.95 4.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.3 mt -100.45 163.73 12.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.429 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -87.39 164.86 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.384 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -59.38 -40.95 88.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 109.505 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.497 ' CB ' ' HH ' ' A' ' 13' ' ' TYR . 9.0 tp -54.53 -39.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.653 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.8 m -61.37 -36.27 79.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -69.75 -40.1 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.2 mt -57.12 -54.92 41.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -57.62 -47.41 82.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -68.66 -29.86 68.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttm-85 -50.74 -47.11 59.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 108.987 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.35 -43.68 73.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.515 -0.741 . . . . 0.0 109.406 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -67.12 -37.3 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 0.0 109.229 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 7.5 t80 -63.19 -43.89 96.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.374 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 61' ' ' HIS . 43.7 mtt-85 -58.41 -39.2 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.31 77.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.47 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 85.6 m -92.39 -12.92 30.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 110.244 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 5.9 m-85 -115.97 -49.09 2.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.932 -1.105 . . . . 0.0 110.153 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.4 t60 -49.86 -42.48 47.72 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.066 -1.021 . . . . 0.0 109.877 -178.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -65.15 -30.14 71.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.789 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.434 ' O ' ' O ' ' A' ' 64' ' ' ASP . 50.2 m-85 -88.13 -0.2 56.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.833 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 56.14 165.65 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.049 -1.032 . . . . 0.0 109.596 -179.747 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 68' ' ' VAL . 72.6 Cg_endo -78.72 -54.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.832 2.355 . . . . 0.0 112.709 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 t -47.22 -33.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -68.7 -44.11 74.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.341 -0.849 . . . . 0.0 109.827 -177.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 65' ' ' PRO . 1.4 m -56.99 -39.92 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.616 -178.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -64.18 -39.37 93.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.473 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.93 23.54 7.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 109.373 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' A' ' 72' ' ' GLN . 11.5 ttp -93.53 160.37 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 109.626 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' H ' ' HG3' ' A' ' 71' ' ' MET . 95.2 mt-30 -101.46 166.5 10.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.3 mt-10 -70.52 -21.93 62.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.13 -31.15 65.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.94 . . . . 0.0 109.468 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.05 -38.23 87.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.424 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 10.5 m -73.57 -29.32 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -67.11 -36.38 81.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 -178.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 13.3 ptm180 -77.87 -41.9 35.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.491 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 1.2 pp -81.46 -7.13 59.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.953 . . . . 0.0 109.637 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 81' ' ' GLN . 9.3 p -49.37 -42.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.688 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.494 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 2.8 pp0? -90.42 20.91 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.006 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.1 t0 -74.94 121.39 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.378 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.54 0.34 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 65.65 43.3 94.6 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -58.55 -165.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.9 tt -56.02 127.89 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -73.24 95.41 2.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.478 ' ND1' ' H ' ' A' ' 91' ' ' LYS . 1.9 t-80 -171.83 69.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -45.02 -36.15 3.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.904 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.03 98.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.53 ' HZ3' ' C ' ' A' ' 39' ' ' GLY . 33.8 tptt -62.43 -43.23 99.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.478 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 mt -54.64 -50.56 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.62 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.89 -30.61 69.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.985 . . . . 0.0 109.384 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -58.78 -44.47 90.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.467 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.9 mp -56.28 -39.8 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.81 -29.23 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.77 -45.13 77.4 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -64.86 -38.02 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -1.185 . . . . 0.0 109.428 -178.548 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.59 80.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -59.53 -43.87 93.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.36 -30.41 66.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.93 -47.25 87.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.28 -44.77 86.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.94 -44.68 94.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.482 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.42 ' SD ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.61 -41.61 79.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -71.45 -27.4 63.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.485 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -52.56 -23.26 6.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.425 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -75.35 -13.11 60.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.84 48.8 6.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -135.34 150.93 73.9 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.187 -1.184 . . . . 0.0 109.653 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.23 119.14 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.571 2.181 . . . . 0.0 111.677 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -75.28 -40.76 58.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.439 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 -48.17 69.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 110.725 -178.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 118' ' ' SER . 44.3 t0 -55.1 -55.28 32.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 111.096 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -55.66 -38.59 69.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 111.249 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.97 -59.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 0.0 111.646 -178.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -87.79 -28.1 21.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.663 -1.273 . . . . 0.0 111.125 -177.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 120' ' ' VAL . 94.1 p -56.34 -26.03 51.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.816 -1.178 . . . . 0.0 109.769 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.47 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.056 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 118' ' ' SER . 10.7 m -89.56 25.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 23.8 t30 80.01 22.06 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.696 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 59.46 49.75 8.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.499 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -154.61 146.46 17.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.37 143.36 43.1 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.642 2.228 . . . . 0.0 111.778 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -100.25 151.35 21.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 109.746 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -136.03 156.89 48.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.176 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 t -129.82 164.12 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.856 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.497 ' OE1' ' ND2' ' A' ' 185' ' ' ASN . 94.2 mt-30 -133.16 50.88 2.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.23 142.2 27.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.704 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 m -92.43 -27.69 17.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 109.361 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -126.15 156.73 39.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -57.88 -34.76 70.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 m -62.35 -36.67 82.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.67 -28.84 70.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.1 mt -67.08 116.55 37.06 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.11 130.19 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.11 2.54 . . . . 0.0 112.503 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.75 -8.15 58.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.5 p -101.05 101.84 12.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.378 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.513 ' HG1' ' H ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -119.82 151.78 52.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.588 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.31 -33.84 97.81 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.75 2.3 . . . . 0.0 112.009 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.89 -35.2 57.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.359 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.513 ' H ' ' HG1' ' A' ' 139' ' ' THR . 82.9 p -62.8 -34.62 77.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.92 -51.01 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.43 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.429 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 0.3 OUTLIER -55.68 -50.14 71.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.6 t -63.81 -42.49 97.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -60.7 -36.98 80.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.03 -51.63 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -32.94 74.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.512 ' HZ1' ' CG1' ' A' ' 157' ' ' VAL . 14.9 mmtm -59.84 -38.37 81.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.397 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -61.72 -36.93 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -69.04 -19.81 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.24 27.16 9.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -1.121 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -112.43 169.37 8.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 51.6 50.78 18.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.512 ' CG1' ' HZ1' ' A' ' 150' ' ' LYS . 9.0 p -120.14 27.05 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.414 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.95 159.46 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 33.5 m -53.2 -29.63 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -1.195 . . . . 0.0 109.492 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.2 p -62.42 -42.26 99.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.5 mp -63.95 -47.61 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.84 -42.61 99.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.306 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.15 -45.13 91.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.461 -0.774 . . . . 0.0 109.357 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.5 m -62.72 -40.25 96.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.306 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.441 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -61.6 -35.13 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 179.342 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -65.39 -52.47 53.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -38.22 84.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.31 -0.869 . . . . 0.0 109.681 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.96 85.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.694 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.522 ' O ' ' O ' ' A' ' 23' ' ' VAL . 64.5 m -81.45 -62.44 1.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.373 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.52 2.74 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.88 -47.51 43.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.26 136.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.404 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -100.76 108.14 19.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 38.5 p30 -116.95 92.22 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -108.72 9.37 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 179' ' ' CYS . 4.2 t 56.59 101.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.3 p -54.99 -34.84 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.38 -44.1 97.34 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.531 ' C ' ' H ' ' A' ' 181' ' ' CYS . 12.4 t -105.37 -178.85 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.55 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 12.1 t 55.09 5.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.875 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 8.7 p 42.22 25.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 1.4 t80 -67.02 117.38 45.22 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 109.572 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.567 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.4 Cg_endo -83.17 -155.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 123.121 2.547 . . . . 0.0 112.369 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.24 57.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' ND2' ' OE1' ' A' ' 128' ' ' GLN . 21.2 t-20 -149.59 32.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -1.131 . . . . 0.0 109.586 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -83.61 153.12 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.306 -1.686 0 C-N-CA 123.021 2.48 . . . . 0.0 112.284 179.916 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mmt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.267 0.556 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' OE1' ' SG ' ' A' ' 179' ' ' CYS . 95.2 mt-10 -89.24 153.95 20.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 3' ' ' ARG . 4.4 ptm180 -148.44 171.79 15.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.8 m -47.93 112.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -71.39 -29.34 68.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -53.41 -7.97 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.466 -179.647 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 5' ' ' GLY . 12.7 p -56.66 134.43 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 t -65.66 140.84 58.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -64.83 -31.45 72.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.38 143.82 6.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -32.3 9.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.829 2.353 . . . . 0.0 112.14 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.01 -41.95 99.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.23 -45.62 76.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.413 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.69 -43.97 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 19' ' ' ASN . . . -62.84 -43.92 97.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.447 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 74.0 t80 -62.41 -41.64 98.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.8 t-80 -61.92 -45.32 94.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -79.95 -47.43 15.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' ALA . 17.0 t-20 -56.55 -42.73 79.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.527 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' HIS . 77.4 mm-40 -138.62 -150.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.463 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 20' ' ' GLU . 11.0 t90 59.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.32 72.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.89 115.39 64.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.215 -1.168 . . . . 0.0 109.423 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.99 121.69 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.758 2.305 . . . . 0.0 111.851 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -117.95 136.17 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.854 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 p -121.26 6.47 10.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.9 . . . . 0.0 109.042 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.287 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 32' ' ' PHE . 15.1 m -74.61 -32.61 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -59.11 -52.4 65.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 109.753 -178.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -64.17 -43.42 95.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.872 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.32 -31.88 62.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.816 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 28' ' ' SER . 47.7 t80 -62.81 -47.78 81.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.95 . . . . 0.0 109.854 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.1 pp20? -75.2 -30.19 60.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 8.1 tpt -66.78 -53.12 36.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -63.06 -33.21 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 83.5 m -71.2 -49.49 42.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.31 -35.93 66.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 32.3 mm-40 -53.93 -33.05 55.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.786 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.81 97.7 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 36' ' ' CYS . 2.8 mp0 -70.0 -24.79 63.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.807 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -45.28 -27.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -178.894 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.77 123.86 7.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.31 -29.77 4.68 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.34 -166.46 1.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -123.83 152.25 42.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -53.78 -39.88 65.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -63.58 -39.4 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.684 -179.182 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.511 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 88.2 m -66.46 -36.74 83.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.719 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.13 -44.85 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.395 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.5 mt -60.61 -46.62 89.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.62 -50.72 71.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.306 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HZ3' ' CG2' ' A' ' 48' ' ' THR . 1.4 mptm? -68.1 -32.65 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.337 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' NH1' ' CE1' ' A' ' 16' ' ' TYR . 43.3 ttm180 -50.42 -44.32 55.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 108.94 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.29 -43.63 63.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 109.394 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -64.69 -40.71 95.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 2.6 m-85 -55.85 -47.15 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.366 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 4.0 mmp_? -59.78 -34.7 73.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.416 -0.802 . . . . 0.0 109.82 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.94 -35.66 73.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 30.2 p -94.1 -36.16 12.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.005 . . . . 0.0 110.266 -179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 -48.03 9.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.926 -1.109 . . . . 0.0 110.2 -178.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 56.9 t60 -50.23 -39.12 43.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.0 . . . . 0.0 109.848 -178.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -56.53 -35.09 67.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' ASP . 62.8 m-85 -95.78 1.89 53.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.913 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.12 162.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 0.0 109.632 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.06 -27.6 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.88 2.386 . . . . 0.0 112.64 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -49.25 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' MET . 7.2 mtpm? -67.29 -33.11 74.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.78 -41.81 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -71.02 -34.64 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.61 17.62 20.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 16.2 ttp -77.79 157.75 29.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.654 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.72 159.96 15.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 48.0 mp0 -60.36 -25.87 66.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.493 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.53 -43.2 93.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 15.9 t70 -61.01 -38.69 86.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.36 -42.99 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.47 -38.35 80.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -63.29 -41.96 99.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.806 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 82' ' ' ASP . 96.4 mt -67.35 -34.34 77.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.69 -33.12 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -86.94 -57.24 3.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.522 ' O ' ' O ' ' A' ' 79' ' ' LEU . 84.1 m-20 -80.04 170.62 16.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 74.14 87.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -61.42 8.64 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.624 ' H ' ' C ' ' A' ' 83' ' ' ALA . 14.0 pt -57.57 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -1.184 . . . . 0.0 109.362 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 76.0 mt -68.02 133.58 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 109.457 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.556 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 38.6 ttm180 -97.79 108.9 21.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.8 m-70 -164.55 85.37 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.515 HH11 ' HG2' ' A' ' 89' ' ' ARG . 19.5 ttt-85 -48.71 -30.51 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.783 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.69 -47.37 68.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.95 -45.09 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -1.212 . . . . 0.0 109.526 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.7 mt -55.88 -44.79 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -58.29 -37.77 75.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.398 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.92 84.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -44.77 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 96' ' ' ILE . 95.8 mt -56.81 -42.34 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.525 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.45 -37.43 94.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 2.9 m120 -61.4 -43.07 99.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.84 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG3' ' NH1' ' A' ' 100' ' ' ARG . 47.9 ttm-85 -63.9 -46.64 83.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.22 77.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.555 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 24.9 t80 -62.95 -41.71 99.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.24 -39.63 87.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.75 -41.3 86.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 51.9 mmm -63.69 -39.56 94.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.11 -27.05 64.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.412 ' O ' ' OE1' ' A' ' 107' ' ' GLN . 1.1 tm0? -51.42 -35.31 38.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -83.46 -3.51 57.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.08 74.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.5 146.88 40.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.144 -1.21 . . . . 0.0 109.644 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.72 124.81 11.47 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.63 2.22 . . . . 0.0 111.713 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -78.33 -45.31 22.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.456 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -55.44 -44.4 76.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.74 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.511 ' O ' ' OG ' ' A' ' 118' ' ' SER . 91.2 m-20 -57.65 -45.55 85.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 111.055 -178.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -60.16 -49.33 78.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.014 -1.053 . . . . 0.0 111.23 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 7.0 m -60.37 -46.65 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 111.731 -176.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.492 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 3.3 p-90 -88.7 -37.26 15.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.733 -1.23 . . . . 0.0 111.1 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 120' ' ' VAL . 41.4 m -56.96 -25.29 57.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.807 -1.183 . . . . 0.0 109.698 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.18 -14.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.022 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.8 m -85.04 23.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m120 58.27 40.27 24.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.752 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.24 14.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -114.65 120.52 37.5 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.59 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.22 153.32 31.6 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.648 2.232 . . . . 0.0 111.86 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -102.53 149.89 23.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.8 mtt -136.61 156.6 48.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 t -117.12 159.57 22.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.885 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.46 53.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.78 -143.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 m -141.76 -30.2 0.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.922 . . . . 0.0 109.353 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -123.48 156.31 35.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.16 -32.57 74.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.1 p -66.66 -33.18 75.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.41 -25.12 67.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 135' ' ' ILE . 32.3 mm -66.51 116.99 39.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.728 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.25 133.54 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.068 2.512 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.59 -9.68 53.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.9 p -96.95 102.21 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.384 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -117.67 152.91 50.37 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.387 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.01 -41.82 25.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.741 2.294 . . . . 0.0 112.041 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.65 61.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.06 -43.3 92.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.61 -38.8 80.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.63 -45.63 93.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.202 -0.936 . . . . 0.0 109.498 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.3 t -58.14 -41.75 84.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -61.79 -39.15 90.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.549 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -48.31 71.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.0 mt -59.68 -35.22 74.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.07 -41.1 82.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.396 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -64.38 -37.81 88.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.593 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 24.4 mmt180 -65.23 -20.62 66.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.346 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.76 29.2 10.97 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 4.0 m-85 -92.16 130.59 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 156' ' ' PHE . 72.9 tttt -93.43 170.33 9.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.45 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 55.2 m-85 57.64 50.86 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.09 28.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.13 159.77 0.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.4 m -52.43 -32.41 39.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -1.172 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.5 m -66.37 -36.54 83.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.36 -44.14 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.513 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 85.7 m -61.04 -41.64 96.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.618 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 42.9 t80 -60.12 -50.59 73.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.306 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.8 m -60.99 -39.25 88.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -64.36 -44.83 90.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.469 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 40.1 mmm -64.69 -41.83 95.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.632 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CE2' ' A' ' 163' ' ' TYR . 42.0 mt-30 -63.47 -43.67 96.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 -179.424 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.46 -45.0 92.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.674 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.7 t -61.65 -23.24 65.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.26 7.88 58.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.1 mp -63.24 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.411 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.21 130.79 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.431 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -94.03 108.54 20.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -88.28 112.06 22.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -138.18 134.93 35.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.88 136.91 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.15 134.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.21 -0.85 72.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.52 ' C ' ' H ' ' A' ' 181' ' ' CYS . 65.9 m -151.74 -178.14 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.565 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.5 t 54.3 6.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 179' ' ' CYS . 2.2 m 69.52 37.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.609 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 16.2 t80 -124.37 80.58 59.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.58 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.84 9.11 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.023 2.482 . . . . 0.0 112.351 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.34 10.24 78.52 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.05 38.06 28.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.53 ' HZ1' ' CB ' ' A' ' 186' ' ' LYS . 8.8 mtmp? -145.47 79.63 11.33 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.985 . . . . 0.0 109.536 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 C-N-CA 123.122 2.548 . . . . 0.0 112.234 -179.88 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 14.1 tm-20 -148.21 145.31 28.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 73.5 mtm180 -126.24 145.8 50.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 p -47.63 163.5 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.43 -7.24 88.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -55.59 -29.13 58.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -1.12 . . . . 0.0 109.392 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 8' ' ' SER . 6.3 p -98.66 126.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER 166.28 72.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -156.36 -128.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.523 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -84.61 152.19 59.81 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.9 -26.72 3.54 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.8 2.333 . . . . 0.0 112.132 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.1 tp -63.18 -44.74 94.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.78 -46.76 71.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.7 -43.96 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.39 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.11 99.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -63.13 -37.46 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLU . 83.7 t60 -58.0 -51.24 70.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.71 -37.93 85.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.527 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.455 ' N ' HD21 ' A' ' 19' ' ' ASN . 2.6 m120 -60.22 -51.86 67.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.469 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.1 mm-40 -142.96 -132.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.478 ' CH2' ' OD2' ' A' ' 174' ' ' ASP . 27.8 t90 58.92 116.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.17 5.59 67.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -120.04 96.01 49.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.293 -1.122 . . . . 0.0 109.412 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.71 120.02 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.738 2.292 . . . . 0.0 111.853 -179.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -95.58 134.53 38.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.863 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.4 p -112.7 0.16 15.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.83 121.0 24.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.647 ' HG ' ' H ' ' A' ' 113' ' ' ALA . 52.0 m -61.57 -38.64 88.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.907 . . . . 0.0 109.627 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -59.93 -55.38 34.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -69.39 -43.51 73.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.935 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.95 -39.28 94.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.842 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.412 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 62.2 t80 -63.0 -34.92 78.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.911 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -74.17 -30.22 62.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.955 . . . . 0.0 109.874 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.552 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 55.0 ttm -64.94 -53.99 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.965 . . . . 0.0 109.785 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 36' ' ' CYS . 3.3 tp -65.19 -39.29 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.032 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 5.7 t -72.89 -40.89 65.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.67 -40.07 94.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 109.822 -178.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' OE2' ' N ' ' A' ' 165' ' ' PHE . 82.5 mt-10 -54.21 -28.7 42.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.772 -179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.15 -39.1 19.43 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -67.79 -30.87 70.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -1.211 . . . . 0.0 109.711 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.9 tt0 -52.64 -35.94 55.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 109.721 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.54 116.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -31.4 6.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.81 -145.0 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -1.189 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 t -148.23 155.41 41.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -50.4 -41.91 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.908 . . . . 0.0 109.514 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 48' ' ' THR . 9.6 tp -52.1 -43.06 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.645 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.451 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 63.1 m -71.64 -33.78 69.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.4 t -58.8 -39.37 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.47 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -53.92 -54.37 39.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.511 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.64 -40.14 82.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -77.28 -19.26 56.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.624 ' NH1' ' NH2' ' A' ' 57' ' ' ARG . 1.2 ttt-85 -60.97 -46.96 88.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.171 -0.956 . . . . 0.0 109.013 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -74.02 -41.33 62.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.363 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -67.44 -45.03 77.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.25 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 42.6 t80 -62.87 -38.13 89.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.42 -0.8 . . . . 0.0 109.284 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.624 ' NH2' ' NH1' ' A' ' 53' ' ' ARG . 48.6 ttm-85 -57.27 -38.49 73.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.31 -22.47 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.26 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.507 ' SG ' ' CB ' ' A' ' 83' ' ' ALA . 63.9 m -92.45 -13.55 29.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.222 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 55.8 m-85 -127.21 -53.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.935 -1.103 . . . . 0.0 110.173 -178.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -57.71 -42.46 83.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -178.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -53.8 -35.14 61.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' ASP . 92.7 m-85 -91.43 8.98 33.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.0 109.908 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER 56.42 156.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 -179.45 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.4 -28.15 39.41 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.853 2.369 . . . . 0.0 112.68 -178.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.35 -49.19 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -67.98 -31.46 71.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.61 -41.12 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.586 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.27 64.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.62 14.63 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.426 ' O ' ' OE1' ' A' ' 72' ' ' GLN . 7.7 mmm -54.83 -176.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.668 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 71' ' ' MET . 15.8 mm100 -136.74 159.15 42.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.2 mt-10 -61.39 -34.97 76.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -72.1 -28.37 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.44 -47.96 65.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 -179.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 73' ' ' GLU . 6.9 m -60.35 -38.08 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.32 -36.99 81.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -65.38 -39.66 92.53 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 109.769 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.35 -31.84 72.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.603 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.5 t -56.25 -34.9 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.71 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -96.38 -33.94 11.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 84' ' ' GLY . 93.1 m-20 -86.75 138.49 31.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.368 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.507 ' CB ' ' SG ' ' A' ' 59' ' ' CYS . . . 70.03 -21.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 47.07 27.49 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 86' ' ' ILE . 6.2 pt -56.35 83.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.334 179.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 85' ' ' ILE . 85.1 mt 57.04 145.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.489 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.1 OUTLIER -101.64 111.64 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.535 ' N ' ' HD1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.58 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.165 179.753 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 89' ' ' ARG . 35.0 ttt-85 -46.87 -36.81 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.39 95.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -67.3 -44.49 79.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.5 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.1 mt -58.52 -49.44 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.551 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -53.57 -34.82 59.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.419 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.4 mm -60.39 -45.37 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mm -55.55 -51.99 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.84 72.67 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.655 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.35 -37.34 77.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -1.188 . . . . 0.0 109.378 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.655 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -71.08 -35.68 71.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.65 -42.49 92.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.2 -32.11 68.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.412 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 32.4 t80 -66.24 -44.03 84.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.86 -40.25 96.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -60.5 -37.84 82.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.519 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.55 -34.25 77.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -68.76 -27.52 65.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -52.17 -27.84 15.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.16 -15.15 60.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.2 17.25 78.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -96.63 149.7 36.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.247 -1.149 . . . . 0.0 109.634 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.14 119.16 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.623 2.216 . . . . 0.0 111.69 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -71.29 -39.94 71.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.822 . . . . 0.0 110.446 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.647 ' H ' ' HG ' ' A' ' 28' ' ' SER . . . -61.72 -50.31 72.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.976 . . . . 0.0 110.771 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' O ' ' OG ' ' A' ' 118' ' ' SER . 29.1 t0 -55.57 -54.13 47.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -0.918 . . . . 0.0 111.081 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -53.85 -43.06 69.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 111.217 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.57 -60.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.097 . . . . 0.0 111.638 -177.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' O ' ' A' ' 113' ' ' ALA . 67.1 p-90 -88.24 -19.28 27.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.787 -1.196 . . . . 0.0 111.141 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 120' ' ' VAL . 34.0 m -56.09 -30.09 61.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.763 -1.21 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.43 -11.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 110.049 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.2 m -86.02 24.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 109.991 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 17.3 t30 77.1 20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 62.38 29.64 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.903 . . . . 0.0 109.568 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -148.01 143.38 17.58 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.593 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.03 142.24 61.03 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.585 2.19 . . . . 0.0 111.833 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.93 155.66 22.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.0 ptp -135.28 156.49 48.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.155 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 t -118.36 155.67 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 109.872 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -115.95 45.04 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.304 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.15 135.12 47.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.872 . . . . 0.0 109.653 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.673 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 9.1 m -88.29 -32.98 18.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.57 166.31 22.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.7 mt -74.27 -8.73 57.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.567 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -87.81 -31.98 19.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.527 -177.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.673 ' CD ' ' H ' ' A' ' 130' ' ' THR . 8.5 pt-20 -86.93 9.96 17.75 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -178.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.16 119.85 62.33 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.756 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.04 120.95 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.179 2.586 . . . . 0.0 112.482 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 t -97.29 21.65 9.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.318 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.6 p -129.61 66.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.375 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.62 153.39 52.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.463 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.85 -30.74 92.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.754 2.303 . . . . 0.0 112.04 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.26 -38.11 51.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.37 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -62.42 -48.6 78.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -64.96 -41.1 95.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.57 86.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.2 tp -59.14 -48.63 80.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.511 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -54.67 -45.61 73.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -60.3 -35.04 74.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.88 -50.55 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.451 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.92 -38.63 91.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.81 -26.5 68.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.78 -40.03 86.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -74.07 -20.17 60.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.22 29.46 7.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.34 137.54 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.519 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -102.1 175.36 5.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 53.4 47.3 24.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 158' ' ' GLY . 7.7 p -122.66 26.54 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.1 167.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.521 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 55.4 m -58.19 -30.41 66.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 0.0 109.435 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 62.9 p -62.26 -42.07 99.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 1.5 mp -65.64 -46.81 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.53 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 12.3 p -63.01 -39.61 95.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.282 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 34.1 t80 -62.67 -47.83 81.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.5 p -59.5 -41.85 90.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.286 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.594 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 1.1 t80 -61.83 -27.04 68.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 178.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -53.56 27.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.682 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -67.89 -36.28 79.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.686 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.649 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 41.7 m -78.59 -64.34 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.37 9.12 2.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mp -50.96 -52.62 40.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -1.134 . . . . 0.0 109.414 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.3 m -98.2 134.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 175' ' ' HIS . 11.5 t-20 -81.15 105.13 12.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.478 ' OD2' ' CH2' ' A' ' 21' ' ' TRP . 11.7 p30 -91.62 107.33 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 109.484 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.864 ' HD1' ' N ' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -156.69 171.03 21.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.527 179.653 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.07 164.7 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.7 t -80.29 140.05 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.467 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.7 -17.46 58.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 15.4 t -91.27 165.95 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -1.119 . . . . 0.0 109.466 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.0 p -76.06 92.63 3.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 180' ' ' CYS . 0.1 OUTLIER 160.6 -39.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.544 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 28.9 t80 -96.31 115.54 65.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.544 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.4 Cg_endo -85.53 179.4 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.141 2.56 . . . . 0.0 112.353 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 96.91 3.43 59.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -143.86 35.51 1.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -1.13 . . . . 0.0 109.601 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -83.87 132.37 48.82 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.993 2.462 . . . . 0.0 112.261 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.7 m 46.96 -162.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.65 -27.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -73.72 -16.69 61.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 0.0 109.447 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 7' ' ' VAL . 34.9 m -67.02 130.17 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLN . 33.4 t -162.68 137.19 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.51 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' SER . 93.2 mt-30 50.53 179.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.535 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' LEU . 5.1 m-20 48.31 77.12 0.48 Allowed Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.251 -0.905 . . . . 0.0 109.409 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -47.69 -10.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.886 2.391 . . . . 0.0 112.073 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.5 mt -62.78 -33.81 75.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 47' ' ' ILE . 54.0 m-85 -63.03 -58.13 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.67 -47.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.66 69.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -72.26 -43.51 64.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.489 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 60.5 t-80 -60.85 -43.53 98.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.62 -41.25 79.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.54 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -60.24 -48.11 83.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' HIS . 80.0 mm-40 -141.97 -131.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.489 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 5.7 t90 56.56 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.16 0.63 65.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 169' ' ' CYS . 10.0 t -118.08 96.61 49.91 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.217 -1.167 . . . . 0.0 109.416 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.25 122.59 5.65 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.778 2.318 . . . . 0.0 111.871 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 27.6 tp10 -110.67 139.31 46.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.885 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.4 p -115.56 3.96 14.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 93.6 m-20 -77.77 123.54 26.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.33 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 t -64.48 -37.81 88.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 9.5 mtmp? -62.88 -55.06 29.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -65.87 -43.91 86.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.803 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.6 -34.79 76.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.103 -0.998 . . . . 0.0 109.924 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.51 -39.45 83.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.885 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 3.6 mp0 -73.77 -31.05 63.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.885 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.565 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 55.9 ttm -59.06 -54.05 51.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.798 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.55 -33.16 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.983 . . . . 0.0 110.034 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 t -71.81 -45.88 60.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.4 mt -64.23 -44.26 92.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 41' ' ' GLN . 97.2 mt-10 -63.1 -33.28 75.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 109.829 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.27 -36.38 7.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 19.3 mp0 -75.47 -14.7 60.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -1.221 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLU . 4.0 pp0? -55.27 -23.77 24.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.62 108.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.92 -34.09 3.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.2 mm? -86.14 178.06 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -1.186 . . . . 0.0 109.489 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.6 m -108.69 149.93 28.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.348 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 p90 -53.79 -36.28 62.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.68 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -62.54 -40.51 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 93.4 m -64.31 -37.25 86.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.9 t -60.09 -39.42 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.44 -46.8 83.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -62.03 -50.99 69.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 109.349 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -66.96 -28.74 68.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' VAL . 64.6 ttt180 -53.37 -44.55 68.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.156 -0.965 . . . . 0.0 108.973 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.66 -43.58 79.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -66.15 -37.53 85.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 14.3 t80 -59.65 -49.06 79.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 21.9 mmm180 -61.24 -29.55 69.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.735 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.64 98.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.875 . . . . 0.0 110.241 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.0 m -93.9 -41.91 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 110.232 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 32.4 m-85 -70.73 -52.09 23.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.218 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 49.7 t60 -51.55 -38.07 52.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.055 -1.028 . . . . 0.0 109.865 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.03 -37.13 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.769 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 64' ' ' ASP . 70.2 m-85 -88.06 -9.0 54.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.007 . . . . 0.0 109.856 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 63' ' ' PHE . 7.2 t70 61.75 129.83 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.74 -31.76 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.841 2.36 . . . . 0.0 112.69 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.62 -50.66 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.632 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 71' ' ' MET . 40.7 mtpt -66.82 -34.5 77.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 109.797 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 96' ' ' ILE . 89.0 t -58.16 -28.9 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' CB ' HD12 ' A' ' 103' ' ' LEU . . . -87.6 -18.39 29.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.57 25.98 5.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.1 ptp -75.22 -160.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -129.58 160.56 32.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 49.2 mp0 -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -70.73 -24.34 62.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.443 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -67.0 -47.65 70.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 0.0 109.386 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 HG22 ' A' ' 92' ' ' ILE . 6.7 m -64.91 -38.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.57 -32.61 73.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.616 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.93 -41.99 81.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.775 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.93 -30.68 70.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.4 t -49.55 -33.8 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.952 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -91.36 -63.45 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -101.55 115.75 31.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.49 -46.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.64 15.07 64.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 pt -123.58 167.39 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -1.131 . . . . 0.0 109.304 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.9 mt -49.07 128.64 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 87' ' ' ARG . 14.0 ptm180 -108.29 128.08 54.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.693 ' O ' ' N ' ' A' ' 90' ' ' GLY . 58.4 t-80 -158.21 1.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.147 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 59.48 -60.65 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.07 -46.73 93.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -42.54 96.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -1.151 . . . . 0.0 109.499 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.495 HG22 HG12 ' A' ' 76' ' ' VAL . 38.6 mt -63.37 -49.41 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.624 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -54.47 -33.14 59.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.401 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.368 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.408 HD13 ' HE2' ' A' ' 56' ' ' TYR . 94.8 mt -58.41 -41.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.495 HD12 ' SD ' ' A' ' 71' ' ' MET . 16.9 mm -55.49 -47.28 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.82 93.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.27 -45.22 91.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.137 . . . . 0.0 109.386 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -70.04 -47.63 61.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.72 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -68.06 -46.17 71.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.439 HD12 ' CB ' ' A' ' 69' ' ' ALA . 96.9 mt -67.73 -38.95 84.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.62 -44.98 85.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.85 -41.19 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -71.7 -27.01 62.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -51.25 -32.1 23.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.31 1.81 39.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.9 9.38 86.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -79.04 129.23 73.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.11 -1.229 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.51 122.16 8.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.673 2.249 . . . . 0.0 111.692 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -76.44 -44.89 33.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.472 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.43 -49.69 76.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.792 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 85.4 m-20 -54.64 -35.1 63.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.949 . . . . 0.0 111.005 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 75.7 t80 -73.54 -48.42 33.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.032 -1.042 . . . . 0.0 111.219 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 117' ' ' TRP . 3.1 m -55.95 -50.34 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.052 -1.03 . . . . 0.0 111.655 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.583 ' O ' HG22 ' A' ' 120' ' ' VAL . 25.2 p-90 -86.66 -22.42 26.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.84 -1.162 . . . . 0.0 111.087 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 120' ' ' VAL . 8.0 t -59.48 -27.95 66.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.821 -1.175 . . . . 0.0 109.658 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.12 -15.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.075 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 117' ' ' TRP . 14.8 m -83.22 22.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 109.979 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.612 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 29.4 t30 61.05 48.27 6.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.046 . . . . 0.0 109.765 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 32.4 p80 41.91 32.99 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 49.9 tt0 -142.84 90.86 7.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -47.16 155.19 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.724 2.282 . . . . 0.0 111.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 16.7 mp0 -105.66 158.92 16.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 109.688 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.9 mtt -135.98 156.9 48.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.134 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.6 t -122.57 160.38 25.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.482 ' N ' ' OE1' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -141.28 43.72 1.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -86.73 169.72 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 m -87.69 -33.24 18.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.68 169.43 17.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.2 mt -67.85 -27.69 66.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.577 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.7 t -59.08 -41.22 87.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.579 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 69.3 mm-40 -64.19 -29.86 70.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.395 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.37 131.76 93.25 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.409 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 98.4 Cg_endo -80.03 141.45 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.141 2.561 . . . . 0.0 112.571 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 6.26 42.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 109.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.1 t -136.37 92.69 2.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.887 . . . . 0.0 109.35 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -98.06 154.53 37.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.74 -40.18 24.25 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.797 2.331 . . . . 0.0 112.061 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.86 70.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.0 m -62.39 -45.58 92.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.05 -43.77 86.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.59 73.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 109.513 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.729 ' C ' HD23 ' A' ' 145' ' ' LEU . 8.2 tt -66.88 -46.73 74.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 87.7 p -58.9 -39.03 80.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.962 . . . . 0.0 109.548 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -63.59 -34.68 78.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.4 -50.28 60.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.22 -32.49 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -57.92 -38.11 75.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.33 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.644 ' NZ ' HH12 ' A' ' 152' ' ' ARG . 7.0 ttpm? -61.55 -38.94 89.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.452 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.644 HH12 ' NZ ' ' A' ' 151' ' ' LYS . 12.7 mpt_? -63.55 -20.22 65.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.28 24.65 10.09 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -89.84 131.92 35.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -1.121 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.34 177.69 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.407 ' O ' HD13 ' A' ' 161' ' ' ILE . 93.6 m-85 54.07 57.19 6.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.9 m -121.78 25.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.412 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.49 166.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 159' ' ' THR . 1.1 p -66.36 -24.53 66.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.397 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 161' ' ' ILE . 15.0 t -72.04 -42.66 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 160' ' ' THR . 81.5 mt -65.65 -41.45 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.552 ' SG ' HD22 ' A' ' 145' ' ' LEU . 50.1 t -63.22 -40.43 97.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CE1' ' O ' ' A' ' 136' ' ' PRO . 68.0 t80 -60.75 -46.85 88.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.395 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -45.55 84.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.888 . . . . 0.0 109.354 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -62.66 -34.45 77.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 178.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 30.7 ttm -63.28 -45.0 93.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.645 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.419 ' NE2' HG21 ' A' ' 172' ' ' VAL . 63.4 mm-40 -70.08 -37.17 75.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.668 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.565 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -64.76 -46.98 79.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 14.4 m -64.66 -61.14 2.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.0 7.54 3.25 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.571 HD21 ' CB ' ' A' ' 117' ' ' TRP . 9.5 mp -50.07 -43.55 51.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 109.38 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.419 HG21 ' NE2' ' A' ' 167' ' ' GLN . 30.8 m -100.61 134.54 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.487 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.406 ' O ' HG22 ' A' ' 127' ' ' THR . 87.5 m-20 -87.19 103.41 15.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -91.92 121.99 34.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.593 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -160.9 100.28 1.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.96 148.17 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.68 129.9 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.23 7.98 63.35 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 52.3 t -79.65 94.2 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.507 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.2 t 65.63 -57.18 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 37.6 t -173.07 60.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.414 ' OH ' ' CB ' ' A' ' 128' ' ' GLN . 21.8 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 109.608 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.614 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 6' ' ' TRP . 14.1 m -150.91 26.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.407 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.98 -44.19 0.16 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . 94.1 m95 -54.63 -35.06 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.463 HG23 ' NE ' ' A' ' 3' ' ' ARG . 5.9 m -73.49 63.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -149.94 48.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -152.96 -125.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.1 150.17 98.07 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.859 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.63 -19.84 41.46 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.899 2.4 . . . . 0.0 112.095 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.29 -41.36 98.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.392 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -65.24 -49.6 69.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.443 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.0 -45.12 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.84 88.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -57.57 -42.39 83.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.536 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 48.7 t-80 -62.32 -41.76 98.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.8 -40.03 94.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -58.77 -53.04 62.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 21' ' ' TRP . 76.3 mm-40 -142.48 -131.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.536 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 24.2 t90 58.76 138.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.535 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.28 -29.0 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 23' ' ' VAL . 11.0 p -75.49 131.59 77.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.11 120.51 6.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.817 2.345 . . . . 0.0 111.885 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -111.5 137.19 49.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.845 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -132.61 4.87 3.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 28' ' ' SER . 63.3 t0 -94.22 142.96 26.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.284 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 60.3 p -64.33 -34.63 78.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.4 -47.64 75.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.91 -48.89 27.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -66.61 -35.37 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.845 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 28' ' ' SER . 48.9 t80 -60.63 -46.97 88.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.864 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.14 -30.11 62.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.83 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -58.47 -53.28 60.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.793 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.583 HD12 ' OE1' ' A' ' 38' ' ' GLU . 4.1 tp -69.77 -31.62 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 110.017 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 69.2 m -73.31 -46.58 48.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.902 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 35' ' ' ILE . 16.5 pt-20 -49.8 -43.5 48.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.778 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . 77.2 171.31 35.19 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.702 ' C ' ' H ' ' A' ' 42' ' ' ALA . 32.7 tt0 -66.35 -43.77 85.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.247 . . . . 0.0 109.737 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 58.34 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 109.704 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -70.84 117.88 12.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.11 -15.25 63.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.0 mp -116.87 -135.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -1.176 . . . . 0.0 109.461 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -153.27 154.8 35.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.434 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.519 ' NE1' HD21 ' A' ' 50' ' ' LEU . 74.4 t-105 -52.31 -35.64 51.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 48' ' ' THR . 10.4 tp -52.91 -40.99 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 47' ' ' ILE . 73.5 m -66.83 -35.65 80.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 0.0 109.701 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.9 t -60.97 -39.91 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.414 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.519 HD21 ' NE1' ' A' ' 46' ' ' TRP . 60.8 mt -59.95 -47.48 85.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.61 ' NZ ' ' NZ ' ' A' ' 52' ' ' LYS . 9.8 mtmp? -64.63 -53.06 53.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.262 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.61 ' NZ ' ' NZ ' ' A' ' 51' ' ' LYS . 13.0 mptt -64.51 -34.36 78.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' VAL . 7.9 tmm_? -50.45 -45.94 56.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.2 -0.938 . . . . 0.0 108.95 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG3' HH21 ' A' ' 57' ' ' ARG . 85.3 tt0 -63.38 -42.24 98.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -66.51 -36.33 82.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.223 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -61.95 -45.66 92.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.3 mtm180 -57.15 -42.1 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.828 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.6 66.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 m -92.34 -12.61 31.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 0.0 110.363 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.84 -43.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.906 -1.121 . . . . 0.0 110.239 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -51.41 -43.76 62.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.113 -0.992 . . . . 0.0 109.885 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -67.11 -39.98 86.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 93.5 m-85 -71.58 -24.17 61.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.854 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.4 t70 69.62 131.48 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.996 -1.065 . . . . 0.0 109.563 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -39.9 -37.24 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.834 2.356 . . . . 0.0 112.679 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.03 -48.38 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.14 -0.975 . . . . 0.0 109.647 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 71' ' ' MET . 60.5 mttp -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.15 -43.4 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 109.626 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.3 -30.3 54.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.68 58.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.407 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.8 mtp -65.08 136.65 56.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -94.37 171.98 8.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.93 -33.28 70.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -59.18 -42.57 91.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -59.26 -38.45 80.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 80' ' ' VAL . 79.4 t -58.85 -44.99 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.571 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.538 ' OE1' ' NH1' ' A' ' 89' ' ' ARG . 41.8 tp10 -56.44 -37.79 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -65.4 -43.74 89.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.718 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.01 -36.21 79.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.637 ' CG1' HH21 ' A' ' 87' ' ' ARG . 52.7 t -50.64 -35.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.723 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.15 -60.04 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 109.518 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -99.91 115.92 30.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.72 -45.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.11 33.38 40.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.42 172.17 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -1.111 . . . . 0.0 109.336 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.0 mt -48.53 135.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.637 HH21 ' CG1' ' A' ' 80' ' ' VAL . 1.3 tpt180 -75.46 122.62 24.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.44 91.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 109.141 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 77' ' ' GLU . 38.3 ttm-85 -48.57 -32.54 8.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.932 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.44 -38.48 93.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HZ1' ' H ' ' A' ' 40' ' ' GLN . 14.1 mmmt -60.04 -47.34 86.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.499 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.404 HG21 HG13 ' A' ' 76' ' ' VAL . 76.5 mt -60.26 -41.39 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.08 -39.08 77.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.0 81.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.655 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 33.3 mm -59.6 -43.74 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.434 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.28 -28.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.548 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.05 -45.65 80.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.655 ' ND2' ' O ' ' A' ' 95' ' ' ILE . 13.7 p30 -63.12 -35.48 80.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -1.148 . . . . 0.0 109.416 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -62.78 -46.79 86.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 109.521 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -71.43 -45.77 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.93 81.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.529 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.41 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 64.8 t80 -63.6 -49.2 74.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.94 -42.71 80.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -65.53 -41.64 92.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.6 ttt -65.31 -41.82 93.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.471 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.68 -27.33 65.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -51.8 -31.13 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -76.74 -12.7 60.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.45 0.46 76.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.83 132.54 64.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.2 -1.177 . . . . 0.0 109.712 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.49 118.58 5.73 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.6 2.2 . . . . 0.0 111.7 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -77.22 -38.57 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.795 . . . . 0.0 110.455 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.709 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.14 -49.72 76.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 110.77 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 118' ' ' SER . 93.0 m-20 -61.27 -44.43 97.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.228 -0.92 . . . . 0.0 111.102 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.77 -53.47 57.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.94 -1.1 . . . . 0.0 111.224 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 117' ' ' TRP . 12.2 m -57.96 -49.71 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.934 -1.104 . . . . 0.0 111.666 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.511 ' CE3' ' O ' ' A' ' 117' ' ' TRP . 2.4 p-90 -86.89 -21.55 26.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.712 -1.242 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 120' ' ' VAL . 17.0 p -58.84 -33.84 70.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.799 -1.188 . . . . 0.0 109.721 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.07 -12.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.915 . . . . 0.0 110.076 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.685 ' O ' HG12 ' A' ' 120' ' ' VAL . 43.1 t -82.32 23.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.073 -1.017 . . . . 0.0 109.939 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 35.1 t30 68.95 18.75 8.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 53.58 50.08 18.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 49.9 tt0 -159.7 121.41 1.82 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.34 151.89 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.716 2.278 . . . . 0.0 111.794 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 87.9 mm-40 -118.44 146.96 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.975 . . . . 0.0 109.72 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -135.91 156.49 48.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.79 . . . . 0.0 109.097 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.7 t -119.4 163.22 17.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.86 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -149.06 43.41 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.26 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB1' ' OE1' ' A' ' 134' ' ' GLU . . . -82.05 -150.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 109.676 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.445 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 14.4 m -138.72 -33.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -121.9 154.34 37.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.13 -33.84 75.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.893 . . . . 0.0 109.618 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -63.03 -33.38 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 130' ' ' THR . 95.6 mt-10 -62.92 -30.87 71.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.8 mp -67.52 117.04 43.44 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.699 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.06 125.65 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.079 2.519 . . . . 0.0 112.537 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 10.2 t -76.65 -18.15 58.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 109.322 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.0 t -102.72 99.19 9.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.11 155.45 37.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -46.89 -40.67 25.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.749 2.299 . . . . 0.0 111.963 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.85 -35.18 67.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.389 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.8 m -60.66 -41.86 95.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -64.8 -45.82 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.49 81.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.761 ' C ' HD23 ' A' ' 145' ' ' LEU . 7.4 tt -66.52 -46.35 76.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -56.33 -47.54 78.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.93 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.59 -45.0 73.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 149' ' ' LEU . 68.0 mt -60.17 -33.85 72.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.606 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -57.37 -40.89 79.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.86 -37.07 85.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.43 -17.81 65.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.19 20.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 136.27 33.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.14 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -105.24 -179.22 3.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.541 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 54.37 56.92 6.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.49 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 m -122.56 26.59 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.87 161.39 0.16 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.1 t -55.66 -32.61 63.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.158 . . . . 0.0 109.425 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 46.7 m -68.57 -46.83 68.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.04 -33.82 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 145' ' ' LEU . 6.4 t -68.42 -41.77 79.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.299 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 137' ' ' THR . 43.4 t80 -62.23 -45.38 93.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.3 t -59.15 -36.9 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.54 -43.36 97.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.418 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.94 -39.74 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.638 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -61.63 -47.12 86.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.859 . . . . 0.0 109.689 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.65 -37.86 80.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.75 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' VAL . 15.6 m -59.59 -28.81 67.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.457 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.06 9.92 55.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.81 -40.65 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 109.483 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 t -96.36 129.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.461 ' CG ' ' NE2' ' A' ' 175' ' ' HIS . 0.4 OUTLIER -100.04 117.53 34.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.378 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -75.42 137.04 40.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.457 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.461 ' NE2' ' CG ' ' A' ' 173' ' ' ASN . 75.6 m-70 -146.22 48.68 1.2 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.95 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.54 144.88 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.9 t -81.69 134.19 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.952 . . . . 0.0 109.503 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.27 25.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 13.8 p -86.94 -160.53 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.527 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.9 t -84.41 -54.16 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 t -64.94 -11.17 35.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.609 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' CYS . 32.8 ptt180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' ARG . 20.2 m 53.94 171.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.07 12.69 1.44 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 2.9 p-90 -148.3 46.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 109.429 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.42 130.36 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.527 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 m -73.81 146.41 44.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 27.6 mp0 -65.29 -29.35 70.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.515 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -53.52 142.65 40.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.85 -23.81 18.54 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.874 2.383 . . . . 0.0 112.163 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.85 -39.79 95.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -79.45 -47.38 15.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.39 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.7 mt -55.41 -49.05 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.416 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -46.08 78.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -62.23 -40.41 96.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t-80 -58.68 -45.86 88.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.38 -46.23 12.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -57.98 -37.66 74.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 21' ' ' TRP . 93.7 mt-10 -144.54 -156.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.464 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.483 ' O ' ' O ' ' A' ' 20' ' ' GLU . 34.6 t90 59.76 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.64 -28.51 10.01 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.56 119.63 68.48 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.33 -1.1 . . . . 0.0 109.409 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.95 129.13 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.868 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -115.58 137.95 51.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.9 p -126.46 4.99 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.888 . . . . 0.0 109.104 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -72.18 119.47 16.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.6 p -60.55 -36.89 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -62.71 -46.98 85.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.828 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.16 -50.74 62.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.8 mp -64.55 -39.0 92.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.119 -0.988 . . . . 0.0 109.887 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 90.4 t80 -61.6 -52.91 62.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 109.864 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -33.11 75.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -56.72 -50.81 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.82 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.32 -40.16 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.995 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -72.24 -39.96 68.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.123 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 56' ' ' TYR . 18.4 mt -72.44 -40.64 66.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 109.848 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -53.63 -35.88 61.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.15 -31.56 26.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.463 ' HA ' ' HZ2' ' A' ' 91' ' ' LYS . 83.8 mt-30 -71.06 -29.83 65.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -1.202 . . . . 0.0 109.742 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' LEU . 6.0 pt20 -51.28 -31.26 20.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.695 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.43 109.75 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.656 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.82 -31.88 5.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLN . 27.1 mt -96.23 -179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.484 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.0 m -105.78 163.15 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.972 . . . . 0.0 109.415 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.2 -46.43 75.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 47' ' ' ILE . 10.3 tp -56.57 -34.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 47' ' ' ILE . 80.9 m -64.54 -33.99 77.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.8 t -63.18 -40.76 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -53.66 -51.38 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -56.91 -39.68 74.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -80.75 -17.87 49.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.375 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.8 ttm-85 -60.99 -49.25 78.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.157 -0.964 . . . . 0.0 108.992 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 19.6 pt-20 -73.95 -42.84 59.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.456 -0.778 . . . . 0.0 109.347 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -66.64 -43.11 85.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 60' ' ' PHE . 35.9 t80 -60.42 -46.14 91.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.364 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' HIS . 76.6 mtm180 -59.48 -37.13 77.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 15.1 p -94.14 -12.33 28.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.301 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.635 ' CD2' ' CZ ' ' A' ' 56' ' ' TYR . 52.4 m-85 -120.95 -54.22 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.967 -1.083 . . . . 0.0 110.2 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 57' ' ' ARG . 44.7 t-80 -55.6 -41.79 73.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -55.77 -32.93 63.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 81.5 m-85 -94.96 3.81 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.856 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 57.7 162.58 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 109.555 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.48 -14.49 22.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.876 2.384 . . . . 0.0 112.694 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.678 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.81 -46.61 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.908 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 69' ' ' ALA . 6.3 m -56.69 -41.9 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.007 . . . . 0.0 109.641 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.548 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -58.9 -40.93 85.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.96 27.98 2.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.6 ttm -71.21 147.83 47.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.689 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -100.08 149.23 23.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 55.7 mp0 -52.34 -31.81 35.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.99 -45.64 88.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.45 -39.13 79.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.428 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.5 t -55.29 -46.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.33 -34.14 70.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.58 -49.27 71.84 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.337 -0.852 . . . . 0.0 109.78 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 mt -63.88 -38.39 90.9 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.97 -30.72 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -89.42 -58.54 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -99.52 124.85 45.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.415 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -170.27 -61.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.442 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.98 75.12 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.502 HG12 ' HB1' ' A' ' 83' ' ' ALA . 22.1 pt -100.3 -169.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.337 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.11 138.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.28 122.27 31.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.468 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -177.6 81.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -48.37 -28.59 3.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.16 98.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HZ2' ' HA ' ' A' ' 40' ' ' GLN . 14.1 mtpt -69.13 -42.48 75.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -1.205 . . . . 0.0 109.571 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.95 -50.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -57.13 -33.48 67.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.443 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -62.21 -43.58 98.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 mm -55.75 -44.3 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -55.36 -50.15 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.69 -29.21 65.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.659 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.31 -40.3 85.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -1.195 . . . . 0.0 109.422 -178.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.659 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -67.8 -38.96 83.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -55.39 -44.83 76.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 109.541 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.33 69.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.442 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 37.0 t80 -60.75 -44.64 96.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.69 -36.31 83.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -57.68 -43.18 84.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.69 -43.86 71.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.62 -28.06 66.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -51.87 -33.04 34.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.5 -12.48 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.19 10.99 83.0 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -93.5 149.16 36.78 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.215 -1.168 . . . . 0.0 109.735 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.66 120.09 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.722 2.282 . . . . 0.0 111.697 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.466 ' O ' HG23 ' A' ' 116' ' ' VAL . 83.7 t80 -66.46 -43.25 86.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 0.0 110.408 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.11 72.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.183 -0.948 . . . . 0.0 110.713 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' O ' ' CB ' ' A' ' 118' ' ' SER . 18.2 t70 -55.11 -51.18 67.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 111.046 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.426 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 69.7 t80 -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 111.261 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -57.02 -58.37 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 111.706 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . 45.0 p-90 -88.19 -20.69 25.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.786 -1.196 . . . . 0.0 111.162 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 120' ' ' VAL . 71.7 p -61.23 -24.29 66.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.159 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.13 -11.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.052 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.6 m -90.23 24.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 109.987 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 8.2 t-20 77.51 -50.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 109.719 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.3 p-80 162.48 -19.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -101.38 148.96 35.92 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.15 154.7 47.05 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.707 2.272 . . . . 0.0 111.779 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -87.44 153.01 21.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 126' ' ' MET . 2.4 mpp? -136.57 150.46 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.431 ' OG1' ' CD1' ' A' ' 135' ' ' ILE . 15.1 t -99.35 171.55 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.864 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -160.17 67.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.31 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.49 -121.46 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 109.676 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 m -158.72 -33.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 134' ' ' GLU . 1.2 t -124.0 170.27 10.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -73.79 -28.57 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.0 m -67.0 -38.1 85.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.525 ' H ' HG23 ' A' ' 131' ' ' THR . 63.1 mm-40 -67.25 -15.04 63.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.186 -0.946 . . . . 0.0 109.445 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CD1' ' OG1' ' A' ' 127' ' ' THR . 44.3 mm -65.68 116.69 34.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -42.53 136.23 4.35 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.071 2.514 . . . . 0.0 112.552 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -4.01 35.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -143.98 83.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.2 p -74.86 153.11 86.94 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.18 -29.97 68.91 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.76 2.307 . . . . 0.0 112.059 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.5 -33.44 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.386 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.5 p -64.27 -40.42 95.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.88 -50.12 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 109.527 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.62 82.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.03 -43.79 91.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.473 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.0 p -55.35 -43.86 75.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -62.58 -32.03 72.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.479 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.04 36.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.488 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.8 mm? -62.36 -37.88 87.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.635 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -59.23 -37.44 77.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.09 -39.89 91.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 152' ' ' ARG . 38.7 mtt-85 -64.65 -19.57 65.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.23 21.91 21.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.06 138.42 36.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -103.53 170.42 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 59.08 47.08 12.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 158' ' ' GLY . 17.2 m -118.92 25.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.71 168.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.3 m -55.8 -32.61 63.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.46 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.1 m -62.28 -48.6 79.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.577 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -65.7 -34.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.94 -47.07 69.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -64.95 -40.78 95.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 109.347 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -59.57 -36.72 76.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.24 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.595 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 81.8 t80 -61.61 -43.09 99.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.5 mtp -70.43 -36.85 74.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -64.59 -54.79 26.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.698 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.32 83.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.595 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 22.9 m -53.88 -38.3 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.6 5.97 47.62 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.69 -33.1 73.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.75 132.32 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -94.57 105.33 17.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -96.02 96.13 8.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.168 -0.957 . . . . 0.0 109.494 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' A' ' 176' ' ' VAL . 21.2 m80 -108.9 -6.88 15.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 177' ' ' VAL . 87.6 t 54.29 163.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.453 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.57 ' N ' HG12 ' A' ' 176' ' ' VAL . 81.8 t -108.08 133.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.83 61.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 181' ' ' CYS . 39.2 m -144.41 168.35 20.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.163 . . . . 0.0 109.525 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 98.5 m 50.09 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 179' ' ' CYS . 38.6 t -155.8 14.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 109.513 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.494 HH11 ' HG3' ' A' ' 3' ' ' ARG . 32.0 mtm-85 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.323 0.583 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -141.39 -142.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.562 ' H ' HD11 ' A' ' 132' ' ' LEU . . . -47.44 -11.99 0.1 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . 44.5 m95 -67.14 -9.48 40.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 6' ' ' TRP . 20.1 m 35.76 -154.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 8' ' ' SER . 10.3 t -178.08 47.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.411 ' N ' HD11 ' A' ' 14' ' ' ILE . 6.6 pt20 -130.63 -105.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 9' ' ' GLN . 58.2 m-20 -43.6 107.09 0.54 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -48.71 -34.84 28.55 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.799 2.333 . . . . 0.0 112.173 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.44 -44.22 95.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.473 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -68.15 -42.6 79.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.468 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.411 HD11 ' N ' ' A' ' 9' ' ' GLN . 61.2 mt -59.36 -42.61 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.424 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' ASN . . . -61.72 -39.12 90.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.88 -41.27 77.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -77.39 -20.87 54.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.912 . . . . 0.0 109.461 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -104.15 -2.04 26.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.523 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . 13.0 m120 -77.27 -74.83 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -147.89 23.43 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -79.85 132.89 36.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.95 -28.35 13.03 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 169' ' ' CYS . 4.0 t -91.39 112.95 56.77 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.212 -1.169 . . . . 0.0 109.41 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.68 137.85 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.759 2.306 . . . . 0.0 111.865 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.7 141.34 51.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.809 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.9 p -90.44 12.4 18.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.376 -0.827 . . . . 0.0 109.107 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -81.36 129.51 34.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 109.317 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.671 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 95.2 p -71.28 -31.03 66.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -58.64 -42.57 88.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.681 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.88 -48.56 65.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 31' ' ' LEU . 11.1 mp -67.89 -42.07 81.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 31.8 t80 -61.5 -52.68 63.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.48 -30.65 71.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -67.97 -55.39 12.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.805 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.4 HG23 ' CG2' ' A' ' 161' ' ' ILE . 9.3 mt -65.75 -43.84 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -58.23 -49.26 77.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 0.0 110.105 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD11 ' CG ' ' A' ' 56' ' ' TYR . 4.2 mm? -76.86 -41.68 43.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.857 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -53.93 -37.97 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.792 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.63 -29.73 25.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.624 ' NE2' ' CZ ' ' A' ' 56' ' ' TYR . 72.3 mt-30 -66.79 -30.03 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.187 . . . . 0.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.699 HE22 ' N ' ' A' ' 46' ' ' TRP . 35.6 tp60 -45.79 -39.05 7.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.935 . . . . 0.0 109.702 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.84 107.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.63 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.28 -32.72 4.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 40' ' ' GLN . 2.5 mt -89.19 -165.11 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -1.126 . . . . 0.0 109.512 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.411 ' HA ' HE22 ' A' ' 41' ' ' GLN . 39.7 t -121.73 149.88 42.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.699 ' N ' HE22 ' A' ' 41' ' ' GLN . 36.2 p90 -57.61 -49.13 77.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 9.4 tp -48.34 -37.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.672 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.474 ' N ' HG23 ' A' ' 47' ' ' ILE . 58.0 m -71.71 -34.2 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.727 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.63 -48.35 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -60.45 -47.22 87.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -61.9 -51.49 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.982 . . . . 0.0 109.305 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.65 -36.2 83.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 109.403 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -48.26 -46.11 35.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.205 -0.934 . . . . 0.0 108.975 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -65.23 -42.32 93.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.362 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.86 -39.08 90.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.286 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.624 ' CZ ' ' NE2' ' A' ' 40' ' ' GLN . 3.6 m-85 -61.87 -44.13 97.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 109.342 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 53.4 mtp180 -54.77 -43.51 72.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.299 -0.875 . . . . 0.0 109.834 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.38 -23.54 65.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.792 . . . . 0.0 110.328 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 79' ' ' LEU . 3.8 t -92.31 -12.64 31.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.271 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -133.16 -46.68 0.84 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.892 -1.13 . . . . 0.0 110.231 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 53.3 t-80 -53.47 -41.55 66.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.037 -1.039 . . . . 0.0 109.901 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.08 -34.87 68.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.792 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' ASP . 88.1 m-85 -91.04 4.41 52.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.874 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.61 160.67 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.601 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.73 -24.22 25.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.856 2.371 . . . . 0.0 112.728 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.85 -48.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.1 mttm -66.09 -33.78 76.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.403 -0.811 . . . . 0.0 109.866 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 71' ' ' MET . 61.0 t -57.43 -43.14 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.058 -1.026 . . . . 0.0 109.576 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.17 -24.35 61.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.63 14.13 28.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.356 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 11.8 ptm -77.61 152.55 33.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -100.62 163.29 12.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.558 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.38 -28.71 60.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.459 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -57.07 -37.42 71.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.13 -38.37 86.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' VAL . 71.0 t -61.5 -38.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.83 -39.4 90.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.391 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 78' ' ' ARG . 53.5 mtm-85 -75.35 -47.85 25.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.318 -0.863 . . . . 0.0 109.767 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.54 HD22 ' SG ' ' A' ' 59' ' ' CYS . 93.1 mt -62.73 -41.85 99.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 76' ' ' VAL . 25.0 t -54.24 -34.28 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.713 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.62 -54.86 3.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.543 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -98.86 109.01 21.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 109.404 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.29 -38.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.87 36.84 46.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -124.5 173.42 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -1.139 . . . . 0.0 109.377 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 87.2 mt -47.71 138.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.593 ' HG2' HH11 ' A' ' 87' ' ' ARG . 9.9 ttt-85 -89.53 126.28 35.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 109.5 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER 170.89 84.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -48.12 -32.09 6.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.935 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.88 93.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -65.13 -40.5 94.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.46 HG21 HG13 ' A' ' 76' ' ' VAL . 4.3 mm -57.82 -47.46 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.49 -38.31 63.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.28 75.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.398 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.514 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 63.2 mt -59.9 -40.74 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.573 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 41.2 mm -54.19 -43.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.96 64.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -65.61 -45.73 82.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.14 . . . . 0.0 109.407 -178.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.516 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.71 -44.97 84.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.71 -41.28 98.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -46.54 38.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.453 ' HH ' ' HG ' ' A' ' 28' ' ' SER . 49.8 t80 -55.45 -44.74 76.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.516 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.19 -32.99 74.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -54.85 -49.83 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.1 mtp -66.53 -38.55 87.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.73 -27.21 67.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -51.6 -34.03 35.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -81.11 -4.69 56.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.9 10.69 80.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -84.74 149.12 53.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.03 119.62 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.626 2.217 . . . . 0.0 111.704 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -73.85 -46.85 42.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -57.85 -47.36 82.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.716 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.473 ' O ' ' OG ' ' A' ' 118' ' ' SER . 19.6 t70 -55.27 -39.1 69.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.907 . . . . 0.0 111.017 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.449 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 92.2 t80 -66.5 -49.43 66.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 111.192 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 116' ' ' VAL . 5.7 m -60.46 -46.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 111.67 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.529 ' O ' HG22 ' A' ' 120' ' ' VAL . 5.1 p-90 -85.97 -33.72 21.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.726 -1.233 . . . . 0.0 111.163 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 120' ' ' VAL . 74.4 m -57.12 -27.5 61.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 109.754 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.4 m -83.78 26.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.056 -1.027 . . . . 0.0 109.988 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.0 m120 74.36 21.57 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 56.51 42.2 27.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.93 . . . . 0.0 109.487 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.455 ' H ' HG23 ' A' ' 120' ' ' VAL . 7.9 pt20 -138.8 146.09 48.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.519 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.67 154.76 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.683 2.255 . . . . 0.0 111.836 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -120.27 147.46 44.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.965 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.7 ptp -135.58 157.31 47.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.838 . . . . 0.0 109.104 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.3 t -127.49 161.2 29.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -147.12 57.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.518 ' HB1' ' OE1' ' A' ' 134' ' ' GLU . . . -98.91 -151.18 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.705 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.3 m -114.31 -28.16 7.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 0.0 109.382 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.3 m -139.18 154.11 48.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.453 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.661 ' H ' HD12 ' A' ' 132' ' ' LEU . 1.0 OUTLIER -62.13 -30.86 71.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -67.2 -32.63 73.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.953 . . . . 0.0 109.513 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.518 ' OE1' ' HB1' ' A' ' 129' ' ' ALA . 95.1 mt-10 -59.08 -26.27 64.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.421 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.7 mp -67.34 121.58 79.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.25 133.94 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.125 2.55 . . . . 0.0 112.504 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 137' ' ' THR . 1.0 OUTLIER -81.67 -17.32 48.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.373 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.1 p -73.05 102.4 3.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -134.8 151.65 76.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.36 -31.39 92.7 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.761 2.307 . . . . 0.0 112.049 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.85 73.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -63.57 -43.63 96.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.31 -44.5 97.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.83 60.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.681 ' C ' HD23 ' A' ' 145' ' ' LEU . 6.8 tt -65.05 -49.05 71.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -57.84 -39.64 78.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.907 . . . . 0.0 109.539 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -62.31 -35.3 78.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.8 -51.57 57.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.2 mt -59.17 -35.02 72.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -58.16 -37.18 74.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.402 ' HB3' HH11 ' A' ' 152' ' ' ARG . 84.3 tttt -62.48 -40.6 97.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.5 mpt_? -64.51 -20.01 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.79 20.82 20.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -84.51 128.04 34.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 156' ' ' PHE . 22.9 tptt -97.41 176.99 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.436 ' H ' ' HG3' ' A' ' 155' ' ' LYS . 67.9 m-85 55.05 47.38 22.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 158' ' ' GLY . 2.6 m -121.71 25.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.69 171.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.443 ' H ' HG23 ' A' ' 159' ' ' THR . 1.1 p -58.31 -32.36 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.455 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.9 m -64.75 -48.46 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -63.37 -39.8 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 109.521 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.527 ' SG ' HD22 ' A' ' 145' ' ' LEU . 31.9 t -68.93 -50.13 52.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.29 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.492 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 53.1 t80 -63.93 -35.63 81.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 109.35 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.3 m -59.41 -41.47 89.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.256 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -65.05 -42.33 94.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.6 mtp -57.38 -40.9 79.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 174' ' ' ASP . 24.1 mm100 -77.1 -36.4 55.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.41 -54.17 27.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.699 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.558 ' O ' ' O ' ' A' ' 23' ' ' VAL . 11.4 p -57.78 -61.14 2.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 144.22 2.76 0.81 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 117' ' ' TRP . 2.6 mp -48.5 -41.81 31.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.419 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.74 128.54 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 32.4 t-20 -81.12 101.29 9.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 109.404 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.526 ' O ' ' ND1' ' A' ' 175' ' ' HIS . 78.6 m-20 -83.87 121.35 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 174' ' ' ASP . 28.4 m-70 -158.57 127.36 5.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.53 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 4' ' ' CYS . 33.7 m -90.41 132.96 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.49 -20.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.78 -3.47 79.82 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 6.9 t -90.17 143.49 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -1.151 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.9 -36.73 80.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.11 -39.33 81.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.9 t80 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.607 -179.908 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 m -48.11 137.73 10.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.39 -11.87 55.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -67.59 -1.86 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -1.154 . . . . 0.0 109.422 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -62.32 137.1 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -58.06 144.9 38.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.26 -32.81 73.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 109.533 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 143.1 78.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.06 -15.34 25.96 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.871 2.381 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.0 -43.06 99.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.22 -47.86 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.6 -46.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.29 92.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.11 -39.19 92.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.514 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 54.4 t-80 -55.27 -47.04 76.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.425 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.09 -42.36 38.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -58.88 -43.36 90.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 21' ' ' TRP . 87.9 mt-10 -146.55 -143.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' O ' ' A' ' 20' ' ' GLU . 35.3 t90 60.06 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.77 67.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -118.38 94.19 46.68 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.272 -1.134 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.04 131.27 21.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.766 2.311 . . . . 0.0 111.834 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.4 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.862 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.1 p -106.28 0.32 25.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.38 134.76 36.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 10.2 p -72.93 -31.72 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -64.7 -54.78 26.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -73.36 -49.75 25.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 109.893 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.2 -44.62 75.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.02 -42.41 98.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.954 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -58.29 -31.51 67.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 109.78 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 tpp -63.67 -46.36 85.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.834 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.53 -47.21 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 110.01 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 14.2 p -60.04 -38.55 83.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.522 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 43.6 mt -66.08 -36.81 84.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.13 -0.981 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 65.3 mm-40 -60.18 -37.9 81.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.704 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.2 -36.05 7.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.443 ' OE1' HG21 ' A' ' 86' ' ' ILE . 74.5 mm-40 -66.09 -31.31 72.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -1.186 . . . . 0.0 109.794 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 44' ' ' LEU . 64.7 tt0 -56.8 -31.73 64.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.736 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.72 109.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.98 -31.89 5.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.6 mp -104.73 -160.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -1.187 . . . . 0.0 109.422 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.2 m -125.44 152.96 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.542 ' CZ3' ' OE2' ' A' ' 38' ' ' GLU . 72.5 t-105 -54.19 -42.52 69.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.366 -0.833 . . . . 0.0 109.493 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.637 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -48.99 -39.74 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.68 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.52 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 52.9 m -71.92 -31.5 66.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 109.686 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ARG . 67.6 t -57.82 -30.8 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 109.438 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 50' ' ' LEU . 4.1 mm? -52.87 -54.68 30.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.419 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.09 -45.89 89.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.351 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.85 -24.62 65.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' VAL . 33.2 ttt-85 -62.23 -47.33 84.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.22 -0.925 . . . . 0.0 109.032 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -44.51 84.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 109.337 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.28 -43.95 69.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 22.9 t80 -63.4 -37.31 86.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.474 -0.766 . . . . 0.0 109.332 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.77 -41.95 92.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.383 -0.823 . . . . 0.0 109.783 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 -21.43 59.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 85' ' ' ILE . 25.8 m -89.46 -11.97 41.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 110.266 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 83.3 m-85 -133.51 -50.91 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.113 . . . . 0.0 110.2 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -49.91 -42.83 48.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.913 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -59.32 -28.52 66.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 64' ' ' ASP . 90.8 m-85 -85.52 17.55 3.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.052 -1.03 . . . . 0.0 109.901 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 55.52 162.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 109.576 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.52 -54.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.884 2.389 . . . . 0.0 112.755 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.9 p -48.48 -44.61 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.703 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.577 ' N ' HG13 ' A' ' 66' ' ' VAL . 80.6 tttt -58.12 -37.99 75.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 64' ' ' ASP . 58.9 t -57.46 -38.96 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.083 -1.01 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.06 -24.45 62.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.83 12.83 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.384 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.5 mtp -61.94 135.98 57.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -95.47 162.95 13.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' CD ' HE22 ' A' ' 93' ' ' GLN . 75.6 mm-40 -57.86 -27.75 63.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -71.82 -29.02 63.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.11 -49.4 70.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 92' ' ' ILE . 14.9 m -60.68 -37.64 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.58 -37.1 70.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.427 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.9 ttt-85 -65.25 -42.32 93.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.402 -0.811 . . . . 0.0 109.775 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.9 mt -67.12 -27.15 67.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.631 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.1 t -61.93 -28.42 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.712 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.79 -56.72 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 109.519 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.666 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 53.1 t0 -99.07 169.89 9.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.77 73.59 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 109.416 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -77.95 33.18 1.7 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.502 HG21 ' SG ' ' A' ' 59' ' ' CYS . 16.0 pt -55.87 -159.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -1.12 . . . . 0.0 109.372 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.714 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 2.9 tt -55.86 -165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 109.515 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.714 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 8.0 mtt-85 -47.65 153.3 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -142.65 -156.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.176 -179.099 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 57.88 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.933 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -66.13 -44.19 91.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -61.59 -42.58 99.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -1.227 . . . . 0.0 109.5 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.59 HG22 HG12 ' A' ' 76' ' ' VAL . 18.8 mt -57.06 -47.29 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.555 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.573 HE22 ' CD ' ' A' ' 73' ' ' GLU . 15.5 mm100 -53.22 -36.99 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.35 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.355 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.586 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 81.4 mt -59.47 -50.0 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.91 -38.5 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.518 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.33 99.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 97.4 m-20 -69.44 -44.68 70.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.423 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.06 95.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.546 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -63.63 -43.93 95.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 109.531 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.99 -34.18 66.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.895 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.64 -51.29 63.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.31 -39.01 91.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -60.13 -42.84 95.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -61.98 -41.43 98.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.65 -27.01 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.127 -0.983 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -51.67 -20.38 2.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.506 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 110' ' ' GLU . 64.3 t30 -75.53 -18.45 59.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.83 65.16 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.517 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 12.0 mp0 -103.48 151.07 38.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.163 -1.198 . . . . 0.0 109.653 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.97 119.65 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.67 2.247 . . . . 0.0 111.676 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -74.88 -45.74 40.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 0.0 110.467 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -62.09 -47.95 82.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 110.734 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.484 ' O ' ' OG ' ' A' ' 118' ' ' SER . 18.4 t70 -55.8 -40.36 72.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.937 . . . . 0.0 111.036 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -64.72 -51.22 63.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.029 -1.045 . . . . 0.0 111.225 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.3 m -56.78 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.98 -1.075 . . . . 0.0 111.716 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.477 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -86.99 -32.82 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.775 -1.203 . . . . 0.0 111.134 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 120' ' ' VAL . 57.1 p -55.65 -21.03 16.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -44.04 -15.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.007 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.9 m -91.77 24.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.044 -1.035 . . . . 0.0 109.982 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.525 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 1.3 m120 72.56 -48.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 3.0 p-80 165.13 -20.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -106.31 149.3 38.06 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.6 149.17 67.58 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.696 2.264 . . . . 0.0 111.805 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -75.38 146.81 40.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.745 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 88.1 mtp -126.44 144.93 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.117 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.09 175.49 6.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -164.86 71.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.279 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.12 -132.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.734 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.9 m -154.22 -35.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -113.13 155.21 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.76 -30.27 70.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.501 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.0 p -70.74 -33.37 70.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.5 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.69 -24.89 67.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.5 mm -66.33 116.77 37.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.686 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.85 126.3 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.187 2.592 . . . . 0.0 112.538 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.453 ' OG1' ' CB ' ' A' ' 163' ' ' TYR . 2.0 t -77.2 -18.26 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.266 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.4 p -89.25 66.61 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.356 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -77.27 152.31 81.59 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.37 -36.02 16.92 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.8 2.333 . . . . 0.0 112.035 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.46 -41.51 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.1 m -59.65 -39.82 85.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -62.17 -48.32 80.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.82 78.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -61.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.528 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.7 p -63.26 -39.43 94.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.918 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.54 43.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.71 -33.44 75.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.564 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.44 -39.67 84.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.422 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -61.16 -39.93 91.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.618 HH11 ' CG ' ' A' ' 152' ' ' ARG . 7.3 mtt-85 -64.43 -21.51 66.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.85 36.99 5.87 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.448 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 1.4 m-85 -84.79 133.51 34.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -1.112 . . . . 0.0 109.517 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.61 159.87 14.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.448 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 56.12 48.38 17.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.7 p -121.82 26.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.457 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.51 156.3 0.07 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -59.88 -14.02 13.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -1.133 . . . . 0.0 109.448 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.6 p -70.86 -44.97 65.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 38' ' ' GLU . 26.0 mt -65.07 -36.34 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.526 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 68.3 m -55.81 -40.81 73.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.321 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.453 ' CB ' ' OG1' ' A' ' 137' ' ' THR . 37.6 t80 -66.78 -47.26 72.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.405 -0.809 . . . . 0.0 109.314 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.7 m -66.05 -40.68 91.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.317 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.77 -49.38 77.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 92.6 mtp -68.94 -39.55 79.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.666 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.47 -41.89 99.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.734 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.58 97.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.678 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.4 m -66.06 -60.82 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 138.8 1.69 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.29 -33.34 72.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -1.167 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -99.74 130.1 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -98.76 105.06 17.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.29 114.23 26.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -135.51 143.18 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.44 142.5 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.441 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.435 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 89.05 15.63 58.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 178' ' ' GLY . 7.7 m -149.8 176.16 10.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 75.3 m 50.75 -97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 181' ' ' CYS . 52.7 t -156.17 15.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.8 t80 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.641 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.338 0.59 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -48.13 167.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.99 9.23 1.54 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.607 ' CD1' HD13 ' A' ' 132' ' ' LEU . 21.6 m95 -83.13 -1.22 52.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.94 132.8 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' GLN . 68.4 m -79.64 177.94 8.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.4 mm-40 -61.03 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 51.54 85.06 0.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.01 -25.76 4.32 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.852 2.368 . . . . 0.0 112.1 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.91 -39.31 93.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.481 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -71.16 -48.11 53.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.12 -44.84 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.376 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.92 81.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.459 ' CG ' HD21 ' A' ' 50' ' ' LEU . 85.5 t80 -61.64 -43.96 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.18 -49.45 77.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.48 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.483 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -56.95 -56.36 22.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -175.25 131.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -159.64 123.05 3.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 109.516 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.98 -5.29 75.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' CYS . 19.3 t -63.4 132.09 95.02 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.209 -1.171 . . . . 0.0 109.343 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.03 120.47 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.777 2.318 . . . . 0.0 111.849 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.46 132.79 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.854 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -115.08 3.5 14.43 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 109.083 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.1 126.02 32.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 m -64.52 -40.44 95.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -60.93 -45.28 95.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.61 -45.01 69.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.895 . . . . 0.0 109.846 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.2 -43.93 96.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.118 -0.989 . . . . 0.0 109.808 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.486 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 44.9 t80 -60.52 -37.03 79.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.919 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.93 -30.55 63.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.878 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.9 tpp -64.45 -54.98 24.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.794 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.3 tp -64.46 -33.32 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 110.045 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.5 m -64.44 -49.9 69.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 110.106 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.19 -28.38 59.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 109.805 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -52.82 -35.26 56.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 109.772 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.61 -33.88 74.03 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -59.05 -32.54 69.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -1.207 . . . . 0.0 109.763 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -52.87 -39.7 62.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.05 120.41 3.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -35.27 4.2 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.02 -138.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.137 . . . . 0.0 109.445 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -142.41 158.92 43.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -56.14 -39.36 72.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.474 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -59.12 -34.46 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.687 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 61.1 m -69.39 -33.47 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.0 t -57.63 -43.16 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.442 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 50' ' ' LEU . 9.8 mp -56.7 -52.15 66.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.57 -44.69 93.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 109.307 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -73.25 -21.61 60.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.193 -0.942 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.8 ttm-85 -60.35 -46.05 91.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -71.13 -45.95 62.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.403 -0.811 . . . . 0.0 109.439 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.99 -35.0 79.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.609 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 25.3 t80 -62.78 -44.61 95.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.563 ' HG2' HH11 ' A' ' 57' ' ' ARG . 27.9 mtt-85 -57.0 -41.81 79.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.828 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -29.9 71.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.258 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 97.9 m -93.49 -12.6 29.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.262 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 61.8 m-85 -125.68 -43.27 1.88 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 0.0 110.181 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 29.9 t-80 -49.89 -40.14 42.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -61.85 -31.73 72.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.739 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.7 m-85 -91.34 -0.85 57.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.077 -1.014 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.05 161.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.107 -0.995 . . . . 0.0 109.623 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.47 -27.11 16.17 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.867 2.378 . . . . 0.0 112.713 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.5 -47.87 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.13 -35.35 80.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 64' ' ' ASP . 46.3 t -58.11 -35.71 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 109.598 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.81 66.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.466 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 23.08 9.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 tpp -61.22 156.45 18.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.671 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -110.47 156.83 20.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.6 mt-10 -55.75 -35.06 65.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.94 -37.59 85.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 80' ' ' VAL . 59.9 t -54.71 -49.5 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.3 mp0 -64.25 -32.74 74.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.63 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.28 -49.2 67.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.806 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.0 -41.18 67.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.605 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 76' ' ' VAL . 38.9 t -51.1 -33.08 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -80.95 -59.79 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -98.96 117.11 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 77.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -22.91 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 84' ' ' GLY . 24.0 pt -62.29 -134.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.321 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.05 136.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -101.29 117.98 36.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.467 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -172.4 94.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.183 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -45.27 -35.43 3.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 109.967 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.33 -47.66 85.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -66.16 -38.12 87.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.25 -50.22 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.12 -32.99 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.326 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.26 99.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.388 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.06 -46.17 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.375 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.61 -36.45 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.63 94.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.473 ' OD1' ' CD2' ' A' ' 154' ' ' PHE . 86.8 m-20 -60.17 -42.52 95.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.66 89.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.512 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -61.23 -44.33 97.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.29 72.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 30.1 t80 -66.93 -43.72 82.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.527 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -66.93 -50.51 62.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -59.9 -35.0 73.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ttt -59.16 -40.96 87.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.29 -27.75 66.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.482 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -51.66 -34.05 36.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -83.4 -1.19 52.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.39 35.92 40.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -116.84 82.16 12.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.657 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -41.67 131.31 3.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.634 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.06 -47.74 83.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -45.45 80.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 110.718 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -59.22 -33.21 70.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 111.034 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.3 t80 -65.26 -53.43 44.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.023 -1.048 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 116' ' ' VAL . 7.0 m -58.02 -40.99 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.719 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -68.56 -31.12 70.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.719 -1.238 . . . . 0.0 111.104 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -65.15 -34.78 79.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 109.676 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -58.72 -44.2 90.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.084 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 123' ' ' GLN . 3.2 p -89.71 20.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.079 -1.013 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 61.62 30.48 18.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 55.45 22.88 5.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.495 ' H ' HG13 ' A' ' 120' ' ' VAL . 65.8 mt-30 -123.39 100.98 38.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.626 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -47.38 139.45 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.728 2.286 . . . . 0.0 111.855 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -85.5 157.38 20.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -131.85 151.3 51.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 109.183 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -131.58 152.52 50.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -133.96 45.67 2.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.324 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.73 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -68.52 147.06 52.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.2 m -74.08 -36.26 64.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.4 m -132.56 157.58 44.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.884 ' H ' HD12 ' A' ' 132' ' ' LEU . 6.0 mp -54.29 -32.34 56.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.2 t -64.93 -33.83 76.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.73 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 71.3 mm-40 -69.34 -19.12 63.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 109.367 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -66.85 124.2 88.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 109.676 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.36 127.24 5.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.143 2.562 . . . . 0.0 112.552 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 -13.79 47.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.304 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -109.15 100.64 9.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 109.374 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -105.51 150.75 39.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.917 . . . . 0.0 109.462 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.96 -41.1 26.01 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.789 2.326 . . . . 0.0 111.982 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.65 -36.91 60.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.3 m -60.9 -43.24 98.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -61.96 -48.07 82.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.21 89.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.22 -41.39 99.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.2 p -57.88 -43.36 85.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.7 -27.68 68.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.502 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.48 -51.33 29.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.42 -36.17 73.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -57.62 -36.6 72.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.34 -40.1 92.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.62 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -67.51 -19.74 65.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.413 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.92 22.25 16.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.473 ' CD2' ' OD1' ' A' ' 98' ' ' ASN . 8.0 m-85 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -1.107 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -101.79 168.52 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.501 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 54.05 53.13 11.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.28 25.16 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.419 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.41 167.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -55.47 -32.18 62.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.436 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 65.9 p -64.38 -47.78 77.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -65.7 -35.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 5.9 t -68.7 -44.13 74.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.259 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -62.23 -44.97 95.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.7 m -57.99 -37.18 73.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.222 -0.924 . . . . 0.0 109.248 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.617 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 72.4 t80 -59.73 -41.36 90.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.398 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.12 -38.57 72.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.533 HE22 ' CG ' ' A' ' 174' ' ' ASP . 98.1 mm-40 -63.34 -46.45 86.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.7 -44.63 49.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.617 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 98.3 m -62.44 -36.13 81.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.462 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.28 8.8 56.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.8 mp -53.41 -26.82 21.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -1.152 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.06 138.61 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.449 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -82.12 102.37 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.533 ' CG ' HE22 ' A' ' 167' ' ' GLN . 34.4 m-20 -91.56 118.17 30.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.56 166.0 28.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.621 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.27 150.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.29 130.23 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 91.2 4.71 68.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 181' ' ' CYS . 53.5 t -76.34 28.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.542 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.45 ' H ' ' C ' ' A' ' 178' ' ' GLY . 3.2 m 63.04 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 179' ' ' CYS . 73.3 m -59.47 -35.35 73.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.0 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.637 ' HG2' HH11 ' A' ' 3' ' ' ARG . 10.2 mtt-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' TRP . 26.6 p -47.23 127.29 10.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.94 -6.27 3.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' CYS . 16.9 m95 -54.53 -37.0 64.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.423 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 7' ' ' VAL . 17.9 m -88.76 127.15 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.564 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' GLN . 75.2 m -165.86 146.46 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.0 mm100 60.32 133.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.552 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' GLN . 1.1 m-20 63.0 125.11 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.26 -7.71 19.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.845 2.364 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.49 -32.86 72.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.55 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 30.8 m-85 -49.47 -44.23 45.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.78 -28.42 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.424 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -58.97 -48.23 82.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.429 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.559 ' CG ' ' N ' ' A' ' 17' ' ' HIS . 2.2 p90 -75.52 -39.09 58.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.559 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 48.3 t-80 -60.85 -48.21 82.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.42 -44.86 67.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 98.4 m-20 -55.28 -45.45 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.3 pt-20 -173.52 -143.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.595 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 11.0 t-105 60.6 125.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.03 -20.28 46.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 169' ' ' CYS . 26.3 m -84.66 141.36 38.64 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.17 -1.194 . . . . 0.0 109.33 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.87 122.85 4.48 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.758 2.306 . . . . 0.0 111.905 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -119.6 131.98 55.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.02 . . . . 0.0 109.857 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -123.21 5.5 9.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.88 135.01 33.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.439 ' CA ' ' HB2' ' A' ' 113' ' ' ALA . 14.5 m -69.63 -39.36 77.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.603 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.47 -43.59 88.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 109.717 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -65.94 -49.64 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.86 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 ' SG ' ' A' ' 169' ' ' CYS . 43.9 mt -72.91 -29.96 63.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.873 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' ' N ' ' A' ' 33' ' ' GLU . 9.2 t80 -59.98 -56.39 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.0 pp20? -68.58 -29.72 68.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.595 ' SD ' ' CH2' ' A' ' 21' ' ' TRP . 55.2 tpp -63.61 -53.36 52.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.88 -46.78 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 110.05 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.9 t -70.34 -39.17 74.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.4 tp -73.34 -38.37 65.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 35.0 mm-40 -52.76 -34.54 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.24 -23.66 41.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.2 -38.01 86.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.176 . . . . 0.0 109.783 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -48.75 -38.93 23.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.786 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.53 106.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.662 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -31.26 6.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -86.03 -165.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -1.192 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 48' ' ' THR . 15.6 p -117.36 150.64 38.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -56.21 -36.65 68.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -79.52 -30.77 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.707 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 45' ' ' SER . 52.4 m -67.64 -40.46 84.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.679 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' ARG . 70.4 t -68.91 -40.89 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 16' ' ' TYR . 85.7 mt -57.05 -47.25 81.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -60.79 -51.45 69.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 109.297 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.48 -26.31 67.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.7 tmm_? -54.47 -46.63 73.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.38 -34.48 76.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.259 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -63.76 -45.8 88.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -0.789 . . . . 0.0 109.327 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 79.3 mtm180 -62.29 -30.63 71.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.864 . . . . 0.0 109.732 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.66 82.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.881 . . . . 0.0 110.276 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -93.77 -13.33 27.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.27 -178.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -113.76 -52.33 2.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.913 -1.117 . . . . 0.0 110.175 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.424 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.9 t-80 -51.94 -40.0 60.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 109.91 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -56.55 -32.5 65.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-85 -88.67 -2.83 58.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 109.883 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER 56.2 158.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.08 -24.04 20.85 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.893 2.396 . . . . 0.0 112.728 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.39 -48.24 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' MET . 12.2 mptt -67.88 -33.7 75.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 64' ' ' ASP . 94.1 t -56.16 -41.22 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.029 . . . . 0.0 109.551 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.11 68.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.46 17.7 20.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.399 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ttp -75.81 155.43 35.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.68 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 18.5 pt20 -105.48 162.53 13.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.96 -30.07 70.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.32 -41.32 84.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.425 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.5 m-20 -60.93 -39.83 90.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.36 -42.51 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -60.15 -34.06 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.635 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.41 -44.55 82.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 13.9 mt -65.04 -33.4 75.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.932 . . . . 0.0 109.626 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.79 -31.99 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -84.88 -60.89 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.552 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.23 123.73 43.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.371 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . . . -166.11 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.78 27.18 57.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ARG . 9.9 pt -133.0 167.38 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.138 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.71 58.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.634 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -106.69 139.79 40.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.471 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' GLY . 14.3 p80 -128.8 44.19 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.146 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HG2' HH11 ' A' ' 89' ' ' ARG . 3.9 ttt-85 65.67 -58.54 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -60.82 -35.35 89.94 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -61.27 -50.98 70.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -1.167 . . . . 0.0 109.461 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -52.39 -39.51 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.691 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.53 -36.63 76.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.0 109.32 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.14 95.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.7 mp -55.54 -47.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -58.46 -30.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.551 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.23 94.83 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.728 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 29.0 p30 -68.63 -33.35 73.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 109.358 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.728 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -67.4 -42.25 83.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -65.23 -45.95 82.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.585 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.72 63.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 29.8 t80 -68.83 -43.44 75.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.549 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -66.57 -47.96 71.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.474 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -57.97 -39.58 78.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 17.2 ttt -66.74 -41.24 88.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.85 -25.94 68.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -51.28 -29.28 14.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 105' ' ' MET . 51.0 p30 -80.16 -1.48 40.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.489 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.66 79.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HB3' HD21 ' A' ' 108' ' ' ASN . 32.4 tt0 -80.76 132.98 56.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.158 -1.201 . . . . 0.0 109.627 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.47 121.27 8.03 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.614 2.21 . . . . 0.0 111.726 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -74.72 -43.86 52.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.393 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' ' CA ' ' A' ' 28' ' ' SER . . . -56.06 -49.99 72.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -0.967 . . . . 0.0 110.708 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 86.5 m-20 -61.23 -42.7 99.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 27.5 t80 -55.31 -48.62 73.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 111.213 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.7 m -63.82 -48.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 0.0 111.721 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.488 ' CD2' ' N ' ' A' ' 118' ' ' SER . 4.3 p-90 -89.32 -37.49 14.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.769 -1.207 . . . . 0.0 111.117 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.4 m -56.18 -26.88 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.781 -1.199 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -13.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.04 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 118' ' ' SER . 18.7 m -82.8 21.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t30 60.36 36.22 20.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.061 -1.024 . . . . 0.0 109.703 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.2 m80 53.54 27.08 6.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.47 87.91 21.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.72 151.78 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.695 2.263 . . . . 0.0 111.842 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -93.44 155.16 17.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.719 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 71.6 mtm -137.15 147.17 45.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.198 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.5 t -142.18 155.82 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.801 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -123.61 45.61 2.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.289 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.2 139.5 35.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.2 m -74.56 -35.52 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.8 t -139.45 178.92 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -68.84 -33.4 73.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.543 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m -63.12 -36.42 83.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.81 -24.44 64.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.161 -0.962 . . . . 0.0 109.404 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 132' ' ' LEU . 87.4 mt -67.28 119.95 68.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.728 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.76 129.22 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.088 2.526 . . . . 0.0 112.487 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 137' ' ' THR . 1.2 t -80.62 -19.19 45.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.4 m -98.05 98.54 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.858 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.5 p -106.23 154.61 39.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.32 -40.12 52.85 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.839 2.36 . . . . 0.0 111.999 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.16 -36.48 58.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.407 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -61.19 -41.3 96.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 -53.13 57.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.27 -35.26 79.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.435 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.01 -50.19 74.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 80.5 p -58.5 -37.69 76.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.91 -36.08 82.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.549 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.31 -50.56 45.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.467 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.603 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.88 -38.82 79.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.355 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -61.92 -39.37 91.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -63.84 -20.54 65.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.92 31.01 8.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.47 137.95 32.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.132 . . . . 0.0 109.454 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -101.19 173.58 6.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.485 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 52.82 50.79 17.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 157' ' ' VAL . 11.3 p -123.68 28.79 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.21 159.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.8 t -52.46 -29.81 26.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.373 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.5 m -65.9 -36.84 84.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.446 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.9 mm -62.24 -44.09 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.22 -48.7 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.411 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 42.9 t80 -60.21 -47.01 87.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.811 . . . . 0.0 109.352 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 22.6 t -61.64 -43.35 99.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.857 . . . . 0.0 109.27 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.411 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -63.08 -32.63 74.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.47 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 31.5 ttm -64.29 -45.13 89.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.609 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.81 -34.1 77.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.672 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.659 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.557 ' SG ' HD22 ' A' ' 31' ' ' LEU . 1.2 m -77.2 -42.5 37.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.65 28.77 5.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.72 -34.33 77.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.41 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.69 132.15 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -84.64 100.95 11.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p-10 -120.64 92.62 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 176' ' ' VAL . 75.5 m80 -132.99 36.35 3.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.67 HG12 ' N ' ' A' ' 177' ' ' VAL . 86.3 t 54.39 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.452 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.67 ' N ' HG12 ' A' ' 176' ' ' VAL . 8.1 p -110.61 136.23 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.75 24.13 75.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 181' ' ' CYS . 66.4 m -143.73 169.9 16.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 109.523 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 84.5 m 48.3 -93.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 179' ' ' CYS . 50.0 m -157.92 33.09 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 7.9 p -47.39 146.02 2.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.66 2.87 46.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' HE1' HD22 ' A' ' 132' ' ' LEU . 8.8 m95 -54.22 -36.56 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -1.135 . . . . 0.0 109.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -97.01 131.14 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 13.0 t -177.31 -168.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.547 ' N ' ' OG ' ' A' ' 8' ' ' SER . 94.9 mt-30 49.38 -117.93 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.85 153.44 91.17 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.352 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.46 -6.14 18.28 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.804 2.336 . . . . 0.0 112.139 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.5 tt -59.82 -39.52 85.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.633 ' CZ ' HD13 ' A' ' 47' ' ' ILE . 88.7 m-85 -56.47 -43.73 79.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.43 -43.95 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.51 76.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.39 -40.15 93.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -63.42 -37.42 87.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -88.41 -4.41 58.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.513 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.561 HD22 HH22 ' A' ' 53' ' ' ARG . 48.0 t30 -74.09 -73.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -150.93 38.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.479 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -92.77 138.83 31.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.02 -21.39 44.18 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.58 132.44 72.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.247 -1.149 . . . . 0.0 109.366 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.48 119.69 6.28 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.724 2.282 . . . . 0.0 111.87 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.67 137.25 41.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -134.54 2.59 3.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.071 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -89.66 135.19 33.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.375 -0.828 . . . . 0.0 109.303 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.739 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 96.2 p -59.94 -38.28 81.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.632 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -57.02 -43.82 82.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.766 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.37 -53.31 24.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.0 mp -69.03 -27.89 66.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.783 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' N ' ' O ' ' A' ' 28' ' ' SER . 56.1 t80 -60.36 -50.53 73.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.928 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -74.44 -31.11 62.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.813 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.89 -54.39 22.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -64.4 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.032 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' N ' HG23 ' A' ' 35' ' ' ILE . 36.1 t -73.36 -46.6 48.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.16 -0.962 . . . . 0.0 110.088 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.1 -41.67 97.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.877 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.22 -28.59 64.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.296 -0.878 . . . . 0.0 109.788 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.75 -37.07 27.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -66.07 -29.0 69.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -1.184 . . . . 0.0 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.4 tt0 -48.11 -34.22 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.72 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.42 111.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -33.12 5.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.0 mt -96.06 -145.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -1.14 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 m -144.68 155.97 43.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -51.17 -38.95 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.374 -0.829 . . . . 0.0 109.461 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.633 HD13 ' CZ ' ' A' ' 13' ' ' TYR . 9.7 tp -61.94 -40.44 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 109.672 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 47' ' ' ILE . 96.1 m -63.91 -35.87 82.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 53' ' ' ARG . 72.9 t -62.06 -42.82 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.473 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.43 -51.06 69.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -60.37 -44.08 95.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 109.348 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -75.78 -19.35 59.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.975 . . . . 0.0 109.361 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.561 HH22 HD22 ' A' ' 19' ' ' ASN . 43.8 ttp180 -61.22 -45.65 93.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 108.994 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 10.2 pt-20 -72.15 -43.0 65.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.34 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.95 -35.29 79.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.229 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 52.7 t80 -57.39 -49.27 76.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.427 -0.795 . . . . 0.0 109.308 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.4 mtp180 -58.42 -43.12 88.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.741 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.97 -39.81 42.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.793 . . . . 0.0 110.305 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -96.78 -28.63 14.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 35.4 m-85 -95.71 -27.75 15.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.977 -1.077 . . . . 0.0 110.231 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.7 t60 -48.77 -21.66 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -90.87 -25.61 19.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.81 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 68' ' ' VAL . 61.9 m-85 -92.03 66.09 4.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 109.925 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' PHE . 3.7 m-20 -41.33 153.77 0.24 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 109.604 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -35.92 -53.66 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.852 2.368 . . . . 0.0 112.722 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.31 -45.11 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.64 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -67.35 -31.67 72.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.853 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 63' ' ' PHE . 93.9 t -56.45 -46.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.572 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.81 58.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.48 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 -3.58 58.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 mtp -70.97 141.1 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 31.1 tp60 -99.85 169.15 9.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 78.7 mm-40 -61.84 -33.87 74.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 46.7 mp0 -60.84 -40.89 94.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.437 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -62.74 -37.76 87.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.41 -43.29 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.48 -33.47 75.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.97 -44.76 91.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.314 -0.866 . . . . 0.0 109.792 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -70.07 -35.48 74.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 109.591 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.1 t -51.19 -34.94 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.739 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -87.83 -60.13 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.614 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -100.17 109.23 21.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.903 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.47 -60.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.47 4.61 70.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 85' ' ' ILE . 12.9 pt -90.02 -155.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.32 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.2 mt -68.62 136.79 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.478 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 87' ' ' ARG . 19.7 mmm-85 -88.6 95.89 10.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -172.41 88.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.13 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -49.96 -29.12 7.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.04 96.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -63.05 -48.19 79.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -1.186 . . . . 0.0 109.479 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.83 -44.13 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.598 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -54.51 -38.62 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.327 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.02 79.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 60' ' ' PHE . 44.1 mm -57.69 -46.66 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.432 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -55.18 -43.74 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.06 -36.23 85.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.588 HD21 ' HZ ' ' A' ' 154' ' ' PHE . 2.4 t-20 -56.87 -48.16 78.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.72 93.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.416 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 46.2 ttm-85 -66.56 -45.16 80.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.525 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.73 -36.06 67.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -71.08 -47.6 57.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.61 -37.79 85.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.865 . . . . 0.0 109.534 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.53 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.601 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 28.2 ttt -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.529 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.35 -27.19 67.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -52.11 -24.08 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.49 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -75.54 -18.12 59.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.8 7.43 68.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.59 150.28 38.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.205 -1.174 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.99 119.17 6.18 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.621 2.214 . . . . 0.0 111.693 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -74.57 -44.91 48.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.803 . . . . 0.0 110.404 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.26 -48.58 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.201 -0.937 . . . . 0.0 110.732 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 83.2 m-20 -56.23 -43.59 78.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.204 -0.935 . . . . 0.0 111.081 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -61.93 -51.31 68.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 111.227 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 117' ' ' TRP . 6.7 m -57.97 -47.37 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 111.722 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -87.6 -28.04 22.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.696 -1.253 . . . . 0.0 111.178 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -59.61 -23.9 63.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 109.709 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -43.85 -19.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.08 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.7 m -82.9 22.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.087 -1.008 . . . . 0.0 109.954 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 58.22 36.92 26.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.0 109.67 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.1 m80 60.27 15.23 5.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.531 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -111.83 128.1 25.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.628 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.57 147.89 41.42 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.672 2.248 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -98.5 144.5 27.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 109.751 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.4 ttp -132.07 135.06 46.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.784 . . . . 0.0 109.097 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.7 t -85.5 156.08 20.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.897 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -151.06 48.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.855 . . . . 0.0 109.3 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB1' ' OE2' ' A' ' 134' ' ' GLU . . . -100.82 -155.81 0.53 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.662 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.587 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.2 m -130.88 -54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.0 m -98.04 161.11 13.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.429 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.513 HD22 ' HE1' ' A' ' 6' ' ' TRP . 20.9 mt -75.53 -11.16 59.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 t -89.72 -39.04 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 130' ' ' THR . 11.2 pt-20 -68.66 -13.31 62.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 132' ' ' LEU . 79.1 mt -67.43 118.41 56.44 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.52 131.29 5.49 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.047 2.498 . . . . 0.0 112.536 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -91.39 -11.85 36.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.9 t -92.88 99.04 11.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.3 p -110.18 151.56 42.63 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -45.71 -40.79 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.815 2.343 . . . . 0.0 112.011 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.24 76.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -61.66 -42.2 98.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.863 . . . . 0.0 109.494 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -61.06 -44.46 97.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.65 -43.61 68.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.4 -49.56 77.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.7 m -54.12 -43.61 70.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.76 -38.14 84.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.11 -49.87 66.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.5 -34.94 74.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.878 . . . . 0.0 109.564 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -60.55 -36.79 79.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -60.76 -37.88 83.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.24 -21.32 63.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.283 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.77 4.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.588 ' HZ ' HD21 ' A' ' 98' ' ' ASN . 7.5 m-85 -97.51 129.92 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -92.97 167.16 11.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 51.54 48.31 23.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.7 p -121.63 25.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.45 165.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.8 t -56.87 -29.88 63.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -1.156 . . . . 0.0 109.442 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 m -59.77 -47.56 85.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 73.3 m -61.04 -42.89 99.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -60.31 -44.58 95.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.46 -0.775 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.5 p -61.98 -36.71 82.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -42.45 83.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 56.8 mtp -61.36 -39.24 89.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -61.69 -47.12 86.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.17 -38.98 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.98 -14.18 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.42 0.04 77.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.3 mp -63.04 -39.92 96.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.07 131.56 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.501 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' THR . 84.2 m-20 -95.66 117.98 31.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.443 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.15 105.15 17.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -145.89 144.5 30.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.67 137.08 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 177' ' ' VAL . 14.9 p -75.13 134.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.22 3.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.507 ' C ' ' H ' ' A' ' 181' ' ' CYS . 34.8 m -98.66 173.72 6.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -1.152 . . . . 0.0 109.534 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 54.1 m 54.45 5.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.443 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.507 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.3 m 62.8 50.19 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.602 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 23.9 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 45.1 mtm-85 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 6' ' ' TRP . 16.3 p -96.39 -176.14 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.39 -24.83 0.9 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.659 ' CD2' HD21 ' A' ' 132' ' ' LEU . 11.4 m0 53.13 55.68 8.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -59.84 -5.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 6' ' ' TRP . 52.6 m -47.22 114.33 0.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 109.418 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -167.84 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -151.55 150.89 27.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.0 -36.97 16.75 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.896 2.397 . . . . 0.0 112.145 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 47' ' ' ILE . 52.3 tp -63.44 -51.25 66.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -70.08 -45.12 67.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 109.379 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.9 mt -59.81 -42.37 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.347 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.94 -47.1 69.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.417 ' CE1' HD22 ' A' ' 50' ' ' LEU . 87.7 t80 -59.85 -44.7 93.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -62.6 -45.54 92.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.27 -22.25 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.19 -75.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -145.15 113.8 6.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.873 . . . . 0.0 109.52 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -172.99 139.61 0.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -29.84 3.1 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 169' ' ' CYS . 3.7 m -68.02 149.19 98.27 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.232 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.99 128.25 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.805 2.337 . . . . 0.0 111.891 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -124.99 130.67 52.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.78 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -123.13 12.21 9.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.072 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.3 136.8 35.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 92.0 p -73.16 -33.61 65.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.07 -51.57 60.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HZ3' ' HB3' ' A' ' 30' ' ' LYS . 8.9 mtpm? -62.79 -46.39 88.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 109.861 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.42 -37.21 80.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 109.834 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -65.15 -51.32 61.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.12 -32.55 73.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.1 tpt -59.36 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.806 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.29 -39.06 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.7 m -65.7 -45.29 83.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.54 -41.23 66.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.13 -34.17 73.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.38 -36.18 88.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.83 -26.63 64.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -1.191 . . . . 0.0 109.748 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -51.47 -26.07 7.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.698 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.09 109.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.95 -33.42 5.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 mt -97.36 175.18 6.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -1.175 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.8 m -100.94 161.79 13.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 45.2 p90 -55.48 -41.29 72.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.862 . . . . 0.0 109.446 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 8.7 tp -57.97 -38.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.724 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.469 ' N ' HG23 ' A' ' 47' ' ' ILE . 90.3 m -64.69 -37.95 89.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.694 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.43 -42.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.466 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 16' ' ' TYR . 74.5 mt -57.99 -42.49 85.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -61.72 -51.5 68.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 11.5 mptt -65.75 -36.58 83.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -47.15 -42.65 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.194 -0.941 . . . . 0.0 109.006 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -70.17 -42.48 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -63.43 -47.46 81.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.266 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CD2' ' CE1' ' A' ' 60' ' ' PHE . 12.3 m-85 -58.68 -49.27 78.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 17.9 mmm180 -53.3 -27.75 24.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.35 -29.43 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 56' ' ' TYR . 16.7 m-85 -81.73 -51.75 7.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.945 -1.097 . . . . 0.0 110.205 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 53.1 t60 -51.62 -42.3 61.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.829 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -73.67 -14.58 61.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CE2' ' SD ' ' A' ' 71' ' ' MET . 16.3 t80 -93.3 2.83 56.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.007 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.93 159.2 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.024 . . . . 0.0 109.598 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.2 -53.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.886 2.391 . . . . 0.0 112.707 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.1 t -48.17 -41.95 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.717 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -64.74 -34.57 78.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.382 -0.824 . . . . 0.0 109.883 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 64' ' ' ASP . 54.5 t -56.93 -40.55 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.614 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -70.68 -32.94 70.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 109.452 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.04 18.57 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.603 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -75.36 155.2 36.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.689 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.8 tp60 -102.63 167.54 9.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 96.4 mt-10 -70.05 -25.92 63.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.2 -30.99 67.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.465 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.27 -49.7 68.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 76' ' ' VAL . 8.5 m -59.65 -37.88 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.9 mt-10 -58.99 -35.98 74.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.3 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -65.72 -40.2 91.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.16 -34.28 77.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.9 -35.49 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -87.06 -62.03 1.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -101.34 107.08 18.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.61 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.85 14.38 65.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 pt -104.09 178.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.391 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.51 140.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HG3' HH11 ' A' ' 87' ' ' ARG . 44.0 mtm-85 -87.81 101.81 14.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.52 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.464 ' CD2' ' HZ2' ' A' ' 91' ' ' LYS . 49.2 t-80 -171.54 82.04 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.218 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 15.3 ptm180 -46.84 -30.46 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.83 93.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HZ2' ' CD2' ' A' ' 88' ' ' HIS . 62.3 mttp -66.11 -42.62 88.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.6 mt -63.64 -49.55 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.37 -35.6 67.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.375 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.3 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.98 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.06 -39.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.539 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.69 95.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.481 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 42.6 m-20 -63.26 -43.83 96.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -1.204 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.06 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 47.6 ttm-85 -58.46 -41.75 85.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.21 70.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.87 -48.46 81.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -61.75 -44.72 96.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.6 -44.26 93.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.604 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 23.7 ttt -67.11 -32.54 73.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.48 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.91 -29.25 69.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -52.29 -24.75 7.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.15 -18.7 59.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.492 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.8 55.11 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -116.85 150.8 46.46 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -1.181 . . . . 0.0 109.691 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.21 130.86 26.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.618 2.212 . . . . 0.0 111.659 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -79.25 -49.21 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.475 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -55.77 -48.92 74.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.53 ' O ' ' OG ' ' A' ' 118' ' ' SER . 85.3 m-20 -60.0 -43.63 95.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 111.053 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.59 -50.92 70.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.067 -1.021 . . . . 0.0 111.188 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.6 m -59.31 -48.45 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.096 -1.003 . . . . 0.0 111.64 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.474 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 5.0 p-90 -88.88 -33.38 17.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 0.0 111.147 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 120' ' ' VAL . 66.8 m -55.08 -26.44 37.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.793 -1.192 . . . . 0.0 109.752 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.32 -14.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 118' ' ' SER . 12.9 m -85.07 27.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.046 -1.034 . . . . 0.0 109.983 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 75.78 19.0 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.747 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 58.72 39.65 24.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.438 ' H ' HG23 ' A' ' 120' ' ' VAL . 8.3 pt20 -146.05 146.77 29.56 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.636 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.86 147.56 44.35 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.691 2.261 . . . . 0.0 111.814 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -111.21 153.72 25.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 58.2 ttm -133.26 148.83 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -122.52 164.84 17.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -133.41 49.68 2.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.308 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.52 -158.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 11.7 m -145.34 -27.48 0.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.57 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 8.9 m -127.73 157.98 38.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -75.22 -12.79 60.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.2 m -93.0 -32.53 14.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 131' ' ' THR . 5.6 pt-20 -74.11 -1.42 20.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.925 . . . . 0.0 109.428 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 28.9 mm -66.9 130.85 93.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.77 126.24 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.096 2.531 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 137' ' ' THR . 3.1 m -89.77 -10.57 45.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.9 . . . . 0.0 109.342 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 72.2 p -94.13 102.26 14.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 p -119.11 149.9 47.92 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.53 -31.84 87.67 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.17 58.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 42.9 t -62.08 -46.33 89.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.469 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -61.67 -46.23 90.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.57 84.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.67 -47.11 82.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.0 t -54.5 -45.09 73.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -60.62 -33.33 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.547 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.24 16.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 149' ' ' LEU . 10.7 mp -60.15 -34.75 73.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.575 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -58.15 -34.97 70.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.43 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -62.66 -36.31 82.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.637 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -72.14 -19.88 61.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.357 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.56 30.11 7.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.481 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 5.1 m-85 -86.29 132.67 33.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -1.108 . . . . 0.0 109.474 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -104.79 177.86 4.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 52.8 47.94 23.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 158' ' ' GLY . 26.9 m -116.32 25.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.58 166.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.0 m -54.01 -32.54 54.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.3 p -65.09 -48.04 75.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -66.31 -39.29 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 7.9 t -68.58 -44.31 74.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.5 -42.03 98.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -59.27 -33.47 71.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.245 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 79.4 t80 -65.77 -35.45 80.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.397 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.2 mmm -63.32 -52.2 62.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.85 -38.0 85.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.45 -54.19 49.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.675 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 8.7 m -66.29 -33.23 75.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.01 35.38 6.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -74.05 -41.39 61.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.425 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 172' ' ' VAL . 3.0 m -96.56 134.27 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -88.66 110.04 20.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -84.57 122.42 29.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -142.38 165.55 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.601 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 4.8 m -122.65 164.11 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 0.0 109.414 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.427 HG22 ' CE2' ' A' ' 182' ' ' TYR . 59.3 t -96.21 133.38 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 72.2 29.48 66.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 178' ' ' GLY . 3.3 m -164.64 178.74 7.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.46 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 43.6 t 51.03 -98.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 7.7 m -162.91 27.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.645 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.605 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.598 HH12 HG23 ' A' ' 14' ' ' ILE . 70.9 mtm180 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.332 0.587 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 m -140.94 71.37 1.36 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 7' ' ' VAL . . . -139.88 -5.67 1.19 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 19.8 m95 49.53 11.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.411 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.8 m -62.25 140.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -168.32 36.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.349 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 70.0 tp60 -142.76 110.03 5.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 6.3 t70 61.71 134.51 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.28 -10.17 23.87 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.819 2.346 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.34 -41.58 98.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -69.65 -41.57 75.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.8 mp -60.8 -51.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.424 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -46.97 65.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.429 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' OH ' ' CZ3' ' A' ' 21' ' ' TRP . 60.5 t80 -61.55 -43.83 98.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.0 -39.96 94.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -88.16 -0.11 56.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -75.19 -78.91 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.835 . . . . 0.0 109.407 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -147.06 40.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CZ3' ' OH ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -103.89 145.47 30.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.57 62.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 23' ' ' VAL . 1.2 m -84.67 152.26 59.72 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.226 -1.161 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 121.13 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.727 2.285 . . . . 0.0 111.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 78.4 mm-40 -123.8 135.92 54.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.9 p -126.75 12.33 7.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.281 -0.887 . . . . 0.0 109.055 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.88 134.44 47.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.385 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 83.4 p -72.44 -37.9 68.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -67.8 -34.57 77.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 0.0 109.804 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' HZ1' ' CD ' ' A' ' 25' ' ' GLU . 30.6 ttmt -75.23 -54.29 7.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD22 ' HB1' ' A' ' 113' ' ' ALA . 8.5 mp -66.57 -37.28 84.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.856 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 51.0 t80 -61.17 -42.73 99.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.938 . . . . 0.0 109.904 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.2 -29.51 64.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.599 ' SD ' ' CH2' ' A' ' 46' ' ' TRP . 49.9 tpp -74.46 -54.28 7.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.783 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 36' ' ' CYS . 9.3 tp -57.18 -37.74 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.043 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 15.0 p -73.16 -46.28 51.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 61.9 tp -73.28 -34.99 66.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -0.99 . . . . 0.0 109.932 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 43.2 tp10 -52.13 -28.66 18.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.69 51.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -62.36 -32.41 73.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 109.754 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.426 HE21 ' H ' ' A' ' 46' ' ' TRP . 50.2 tt0 -50.21 -35.07 24.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.705 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.43 116.84 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.42 -20.2 49.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.48 -144.34 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -1.205 . . . . 0.0 109.414 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.7 t -146.4 151.22 37.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 72.6 t-105 -55.35 -28.47 54.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.609 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -54.05 -37.89 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.727 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 18.8 m -85.26 -33.84 22.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 109.657 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -61.06 -36.99 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.45 HD21 ' HE1' ' A' ' 46' ' ' TRP . 19.8 mt -54.63 -54.05 46.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.1 -49.96 75.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.262 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -65.51 -33.33 75.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HG2' HH11 ' A' ' 53' ' ' ARG . 28.0 ttt-85 -48.97 -43.71 40.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.14 -40.62 86.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -66.36 -40.84 90.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.288 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD1' HD12 ' A' ' 85' ' ' ILE . 4.5 m-85 -56.22 -48.61 76.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 84.7 mtm180 -64.74 -27.08 68.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 0.0 109.81 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.1 94.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 83' ' ' ALA . 86.9 m -94.45 -40.79 9.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.3 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.74 -52.01 16.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 0.0 110.224 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 39.2 t60 -50.94 -38.28 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.899 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -54.32 -36.98 64.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.12 -0.988 . . . . 0.0 109.811 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' ASP . 86.9 m-85 -97.54 3.71 50.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.883 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.92 161.44 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.096 -1.003 . . . . 0.0 109.569 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.12 -26.37 21.42 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.885 2.39 . . . . 0.0 112.694 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.6 t -62.68 -48.81 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.734 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' MET . 89.2 mttt -67.17 -31.79 72.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 64' ' ' ASP . 75.1 t -56.32 -41.37 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 109.606 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.96 62.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.507 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.24 3.06 51.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.3 mtp -66.2 136.67 56.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.617 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -92.12 168.12 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 57.4 mp0 -59.23 -29.7 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.462 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.4 -44.35 88.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.5 -37.52 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.82 -44.02 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -35.72 76.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -60.56 -41.5 94.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 109.736 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 82' ' ' ASP . 92.1 mt -72.73 -31.92 65.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.175 -0.953 . . . . 0.0 109.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.83 -31.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.938 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -84.29 -59.27 2.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.978 . . . . 0.0 109.568 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 21.3 t70 -96.33 148.27 22.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.897 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.09 71.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.406 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -89.24 30.59 5.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' O ' ' A' ' 86' ' ' ILE . 4.9 pt -45.75 117.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.31 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.715 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 3.5 tt 38.63 -168.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.504 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.715 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -52.16 152.56 3.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.504 ' ND1' HD11 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -141.91 -162.9 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 109.184 -178.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.684 ' H ' ' CD1' ' A' ' 92' ' ' ILE . 56.7 ttt180 62.37 -77.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 109.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -71.86 -48.07 29.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.21 -38.6 87.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.684 ' CD1' ' H ' ' A' ' 89' ' ' ARG . 52.5 mt -55.07 -46.64 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 109.648 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.428 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.57 82.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.8 -38.79 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.5 mt -54.22 -46.59 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.18 -36.1 92.49 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.541 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -60.96 -49.08 78.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -1.23 . . . . 0.0 109.422 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.89 89.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -64.62 -46.83 80.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.25 69.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.421 ' CD1' ' CE1' ' A' ' 32' ' ' PHE . 77.2 t80 -64.64 -46.81 80.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 109.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.05 -40.65 98.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -57.45 -42.51 82.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 25.5 ttt -71.09 -33.26 70.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.548 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.69 -30.77 71.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -51.4 -25.91 6.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 109.548 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -76.47 -16.65 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.01 41.65 47.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -129.79 151.11 77.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.186 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.2 125.7 15.06 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.592 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 23.9 t80 -72.99 -44.1 61.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.42 -0.8 . . . . 0.0 110.417 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -54.98 -48.85 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.742 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 118' ' ' SER . 87.2 m-20 -52.16 -38.38 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 111.102 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -72.7 -49.87 28.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 111.244 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.45 -49.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.01 -1.056 . . . . 0.0 111.696 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.452 ' HB2' HD11 ' A' ' 171' ' ' LEU . 15.8 p-90 -87.01 -24.38 24.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.709 -1.244 . . . . 0.0 111.147 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' VAL . 7.7 t -57.63 -32.99 67.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.61 -12.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 7.3 p -83.09 23.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 12.0 t-20 79.33 16.63 0.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 7.1 m80 57.74 43.54 21.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -155.31 148.44 18.29 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.0 151.34 73.42 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.655 2.237 . . . . 0.0 111.833 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -120.35 146.49 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 109.801 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.6 mtp -129.59 156.26 44.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 109.184 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 173' ' ' ASN . 6.6 t -128.9 147.59 50.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.908 . . . . 0.0 109.797 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -113.24 43.02 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 109.302 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.437 ' HB1' ' CG ' ' A' ' 134' ' ' GLU . . . -75.58 152.1 37.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 m -92.48 -34.41 14.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.79 30.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.481 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -74.06 -9.11 58.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.6 p -83.4 -31.53 26.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.437 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -78.19 -18.47 55.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.51 116.88 41.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.765 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.11 136.83 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.146 2.564 . . . . 0.0 112.5 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 t -85.05 -4.25 59.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.2 t -98.39 103.66 15.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.367 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -126.89 152.68 75.69 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.13 -42.53 26.34 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.758 2.305 . . . . 0.0 112.043 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.36 -37.85 63.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -49.73 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.32 -39.41 93.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.04 77.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.0 OUTLIER -62.68 -44.25 96.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.4 p -62.16 -38.07 87.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.52 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -65.05 -36.47 84.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.86 -50.51 56.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.75 -34.32 76.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -60.24 -41.69 93.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -63.89 -38.19 90.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.55 HH22 ' CE ' ' A' ' 105' ' ' MET . 11.7 tpp180 -64.4 -21.47 66.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.34 24.18 6.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -95.39 130.65 42.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -1.111 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 63.2 mttp -98.06 -167.12 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 19.0 p90 40.31 38.86 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.5 OUTLIER -102.34 25.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -45.38 163.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 2.5 t -63.43 -23.99 67.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -1.161 . . . . 0.0 109.478 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.5 p -70.07 -38.45 75.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -69.74 -41.24 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.3 p -64.88 -33.72 76.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.457 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 51.9 t80 -65.61 -50.97 63.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.374 -0.829 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 18.9 t -58.69 -33.11 69.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 109.28 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.84 -42.18 88.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.444 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 52.0 mtt -62.96 -37.43 87.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -55.07 -40.26 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.76 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.91 11.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.504 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 10.5 t -59.29 -37.27 77.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.94 14.28 52.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.504 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mp -54.83 -56.81 15.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.16 134.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.457 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.667 HD21 ' CE1' ' A' ' 175' ' ' HIS . 17.2 t-20 -100.56 103.78 15.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.435 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 32.4 p30 -103.47 91.47 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.536 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.667 ' CE1' HD21 ' A' ' 173' ' ' ASN . 44.6 m170 -102.81 0.3 32.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.592 ' O ' ' O ' ' A' ' 175' ' ' HIS . 6.2 t 56.61 139.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.55 123.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.98 -50.15 0.71 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 7.8 t -150.46 -132.67 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -1.157 . . . . 0.0 109.519 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 8.5 t 52.95 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 35.9 t -162.49 32.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.3 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.643 -179.47 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 44.3 mtm-85 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 180' ' ' CYS . 8.0 m -59.8 151.83 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.419 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.22 -20.68 16.27 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -52.64 -34.96 53.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.436 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.34 128.81 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.555 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 9' ' ' GLN . 22.6 t -169.68 129.97 1.02 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 8' ' ' SER . 92.8 mm-40 44.8 -156.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 109.526 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 52.38 64.09 7.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -45.64 -34.94 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.771 2.314 . . . . 0.0 112.185 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' CD2' ' HZ3' ' A' ' 51' ' ' LYS . 60.1 tp -63.87 -38.63 91.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 17' ' ' HIS . 86.6 t80 -66.65 -43.61 84.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.44 -43.65 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.23 83.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -59.94 -42.83 94.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.365 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 13' ' ' TYR . 2.4 m-70 -62.24 -39.47 92.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -60.63 -27.45 67.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.61 -77.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.506 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -143.64 116.24 8.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -172.17 140.09 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.59 -28.22 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.538 HG23 ' OE2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -67.9 154.4 93.69 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.184 -1.186 . . . . 0.0 109.412 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.07 120.09 4.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.762 2.308 . . . . 0.0 111.959 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.538 ' OE2' HG23 ' A' ' 23' ' ' VAL . 18.8 mp0 -103.15 133.86 47.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.812 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -134.77 4.1 3.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.93 133.2 35.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 p -61.35 -34.44 75.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.86 -52.3 57.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -68.74 -45.9 70.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.884 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.29 -46.55 89.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.868 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.475 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 93.8 t80 -68.05 -47.29 68.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -64.08 -30.72 71.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.854 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.671 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 55.7 ttm -64.71 -51.83 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -58.28 -47.41 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 12.4 p -62.55 -37.89 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.052 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.525 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 6.2 tp -66.69 -39.81 88.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.12 -27.81 69.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.5 -36.51 11.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.522 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 1.7 mp0 -59.9 -33.79 72.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.2 tt0 -57.18 -29.74 63.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.715 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.03 109.83 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.626 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.67 -32.3 5.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.0 mt -103.67 -155.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -1.153 . . . . 0.0 109.464 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 m -121.97 149.67 43.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 47' ' ' ILE . 23.7 p90 -49.05 -36.51 18.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.642 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -60.9 -37.2 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.659 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.463 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 57.2 m -64.46 -33.69 76.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.95 -38.96 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.1 mp -54.3 -52.06 62.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HZ3' ' CD2' ' A' ' 12' ' ' LEU . 61.0 mttm -59.67 -49.21 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.325 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.22 -34.13 77.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.62 ' NH1' HH21 ' A' ' 57' ' ' ARG . 3.1 ttt-85 -49.5 -45.44 47.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.118 -0.989 . . . . 0.0 108.937 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -66.84 -40.6 88.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.376 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 55' ' ' ASN . 0.3 OUTLIER -64.51 -40.98 96.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.851 . . . . 0.0 109.249 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' PHE . 4.4 m-85 -56.59 -43.34 79.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 109.304 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.62 HH21 ' NH1' ' A' ' 53' ' ' ARG . 96.7 mtt180 -58.61 -36.22 73.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -49.29 76.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.198 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' CE2' ' A' ' 60' ' ' PHE . 3.2 p -94.68 -13.2 26.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.285 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' TYR . 63.6 m-85 -133.27 32.16 3.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.913 -1.117 . . . . 0.0 110.192 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 p80 -46.91 -42.94 18.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' PHE . 40.6 tt0 -79.64 -42.9 23.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.806 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 69.5 t80 44.07 36.64 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -56.57 113.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 109.558 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.07 -45.12 7.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.944 2.429 . . . . 0.0 112.678 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.8 p -66.27 -45.33 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 66' ' ' VAL . 55.3 tttp -61.94 -45.24 94.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.82 -39.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.095 . . . . 0.0 109.628 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.31 64.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.494 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 12.77 23.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.6 tpp -50.41 161.05 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.625 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.82 156.99 19.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.81 -33.38 74.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.5 -39.22 86.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' VAL . 91.3 t -71.84 -28.54 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -68.34 -43.57 77.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.341 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 30.9 ptt180 -76.42 -34.63 58.8 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.838 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 mt -61.84 -39.05 90.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.678 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 76' ' ' VAL . 53.5 t -58.56 -28.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.988 . . . . 0.0 109.736 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.55 -53.79 3.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 78' ' ' ARG . 1.9 p30 -99.77 106.52 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.72 -64.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.34 -1.48 76.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 85' ' ' ILE . 15.5 pt -77.11 -159.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 109.36 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.42 136.56 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 96.6 mtt180 -79.35 95.68 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.6 m-70 -166.47 82.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 109.214 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -46.56 -35.25 5.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.984 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.83 -34.37 82.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -72.45 -41.69 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.509 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.6 -56.29 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.29 -30.95 63.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.7 99.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.39 -43.11 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.6 mm -54.59 -48.1 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.28 -34.28 89.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 32' ' ' PHE . 15.8 t-20 -56.65 -45.8 81.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.184 . . . . 0.0 109.337 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.76 73.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.542 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.29 -43.4 98.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.434 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.38 -33.38 75.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.579 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.34 -46.42 83.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.21 -42.65 99.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -59.12 -53.87 53.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.543 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 26.0 ttt -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.73 -27.41 65.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -52.05 -26.42 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -75.69 -19.09 59.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.44 18.86 65.46 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.34 151.65 37.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.9 119.18 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.618 2.212 . . . . 0.0 111.668 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -75.42 -43.33 50.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -59.79 -47.62 84.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 118' ' ' SER . 92.2 m-20 -51.1 -54.93 20.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 0.0 111.029 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.25 -43.35 82.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' O ' HD11 ' A' ' 145' ' ' LEU . 62.3 t -54.39 -60.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.679 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.708 ' O ' HG22 ' A' ' 120' ' ' VAL . 67.8 p-90 -86.03 -17.86 34.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.727 -1.233 . . . . 0.0 111.153 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.508 ' OG ' ' NE2' ' A' ' 122' ' ' HIS . 9.2 t -54.98 -30.61 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.872 -1.142 . . . . 0.0 109.744 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -43.43 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 178.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.9 m -82.84 24.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.945 . . . . 0.0 110.004 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.87 29.28 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.508 ' NE2' ' OG ' ' A' ' 118' ' ' SER . 26.1 m80 55.62 34.48 23.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.592 ' H ' HG23 ' A' ' 120' ' ' VAL . 72.6 mt-30 -141.91 114.53 6.52 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.45 154.49 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.648 2.232 . . . . 0.0 111.861 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -106.59 144.4 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.1 mtp -137.61 151.73 48.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.797 . . . . 0.0 109.187 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.1 t -129.65 160.09 34.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.904 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.04 46.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 0.0 109.26 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.45 -135.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.73 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 m -143.34 -33.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.378 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 t -137.96 170.77 15.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.757 ' H ' HD12 ' A' ' 132' ' ' LEU . 5.5 mp -68.31 -32.29 72.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.4 m -54.21 -37.3 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.184 -0.947 . . . . 0.0 109.478 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.7 -35.04 78.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.917 . . . . 0.0 109.427 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.767 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.8 mp -81.36 117.82 69.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.663 ' C ' ' H ' ' A' ' 138' ' ' SER . 89.0 Cg_endo -82.59 2.49 8.47 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.133 2.556 . . . . 0.0 112.555 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.531 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER 56.08 -4.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 136' ' ' PRO . 65.2 p -123.41 80.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.319 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -83.74 153.78 64.53 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.49 -37.01 19.22 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.773 2.315 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.97 -36.83 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.311 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.2 m -61.38 -49.07 78.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.462 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 49.8 t0 -62.93 -45.91 90.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.42 86.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 116' ' ' VAL . 6.5 tt -66.0 -43.52 87.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -54.64 -44.99 73.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.462 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 61.1 mttp -63.81 -30.74 71.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.573 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.56 -52.03 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.8 mm? -62.91 -39.09 93.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.78 -37.54 87.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -60.8 -38.14 84.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.359 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.583 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -63.8 -22.7 67.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.378 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 116.53 9.51 11.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.434 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 46.8 m-85 -82.53 133.74 35.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -1.143 . . . . 0.0 109.494 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 60.6 mttp -99.97 -169.39 1.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 14.5 p90 39.43 40.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 158' ' ' GLY . 0.3 OUTLIER -110.57 25.44 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.364 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.49 170.7 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.5 t -62.77 -28.13 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -1.097 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 68.3 p -64.59 -48.17 75.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -63.92 -35.9 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.88 -48.54 73.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.312 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -60.11 -43.21 95.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -59.63 -39.19 83.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -68.03 -41.01 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.437 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.441 ' SD ' HD22 ' A' ' 171' ' ' LEU . 35.4 mmm -59.74 -41.2 90.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.0 109.573 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.8 -46.14 66.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.671 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -63.8 -34.34 77.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.504 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 17.2 t -81.41 -4.35 55.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 65.77 24.13 71.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.441 HD22 ' SD ' ' A' ' 166' ' ' MET . 1.8 tp -68.8 -47.16 66.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 109.422 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 172' ' ' VAL . 8.2 p -103.45 131.98 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.406 ' O ' HG22 ' A' ' 127' ' ' THR . 10.0 m120 -90.54 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -98.27 119.05 36.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.498 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.652 ' ND1' ' CD2' ' A' ' 182' ' ' TYR . 2.5 p80 -164.33 127.28 2.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.55 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.81 150.98 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.413 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 140.72 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.131 -0.981 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.75 1.62 70.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.476 ' C ' ' H ' ' A' ' 181' ' ' CYS . 49.9 m -155.01 179.5 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 5.2 t 60.4 1.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.4 t 65.82 50.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.902 . . . . 0.0 109.614 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.652 ' CD2' ' ND1' ' A' ' 175' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -46.52 159.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -109.87 -21.76 6.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -66.08 -11.83 51.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG12 ' H ' ' A' ' 8' ' ' SER . 43.6 t -82.39 -123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.765 ' H ' HG12 ' A' ' 7' ' ' VAL . 23.8 t 53.5 170.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 8' ' ' SER . 52.3 tt0 59.5 135.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' LEU . 13.4 m-20 50.45 82.05 0.25 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.3 -10.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.828 2.352 . . . . 0.0 112.108 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 47' ' ' ILE . 18.3 tp -62.7 -34.01 76.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 33.2 m-85 -54.26 -41.97 69.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 109.504 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.8 mt -80.0 -33.14 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.435 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.32 -48.19 71.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 109.509 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 13' ' ' TYR . 1.5 p90 -76.51 -34.27 58.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.482 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 57.3 t-80 -55.77 -50.01 71.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.26 -38.44 65.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.419 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -56.02 -46.59 78.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.9 pt-20 -173.28 -146.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' A' ' 20' ' ' GLU . 27.9 t-105 58.94 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.14 -9.0 59.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.2 154.43 37.68 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.94 119.9 7.02 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.786 2.324 . . . . 0.0 111.899 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -127.47 136.69 52.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.975 . . . . 0.0 109.826 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.0 p -131.55 9.46 4.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 0.0 109.075 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -90.68 135.17 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 0.0 109.299 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.744 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 89.4 p -61.67 -39.31 90.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.9 -41.09 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 0.0 109.774 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -77.23 -53.89 7.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.905 . . . . 0.0 109.863 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD22 ' HB1' ' A' ' 113' ' ' ALA . 10.9 mp -64.6 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 80.0 t80 -62.33 -56.45 18.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 109.854 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.84 -31.14 70.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.902 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.501 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.56 -51.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.866 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -62.43 -43.3 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -60.86 -48.38 82.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 110.086 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 8.2 mp -73.69 -44.68 55.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.929 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.89 -37.13 75.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.69 -25.1 34.88 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -82.64 -18.39 41.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.234 . . . . 0.0 109.773 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.6 pp0? -61.95 -21.44 64.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.71 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.07 110.22 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.695 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.03 -32.9 5.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.05 164.37 12.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -1.142 . . . . 0.0 109.448 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -86.26 167.06 15.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 47' ' ' ILE . 5.4 p90 -61.07 -43.78 98.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 48' ' ' THR . 10.4 tp -43.52 -42.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.553 ' N ' HG23 ' A' ' 47' ' ' ILE . 95.1 m -61.13 -34.21 74.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 46' ' ' TRP . 16.4 t -66.56 -46.7 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.33 -53.06 61.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -61.64 -46.21 90.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.351 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 56' ' ' TYR . 43.6 tttm -65.44 -30.18 70.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.383 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.2 ttm180 -55.72 -48.37 75.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.267 -0.895 . . . . 0.0 108.952 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.47 -46.64 87.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.45 -0.781 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 94.4 m-20 -69.07 -32.42 71.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.251 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.7 t80 -62.28 -44.61 96.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.405 -0.809 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 61' ' ' HIS . 14.5 mtm180 -60.08 -42.22 94.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 109.764 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.52 69.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -0.815 . . . . 0.0 110.301 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.6 m -92.98 -12.1 31.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 110.281 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 65.6 m-85 -129.47 -48.11 1.17 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.882 -1.137 . . . . 0.0 110.155 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' ARG . 62.3 t60 -50.14 -43.46 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.085 -1.009 . . . . 0.0 109.904 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -66.56 -25.92 66.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 93.4 m-85 -91.88 16.48 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 109.889 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 55.12 167.05 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.94 -55.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.832 2.355 . . . . 0.0 112.68 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -48.93 -44.29 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.557 ' N ' HG13 ' A' ' 66' ' ' VAL . 48.3 tttp -58.28 -36.91 74.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.845 . . . . 0.0 109.82 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 64' ' ' ASP . 56.5 t -57.18 -37.92 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 109.575 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.53 -29.82 68.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.81 22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.342 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.42 ' SD ' ' CB ' ' A' ' 75' ' ' ASP . 3.4 mmm -60.48 173.76 0.66 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.638 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -131.8 158.29 41.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.35 -29.76 71.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -72.57 -31.55 65.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.478 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' CB ' ' SD ' ' A' ' 71' ' ' MET . 85.6 m-20 -65.06 -48.14 74.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 80' ' ' VAL . 11.2 m -61.75 -40.19 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.537 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -62.28 -30.62 71.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.309 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.21 -46.42 77.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.379 -0.826 . . . . 0.0 109.803 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.3 pp -78.58 -22.78 46.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 109.572 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 76' ' ' VAL . 3.6 t -51.17 -36.71 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.801 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -50.61 -42.41 56.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -89.86 115.02 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -80.28 26.12 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.432 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.439 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . -45.06 -23.49 0.65 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.3 pt -124.19 177.19 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -1.136 . . . . 0.0 109.322 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.4 mt -45.28 137.31 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 59.8 mtp180 -80.05 95.36 6.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 11.7 m-70 -168.37 83.66 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.134 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.301 -0.874 . . . . 0.0 109.97 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.16 97.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -62.19 -38.47 89.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -1.215 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.436 HG22 HG12 ' A' ' 76' ' ' VAL . 23.3 mt -57.23 -48.66 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.573 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.45 -38.72 69.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 0.0 109.402 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -36.66 71.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.26 -40.43 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.368 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.4 mt -56.16 -50.29 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.534 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.79 -36.68 92.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.598 ' ND2' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -56.67 -41.84 77.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -1.157 . . . . 0.0 109.38 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.3 74.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.08 -41.83 93.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 -29.92 70.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 35.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.0 -36.37 83.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.41 -38.71 84.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.577 ' SD ' ' NH2' ' A' ' 152' ' ' ARG . 2.0 tpt -67.79 -38.79 83.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -61.67 -30.09 70.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.437 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -52.52 -31.51 35.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.475 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -87.0 -5.59 59.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.77 69.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -105.28 119.42 53.02 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -1.183 . . . . 0.0 109.654 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.72 119.43 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.548 2.166 . . . . 0.0 111.714 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.48 -35.98 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.828 . . . . 0.0 110.427 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -67.95 -50.07 58.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.182 -0.949 . . . . 0.0 110.707 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 118' ' ' SER . 40.8 t0 -60.5 -46.76 88.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -56.92 -52.77 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.089 -1.007 . . . . 0.0 111.209 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 117' ' ' TRP . 15.4 m -56.74 -48.94 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.03 -1.044 . . . . 0.0 111.677 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.495 ' HB2' HD11 ' A' ' 171' ' ' LEU . 3.4 p-90 -88.35 -27.7 21.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.819 -1.176 . . . . 0.0 111.121 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 120' ' ' VAL . 28.3 t -55.92 -27.21 51.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.717 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.57 -14.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.718 ' O ' HG12 ' A' ' 120' ' ' VAL . 59.9 t -83.9 23.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.06 -1.025 . . . . 0.0 109.911 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 14.6 t-20 72.82 22.66 3.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.2 t60 60.26 49.65 6.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.94 149.13 22.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.03 155.16 29.79 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.676 2.251 . . . . 0.0 111.816 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -119.2 145.51 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.744 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.9 ttm -136.34 149.81 48.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.16 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 t -134.81 156.76 48.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.37 48.53 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -69.81 128.98 38.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.636 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.413 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.4 m -71.07 -33.43 70.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 t -136.84 174.5 10.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.27 -31.05 71.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -60.36 -39.34 86.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.511 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.1 mt-10 -65.39 -29.44 70.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.44 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.25 116.18 33.78 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.693 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -86.95 117.49 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.14 2.56 . . . . 0.0 112.511 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.8 m -74.04 -17.66 60.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 138' ' ' SER . 24.6 p -94.72 100.67 12.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.89 151.54 44.86 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 -32.1 92.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.854 2.369 . . . . 0.0 112.036 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.83 -38.69 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 m -56.52 -44.41 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.83 -45.58 88.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.14 81.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -63.46 -43.91 95.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -56.83 -44.45 82.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.21 -36.2 81.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.77 73.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.438 HD11 HD22 ' A' ' 145' ' ' LEU . 50.8 mt -60.77 -40.57 93.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.393 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -60.93 -40.59 93.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.577 ' NH2' ' SD ' ' A' ' 105' ' ' MET . 5.8 tpp180 -65.72 -22.63 66.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.335 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.33 9.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.84 133.15 34.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -1.165 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -97.68 175.5 6.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 54.3 51.81 13.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 158' ' ' GLY . 15.4 m -119.89 26.2 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.24 167.62 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.9 t -59.58 -28.28 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -1.147 . . . . 0.0 109.477 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 p -63.56 -43.08 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -66.21 -39.77 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.73 -40.25 96.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.286 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -60.57 -48.93 79.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 m -61.97 -37.97 86.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.28 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.68 -46.01 91.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 75.2 mtp -65.78 -39.7 91.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.0 109.594 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.76 -41.24 97.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.501 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -74.16 -54.7 7.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.609 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.1 t -47.84 -24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.24 7.46 67.61 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 120' ' ' VAL . 4.0 mp -54.68 -52.0 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 172' ' ' VAL . 25.6 m -98.81 130.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -94.26 101.95 13.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 90.5 m-20 -94.09 119.88 33.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 73.0 m80 -157.72 128.9 6.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 179' ' ' CYS . 29.0 m -78.27 144.41 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.83 -38.33 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.86 -23.97 47.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.41 ' H ' HG23 ' A' ' 176' ' ' VAL . 48.8 t -79.94 139.16 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.505 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.95 -37.17 83.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.461 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.84 -28.82 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.568 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.9 t80 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.951 . . . . 0.0 109.574 -179.864 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.265 0.555 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.67 132.3 53.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.884 . . . . 0.0 109.408 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -74.44 -39.13 43.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -63.27 1.75 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 109.449 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 5' ' ' GLY . 8.3 p -59.01 -14.89 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.505 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.0 m 60.79 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 10' ' ' ASP . 23.5 pt20 -82.78 -17.49 43.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLN . 9.5 m-20 -43.34 106.39 0.49 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.384 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.5 -38.24 35.1 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.824 2.35 . . . . 0.0 112.156 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.4 tp -62.89 -41.2 99.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.466 ' CE2' ' CE1' ' A' ' 17' ' ' HIS . 40.9 t80 -68.13 -42.57 79.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.83 -44.25 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.06 89.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -59.27 -43.54 92.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.466 ' CE1' ' CE2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.64 -49.35 68.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.65 -39.94 95.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.31 -54.56 44.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -177.37 124.93 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 59.1 t90 -171.22 124.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.457 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.7 1.04 83.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.96 120.16 71.43 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -45.98 120.83 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -128.17 135.62 49.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.962 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 56.9 p -115.41 9.05 15.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.076 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.65 132.47 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.302 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.574 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 77.5 p -73.7 -38.13 64.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.605 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.58 -42.64 98.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -70.37 -51.94 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 109.869 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.553 HD22 ' HB1' ' A' ' 113' ' ' ALA . 7.8 mp -66.77 -38.37 86.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.798 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 67.2 t80 -61.55 -38.96 89.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.76 -30.63 64.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.9 tpp -73.21 -54.45 8.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.853 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.31 -32.72 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 110.007 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.6 m -72.13 -49.99 31.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.139 -0.976 . . . . 0.0 110.057 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 56' ' ' TYR . 4.5 mt -75.2 -28.99 60.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 109.888 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 39.0 tp10 -52.08 -31.94 32.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.792 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.47 -21.81 69.02 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.43 -27.42 62.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -1.204 . . . . 0.0 109.733 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -60.27 -33.06 71.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.771 -178.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 41' ' ' GLN . . . -46.02 110.85 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.47 -6.71 68.27 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.16 -169.94 2.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -1.183 . . . . 0.0 109.406 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -108.97 153.0 24.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.526 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 6.0 t-105 -54.86 -46.22 74.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.65 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.96 -38.97 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.692 -178.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 98.4 m -63.02 -35.22 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.714 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.5 t -60.19 -44.74 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -55.13 -44.29 74.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.487 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.43 -52.84 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.354 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 10.9 mptt -69.55 -25.79 64.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 49' ' ' VAL . 37.0 ttp180 -54.23 -44.6 71.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 109.004 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -72.74 -43.97 62.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -64.08 -49.61 71.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.239 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 21.7 t80 -58.48 -39.94 81.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.309 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -55.76 -37.91 69.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.844 . . . . 0.0 109.77 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.0 -23.46 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.256 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.7 m -91.77 -12.14 34.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.146 -0.971 . . . . 0.0 110.251 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 43.9 m-85 -125.46 -51.68 1.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.135 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -53.44 -41.68 66.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 109.835 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.06 -38.85 73.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 96.9 m-85 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 130.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.002 . . . . 0.0 109.611 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -40.6 -36.05 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.68 -49.29 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.9 mttm -72.25 -31.2 65.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.869 . . . . 0.0 109.862 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.93 -44.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 109.605 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.54 -34.21 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.539 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.01 18.18 17.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.309 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.7 tpp -63.69 157.6 23.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -103.63 167.36 9.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.47 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 96.7 mt-10 -71.19 -24.17 62.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -72.04 -31.82 66.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.59 -47.14 79.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.418 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.451 HG12 ' CG2' ' A' ' 92' ' ' ILE . 14.4 m -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.12 -33.66 71.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 78' ' ' ARG . 42.0 ttm-85 -66.67 -46.08 76.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.774 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.4 mt -66.47 -34.38 77.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 76' ' ' VAL . 52.1 t -51.79 -35.82 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -81.26 -60.33 2.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 62.7 t0 -100.06 139.69 35.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.72 76.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -74.22 -31.99 58.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.613 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.3 pt 28.96 41.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.348 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 84' ' ' GLY . 54.9 mt 52.12 4.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.607 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -97.85 109.49 22.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 89' ' ' ARG . 84.0 t60 -96.99 172.17 8.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.165 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' N ' ' CG ' ' A' ' 88' ' ' HIS . 38.4 ttm180 -48.63 -41.91 32.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.74 -47.39 61.6 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 29.2 mmtm -64.72 -51.81 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 109.524 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.451 ' CG2' HG12 ' A' ' 76' ' ' VAL . 91.6 mt -54.77 -47.39 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.625 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -53.02 -33.45 51.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -61.29 -42.09 98.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.354 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.607 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.8 mp -60.77 -48.13 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.383 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.11 -50.0 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.43 84.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.66 -36.98 79.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -1.194 . . . . 0.0 109.465 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -65.97 -37.41 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.38 -45.19 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.541 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -71.84 -31.25 66.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 16.7 t80 -69.29 -50.53 45.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.73 -37.53 86.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.29 -42.02 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.8 ttt -64.22 -41.3 97.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.54 -27.41 69.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -51.97 -29.15 19.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.552 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -76.26 -17.23 59.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.08 3.55 67.67 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.75 115.6 65.34 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.65 124.64 7.01 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.619 2.213 . . . . 0.0 111.714 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.63 ' CZ ' ' NH1' ' A' ' 152' ' ' ARG . 49.6 t80 -61.1 -37.47 82.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -68.11 -49.83 58.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.126 -0.984 . . . . 0.0 110.745 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' O ' ' OG ' ' A' ' 118' ' ' SER . 56.5 t0 -52.07 -35.39 47.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 111.032 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.577 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 14.7 t80 -76.41 -46.24 28.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 2.6 p -56.49 -45.87 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.974 -1.079 . . . . 0.0 111.729 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 18.2 p-90 -88.92 -26.9 21.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.735 -1.228 . . . . 0.0 111.114 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.7 m -58.06 -27.52 63.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.875 -1.141 . . . . 0.0 109.719 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.76 -13.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.084 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.9 m -82.51 22.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.025 . . . . 0.0 109.947 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 59.64 35.0 22.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -0.942 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.4 m80 54.84 26.88 8.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.403 ' H ' HG23 ' A' ' 120' ' ' VAL . 50.3 tt0 -137.07 89.63 16.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.558 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.03 155.03 1.96 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.673 2.248 . . . . 0.0 111.779 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.5 156.15 16.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.729 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 48.3 ttp -127.62 136.15 51.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.4 t -95.57 169.14 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.906 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -168.99 44.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.543 ' HB1' ' CG ' ' A' ' 134' ' ' GLU . . . -83.9 -174.23 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.63 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.5 m -114.34 -29.81 6.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -128.63 157.86 40.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.7 mt -74.66 -10.97 60.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.8 m -87.64 -31.49 19.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.9 pt-20 -80.14 -7.81 59.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.72 118.38 57.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.718 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.68 130.27 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.095 2.53 . . . . 0.0 112.544 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.0 t -86.91 -15.11 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.267 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.5 t -85.52 102.18 13.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.4 p -118.71 152.69 51.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.93 . . . . 0.0 109.508 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.66 -35.15 92.47 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.093 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -41.13 52.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.2 p -61.4 -37.46 83.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.23 -46.46 86.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 0.0 109.568 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.89 -30.42 65.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -66.09 -46.68 76.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -63.19 -42.63 99.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -61.28 -35.41 77.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.562 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.79 42.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.68 -32.42 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.858 . . . . 0.0 109.583 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -60.48 -40.73 92.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.429 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -61.0 -37.02 81.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.63 ' NH1' ' CZ ' ' A' ' 112' ' ' PHE . 98.8 mtt180 -64.87 -20.03 66.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.49 22.92 13.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 2.6 m-85 -84.65 141.03 30.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -1.107 . . . . 0.0 109.535 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -109.1 175.29 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 53.91 44.18 29.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.584 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.5 p -122.66 26.02 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.82 166.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.1 m -54.58 -33.6 60.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.3 m -61.02 -46.49 90.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.4 mp -64.67 -41.57 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 157' ' ' VAL . 83.1 m -64.37 -40.4 95.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 109.264 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.26 -47.63 85.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.271 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.526 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 29.7 t -59.63 -37.15 77.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.288 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.69 -37.66 79.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.8 mtp -65.25 -47.29 77.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.617 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.41 -35.88 80.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.713 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.74 -44.18 93.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.7 m -83.02 -59.13 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.45 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.85 18.04 1.01 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 mt -58.95 -32.82 69.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -1.095 . . . . 0.0 109.427 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.09 141.83 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' HG22 ' A' ' 127' ' ' THR . 23.5 t30 -76.02 102.56 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 22.9 t70 -94.03 101.35 13.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 81.7 m-70 -160.05 123.39 3.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.54 HG22 ' H ' ' A' ' 178' ' ' GLY . 8.0 p -74.79 134.5 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.3 p -54.99 -25.76 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.423 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.54 ' H ' HG22 ' A' ' 176' ' ' VAL . . . -64.08 -24.27 68.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.521 ' H ' HG13 ' A' ' 176' ' ' VAL . 3.7 m -77.67 140.86 39.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.193 . . . . 0.0 109.535 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 182' ' ' TYR . 83.3 m -62.9 -38.61 91.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.91 . . . . 0.0 109.438 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 95.1 m -51.29 -7.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 180' ' ' CYS . 20.9 t80 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -92.82 -153.52 0.35 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.427 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.2 -5.11 56.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 28.6 m95 45.73 38.41 4.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.405 ' H ' HG12 ' A' ' 7' ' ' VAL . 1.3 p -60.99 131.19 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -171.47 29.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.81 -130.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.91 153.08 45.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.48 -27.51 3.44 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.862 2.375 . . . . 0.0 112.184 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.33 -39.68 95.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.404 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -66.11 -45.36 81.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.425 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.92 -39.82 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.72 92.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -66.87 -40.12 87.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' GLU . 59.1 t-80 -56.38 -48.53 76.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.77 -39.11 70.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -58.9 -44.49 91.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.502 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 39.9 mt-10 -149.1 -137.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.496 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.482 ' O ' ' O ' ' A' ' 20' ' ' GLU . 23.5 t90 59.82 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.547 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.41 82.94 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.9 t -119.71 94.74 48.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 0.0 109.34 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -46.87 121.96 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.764 2.309 . . . . 0.0 111.878 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.48 140.71 37.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -128.28 -2.02 5.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.0 109.109 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -81.33 130.7 35.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.4 t -57.17 -34.42 68.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.204 -0.935 . . . . 0.0 109.608 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -67.21 -55.55 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.763 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -66.92 -43.73 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.923 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.33 -44.14 95.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.835 -179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.96 -36.71 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 109.903 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.25 -32.05 71.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 43.3 tpp -63.84 -53.31 52.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.785 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 3.2 tp -72.11 -32.12 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.75 -50.35 30.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.132 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 6.7 mp -74.08 -16.38 61.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -52.24 -42.1 63.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.953 . . . . 0.0 109.841 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.583 ' N ' ' OE1' ' A' ' 38' ' ' GLU . . . 61.69 171.97 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.687 ' C ' ' H ' ' A' ' 42' ' ' ALA . 31.4 tp60 -60.07 -45.15 93.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -1.193 . . . . 0.0 109.77 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 60.13 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.671 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -58.28 143.27 45.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 -24.03 0.62 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 42' ' ' ALA . 17.4 mt -104.04 -141.23 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 109.476 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -153.43 155.0 35.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -48.08 -39.05 19.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 48' ' ' THR . 9.7 tp -54.41 -40.59 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' HG23 ' A' ' 47' ' ' ILE . 85.5 m -63.83 -38.73 92.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.735 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.18 -40.75 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.422 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.26 -44.78 92.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -65.64 -49.49 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.394 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' CD ' HD23 ' A' ' 37' ' ' LEU . 37.1 ttp180 -52.39 -45.39 65.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.158 -0.964 . . . . 0.0 109.038 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.4 -44.87 96.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 24.0 m120 -66.2 -38.45 88.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.254 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CG ' ' A' ' 60' ' ' PHE . 25.3 t80 -62.8 -50.43 71.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.348 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 20.7 mmm180 -60.8 -21.37 63.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.798 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -48.58 62.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.6 m -95.65 -43.34 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 110.254 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CG ' ' CE2' ' A' ' 56' ' ' TYR . 53.9 m-85 -66.91 -50.79 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 57.5 t60 -48.78 -41.67 33.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -61.6 -37.37 83.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.734 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.573 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 48.0 m-85 -78.5 -48.24 15.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 109.832 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.1 t70 79.87 136.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.534 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -40.05 -22.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.909 2.406 . . . . 0.0 112.745 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' ASP . 91.9 t -75.97 -44.55 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.653 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' LYS . 3.2 mptp? -72.61 -45.07 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.845 . . . . 0.0 109.895 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.1 m -56.05 -42.84 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.612 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.547 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -62.19 -38.0 87.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.53 13.13 32.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.373 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.502 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 27.3 ttp -83.26 158.14 22.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -103.98 160.52 14.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.5 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.56 -30.29 69.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.69 -43.72 72.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 55.1 t0 -61.58 -38.33 87.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.444 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.08 -44.13 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -56.2 -37.18 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.44 -38.66 90.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.341 -0.849 . . . . 0.0 109.782 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.2 mt -70.99 -29.32 65.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.77 -36.38 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.04 -62.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.0 109.514 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -100.01 116.13 31.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.431 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.66 -46.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 55' ' ' ASN . . . 78.74 26.36 58.85 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 pt -116.43 171.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.0 mt -47.22 135.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.628 ' HG2' HH11 ' A' ' 87' ' ' ARG . 9.0 mtt-85 -74.9 102.49 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.42 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -171.73 80.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.208 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG2' HH11 ' A' ' 89' ' ' ARG . 11.9 ptt-85 -47.67 -32.97 6.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.908 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.75 95.47 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.08 -45.24 95.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.52 -41.56 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -60.67 -37.63 82.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.26 96.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.355 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 ' HE2' ' A' ' 56' ' ' TYR . 97.3 mt -57.99 -46.41 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 68' ' ' VAL . 78.5 mt -54.66 -39.23 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.74 -33.39 87.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 88.1 m-20 -61.6 -41.83 98.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 109.423 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.74 86.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 109.51 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -57.71 -45.03 86.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.71 -33.5 68.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -64.5 -45.5 87.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 103' ' ' LEU . 3.5 mm? -59.78 -39.18 84.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -60.54 -37.01 79.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.525 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.5 mmm -63.35 -37.08 85.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.73 -29.42 69.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -51.72 -35.35 42.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -91.8 -1.34 57.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.8 66.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -97.05 149.15 35.38 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.154 -1.203 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.82 124.57 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.662 2.241 . . . . 0.0 111.698 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.409 ' CE1' ' NH1' ' A' ' 152' ' ' ARG . 72.3 t80 -79.11 -45.47 19.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.49 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.711 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 20.0 t70 -52.65 -36.5 56.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 111.043 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.66 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 48.3 t80 -73.09 -49.6 27.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.081 -1.012 . . . . 0.0 111.221 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 116' ' ' VAL . 3.0 m -56.12 -49.35 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.023 -1.048 . . . . 0.0 111.675 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.569 ' O ' HG22 ' A' ' 120' ' ' VAL . 20.0 p-90 -86.88 -28.06 23.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.742 -1.224 . . . . 0.0 111.09 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 21.7 p -56.75 -28.41 61.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.874 -1.142 . . . . 0.0 109.725 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -46.63 -11.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 117' ' ' TRP . 18.5 m -84.7 24.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 123' ' ' GLN . 3.5 m-20 72.51 17.62 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.023 . . . . 0.0 109.701 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 16.8 t60 73.58 -23.14 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.544 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 121' ' ' ASN . 9.5 pt20 -86.52 145.76 40.28 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.532 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 154.06 72.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.666 2.244 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.435 ' O ' ' SD ' ' A' ' 126' ' ' MET . 25.0 mt-30 -104.68 149.0 25.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.771 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.445 ' SD ' ' CG ' ' A' ' 173' ' ' ASN . 71.2 mmm -135.78 145.95 47.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 109.172 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.2 t -115.7 164.79 13.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.929 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -139.15 47.12 1.91 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.299 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -86.57 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.7 m -72.15 -37.8 69.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.1 t -133.95 177.93 7.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.454 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.09 -34.11 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.604 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -59.11 -35.23 73.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.55 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 93.1 mt-10 -72.72 -23.25 60.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.483 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 5.7 mm -65.57 120.47 68.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.749 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.473 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 85.1 Cg_endo -83.72 135.72 6.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.072 2.514 . . . . 0.0 112.525 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 137' ' ' THR . 1.7 t -91.52 6.72 44.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.33 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.9 m -138.81 90.23 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.28 160.61 29.38 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -47.88 -41.78 31.89 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.874 2.382 . . . . 0.0 112.035 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.38 -38.45 71.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -58.45 -43.92 88.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -61.84 -45.16 95.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.511 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.04 73.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.1 tt -60.05 -48.68 80.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.486 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.6 t -61.23 -37.18 82.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.58 ' HZ3' ' HZ3' ' A' ' 151' ' ' LYS . 63.4 tttm -62.0 -42.04 98.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.18 71.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.7 -34.53 74.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.593 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -59.78 -40.91 89.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 109.4 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.58 ' HZ3' ' HZ3' ' A' ' 147' ' ' LYS . 38.7 mmtm -61.17 -40.38 93.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.447 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.66 ' NH2' ' CD1' ' A' ' 115' ' ' PHE . 98.6 mtt180 -67.98 -19.89 64.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.23 13.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.482 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 2.1 m-85 -86.29 127.34 34.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -1.118 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -97.23 -176.85 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 40' ' ' GLN . 76.4 m-85 53.2 48.32 22.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.73 24.17 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.1 162.67 0.21 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 159' ' ' THR . 1.0 OUTLIER -55.62 -31.49 62.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -1.167 . . . . 0.0 109.446 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.6 m -66.77 -47.77 71.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.81 -44.42 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.1 m -60.29 -43.9 95.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.325 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.483 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 73.4 t80 -60.53 -43.26 97.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 0.0 109.334 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -57.08 -38.97 74.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 31' ' ' LEU . 16.2 t80 -61.75 -31.18 71.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.418 ' SD ' HD12 ' A' ' 171' ' ' LEU . 63.0 mmm -68.12 -54.18 19.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.623 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -72.19 -42.49 65.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.708 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.52 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -60.96 -34.7 75.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 26.2 t -83.31 -61.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.424 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.04 14.43 1.83 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.486 HD11 ' CE2' ' A' ' 165' ' ' PHE . 27.7 mt -65.55 -34.23 77.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.56 140.59 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.445 ' CG ' ' SD ' ' A' ' 126' ' ' MET . 4.3 m120 -88.88 115.09 26.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -98.63 113.02 24.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -152.18 143.06 23.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.522 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 m -97.04 145.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.1 m -54.75 142.82 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.09 -83.01 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 73.8 m -74.25 -171.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -1.158 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.601 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 33.3 m 52.4 17.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.468 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.601 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 13.7 p 42.46 43.63 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 30.4 t80 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 109.621 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' TRP . 63.5 m 45.91 31.25 1.04 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.97 -46.01 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.664 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -149.84 -91.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -1.201 . . . . 0.0 109.452 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 7' ' ' VAL . 38.6 t 54.39 -0.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.608 ' H ' ' C ' ' A' ' 6' ' ' TRP . 72.1 m -79.87 28.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.424 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' SER . 35.1 tt0 -61.27 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 5.6 p30 -94.77 152.23 39.62 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.35 -34.09 13.53 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.819 2.346 . . . . 0.0 112.098 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.68 -43.3 99.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.476 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.55 -46.61 75.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 109.393 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.0 mt -62.14 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.373 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.12 98.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -62.01 -40.77 96.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 23.8 t-80 -60.65 -48.9 79.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.81 -39.31 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.551 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.85 -47.33 83.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 89.5 mt-10 -151.82 -125.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.497 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.523 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 37.7 t90 57.99 114.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.52 -6.31 67.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.669 ' O ' HG13 ' A' ' 23' ' ' VAL . 8.3 p -105.78 109.92 63.65 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.183 -1.186 . . . . 0.0 109.429 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.1 121.12 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.742 2.294 . . . . 0.0 111.896 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -92.94 134.73 34.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.141 -0.974 . . . . 0.0 109.887 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -132.59 -2.25 3.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 109.042 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.14 147.53 46.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.649 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -71.0 -60.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -178.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.86 -37.02 82.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.72 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.04 -42.81 84.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.871 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -66.7 -40.8 88.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.215 -0.928 . . . . 0.0 109.862 -176.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.3 m-30 -60.51 -41.42 94.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.896 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 37' ' ' LEU . 98.6 mt-10 -64.4 -32.81 74.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 ttm -68.42 -53.7 21.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.801 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 36' ' ' CYS . 8.4 tp -70.6 -39.18 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 110.027 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.486 ' N ' HG23 ' A' ' 35' ' ' ILE . 77.0 m -71.31 -47.19 58.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 17.2 tp -64.84 -41.5 95.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 109.811 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 44.2 tp10 -56.22 -29.74 61.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.85 -38.38 59.64 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 40' ' ' GLN . 18.9 mp0 -60.3 -30.75 69.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -1.233 . . . . 0.0 109.724 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.7 tt0 -48.09 -29.7 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 109.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.66 109.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.23 -32.11 5.36 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.9 mp -98.21 -160.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -1.209 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.9 m -131.99 152.55 51.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.362 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 43.6 p90 -55.63 -33.49 64.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -57.99 -40.68 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 54.6 m -73.5 -32.52 64.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.692 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 73.0 t -57.4 -36.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -54.38 -54.93 33.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.57 -45.97 90.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.123 -0.986 . . . . 0.0 109.35 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -68.86 -28.47 66.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.582 ' HG2' HH11 ' A' ' 53' ' ' ARG . 6.4 ttt-85 -52.82 -45.95 67.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -0.986 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -70.47 -43.77 69.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -65.48 -38.16 88.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.325 -0.859 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.13 -49.75 76.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' HIS . 73.8 mtm180 -54.75 -43.39 72.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.41 71.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.29 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.86 -20.19 19.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.201 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -104.33 -38.96 6.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.849 -1.157 . . . . 0.0 110.238 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.5 t60 -49.77 -41.91 45.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 109.898 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.44 -31.39 72.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.722 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 53.7 m-85 -91.31 62.79 4.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -39.31 153.6 0.18 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.618 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -35.34 -53.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.856 2.371 . . . . 0.0 112.757 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -54.44 -44.93 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.647 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 71' ' ' MET . 20.3 tptp -65.73 -37.1 85.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.388 -0.82 . . . . 0.0 109.876 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 63' ' ' PHE . 21.4 t -56.98 -49.89 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.076 -1.015 . . . . 0.0 109.594 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.63 70.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.511 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.06 -0.83 57.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.398 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 63' ' ' PHE . 8.9 ttp -71.52 158.35 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -104.67 156.8 17.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.57 -31.28 69.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.51 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -60.49 -39.2 86.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.86 -40.85 94.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.05 -44.03 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.579 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.79 -36.67 81.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.308 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 78' ' ' ARG . 33.2 ttm-85 -63.22 -42.29 99.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -36.13 82.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.2 t -51.29 -33.44 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -93.64 -60.28 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.523 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -101.3 108.1 19.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.92 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.418 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.94 27.94 57.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 pt -121.03 171.78 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -1.15 . . . . 0.0 109.38 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -46.69 141.62 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -94.0 97.6 10.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.431 -179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 15.6 m-70 -162.71 86.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.176 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 89' ' ' ARG . 24.9 ttt-85 -48.65 -29.88 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.38 -47.05 92.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -63.85 -48.81 75.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.27 -41.08 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.9 -36.63 72.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.399 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.318 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.478 ' HA ' HD21 ' A' ' 98' ' ' ASN . 98.9 mt -57.59 -41.66 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 109.417 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 mm -56.29 -50.76 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.12 95.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.478 HD21 ' HA ' ' A' ' 95' ' ' ILE . 91.4 m-20 -57.85 -35.94 71.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.14 68.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.88 -42.61 99.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.47 -35.12 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 10.3 t80 -63.98 -48.13 77.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 tp -63.29 -39.27 94.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -60.75 -38.3 84.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -64.13 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.242 -0.912 . . . . 0.0 109.468 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.75 -29.12 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -52.39 -24.45 7.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.514 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.92 -16.88 59.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.512 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.77 9.6 74.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.58 114.42 63.1 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.246 -1.15 . . . . 0.0 109.677 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.02 120.53 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.578 2.185 . . . . 0.0 111.692 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -58.47 -35.03 71.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 0.0 110.504 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.21 -50.87 68.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.0 110.742 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 118' ' ' SER . 90.2 m-20 -62.67 -43.56 98.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 111.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.88 -49.33 73.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.991 -1.068 . . . . 0.0 111.155 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -63.8 -48.9 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.034 -1.041 . . . . 0.0 111.632 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.509 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 2.7 p-90 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.775 -1.203 . . . . 0.0 111.207 -177.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 33.1 m -55.41 -28.57 55.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.861 -1.149 . . . . 0.0 109.766 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.23 -14.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.1 p -83.24 26.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.901 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 120' ' ' VAL . 2.4 m-80 76.03 17.61 2.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.706 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 59.94 39.34 20.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.492 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.474 ' H ' HG13 ' A' ' 120' ' ' VAL . 77.3 mt-30 -151.13 144.84 17.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.59 146.95 50.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.694 2.262 . . . . 0.0 111.872 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -103.2 134.58 46.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.982 . . . . 0.0 109.741 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 38.7 ttp -109.36 125.41 52.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.4 t -94.28 166.56 12.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 109.868 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -147.43 53.3 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.403 -0.811 . . . . 0.0 109.252 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.688 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -91.21 142.88 27.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -80.48 -33.47 36.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.0 m -128.91 159.29 36.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.417 ' CD1' ' NE1' ' A' ' 6' ' ' TRP . 31.5 mt -55.94 -35.56 66.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.9 p -66.85 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.688 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.9 mm-40 -65.92 -23.1 66.55 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.142 -0.974 . . . . 0.0 109.411 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.26 116.98 42.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -84.18 132.1 5.19 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.132 2.555 . . . . 0.0 112.516 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.1 t -92.44 -12.46 32.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.309 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 80.0 p -92.57 100.93 13.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.36 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -116.74 151.45 47.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.07 -31.87 93.99 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.844 2.362 . . . . 0.0 111.966 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.92 -41.47 51.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.1 m -60.74 -41.15 94.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.56 -48.93 77.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.522 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.41 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.692 ' C ' HD23 ' A' ' 145' ' ' LEU . 7.5 tt -59.56 -48.29 82.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.47 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -59.97 -41.77 92.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.21 -33.15 74.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.76 -51.38 49.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.548 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 145' ' ' LEU . 76.6 mt -60.89 -34.63 74.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -58.03 -40.33 80.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.382 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.6 -37.13 82.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -63.91 -20.11 65.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.09 19.39 19.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.45 ' CE2' ' OD1' ' A' ' 98' ' ' ASN . 6.0 m-85 -88.51 133.6 34.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.52 177.75 5.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 55.05 53.67 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.86 24.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.45 167.51 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 159' ' ' THR . 1.1 p -66.05 -25.27 66.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 109.37 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.9 p -70.9 -46.17 63.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.01 -34.52 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.536 ' SG ' HD22 ' A' ' 145' ' ' LEU . 43.1 t -68.12 -46.0 72.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.317 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.07 -42.49 99.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.1 m -57.57 -32.6 67.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.28 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.43 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.61 -31.25 69.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.446 178.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 25.5 mtt -68.5 -53.95 19.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.523 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 1.9 pp0? -62.39 -36.46 82.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.704 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.478 ' N ' ' CD ' ' A' ' 167' ' ' GLN . . . -74.71 -38.96 62.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.744 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 23' ' ' VAL . 10.3 t -74.54 -29.05 61.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.444 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.14 56.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.446 HD13 ' SG ' ' A' ' 169' ' ' CYS . 1.1 mp -52.69 -52.88 54.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 0.0 109.39 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.1 m -91.9 135.84 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' THR . 6.4 m120 -82.67 105.03 13.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 109.46 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -93.71 123.92 37.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CD2' ' CD2' ' A' ' 182' ' ' TYR . 1.9 p-80 -164.06 159.23 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -111.39 122.73 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 178' ' ' GLY . 8.6 p -70.19 -40.02 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.507 ' N ' HG13 ' A' ' 177' ' ' VAL . . . -60.03 -18.94 49.6 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 96.5 m -86.37 -176.67 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.503 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.6 t -106.12 -21.77 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.523 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.7 t -54.27 -33.92 59.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.1 t80 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.527 HH21 HG23 ' A' ' 7' ' ' VAL . 23.9 ptt-85 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.521 ' C ' ' H ' ' A' ' 6' ' ' TRP . 4.1 m -96.87 -155.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.88 -16.18 0.86 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.521 ' H ' ' C ' ' A' ' 4' ' ' CYS . 26.6 m95 44.46 37.8 2.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.183 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.5 m -64.91 126.74 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' GLN . 29.4 t -164.08 156.84 17.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' SER . 41.3 tt0 56.94 159.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 109.561 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.2 72.74 0.82 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.9 -28.78 13.83 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.844 2.363 . . . . 0.0 112.147 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.36 -39.32 94.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.72 -46.54 78.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.56 -48.78 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.383 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.77 -36.77 76.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.52 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.556 ' CE2' HD22 ' A' ' 50' ' ' LEU . 63.3 t80 -59.89 -44.11 94.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.484 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.15 -49.05 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -64.53 -40.28 95.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -64.42 -64.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.519 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.9 mm-40 -140.13 -151.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.628 ' CZ2' ' HB2' ' A' ' 168' ' ' ALA . 27.1 t-105 62.19 130.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.475 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.62 -17.69 58.51 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.8 m -78.11 149.69 76.72 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.416 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.01 119.41 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.858 2.372 . . . . 0.0 111.785 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.6 133.41 56.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.985 . . . . 0.0 109.809 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 p -134.46 9.09 3.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.033 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.73 141.49 31.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.711 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 14.9 m -68.63 -36.38 78.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -58.97 -52.43 65.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -40.29 96.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.685 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 2.3 mm? -58.66 -39.38 80.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.11 -0.994 . . . . 0.0 109.871 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -67.1 -54.24 23.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.873 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -71.11 -31.46 67.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.4 tpp -60.04 -53.75 54.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 109.676 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 36' ' ' CYS . 18.3 tt -82.76 -42.99 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.062 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.548 ' N ' HG23 ' A' ' 35' ' ' ILE . 33.7 t -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.944 . . . . 0.0 110.044 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.6 -40.42 76.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.867 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -59.91 -24.35 64.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.802 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.43 -28.72 3.5 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.18 -31.64 72.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.24 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -47.98 -34.41 9.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.78 111.33 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.727 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.61 -39.24 2.84 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -105.78 -138.15 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.7 t -141.73 155.26 45.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 22.7 p90 -55.54 -31.85 62.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.57 -39.64 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.7 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -73.28 -32.26 64.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.9 t -58.69 -37.68 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 16' ' ' TYR . 31.7 mt -53.83 -55.49 26.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -59.27 -42.19 90.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HB2' ' HZ2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.57 -21.59 60.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.376 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.57 ' HG2' HH11 ' A' ' 53' ' ' ARG . 7.9 ttt-85 -58.62 -47.64 83.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.209 -0.932 . . . . 0.0 108.99 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' A' ' 54' ' ' GLU . 10.1 pt-20 -69.63 -41.02 76.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -66.05 -50.72 63.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.269 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 28.0 t80 -60.45 -37.51 81.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.379 -0.826 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 40.8 ttp180 -55.83 -38.12 69.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.859 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.25 53.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.07 -11.69 35.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 110.286 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 56.4 m-85 -130.04 -51.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.97 -1.082 . . . . 0.0 110.193 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.2 t-80 -49.25 -38.3 26.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.083 -1.01 . . . . 0.0 109.909 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -55.45 -37.44 67.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.781 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.09 -16.79 52.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.866 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 63.99 132.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.064 -1.022 . . . . 0.0 109.578 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.33 -34.5 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.904 2.402 . . . . 0.0 112.688 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.2 t -55.16 -49.35 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mtpt -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -58.09 -42.17 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.595 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.83 -42.24 67.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.25 23.91 8.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.1 ttm -62.36 163.04 9.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -109.9 154.22 23.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -34.92 69.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.28 -37.38 85.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.456 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -60.13 -44.11 95.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 80' ' ' VAL . 92.5 t -56.41 -43.18 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.596 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.15 -33.46 74.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.315 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -58.89 -44.23 91.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.799 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 92.3 mt -73.32 -32.6 64.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 76' ' ' VAL . 51.3 t -51.78 -36.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.763 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -75.57 -62.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -99.89 107.84 19.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.423 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -175.62 75.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.397 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.66 10.4 1.51 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.521 HD12 ' CG ' ' A' ' 87' ' ' ARG . 5.1 pt -79.59 -175.92 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -1.146 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 86' ' ' ILE . 67.6 mt -83.34 -2.33 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 85' ' ' ILE . 3.6 mmp_? -66.88 145.58 55.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.427 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' O ' ' N ' ' A' ' 90' ' ' GLY . 53.0 m80 -141.96 70.52 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.133 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.424 HH11 ' HG3' ' A' ' 89' ' ' ARG . 27.2 ttm-85 59.02 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.397 -0.814 . . . . 0.0 109.927 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -56.57 -37.48 75.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -59.59 -45.47 91.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.73 -44.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.629 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.332 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.21 -36.31 79.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.419 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.9 mm -69.03 -44.52 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.96 -47.93 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 109.543 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.42 -42.92 99.88 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 23.9 m120 -58.86 -43.77 90.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -1.207 . . . . 0.0 109.42 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.71 92.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.57 -44.28 91.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.4 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.11 -53.74 7.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -56.99 -44.71 83.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -61.04 -33.87 73.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -62.33 -35.87 80.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' N ' ' A' ' 108' ' ' ASN . 84.3 tt0 -70.82 -30.77 67.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -51.89 -14.38 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.561 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 106' ' ' GLU . 77.7 m-20 -75.97 -14.98 60.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 36.6 18.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -138.75 152.17 70.09 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.76 119.12 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.612 2.208 . . . . 0.0 111.685 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -74.57 -43.51 55.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.0 110.465 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.42 -47.21 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.168 -0.958 . . . . 0.0 110.772 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.564 ' O ' ' OG ' ' A' ' 118' ' ' SER . 53.6 t0 -54.9 -37.7 66.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 111.056 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 -48.35 39.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.088 -1.008 . . . . 0.0 111.221 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 3.6 m -53.96 -49.35 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.058 -1.026 . . . . 0.0 111.679 -175.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 114' ' ' ASP . 21.9 p-90 -87.69 -24.94 23.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.729 -1.232 . . . . 0.0 111.09 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 6.8 m -56.02 -23.95 36.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.783 -1.198 . . . . 0.0 109.708 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -44.46 -15.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.166 -0.958 . . . . 0.0 110.076 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.3 m -88.15 24.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.001 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 1.6 m120 72.14 38.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 109.641 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 51.4 p-80 41.96 40.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.579 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.416 ' H ' HG23 ' A' ' 120' ' ' VAL . 81.5 mt-30 -147.52 148.09 30.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.542 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.42 135.58 36.99 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.671 2.247 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -100.08 148.41 24.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.776 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.6 ptm -133.27 156.68 47.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.447 -0.783 . . . . 0.0 109.155 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.3 t -124.03 163.3 21.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.921 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -137.69 54.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -89.99 -158.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.663 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.58 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 6.4 m -140.9 -29.6 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.34 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.405 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 14.2 m -135.06 161.17 36.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.469 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.431 HD11 ' CD1' ' A' ' 6' ' ' TRP . 50.4 mt -73.58 -16.73 61.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.84 -41.21 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.8 pt-20 -71.93 -26.04 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.174 -0.954 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.0 117.45 48.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.03 131.28 5.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.096 2.53 . . . . 0.0 112.563 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.464 ' H ' HG22 ' A' ' 137' ' ' THR . 0.7 OUTLIER -76.98 -13.38 59.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.259 179.585 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.2 m -94.73 101.87 13.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.91 154.62 49.64 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.05 -42.68 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.843 2.362 . . . . 0.0 112.009 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.73 -41.38 53.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -62.05 -42.53 99.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.412 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 44.1 t0 -62.87 -45.24 93.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.17 80.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 162' ' ' CYS . 23.6 tp -57.96 -50.9 71.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.3 p -58.6 -39.36 80.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.55 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 60.7 mttp -60.69 -32.72 71.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.06 -55.11 10.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.5 mp -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.626 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.63 -41.38 85.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.419 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.01 -35.45 80.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.498 HH11 ' HG3' ' A' ' 152' ' ' ARG . 26.6 ttm-85 -63.86 -21.75 66.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.8 21.47 8.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.69 136.76 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -1.112 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 1.8 mptm? -97.67 -169.64 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 16.5 p90 39.47 41.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 157' ' ' VAL . 5.5 m -96.38 25.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.54 154.58 1.21 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.7 m -55.87 -28.03 54.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.423 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -48.33 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.9 mp -58.74 -44.24 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 109.438 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' A' ' 145' ' ' LEU . 2.2 t -62.64 -49.04 76.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -62.74 -40.0 95.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.364 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -60.71 -38.65 85.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CZ ' HD11 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -61.12 -43.63 98.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.529 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.3 mtp -59.33 -40.2 85.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.75 -34.16 77.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.628 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -67.31 -63.2 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.685 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.8 t -63.26 -40.31 97.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.98 21.64 15.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 34.8 mt -54.17 -35.1 61.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.395 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.18 133.95 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.546 ' OD1' ' ND1' ' A' ' 175' ' ' HIS . 5.8 t-20 -81.48 100.96 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.45 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -86.26 118.46 25.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.546 ' ND1' ' OD1' ' A' ' 173' ' ' ASN . 15.0 m170 -147.62 162.22 39.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.519 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 130' ' ' THR . 38.9 t -110.82 132.71 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 129' ' ' ALA . 83.3 t -71.88 -39.25 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.495 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.91 28.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 29.7 t -91.03 167.29 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -1.138 . . . . 0.0 109.49 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.3 p -90.84 -37.87 13.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.503 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.479 ' HG ' ' HG ' ' A' ' 179' ' ' CYS . 17.0 p -53.31 -35.9 60.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.464 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 39.8 t80 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.449 HH11 ' HG3' ' A' ' 3' ' ' ARG . 50.7 mtm-85 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.08 -164.83 1.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.387 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.12 3.24 63.71 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.608 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 1.4 m0 47.83 42.89 16.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.477 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 8' ' ' SER . 33.2 m -66.29 127.99 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER 166.6 178.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.497 ' N ' ' OG ' ' A' ' 8' ' ' SER . 49.4 tp60 59.41 -127.86 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.12 150.74 91.66 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 -11.63 26.29 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.159 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.75 -33.08 74.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.555 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 42.3 m-85 -54.16 -46.47 72.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.444 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.93 -28.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.4 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.84 -47.14 81.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 1.3 p90 -75.76 -38.73 58.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.502 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.552 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 83.9 t60 -54.16 -46.27 72.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.498 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -71.38 -34.51 70.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.514 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -61.81 -62.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.545 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TRP . 10.3 pt-20 -174.04 -115.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.796 ' CZ2' ' HB2' ' A' ' 168' ' ' ALA . 34.5 t-105 60.07 130.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.524 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.81 60.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.7 OUTLIER -76.89 152.74 82.77 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.264 -1.139 . . . . 0.0 109.376 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 123.01 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.752 2.301 . . . . 0.0 111.857 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -108.57 135.22 50.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.858 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -134.94 5.32 3.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 109.038 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.91 128.45 35.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.277 -0.889 . . . . 0.0 109.296 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.536 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -61.71 -55.89 25.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.581 -178.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -62.73 -43.63 98.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.708 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.619 ' NZ ' ' NH2' ' A' ' 53' ' ' ARG . 15.9 tptp -64.63 -44.35 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.85 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 113' ' ' ALA . 5.3 tp -60.87 -42.07 97.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.85 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.9 m-30 -60.34 -35.89 76.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 0.0 109.892 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.76 -30.06 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.819 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.0 tpp -74.34 -56.23 5.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.837 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.445 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -61.69 -36.7 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 75.9 m -71.72 -44.72 63.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.6 tp -73.53 -39.8 64.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.977 . . . . 0.0 109.876 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -53.71 -34.56 59.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.775 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.72 -34.27 56.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -64.22 -29.14 70.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.161 . . . . 0.0 109.778 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.1 tt0 -49.04 -31.01 6.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.759 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.99 110.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -31.84 6.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 41' ' ' GLN . 19.4 mt -99.47 -150.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.8 m -145.98 161.34 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -52.39 -41.25 62.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -51.9 -40.99 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -75.65 -34.63 60.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.71 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.65 -44.21 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HZ2' HD12 ' A' ' 47' ' ' ILE . 46.5 mttp -59.36 -49.39 78.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -72.51 -22.5 61.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.334 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.619 ' NH2' ' NZ ' ' A' ' 30' ' ' LYS . 3.8 ttt-85 -57.57 -44.29 85.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.111 -0.993 . . . . 0.0 108.975 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.11 -44.56 65.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -66.38 -35.03 79.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.242 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 29.4 t80 -57.06 -49.25 76.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.468 -0.77 . . . . 0.0 109.379 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 80.4 mtm180 -59.67 -41.37 90.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.06 39.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.213 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.9 m -95.9 -33.97 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 30.1 m-85 -86.05 -32.85 21.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.047 -1.033 . . . . 0.0 110.233 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 85.5 t60 -47.47 -16.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 60' ' ' PHE . 7.2 pt20 -100.35 -22.07 15.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.818 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.467 ' O ' HG23 ' A' ' 68' ' ' VAL . 60.0 m-85 -99.94 68.79 1.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.077 -1.015 . . . . 0.0 109.871 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 63' ' ' PHE . 4.9 m-20 -41.42 154.3 0.24 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.995 . . . . 0.0 109.607 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -34.46 -53.97 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.948 2.432 . . . . 0.0 112.627 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.82 -44.76 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.125 -0.984 . . . . 0.0 109.632 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.7 -32.78 74.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 63' ' ' PHE . 49.0 t -57.34 -43.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.617 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.497 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.41 -3.1 58.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.6 mtp -55.74 146.68 20.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.2 tp60 -105.97 166.46 10.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 97.2 mt-10 -63.25 -29.31 70.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.442 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.41 -37.16 84.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 109.441 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.63 -39.28 80.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.421 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' VAL . 96.8 t -63.82 -44.14 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -56.98 -37.25 71.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.377 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -61.05 -44.09 97.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.416 -0.803 . . . . 0.0 109.81 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.8 mt -73.78 -33.07 64.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 76' ' ' VAL . 40.9 t -50.55 -35.63 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.953 . . . . 0.0 109.788 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -88.93 -50.19 6.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.089 -1.007 . . . . 0.0 109.568 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.5 m-20 -71.33 153.27 42.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.38 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.12 26.65 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -47.33 -34.74 9.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 85' ' ' ILE . 22.3 pt -148.61 -174.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.343 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.47 138.04 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -89.92 106.88 18.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 109.445 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 91' ' ' LYS . 1.1 t60 -176.34 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -45.02 -34.72 2.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.894 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.86 -44.52 88.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 15.1 ttmm -66.44 -43.12 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.491 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.94 -46.67 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -59.71 -33.22 71.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.42 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.99 90.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 80.5 mt -64.13 -44.79 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.05 -45.82 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.22 -38.06 95.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.508 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 22.0 t-20 -57.64 -40.87 80.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.356 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.71 95.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.57 -40.81 75.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.44 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.77 -31.97 73.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.451 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 22.6 t80 -62.1 -48.4 80.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.3 mm? -58.35 -37.4 75.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 109.488 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -61.28 -51.71 67.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.606 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 27.3 ttt -69.97 -39.45 75.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.36 -26.78 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 109.443 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -51.7 -25.11 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.14 -19.0 58.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.496 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.58 17.47 68.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.11 152.74 38.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.151 -1.205 . . . . 0.0 109.741 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.83 122.92 10.63 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.641 2.228 . . . . 0.0 111.669 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.606 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 26.3 t80 -76.73 -42.16 42.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -69.91 -50.68 39.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 118' ' ' SER . 43.8 t0 -53.01 -33.32 51.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.012 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 16.2 t80 -76.24 -52.28 10.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.036 -1.04 . . . . 0.0 111.223 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.471 HG23 ' N ' ' A' ' 117' ' ' TRP . 10.1 m -56.56 -50.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.972 -1.08 . . . . 0.0 111.683 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.521 ' HB2' HD11 ' A' ' 171' ' ' LEU . 7.6 p-90 -82.05 -31.12 31.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.709 -1.244 . . . . 0.0 111.163 -176.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 18.0 t -56.28 -24.01 40.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.871 -1.143 . . . . 0.0 109.785 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -43.11 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.279 -0.888 . . . . 0.0 110.083 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 118' ' ' SER . 19.5 m -83.11 24.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.973 -1.079 . . . . 0.0 110.003 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 67.35 36.23 4.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.2 m80 53.82 26.16 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.465 ' H ' HG23 ' A' ' 120' ' ' VAL . 31.7 mt-30 -142.89 103.67 5.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.75 147.61 4.46 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.685 2.257 . . . . 0.0 111.808 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -95.83 157.97 15.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.727 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -121.95 142.49 50.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.7 t -86.14 160.19 19.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.938 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -141.73 46.83 1.67 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.645 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -101.79 135.75 42.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.8 m -76.8 -30.22 56.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.353 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -133.39 175.75 9.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.582 HD22 ' HE1' ' A' ' 6' ' ' TRP . 34.6 mt -67.79 -31.92 72.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.556 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.1 p -63.51 -34.86 78.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.645 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.3 mt-10 -73.51 -21.6 60.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.125 -0.985 . . . . 0.0 109.435 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 132' ' ' LEU . 84.9 mt -66.96 120.02 68.55 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.28 136.53 7.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.11 2.54 . . . . 0.0 112.561 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -95.15 4.78 53.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.325 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.9 t -137.14 90.74 2.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.59 156.27 39.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.74 -40.08 24.18 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.777 2.318 . . . . 0.0 112.03 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.96 -38.38 66.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.307 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.6 t -62.54 -47.38 84.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.03 -45.45 92.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.88 75.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.53 -46.64 78.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.537 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.3 t -56.09 -43.73 78.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.22 -35.96 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.08 -52.41 35.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.4 mp -66.29 -37.13 84.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.38 -0.825 . . . . 0.0 109.546 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -62.45 -37.23 85.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.333 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.62 -37.58 86.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 0.0 109.441 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.608 ' NH2' ' CE1' ' A' ' 115' ' ' PHE . 99.3 mtt180 -63.77 -23.41 67.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.46 12.21 9.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.508 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 43.0 m-85 -78.41 135.01 37.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -1.108 . . . . 0.0 109.51 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 19.9 tptt -101.35 -166.19 1.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 14.6 p90 37.83 33.95 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.407 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -101.77 24.89 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.388 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.62 157.0 1.67 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.7 m -53.61 -31.01 45.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.0 m -63.53 -47.18 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -64.98 -40.53 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.4 -41.05 96.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.319 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.5 -46.41 90.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.288 -0.883 . . . . 0.0 109.306 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 95.5 p -60.74 -36.8 79.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.02 -49.42 76.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.8 mtp -59.95 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.97 -46.05 90.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.796 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -72.62 -43.61 63.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.671 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' VAL . 13.6 t -58.13 -29.56 65.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.986 . . . . 0.0 109.425 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 0.33 61.3 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 117' ' ' TRP . 3.7 mp -55.07 -43.29 73.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -1.17 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.99 135.97 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.53 ' O ' HG22 ' A' ' 127' ' ' THR . 16.2 m-20 -86.43 117.89 25.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 42.1 p-10 -91.86 93.43 8.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -149.23 130.98 15.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.55 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 26.3 m -100.02 139.75 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.23 -33.77 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.11 65.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 176' ' ' VAL . 12.6 p -79.09 129.63 34.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.548 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 71.2 m -63.1 -29.67 70.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.9 t -48.73 -28.74 3.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.2 t80 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.619 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.7 p -43.35 159.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -125.98 -17.93 2.44 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -65.58 5.16 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 5' ' ' GLY . 4.6 t -63.32 140.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 p -61.8 151.29 34.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 109.475 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.81 -31.69 68.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -49.14 143.49 9.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.444 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.08 -28.5 12.8 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.898 2.399 . . . . 0.0 112.161 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.4 tp -62.13 -39.97 94.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.71 -49.13 67.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.91 . . . . 0.0 109.427 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.59 -40.9 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.69 -36.66 84.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -62.12 -43.09 99.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -60.92 -42.89 98.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.463 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.99 -39.45 85.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -63.63 -55.37 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -175.84 130.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.95 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -173.92 122.14 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.75 -0.03 79.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 169' ' ' CYS . 6.6 m -80.42 148.62 66.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.291 -1.123 . . . . 0.0 109.33 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 119.7 6.68 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.754 2.303 . . . . 0.0 111.857 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.26 130.86 53.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.832 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -117.05 4.09 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.865 . . . . 0.0 109.006 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -78.53 116.84 19.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 76.1 p -61.58 -33.52 74.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.599 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -58.04 -47.15 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -70.28 -48.8 55.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.09 -39.77 93.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 61.5 t80 -60.3 -45.0 94.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.893 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.59 -31.67 72.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 109.88 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.52 -53.22 57.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.805 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.84 -42.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.025 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.589 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 12.1 m -62.27 -51.74 66.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 mt -76.07 -42.4 47.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 161' ' ' ILE . 44.2 tt0 -54.25 -36.49 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.797 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.46 -32.97 61.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.54 -27.56 69.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -1.22 . . . . 0.0 109.718 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -48.53 -36.9 16.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 109.624 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.47 114.71 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.659 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.59 -33.36 5.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 mt -97.44 -141.83 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -1.17 . . . . 0.0 109.43 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.0 p -147.3 154.49 41.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -50.88 -45.03 59.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.219 -0.925 . . . . 0.0 109.494 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 47' ' ' ILE . 7.8 tp -55.35 -34.77 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.684 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.1 m -72.02 -35.08 69.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.0 t -59.19 -49.06 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.49 -50.84 70.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -59.37 -48.45 81.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.304 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -69.36 -30.57 68.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HG2' HH11 ' A' ' 53' ' ' ARG . 20.2 ttt-85 -50.99 -46.27 61.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 108.943 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.33 -44.22 72.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.355 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.58 -41.51 98.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.479 ' CD2' ' CE2' ' A' ' 60' ' ' PHE . 3.3 m-85 -55.87 -49.68 72.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.393 -0.817 . . . . 0.0 109.369 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' HIS . 58.8 mtp180 -51.72 -45.04 63.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.782 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.75 -43.14 47.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.1 m -96.4 -27.55 14.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.278 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.479 ' CE2' ' CD2' ' A' ' 56' ' ' TYR . 38.9 m-85 -92.36 -34.38 14.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.093 . . . . 0.0 110.133 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 86.5 t60 -48.29 -38.92 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -68.4 -34.12 75.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.716 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 64' ' ' ASP . 40.2 m-85 -88.9 62.97 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.85 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -39.77 159.0 0.13 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 109.558 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -38.61 -53.45 1.82 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.923 2.415 . . . . 0.0 112.651 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.9 t -53.36 -44.63 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -66.71 -34.39 77.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 63' ' ' PHE . 48.5 t -58.23 -48.77 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 109.661 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.32 63.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.49 7.07 43.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.633 ' SD ' HD11 ' A' ' 96' ' ' ILE . 41.9 ttm -57.06 146.97 25.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' OE1' ' OE2' ' A' ' 74' ' ' GLU . 95.3 mt-30 -107.44 162.02 14.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.07 -28.51 70.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' OE1' ' A' ' 72' ' ' GLN . 24.9 pt-20 -72.29 -27.76 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.81 -47.71 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 80' ' ' VAL . 10.7 m -64.05 -36.85 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -54.82 -37.97 66.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -70.05 -43.74 70.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.367 -0.833 . . . . 0.0 109.803 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 79' ' ' LEU . 96.0 mt -70.04 -41.45 74.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.99 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 76' ' ' VAL . 54.3 t -50.86 -36.3 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.31 -62.41 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -99.84 114.14 27.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.92 79.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -25.95 7.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' GLY . 22.1 pt -57.85 -160.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.249 -1.147 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.98 132.67 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.52 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.0 ptm180 -102.48 136.33 42.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.16 100.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.152 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -47.51 -30.28 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.923 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.8 -48.82 15.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.61 -43.39 98.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -1.145 . . . . 0.0 109.489 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.436 ' CG2' HG12 ' A' ' 76' ' ' VAL . 61.1 mt -63.47 -55.33 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.628 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -58.17 -31.58 67.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.72 93.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 109.39 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.5 -41.7 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.633 HD11 ' SD ' ' A' ' 71' ' ' MET . 70.9 mt -55.4 -54.3 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.82 94.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.589 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -58.03 -40.29 80.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -70.75 -37.05 73.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.04 -43.42 98.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -70.0 -33.85 72.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 19.4 t80 -69.84 -46.66 65.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 109.527 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.87 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 28.1 ttt -61.71 -41.53 97.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.485 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.1 -27.09 63.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -52.07 -21.82 3.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.513 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.46 -13.71 60.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.7 4.55 72.74 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.46 167.25 16.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -1.213 . . . . 0.0 109.696 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.76 118.55 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.546 2.164 . . . . 0.0 111.704 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 36.4 t80 -66.35 -44.23 83.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.467 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.47 89.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.774 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 24.7 t70 -53.41 -54.43 36.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 111.082 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -39.06 68.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.998 -1.064 . . . . 0.0 111.313 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.02 -60.4 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.997 -1.064 . . . . 0.0 111.676 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.673 ' O ' HG22 ' A' ' 120' ' ' VAL . 63.0 p-90 -87.99 -20.99 25.1 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.759 -1.213 . . . . 0.0 111.151 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 58.3 m -56.93 -32.25 65.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.838 -1.164 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -45.89 -14.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.5 m -82.23 24.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.1 -1.0 . . . . 0.0 109.949 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 71.95 29.65 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 109.764 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.1 t60 53.9 31.98 14.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 0.0 109.59 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.508 ' H ' HG23 ' A' ' 120' ' ' VAL . 39.1 mt-30 -150.32 121.52 3.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.97 153.26 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.732 2.288 . . . . 0.0 111.809 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 91.9 mm-40 -110.89 148.22 32.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.731 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.595 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 31.5 tpp -120.85 135.06 55.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.103 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -85.94 164.17 17.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -142.91 43.08 1.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.835 . . . . 0.0 109.364 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.18 -164.6 1.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.483 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 40.3 m -158.91 -26.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.61 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.3 m -115.36 158.13 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.92 -13.78 60.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -92.87 -32.87 14.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 131' ' ' THR . 6.5 pt-20 -77.36 3.56 12.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -0.964 . . . . 0.0 109.409 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.89 126.09 91.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.695 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.12 128.24 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.159 2.573 . . . . 0.0 112.512 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.0 t -101.07 7.86 43.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 t -144.34 88.98 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.396 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.95 160.98 32.71 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.43 -40.29 28.93 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.801 2.334 . . . . 0.0 112.01 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.85 75.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.347 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 t -61.39 -46.95 88.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 147' ' ' LYS . 24.4 t70 -61.49 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.88 83.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 149' ' ' LEU . 9.3 tt -65.82 -39.79 91.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 109.537 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -55.66 -48.95 74.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' NZ ' ' OD2' ' A' ' 143' ' ' ASP . 61.0 mttp -62.96 -28.8 70.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.52 -47.51 69.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 145' ' ' LEU . 91.0 mt -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -57.45 -37.88 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -61.33 -40.06 92.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.402 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -68.06 -19.99 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 109.377 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.05 26.25 19.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 1.9 m-85 -85.23 135.87 33.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -101.73 175.0 5.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 55.66 46.92 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' GLY . 25.8 m -120.18 25.93 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.62 164.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.2 m -53.84 -31.27 48.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -1.089 . . . . 0.0 109.386 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 -47.3 76.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.83 -36.32 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.5 m -67.99 -48.82 64.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.287 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.92 -41.56 98.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.416 -0.803 . . . . 0.0 109.316 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.0 m -59.13 -38.5 79.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -60.68 -45.68 93.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mmm -58.91 -41.83 88.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.611 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -71.02 -31.34 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' VAL . 2.5 p -80.74 -63.98 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 109.472 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.683 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 158.04 -98.78 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mt 61.52 -22.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.683 ' H ' ' C ' ' A' ' 170' ' ' GLY . 12.9 m -132.39 143.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.595 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 6.1 m-20 -92.53 102.18 14.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.407 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.39 97.34 11.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.496 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.53 141.08 32.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 m -94.63 136.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.77 138.19 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.62 2.95 62.95 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 180' ' ' CYS . 7.6 m -153.24 155.06 35.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -1.163 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 1.7 t 71.01 3.87 4.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 3.2 m 62.71 56.36 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.538 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.55 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.74 HH21 HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.261 0.553 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 m -52.59 166.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.62 -17.53 61.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.506 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -76.51 6.91 5.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.427 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.9 p -78.83 133.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -71.47 162.56 29.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.935 . . . . 0.0 109.447 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.647 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 0.7 OUTLIER -84.07 1.23 44.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.92 144.87 73.12 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.74 -17.15 26.17 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.893 2.395 . . . . 0.0 112.102 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.81 -46.71 14.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -66.42 -44.58 82.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.434 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.74 HD11 HH21 ' A' ' 3' ' ' ARG . 15.2 tt -59.78 -42.17 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 14' ' ' ILE . . . -72.43 -41.59 66.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.504 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.54 ' OH ' ' NE1' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -59.62 -37.53 78.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.47 -43.45 85.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.7 p30 -91.63 1.09 57.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ALA . 31.5 t30 -63.59 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -153.08 -16.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.54 ' NE1' ' OH ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -50.13 145.89 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.32 -5.51 62.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.61 119.06 65.75 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.243 -1.151 . . . . 0.0 109.335 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.15 121.01 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.806 2.337 . . . . 0.0 111.855 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -103.72 138.92 39.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -134.63 0.31 2.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.033 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -81.26 118.7 22.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -53.81 -37.85 63.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.22 -42.09 94.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -70.98 -48.81 51.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.2 mp -64.49 -36.69 85.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.817 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 35' ' ' ILE . 20.8 t80 -61.42 -50.81 71.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.11 -28.97 65.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.421 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 47.5 tpp -57.28 -52.6 64.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.795 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.457 HD12 ' OE2' ' A' ' 38' ' ' GLU . 2.8 tp -65.83 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.971 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 78.4 m -74.48 -38.87 62.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.096 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.07 -50.08 51.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 109.887 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE2' HD12 ' A' ' 35' ' ' ILE . 25.9 pt-20 -62.82 -27.89 69.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.8 -33.97 28.62 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -63.79 -27.54 69.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.263 . . . . 0.0 109.776 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 56.9 tt0 -50.37 -41.3 51.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.93 112.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.669 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.17 -37.16 3.63 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 86' ' ' ILE . 25.9 mt -100.88 -140.4 0.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.172 . . . . 0.0 109.41 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 p -141.59 159.92 41.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.512 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 74.9 t-105 -57.08 -44.62 83.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.484 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 48' ' ' THR . 9.9 tp -56.87 -34.61 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 47' ' ' ILE . 69.4 m -70.63 -34.62 72.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.96 . . . . 0.0 109.723 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.3 t -70.16 -44.3 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.1 mt -53.26 -53.97 43.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.8 -45.6 82.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.097 -1.002 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 85' ' ' ILE . 63.5 mttm -79.79 -11.55 59.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 49' ' ' VAL . 27.5 ttt-85 -64.65 -48.54 74.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.189 -0.944 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 19.7 pt-20 -72.61 -39.25 67.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.809 . . . . 0.0 109.307 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -70.07 -41.55 73.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.294 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 32.2 t80 -60.2 -44.75 94.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.407 -0.808 . . . . 0.0 109.375 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' HIS . 52.2 mtp180 -58.57 -38.49 78.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.849 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.06 80.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 1.9 p -93.4 -12.83 28.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 37.6 m-85 -117.0 -54.21 2.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.941 -1.1 . . . . 0.0 110.173 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ARG . 74.8 t60 -54.87 -42.15 71.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.112 -0.992 . . . . 0.0 109.882 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -57.37 -35.26 69.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 46.8 m-85 -72.57 -22.7 60.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 131.44 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.005 . . . . 0.0 109.608 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -40.52 -34.29 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.93 2.42 . . . . 0.0 112.701 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.7 t -56.34 -49.77 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' MET . 53.6 mtpt -73.24 -30.27 63.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.848 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.519 ' O ' ' SD ' ' A' ' 71' ' ' MET . 62.1 t -56.02 -44.15 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.41 42.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.65 34.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 9.6 ptm -61.64 144.91 53.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.701 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -95.22 171.36 8.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.578 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.67 -33.53 68.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.451 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 49.3 mp0 -56.07 -36.91 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.86 -38.28 90.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.3 t -59.47 -44.51 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.1 -34.94 79.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.187 -0.945 . . . . 0.0 109.338 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -58.8 -43.86 90.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.338 -0.852 . . . . 0.0 109.783 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.8 mt -69.58 -32.63 71.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.97 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.15 -32.95 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -92.93 -51.96 4.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 87.4 m-20 -90.89 155.65 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.361 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.73 84.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -70.42 25.99 0.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 83' ' ' ALA . 2.5 pt -47.18 -97.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -1.176 . . . . 0.0 109.312 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.48 HD11 HD11 ' A' ' 44' ' ' LEU . 14.4 tt -114.55 131.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.653 ' HG2' HH11 ' A' ' 87' ' ' ARG . 8.9 mtt-85 -86.36 94.11 9.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -173.44 80.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -47.16 -33.8 5.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.938 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.01 -42.7 97.06 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -63.5 -44.53 94.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -1.193 . . . . 0.0 109.489 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.85 -43.71 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -57.16 -37.24 71.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.91 88.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.384 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -57.56 -42.71 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.83 . . . . 0.0 109.44 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.561 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 26.9 mm -54.1 -50.17 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.91 -32.2 80.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 24.4 m120 -62.86 -46.91 85.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -1.177 . . . . 0.0 109.414 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.77 83.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -64.57 -39.59 94.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.4 61.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.535 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -68.8 -48.39 63.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.55 -41.48 90.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.59 -38.87 91.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.543 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -35.39 80.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.44 -29.46 68.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -51.77 -19.88 1.87 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.496 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -75.73 -17.85 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.54 63.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.39 151.13 42.48 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -1.154 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -68.43 119.35 6.35 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.636 2.224 . . . . 0.0 111.675 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -74.32 -40.19 62.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.504 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.93 -49.99 73.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 118' ' ' SER . 89.5 m-20 -57.84 -54.3 48.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 111.064 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 57.8 t80 -53.69 -42.46 68.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 111.256 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.38 -59.56 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.974 -1.079 . . . . 0.0 111.662 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.614 ' CB ' HD21 ' A' ' 171' ' ' LEU . 59.2 p-90 -88.22 -21.28 24.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.735 -1.228 . . . . 0.0 111.122 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' VAL . 72.7 p -58.94 -28.59 66.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.825 -1.172 . . . . 0.0 109.77 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.01 -14.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.01 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.4 m -84.17 24.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.041 -1.037 . . . . 0.0 109.974 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.3 t-20 72.52 31.35 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.682 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 81.9 t60 53.05 33.47 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.539 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.547 ' H ' HG23 ' A' ' 120' ' ' VAL . 69.3 mt-30 -142.52 106.5 5.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.558 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -46.61 151.58 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.611 2.207 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.79 143.53 29.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.723 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.3 ttm -126.76 130.38 50.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.843 . . . . 0.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.0 OUTLIER -94.18 164.75 12.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.875 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -164.03 41.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 109.3 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.37 -176.72 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 109.67 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -76.53 -41.48 46.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.398 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.415 HG23 ' OG ' ' A' ' 133' ' ' SER . 1.2 t -147.44 175.0 11.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.11 -32.18 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.415 ' OG ' HG23 ' A' ' 131' ' ' THR . 85.4 p -57.46 -38.03 73.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.444 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.54 -32.01 72.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.47 131.96 89.73 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.78 138.59 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.152 2.568 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -84.59 4.25 33.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -140.96 88.47 2.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -94.9 174.8 3.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 139' ' ' THR . 35.9 Cg_exo -56.9 -42.24 66.66 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.07 74.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 t -60.97 -48.84 79.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.14 -41.36 94.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.04 89.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.2 tp -60.45 -48.27 82.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -55.33 -43.67 75.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -59.29 -37.87 78.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.544 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.24 -51.67 28.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 109.593 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -59.12 -41.68 88.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.09 -37.38 86.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.564 ' HG2' HH11 ' A' ' 152' ' ' ARG . 28.2 mtt-85 -64.15 -21.4 66.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.342 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.02 6.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 10.0 m-85 -96.1 137.08 35.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -1.116 . . . . 0.0 109.475 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -94.59 -166.98 1.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 31.6 p90 40.03 37.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.52 24.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.21 158.93 3.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -57.82 -29.82 65.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.1 m -66.94 -44.85 79.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.28 -37.79 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.15 -41.14 92.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.56 -44.01 97.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.431 -0.793 . . . . 0.0 109.337 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 22.9 t -57.71 -38.02 74.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -59.25 -41.77 89.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.399 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 57.6 mtt -63.91 -38.39 90.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.632 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -59.19 -38.94 81.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.687 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -80.44 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.542 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 37.3 t -49.96 -43.38 50.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.495 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.83 15.66 26.0 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.614 HD21 ' CB ' ' A' ' 117' ' ' TRP . 6.0 mp -51.71 -51.1 58.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.4 m -90.88 136.31 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 127' ' ' THR . 62.1 t30 -85.6 103.39 14.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.932 . . . . 0.0 109.447 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 63.6 t0 -96.52 115.43 27.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.526 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 51.2 m80 -159.82 15.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 177' ' ' VAL . 9.4 t 52.49 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.684 ' H ' HG12 ' A' ' 176' ' ' VAL . 10.4 p -94.94 -8.86 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.03 47.6 0.71 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 181' ' ' CYS . 4.8 t -146.49 170.11 17.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 109.516 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 72.1 m 53.55 -86.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.539 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.1 p -166.05 36.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.596 179.913 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.629 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.01 161.35 30.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.56 -5.79 86.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -54.39 -33.64 59.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.483 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 14' ' ' ILE . 9.1 p -105.03 137.08 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 17.4 p -157.53 -136.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.505 ' N ' ' OG ' ' A' ' 8' ' ' SER . 51.7 mt-30 -61.22 -147.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.533 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 53.61 74.62 0.73 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.36 -27.62 13.89 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.9 2.4 . . . . 0.0 112.108 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.5 tt -73.17 -39.1 65.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.465 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -65.82 -53.75 35.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 7' ' ' VAL . 4.4 pt -63.79 -33.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.355 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.28 -43.71 83.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -72.87 -44.57 61.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 109.478 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.599 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 30.0 t-80 -64.0 -49.42 72.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.84 -34.06 74.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -65.38 -69.62 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.526 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.83 119.13 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.599 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 77.7 t90 -172.65 128.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.42 83.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.2 114.91 64.83 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.4 120.48 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.75 2.3 . . . . 0.0 111.896 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HB2' HD21 ' A' ' 31' ' ' LEU . 79.2 mm-40 -101.65 128.91 47.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.85 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.6 p -103.09 -4.4 24.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -79.71 117.81 20.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 0.0 109.367 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.0 m -59.64 -34.08 72.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 109.628 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.02 -46.23 85.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.87 -44.17 73.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 25' ' ' GLU . 84.3 mt -63.67 -47.18 82.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.835 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -60.7 -42.17 96.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.837 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -73.46 -30.46 63.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.6 tpp -63.0 -54.63 35.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 109.803 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 36' ' ' CYS . 3.4 tp -65.01 -35.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.998 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 35' ' ' ILE . 75.0 m -71.92 -44.21 64.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.072 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.7 -43.32 72.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -0.994 . . . . 0.0 109.845 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.31 -31.18 70.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.788 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.3 -32.94 22.8 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.2 -29.34 70.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -1.215 . . . . 0.0 109.7 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -51.92 -23.4 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.662 -179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.14 109.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 0.0 109.684 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.05 -32.23 5.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 23.2 mt -105.79 160.98 14.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 p -89.06 157.09 18.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.425 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -56.32 -29.6 61.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.639 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.16 -38.05 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.686 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.5 m -74.46 -33.14 62.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -58.27 -35.01 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.44 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.2 mt -54.69 -51.4 65.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.34 -46.32 89.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 56' ' ' TYR . 68.0 mmtt -71.18 -22.74 61.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.37 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -59.17 -47.59 84.74 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 109.001 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 57' ' ' ARG . 78.0 mm-40 -66.6 -44.35 82.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.398 -0.814 . . . . 0.0 109.394 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.6 -32.72 71.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.245 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.643 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 60.4 t80 -64.27 -45.96 85.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.464 -0.773 . . . . 0.0 109.403 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 54' ' ' GLU . 58.4 mtm180 -58.27 -42.3 86.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.75 73.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 110.303 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.504 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 10.7 m -94.92 -12.38 26.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.065 -1.022 . . . . 0.0 110.232 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 54.6 m-85 -123.83 -43.18 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.877 -1.139 . . . . 0.0 110.218 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 57' ' ' ARG . 36.4 t-80 -49.39 -43.12 43.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -67.78 -34.43 76.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.735 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 38.5 m-85 -71.29 -44.95 64.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 5.0 t70 73.85 136.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.066 -1.021 . . . . 0.0 109.613 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -41.16 -25.67 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.864 2.376 . . . . 0.0 112.739 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.97 -47.78 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -67.25 -49.65 63.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.841 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 69' ' ' ALA . 8.3 m -55.16 -44.32 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 109.541 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.594 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -66.48 -21.49 66.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.95 . . . . 0.0 109.445 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.74 1.28 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.369 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.4 mtm -78.83 159.4 27.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -104.34 168.83 8.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.54 -34.04 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 109.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.52 -37.45 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.902 . . . . 0.0 109.469 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.64 -38.33 90.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.466 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 80' ' ' VAL . 77.6 t -56.73 -42.97 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.625 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.97 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.336 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.424 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.7 ttt-85 -60.91 -47.04 88.25 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.458 ' O ' ' CA ' ' A' ' 84' ' ' GLY . 96.0 mt -69.68 -39.07 77.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.7 t -50.71 -33.1 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.722 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -91.69 -56.87 2.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -95.06 122.4 37.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.438 ' HB1' ' SG ' ' A' ' 59' ' ' CYS . . . 55.49 47.0 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.425 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -86.87 31.89 4.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.72 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 20.01 -116.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -1.13 . . . . 0.0 109.32 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.89 140.54 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.626 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -77.14 94.56 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.7 m170 -164.22 88.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.157 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 80' ' ' VAL . 54.1 mtp180 -51.24 -28.71 12.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.828 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.96 -42.5 77.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -60.88 -52.44 65.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -1.135 . . . . 0.0 109.577 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 89.3 mt -57.49 -50.73 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -57.33 -32.69 66.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.407 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.97 -40.14 94.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CE1' ' A' ' 60' ' ' PHE . 23.6 mm -58.41 -50.95 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 109.352 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 68' ' ' VAL . 80.0 mt -53.99 -48.22 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.578 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.35 -33.94 83.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 24.7 m120 -62.67 -40.43 97.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.428 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.13 -40.76 86.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.426 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 48.1 ttm-85 -59.17 -41.44 88.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -37.05 67.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.594 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 17.8 t80 -73.52 -48.61 31.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 103' ' ' LEU . 25.5 tp -58.36 -45.91 87.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.895 . . . . 0.0 109.472 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -63.33 -36.12 82.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.8 ttt -61.17 -43.17 99.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.132 -0.98 . . . . 0.0 109.459 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -71.9 -27.3 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.19 -31.93 33.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.04 0.84 34.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.21 40.1 34.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.82 82.37 49.42 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -1.182 . . . . 0.0 109.634 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -37.29 127.99 0.63 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.626 2.218 . . . . 0.0 111.732 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -63.98 -48.18 77.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.09 -41.3 71.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 110.678 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -62.42 -33.72 75.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 111.008 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.541 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 84.1 t80 -63.92 -52.55 59.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.064 -1.022 . . . . 0.0 111.241 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 116' ' ' VAL . 8.4 m -58.1 -41.42 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.0 111.692 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.512 ' O ' ' N ' ' A' ' 122' ' ' HIS . 59.6 m95 -63.88 -33.55 75.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.775 -1.203 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.4 t -66.03 -34.61 78.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.81 -1.181 . . . . 0.0 109.746 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.83 -43.01 99.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.101 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.4 p -87.76 24.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.947 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.51 22.05 7.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.641 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 117' ' ' TRP . 84.7 t60 49.27 45.68 23.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -151.37 114.91 3.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 138.72 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.716 2.277 . . . . 0.0 111.836 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.528 ' NE2' HG23 ' A' ' 120' ' ' VAL . 40.2 mt-30 -97.58 149.7 21.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 109.762 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -135.68 148.11 48.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.121 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 13.5 t -133.51 154.93 50.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 109.82 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -110.8 44.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.86 163.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.643 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 134' ' ' GLU . 9.0 m -116.23 -28.58 6.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 109.361 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 132' ' ' LEU . 1.7 t -142.06 -179.9 6.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.412 ' N ' ' OG1' ' A' ' 131' ' ' THR . 39.5 mt -64.23 -35.95 82.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -67.27 -29.57 69.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 130' ' ' THR . 40.0 mm-40 -63.15 -20.14 65.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.445 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.6 mp -67.04 119.83 67.25 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 109.698 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.19 130.68 5.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.065 2.51 . . . . 0.0 112.472 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.24 11.12 40.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 109.324 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.1 p -138.52 88.41 2.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.86 154.8 37.21 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.09 -32.11 94.27 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.813 2.342 . . . . 0.0 112.08 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.51 -40.89 48.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.4 p -62.51 -41.25 98.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.86 -48.08 75.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.41 82.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -47.41 84.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.85 . . . . 0.0 109.51 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.5 m -55.92 -43.62 77.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.47 -35.9 78.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.513 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.65 -52.59 36.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.952 . . . . 0.0 109.531 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.8 mp -63.58 -38.11 89.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -61.35 -39.69 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.406 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.4 -37.05 85.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' A' ' 152' ' ' ARG . 44.9 mtt-85 -64.32 -23.24 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.404 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.74 10.51 16.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -74.68 137.74 42.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -1.115 . . . . 0.0 109.523 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.597 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -97.97 -168.4 1.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 21.8 p90 39.53 38.32 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.509 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 157' ' ' VAL . 3.1 m -97.68 24.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.52 155.18 3.98 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 57.0 m -54.91 -30.4 58.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.451 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.1 m -67.03 -47.91 69.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -64.95 -37.08 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.53 -42.16 92.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.31 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.99 -43.51 98.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.3 m -57.4 -37.32 72.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 109.265 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.92 -39.94 91.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.452 ' SD ' HD12 ' A' ' 171' ' ' LEU . 64.3 mmm -66.11 -49.24 68.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.656 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.511 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 28.3 mm100 -69.24 -41.93 76.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.715 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.54 84.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.98 -45.28 71.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.09 12.3 22.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.467 HD23 ' CH2' ' A' ' 117' ' ' TRP . 83.0 mt -58.64 -31.31 68.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.7 p -122.66 139.95 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.434 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -97.28 105.25 17.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 97.8 m-20 -94.76 97.58 10.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.506 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -139.7 150.23 44.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 m -68.75 -160.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.43 139.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.43 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 81.1 29.32 41.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.2 m -149.82 162.02 41.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.465 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 80.8 m 52.52 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.553 ' N ' ' O ' ' A' ' 179' ' ' CYS . 22.4 p -169.96 24.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.478 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 74.0 t80 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.685 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 p -46.13 160.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.71 -0.78 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -78.26 8.69 4.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.6 p -130.14 130.87 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.922 . . . . 0.0 109.455 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.506 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 12.0 p -173.95 54.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 8' ' ' SER . 89.7 mm-40 -137.58 -135.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.34 153.91 4.75 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.335 -0.853 . . . . 0.0 109.448 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.7 -11.44 31.91 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.791 2.328 . . . . 0.0 112.174 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.48 -36.4 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.442 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 87.4 m-85 -73.67 -54.72 7.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.46 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.24 -48.9 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.342 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.96 87.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.59 -41.22 94.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 13' ' ' TYR . 28.1 m80 -62.99 -45.9 90.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.5 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.51 -37.26 51.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.479 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -57.94 -60.47 3.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -153.69 104.98 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.534 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -171.28 116.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.38 6.18 71.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' CYS . 2.3 t -110.68 104.12 55.5 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.245 -1.15 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.65 132.03 16.29 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.765 2.31 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.22 136.26 52.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.779 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.4 p -104.91 0.72 28.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.096 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -77.79 123.48 26.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.795 . . . . 0.0 109.35 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.3 p -66.84 -33.26 75.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 109.638 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -59.06 -43.54 91.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.152 -0.967 . . . . 0.0 109.771 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.57 -50.61 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.47 -38.51 77.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.16 -41.47 92.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 109.841 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' ' HG ' ' A' ' 36' ' ' CYS . 97.5 mt-10 -73.81 -31.06 63.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 109.84 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.48 -52.96 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.0 tp -55.1 -42.58 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.0 109.989 -178.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 30.7 p -72.81 -48.83 34.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.141 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 84.8 mt -65.75 -29.93 70.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.075 -1.016 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -51.77 -36.87 49.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.77 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.65 -29.29 61.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.04 -34.51 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.4 tt0 -57.68 -32.86 67.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.0 109.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 109.645 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.52 3.37 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.5 mm? -85.94 -160.01 0.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -1.192 . . . . 0.0 109.455 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 m -118.53 152.32 36.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -56.07 -33.24 64.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 0.0 109.513 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -29.56 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 109.611 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.2 m -64.78 -39.61 93.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.5 t -61.99 -38.91 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 mt -55.69 -55.13 35.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 51' ' ' LYS . 9.4 mtmp? -60.38 -45.12 94.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.325 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.476 ' NZ ' ' CG1' ' A' ' 86' ' ' ILE . 1.0 OUTLIER -68.91 -29.45 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.351 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.601 ' HG2' HH11 ' A' ' 53' ' ' ARG . 2.5 ttt-85 -54.27 -43.08 70.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.15 -0.968 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.99 -43.78 70.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.435 -0.791 . . . . 0.0 109.376 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -65.61 -43.87 88.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t80 -60.88 -44.72 96.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.389 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 42.9 ttp180 -59.68 -27.31 66.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 109.77 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.44 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.425 -0.797 . . . . 0.0 110.265 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.0 m -92.89 -20.85 20.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.133 -0.979 . . . . 0.0 110.262 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 27.9 m-85 -102.75 -52.43 3.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.976 -1.077 . . . . 0.0 110.16 -178.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t60 -54.0 -39.14 65.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.972 -1.08 . . . . 0.0 109.88 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -56.32 -37.92 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' ASP . 54.9 m-85 -91.36 3.85 53.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 0.0 109.956 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 57.45 162.57 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.604 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.52 -28.49 8.31 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.904 2.403 . . . . 0.0 112.746 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -62.95 -48.96 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.681 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 71' ' ' MET . 91.1 mttt -65.51 -34.58 78.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.846 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 64' ' ' ASP . 55.8 t -56.09 -39.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -72.05 -34.31 68.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.1 16.53 22.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.361 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' LYS . 20.7 ttp -79.65 159.87 26.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.7 159.86 16.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.79 -25.17 62.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.48 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -55.68 -44.02 76.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 63.6 m-20 -61.83 -38.37 87.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.08 -41.44 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.58 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.18 -38.76 84.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 75' ' ' ASP . 72.8 mtm180 -68.94 -39.93 79.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.392 -0.817 . . . . 0.0 109.799 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.57 -46.45 69.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.3 t -51.78 -31.59 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.751 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.01 -57.61 3.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.515 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.79 126.37 44.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 51.89 47.05 25.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -75.85 15.56 4.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.615 ' C ' ' O ' ' A' ' 84' ' ' GLY . 3.9 pt 28.88 90.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.107 . . . . 0.0 109.346 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 85' ' ' ILE . 79.0 mt 58.02 151.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.541 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 53.8 mtm-85 -89.01 105.39 17.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 16.8 m-70 -163.47 61.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.219 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -47.56 -35.86 9.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.33 88.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 2.6 tppt? -73.41 -41.93 62.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -1.173 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.67 -53.53 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.609 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -56.36 -33.32 65.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.977 . . . . 0.0 109.323 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -59.55 -37.79 79.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.38 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.19 -40.49 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.4 mt -54.41 -45.68 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.8 -37.93 93.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 59.3 m-20 -58.53 -42.73 88.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -1.187 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.8 77.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 43.0 ttm-85 -59.1 -39.56 82.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.73 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.579 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -59.39 -48.32 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.39 -41.5 98.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.432 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.2 -44.19 96.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 109.563 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.85 -43.18 75.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.943 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.64 -26.66 65.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -52.49 -27.34 15.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.546 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -75.95 -14.04 60.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.472 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.95 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -94.9 114.71 64.26 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.713 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -46.27 125.48 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.614 2.209 . . . . 0.0 111.698 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.89 -34.44 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.87 -49.31 59.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.176 -0.952 . . . . 0.0 110.685 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 118' ' ' SER . 86.2 m-20 -56.06 -55.63 30.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 111.079 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -56.11 -38.23 70.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 111.21 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 117' ' ' TRP . 2.4 t -55.93 -59.64 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 111.66 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.632 ' CB ' HD21 ' A' ' 171' ' ' LEU . 57.8 p-90 -88.97 -20.48 24.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.806 -1.184 . . . . 0.0 111.173 -178.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -60.41 -28.04 67.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.754 -1.216 . . . . 0.0 109.72 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.015 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 5.4 m -92.15 24.6 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 109.964 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 5.3 t-20 79.23 19.49 0.75 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 59.94 48.16 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.533 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.9 pt20 -154.15 147.97 18.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.92 154.78 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.652 2.234 . . . . 0.0 111.815 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 19.9 mp0 -122.83 152.85 40.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 0.0 109.725 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 61.1 mtt -136.49 155.01 50.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -135.25 158.81 43.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.924 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 128' ' ' GLN . 7.6 mp0 -117.27 47.35 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.324 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.15 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 m -83.98 -41.25 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 132' ' ' LEU . 29.6 m -131.85 164.55 25.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.522 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.5 mp -69.62 -11.0 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.1 m -85.12 -35.75 21.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -12.5 61.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -178.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.414 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 85.2 mt -68.52 118.0 55.69 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.767 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.01 128.63 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.63 -19.55 48.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.336 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 m -87.42 102.65 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.328 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.9 p -121.34 150.31 53.99 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.96 -40.71 33.16 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.746 2.297 . . . . 0.0 112.042 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.16 -38.75 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.4 m -61.33 -45.46 94.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.39 -44.57 94.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -41.3 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.515 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.31 -44.36 88.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.7 t -57.48 -42.32 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -62.62 -35.24 78.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.33 -51.91 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.03 -34.35 74.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -58.37 -36.43 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HB2' HH11 ' A' ' 152' ' ' ARG . 59.8 mttp -62.1 -39.28 91.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.421 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.7 mpt_? -63.79 -21.26 66.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.26 22.23 10.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.48 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 11.8 m-85 -83.27 133.4 34.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -101.67 170.33 8.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 53.35 47.88 23.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.617 HG22 ' SG ' ' A' ' 162' ' ' CYS . 10.7 p -122.32 26.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.417 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.76 170.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.9 t -59.0 -31.63 68.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -1.169 . . . . 0.0 109.427 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.465 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -62.98 -47.21 84.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 -179.877 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.96 -39.95 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.499 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 157' ' ' VAL . 79.9 m -67.21 -41.71 85.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.414 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 75.9 t80 -60.25 -45.39 93.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.467 -0.771 . . . . 0.0 109.348 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 m -58.85 -39.17 80.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.304 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -41.96 96.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.0 mtp -56.54 -41.7 77.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.81 -36.41 83.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.677 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.04 75.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.546 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 9.1 t -71.15 -62.89 1.23 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.466 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.17 15.32 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.632 HD21 ' CB ' ' A' ' 117' ' ' TRP . 8.4 mp -52.79 -52.36 57.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.39 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -102.24 135.66 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.94 101.73 14.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 11.3 p30 -91.76 115.63 28.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -142.23 162.15 36.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.472 ' CG2' ' SG ' ' A' ' 179' ' ' CYS . 19.5 m -115.74 144.19 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.05 -34.54 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.76 -29.1 57.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 176' ' ' VAL . 52.7 m -82.29 146.82 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -1.216 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.2 t -65.53 -29.29 69.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 182' ' ' TYR . 30.0 p -49.74 -45.0 48.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.62 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 22.9 t80 . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 7.4 tpt180 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.3 m -47.07 138.25 6.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.15 22.49 12.24 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 6' ' ' TRP . 40.6 p-90 -147.09 52.85 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.0 109.475 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 p -152.07 -16.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.6 p -84.32 14.1 4.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -54.67 -39.97 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.39 159.59 1.38 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.35 -35.04 43.12 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.79 2.327 . . . . 0.0 112.14 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 12' ' ' LEU . 31.7 tp -61.04 -37.8 83.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.813 . . . . 0.0 109.48 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.47 -44.5 90.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.52 -43.96 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 109.383 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.39 98.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.34 -40.82 98.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -63.59 -48.0 79.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.58 -33.14 72.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -51.53 -51.11 57.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.22 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CD2' ' N ' ' A' ' 22' ' ' GLY . 46.4 t90 -144.77 147.92 33.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.518 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 21' ' ' TRP . . . 86.39 -29.28 4.88 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 169' ' ' CYS . 32.8 m -72.15 145.64 88.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.26 120.04 6.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.778 2.319 . . . . 0.0 111.893 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.495 ' OE1' ' SG ' ' A' ' 169' ' ' CYS . 74.3 mt-10 -95.33 128.04 41.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.952 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -133.98 -3.08 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.058 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -81.44 137.08 35.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 p -61.91 -38.12 87.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.585 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.94 -49.37 62.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -64.61 -38.68 91.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.845 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.499 HD11 ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -73.3 -33.97 65.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -65.17 -48.13 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.878 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -65.61 -30.41 71.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.821 -178.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.5 tpt -70.72 -53.37 15.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.19 -34.11 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.994 -178.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -72.18 -49.52 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 110.123 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.3 -39.5 78.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 50.4 mm-40 -57.08 -35.87 69.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.66 -31.25 57.55 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -63.75 -31.52 72.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.237 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 38' ' ' GLU . 5.1 pt20 -52.64 -23.44 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 -179.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.19 108.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.965 . . . . 0.0 109.665 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.9 -33.3 2.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.397 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -87.69 169.52 12.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.5 p -82.11 165.01 20.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -67.81 -35.29 78.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.506 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.19 -39.1 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.639 -179.7 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.476 ' N ' HG23 ' A' ' 47' ' ' ILE . 92.5 m -49.92 -35.76 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.645 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.45 -29.81 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.49 -56.47 9.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -60.92 -37.29 81.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.152 -0.967 . . . . 0.0 109.265 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' TYR . 53.1 tttm -73.91 -26.69 60.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -57.7 -48.9 78.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.242 -0.911 . . . . 0.0 108.989 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.32 -47.69 69.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.841 . . . . 0.0 109.284 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.61 -34.54 78.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 29.7 t80 -59.47 -47.43 85.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.321 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -57.1 -30.85 64.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.779 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.04 93.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.7 m -94.32 -13.1 26.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.072 -1.017 . . . . 0.0 110.262 -178.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 43.2 m-85 -111.26 -52.78 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.937 -1.102 . . . . 0.0 110.201 -178.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -52.94 -36.96 60.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 109.87 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -55.55 -33.7 64.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.3 m-85 -97.08 4.9 51.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 0.0 109.864 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.22 164.52 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.04 -1.038 . . . . 0.0 109.609 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.37 -34.06 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.869 2.379 . . . . 0.0 112.713 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.93 -49.12 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' MET . 46.4 mtpt -65.1 -35.17 80.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.84 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 64' ' ' ASP . 54.7 t -54.81 -40.3 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 109.557 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -35.49 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.913 . . . . 0.0 109.462 179.04 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.39 15.31 26.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.1 tmm? -83.86 149.64 26.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.406 ' O ' ' SD ' ' A' ' 71' ' ' MET . 14.9 pt20 -102.97 167.04 10.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.42 -28.12 69.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -56.54 -44.36 80.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.497 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.57 -38.72 81.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.612 ' O ' HG23 ' A' ' 80' ' ' VAL . 77.4 t -60.98 -45.64 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.02 -31.63 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -68.0 -48.47 65.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.336 -0.853 . . . . 0.0 109.795 -178.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.3 pp -80.5 -20.13 44.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.635 -178.12 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 76' ' ' VAL . 6.0 t -54.35 -45.14 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.908 . . . . 0.0 109.774 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -58.04 -50.54 73.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.498 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -99.67 107.05 19.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 178.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.09 74.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.41 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.41 -23.89 4.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' GLY . 21.2 pt -56.46 -164.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 109.352 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.28 136.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -92.44 96.52 10.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 10.9 m80 -165.69 87.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.595 ' HG2' HH11 ' A' ' 89' ' ' ARG . 1.4 ptt-85 -47.31 -29.34 2.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.992 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.03 97.89 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -62.61 -45.07 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.451 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.503 HG21 HG13 ' A' ' 76' ' ' VAL . 98.3 mt -56.8 -42.2 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 76' ' ' VAL . 98.0 mm-40 -60.27 -37.82 81.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.12 78.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mm -62.57 -40.92 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -57.04 -40.67 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.8 -40.68 99.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -57.38 -47.65 81.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.458 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.71 -42.84 85.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -63.88 -43.71 95.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.88 -38.1 58.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -66.63 -48.6 68.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.43 -42.49 87.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.46 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.55 -41.97 87.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.576 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -40.4 96.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.68 -27.07 64.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -51.99 -17.73 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.487 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 78.5 m-20 -74.88 -16.25 60.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.04 19.2 65.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.3 mp0 -115.87 151.93 46.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.188 -1.184 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.06 123.53 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.535 2.156 . . . . 0.0 111.696 179.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -76.18 -43.48 42.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 110.43 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -60.69 -49.85 75.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.095 -1.003 . . . . 0.0 110.704 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 92.1 m-20 -51.56 -36.36 44.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 111.019 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.39 -47.92 21.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 111.207 -177.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -56.34 -46.52 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.017 . . . . 0.0 111.653 -175.219 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' HG13 ' A' ' 116' ' ' VAL . 16.9 p-90 -88.18 -27.85 21.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.745 -1.222 . . . . 0.0 111.131 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 120' ' ' VAL . 10.2 t -56.08 -29.26 60.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.871 -1.143 . . . . 0.0 109.772 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.25 -13.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' SER . 14.1 m -82.54 24.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.051 -1.03 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.573 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 13.6 t-20 74.17 17.21 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 109.68 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER 66.68 -13.35 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 121' ' ' ASN . 77.5 mt-30 -86.37 150.61 52.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.72 149.59 73.4 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.631 2.221 . . . . 0.0 111.849 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -110.27 145.66 37.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.3 mtt -135.84 152.55 51.18 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.173 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 173' ' ' ASN . 10.6 t -94.73 160.65 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.29 49.63 1.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 109.317 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.99 135.05 42.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.682 -179.356 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.8 m -76.05 -34.29 59.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.32 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.3 m -127.34 159.22 35.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.7 mt -56.26 -30.89 63.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.7 p -71.81 -29.94 64.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.82 1.12 15.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.11 119.81 67.29 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.766 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.92 130.05 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.144 2.562 . . . . 0.0 112.544 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 t -104.63 12.58 32.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.268 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -139.0 92.41 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 161.64 22.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.9 -39.55 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.829 2.352 . . . . 0.0 111.975 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.59 73.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.2 m -59.95 -45.97 90.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.26 -42.2 99.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.38 -43.2 67.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -60.55 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -53.84 -43.27 69.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -62.45 -33.74 75.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.49 -51.19 38.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -33.16 72.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.589 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -58.36 -39.23 79.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.356 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.99 -40.48 97.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 109.443 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.45 -20.46 66.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.18 32.42 7.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.43 132.11 37.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.94 174.85 6.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 53.24 48.03 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLY . 5.4 m -115.2 26.22 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.07 167.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 159' ' ' THR . 1.0 OUTLIER -61.35 -28.31 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -1.158 . . . . 0.0 109.417 -179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -70.32 -41.26 73.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.425 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.43 -47.82 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.0 p -64.28 -38.81 92.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.263 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.542 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 53.7 t80 -62.26 -46.5 88.54 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -61.6 -37.86 85.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.275 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.499 ' CE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -61.71 -55.07 34.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 179.692 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.455 ' N ' ' CG ' ' A' ' 165' ' ' PHE . 48.0 mtm -63.72 -41.31 98.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.646 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -66.41 -42.92 87.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 -42.32 75.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 109.697 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' ' OE1' ' A' ' 25' ' ' GLU . 3.5 m -60.91 -61.1 2.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.413 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 144.31 1.78 0.89 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 171' ' ' LEU . 4.3 mm? -57.43 -43.12 83.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 109.396 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.75 136.57 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 127' ' ' THR . 86.7 m-20 -87.95 112.58 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.429 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -86.82 110.02 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.532 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -153.8 126.69 8.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.558 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.26 137.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.75 135.68 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.43 5.71 60.22 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 16.4 p -77.15 -150.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.491 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.53 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 71.9 m -57.85 -39.6 78.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 0.9 OUTLIER 173.15 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.979 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' ARG . 14.2 m 55.76 167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.0 109.397 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.93 -29.13 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -72.85 -0.0 12.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' SER . 7.1 p -108.88 134.72 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 167.27 0.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -79.26 -130.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.877 . . . . 0.0 109.484 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 152.08 14.28 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.96 -11.47 32.33 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.863 2.376 . . . . 0.0 112.137 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.4 tt -63.28 -38.72 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -59.82 -47.93 83.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.7 mt -66.64 -41.6 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.359 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -46.84 87.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CD1' HD22 ' A' ' 50' ' ' LEU . 64.9 t80 -66.97 -41.46 86.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -59.97 -42.18 93.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.87 -10.71 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -78.29 -76.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.433 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.44 101.53 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -170.04 126.47 0.83 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.69 -29.15 8.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.5 m -72.17 149.33 91.85 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.23 -1.159 . . . . 0.0 109.32 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.43 119.29 6.3 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.776 2.317 . . . . 0.0 111.89 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -112.67 132.87 54.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.804 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 p -134.87 3.06 3.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.029 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -80.72 122.37 27.04 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.364 -0.835 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 t -58.69 -39.81 81.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.25 -43.22 82.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.723 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.35 -50.77 50.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -67.81 -35.72 79.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.88 -45.59 93.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -74.61 -31.27 61.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.77 -179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.7 ttm -71.67 -54.59 9.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.723 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 36' ' ' CYS . 2.9 tp -59.37 -40.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 0.0 110.035 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.52 ' N ' HG23 ' A' ' 35' ' ' ILE . 76.7 m -72.76 -46.43 53.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.123 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD2' ' NH1' ' A' ' 53' ' ' ARG . 9.6 tp -69.8 -33.71 72.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.01 . . . . 0.0 109.863 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -52.15 -34.94 46.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.803 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.455 ' HA3' ' HZ1' ' A' ' 91' ' ' LYS . . . -52.23 -27.0 22.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.15 -31.94 72.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -1.22 . . . . 0.0 109.777 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.62 -26.34 63.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.965 . . . . 0.0 109.728 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.59 109.08 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.694 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.91 -29.95 4.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.3 mt -100.45 163.73 12.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.429 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -87.39 164.86 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.384 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -59.38 -40.95 88.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 109.505 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 48' ' ' THR . 9.0 tp -54.53 -39.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.653 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 47' ' ' ILE . 88.8 m -61.37 -36.27 79.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -69.75 -40.1 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 16' ' ' TYR . 79.2 mt -57.12 -54.92 41.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -57.62 -47.41 82.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -68.66 -29.86 68.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttm-85 -50.74 -47.11 59.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 108.987 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.35 -43.68 73.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.515 -0.741 . . . . 0.0 109.406 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -67.12 -37.3 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 0.0 109.229 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 7.5 t80 -63.19 -43.89 96.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.374 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.533 ' HG2' HH11 ' A' ' 57' ' ' ARG . 43.7 mtt-85 -58.41 -39.2 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.31 77.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.458 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 85.6 m -92.39 -12.92 30.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 110.244 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 5.9 m-85 -115.97 -49.09 2.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.932 -1.105 . . . . 0.0 110.153 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.4 t60 -49.86 -42.48 47.72 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.066 -1.021 . . . . 0.0 109.877 -178.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -65.15 -30.14 71.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.789 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.434 ' O ' ' O ' ' A' ' 64' ' ' ASP . 50.2 m-85 -88.13 -0.2 56.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.833 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 56.14 165.65 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.049 -1.032 . . . . 0.0 109.596 -179.747 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.649 ' O ' HG22 ' A' ' 68' ' ' VAL . 72.6 Cg_endo -78.72 -54.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.832 2.355 . . . . 0.0 112.709 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 t -47.22 -33.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -68.7 -44.11 74.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.341 -0.849 . . . . 0.0 109.827 -177.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 65' ' ' PRO . 1.4 m -56.99 -39.92 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.616 -178.048 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -64.18 -39.37 93.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.473 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.93 23.54 7.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 109.373 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.407 ' HG3' ' H ' ' A' ' 72' ' ' GLN . 11.5 ttp -93.53 160.37 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 109.626 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.407 ' H ' ' HG3' ' A' ' 71' ' ' MET . 95.2 mt-30 -101.46 166.5 10.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.3 mt-10 -70.52 -21.93 62.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.13 -31.15 65.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.94 . . . . 0.0 109.468 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.05 -38.23 87.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.424 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 76' ' ' VAL . 10.5 m -73.57 -29.32 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 80' ' ' VAL . 44.5 tp10 -67.11 -36.38 81.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 -178.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 13.3 ptm180 -77.87 -41.9 35.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.897 ' O ' HD12 ' A' ' 79' ' ' LEU . 1.2 pp -81.46 -7.13 59.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.953 . . . . 0.0 109.637 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 81' ' ' GLN . 9.3 p -49.37 -42.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.688 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.537 ' N ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -90.42 20.91 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.006 . . . . 0.0 109.441 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.1 t0 -74.94 121.39 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.378 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.54 0.34 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 65.65 43.3 94.6 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -58.55 -165.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 86' ' ' ILE . 18.9 tt -56.02 127.89 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 87' ' ' ARG . 9.4 ptm180 -73.24 95.41 2.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -171.83 69.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -45.02 -36.15 3.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.904 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.03 98.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 33.8 tptt -62.43 -43.23 99.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.478 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 92' ' ' ILE . 18.2 mt -54.64 -50.56 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.62 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.89 -30.61 69.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.985 . . . . 0.0 109.384 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -58.78 -44.47 90.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.9 mp -56.28 -39.8 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 68' ' ' VAL . 87.9 mt -62.81 -29.23 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.77 -45.13 77.4 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -64.86 -38.02 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -1.185 . . . . 0.0 109.428 -178.548 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.59 80.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -59.53 -43.87 93.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.36 -30.41 66.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.93 -47.25 87.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.28 -44.77 86.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.94 -44.68 94.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.482 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.61 -41.61 79.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -71.45 -27.4 63.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.485 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -52.56 -23.26 6.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.425 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -75.35 -13.11 60.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.84 48.8 6.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -135.34 150.93 73.9 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.187 -1.184 . . . . 0.0 109.653 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.23 119.14 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.571 2.181 . . . . 0.0 111.677 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -75.28 -40.76 58.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.439 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 -48.17 69.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 110.725 -178.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 118' ' ' SER . 44.3 t0 -55.1 -55.28 32.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 111.096 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -55.66 -38.59 69.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 111.249 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.97 -59.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 0.0 111.646 -178.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.43 ' O ' HG22 ' A' ' 120' ' ' VAL . 61.1 p-90 -87.79 -28.1 21.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.663 -1.273 . . . . 0.0 111.125 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 120' ' ' VAL . 94.1 p -56.34 -26.03 51.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.816 -1.178 . . . . 0.0 109.769 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.47 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.056 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 118' ' ' SER . 10.7 m -89.56 25.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 23.8 t30 80.01 22.06 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.696 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 59.46 49.75 8.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.499 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.476 ' H ' HG23 ' A' ' 120' ' ' VAL . 2.6 pt20 -154.61 146.46 17.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.37 143.36 43.1 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.642 2.228 . . . . 0.0 111.778 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -100.25 151.35 21.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 109.746 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -136.03 156.89 48.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.176 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.4 t -129.82 164.12 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -133.16 50.88 2.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -94.23 142.2 27.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.704 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 m -92.43 -27.69 17.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 109.361 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -126.15 156.73 39.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -57.88 -34.76 70.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 m -62.35 -36.67 82.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.68 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.8 mt-10 -63.67 -28.84 70.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.1 mt -67.08 116.55 37.06 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.11 130.19 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.11 2.54 . . . . 0.0 112.503 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.75 -8.15 58.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.5 p -101.05 101.84 12.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.378 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.82 151.78 52.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.31 -33.84 97.81 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.75 2.3 . . . . 0.0 112.009 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.89 -35.2 57.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.359 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.9 p -62.8 -34.62 77.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.92 -51.01 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.43 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.429 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.617 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -55.68 -50.14 71.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.6 t -63.81 -42.49 97.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -60.7 -36.98 80.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.03 -51.63 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -32.94 74.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.536 ' HZ2' ' CG1' ' A' ' 157' ' ' VAL . 14.9 mmtm -59.84 -38.37 81.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.397 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -61.72 -36.93 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -69.04 -19.81 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.24 27.16 9.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -1.121 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -112.43 169.37 8.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 51.6 50.78 18.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.0 p -120.14 27.05 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.414 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.95 159.46 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 33.5 m -53.2 -29.63 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -1.195 . . . . 0.0 109.492 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.2 p -62.42 -42.26 99.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.5 mp -63.95 -47.61 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.84 -42.61 99.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.306 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.15 -45.13 91.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.461 -0.774 . . . . 0.0 109.357 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.5 m -62.72 -40.25 96.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.306 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -35.13 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -65.39 -52.47 53.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -38.22 84.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.31 -0.869 . . . . 0.0 109.681 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.96 85.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.694 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.522 ' O ' ' O ' ' A' ' 23' ' ' VAL . 64.5 m -81.45 -62.44 1.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.373 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.52 2.74 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.88 -47.51 43.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.26 136.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.404 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.464 ' O ' HG22 ' A' ' 127' ' ' THR . 40.3 m-20 -100.76 108.14 19.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 38.5 p30 -116.95 92.22 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -108.72 9.37 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 179' ' ' CYS . 4.2 t 56.59 101.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.3 p -54.99 -34.84 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.38 -44.1 97.34 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 181' ' ' CYS . 12.4 t -105.37 -178.85 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.55 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 12.1 t 55.09 5.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.875 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 8.7 p 42.22 25.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 180' ' ' CYS . 1.4 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 109.572 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 3' ' ' ARG . 4.4 ptm180 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.287 0.565 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.8 m -47.93 112.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -71.39 -29.34 68.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -53.41 -7.97 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.466 -179.647 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.489 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 12.7 p -56.66 134.43 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 t -65.66 140.84 58.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -64.83 -31.45 72.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.38 143.82 6.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -32.3 9.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.829 2.353 . . . . 0.0 112.14 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.01 -41.95 99.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.23 -45.62 76.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.413 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.69 -43.97 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.92 97.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.447 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 74.0 t80 -62.41 -41.64 98.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.8 t-80 -61.92 -45.32 94.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -79.95 -47.43 15.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -56.55 -42.73 79.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.527 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' HIS . 77.4 mm-40 -138.62 -150.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.463 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 20' ' ' GLU . 11.0 t90 59.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.32 72.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.89 115.39 64.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.215 -1.168 . . . . 0.0 109.423 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.99 121.69 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.758 2.305 . . . . 0.0 111.851 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -117.95 136.17 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.854 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 p -121.26 6.47 10.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.9 . . . . 0.0 109.042 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.287 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.719 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 15.1 m -74.61 -32.61 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -59.11 -52.4 65.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 109.753 -178.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -64.17 -43.42 95.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.872 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 113' ' ' ALA . 9.1 mp -74.32 -31.88 62.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.816 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 28' ' ' SER . 47.7 t80 -62.81 -47.78 81.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.95 . . . . 0.0 109.854 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.1 pp20? -75.2 -30.19 60.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 8.1 tpt -66.78 -53.12 36.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -63.06 -33.21 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.566 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 83.5 m -71.2 -49.49 42.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.31 -35.93 66.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 32.3 mm-40 -53.93 -33.05 55.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.786 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.81 97.7 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 36' ' ' CYS . 2.2 mp0 -70.0 -24.79 63.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.807 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -45.28 -27.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -178.894 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.77 123.86 7.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.31 -29.77 4.68 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.34 -166.46 1.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -123.83 152.25 42.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -53.78 -39.88 65.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.671 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -63.58 -39.4 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.684 -179.182 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.511 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 88.2 m -66.46 -36.74 83.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.719 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.13 -44.85 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.395 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.5 mt -60.61 -46.62 89.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.62 -50.72 71.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.306 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -68.1 -32.65 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.337 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' NH1' ' CE1' ' A' ' 16' ' ' TYR . 43.3 ttm180 -50.42 -44.32 55.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 108.94 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.29 -43.63 63.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 109.394 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -64.69 -40.71 95.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -55.85 -47.15 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.366 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 4.0 mmp_? -59.78 -34.7 73.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.416 -0.802 . . . . 0.0 109.82 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.94 -35.66 73.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.1 -36.16 12.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.005 . . . . 0.0 110.266 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 -48.03 9.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.926 -1.109 . . . . 0.0 110.2 -178.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 56.9 t60 -50.23 -39.12 43.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.0 . . . . 0.0 109.848 -178.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -56.53 -35.09 67.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' ASP . 62.8 m-85 -95.78 1.89 53.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.913 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.12 162.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 0.0 109.632 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.06 -27.6 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.88 2.386 . . . . 0.0 112.64 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -49.25 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' MET . 7.2 mtpm? -67.29 -33.11 74.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 64' ' ' ASP . 57.5 t -55.78 -41.81 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -71.02 -34.64 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.61 17.62 20.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 16.2 ttp -77.79 157.75 29.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.654 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.72 159.96 15.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 48.0 mp0 -60.36 -25.87 66.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.493 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.53 -43.2 93.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 15.9 t70 -61.01 -38.69 86.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.36 -42.99 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.47 -38.35 80.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -63.29 -41.96 99.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.806 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 82' ' ' ASP . 96.4 mt -67.35 -34.34 77.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.69 -33.12 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -86.94 -57.24 3.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 84.1 m-20 -80.04 170.62 16.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.14 87.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -61.42 8.64 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.6 ' H ' ' C ' ' A' ' 83' ' ' ALA . 14.0 pt -57.57 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -1.184 . . . . 0.0 109.362 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 76.0 mt -68.02 133.58 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 109.457 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.556 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 38.6 ttm180 -97.79 108.9 21.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.8 m-70 -164.55 85.37 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' A' ' 89' ' ' ARG . 19.5 ttt-85 -48.71 -30.51 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.783 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.69 -47.37 68.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.95 -45.09 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -1.212 . . . . 0.0 109.526 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.7 mt -55.88 -44.79 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -58.29 -37.77 75.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.398 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.92 84.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -44.77 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.8 mt -56.81 -42.34 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.525 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.45 -37.43 94.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.476 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 43.9 m-20 -61.4 -43.07 99.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.84 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.418 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 47.9 ttm-85 -63.9 -46.64 83.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.22 77.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.555 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 24.9 t80 -62.95 -41.71 99.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.24 -39.63 87.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.75 -41.3 86.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 51.9 mmm -63.69 -39.56 94.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.11 -27.05 64.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 107' ' ' GLN . 1.1 tm0? -51.42 -35.31 38.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -83.46 -3.51 57.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.08 74.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.5 146.88 40.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.144 -1.21 . . . . 0.0 109.644 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.72 124.81 11.47 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.63 2.22 . . . . 0.0 111.713 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -78.33 -45.31 22.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.456 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -55.44 -44.4 76.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.74 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.505 ' O ' ' OG ' ' A' ' 118' ' ' SER . 91.2 m-20 -57.65 -45.55 85.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 111.055 -178.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -60.16 -49.33 78.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.014 -1.053 . . . . 0.0 111.23 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 116' ' ' VAL . 7.0 m -60.37 -46.65 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 111.731 -176.69 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.492 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 3.3 p-90 -88.7 -37.26 15.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.733 -1.23 . . . . 0.0 111.1 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 120' ' ' VAL . 41.4 m -56.96 -25.29 57.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.807 -1.183 . . . . 0.0 109.698 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.18 -14.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.022 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.8 m -85.04 23.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 58.27 40.27 24.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.752 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.24 14.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -114.65 120.52 37.5 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.59 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.22 153.32 31.6 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.648 2.232 . . . . 0.0 111.86 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -102.53 149.89 23.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.8 mtt -136.61 156.6 48.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.6 t -117.12 159.57 22.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.885 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -150.46 53.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.835 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.78 -143.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 m -141.76 -30.2 0.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.922 . . . . 0.0 109.353 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -123.48 156.31 35.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.16 -32.57 74.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.1 p -66.66 -33.18 75.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.41 -25.12 67.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 32.3 mm -66.51 116.99 39.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.728 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.25 133.54 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.068 2.512 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.59 -9.68 53.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.9 p -96.95 102.21 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.384 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -117.67 152.91 50.37 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.387 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.01 -41.82 25.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.741 2.294 . . . . 0.0 112.041 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.65 61.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.06 -43.3 92.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.61 -38.8 80.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.1 tt -61.63 -45.63 93.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.202 -0.936 . . . . 0.0 109.498 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.3 t -58.14 -41.75 84.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -61.79 -39.15 90.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.549 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -48.31 71.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.0 mt -59.68 -35.22 74.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.07 -41.1 82.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.396 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -64.38 -37.81 88.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.593 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 24.4 mmt180 -65.23 -20.62 66.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.346 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.76 29.2 10.97 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 4.0 m-85 -92.16 130.59 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HG2' ' H ' ' A' ' 156' ' ' PHE . 72.9 tttt -93.43 170.33 9.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.452 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 55.2 m-85 57.64 50.86 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.09 28.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.13 159.77 0.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.4 m -52.43 -32.41 39.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -1.172 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.5 m -66.37 -36.54 83.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.36 -44.14 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.513 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 85.7 m -61.04 -41.64 96.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.47 ' CD2' ' OE1' ' A' ' 167' ' ' GLN . 42.9 t80 -60.12 -50.59 73.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.306 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.8 m -60.99 -39.25 88.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -64.36 -44.83 90.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.469 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.504 ' SD ' HD22 ' A' ' 171' ' ' LEU . 40.1 mmm -64.69 -41.83 95.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.632 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.47 ' OE1' ' CD2' ' A' ' 163' ' ' TYR . 66.6 mt-30 -63.47 -43.67 96.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 -179.424 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.46 -45.0 92.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.674 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.7 t -61.65 -23.24 65.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.26 7.88 58.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.504 HD22 ' SD ' ' A' ' 166' ' ' MET . 5.1 mp -63.24 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.411 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.21 130.79 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.431 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.41 ' O ' HG22 ' A' ' 127' ' ' THR . 87.3 m-20 -94.03 108.54 20.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -88.28 112.06 22.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -138.18 134.93 35.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.88 136.91 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.15 134.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.21 -0.85 72.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 181' ' ' CYS . 65.9 m -151.74 -178.14 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.565 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.5 t 54.3 6.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 179' ' ' CYS . 2.2 m 69.52 37.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.609 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 16.2 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.58 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.374 0.606 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 p -47.63 163.5 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.619 ' H ' HD11 ' A' ' 132' ' ' LEU . . . -80.43 -7.24 88.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -55.59 -29.13 58.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -1.12 . . . . 0.0 109.392 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 8' ' ' SER . 6.3 p -98.66 126.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER 166.28 72.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.521 ' OE1' HD13 ' A' ' 47' ' ' ILE . 36.7 tt0 -156.36 -128.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -84.61 152.19 59.81 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.9 -26.72 3.54 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.8 2.333 . . . . 0.0 112.132 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.1 tp -63.18 -44.74 94.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.78 -46.76 71.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.7 -43.96 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.39 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.11 99.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -63.13 -37.46 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLU . 46.2 t-80 -58.0 -51.24 70.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.71 -37.93 85.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.527 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -60.22 -51.86 67.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.469 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.1 mm-40 -142.96 -132.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.478 ' CH2' ' OD2' ' A' ' 174' ' ' ASP . 27.8 t90 58.92 116.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.17 5.59 67.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -120.04 96.01 49.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.293 -1.122 . . . . 0.0 109.412 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.71 120.02 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.738 2.292 . . . . 0.0 111.853 -179.277 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -95.58 134.53 38.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.863 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.4 p -112.7 0.16 15.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.83 121.0 24.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.0 m -61.57 -38.64 88.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.907 . . . . 0.0 109.627 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -59.93 -55.38 34.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -69.39 -43.51 73.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.935 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' SG ' ' A' ' 169' ' ' CYS . 6.9 tp -62.95 -39.28 94.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.842 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.412 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 62.2 t80 -63.0 -34.92 78.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.911 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -74.17 -30.22 62.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.955 . . . . 0.0 109.874 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.552 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 55.0 ttm -64.94 -53.99 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.965 . . . . 0.0 109.785 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 36' ' ' CYS . 3.3 tp -65.19 -39.29 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.032 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 35' ' ' ILE . 5.7 t -72.89 -40.89 65.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.67 -40.07 94.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 109.822 -178.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.44 ' OE2' ' N ' ' A' ' 165' ' ' PHE . 82.5 mt-10 -54.21 -28.7 42.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.772 -179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.15 -39.1 19.43 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -67.79 -30.87 70.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -1.211 . . . . 0.0 109.711 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.9 tt0 -52.64 -35.94 55.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 109.721 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.54 116.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -31.4 6.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.81 -145.0 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -1.189 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 t -148.23 155.41 41.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -50.4 -41.91 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.908 . . . . 0.0 109.514 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.571 HG23 ' N ' ' A' ' 48' ' ' THR . 9.6 tp -52.1 -43.06 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.645 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.571 ' N ' HG23 ' A' ' 47' ' ' ILE . 63.1 m -71.64 -33.78 69.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.4 t -58.8 -39.37 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.47 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -53.92 -54.37 39.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.511 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.64 -40.14 82.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -77.28 -19.26 56.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.624 ' NH1' ' NH2' ' A' ' 57' ' ' ARG . 1.2 ttt-85 -60.97 -46.96 88.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.171 -0.956 . . . . 0.0 109.013 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -74.02 -41.33 62.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.363 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -67.44 -45.03 77.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.25 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 42.6 t80 -62.87 -38.13 89.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.42 -0.8 . . . . 0.0 109.284 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.624 ' NH2' ' NH1' ' A' ' 53' ' ' ARG . 48.6 ttm-85 -57.27 -38.49 73.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.31 -22.47 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.26 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.507 ' SG ' ' CB ' ' A' ' 83' ' ' ALA . 63.9 m -92.45 -13.55 29.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.222 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 55.8 m-85 -127.21 -53.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.935 -1.103 . . . . 0.0 110.173 -178.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -57.71 -42.46 83.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -178.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -53.8 -35.14 61.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' ASP . 92.7 m-85 -91.43 8.98 33.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.0 109.908 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER 56.42 156.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 -179.45 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.4 -28.15 39.41 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.853 2.369 . . . . 0.0 112.68 -178.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.35 -49.19 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -67.98 -31.46 71.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 64' ' ' ASP . 73.7 t -56.61 -41.12 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.586 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.27 64.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.62 14.63 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.417 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 7.7 mmm -54.83 -176.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.668 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 71' ' ' MET . 28.5 mm-40 -136.74 159.15 42.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.258 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.2 mt-10 -61.39 -34.97 76.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -72.1 -28.37 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.44 -47.96 65.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 -179.203 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 92' ' ' ILE . 6.9 m -60.35 -38.08 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.32 -36.99 81.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -65.38 -39.66 92.53 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 109.769 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.35 -31.84 72.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.603 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.5 t -56.25 -34.9 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.71 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -96.38 -33.94 11.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.602 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 93.1 m-20 -86.75 138.49 31.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.368 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.03 -21.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 47.07 27.49 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 86' ' ' ILE . 6.2 pt -56.35 83.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.334 179.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 85' ' ' ILE . 85.1 mt 57.04 145.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.489 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.621 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.1 OUTLIER -101.64 111.64 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.53 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.58 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.165 179.753 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 89' ' ' ARG . 35.0 ttt-85 -46.87 -36.81 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.39 95.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -67.3 -44.49 79.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.5 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.481 HG22 HG12 ' A' ' 76' ' ' VAL . 37.1 mt -58.52 -49.44 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.551 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -53.57 -34.82 59.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.419 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.548 HG21 ' CE2' ' A' ' 60' ' ' PHE . 30.4 mm -60.39 -45.37 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mm -55.55 -51.99 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.84 72.67 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.655 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.35 -37.34 77.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -1.188 . . . . 0.0 109.378 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.655 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -71.08 -35.68 71.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.65 -42.49 92.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -71.2 -32.11 68.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.412 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 32.4 t80 -66.24 -44.03 84.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.86 -40.25 96.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -60.5 -37.84 82.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.519 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.55 -34.25 77.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -68.76 -27.52 65.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -52.17 -27.84 15.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.16 -15.15 60.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.2 17.25 78.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -96.63 149.7 36.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.247 -1.149 . . . . 0.0 109.634 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.14 119.16 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.623 2.216 . . . . 0.0 111.69 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -71.29 -39.94 71.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.822 . . . . 0.0 110.446 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.72 -50.31 72.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.976 . . . . 0.0 110.771 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.509 ' O ' ' OG ' ' A' ' 118' ' ' SER . 29.1 t0 -55.57 -54.13 47.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -0.918 . . . . 0.0 111.081 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -53.85 -43.06 69.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 111.217 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.57 -60.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.097 . . . . 0.0 111.638 -177.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.683 ' CB ' HD21 ' A' ' 171' ' ' LEU . 67.1 p-90 -88.24 -19.28 27.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.787 -1.196 . . . . 0.0 111.141 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 120' ' ' VAL . 34.0 m -56.09 -30.09 61.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.763 -1.21 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.43 -11.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 110.049 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 117' ' ' TRP . 15.2 m -86.02 24.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 109.991 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.9 t-20 77.1 20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 62.38 29.64 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.903 . . . . 0.0 109.568 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.462 ' H ' HG23 ' A' ' 120' ' ' VAL . 12.4 pt20 -148.01 143.38 17.58 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.593 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.03 142.24 61.03 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.585 2.19 . . . . 0.0 111.833 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -110.93 155.66 22.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.0 ptp -135.28 156.49 48.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.155 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.0 t -118.36 155.67 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 109.872 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -115.95 45.04 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.304 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.15 135.12 47.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.872 . . . . 0.0 109.653 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.72 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 9.1 m -88.29 -32.98 18.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.432 HG22 ' OE1' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -133.57 166.31 22.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.619 HD11 ' H ' ' A' ' 5' ' ' GLY . 24.7 mt -74.27 -8.73 57.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.567 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -87.81 -31.98 19.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.527 -177.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.72 ' CD ' ' H ' ' A' ' 130' ' ' THR . 8.5 pt-20 -86.93 9.96 17.75 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -178.215 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.16 119.85 62.33 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.756 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.04 120.95 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.179 2.586 . . . . 0.0 112.482 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 t -97.29 21.65 9.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.318 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.6 p -129.61 66.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.375 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -87.62 153.39 52.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.463 179.642 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.85 -30.74 92.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.754 2.303 . . . . 0.0 112.04 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.26 -38.11 51.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.37 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -62.42 -48.6 78.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -64.96 -41.1 95.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.57 86.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.2 tp -59.14 -48.63 80.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.511 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -54.67 -45.61 73.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -60.3 -35.04 74.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.88 -50.55 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.451 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.92 -38.63 91.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.81 -26.5 68.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.78 -40.03 86.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -74.07 -20.17 60.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.22 29.46 7.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.441 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 1.4 m-85 -78.34 137.54 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.519 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -102.1 175.36 5.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 53.4 47.3 24.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.7 p -122.66 26.54 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.1 167.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.4 m -58.19 -30.41 66.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 0.0 109.435 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 62.9 p -62.26 -42.07 99.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.5 mp -65.64 -46.81 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.53 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 12.3 p -63.01 -39.61 95.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.282 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 34.1 t80 -62.67 -47.83 81.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.5 p -59.5 -41.85 90.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.286 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 1.1 t80 -61.83 -27.04 68.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 178.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -53.56 27.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.682 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -67.89 -36.28 79.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.686 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.649 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 41.7 m -78.59 -64.34 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.37 9.12 2.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.683 HD21 ' CB ' ' A' ' 117' ' ' TRP . 9.4 mp -50.96 -52.62 40.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -1.134 . . . . 0.0 109.414 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.3 m -98.2 134.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 175' ' ' HIS . 11.5 t-20 -81.15 105.13 12.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.478 ' OD2' ' CH2' ' A' ' 21' ' ' TRP . 11.7 p30 -91.62 107.33 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 109.484 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.726 ' N ' ' ND1' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -156.69 171.03 21.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.527 179.653 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.07 164.7 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 182' ' ' TYR . 14.7 t -80.29 140.05 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.467 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.7 -17.46 58.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 15.4 t -91.27 165.95 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -1.119 . . . . 0.0 109.466 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.0 p -76.06 92.63 3.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 180' ' ' CYS . 0.1 OUTLIER 160.6 -39.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' A' ' 177' ' ' VAL . 28.9 t80 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 1.8 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -129.34 144.93 51.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -144.93 140.07 28.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.7 m 46.96 -162.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.65 -27.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -73.72 -16.69 61.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 0.0 109.447 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 7' ' ' VAL . 34.9 m -67.02 130.17 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLN . 33.4 t -162.68 137.19 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.51 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' SER . 93.2 mt-30 50.53 179.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.535 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' LEU . 5.1 m-20 48.31 77.12 0.48 Allowed Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.251 -0.905 . . . . 0.0 109.409 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -47.69 -10.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.886 2.391 . . . . 0.0 112.073 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.5 mt -62.78 -33.81 75.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 47' ' ' ILE . 54.0 m-85 -63.03 -58.13 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.67 -47.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.66 69.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -72.26 -43.51 64.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.489 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 60.5 t-80 -60.85 -43.53 98.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.62 -41.25 79.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.54 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -60.24 -48.11 83.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' HIS . 80.0 mm-40 -141.97 -131.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.489 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 5.7 t90 56.56 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.16 0.63 65.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 169' ' ' CYS . 10.0 t -118.08 96.61 49.91 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.217 -1.167 . . . . 0.0 109.416 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.25 122.59 5.65 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.778 2.318 . . . . 0.0 111.871 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 27.6 tp10 -110.67 139.31 46.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.885 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.4 p -115.56 3.96 14.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 93.6 m-20 -77.77 123.54 26.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.33 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 t -64.48 -37.81 88.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 9.5 mtmp? -62.88 -55.06 29.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -65.87 -43.91 86.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.803 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.6 -34.79 76.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.103 -0.998 . . . . 0.0 109.924 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.51 -39.45 83.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.885 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 3.6 mp0 -73.77 -31.05 63.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.885 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.565 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 55.9 ttm -59.06 -54.05 51.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.798 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.55 -33.16 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.983 . . . . 0.0 110.034 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 t -71.81 -45.88 60.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.4 mt -64.23 -44.26 92.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 41' ' ' GLN . 97.2 mt-10 -63.1 -33.28 75.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 109.829 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.27 -36.38 7.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 19.3 mp0 -75.47 -14.7 60.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -1.221 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLU . 4.0 pp0? -55.27 -23.77 24.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.62 108.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.92 -34.09 3.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.2 mm? -86.14 178.06 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -1.186 . . . . 0.0 109.489 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.6 m -108.69 149.93 28.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.348 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 p90 -53.79 -36.28 62.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.68 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -62.54 -40.51 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 93.4 m -64.31 -37.25 86.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.9 t -60.09 -39.42 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.44 -46.8 83.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -62.03 -50.99 69.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 109.349 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -66.96 -28.74 68.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' VAL . 64.6 ttt180 -53.37 -44.55 68.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.156 -0.965 . . . . 0.0 108.973 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.66 -43.58 79.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -66.15 -37.53 85.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 14.3 t80 -59.65 -49.06 79.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 21.9 mmm180 -61.24 -29.55 69.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.735 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.64 98.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.875 . . . . 0.0 110.241 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.0 m -93.9 -41.91 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 110.232 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 32.4 m-85 -70.73 -52.09 23.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.218 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 49.7 t60 -51.55 -38.07 52.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.055 -1.028 . . . . 0.0 109.865 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.03 -37.13 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.769 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 64' ' ' ASP . 70.2 m-85 -88.06 -9.0 54.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.007 . . . . 0.0 109.856 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 63' ' ' PHE . 7.2 t70 61.75 129.83 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.74 -31.76 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.841 2.36 . . . . 0.0 112.69 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.62 -50.66 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.632 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 71' ' ' MET . 40.7 mtpt -66.82 -34.5 77.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 109.797 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 96' ' ' ILE . 89.0 t -58.16 -28.9 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' CB ' HD12 ' A' ' 103' ' ' LEU . . . -87.6 -18.39 29.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.57 25.98 5.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.1 ptp -75.22 -160.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -129.58 160.56 32.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 49.2 mp0 -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -70.73 -24.34 62.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.443 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -67.0 -47.65 70.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 0.0 109.386 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 HG22 ' A' ' 92' ' ' ILE . 6.7 m -64.91 -38.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.57 -32.61 73.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.616 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.93 -41.99 81.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.775 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.93 -30.68 70.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.4 t -49.55 -33.8 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.952 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -91.36 -63.45 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -101.55 115.75 31.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.49 -46.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.64 15.07 64.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 pt -123.58 167.39 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -1.131 . . . . 0.0 109.304 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.9 mt -49.07 128.64 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 87' ' ' ARG . 14.0 ptm180 -108.29 128.08 54.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.693 ' O ' ' N ' ' A' ' 90' ' ' GLY . 58.4 t-80 -158.21 1.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.147 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 59.48 -60.65 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.07 -46.73 93.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -42.54 96.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -1.151 . . . . 0.0 109.499 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.495 HG22 HG12 ' A' ' 76' ' ' VAL . 38.6 mt -63.37 -49.41 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.624 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -54.47 -33.14 59.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.401 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.368 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.408 HD13 ' HE2' ' A' ' 56' ' ' TYR . 94.8 mt -58.41 -41.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.495 HD12 ' SD ' ' A' ' 71' ' ' MET . 16.9 mm -55.49 -47.28 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.82 93.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.27 -45.22 91.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.137 . . . . 0.0 109.386 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -70.04 -47.63 61.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.72 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -68.06 -46.17 71.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.439 HD12 ' CB ' ' A' ' 69' ' ' ALA . 96.9 mt -67.73 -38.95 84.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.62 -44.98 85.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.85 -41.19 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -71.7 -27.01 62.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -51.25 -32.1 23.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.31 1.81 39.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.9 9.38 86.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -79.04 129.23 73.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.11 -1.229 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.51 122.16 8.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.673 2.249 . . . . 0.0 111.692 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -76.44 -44.89 33.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.472 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.43 -49.69 76.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.792 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 85.4 m-20 -54.64 -35.1 63.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.949 . . . . 0.0 111.005 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 75.7 t80 -73.54 -48.42 33.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.032 -1.042 . . . . 0.0 111.219 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 117' ' ' TRP . 3.1 m -55.95 -50.34 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.052 -1.03 . . . . 0.0 111.655 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.583 ' O ' HG22 ' A' ' 120' ' ' VAL . 25.2 p-90 -86.66 -22.42 26.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.84 -1.162 . . . . 0.0 111.087 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 120' ' ' VAL . 8.0 t -59.48 -27.95 66.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.821 -1.175 . . . . 0.0 109.658 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.12 -15.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.075 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 117' ' ' TRP . 14.8 m -83.22 22.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 109.979 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.612 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 29.4 t30 61.05 48.27 6.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.046 . . . . 0.0 109.765 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 32.4 p80 41.91 32.99 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 49.9 tt0 -142.84 90.86 7.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -47.16 155.19 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.724 2.282 . . . . 0.0 111.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 16.7 mp0 -105.66 158.92 16.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 109.688 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.9 mtt -135.98 156.9 48.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.134 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.6 t -122.57 160.38 25.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.482 ' N ' ' OE1' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -141.28 43.72 1.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -86.73 169.72 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 m -87.69 -33.24 18.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.68 169.43 17.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.2 mt -67.85 -27.69 66.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.577 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.7 t -59.08 -41.22 87.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.579 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 69.3 mm-40 -64.19 -29.86 70.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.395 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.37 131.76 93.25 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.409 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 98.4 Cg_endo -80.03 141.45 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.141 2.561 . . . . 0.0 112.571 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 6.26 42.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 109.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.1 t -136.37 92.69 2.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.887 . . . . 0.0 109.35 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -98.06 154.53 37.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.74 -40.18 24.25 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.797 2.331 . . . . 0.0 112.061 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.86 70.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.0 m -62.39 -45.58 92.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.05 -43.77 86.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.59 73.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 109.513 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.729 ' C ' HD23 ' A' ' 145' ' ' LEU . 8.2 tt -66.88 -46.73 74.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 87.7 p -58.9 -39.03 80.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.962 . . . . 0.0 109.548 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -63.59 -34.68 78.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.4 -50.28 60.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.22 -32.49 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -57.92 -38.11 75.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.33 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.644 ' NZ ' HH12 ' A' ' 152' ' ' ARG . 7.0 ttpm? -61.55 -38.94 89.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.452 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.644 HH12 ' NZ ' ' A' ' 151' ' ' LYS . 12.7 mpt_? -63.55 -20.22 65.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.28 24.65 10.09 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -89.84 131.92 35.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -1.121 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.34 177.69 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.407 ' O ' HD13 ' A' ' 161' ' ' ILE . 93.6 m-85 54.07 57.19 6.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.9 m -121.78 25.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.412 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.49 166.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 159' ' ' THR . 1.1 p -66.36 -24.53 66.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.397 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 161' ' ' ILE . 15.0 t -72.04 -42.66 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 160' ' ' THR . 81.5 mt -65.65 -41.45 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.552 ' SG ' HD22 ' A' ' 145' ' ' LEU . 50.1 t -63.22 -40.43 97.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CE1' ' O ' ' A' ' 136' ' ' PRO . 68.0 t80 -60.75 -46.85 88.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.395 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -45.55 84.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.888 . . . . 0.0 109.354 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -62.66 -34.45 77.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 178.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 30.7 ttm -63.28 -45.0 93.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.645 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.419 ' NE2' HG21 ' A' ' 172' ' ' VAL . 63.4 mm-40 -70.08 -37.17 75.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.668 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.565 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -64.76 -46.98 79.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 14.4 m -64.66 -61.14 2.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.0 7.54 3.25 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.571 HD21 ' CB ' ' A' ' 117' ' ' TRP . 9.5 mp -50.07 -43.55 51.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 109.38 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.419 HG21 ' NE2' ' A' ' 167' ' ' GLN . 30.8 m -100.61 134.54 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.487 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.406 ' O ' HG22 ' A' ' 127' ' ' THR . 87.5 m-20 -87.19 103.41 15.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -91.92 121.99 34.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.593 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -160.9 100.28 1.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.96 148.17 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.68 129.9 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.23 7.98 63.35 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 52.3 t -79.65 94.2 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.507 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.512 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 3.2 t 65.63 -57.18 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 37.6 t -173.07 60.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 21.8 t80 -83.27 118.41 71.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.528 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 88.0 Cg_endo -85.72 176.26 5.54 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.017 2.478 . . . . 0.0 112.331 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.71 -10.92 64.68 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -90.12 18.38 5.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -1.122 . . . . 0.0 109.668 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -83.42 151.32 62.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.306 -1.673 0 C-N-CA 123.086 2.524 . . . . 0.0 112.216 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.295 0.569 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -141.29 157.52 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.614 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -137.18 140.0 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 6' ' ' TRP . 14.1 m -150.91 26.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.407 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.98 -44.19 0.16 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . 94.1 m95 -54.63 -35.06 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.463 HG23 ' NE ' ' A' ' 3' ' ' ARG . 5.9 m -73.49 63.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -149.94 48.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -152.96 -125.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.1 150.17 98.07 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.859 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.63 -19.84 41.46 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.899 2.4 . . . . 0.0 112.095 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.29 -41.36 98.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.392 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -65.24 -49.6 69.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.443 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.0 -45.12 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.84 88.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -57.57 -42.39 83.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.536 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 48.7 t-80 -62.32 -41.76 98.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.8 -40.03 94.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -58.77 -53.04 62.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 21' ' ' TRP . 76.3 mm-40 -142.48 -131.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.536 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 24.2 t90 58.76 138.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.535 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.28 -29.0 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 23' ' ' VAL . 11.0 p -75.49 131.59 77.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.11 120.51 6.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.817 2.345 . . . . 0.0 111.885 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -111.5 137.19 49.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.845 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -132.61 4.87 3.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 28' ' ' SER . 63.3 t0 -94.22 142.96 26.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.284 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 60.3 p -64.33 -34.63 78.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.4 -47.64 75.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.91 -48.89 27.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -66.61 -35.37 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.845 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 28' ' ' SER . 48.9 t80 -60.63 -46.97 88.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.864 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.14 -30.11 62.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.83 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -58.47 -53.28 60.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.793 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.583 HD12 ' OE1' ' A' ' 38' ' ' GLU . 4.1 tp -69.77 -31.62 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 110.017 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 69.2 m -73.31 -46.58 48.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.902 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 35' ' ' ILE . 16.5 pt-20 -49.8 -43.5 48.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.778 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . 77.2 171.31 35.19 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.702 ' C ' ' H ' ' A' ' 42' ' ' ALA . 32.7 tt0 -66.35 -43.77 85.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.247 . . . . 0.0 109.737 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 58.34 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 109.704 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -70.84 117.88 12.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.11 -15.25 63.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.0 mp -116.87 -135.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -1.176 . . . . 0.0 109.461 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -153.27 154.8 35.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.434 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.519 ' NE1' HD21 ' A' ' 50' ' ' LEU . 74.4 t-105 -52.31 -35.64 51.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 48' ' ' THR . 10.4 tp -52.91 -40.99 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 47' ' ' ILE . 73.5 m -66.83 -35.65 80.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 0.0 109.701 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.9 t -60.97 -39.91 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.414 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.519 HD21 ' NE1' ' A' ' 46' ' ' TRP . 60.8 mt -59.95 -47.48 85.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.61 ' NZ ' ' NZ ' ' A' ' 52' ' ' LYS . 9.8 mtmp? -64.63 -53.06 53.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.262 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.61 ' NZ ' ' NZ ' ' A' ' 51' ' ' LYS . 13.0 mptt -64.51 -34.36 78.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' VAL . 7.9 tmm_? -50.45 -45.94 56.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.2 -0.938 . . . . 0.0 108.95 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG3' HH21 ' A' ' 57' ' ' ARG . 85.3 tt0 -63.38 -42.24 98.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -66.51 -36.33 82.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.223 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -61.95 -45.66 92.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.3 mtm180 -57.15 -42.1 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.828 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.6 66.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 m -92.34 -12.61 31.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 0.0 110.363 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.84 -43.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.906 -1.121 . . . . 0.0 110.239 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -51.41 -43.76 62.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.113 -0.992 . . . . 0.0 109.885 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -67.11 -39.98 86.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 93.5 m-85 -71.58 -24.17 61.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.854 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.4 t70 69.62 131.48 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.996 -1.065 . . . . 0.0 109.563 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -39.9 -37.24 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.834 2.356 . . . . 0.0 112.679 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.03 -48.38 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.14 -0.975 . . . . 0.0 109.647 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 71' ' ' MET . 60.5 mttp -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.15 -43.4 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 109.626 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.3 -30.3 54.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.68 58.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.407 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.8 mtp -65.08 136.65 56.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -94.37 171.98 8.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.93 -33.28 70.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -59.18 -42.57 91.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -59.26 -38.45 80.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 80' ' ' VAL . 79.4 t -58.85 -44.99 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.571 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.538 ' OE1' ' NH1' ' A' ' 89' ' ' ARG . 41.8 tp10 -56.44 -37.79 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -65.4 -43.74 89.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.718 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.01 -36.21 79.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.637 ' CG1' HH21 ' A' ' 87' ' ' ARG . 52.7 t -50.64 -35.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.723 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.15 -60.04 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 109.518 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -99.91 115.92 30.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.72 -45.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.11 33.38 40.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.42 172.17 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -1.111 . . . . 0.0 109.336 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.0 mt -48.53 135.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.637 HH21 ' CG1' ' A' ' 80' ' ' VAL . 1.3 tpt180 -75.46 122.62 24.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.44 91.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 109.141 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 77' ' ' GLU . 38.3 ttm-85 -48.57 -32.54 8.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.932 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.44 -38.48 93.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HZ1' ' H ' ' A' ' 40' ' ' GLN . 14.1 mmmt -60.04 -47.34 86.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.499 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.404 HG21 HG13 ' A' ' 76' ' ' VAL . 76.5 mt -60.26 -41.39 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.08 -39.08 77.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.0 81.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.655 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 33.3 mm -59.6 -43.74 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.434 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.28 -28.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.548 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.05 -45.65 80.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.655 ' ND2' ' O ' ' A' ' 95' ' ' ILE . 13.7 p30 -63.12 -35.48 80.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -1.148 . . . . 0.0 109.416 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -62.78 -46.79 86.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 109.521 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -71.43 -45.77 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.93 81.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.529 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.41 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 64.8 t80 -63.6 -49.2 74.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.94 -42.71 80.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -65.53 -41.64 92.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.6 ttt -65.31 -41.82 93.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.471 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.68 -27.33 65.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -51.8 -31.13 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -76.74 -12.7 60.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.45 0.46 76.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.83 132.54 64.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.2 -1.177 . . . . 0.0 109.712 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.49 118.58 5.73 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.6 2.2 . . . . 0.0 111.7 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -77.22 -38.57 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.795 . . . . 0.0 110.455 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.709 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.14 -49.72 76.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 110.77 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 118' ' ' SER . 93.0 m-20 -61.27 -44.43 97.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.228 -0.92 . . . . 0.0 111.102 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.77 -53.47 57.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.94 -1.1 . . . . 0.0 111.224 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 117' ' ' TRP . 12.2 m -57.96 -49.71 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.934 -1.104 . . . . 0.0 111.666 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.511 ' CE3' ' O ' ' A' ' 117' ' ' TRP . 2.4 p-90 -86.89 -21.55 26.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.712 -1.242 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 120' ' ' VAL . 17.0 p -58.84 -33.84 70.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.799 -1.188 . . . . 0.0 109.721 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.07 -12.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.915 . . . . 0.0 110.076 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.685 ' O ' HG12 ' A' ' 120' ' ' VAL . 43.1 t -82.32 23.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.073 -1.017 . . . . 0.0 109.939 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 35.1 t30 68.95 18.75 8.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 53.58 50.08 18.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 49.9 tt0 -159.7 121.41 1.82 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.34 151.89 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.716 2.278 . . . . 0.0 111.794 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 87.9 mm-40 -118.44 146.96 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.975 . . . . 0.0 109.72 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -135.91 156.49 48.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.79 . . . . 0.0 109.097 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.7 t -119.4 163.22 17.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.86 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -149.06 43.41 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.26 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB1' ' OE1' ' A' ' 134' ' ' GLU . . . -82.05 -150.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 109.676 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.445 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 14.4 m -138.72 -33.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -121.9 154.34 37.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.13 -33.84 75.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.893 . . . . 0.0 109.618 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -63.03 -33.38 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 130' ' ' THR . 95.6 mt-10 -62.92 -30.87 71.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.8 mp -67.52 117.04 43.44 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.699 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.06 125.65 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.079 2.519 . . . . 0.0 112.537 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 10.2 t -76.65 -18.15 58.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 109.322 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.0 t -102.72 99.19 9.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.11 155.45 37.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -46.89 -40.67 25.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.749 2.299 . . . . 0.0 111.963 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.85 -35.18 67.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.389 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.8 m -60.66 -41.86 95.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -64.8 -45.82 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.49 81.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.761 ' C ' HD23 ' A' ' 145' ' ' LEU . 7.4 tt -66.52 -46.35 76.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -56.33 -47.54 78.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.93 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.59 -45.0 73.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 149' ' ' LEU . 68.0 mt -60.17 -33.85 72.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.606 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -57.37 -40.89 79.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.86 -37.07 85.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.43 -17.81 65.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.19 20.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 136.27 33.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.14 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -105.24 -179.22 3.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.541 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 54.37 56.92 6.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.49 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 m -122.56 26.59 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.87 161.39 0.16 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.1 t -55.66 -32.61 63.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.158 . . . . 0.0 109.425 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 46.7 m -68.57 -46.83 68.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.04 -33.82 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 145' ' ' LEU . 6.4 t -68.42 -41.77 79.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.299 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 137' ' ' THR . 43.4 t80 -62.23 -45.38 93.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.3 t -59.15 -36.9 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.54 -43.36 97.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.418 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.94 -39.74 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.638 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -61.63 -47.12 86.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.859 . . . . 0.0 109.689 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.65 -37.86 80.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.75 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' VAL . 15.6 m -59.59 -28.81 67.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.457 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.06 9.92 55.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.81 -40.65 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 109.483 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 t -96.36 129.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.461 ' CG ' ' NE2' ' A' ' 175' ' ' HIS . 0.4 OUTLIER -100.04 117.53 34.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.378 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -75.42 137.04 40.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.457 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.461 ' NE2' ' CG ' ' A' ' 173' ' ' ASN . 75.6 m-70 -146.22 48.68 1.2 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.95 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.54 144.88 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.9 t -81.69 134.19 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.952 . . . . 0.0 109.503 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.27 25.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 13.8 p -86.94 -160.53 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.527 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.9 t -84.41 -54.16 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 t -64.94 -11.17 35.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.53 83.01 47.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.609 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.58 41.43 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 123.142 2.561 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.68 25.72 66.84 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.34 43.38 20.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -1.147 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -129.45 79.63 73.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 109.563 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 C--N 1.306 -1.698 0 C-N-CA 123.072 2.515 . . . . 0.0 112.173 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -98.78 158.87 15.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.59 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' CYS . 32.8 ptt180 -146.66 158.96 44.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' ARG . 20.2 m 53.94 171.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.07 12.69 1.44 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 2.9 p-90 -148.3 46.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 109.429 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.42 130.36 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.527 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 m -73.81 146.41 44.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 27.6 mp0 -65.29 -29.35 70.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.515 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -53.52 142.65 40.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.85 -23.81 18.54 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.874 2.383 . . . . 0.0 112.163 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.85 -39.79 95.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -79.45 -47.38 15.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.39 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.7 mt -55.41 -49.05 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.416 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -46.08 78.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -62.23 -40.41 96.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t-80 -58.68 -45.86 88.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.38 -46.23 12.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -57.98 -37.66 74.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 21' ' ' TRP . 93.7 mt-10 -144.54 -156.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.464 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.483 ' O ' ' O ' ' A' ' 20' ' ' GLU . 34.6 t90 59.76 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.64 -28.51 10.01 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.56 119.63 68.48 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.33 -1.1 . . . . 0.0 109.409 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.95 129.13 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.868 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -115.58 137.95 51.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.9 p -126.46 4.99 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.888 . . . . 0.0 109.104 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -72.18 119.47 16.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.6 p -60.55 -36.89 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -62.71 -46.98 85.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.828 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.16 -50.74 62.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.8 mp -64.55 -39.0 92.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.119 -0.988 . . . . 0.0 109.887 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 90.4 t80 -61.6 -52.91 62.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 109.864 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -33.11 75.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -56.72 -50.81 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.82 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.32 -40.16 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.995 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -72.24 -39.96 68.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.123 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 56' ' ' TYR . 18.4 mt -72.44 -40.64 66.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 109.848 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -53.63 -35.88 61.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.15 -31.56 26.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.463 ' HA ' ' HZ2' ' A' ' 91' ' ' LYS . 83.8 mt-30 -71.06 -29.83 65.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -1.202 . . . . 0.0 109.742 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' LEU . 6.0 pt20 -51.28 -31.26 20.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.695 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.43 109.75 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.656 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.82 -31.88 5.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLN . 27.1 mt -96.23 -179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.484 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.0 m -105.78 163.15 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.972 . . . . 0.0 109.415 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.2 -46.43 75.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 47' ' ' ILE . 10.3 tp -56.57 -34.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 47' ' ' ILE . 80.9 m -64.54 -33.99 77.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.8 t -63.18 -40.76 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -53.66 -51.38 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -56.91 -39.68 74.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -80.75 -17.87 49.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.375 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.8 ttm-85 -60.99 -49.25 78.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.157 -0.964 . . . . 0.0 108.992 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 19.6 pt-20 -73.95 -42.84 59.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.456 -0.778 . . . . 0.0 109.347 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -66.64 -43.11 85.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 60' ' ' PHE . 35.9 t80 -60.42 -46.14 91.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.364 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' HIS . 76.6 mtm180 -59.48 -37.13 77.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 15.1 p -94.14 -12.33 28.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.301 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.635 ' CD2' ' CZ ' ' A' ' 56' ' ' TYR . 52.4 m-85 -120.95 -54.22 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.967 -1.083 . . . . 0.0 110.2 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 57' ' ' ARG . 44.7 t-80 -55.6 -41.79 73.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -55.77 -32.93 63.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 81.5 m-85 -94.96 3.81 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.856 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 57.7 162.58 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 109.555 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.48 -14.49 22.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.876 2.384 . . . . 0.0 112.694 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.678 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.81 -46.61 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.908 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 69' ' ' ALA . 6.3 m -56.69 -41.9 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.007 . . . . 0.0 109.641 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.548 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -58.9 -40.93 85.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.96 27.98 2.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.6 ttm -71.21 147.83 47.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.689 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -100.08 149.23 23.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 55.7 mp0 -52.34 -31.81 35.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.99 -45.64 88.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.45 -39.13 79.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.428 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.5 t -55.29 -46.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.33 -34.14 70.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.58 -49.27 71.84 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.337 -0.852 . . . . 0.0 109.78 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 mt -63.88 -38.39 90.9 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.97 -30.72 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -89.42 -58.54 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -99.52 124.85 45.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.415 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -170.27 -61.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.442 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.98 75.12 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.502 HG12 ' HB1' ' A' ' 83' ' ' ALA . 22.1 pt -100.3 -169.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.337 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.11 138.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.28 122.27 31.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.468 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -177.6 81.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -48.37 -28.59 3.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.16 98.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HZ2' ' HA ' ' A' ' 40' ' ' GLN . 14.1 mtpt -69.13 -42.48 75.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -1.205 . . . . 0.0 109.571 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.95 -50.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -57.13 -33.48 67.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.443 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -62.21 -43.58 98.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 mm -55.75 -44.3 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -55.36 -50.15 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.69 -29.21 65.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.659 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.31 -40.3 85.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -1.195 . . . . 0.0 109.422 -178.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.659 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -67.8 -38.96 83.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -55.39 -44.83 76.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 109.541 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.33 69.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.442 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 37.0 t80 -60.75 -44.64 96.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.69 -36.31 83.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -57.68 -43.18 84.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.69 -43.86 71.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.62 -28.06 66.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -51.87 -33.04 34.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.5 -12.48 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.19 10.99 83.0 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -93.5 149.16 36.78 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.215 -1.168 . . . . 0.0 109.735 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.66 120.09 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.722 2.282 . . . . 0.0 111.697 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.466 ' O ' HG23 ' A' ' 116' ' ' VAL . 83.7 t80 -66.46 -43.25 86.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 0.0 110.408 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.11 72.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.183 -0.948 . . . . 0.0 110.713 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' O ' ' CB ' ' A' ' 118' ' ' SER . 18.2 t70 -55.11 -51.18 67.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 111.046 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.426 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 69.7 t80 -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 111.261 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -57.02 -58.37 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 111.706 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . 45.0 p-90 -88.19 -20.69 25.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.786 -1.196 . . . . 0.0 111.162 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 120' ' ' VAL . 71.7 p -61.23 -24.29 66.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.159 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.13 -11.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.052 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.6 m -90.23 24.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 109.987 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 8.2 t-20 77.51 -50.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 109.719 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.3 p-80 162.48 -19.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -101.38 148.96 35.92 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.15 154.7 47.05 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.707 2.272 . . . . 0.0 111.779 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -87.44 153.01 21.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 126' ' ' MET . 2.4 mpp? -136.57 150.46 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.431 ' OG1' ' CD1' ' A' ' 135' ' ' ILE . 15.1 t -99.35 171.55 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.864 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -160.17 67.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.31 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.49 -121.46 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 109.676 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 m -158.72 -33.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 134' ' ' GLU . 1.2 t -124.0 170.27 10.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -73.79 -28.57 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.0 m -67.0 -38.1 85.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.525 ' H ' HG23 ' A' ' 131' ' ' THR . 63.1 mm-40 -67.25 -15.04 63.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.186 -0.946 . . . . 0.0 109.445 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CD1' ' OG1' ' A' ' 127' ' ' THR . 44.3 mm -65.68 116.69 34.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -42.53 136.23 4.35 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.071 2.514 . . . . 0.0 112.552 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -4.01 35.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -143.98 83.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.2 p -74.86 153.11 86.94 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.18 -29.97 68.91 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.76 2.307 . . . . 0.0 112.059 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.5 -33.44 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.386 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.5 p -64.27 -40.42 95.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.88 -50.12 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 109.527 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.62 82.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.03 -43.79 91.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.473 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.0 p -55.35 -43.86 75.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -62.58 -32.03 72.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.479 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.04 36.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.488 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.8 mm? -62.36 -37.88 87.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.635 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -59.23 -37.44 77.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.09 -39.89 91.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 152' ' ' ARG . 38.7 mtt-85 -64.65 -19.57 65.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.23 21.91 21.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.06 138.42 36.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -103.53 170.42 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 59.08 47.08 12.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 158' ' ' GLY . 17.2 m -118.92 25.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.71 168.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.3 m -55.8 -32.61 63.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.46 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.1 m -62.28 -48.6 79.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.577 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -65.7 -34.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.94 -47.07 69.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -64.95 -40.78 95.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 109.347 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -59.57 -36.72 76.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.24 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.595 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 81.8 t80 -61.61 -43.09 99.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.5 mtp -70.43 -36.85 74.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -64.59 -54.79 26.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.698 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.32 83.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.595 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 22.9 m -53.88 -38.3 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.6 5.97 47.62 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.69 -33.1 73.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.75 132.32 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -94.57 105.33 17.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -96.02 96.13 8.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.168 -0.957 . . . . 0.0 109.494 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' A' ' 176' ' ' VAL . 21.2 m80 -108.9 -6.88 15.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 177' ' ' VAL . 87.6 t 54.29 163.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.453 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.57 ' N ' HG12 ' A' ' 176' ' ' VAL . 81.8 t -108.08 133.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.83 61.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 181' ' ' CYS . 39.2 m -144.41 168.35 20.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.163 . . . . 0.0 109.525 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 98.5 m 50.09 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 179' ' ' CYS . 38.6 t -155.8 14.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.623 ' O ' ' O ' ' A' ' 183' ' ' PRO . 30.0 t80 -71.42 139.46 84.17 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 109.513 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.623 ' O ' ' O ' ' A' ' 182' ' ' TYR . 89.8 Cg_exo -40.07 -175.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.156 2.571 . . . . 0.0 112.375 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.21 -14.1 63.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.37 21.92 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.099 . . . . 0.0 109.593 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.13 80.15 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 109.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--N 1.305 -1.736 0 C-N-CA 123.065 2.51 . . . . 0.0 112.288 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.37 151.83 25.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.494 HH11 ' HG3' ' A' ' 3' ' ' ARG . 32.0 mtm-85 -139.88 -174.05 3.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.442 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -141.39 -142.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.562 ' H ' HD11 ' A' ' 132' ' ' LEU . . . -47.44 -11.99 0.1 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . 44.5 m95 -67.14 -9.48 40.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 6' ' ' TRP . 20.1 m 35.76 -154.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 8' ' ' SER . 10.3 t -178.08 47.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.411 ' N ' HD11 ' A' ' 14' ' ' ILE . 6.6 pt20 -130.63 -105.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 9' ' ' GLN . 58.2 m-20 -43.6 107.09 0.54 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -48.71 -34.84 28.55 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.799 2.333 . . . . 0.0 112.173 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.44 -44.22 95.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.473 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -68.15 -42.6 79.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.468 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.411 HD11 ' N ' ' A' ' 9' ' ' GLN . 61.2 mt -59.36 -42.61 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.424 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' ASN . . . -61.72 -39.12 90.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.88 -41.27 77.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -77.39 -20.87 54.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.912 . . . . 0.0 109.461 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -104.15 -2.04 26.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.523 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . 13.0 m120 -77.27 -74.83 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -147.89 23.43 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -79.85 132.89 36.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.95 -28.35 13.03 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 169' ' ' CYS . 4.0 t -91.39 112.95 56.77 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.212 -1.169 . . . . 0.0 109.41 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.68 137.85 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.759 2.306 . . . . 0.0 111.865 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.7 141.34 51.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.809 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.9 p -90.44 12.4 18.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.376 -0.827 . . . . 0.0 109.107 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -81.36 129.51 34.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 109.317 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.671 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 95.2 p -71.28 -31.03 66.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -58.64 -42.57 88.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.681 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.88 -48.56 65.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 31' ' ' LEU . 11.1 mp -67.89 -42.07 81.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 31.8 t80 -61.5 -52.68 63.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.48 -30.65 71.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -67.97 -55.39 12.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.805 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.4 HG23 ' CG2' ' A' ' 161' ' ' ILE . 9.3 mt -65.75 -43.84 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -58.23 -49.26 77.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 0.0 110.105 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD11 ' CG ' ' A' ' 56' ' ' TYR . 4.2 mm? -76.86 -41.68 43.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.857 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -53.93 -37.97 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.792 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.63 -29.73 25.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.624 ' NE2' ' CZ ' ' A' ' 56' ' ' TYR . 72.3 mt-30 -66.79 -30.03 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.187 . . . . 0.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.699 HE22 ' N ' ' A' ' 46' ' ' TRP . 35.6 tp60 -45.79 -39.05 7.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.935 . . . . 0.0 109.702 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.84 107.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.63 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.28 -32.72 4.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 40' ' ' GLN . 2.5 mt -89.19 -165.11 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -1.126 . . . . 0.0 109.512 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.411 ' HA ' HE22 ' A' ' 41' ' ' GLN . 39.7 t -121.73 149.88 42.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.699 ' N ' HE22 ' A' ' 41' ' ' GLN . 36.2 p90 -57.61 -49.13 77.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 9.4 tp -48.34 -37.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.672 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.474 ' N ' HG23 ' A' ' 47' ' ' ILE . 58.0 m -71.71 -34.2 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.727 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.63 -48.35 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -60.45 -47.22 87.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -61.9 -51.49 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.982 . . . . 0.0 109.305 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.65 -36.2 83.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 109.403 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -48.26 -46.11 35.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.205 -0.934 . . . . 0.0 108.975 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -65.23 -42.32 93.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.362 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.86 -39.08 90.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.286 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.624 ' CZ ' ' NE2' ' A' ' 40' ' ' GLN . 3.6 m-85 -61.87 -44.13 97.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 109.342 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 53.4 mtp180 -54.77 -43.51 72.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.299 -0.875 . . . . 0.0 109.834 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.38 -23.54 65.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.792 . . . . 0.0 110.328 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 79' ' ' LEU . 3.8 t -92.31 -12.64 31.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.271 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -133.16 -46.68 0.84 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.892 -1.13 . . . . 0.0 110.231 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 53.3 t-80 -53.47 -41.55 66.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.037 -1.039 . . . . 0.0 109.901 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.08 -34.87 68.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.792 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' ASP . 88.1 m-85 -91.04 4.41 52.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.874 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.61 160.67 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.601 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.73 -24.22 25.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.856 2.371 . . . . 0.0 112.728 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.85 -48.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.1 mttm -66.09 -33.78 76.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.403 -0.811 . . . . 0.0 109.866 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 71' ' ' MET . 61.0 t -57.43 -43.14 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.058 -1.026 . . . . 0.0 109.576 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.17 -24.35 61.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.63 14.13 28.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.356 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 11.8 ptm -77.61 152.55 33.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -100.62 163.29 12.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.558 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.38 -28.71 60.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.459 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -57.07 -37.42 71.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.13 -38.37 86.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' VAL . 71.0 t -61.5 -38.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.83 -39.4 90.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.391 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 78' ' ' ARG . 53.5 mtm-85 -75.35 -47.85 25.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.318 -0.863 . . . . 0.0 109.767 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD22 ' SG ' ' A' ' 59' ' ' CYS . 93.1 mt -62.73 -41.85 99.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 76' ' ' VAL . 25.0 t -54.24 -34.28 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.713 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.62 -54.86 3.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.543 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -98.86 109.01 21.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 109.404 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.29 -38.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.87 36.84 46.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -124.5 173.42 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -1.139 . . . . 0.0 109.377 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 87.2 mt -47.71 138.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.593 ' HG2' HH11 ' A' ' 87' ' ' ARG . 9.9 ttt-85 -89.53 126.28 35.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 109.5 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER 170.89 84.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -48.12 -32.09 6.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.935 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.88 93.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -65.13 -40.5 94.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.46 HG21 HG13 ' A' ' 76' ' ' VAL . 4.3 mm -57.82 -47.46 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.49 -38.31 63.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.28 75.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.398 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.514 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 63.2 mt -59.9 -40.74 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.573 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 41.2 mm -54.19 -43.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.96 64.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -65.61 -45.73 82.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.14 . . . . 0.0 109.407 -178.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.516 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.71 -44.97 84.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.71 -41.28 98.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -46.54 38.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.453 ' HH ' ' HG ' ' A' ' 28' ' ' SER . 49.8 t80 -55.45 -44.74 76.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.516 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.19 -32.99 74.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -54.85 -49.83 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.1 mtp -66.53 -38.55 87.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.73 -27.21 67.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -51.6 -34.03 35.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -81.11 -4.69 56.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.9 10.69 80.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -84.74 149.12 53.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.03 119.62 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.626 2.217 . . . . 0.0 111.704 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -73.85 -46.85 42.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -57.85 -47.36 82.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.716 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.473 ' O ' ' OG ' ' A' ' 118' ' ' SER . 19.6 t70 -55.27 -39.1 69.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.907 . . . . 0.0 111.017 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.449 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 92.2 t80 -66.5 -49.43 66.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 111.192 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 116' ' ' VAL . 5.7 m -60.46 -46.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 111.67 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.529 ' O ' HG22 ' A' ' 120' ' ' VAL . 5.1 p-90 -85.97 -33.72 21.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.726 -1.233 . . . . 0.0 111.163 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 120' ' ' VAL . 74.4 m -57.12 -27.5 61.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 109.754 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.4 m -83.78 26.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.056 -1.027 . . . . 0.0 109.988 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.0 m120 74.36 21.57 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 56.51 42.2 27.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.93 . . . . 0.0 109.487 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.455 ' H ' HG23 ' A' ' 120' ' ' VAL . 7.9 pt20 -138.8 146.09 48.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.519 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.67 154.76 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.683 2.255 . . . . 0.0 111.836 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -120.27 147.46 44.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.965 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.7 ptp -135.58 157.31 47.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.838 . . . . 0.0 109.104 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.3 t -127.49 161.2 29.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -147.12 57.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.518 ' HB1' ' OE1' ' A' ' 134' ' ' GLU . . . -98.91 -151.18 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.705 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.3 m -114.31 -28.16 7.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 0.0 109.382 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.3 m -139.18 154.11 48.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.453 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.661 ' H ' HD12 ' A' ' 132' ' ' LEU . 1.0 OUTLIER -62.13 -30.86 71.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -67.2 -32.63 73.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.953 . . . . 0.0 109.513 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.518 ' OE1' ' HB1' ' A' ' 129' ' ' ALA . 95.1 mt-10 -59.08 -26.27 64.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.421 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.7 mp -67.34 121.58 79.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.25 133.94 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.125 2.55 . . . . 0.0 112.504 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 137' ' ' THR . 1.0 OUTLIER -81.67 -17.32 48.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.373 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.1 p -73.05 102.4 3.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -134.8 151.65 76.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.36 -31.39 92.7 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.761 2.307 . . . . 0.0 112.049 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.85 73.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -63.57 -43.63 96.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.31 -44.5 97.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.83 60.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.681 ' C ' HD23 ' A' ' 145' ' ' LEU . 6.8 tt -65.05 -49.05 71.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -57.84 -39.64 78.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.907 . . . . 0.0 109.539 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -62.31 -35.3 78.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.8 -51.57 57.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.2 mt -59.17 -35.02 72.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -58.16 -37.18 74.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.402 ' HB3' HH11 ' A' ' 152' ' ' ARG . 84.3 tttt -62.48 -40.6 97.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.5 mpt_? -64.51 -20.01 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.79 20.82 20.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -84.51 128.04 34.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 156' ' ' PHE . 22.9 tptt -97.41 176.99 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.436 ' H ' ' HG3' ' A' ' 155' ' ' LYS . 67.9 m-85 55.05 47.38 22.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 158' ' ' GLY . 2.6 m -121.71 25.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.69 171.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.443 ' H ' HG23 ' A' ' 159' ' ' THR . 1.1 p -58.31 -32.36 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.455 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.9 m -64.75 -48.46 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -63.37 -39.8 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 109.521 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.527 ' SG ' HD22 ' A' ' 145' ' ' LEU . 31.9 t -68.93 -50.13 52.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.29 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.492 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 53.1 t80 -63.93 -35.63 81.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 109.35 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.3 m -59.41 -41.47 89.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.256 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -65.05 -42.33 94.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.6 mtp -57.38 -40.9 79.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 174' ' ' ASP . 24.1 mm100 -77.1 -36.4 55.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.41 -54.17 27.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.699 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.558 ' O ' ' O ' ' A' ' 23' ' ' VAL . 11.4 p -57.78 -61.14 2.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 144.22 2.76 0.81 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 117' ' ' TRP . 2.6 mp -48.5 -41.81 31.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.419 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.74 128.54 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 32.4 t-20 -81.12 101.29 9.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 109.404 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.526 ' O ' ' ND1' ' A' ' 175' ' ' HIS . 78.6 m-20 -83.87 121.35 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 174' ' ' ASP . 28.4 m-70 -158.57 127.36 5.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.53 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 4' ' ' CYS . 33.7 m -90.41 132.96 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.49 -20.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.78 -3.47 79.82 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 6.9 t -90.17 143.49 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -1.151 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.9 -36.73 80.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.11 -39.33 81.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -124.69 81.12 61.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.607 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -86.16 28.62 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.086 2.524 . . . . 0.0 112.332 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.03 23.46 76.12 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.3 t30 56.74 40.09 29.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.091 . . . . 0.0 109.605 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -100.91 131.86 22.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo . . . . . 0 C--N 1.306 -1.702 0 C-N-CA 123.021 2.481 . . . . 0.0 112.308 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.254 0.549 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -75.1 147.32 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -148.52 164.74 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 m -48.11 137.73 10.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.39 -11.87 55.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -67.59 -1.86 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -1.154 . . . . 0.0 109.422 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -62.32 137.1 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -58.06 144.9 38.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.26 -32.81 73.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 109.533 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 143.1 78.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.06 -15.34 25.96 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.871 2.381 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.0 -43.06 99.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.22 -47.86 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.6 -46.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.29 92.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.11 -39.19 92.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.514 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 54.4 t-80 -55.27 -47.04 76.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.425 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.09 -42.36 38.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -58.88 -43.36 90.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 21' ' ' TRP . 87.9 mt-10 -146.55 -143.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' O ' ' A' ' 20' ' ' GLU . 35.3 t90 60.06 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.77 67.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -118.38 94.19 46.68 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.272 -1.134 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.04 131.27 21.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.766 2.311 . . . . 0.0 111.834 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.4 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.862 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.1 p -106.28 0.32 25.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.38 134.76 36.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 10.2 p -72.93 -31.72 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -64.7 -54.78 26.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -73.36 -49.75 25.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 109.893 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.2 -44.62 75.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.02 -42.41 98.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.954 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -58.29 -31.51 67.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 109.78 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 tpp -63.67 -46.36 85.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.834 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.53 -47.21 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 110.01 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 14.2 p -60.04 -38.55 83.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.522 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 43.6 mt -66.08 -36.81 84.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.13 -0.981 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 65.3 mm-40 -60.18 -37.9 81.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.704 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.2 -36.05 7.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.443 ' OE1' HG21 ' A' ' 86' ' ' ILE . 74.5 mm-40 -66.09 -31.31 72.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -1.186 . . . . 0.0 109.794 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 44' ' ' LEU . 64.7 tt0 -56.8 -31.73 64.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.736 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.72 109.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.98 -31.89 5.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.6 mp -104.73 -160.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -1.187 . . . . 0.0 109.422 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.2 m -125.44 152.96 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.542 ' CZ3' ' OE2' ' A' ' 38' ' ' GLU . 72.5 t-105 -54.19 -42.52 69.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.366 -0.833 . . . . 0.0 109.493 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.637 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -48.99 -39.74 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.68 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.52 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 52.9 m -71.92 -31.5 66.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 109.686 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ARG . 67.6 t -57.82 -30.8 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 109.438 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 50' ' ' LEU . 4.1 mm? -52.87 -54.68 30.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.419 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.09 -45.89 89.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.351 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.85 -24.62 65.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' VAL . 33.2 ttt-85 -62.23 -47.33 84.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.22 -0.925 . . . . 0.0 109.032 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -44.51 84.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 109.337 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.28 -43.95 69.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 22.9 t80 -63.4 -37.31 86.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.474 -0.766 . . . . 0.0 109.332 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.77 -41.95 92.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.383 -0.823 . . . . 0.0 109.783 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 -21.43 59.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 85' ' ' ILE . 25.8 m -89.46 -11.97 41.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 110.266 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 83.3 m-85 -133.51 -50.91 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.113 . . . . 0.0 110.2 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -49.91 -42.83 48.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.913 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -59.32 -28.52 66.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 64' ' ' ASP . 90.8 m-85 -85.52 17.55 3.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.052 -1.03 . . . . 0.0 109.901 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 55.52 162.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 109.576 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.52 -54.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.884 2.389 . . . . 0.0 112.755 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.9 p -48.48 -44.61 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.703 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.577 ' N ' HG13 ' A' ' 66' ' ' VAL . 80.6 tttt -58.12 -37.99 75.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 64' ' ' ASP . 58.9 t -57.46 -38.96 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.083 -1.01 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.06 -24.45 62.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.83 12.83 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.384 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.5 mtp -61.94 135.98 57.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -95.47 162.95 13.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' CD ' HE22 ' A' ' 93' ' ' GLN . 75.6 mm-40 -57.86 -27.75 63.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -71.82 -29.02 63.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.11 -49.4 70.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 92' ' ' ILE . 14.9 m -60.68 -37.64 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.58 -37.1 70.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.427 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.9 ttt-85 -65.25 -42.32 93.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.402 -0.811 . . . . 0.0 109.775 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.9 mt -67.12 -27.15 67.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.631 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.1 t -61.93 -28.42 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.712 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.79 -56.72 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 109.519 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.666 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 53.1 t0 -99.07 169.89 9.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.77 73.59 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 109.416 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -77.95 33.18 1.7 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.502 HG21 ' SG ' ' A' ' 59' ' ' CYS . 16.0 pt -55.87 -159.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -1.12 . . . . 0.0 109.372 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.714 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 2.9 tt -55.86 -165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 109.515 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.714 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 8.0 mtt-85 -47.65 153.3 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -142.65 -156.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.176 -179.099 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 57.88 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.933 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -66.13 -44.19 91.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -61.59 -42.58 99.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -1.227 . . . . 0.0 109.5 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.59 HG22 HG12 ' A' ' 76' ' ' VAL . 18.8 mt -57.06 -47.29 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.555 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.573 HE22 ' CD ' ' A' ' 73' ' ' GLU . 15.5 mm100 -53.22 -36.99 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.35 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.355 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.586 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 81.4 mt -59.47 -50.0 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.91 -38.5 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.518 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.33 99.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 97.4 m-20 -69.44 -44.68 70.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.423 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.06 95.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.546 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -63.63 -43.93 95.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 109.531 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.99 -34.18 66.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.895 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.64 -51.29 63.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.31 -39.01 91.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -60.13 -42.84 95.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -61.98 -41.43 98.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.65 -27.01 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.127 -0.983 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -51.67 -20.38 2.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.506 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 110' ' ' GLU . 64.3 t30 -75.53 -18.45 59.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.83 65.16 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.517 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 12.0 mp0 -103.48 151.07 38.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.163 -1.198 . . . . 0.0 109.653 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.97 119.65 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.67 2.247 . . . . 0.0 111.676 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -74.88 -45.74 40.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 0.0 110.467 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -62.09 -47.95 82.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 110.734 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.484 ' O ' ' OG ' ' A' ' 118' ' ' SER . 18.4 t70 -55.8 -40.36 72.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.937 . . . . 0.0 111.036 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -64.72 -51.22 63.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.029 -1.045 . . . . 0.0 111.225 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.3 m -56.78 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.98 -1.075 . . . . 0.0 111.716 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.477 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -86.99 -32.82 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.775 -1.203 . . . . 0.0 111.134 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 120' ' ' VAL . 57.1 p -55.65 -21.03 16.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -44.04 -15.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.007 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.9 m -91.77 24.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.044 -1.035 . . . . 0.0 109.982 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.525 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 1.3 m120 72.56 -48.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 3.0 p-80 165.13 -20.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -106.31 149.3 38.06 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.6 149.17 67.58 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.696 2.264 . . . . 0.0 111.805 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -75.38 146.81 40.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.745 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 88.1 mtp -126.44 144.93 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.117 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.09 175.49 6.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -164.86 71.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.279 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.12 -132.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.734 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.9 m -154.22 -35.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -113.13 155.21 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.76 -30.27 70.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.501 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.0 p -70.74 -33.37 70.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.5 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.69 -24.89 67.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.5 mm -66.33 116.77 37.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.686 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.85 126.3 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.187 2.592 . . . . 0.0 112.538 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.453 ' OG1' ' CB ' ' A' ' 163' ' ' TYR . 2.0 t -77.2 -18.26 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.266 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.4 p -89.25 66.61 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.356 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -77.27 152.31 81.59 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.37 -36.02 16.92 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.8 2.333 . . . . 0.0 112.035 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.46 -41.51 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.1 m -59.65 -39.82 85.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -62.17 -48.32 80.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.82 78.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -61.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.528 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.7 p -63.26 -39.43 94.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.918 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.54 43.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.71 -33.44 75.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.564 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.44 -39.67 84.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.422 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -61.16 -39.93 91.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.618 HH11 ' CG ' ' A' ' 152' ' ' ARG . 7.3 mtt-85 -64.43 -21.51 66.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.85 36.99 5.87 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.448 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 1.4 m-85 -84.79 133.51 34.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -1.112 . . . . 0.0 109.517 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.61 159.87 14.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.448 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 56.12 48.38 17.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.7 p -121.82 26.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.457 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.51 156.3 0.07 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -59.88 -14.02 13.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -1.133 . . . . 0.0 109.448 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.6 p -70.86 -44.97 65.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 38' ' ' GLU . 26.0 mt -65.07 -36.34 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.526 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 68.3 m -55.81 -40.81 73.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.321 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.453 ' CB ' ' OG1' ' A' ' 137' ' ' THR . 37.6 t80 -66.78 -47.26 72.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.405 -0.809 . . . . 0.0 109.314 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.7 m -66.05 -40.68 91.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.317 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.77 -49.38 77.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 92.6 mtp -68.94 -39.55 79.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.666 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.47 -41.89 99.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.734 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.58 97.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.678 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.4 m -66.06 -60.82 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 138.8 1.69 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.29 -33.34 72.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -1.167 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -99.74 130.1 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -98.76 105.06 17.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.29 114.23 26.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -135.51 143.18 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.44 142.5 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.441 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.435 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 89.05 15.63 58.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 178' ' ' GLY . 7.7 m -149.8 176.16 10.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 75.3 m 50.75 -97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 181' ' ' CYS . 52.7 t -156.17 15.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 29.8 t80 -66.46 117.09 40.56 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.641 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.569 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 84.9 Cg_endo -83.55 -163.74 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.074 2.516 . . . . 0.0 112.397 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.23 67.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.46 40.74 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -1.155 . . . . 0.0 109.605 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -130.8 79.63 71.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.144 -0.973 . . . . 0.0 109.491 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.307 -1.648 0 C-N-CA 123.004 2.469 . . . . 0.0 112.259 -179.916 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.5 tpp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 13.8 pt-20 -87.35 143.53 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -149.45 174.16 12.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -48.13 167.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.99 9.23 1.54 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.607 ' CD1' HD13 ' A' ' 132' ' ' LEU . 21.6 m95 -83.13 -1.22 52.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.94 132.8 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' GLN . 68.4 m -79.64 177.94 8.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.4 mm-40 -61.03 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 51.54 85.06 0.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.01 -25.76 4.32 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.852 2.368 . . . . 0.0 112.1 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.91 -39.31 93.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.481 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -71.16 -48.11 53.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.12 -44.84 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.376 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.92 81.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.459 ' CG ' HD21 ' A' ' 50' ' ' LEU . 85.5 t80 -61.64 -43.96 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.18 -49.45 77.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.48 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.483 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -56.95 -56.36 22.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -175.25 131.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -159.64 123.05 3.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 109.516 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.98 -5.29 75.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' CYS . 19.3 t -63.4 132.09 95.02 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.209 -1.171 . . . . 0.0 109.343 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.03 120.47 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.777 2.318 . . . . 0.0 111.849 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.46 132.79 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.854 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -115.08 3.5 14.43 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 109.083 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.1 126.02 32.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 m -64.52 -40.44 95.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -60.93 -45.28 95.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.61 -45.01 69.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.895 . . . . 0.0 109.846 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.2 -43.93 96.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.118 -0.989 . . . . 0.0 109.808 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 44.9 t80 -60.52 -37.03 79.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.919 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.93 -30.55 63.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.878 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.9 tpp -64.45 -54.98 24.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.794 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.3 tp -64.46 -33.32 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 110.045 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.5 m -64.44 -49.9 69.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 110.106 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.19 -28.38 59.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 109.805 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -52.82 -35.26 56.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 109.772 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.61 -33.88 74.03 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -59.05 -32.54 69.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -1.207 . . . . 0.0 109.763 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -52.87 -39.7 62.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.05 120.41 3.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -35.27 4.2 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.02 -138.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.137 . . . . 0.0 109.445 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -142.41 158.92 43.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -56.14 -39.36 72.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.474 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -59.12 -34.46 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.687 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 61.1 m -69.39 -33.47 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.0 t -57.63 -43.16 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.442 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 50' ' ' LEU . 9.8 mp -56.7 -52.15 66.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.57 -44.69 93.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 109.307 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -73.25 -21.61 60.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.193 -0.942 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.8 ttm-85 -60.35 -46.05 91.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -71.13 -45.95 62.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.403 -0.811 . . . . 0.0 109.439 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.99 -35.0 79.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.609 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 25.3 t80 -62.78 -44.61 95.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.563 ' HG2' HH11 ' A' ' 57' ' ' ARG . 27.9 mtt-85 -57.0 -41.81 79.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.828 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -29.9 71.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.258 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 97.9 m -93.49 -12.6 29.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.262 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 61.8 m-85 -125.68 -43.27 1.88 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 0.0 110.181 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 29.9 t-80 -49.89 -40.14 42.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -61.85 -31.73 72.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.739 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.7 m-85 -91.34 -0.85 57.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.077 -1.014 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.05 161.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.107 -0.995 . . . . 0.0 109.623 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.47 -27.11 16.17 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.867 2.378 . . . . 0.0 112.713 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.5 -47.87 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.13 -35.35 80.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 64' ' ' ASP . 46.3 t -58.11 -35.71 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 109.598 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.81 66.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.466 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 23.08 9.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 tpp -61.22 156.45 18.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.671 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -110.47 156.83 20.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.6 mt-10 -55.75 -35.06 65.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.94 -37.59 85.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 80' ' ' VAL . 59.9 t -54.71 -49.5 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.3 mp0 -64.25 -32.74 74.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.63 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.28 -49.2 67.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.806 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.0 -41.18 67.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.605 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 76' ' ' VAL . 38.9 t -51.1 -33.08 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -80.95 -59.79 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -98.96 117.11 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 77.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -22.91 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 84' ' ' GLY . 24.0 pt -62.29 -134.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.321 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.05 136.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -101.29 117.98 36.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.467 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -172.4 94.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.183 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -45.27 -35.43 3.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 109.967 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.33 -47.66 85.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -66.16 -38.12 87.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.25 -50.22 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.12 -32.99 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.326 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.26 99.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.388 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.06 -46.17 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.375 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.61 -36.45 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.63 94.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.473 ' OD1' ' CD2' ' A' ' 154' ' ' PHE . 86.8 m-20 -60.17 -42.52 95.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.66 89.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.512 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -61.23 -44.33 97.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.29 72.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 30.1 t80 -66.93 -43.72 82.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.527 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -66.93 -50.51 62.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -59.9 -35.0 73.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ttt -59.16 -40.96 87.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.29 -27.75 66.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.482 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -51.66 -34.05 36.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -83.4 -1.19 52.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.39 35.92 40.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -116.84 82.16 12.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.657 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -41.67 131.31 3.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.634 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.06 -47.74 83.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -45.45 80.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 110.718 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -59.22 -33.21 70.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 111.034 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.3 t80 -65.26 -53.43 44.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.023 -1.048 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 116' ' ' VAL . 7.0 m -58.02 -40.99 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.719 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -68.56 -31.12 70.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.719 -1.238 . . . . 0.0 111.104 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -65.15 -34.78 79.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 109.676 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -58.72 -44.2 90.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.084 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 123' ' ' GLN . 3.2 p -89.71 20.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.079 -1.013 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 61.62 30.48 18.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 55.45 22.88 5.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.495 ' H ' HG13 ' A' ' 120' ' ' VAL . 65.8 mt-30 -123.39 100.98 38.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.626 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -47.38 139.45 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.728 2.286 . . . . 0.0 111.855 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -85.5 157.38 20.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -131.85 151.3 51.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 109.183 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -131.58 152.52 50.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -133.96 45.67 2.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.324 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.73 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -68.52 147.06 52.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.2 m -74.08 -36.26 64.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.4 m -132.56 157.58 44.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.884 ' H ' HD12 ' A' ' 132' ' ' LEU . 6.0 mp -54.29 -32.34 56.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.2 t -64.93 -33.83 76.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.73 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 71.3 mm-40 -69.34 -19.12 63.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 109.367 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -66.85 124.2 88.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 109.676 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.36 127.24 5.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.143 2.562 . . . . 0.0 112.552 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 -13.79 47.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.304 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -109.15 100.64 9.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 109.374 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -105.51 150.75 39.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.917 . . . . 0.0 109.462 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.96 -41.1 26.01 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.789 2.326 . . . . 0.0 111.982 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.65 -36.91 60.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.3 m -60.9 -43.24 98.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -61.96 -48.07 82.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.21 89.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.22 -41.39 99.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.2 p -57.88 -43.36 85.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.7 -27.68 68.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.502 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.48 -51.33 29.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.42 -36.17 73.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -57.62 -36.6 72.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.34 -40.1 92.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.62 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -67.51 -19.74 65.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.413 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.92 22.25 16.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.473 ' CD2' ' OD1' ' A' ' 98' ' ' ASN . 8.0 m-85 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -1.107 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -101.79 168.52 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.501 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 54.05 53.13 11.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.28 25.16 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.419 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.41 167.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -55.47 -32.18 62.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.436 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 65.9 p -64.38 -47.78 77.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -65.7 -35.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 5.9 t -68.7 -44.13 74.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.259 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -62.23 -44.97 95.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.7 m -57.99 -37.18 73.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.222 -0.924 . . . . 0.0 109.248 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.617 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 72.4 t80 -59.73 -41.36 90.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.398 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.12 -38.57 72.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.533 HE22 ' CG ' ' A' ' 174' ' ' ASP . 98.1 mm-40 -63.34 -46.45 86.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.7 -44.63 49.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.617 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 98.3 m -62.44 -36.13 81.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.462 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.28 8.8 56.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.8 mp -53.41 -26.82 21.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -1.152 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.06 138.61 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.449 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -82.12 102.37 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.533 ' CG ' HE22 ' A' ' 167' ' ' GLN . 34.4 m-20 -91.56 118.17 30.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.56 166.0 28.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.621 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.27 150.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.29 130.23 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.531 ' H ' ' HA ' ' A' ' 183' ' ' PRO . . . 91.2 4.71 68.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 181' ' ' CYS . 53.5 t -76.34 28.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.542 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 3.2 m 63.04 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 179' ' ' CYS . 73.3 m -59.47 -35.35 73.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.0 t80 -125.47 80.67 65.43 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.531 ' HA ' ' H ' ' A' ' 178' ' ' GLY . 85.3 Cg_endo -85.88 47.97 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.028 2.485 . . . . 0.0 112.359 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.07 64.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 57.87 42.79 22.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 109.535 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -134.78 78.72 54.31 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.518 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 C--N 1.306 -1.702 0 C-N-CA 123.097 2.531 . . . . 0.0 112.211 -179.89 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.318 0.58 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' OE2' ' SG ' ' A' ' 179' ' ' CYS . 22.3 pt-20 -83.71 145.58 28.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.637 ' HG2' HH11 ' A' ' 3' ' ' ARG . 10.2 mtt-85 -108.32 160.53 15.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' TRP . 26.6 p -47.23 127.29 10.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.94 -6.27 3.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' CYS . 16.9 m95 -54.53 -37.0 64.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.423 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 7' ' ' VAL . 17.9 m -88.76 127.15 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.564 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' GLN . 75.2 m -165.86 146.46 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.0 mm100 60.32 133.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.552 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' GLN . 1.1 m-20 63.0 125.11 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.26 -7.71 19.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.845 2.364 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.49 -32.86 72.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.55 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 30.8 m-85 -49.47 -44.23 45.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.78 -28.42 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.424 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -58.97 -48.23 82.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.429 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.559 ' CG ' ' N ' ' A' ' 17' ' ' HIS . 2.2 p90 -75.52 -39.09 58.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.559 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 48.3 t-80 -60.85 -48.21 82.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.42 -44.86 67.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 98.4 m-20 -55.28 -45.45 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.3 pt-20 -173.52 -143.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.595 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 11.0 t-105 60.6 125.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.03 -20.28 46.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 169' ' ' CYS . 26.3 m -84.66 141.36 38.64 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.17 -1.194 . . . . 0.0 109.33 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.87 122.85 4.48 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.758 2.306 . . . . 0.0 111.905 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -119.6 131.98 55.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.02 . . . . 0.0 109.857 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -123.21 5.5 9.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.88 135.01 33.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.439 ' CA ' ' HB2' ' A' ' 113' ' ' ALA . 14.5 m -69.63 -39.36 77.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.603 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.47 -43.59 88.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 109.717 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -65.94 -49.64 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.86 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 ' SG ' ' A' ' 169' ' ' CYS . 43.9 mt -72.91 -29.96 63.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.873 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' ' N ' ' A' ' 33' ' ' GLU . 9.2 t80 -59.98 -56.39 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.0 pp20? -68.58 -29.72 68.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.595 ' SD ' ' CH2' ' A' ' 21' ' ' TRP . 55.2 tpp -63.61 -53.36 52.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.88 -46.78 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 110.05 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.9 t -70.34 -39.17 74.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.4 tp -73.34 -38.37 65.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 35.0 mm-40 -52.76 -34.54 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.24 -23.66 41.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.2 -38.01 86.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.176 . . . . 0.0 109.783 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -48.75 -38.93 23.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.786 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.53 106.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.662 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -31.26 6.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -86.03 -165.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -1.192 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 48' ' ' THR . 15.6 p -117.36 150.64 38.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -56.21 -36.65 68.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -79.52 -30.77 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.707 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 45' ' ' SER . 52.4 m -67.64 -40.46 84.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.679 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' ARG . 70.4 t -68.91 -40.89 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 16' ' ' TYR . 85.7 mt -57.05 -47.25 81.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -60.79 -51.45 69.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 109.297 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.48 -26.31 67.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.7 tmm_? -54.47 -46.63 73.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.38 -34.48 76.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.259 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -63.76 -45.8 88.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -0.789 . . . . 0.0 109.327 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 79.3 mtm180 -62.29 -30.63 71.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.864 . . . . 0.0 109.732 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.66 82.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.881 . . . . 0.0 110.276 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -93.77 -13.33 27.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.27 -178.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -113.76 -52.33 2.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.913 -1.117 . . . . 0.0 110.175 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.424 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.9 t-80 -51.94 -40.0 60.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 109.91 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -56.55 -32.5 65.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-85 -88.67 -2.83 58.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 109.883 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER 56.2 158.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.08 -24.04 20.85 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.893 2.396 . . . . 0.0 112.728 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.39 -48.24 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' MET . 12.2 mptt -67.88 -33.7 75.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 64' ' ' ASP . 94.1 t -56.16 -41.22 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.029 . . . . 0.0 109.551 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.11 68.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.46 17.7 20.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.399 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ttp -75.81 155.43 35.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.68 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 18.5 pt20 -105.48 162.53 13.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.96 -30.07 70.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.32 -41.32 84.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.425 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.5 m-20 -60.93 -39.83 90.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.36 -42.51 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -60.15 -34.06 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.635 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.41 -44.55 82.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 13.9 mt -65.04 -33.4 75.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.932 . . . . 0.0 109.626 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.79 -31.99 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -84.88 -60.89 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.552 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.23 123.73 43.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.371 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . . . -166.11 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.78 27.18 57.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ARG . 9.9 pt -133.0 167.38 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.138 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.71 58.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.634 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -106.69 139.79 40.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.471 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' GLY . 14.3 p80 -128.8 44.19 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.146 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HG2' HH11 ' A' ' 89' ' ' ARG . 3.9 ttt-85 65.67 -58.54 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -60.82 -35.35 89.94 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -61.27 -50.98 70.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -1.167 . . . . 0.0 109.461 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -52.39 -39.51 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.691 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.53 -36.63 76.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.0 109.32 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.14 95.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.7 mp -55.54 -47.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -58.46 -30.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.551 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.23 94.83 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.728 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 29.0 p30 -68.63 -33.35 73.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 109.358 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.728 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -67.4 -42.25 83.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -65.23 -45.95 82.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.585 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.72 63.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 29.8 t80 -68.83 -43.44 75.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.549 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -66.57 -47.96 71.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.474 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -57.97 -39.58 78.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 17.2 ttt -66.74 -41.24 88.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.85 -25.94 68.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -51.28 -29.28 14.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 105' ' ' MET . 51.0 p30 -80.16 -1.48 40.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.489 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.66 79.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HB3' HD21 ' A' ' 108' ' ' ASN . 32.4 tt0 -80.76 132.98 56.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.158 -1.201 . . . . 0.0 109.627 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.47 121.27 8.03 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.614 2.21 . . . . 0.0 111.726 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -74.72 -43.86 52.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.393 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' ' CA ' ' A' ' 28' ' ' SER . . . -56.06 -49.99 72.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -0.967 . . . . 0.0 110.708 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 86.5 m-20 -61.23 -42.7 99.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 27.5 t80 -55.31 -48.62 73.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 111.213 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.7 m -63.82 -48.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 0.0 111.721 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.488 ' CD2' ' N ' ' A' ' 118' ' ' SER . 4.3 p-90 -89.32 -37.49 14.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.769 -1.207 . . . . 0.0 111.117 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.4 m -56.18 -26.88 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.781 -1.199 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -13.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.04 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 118' ' ' SER . 18.7 m -82.8 21.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t30 60.36 36.22 20.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.061 -1.024 . . . . 0.0 109.703 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.2 m80 53.54 27.08 6.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.47 87.91 21.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.72 151.78 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.695 2.263 . . . . 0.0 111.842 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -93.44 155.16 17.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.719 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 71.6 mtm -137.15 147.17 45.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.198 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.5 t -142.18 155.82 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.801 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -123.61 45.61 2.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.289 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.2 139.5 35.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.2 m -74.56 -35.52 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.8 t -139.45 178.92 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -68.84 -33.4 73.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.543 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m -63.12 -36.42 83.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.81 -24.44 64.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.161 -0.962 . . . . 0.0 109.404 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 132' ' ' LEU . 87.4 mt -67.28 119.95 68.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.728 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.76 129.22 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.088 2.526 . . . . 0.0 112.487 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 137' ' ' THR . 1.2 t -80.62 -19.19 45.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.4 m -98.05 98.54 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.858 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.5 p -106.23 154.61 39.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.32 -40.12 52.85 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.839 2.36 . . . . 0.0 111.999 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.16 -36.48 58.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.407 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -61.19 -41.3 96.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 -53.13 57.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.27 -35.26 79.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.435 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.01 -50.19 74.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 80.5 p -58.5 -37.69 76.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.91 -36.08 82.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.549 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.31 -50.56 45.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.467 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.603 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.88 -38.82 79.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.355 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -61.92 -39.37 91.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -63.84 -20.54 65.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.92 31.01 8.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.47 137.95 32.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.132 . . . . 0.0 109.454 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -101.19 173.58 6.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.485 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 52.82 50.79 17.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 157' ' ' VAL . 11.3 p -123.68 28.79 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.21 159.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.8 t -52.46 -29.81 26.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.373 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.5 m -65.9 -36.84 84.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.446 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.9 mm -62.24 -44.09 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.22 -48.7 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.411 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 42.9 t80 -60.21 -47.01 87.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.811 . . . . 0.0 109.352 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 22.6 t -61.64 -43.35 99.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.857 . . . . 0.0 109.27 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.411 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -63.08 -32.63 74.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.47 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 31.5 ttm -64.29 -45.13 89.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.609 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.81 -34.1 77.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.672 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.659 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.557 ' SG ' HD22 ' A' ' 31' ' ' LEU . 1.2 m -77.2 -42.5 37.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.65 28.77 5.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.72 -34.33 77.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.41 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.69 132.15 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -84.64 100.95 11.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p-10 -120.64 92.62 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 176' ' ' VAL . 75.5 m80 -132.99 36.35 3.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.67 HG12 ' N ' ' A' ' 177' ' ' VAL . 86.3 t 54.39 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.452 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.67 ' N ' HG12 ' A' ' 176' ' ' VAL . 8.1 p -110.61 136.23 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.75 24.13 75.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 181' ' ' CYS . 66.4 m -143.73 169.9 16.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 109.523 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 84.5 m 48.3 -93.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 179' ' ' CYS . 50.0 m -157.92 33.09 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 30.8 t80 -88.27 117.06 67.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.552 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 87.8 Cg_endo -84.1 -159.61 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.15 2.567 . . . . 0.0 112.374 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.53 7.87 66.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -143.67 33.64 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -127.34 80.15 72.15 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 123.077 2.518 . . . . 0.0 112.226 -179.836 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.4 161.85 40.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -88.55 148.64 24.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.965 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 7.9 p -47.39 146.02 2.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.66 2.87 46.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' HE1' HD22 ' A' ' 132' ' ' LEU . 8.8 m95 -54.22 -36.56 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -1.135 . . . . 0.0 109.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -97.01 131.14 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 13.0 t -177.31 -168.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.547 ' N ' ' OG ' ' A' ' 8' ' ' SER . 94.9 mt-30 49.38 -117.93 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.85 153.44 91.17 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.352 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.46 -6.14 18.28 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.804 2.336 . . . . 0.0 112.139 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.5 tt -59.82 -39.52 85.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.633 ' CZ ' HD13 ' A' ' 47' ' ' ILE . 88.7 m-85 -56.47 -43.73 79.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.43 -43.95 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.51 76.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.39 -40.15 93.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -63.42 -37.42 87.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -88.41 -4.41 58.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.513 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.561 HD22 HH22 ' A' ' 53' ' ' ARG . 48.0 t30 -74.09 -73.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -150.93 38.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.479 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -92.77 138.83 31.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.02 -21.39 44.18 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.58 132.44 72.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.247 -1.149 . . . . 0.0 109.366 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.48 119.69 6.28 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.724 2.282 . . . . 0.0 111.87 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.67 137.25 41.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -134.54 2.59 3.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.071 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -89.66 135.19 33.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.375 -0.828 . . . . 0.0 109.303 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.739 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 96.2 p -59.94 -38.28 81.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.632 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -57.02 -43.82 82.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.766 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.37 -53.31 24.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.0 mp -69.03 -27.89 66.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.783 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' N ' ' O ' ' A' ' 28' ' ' SER . 56.1 t80 -60.36 -50.53 73.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.928 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -74.44 -31.11 62.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.813 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.89 -54.39 22.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -64.4 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.032 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' N ' HG23 ' A' ' 35' ' ' ILE . 36.1 t -73.36 -46.6 48.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.16 -0.962 . . . . 0.0 110.088 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.1 -41.67 97.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.877 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.22 -28.59 64.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.296 -0.878 . . . . 0.0 109.788 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.75 -37.07 27.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -66.07 -29.0 69.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -1.184 . . . . 0.0 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.4 tt0 -48.11 -34.22 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.72 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.42 111.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -33.12 5.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.0 mt -96.06 -145.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -1.14 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 m -144.68 155.97 43.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -51.17 -38.95 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.374 -0.829 . . . . 0.0 109.461 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.633 HD13 ' CZ ' ' A' ' 13' ' ' TYR . 9.7 tp -61.94 -40.44 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 109.672 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 47' ' ' ILE . 96.1 m -63.91 -35.87 82.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 53' ' ' ARG . 72.9 t -62.06 -42.82 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.473 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.43 -51.06 69.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -60.37 -44.08 95.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 109.348 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -75.78 -19.35 59.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.975 . . . . 0.0 109.361 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.561 HH22 HD22 ' A' ' 19' ' ' ASN . 43.8 ttp180 -61.22 -45.65 93.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 108.994 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 10.2 pt-20 -72.15 -43.0 65.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.34 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.95 -35.29 79.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.229 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 52.7 t80 -57.39 -49.27 76.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.427 -0.795 . . . . 0.0 109.308 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.4 mtp180 -58.42 -43.12 88.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.741 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.97 -39.81 42.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.793 . . . . 0.0 110.305 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -96.78 -28.63 14.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 35.4 m-85 -95.71 -27.75 15.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.977 -1.077 . . . . 0.0 110.231 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.7 t60 -48.77 -21.66 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -90.87 -25.61 19.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.81 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 68' ' ' VAL . 61.9 m-85 -92.03 66.09 4.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 109.925 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' PHE . 3.7 m-20 -41.33 153.77 0.24 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 109.604 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -35.92 -53.66 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.852 2.368 . . . . 0.0 112.722 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.31 -45.11 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.64 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -67.35 -31.67 72.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.853 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 63' ' ' PHE . 93.9 t -56.45 -46.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.572 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.81 58.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.48 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 -3.58 58.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 mtp -70.97 141.1 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 31.1 tp60 -99.85 169.15 9.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 78.7 mm-40 -61.84 -33.87 74.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 46.7 mp0 -60.84 -40.89 94.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.437 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -62.74 -37.76 87.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.41 -43.29 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.48 -33.47 75.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.97 -44.76 91.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.314 -0.866 . . . . 0.0 109.792 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -70.07 -35.48 74.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 109.591 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.1 t -51.19 -34.94 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.739 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -87.83 -60.13 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.614 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -100.17 109.23 21.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.903 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.47 -60.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.47 4.61 70.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 85' ' ' ILE . 12.9 pt -90.02 -155.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.32 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.2 mt -68.62 136.79 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.478 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 87' ' ' ARG . 19.7 mmm-85 -88.6 95.89 10.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -172.41 88.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.13 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -49.96 -29.12 7.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.04 96.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -63.05 -48.19 79.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -1.186 . . . . 0.0 109.479 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.83 -44.13 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.598 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -54.51 -38.62 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.327 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.02 79.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 60' ' ' PHE . 44.1 mm -57.69 -46.66 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.432 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -55.18 -43.74 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.06 -36.23 85.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.588 HD21 ' HZ ' ' A' ' 154' ' ' PHE . 2.4 t-20 -56.87 -48.16 78.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.72 93.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.416 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 46.2 ttm-85 -66.56 -45.16 80.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.525 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.73 -36.06 67.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -71.08 -47.6 57.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.61 -37.79 85.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.865 . . . . 0.0 109.534 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.53 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.601 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 28.2 ttt -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.529 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.35 -27.19 67.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -52.11 -24.08 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.49 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -75.54 -18.12 59.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.8 7.43 68.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.59 150.28 38.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.205 -1.174 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.99 119.17 6.18 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.621 2.214 . . . . 0.0 111.693 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -74.57 -44.91 48.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.803 . . . . 0.0 110.404 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.26 -48.58 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.201 -0.937 . . . . 0.0 110.732 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 83.2 m-20 -56.23 -43.59 78.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.204 -0.935 . . . . 0.0 111.081 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -61.93 -51.31 68.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 111.227 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 117' ' ' TRP . 6.7 m -57.97 -47.37 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 111.722 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -87.6 -28.04 22.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.696 -1.253 . . . . 0.0 111.178 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -59.61 -23.9 63.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 109.709 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -43.85 -19.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.08 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.7 m -82.9 22.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.087 -1.008 . . . . 0.0 109.954 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 58.22 36.92 26.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.0 109.67 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.1 m80 60.27 15.23 5.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.531 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -111.83 128.1 25.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.628 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.57 147.89 41.42 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.672 2.248 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -98.5 144.5 27.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 109.751 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.4 ttp -132.07 135.06 46.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.784 . . . . 0.0 109.097 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.7 t -85.5 156.08 20.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.897 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -151.06 48.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.855 . . . . 0.0 109.3 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB1' ' OE2' ' A' ' 134' ' ' GLU . . . -100.82 -155.81 0.53 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.662 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.587 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.2 m -130.88 -54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.0 m -98.04 161.11 13.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.429 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.513 HD22 ' HE1' ' A' ' 6' ' ' TRP . 20.9 mt -75.53 -11.16 59.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 t -89.72 -39.04 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 130' ' ' THR . 11.2 pt-20 -68.66 -13.31 62.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 132' ' ' LEU . 79.1 mt -67.43 118.41 56.44 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.52 131.29 5.49 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.047 2.498 . . . . 0.0 112.536 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -91.39 -11.85 36.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.9 t -92.88 99.04 11.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.3 p -110.18 151.56 42.63 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -45.71 -40.79 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.815 2.343 . . . . 0.0 112.011 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.24 76.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -61.66 -42.2 98.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.863 . . . . 0.0 109.494 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -61.06 -44.46 97.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.65 -43.61 68.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.4 -49.56 77.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.7 m -54.12 -43.61 70.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.76 -38.14 84.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.11 -49.87 66.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.5 -34.94 74.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.878 . . . . 0.0 109.564 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -60.55 -36.79 79.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -60.76 -37.88 83.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.24 -21.32 63.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.283 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.77 4.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.588 ' HZ ' HD21 ' A' ' 98' ' ' ASN . 7.5 m-85 -97.51 129.92 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -92.97 167.16 11.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 51.54 48.31 23.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.7 p -121.63 25.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.45 165.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.8 t -56.87 -29.88 63.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -1.156 . . . . 0.0 109.442 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 m -59.77 -47.56 85.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 73.3 m -61.04 -42.89 99.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -60.31 -44.58 95.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.46 -0.775 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.5 p -61.98 -36.71 82.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -42.45 83.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 56.8 mtp -61.36 -39.24 89.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -61.69 -47.12 86.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.17 -38.98 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.98 -14.18 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.42 0.04 77.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.3 mp -63.04 -39.92 96.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.07 131.56 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.501 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' THR . 84.2 m-20 -95.66 117.98 31.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.443 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.15 105.15 17.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -145.89 144.5 30.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.67 137.08 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 177' ' ' VAL . 14.9 p -75.13 134.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.22 3.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.507 ' C ' ' H ' ' A' ' 181' ' ' CYS . 34.8 m -98.66 173.72 6.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -1.152 . . . . 0.0 109.534 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 54.1 m 54.45 5.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.443 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.507 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.3 m 62.8 50.19 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.602 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 23.9 t80 -124.6 80.33 61.45 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.59 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -84.99 30.79 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.067 2.511 . . . . 0.0 112.358 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.21 20.28 79.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 53.48 39.97 30.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -1.131 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 187' ' ' PRO . 16.6 pttp -83.16 147.42 53.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 186' ' ' LYS . 88.8 Cg_exo . . . . . 0 C--N 1.306 -1.659 0 C-N-CA 123.017 2.478 . . . . 0.0 112.238 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 2.3 pm0 -98.7 149.37 22.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 45.1 mtm-85 -107.98 149.84 27.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.487 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 6' ' ' TRP . 16.3 p -96.39 -176.14 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.39 -24.83 0.9 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.659 ' CD2' HD21 ' A' ' 132' ' ' LEU . 11.4 m0 53.13 55.68 8.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -59.84 -5.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 6' ' ' TRP . 52.6 m -47.22 114.33 0.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 109.418 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -167.84 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -151.55 150.89 27.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.0 -36.97 16.75 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.896 2.397 . . . . 0.0 112.145 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 47' ' ' ILE . 52.3 tp -63.44 -51.25 66.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -70.08 -45.12 67.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 109.379 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.9 mt -59.81 -42.37 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.347 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.94 -47.1 69.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.417 ' CE1' HD22 ' A' ' 50' ' ' LEU . 87.7 t80 -59.85 -44.7 93.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -62.6 -45.54 92.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.27 -22.25 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.19 -75.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -145.15 113.8 6.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.873 . . . . 0.0 109.52 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -172.99 139.61 0.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -29.84 3.1 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 169' ' ' CYS . 3.7 m -68.02 149.19 98.27 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.232 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.99 128.25 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.805 2.337 . . . . 0.0 111.891 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -124.99 130.67 52.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.78 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -123.13 12.21 9.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.072 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.3 136.8 35.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 92.0 p -73.16 -33.61 65.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.07 -51.57 60.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HZ3' ' HB3' ' A' ' 30' ' ' LYS . 8.9 mtpm? -62.79 -46.39 88.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 109.861 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.42 -37.21 80.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 109.834 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -65.15 -51.32 61.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.12 -32.55 73.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.1 tpt -59.36 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.806 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.29 -39.06 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.7 m -65.7 -45.29 83.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.54 -41.23 66.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.13 -34.17 73.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.38 -36.18 88.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.83 -26.63 64.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -1.191 . . . . 0.0 109.748 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -51.47 -26.07 7.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.698 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.09 109.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.95 -33.42 5.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 mt -97.36 175.18 6.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -1.175 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.8 m -100.94 161.79 13.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 45.2 p90 -55.48 -41.29 72.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.862 . . . . 0.0 109.446 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 8.7 tp -57.97 -38.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.724 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.469 ' N ' HG23 ' A' ' 47' ' ' ILE . 90.3 m -64.69 -37.95 89.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.694 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.43 -42.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.466 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 16' ' ' TYR . 74.5 mt -57.99 -42.49 85.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -61.72 -51.5 68.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 11.5 mptt -65.75 -36.58 83.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -47.15 -42.65 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.194 -0.941 . . . . 0.0 109.006 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -70.17 -42.48 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -63.43 -47.46 81.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.266 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CD2' ' CE1' ' A' ' 60' ' ' PHE . 12.3 m-85 -58.68 -49.27 78.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 17.9 mmm180 -53.3 -27.75 24.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.35 -29.43 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 56' ' ' TYR . 16.7 m-85 -81.73 -51.75 7.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.945 -1.097 . . . . 0.0 110.205 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 53.1 t60 -51.62 -42.3 61.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.829 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -73.67 -14.58 61.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CE2' ' SD ' ' A' ' 71' ' ' MET . 16.3 t80 -93.3 2.83 56.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.007 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.93 159.2 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.024 . . . . 0.0 109.598 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.2 -53.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.886 2.391 . . . . 0.0 112.707 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.1 t -48.17 -41.95 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.717 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -64.74 -34.57 78.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.382 -0.824 . . . . 0.0 109.883 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 64' ' ' ASP . 54.5 t -56.93 -40.55 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.614 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -70.68 -32.94 70.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 109.452 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.04 18.57 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.603 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -75.36 155.2 36.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.689 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.8 tp60 -102.63 167.54 9.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 96.4 mt-10 -70.05 -25.92 63.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.2 -30.99 67.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.465 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.27 -49.7 68.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 76' ' ' VAL . 8.5 m -59.65 -37.88 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.9 mt-10 -58.99 -35.98 74.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.3 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -65.72 -40.2 91.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.16 -34.28 77.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.9 -35.49 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -87.06 -62.03 1.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -101.34 107.08 18.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.61 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.85 14.38 65.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 pt -104.09 178.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.391 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.51 140.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HG3' HH11 ' A' ' 87' ' ' ARG . 44.0 mtm-85 -87.81 101.81 14.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.52 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.464 ' CD2' ' HZ2' ' A' ' 91' ' ' LYS . 49.2 t-80 -171.54 82.04 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.218 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 15.3 ptm180 -46.84 -30.46 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.83 93.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HZ2' ' CD2' ' A' ' 88' ' ' HIS . 62.3 mttp -66.11 -42.62 88.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.6 mt -63.64 -49.55 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.37 -35.6 67.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.375 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.3 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.98 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.06 -39.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.539 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.69 95.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.481 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 42.6 m-20 -63.26 -43.83 96.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -1.204 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.06 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 47.6 ttm-85 -58.46 -41.75 85.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.21 70.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.87 -48.46 81.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -61.75 -44.72 96.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.6 -44.26 93.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.604 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 23.7 ttt -67.11 -32.54 73.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.48 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.91 -29.25 69.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -52.29 -24.75 7.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.15 -18.7 59.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.492 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.8 55.11 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -116.85 150.8 46.46 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -1.181 . . . . 0.0 109.691 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.21 130.86 26.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.618 2.212 . . . . 0.0 111.659 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -79.25 -49.21 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.475 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -55.77 -48.92 74.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.53 ' O ' ' OG ' ' A' ' 118' ' ' SER . 85.3 m-20 -60.0 -43.63 95.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 111.053 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.59 -50.92 70.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.067 -1.021 . . . . 0.0 111.188 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.6 m -59.31 -48.45 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.096 -1.003 . . . . 0.0 111.64 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.474 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 5.0 p-90 -88.88 -33.38 17.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 0.0 111.147 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 120' ' ' VAL . 66.8 m -55.08 -26.44 37.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.793 -1.192 . . . . 0.0 109.752 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.32 -14.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 118' ' ' SER . 12.9 m -85.07 27.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.046 -1.034 . . . . 0.0 109.983 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 75.78 19.0 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.747 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 58.72 39.65 24.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.438 ' H ' HG23 ' A' ' 120' ' ' VAL . 8.3 pt20 -146.05 146.77 29.56 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.636 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.86 147.56 44.35 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.691 2.261 . . . . 0.0 111.814 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -111.21 153.72 25.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 58.2 ttm -133.26 148.83 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -122.52 164.84 17.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -133.41 49.68 2.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.308 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.52 -158.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 11.7 m -145.34 -27.48 0.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.57 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 8.9 m -127.73 157.98 38.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -75.22 -12.79 60.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.2 m -93.0 -32.53 14.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 131' ' ' THR . 5.6 pt-20 -74.11 -1.42 20.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.925 . . . . 0.0 109.428 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 28.9 mm -66.9 130.85 93.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.77 126.24 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.096 2.531 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 137' ' ' THR . 3.1 m -89.77 -10.57 45.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.9 . . . . 0.0 109.342 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 72.2 p -94.13 102.26 14.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 p -119.11 149.9 47.92 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.53 -31.84 87.67 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.17 58.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 42.9 t -62.08 -46.33 89.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.469 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -61.67 -46.23 90.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.57 84.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.67 -47.11 82.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.0 t -54.5 -45.09 73.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -60.62 -33.33 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.547 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.24 16.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 149' ' ' LEU . 10.7 mp -60.15 -34.75 73.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.575 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -58.15 -34.97 70.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.43 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -62.66 -36.31 82.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.637 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -72.14 -19.88 61.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.357 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.56 30.11 7.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.481 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 5.1 m-85 -86.29 132.67 33.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -1.108 . . . . 0.0 109.474 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -104.79 177.86 4.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 52.8 47.94 23.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 158' ' ' GLY . 26.9 m -116.32 25.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.58 166.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.0 m -54.01 -32.54 54.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.3 p -65.09 -48.04 75.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -66.31 -39.29 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 7.9 t -68.58 -44.31 74.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.5 -42.03 98.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -59.27 -33.47 71.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.245 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 79.4 t80 -65.77 -35.45 80.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.397 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.2 mmm -63.32 -52.2 62.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.85 -38.0 85.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.45 -54.19 49.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.675 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 8.7 m -66.29 -33.23 75.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.01 35.38 6.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -74.05 -41.39 61.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.425 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 172' ' ' VAL . 3.0 m -96.56 134.27 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -88.66 110.04 20.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -84.57 122.42 29.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -142.38 165.55 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.601 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 4.8 m -122.65 164.11 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 0.0 109.414 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.427 HG22 ' CE2' ' A' ' 182' ' ' TYR . 59.3 t -96.21 133.38 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 72.2 29.48 66.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 178' ' ' GLY . 3.3 m -164.64 178.74 7.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.46 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 43.6 t 51.03 -98.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 7.7 m -162.91 27.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.645 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -116.01 97.03 48.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.605 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.543 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 90.7 Cg_endo -86.56 -153.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.02 2.48 . . . . 0.0 112.378 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.82 9.32 37.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -151.67 32.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.54 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -83.68 154.22 65.0 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.555 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 123.034 2.49 . . . . 0.0 112.223 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 tpp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.256 0.55 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -88.81 146.11 25.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.598 HH12 HG23 ' A' ' 14' ' ' ILE . 70.9 mtm180 -101.94 174.59 5.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 m -140.94 71.37 1.36 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 7' ' ' VAL . . . -139.88 -5.67 1.19 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 19.8 m95 49.53 11.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.411 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.8 m -62.25 140.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -168.32 36.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.349 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 70.0 tp60 -142.76 110.03 5.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 6.3 t70 61.71 134.51 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.28 -10.17 23.87 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.819 2.346 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.34 -41.58 98.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -69.65 -41.57 75.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.8 mp -60.8 -51.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.424 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -46.97 65.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.429 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' OH ' ' CZ3' ' A' ' 21' ' ' TRP . 60.5 t80 -61.55 -43.83 98.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.0 -39.96 94.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -88.16 -0.11 56.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -75.19 -78.91 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.835 . . . . 0.0 109.407 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -147.06 40.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CZ3' ' OH ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -103.89 145.47 30.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.57 62.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 23' ' ' VAL . 1.2 m -84.67 152.26 59.72 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.226 -1.161 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 121.13 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.727 2.285 . . . . 0.0 111.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 78.4 mm-40 -123.8 135.92 54.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.9 p -126.75 12.33 7.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.281 -0.887 . . . . 0.0 109.055 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.88 134.44 47.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.385 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 83.4 p -72.44 -37.9 68.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -67.8 -34.57 77.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 0.0 109.804 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' HZ1' ' CD ' ' A' ' 25' ' ' GLU . 30.6 ttmt -75.23 -54.29 7.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD22 ' HB1' ' A' ' 113' ' ' ALA . 8.5 mp -66.57 -37.28 84.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.856 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 51.0 t80 -61.17 -42.73 99.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.938 . . . . 0.0 109.904 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.2 -29.51 64.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.599 ' SD ' ' CH2' ' A' ' 46' ' ' TRP . 49.9 tpp -74.46 -54.28 7.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.783 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 36' ' ' CYS . 9.3 tp -57.18 -37.74 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.043 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 15.0 p -73.16 -46.28 51.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 61.9 tp -73.28 -34.99 66.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -0.99 . . . . 0.0 109.932 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 43.2 tp10 -52.13 -28.66 18.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.69 51.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -62.36 -32.41 73.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 109.754 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.426 HE21 ' H ' ' A' ' 46' ' ' TRP . 50.2 tt0 -50.21 -35.07 24.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.705 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.43 116.84 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.42 -20.2 49.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.48 -144.34 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -1.205 . . . . 0.0 109.414 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.7 t -146.4 151.22 37.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 72.6 t-105 -55.35 -28.47 54.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.609 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -54.05 -37.89 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.727 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 18.8 m -85.26 -33.84 22.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 109.657 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -61.06 -36.99 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.45 HD21 ' HE1' ' A' ' 46' ' ' TRP . 19.8 mt -54.63 -54.05 46.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.1 -49.96 75.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.262 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -65.51 -33.33 75.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HG2' HH11 ' A' ' 53' ' ' ARG . 28.0 ttt-85 -48.97 -43.71 40.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.14 -40.62 86.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -66.36 -40.84 90.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.288 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD1' HD12 ' A' ' 85' ' ' ILE . 4.5 m-85 -56.22 -48.61 76.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 84.7 mtm180 -64.74 -27.08 68.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 0.0 109.81 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.1 94.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 83' ' ' ALA . 86.9 m -94.45 -40.79 9.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.3 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.74 -52.01 16.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 0.0 110.224 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 39.2 t60 -50.94 -38.28 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.899 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -54.32 -36.98 64.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.12 -0.988 . . . . 0.0 109.811 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' ASP . 86.9 m-85 -97.54 3.71 50.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.883 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.92 161.44 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.096 -1.003 . . . . 0.0 109.569 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.12 -26.37 21.42 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.885 2.39 . . . . 0.0 112.694 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.6 t -62.68 -48.81 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.734 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' MET . 89.2 mttt -67.17 -31.79 72.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 64' ' ' ASP . 75.1 t -56.32 -41.37 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 109.606 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.96 62.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.507 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.24 3.06 51.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.3 mtp -66.2 136.67 56.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.617 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -92.12 168.12 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 57.4 mp0 -59.23 -29.7 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.462 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.4 -44.35 88.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.5 -37.52 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.82 -44.02 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -35.72 76.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -60.56 -41.5 94.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 109.736 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 82' ' ' ASP . 92.1 mt -72.73 -31.92 65.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.175 -0.953 . . . . 0.0 109.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.83 -31.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.938 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -84.29 -59.27 2.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.978 . . . . 0.0 109.568 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 21.3 t70 -96.33 148.27 22.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.897 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.09 71.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.406 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -89.24 30.59 5.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' O ' ' A' ' 86' ' ' ILE . 4.9 pt -45.75 117.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.31 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.715 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 3.5 tt 38.63 -168.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.504 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.715 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -52.16 152.56 3.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.504 ' ND1' HD11 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -141.91 -162.9 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 109.184 -178.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.684 ' H ' ' CD1' ' A' ' 92' ' ' ILE . 56.7 ttt180 62.37 -77.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 109.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -71.86 -48.07 29.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.21 -38.6 87.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.684 ' CD1' ' H ' ' A' ' 89' ' ' ARG . 52.5 mt -55.07 -46.64 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 109.648 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.428 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.57 82.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.8 -38.79 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.5 mt -54.22 -46.59 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.18 -36.1 92.49 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.541 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -60.96 -49.08 78.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -1.23 . . . . 0.0 109.422 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.89 89.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -64.62 -46.83 80.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.25 69.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.421 ' CD1' ' CE1' ' A' ' 32' ' ' PHE . 77.2 t80 -64.64 -46.81 80.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 109.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.05 -40.65 98.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -57.45 -42.51 82.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 25.5 ttt -71.09 -33.26 70.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.548 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.69 -30.77 71.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -51.4 -25.91 6.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 109.548 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -76.47 -16.65 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.01 41.65 47.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -129.79 151.11 77.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.186 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.2 125.7 15.06 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.592 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 23.9 t80 -72.99 -44.1 61.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.42 -0.8 . . . . 0.0 110.417 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -54.98 -48.85 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.742 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 118' ' ' SER . 87.2 m-20 -52.16 -38.38 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 111.102 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -72.7 -49.87 28.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 111.244 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.45 -49.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.01 -1.056 . . . . 0.0 111.696 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.452 ' HB2' HD11 ' A' ' 171' ' ' LEU . 15.8 p-90 -87.01 -24.38 24.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.709 -1.244 . . . . 0.0 111.147 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' VAL . 7.7 t -57.63 -32.99 67.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.61 -12.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 7.3 p -83.09 23.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 12.0 t-20 79.33 16.63 0.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 7.1 m80 57.74 43.54 21.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -155.31 148.44 18.29 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.0 151.34 73.42 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.655 2.237 . . . . 0.0 111.833 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -120.35 146.49 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 109.801 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.6 mtp -129.59 156.26 44.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 109.184 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 173' ' ' ASN . 6.6 t -128.9 147.59 50.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.908 . . . . 0.0 109.797 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -113.24 43.02 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 109.302 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.437 ' HB1' ' CG ' ' A' ' 134' ' ' GLU . . . -75.58 152.1 37.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 m -92.48 -34.41 14.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.79 30.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.481 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -74.06 -9.11 58.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.6 p -83.4 -31.53 26.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.437 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -78.19 -18.47 55.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.51 116.88 41.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.765 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.11 136.83 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.146 2.564 . . . . 0.0 112.5 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 t -85.05 -4.25 59.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.2 t -98.39 103.66 15.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.367 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -126.89 152.68 75.69 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.13 -42.53 26.34 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.758 2.305 . . . . 0.0 112.043 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.36 -37.85 63.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -49.73 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.32 -39.41 93.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.04 77.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.0 OUTLIER -62.68 -44.25 96.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.4 p -62.16 -38.07 87.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.52 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -65.05 -36.47 84.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.86 -50.51 56.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.75 -34.32 76.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -60.24 -41.69 93.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -63.89 -38.19 90.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.55 HH22 ' CE ' ' A' ' 105' ' ' MET . 11.7 tpp180 -64.4 -21.47 66.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.34 24.18 6.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -95.39 130.65 42.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -1.111 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 63.2 mttp -98.06 -167.12 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 19.0 p90 40.31 38.86 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.5 OUTLIER -102.34 25.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -45.38 163.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 2.5 t -63.43 -23.99 67.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -1.161 . . . . 0.0 109.478 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.5 p -70.07 -38.45 75.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -69.74 -41.24 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.3 p -64.88 -33.72 76.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.457 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 51.9 t80 -65.61 -50.97 63.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.374 -0.829 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 18.9 t -58.69 -33.11 69.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 109.28 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.84 -42.18 88.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.444 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 52.0 mtt -62.96 -37.43 87.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -55.07 -40.26 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.76 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.91 11.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.504 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 10.5 t -59.29 -37.27 77.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.94 14.28 52.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.504 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mp -54.83 -56.81 15.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.16 134.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.457 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.667 HD21 ' CE1' ' A' ' 175' ' ' HIS . 17.2 t-20 -100.56 103.78 15.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.435 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 32.4 p30 -103.47 91.47 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.536 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.667 ' CE1' HD21 ' A' ' 173' ' ' ASN . 44.6 m170 -102.81 0.3 32.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.592 ' O ' ' O ' ' A' ' 175' ' ' HIS . 6.2 t 56.61 139.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.55 123.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.98 -50.15 0.71 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 7.8 t -150.46 -132.67 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -1.157 . . . . 0.0 109.519 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 8.5 t 52.95 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 35.9 t -162.49 32.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 183' ' ' PRO . 26.3 t80 -124.25 97.76 39.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.643 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 182' ' ' TYR . 68.6 Cg_exo -51.38 -135.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.037 2.491 . . . . 0.0 112.368 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 91.74 3.78 68.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -169.58 37.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.607 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.426 ' CB ' ' NZ ' ' A' ' 186' ' ' LYS . 7.3 ttpm? -140.02 79.5 22.33 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.209 -0.932 . . . . 0.0 109.566 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--N 1.306 -1.662 0 C-N-CA 123.06 2.506 . . . . 0.0 112.264 -179.766 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.414 ' OE1' ' SG ' ' A' ' 179' ' ' CYS . 95.1 mt-10 -86.47 148.37 25.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 44.3 mtm-85 -139.39 150.03 44.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 180' ' ' CYS . 8.0 m -59.8 151.83 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.419 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.22 -20.68 16.27 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -52.64 -34.96 53.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.436 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.34 128.81 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.555 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 9' ' ' GLN . 22.6 t -169.68 129.97 1.02 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 8' ' ' SER . 92.8 mm-40 44.8 -156.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 109.526 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 52.38 64.09 7.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -45.64 -34.94 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.771 2.314 . . . . 0.0 112.185 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' CD2' ' HZ3' ' A' ' 51' ' ' LYS . 60.1 tp -63.87 -38.63 91.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 17' ' ' HIS . 86.6 t80 -66.65 -43.61 84.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.44 -43.65 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.23 83.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -59.94 -42.83 94.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.365 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 13' ' ' TYR . 2.4 m-70 -62.24 -39.47 92.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -60.63 -27.45 67.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.61 -77.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.506 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -143.64 116.24 8.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -172.17 140.09 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.59 -28.22 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.538 HG23 ' OE2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -67.9 154.4 93.69 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.184 -1.186 . . . . 0.0 109.412 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.07 120.09 4.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.762 2.308 . . . . 0.0 111.959 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.538 ' OE2' HG23 ' A' ' 23' ' ' VAL . 18.8 mp0 -103.15 133.86 47.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.812 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -134.77 4.1 3.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.93 133.2 35.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 p -61.35 -34.44 75.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.86 -52.3 57.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -68.74 -45.9 70.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.884 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.29 -46.55 89.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.868 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.475 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 93.8 t80 -68.05 -47.29 68.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -64.08 -30.72 71.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.854 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.671 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 55.7 ttm -64.71 -51.83 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -58.28 -47.41 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 12.4 p -62.55 -37.89 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.052 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.525 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 6.2 tp -66.69 -39.81 88.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.12 -27.81 69.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.5 -36.51 11.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.522 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 1.7 mp0 -59.9 -33.79 72.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.2 tt0 -57.18 -29.74 63.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.715 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.03 109.83 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.626 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.67 -32.3 5.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.0 mt -103.67 -155.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -1.153 . . . . 0.0 109.464 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 m -121.97 149.67 43.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 47' ' ' ILE . 23.7 p90 -49.05 -36.51 18.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.642 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -60.9 -37.2 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.659 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.463 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 57.2 m -64.46 -33.69 76.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.95 -38.96 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.1 mp -54.3 -52.06 62.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HZ3' ' CD2' ' A' ' 12' ' ' LEU . 61.0 mttm -59.67 -49.21 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.325 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.22 -34.13 77.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.62 ' NH1' HH21 ' A' ' 57' ' ' ARG . 3.1 ttt-85 -49.5 -45.44 47.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.118 -0.989 . . . . 0.0 108.937 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -66.84 -40.6 88.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.376 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 55' ' ' ASN . 0.3 OUTLIER -64.51 -40.98 96.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.851 . . . . 0.0 109.249 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' PHE . 4.4 m-85 -56.59 -43.34 79.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 109.304 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.62 HH21 ' NH1' ' A' ' 53' ' ' ARG . 96.7 mtt180 -58.61 -36.22 73.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -49.29 76.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.198 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' CE2' ' A' ' 60' ' ' PHE . 3.2 p -94.68 -13.2 26.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.285 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' TYR . 63.6 m-85 -133.27 32.16 3.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.913 -1.117 . . . . 0.0 110.192 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 p80 -46.91 -42.94 18.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' PHE . 40.6 tt0 -79.64 -42.9 23.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.806 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 69.5 t80 44.07 36.64 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -56.57 113.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 109.558 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.07 -45.12 7.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.944 2.429 . . . . 0.0 112.678 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.8 p -66.27 -45.33 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 66' ' ' VAL . 55.3 tttp -61.94 -45.24 94.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.82 -39.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.095 . . . . 0.0 109.628 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.31 64.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.494 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 12.77 23.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.6 tpp -50.41 161.05 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.625 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.82 156.99 19.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.81 -33.38 74.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.5 -39.22 86.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' VAL . 91.3 t -71.84 -28.54 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -68.34 -43.57 77.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.341 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 30.9 ptt180 -76.42 -34.63 58.8 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.838 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 mt -61.84 -39.05 90.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.678 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 76' ' ' VAL . 53.5 t -58.56 -28.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.988 . . . . 0.0 109.736 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.55 -53.79 3.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 78' ' ' ARG . 1.9 p30 -99.77 106.52 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.72 -64.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.34 -1.48 76.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 85' ' ' ILE . 15.5 pt -77.11 -159.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 109.36 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.42 136.56 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 96.6 mtt180 -79.35 95.68 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.6 m-70 -166.47 82.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 109.214 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -46.56 -35.25 5.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.984 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.83 -34.37 82.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -72.45 -41.69 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.509 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.6 -56.29 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.29 -30.95 63.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.7 99.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.39 -43.11 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.6 mm -54.59 -48.1 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.28 -34.28 89.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 32' ' ' PHE . 15.8 t-20 -56.65 -45.8 81.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.184 . . . . 0.0 109.337 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.76 73.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.542 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.29 -43.4 98.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.434 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.38 -33.38 75.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.579 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.34 -46.42 83.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.21 -42.65 99.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -59.12 -53.87 53.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.543 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 26.0 ttt -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.73 -27.41 65.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -52.05 -26.42 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -75.69 -19.09 59.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.44 18.86 65.46 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.34 151.65 37.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.9 119.18 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.618 2.212 . . . . 0.0 111.668 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -75.42 -43.33 50.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -59.79 -47.62 84.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 118' ' ' SER . 92.2 m-20 -51.1 -54.93 20.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 0.0 111.029 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.25 -43.35 82.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' O ' HD11 ' A' ' 145' ' ' LEU . 62.3 t -54.39 -60.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.679 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.708 ' O ' HG22 ' A' ' 120' ' ' VAL . 67.8 p-90 -86.03 -17.86 34.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.727 -1.233 . . . . 0.0 111.153 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.508 ' OG ' ' NE2' ' A' ' 122' ' ' HIS . 9.2 t -54.98 -30.61 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.872 -1.142 . . . . 0.0 109.744 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -43.43 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 178.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.9 m -82.84 24.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.945 . . . . 0.0 110.004 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.87 29.28 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.508 ' NE2' ' OG ' ' A' ' 118' ' ' SER . 26.1 m80 55.62 34.48 23.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.592 ' H ' HG23 ' A' ' 120' ' ' VAL . 72.6 mt-30 -141.91 114.53 6.52 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.45 154.49 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.648 2.232 . . . . 0.0 111.861 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -106.59 144.4 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.1 mtp -137.61 151.73 48.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.797 . . . . 0.0 109.187 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.1 t -129.65 160.09 34.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.904 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.04 46.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 0.0 109.26 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.45 -135.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.73 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 m -143.34 -33.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.378 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 t -137.96 170.77 15.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.757 ' H ' HD12 ' A' ' 132' ' ' LEU . 5.5 mp -68.31 -32.29 72.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.4 m -54.21 -37.3 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.184 -0.947 . . . . 0.0 109.478 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.7 -35.04 78.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.917 . . . . 0.0 109.427 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.767 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.8 mp -81.36 117.82 69.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.663 ' C ' ' H ' ' A' ' 138' ' ' SER . 89.0 Cg_endo -82.59 2.49 8.47 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.133 2.556 . . . . 0.0 112.555 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.531 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER 56.08 -4.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 136' ' ' PRO . 65.2 p -123.41 80.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.319 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -83.74 153.78 64.53 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.49 -37.01 19.22 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.773 2.315 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.97 -36.83 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.311 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.2 m -61.38 -49.07 78.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.462 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 49.8 t0 -62.93 -45.91 90.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.42 86.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 116' ' ' VAL . 6.5 tt -66.0 -43.52 87.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -54.64 -44.99 73.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.462 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 61.1 mttp -63.81 -30.74 71.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.573 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.56 -52.03 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.8 mm? -62.91 -39.09 93.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.78 -37.54 87.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -60.8 -38.14 84.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.359 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.583 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -63.8 -22.7 67.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.378 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 116.53 9.51 11.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.434 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 46.8 m-85 -82.53 133.74 35.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -1.143 . . . . 0.0 109.494 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 60.6 mttp -99.97 -169.39 1.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 14.5 p90 39.43 40.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 158' ' ' GLY . 0.3 OUTLIER -110.57 25.44 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.364 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.49 170.7 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.5 t -62.77 -28.13 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -1.097 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 68.3 p -64.59 -48.17 75.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -63.92 -35.9 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.88 -48.54 73.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.312 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -60.11 -43.21 95.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -59.63 -39.19 83.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -68.03 -41.01 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.437 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.441 ' SD ' HD22 ' A' ' 171' ' ' LEU . 35.4 mmm -59.74 -41.2 90.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.0 109.573 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.8 -46.14 66.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.671 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -63.8 -34.34 77.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.504 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 17.2 t -81.41 -4.35 55.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 65.77 24.13 71.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.441 HD22 ' SD ' ' A' ' 166' ' ' MET . 1.8 tp -68.8 -47.16 66.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 109.422 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 172' ' ' VAL . 8.2 p -103.45 131.98 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.406 ' O ' HG22 ' A' ' 127' ' ' THR . 10.0 m120 -90.54 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -98.27 119.05 36.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.498 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.652 ' ND1' ' CD2' ' A' ' 182' ' ' TYR . 2.5 p80 -164.33 127.28 2.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.55 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.81 150.98 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.413 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 140.72 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.131 -0.981 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 91.75 1.62 70.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.476 ' C ' ' H ' ' A' ' 181' ' ' CYS . 49.9 m -155.01 179.5 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 5.2 t 60.4 1.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.4 t 65.82 50.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.902 . . . . 0.0 109.614 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.652 ' CD2' ' ND1' ' A' ' 175' ' ' HIS . 0.4 OUTLIER -116.49 95.91 46.8 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.538 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 93.4 Cg_endo -86.91 -168.42 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.101 2.534 . . . . 0.0 112.35 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 94.87 -14.32 65.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.25 19.33 5.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -1.157 . . . . 0.0 109.638 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -83.27 151.47 62.88 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.307 -1.626 0 C-N-CA 122.997 2.465 . . . . 0.0 112.242 179.937 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.607 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.265 0.555 . . . . 0.0 109.525 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.607 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.8 pm0 -134.67 162.58 31.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -143.6 172.52 12.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -46.52 159.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -109.87 -21.76 6.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -66.08 -11.83 51.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG12 ' H ' ' A' ' 8' ' ' SER . 43.6 t -82.39 -123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.765 ' H ' HG12 ' A' ' 7' ' ' VAL . 23.8 t 53.5 170.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 8' ' ' SER . 52.3 tt0 59.5 135.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' LEU . 13.4 m-20 50.45 82.05 0.25 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.3 -10.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.828 2.352 . . . . 0.0 112.108 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 47' ' ' ILE . 18.3 tp -62.7 -34.01 76.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 33.2 m-85 -54.26 -41.97 69.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 109.504 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.8 mt -80.0 -33.14 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.435 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.32 -48.19 71.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 109.509 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 13' ' ' TYR . 1.5 p90 -76.51 -34.27 58.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.482 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 57.3 t-80 -55.77 -50.01 71.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.26 -38.44 65.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.419 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -56.02 -46.59 78.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.9 pt-20 -173.28 -146.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' A' ' 20' ' ' GLU . 27.9 t-105 58.94 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.14 -9.0 59.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.2 154.43 37.68 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.94 119.9 7.02 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.786 2.324 . . . . 0.0 111.899 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -127.47 136.69 52.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.975 . . . . 0.0 109.826 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.0 p -131.55 9.46 4.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 0.0 109.075 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -90.68 135.17 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 0.0 109.299 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.744 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 89.4 p -61.67 -39.31 90.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.9 -41.09 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 0.0 109.774 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -77.23 -53.89 7.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.905 . . . . 0.0 109.863 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD22 ' HB1' ' A' ' 113' ' ' ALA . 10.9 mp -64.6 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 80.0 t80 -62.33 -56.45 18.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 109.854 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.84 -31.14 70.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.902 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.501 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.56 -51.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.866 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -62.43 -43.3 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -60.86 -48.38 82.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 110.086 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 8.2 mp -73.69 -44.68 55.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.929 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.89 -37.13 75.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.69 -25.1 34.88 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -82.64 -18.39 41.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.234 . . . . 0.0 109.773 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.6 pp0? -61.95 -21.44 64.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.71 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.07 110.22 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.695 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.03 -32.9 5.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.05 164.37 12.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -1.142 . . . . 0.0 109.448 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -86.26 167.06 15.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 47' ' ' ILE . 5.4 p90 -61.07 -43.78 98.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 48' ' ' THR . 10.4 tp -43.52 -42.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.553 ' N ' HG23 ' A' ' 47' ' ' ILE . 95.1 m -61.13 -34.21 74.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 46' ' ' TRP . 16.4 t -66.56 -46.7 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.33 -53.06 61.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -61.64 -46.21 90.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.351 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 56' ' ' TYR . 43.6 tttm -65.44 -30.18 70.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.383 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.2 ttm180 -55.72 -48.37 75.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.267 -0.895 . . . . 0.0 108.952 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.47 -46.64 87.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.45 -0.781 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 94.4 m-20 -69.07 -32.42 71.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.251 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.7 t80 -62.28 -44.61 96.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.405 -0.809 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 61' ' ' HIS . 14.5 mtm180 -60.08 -42.22 94.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 109.764 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.52 69.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -0.815 . . . . 0.0 110.301 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.6 m -92.98 -12.1 31.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 110.281 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 65.6 m-85 -129.47 -48.11 1.17 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.882 -1.137 . . . . 0.0 110.155 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' ARG . 62.3 t60 -50.14 -43.46 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.085 -1.009 . . . . 0.0 109.904 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -66.56 -25.92 66.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 93.4 m-85 -91.88 16.48 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 109.889 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 55.12 167.05 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.94 -55.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.832 2.355 . . . . 0.0 112.68 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -48.93 -44.29 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.557 ' N ' HG13 ' A' ' 66' ' ' VAL . 48.3 tttp -58.28 -36.91 74.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.845 . . . . 0.0 109.82 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 64' ' ' ASP . 56.5 t -57.18 -37.92 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 109.575 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.53 -29.82 68.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.81 22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.342 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.42 ' SD ' ' CB ' ' A' ' 75' ' ' ASP . 3.4 mmm -60.48 173.76 0.66 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.638 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -131.8 158.29 41.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.35 -29.76 71.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -72.57 -31.55 65.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.478 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' CB ' ' SD ' ' A' ' 71' ' ' MET . 85.6 m-20 -65.06 -48.14 74.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 80' ' ' VAL . 11.2 m -61.75 -40.19 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.537 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -62.28 -30.62 71.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.309 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.21 -46.42 77.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.379 -0.826 . . . . 0.0 109.803 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.3 pp -78.58 -22.78 46.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 109.572 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 76' ' ' VAL . 3.6 t -51.17 -36.71 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.801 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -50.61 -42.41 56.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -89.86 115.02 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -80.28 26.12 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.432 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.439 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . -45.06 -23.49 0.65 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.3 pt -124.19 177.19 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -1.136 . . . . 0.0 109.322 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.4 mt -45.28 137.31 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 59.8 mtp180 -80.05 95.36 6.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 11.7 m-70 -168.37 83.66 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.134 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.301 -0.874 . . . . 0.0 109.97 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.16 97.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -62.19 -38.47 89.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -1.215 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.436 HG22 HG12 ' A' ' 76' ' ' VAL . 23.3 mt -57.23 -48.66 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.573 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.45 -38.72 69.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 0.0 109.402 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -36.66 71.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.26 -40.43 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.368 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.4 mt -56.16 -50.29 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.534 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.79 -36.68 92.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.598 ' ND2' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -56.67 -41.84 77.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -1.157 . . . . 0.0 109.38 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.3 74.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.08 -41.83 93.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 -29.92 70.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 35.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.0 -36.37 83.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.41 -38.71 84.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.577 ' SD ' ' NH2' ' A' ' 152' ' ' ARG . 2.0 tpt -67.79 -38.79 83.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -61.67 -30.09 70.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.437 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -52.52 -31.51 35.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.475 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -87.0 -5.59 59.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.77 69.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -105.28 119.42 53.02 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -1.183 . . . . 0.0 109.654 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.72 119.43 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.548 2.166 . . . . 0.0 111.714 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.48 -35.98 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.828 . . . . 0.0 110.427 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -67.95 -50.07 58.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.182 -0.949 . . . . 0.0 110.707 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 118' ' ' SER . 40.8 t0 -60.5 -46.76 88.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -56.92 -52.77 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.089 -1.007 . . . . 0.0 111.209 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 117' ' ' TRP . 15.4 m -56.74 -48.94 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.03 -1.044 . . . . 0.0 111.677 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.495 ' HB2' HD11 ' A' ' 171' ' ' LEU . 3.4 p-90 -88.35 -27.7 21.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.819 -1.176 . . . . 0.0 111.121 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 120' ' ' VAL . 28.3 t -55.92 -27.21 51.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.717 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.57 -14.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.718 ' O ' HG12 ' A' ' 120' ' ' VAL . 59.9 t -83.9 23.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.06 -1.025 . . . . 0.0 109.911 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 14.6 t-20 72.82 22.66 3.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.2 t60 60.26 49.65 6.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.94 149.13 22.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.03 155.16 29.79 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.676 2.251 . . . . 0.0 111.816 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -119.2 145.51 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.744 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.9 ttm -136.34 149.81 48.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.16 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 t -134.81 156.76 48.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.37 48.53 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -69.81 128.98 38.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.636 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.413 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.4 m -71.07 -33.43 70.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 t -136.84 174.5 10.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.27 -31.05 71.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -60.36 -39.34 86.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.511 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.1 mt-10 -65.39 -29.44 70.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.44 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.25 116.18 33.78 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.693 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -86.95 117.49 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.14 2.56 . . . . 0.0 112.511 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.8 m -74.04 -17.66 60.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 138' ' ' SER . 24.6 p -94.72 100.67 12.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.89 151.54 44.86 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 -32.1 92.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.854 2.369 . . . . 0.0 112.036 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.83 -38.69 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 m -56.52 -44.41 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.83 -45.58 88.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.14 81.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -63.46 -43.91 95.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -56.83 -44.45 82.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.21 -36.2 81.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.77 73.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.438 HD11 HD22 ' A' ' 145' ' ' LEU . 50.8 mt -60.77 -40.57 93.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.393 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -60.93 -40.59 93.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.577 ' NH2' ' SD ' ' A' ' 105' ' ' MET . 5.8 tpp180 -65.72 -22.63 66.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.335 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.33 9.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.84 133.15 34.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -1.165 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -97.68 175.5 6.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 54.3 51.81 13.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 158' ' ' GLY . 15.4 m -119.89 26.2 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.24 167.62 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.9 t -59.58 -28.28 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -1.147 . . . . 0.0 109.477 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 p -63.56 -43.08 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -66.21 -39.77 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.73 -40.25 96.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.286 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -60.57 -48.93 79.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 m -61.97 -37.97 86.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.28 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.68 -46.01 91.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 75.2 mtp -65.78 -39.7 91.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.0 109.594 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.76 -41.24 97.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.501 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -74.16 -54.7 7.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.609 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.1 t -47.84 -24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.24 7.46 67.61 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 120' ' ' VAL . 4.0 mp -54.68 -52.0 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 172' ' ' VAL . 25.6 m -98.81 130.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -94.26 101.95 13.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 90.5 m-20 -94.09 119.88 33.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 73.0 m80 -157.72 128.9 6.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 179' ' ' CYS . 29.0 m -78.27 144.41 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.83 -38.33 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.86 -23.97 47.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.41 ' H ' HG23 ' A' ' 176' ' ' VAL . 48.8 t -79.94 139.16 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.505 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.95 -37.17 83.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.461 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.84 -28.82 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.568 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.535 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 30.9 t80 -97.35 115.2 65.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.951 . . . . 0.0 109.574 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.535 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.2 Cg_endo -85.47 177.41 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.111 2.541 . . . . 0.0 112.368 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.44 60.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -149.04 44.32 0.98 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.59 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -83.2 148.88 57.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo . . . . . 0 C--N 1.307 -1.624 0 C-N-CA 123.016 2.478 . . . . 0.0 112.279 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -135.6 150.1 49.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -141.99 158.17 44.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.67 132.3 53.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.884 . . . . 0.0 109.408 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -74.44 -39.13 43.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -63.27 1.75 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 109.449 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 5' ' ' GLY . 8.3 p -59.01 -14.89 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.505 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.0 m 60.79 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 10' ' ' ASP . 23.5 pt20 -82.78 -17.49 43.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLN . 9.5 m-20 -43.34 106.39 0.49 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.384 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.5 -38.24 35.1 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.824 2.35 . . . . 0.0 112.156 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.4 tp -62.89 -41.2 99.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.466 ' CE2' ' CE1' ' A' ' 17' ' ' HIS . 40.9 t80 -68.13 -42.57 79.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.83 -44.25 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.06 89.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -59.27 -43.54 92.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.466 ' CE1' ' CE2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.64 -49.35 68.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.65 -39.94 95.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.31 -54.56 44.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -177.37 124.93 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 59.1 t90 -171.22 124.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.457 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.7 1.04 83.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.96 120.16 71.43 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -45.98 120.83 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -128.17 135.62 49.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.962 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 56.9 p -115.41 9.05 15.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.076 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.65 132.47 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.302 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.574 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 77.5 p -73.7 -38.13 64.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.605 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.58 -42.64 98.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -70.37 -51.94 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 109.869 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.553 HD22 ' HB1' ' A' ' 113' ' ' ALA . 7.8 mp -66.77 -38.37 86.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.798 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 67.2 t80 -61.55 -38.96 89.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.76 -30.63 64.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.9 tpp -73.21 -54.45 8.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.853 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.31 -32.72 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 110.007 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.6 m -72.13 -49.99 31.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.139 -0.976 . . . . 0.0 110.057 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 56' ' ' TYR . 4.5 mt -75.2 -28.99 60.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 109.888 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 39.0 tp10 -52.08 -31.94 32.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.792 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.47 -21.81 69.02 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.43 -27.42 62.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -1.204 . . . . 0.0 109.733 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -60.27 -33.06 71.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.771 -178.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 41' ' ' GLN . . . -46.02 110.85 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.47 -6.71 68.27 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.16 -169.94 2.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -1.183 . . . . 0.0 109.406 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -108.97 153.0 24.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.526 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 6.0 t-105 -54.86 -46.22 74.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.65 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.96 -38.97 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.692 -178.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 98.4 m -63.02 -35.22 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.714 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.5 t -60.19 -44.74 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -55.13 -44.29 74.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.487 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.43 -52.84 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.354 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 10.9 mptt -69.55 -25.79 64.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 49' ' ' VAL . 37.0 ttp180 -54.23 -44.6 71.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 109.004 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -72.74 -43.97 62.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -64.08 -49.61 71.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.239 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 21.7 t80 -58.48 -39.94 81.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.309 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -55.76 -37.91 69.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.844 . . . . 0.0 109.77 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.0 -23.46 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.256 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.7 m -91.77 -12.14 34.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.146 -0.971 . . . . 0.0 110.251 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 43.9 m-85 -125.46 -51.68 1.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.135 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -53.44 -41.68 66.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 109.835 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.06 -38.85 73.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 96.9 m-85 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 130.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.002 . . . . 0.0 109.611 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -40.6 -36.05 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.68 -49.29 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.9 mttm -72.25 -31.2 65.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.869 . . . . 0.0 109.862 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.93 -44.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 109.605 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.54 -34.21 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.539 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.01 18.18 17.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.309 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.7 tpp -63.69 157.6 23.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -103.63 167.36 9.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.47 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 96.7 mt-10 -71.19 -24.17 62.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -72.04 -31.82 66.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.59 -47.14 79.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.418 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG12 ' CG2' ' A' ' 92' ' ' ILE . 14.4 m -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.12 -33.66 71.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 78' ' ' ARG . 42.0 ttm-85 -66.67 -46.08 76.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.774 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.4 mt -66.47 -34.38 77.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 76' ' ' VAL . 52.1 t -51.79 -35.82 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -81.26 -60.33 2.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 62.7 t0 -100.06 139.69 35.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.72 76.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -74.22 -31.99 58.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.613 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.3 pt 28.96 41.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.348 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 84' ' ' GLY . 54.9 mt 52.12 4.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.607 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -97.85 109.49 22.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 89' ' ' ARG . 84.0 t60 -96.99 172.17 8.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.165 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' N ' ' CG ' ' A' ' 88' ' ' HIS . 38.4 ttm180 -48.63 -41.91 32.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.74 -47.39 61.6 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 29.2 mmtm -64.72 -51.81 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 109.524 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.451 ' CG2' HG12 ' A' ' 76' ' ' VAL . 91.6 mt -54.77 -47.39 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.625 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -53.02 -33.45 51.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -61.29 -42.09 98.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.354 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.607 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.8 mp -60.77 -48.13 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.383 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.11 -50.0 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.43 84.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.66 -36.98 79.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -1.194 . . . . 0.0 109.465 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -65.97 -37.41 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.38 -45.19 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.541 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -71.84 -31.25 66.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 16.7 t80 -69.29 -50.53 45.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.73 -37.53 86.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.29 -42.02 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.8 ttt -64.22 -41.3 97.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.54 -27.41 69.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -51.97 -29.15 19.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.552 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -76.26 -17.23 59.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.08 3.55 67.67 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.75 115.6 65.34 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.65 124.64 7.01 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.619 2.213 . . . . 0.0 111.714 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.63 ' CZ ' ' NH1' ' A' ' 152' ' ' ARG . 49.6 t80 -61.1 -37.47 82.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -68.11 -49.83 58.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.126 -0.984 . . . . 0.0 110.745 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' O ' ' OG ' ' A' ' 118' ' ' SER . 56.5 t0 -52.07 -35.39 47.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 111.032 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.577 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 14.7 t80 -76.41 -46.24 28.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 2.6 p -56.49 -45.87 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.974 -1.079 . . . . 0.0 111.729 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 18.2 p-90 -88.92 -26.9 21.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.735 -1.228 . . . . 0.0 111.114 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.7 m -58.06 -27.52 63.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.875 -1.141 . . . . 0.0 109.719 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.76 -13.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.084 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.9 m -82.51 22.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.025 . . . . 0.0 109.947 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 59.64 35.0 22.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -0.942 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.4 m80 54.84 26.88 8.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.403 ' H ' HG23 ' A' ' 120' ' ' VAL . 50.3 tt0 -137.07 89.63 16.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.558 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.03 155.03 1.96 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.673 2.248 . . . . 0.0 111.779 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.5 156.15 16.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.729 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 48.3 ttp -127.62 136.15 51.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.4 t -95.57 169.14 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.906 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -168.99 44.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.543 ' HB1' ' CG ' ' A' ' 134' ' ' GLU . . . -83.9 -174.23 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.63 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.5 m -114.34 -29.81 6.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -128.63 157.86 40.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.7 mt -74.66 -10.97 60.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.8 m -87.64 -31.49 19.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.9 pt-20 -80.14 -7.81 59.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.72 118.38 57.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.718 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.68 130.27 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.095 2.53 . . . . 0.0 112.544 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.0 t -86.91 -15.11 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.267 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.5 t -85.52 102.18 13.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.4 p -118.71 152.69 51.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.93 . . . . 0.0 109.508 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.66 -35.15 92.47 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.093 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -41.13 52.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.2 p -61.4 -37.46 83.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.23 -46.46 86.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 0.0 109.568 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.89 -30.42 65.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -66.09 -46.68 76.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -63.19 -42.63 99.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -61.28 -35.41 77.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.562 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.79 42.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.68 -32.42 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.858 . . . . 0.0 109.583 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -60.48 -40.73 92.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.429 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -61.0 -37.02 81.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.63 ' NH1' ' CZ ' ' A' ' 112' ' ' PHE . 98.8 mtt180 -64.87 -20.03 66.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.49 22.92 13.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 2.6 m-85 -84.65 141.03 30.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -1.107 . . . . 0.0 109.535 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -109.1 175.29 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 53.91 44.18 29.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.584 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.5 p -122.66 26.02 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.82 166.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.1 m -54.58 -33.6 60.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.3 m -61.02 -46.49 90.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.4 mp -64.67 -41.57 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 157' ' ' VAL . 83.1 m -64.37 -40.4 95.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 109.264 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.26 -47.63 85.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.271 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.526 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 29.7 t -59.63 -37.15 77.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.288 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.69 -37.66 79.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.8 mtp -65.25 -47.29 77.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.617 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.41 -35.88 80.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.713 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.74 -44.18 93.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.7 m -83.02 -59.13 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.45 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.85 18.04 1.01 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 mt -58.95 -32.82 69.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -1.095 . . . . 0.0 109.427 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.09 141.83 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' HG22 ' A' ' 127' ' ' THR . 23.5 t30 -76.02 102.56 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 22.9 t70 -94.03 101.35 13.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 81.7 m-70 -160.05 123.39 3.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.54 HG22 ' H ' ' A' ' 178' ' ' GLY . 8.0 p -74.79 134.5 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.3 p -54.99 -25.76 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.423 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.54 ' H ' HG22 ' A' ' 176' ' ' VAL . . . -64.08 -24.27 68.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.521 ' H ' HG13 ' A' ' 176' ' ' VAL . 3.7 m -77.67 140.86 39.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.193 . . . . 0.0 109.535 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 182' ' ' TYR . 83.3 m -62.9 -38.61 91.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.91 . . . . 0.0 109.438 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 95.1 m -51.29 -7.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.551 ' C ' ' H ' ' A' ' 184' ' ' GLY . 20.9 t80 -124.59 80.65 61.06 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 109.576 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -50.43 0.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.044 2.496 . . . . 0.0 112.356 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 182' ' ' TYR . . . 75.08 9.29 83.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 57.5 42.15 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -1.107 . . . . 0.0 109.603 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.55 147.66 53.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 123.043 2.495 . . . . 0.0 112.266 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -125.81 160.69 29.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -85.47 138.99 31.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -92.82 -153.52 0.35 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.427 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.2 -5.11 56.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 28.6 m95 45.73 38.41 4.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.405 ' H ' HG12 ' A' ' 7' ' ' VAL . 1.3 p -60.99 131.19 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -171.47 29.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.81 -130.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.91 153.08 45.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.48 -27.51 3.44 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.862 2.375 . . . . 0.0 112.184 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.33 -39.68 95.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.404 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -66.11 -45.36 81.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.425 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.92 -39.82 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.72 92.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -66.87 -40.12 87.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' GLU . 59.1 t-80 -56.38 -48.53 76.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.77 -39.11 70.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -58.9 -44.49 91.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.502 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 39.9 mt-10 -149.1 -137.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.496 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.482 ' O ' ' O ' ' A' ' 20' ' ' GLU . 23.5 t90 59.82 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.547 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.41 82.94 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.9 t -119.71 94.74 48.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 0.0 109.34 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -46.87 121.96 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.764 2.309 . . . . 0.0 111.878 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.48 140.71 37.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -128.28 -2.02 5.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.0 109.109 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -81.33 130.7 35.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.4 t -57.17 -34.42 68.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.204 -0.935 . . . . 0.0 109.608 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -67.21 -55.55 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.763 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -66.92 -43.73 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.923 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.33 -44.14 95.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.835 -179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.96 -36.71 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 109.903 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.25 -32.05 71.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 43.3 tpp -63.84 -53.31 52.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.785 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 3.2 tp -72.11 -32.12 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.75 -50.35 30.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.132 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 6.7 mp -74.08 -16.38 61.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -52.24 -42.1 63.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.953 . . . . 0.0 109.841 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.583 ' N ' ' OE1' ' A' ' 38' ' ' GLU . . . 61.69 171.97 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.687 ' C ' ' H ' ' A' ' 42' ' ' ALA . 31.4 tp60 -60.07 -45.15 93.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -1.193 . . . . 0.0 109.77 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 60.13 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.671 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -58.28 143.27 45.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 -24.03 0.62 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 42' ' ' ALA . 17.4 mt -104.04 -141.23 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 109.476 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -153.43 155.0 35.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -48.08 -39.05 19.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 48' ' ' THR . 9.7 tp -54.41 -40.59 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' HG23 ' A' ' 47' ' ' ILE . 85.5 m -63.83 -38.73 92.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.735 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.18 -40.75 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.422 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.26 -44.78 92.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -65.64 -49.49 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.394 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' CD ' HD23 ' A' ' 37' ' ' LEU . 37.1 ttp180 -52.39 -45.39 65.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.158 -0.964 . . . . 0.0 109.038 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.4 -44.87 96.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 24.0 m120 -66.2 -38.45 88.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.254 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CG ' ' A' ' 60' ' ' PHE . 25.3 t80 -62.8 -50.43 71.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.348 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 20.7 mmm180 -60.8 -21.37 63.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.798 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -48.58 62.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.6 m -95.65 -43.34 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 110.254 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CG ' ' CE2' ' A' ' 56' ' ' TYR . 53.9 m-85 -66.91 -50.79 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 57.5 t60 -48.78 -41.67 33.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -61.6 -37.37 83.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.734 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.573 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 48.0 m-85 -78.5 -48.24 15.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 109.832 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.1 t70 79.87 136.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.534 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -40.05 -22.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.909 2.406 . . . . 0.0 112.745 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' ASP . 91.9 t -75.97 -44.55 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.653 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' LYS . 3.2 mptp? -72.61 -45.07 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.845 . . . . 0.0 109.895 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.1 m -56.05 -42.84 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.612 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.547 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -62.19 -38.0 87.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.53 13.13 32.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.373 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.502 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 27.3 ttp -83.26 158.14 22.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -103.98 160.52 14.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.5 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.56 -30.29 69.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.69 -43.72 72.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 55.1 t0 -61.58 -38.33 87.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.444 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.08 -44.13 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -56.2 -37.18 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.44 -38.66 90.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.341 -0.849 . . . . 0.0 109.782 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.2 mt -70.99 -29.32 65.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.77 -36.38 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.04 -62.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.0 109.514 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -100.01 116.13 31.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.431 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.66 -46.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 55' ' ' ASN . . . 78.74 26.36 58.85 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 pt -116.43 171.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.0 mt -47.22 135.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.628 ' HG2' HH11 ' A' ' 87' ' ' ARG . 9.0 mtt-85 -74.9 102.49 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.42 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -171.73 80.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.208 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG2' HH11 ' A' ' 89' ' ' ARG . 11.9 ptt-85 -47.67 -32.97 6.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.908 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.75 95.47 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.08 -45.24 95.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.52 -41.56 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -60.67 -37.63 82.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.26 96.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.355 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 ' HE2' ' A' ' 56' ' ' TYR . 97.3 mt -57.99 -46.41 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 68' ' ' VAL . 78.5 mt -54.66 -39.23 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.74 -33.39 87.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 88.1 m-20 -61.6 -41.83 98.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 109.423 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.74 86.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 109.51 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -57.71 -45.03 86.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.71 -33.5 68.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -64.5 -45.5 87.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 103' ' ' LEU . 3.5 mm? -59.78 -39.18 84.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -60.54 -37.01 79.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.525 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.5 mmm -63.35 -37.08 85.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.73 -29.42 69.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -51.72 -35.35 42.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -91.8 -1.34 57.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.8 66.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -97.05 149.15 35.38 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.154 -1.203 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.82 124.57 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.662 2.241 . . . . 0.0 111.698 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.409 ' CE1' ' NH1' ' A' ' 152' ' ' ARG . 72.3 t80 -79.11 -45.47 19.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.49 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.711 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 20.0 t70 -52.65 -36.5 56.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 111.043 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.66 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 48.3 t80 -73.09 -49.6 27.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.081 -1.012 . . . . 0.0 111.221 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 116' ' ' VAL . 3.0 m -56.12 -49.35 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.023 -1.048 . . . . 0.0 111.675 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.569 ' O ' HG22 ' A' ' 120' ' ' VAL . 20.0 p-90 -86.88 -28.06 23.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.742 -1.224 . . . . 0.0 111.09 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 21.7 p -56.75 -28.41 61.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.874 -1.142 . . . . 0.0 109.725 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -46.63 -11.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 117' ' ' TRP . 18.5 m -84.7 24.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 123' ' ' GLN . 3.5 m-20 72.51 17.62 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.023 . . . . 0.0 109.701 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 16.8 t60 73.58 -23.14 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.544 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 121' ' ' ASN . 9.5 pt20 -86.52 145.76 40.28 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.532 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 154.06 72.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.666 2.244 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.435 ' O ' ' SD ' ' A' ' 126' ' ' MET . 25.0 mt-30 -104.68 149.0 25.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.771 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.445 ' SD ' ' CG ' ' A' ' 173' ' ' ASN . 71.2 mmm -135.78 145.95 47.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 109.172 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.2 t -115.7 164.79 13.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.929 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -139.15 47.12 1.91 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.299 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -86.57 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.7 m -72.15 -37.8 69.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.1 t -133.95 177.93 7.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.454 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.09 -34.11 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.604 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -59.11 -35.23 73.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.55 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 93.1 mt-10 -72.72 -23.25 60.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.483 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 5.7 mm -65.57 120.47 68.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.749 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.473 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 85.1 Cg_endo -83.72 135.72 6.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.072 2.514 . . . . 0.0 112.525 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 137' ' ' THR . 1.7 t -91.52 6.72 44.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.33 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.9 m -138.81 90.23 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.28 160.61 29.38 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -47.88 -41.78 31.89 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.874 2.382 . . . . 0.0 112.035 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.38 -38.45 71.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -58.45 -43.92 88.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -61.84 -45.16 95.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.511 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.04 73.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.1 tt -60.05 -48.68 80.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.486 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.6 t -61.23 -37.18 82.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.58 ' HZ3' ' HZ3' ' A' ' 151' ' ' LYS . 63.4 tttm -62.0 -42.04 98.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.18 71.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.7 -34.53 74.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.593 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -59.78 -40.91 89.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 109.4 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.58 ' HZ3' ' HZ3' ' A' ' 147' ' ' LYS . 38.7 mmtm -61.17 -40.38 93.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.447 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.66 ' NH2' ' CD1' ' A' ' 115' ' ' PHE . 98.6 mtt180 -67.98 -19.89 64.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.23 13.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.482 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 2.1 m-85 -86.29 127.34 34.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -1.118 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -97.23 -176.85 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 40' ' ' GLN . 76.4 m-85 53.2 48.32 22.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.73 24.17 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.1 162.67 0.21 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 159' ' ' THR . 1.0 OUTLIER -55.62 -31.49 62.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -1.167 . . . . 0.0 109.446 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.6 m -66.77 -47.77 71.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.81 -44.42 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.1 m -60.29 -43.9 95.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.325 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.483 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 73.4 t80 -60.53 -43.26 97.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 0.0 109.334 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -57.08 -38.97 74.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 31' ' ' LEU . 16.2 t80 -61.75 -31.18 71.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.418 ' SD ' HD12 ' A' ' 171' ' ' LEU . 63.0 mmm -68.12 -54.18 19.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.623 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -72.19 -42.49 65.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.708 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.52 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -60.96 -34.7 75.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 26.2 t -83.31 -61.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.424 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.04 14.43 1.83 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.486 HD11 ' CE2' ' A' ' 165' ' ' PHE . 27.7 mt -65.55 -34.23 77.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.56 140.59 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.445 ' CG ' ' SD ' ' A' ' 126' ' ' MET . 4.3 m120 -88.88 115.09 26.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -98.63 113.02 24.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -152.18 143.06 23.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.522 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 m -97.04 145.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.1 m -54.75 142.82 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.09 -83.01 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 73.8 m -74.25 -171.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -1.158 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.601 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 33.3 m 52.4 17.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.468 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.601 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 13.7 p 42.46 43.63 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 30.4 t80 -121.59 82.83 40.96 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 109.621 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.75 36.47 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.131 2.554 . . . . 0.0 112.378 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.46 26.12 66.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.7 t30 57.56 43.27 22.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.546 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -134.77 78.83 54.1 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 122.969 2.446 . . . . 0.0 112.293 -179.794 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.288 0.566 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -84.01 152.54 24.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.594 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -146.44 148.2 32.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' TRP . 63.5 m 45.91 31.25 1.04 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.97 -46.01 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.664 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -149.84 -91.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -1.201 . . . . 0.0 109.452 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 7' ' ' VAL . 38.6 t 54.39 -0.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.608 ' H ' ' C ' ' A' ' 6' ' ' TRP . 72.1 m -79.87 28.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.424 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' SER . 35.1 tt0 -61.27 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 5.6 p30 -94.77 152.23 39.62 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.35 -34.09 13.53 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.819 2.346 . . . . 0.0 112.098 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.68 -43.3 99.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.476 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.55 -46.61 75.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 109.393 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.0 mt -62.14 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.373 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.12 98.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -62.01 -40.77 96.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 23.8 t-80 -60.65 -48.9 79.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.81 -39.31 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.551 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.85 -47.33 83.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 89.5 mt-10 -151.82 -125.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.497 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.523 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 37.7 t90 57.99 114.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.52 -6.31 67.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.669 ' O ' HG13 ' A' ' 23' ' ' VAL . 8.3 p -105.78 109.92 63.65 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.183 -1.186 . . . . 0.0 109.429 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.1 121.12 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.742 2.294 . . . . 0.0 111.896 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -92.94 134.73 34.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.141 -0.974 . . . . 0.0 109.887 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -132.59 -2.25 3.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 109.042 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.14 147.53 46.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.649 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -71.0 -60.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -178.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.86 -37.02 82.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.72 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.04 -42.81 84.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.871 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -66.7 -40.8 88.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.215 -0.928 . . . . 0.0 109.862 -176.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.3 m-30 -60.51 -41.42 94.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.896 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 37' ' ' LEU . 98.6 mt-10 -64.4 -32.81 74.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 ttm -68.42 -53.7 21.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.801 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 36' ' ' CYS . 8.4 tp -70.6 -39.18 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 110.027 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.486 ' N ' HG23 ' A' ' 35' ' ' ILE . 77.0 m -71.31 -47.19 58.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 17.2 tp -64.84 -41.5 95.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 109.811 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 44.2 tp10 -56.22 -29.74 61.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.85 -38.38 59.64 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 40' ' ' GLN . 18.9 mp0 -60.3 -30.75 69.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -1.233 . . . . 0.0 109.724 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.7 tt0 -48.09 -29.7 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 109.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.66 109.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.23 -32.11 5.36 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.9 mp -98.21 -160.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -1.209 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.9 m -131.99 152.55 51.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.362 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 43.6 p90 -55.63 -33.49 64.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -57.99 -40.68 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 54.6 m -73.5 -32.52 64.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.692 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 73.0 t -57.4 -36.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -54.38 -54.93 33.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.57 -45.97 90.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.123 -0.986 . . . . 0.0 109.35 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -68.86 -28.47 66.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.582 ' HG2' HH11 ' A' ' 53' ' ' ARG . 6.4 ttt-85 -52.82 -45.95 67.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -0.986 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -70.47 -43.77 69.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -65.48 -38.16 88.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.325 -0.859 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.13 -49.75 76.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' HIS . 73.8 mtm180 -54.75 -43.39 72.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.41 71.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.29 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.86 -20.19 19.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.201 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -104.33 -38.96 6.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.849 -1.157 . . . . 0.0 110.238 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.5 t60 -49.77 -41.91 45.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 109.898 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.44 -31.39 72.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.722 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 53.7 m-85 -91.31 62.79 4.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -39.31 153.6 0.18 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.618 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -35.34 -53.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.856 2.371 . . . . 0.0 112.757 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -54.44 -44.93 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.647 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 71' ' ' MET . 20.3 tptp -65.73 -37.1 85.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.388 -0.82 . . . . 0.0 109.876 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 63' ' ' PHE . 21.4 t -56.98 -49.89 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.076 -1.015 . . . . 0.0 109.594 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.63 70.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.511 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.06 -0.83 57.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.398 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 63' ' ' PHE . 8.9 ttp -71.52 158.35 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -104.67 156.8 17.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.57 -31.28 69.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.51 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -60.49 -39.2 86.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.86 -40.85 94.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.05 -44.03 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.579 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.79 -36.67 81.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.308 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 78' ' ' ARG . 33.2 ttm-85 -63.22 -42.29 99.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -36.13 82.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.2 t -51.29 -33.44 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -93.64 -60.28 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.523 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -101.3 108.1 19.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.92 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.418 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.94 27.94 57.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 pt -121.03 171.78 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -1.15 . . . . 0.0 109.38 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -46.69 141.62 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -94.0 97.6 10.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.431 -179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 15.6 m-70 -162.71 86.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.176 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 89' ' ' ARG . 24.9 ttt-85 -48.65 -29.88 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.38 -47.05 92.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -63.85 -48.81 75.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.27 -41.08 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.9 -36.63 72.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.399 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.318 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.478 ' HA ' HD21 ' A' ' 98' ' ' ASN . 98.9 mt -57.59 -41.66 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 109.417 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 mm -56.29 -50.76 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.12 95.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.478 HD21 ' HA ' ' A' ' 95' ' ' ILE . 91.4 m-20 -57.85 -35.94 71.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.14 68.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.88 -42.61 99.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.47 -35.12 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 10.3 t80 -63.98 -48.13 77.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 tp -63.29 -39.27 94.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -60.75 -38.3 84.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -64.13 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.242 -0.912 . . . . 0.0 109.468 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.75 -29.12 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -52.39 -24.45 7.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.514 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.92 -16.88 59.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.512 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.77 9.6 74.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.58 114.42 63.1 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.246 -1.15 . . . . 0.0 109.677 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.02 120.53 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.578 2.185 . . . . 0.0 111.692 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -58.47 -35.03 71.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 0.0 110.504 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.21 -50.87 68.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.0 110.742 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 118' ' ' SER . 90.2 m-20 -62.67 -43.56 98.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 111.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.88 -49.33 73.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.991 -1.068 . . . . 0.0 111.155 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -63.8 -48.9 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.034 -1.041 . . . . 0.0 111.632 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.509 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 2.7 p-90 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.775 -1.203 . . . . 0.0 111.207 -177.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 33.1 m -55.41 -28.57 55.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.861 -1.149 . . . . 0.0 109.766 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.23 -14.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.1 p -83.24 26.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.901 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 120' ' ' VAL . 2.4 m-80 76.03 17.61 2.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.706 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 59.94 39.34 20.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.492 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.474 ' H ' HG13 ' A' ' 120' ' ' VAL . 77.3 mt-30 -151.13 144.84 17.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.59 146.95 50.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.694 2.262 . . . . 0.0 111.872 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -103.2 134.58 46.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.982 . . . . 0.0 109.741 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 38.7 ttp -109.36 125.41 52.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.4 t -94.28 166.56 12.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 109.868 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -147.43 53.3 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.403 -0.811 . . . . 0.0 109.252 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.688 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -91.21 142.88 27.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -80.48 -33.47 36.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.0 m -128.91 159.29 36.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.417 ' CD1' ' NE1' ' A' ' 6' ' ' TRP . 31.5 mt -55.94 -35.56 66.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.9 p -66.85 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.688 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.9 mm-40 -65.92 -23.1 66.55 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.142 -0.974 . . . . 0.0 109.411 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.26 116.98 42.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -84.18 132.1 5.19 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.132 2.555 . . . . 0.0 112.516 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.1 t -92.44 -12.46 32.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.309 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 80.0 p -92.57 100.93 13.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.36 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -116.74 151.45 47.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.07 -31.87 93.99 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.844 2.362 . . . . 0.0 111.966 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.92 -41.47 51.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.1 m -60.74 -41.15 94.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.56 -48.93 77.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.522 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.41 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.692 ' C ' HD23 ' A' ' 145' ' ' LEU . 7.5 tt -59.56 -48.29 82.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.47 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -59.97 -41.77 92.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.21 -33.15 74.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.76 -51.38 49.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.548 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 145' ' ' LEU . 76.6 mt -60.89 -34.63 74.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -58.03 -40.33 80.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.382 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.6 -37.13 82.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -63.91 -20.11 65.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.09 19.39 19.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.45 ' CE2' ' OD1' ' A' ' 98' ' ' ASN . 6.0 m-85 -88.51 133.6 34.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.52 177.75 5.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 55.05 53.67 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.86 24.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.45 167.51 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 159' ' ' THR . 1.1 p -66.05 -25.27 66.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 109.37 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.9 p -70.9 -46.17 63.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.01 -34.52 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.536 ' SG ' HD22 ' A' ' 145' ' ' LEU . 43.1 t -68.12 -46.0 72.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.317 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.07 -42.49 99.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.1 m -57.57 -32.6 67.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.28 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.43 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.61 -31.25 69.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.446 178.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 25.5 mtt -68.5 -53.95 19.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.523 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 1.9 pp0? -62.39 -36.46 82.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.704 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.478 ' N ' ' CD ' ' A' ' 167' ' ' GLN . . . -74.71 -38.96 62.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.744 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 23' ' ' VAL . 10.3 t -74.54 -29.05 61.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.444 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.14 56.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.446 HD13 ' SG ' ' A' ' 169' ' ' CYS . 1.1 mp -52.69 -52.88 54.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 0.0 109.39 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.1 m -91.9 135.84 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' THR . 6.4 m120 -82.67 105.03 13.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 109.46 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -93.71 123.92 37.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CD2' ' CD2' ' A' ' 182' ' ' TYR . 1.9 p-80 -164.06 159.23 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -111.39 122.73 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 178' ' ' GLY . 8.6 p -70.19 -40.02 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.507 ' N ' HG13 ' A' ' 177' ' ' VAL . . . -60.03 -18.94 49.6 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 96.5 m -86.37 -176.67 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.503 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.6 t -106.12 -21.77 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.523 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.7 t -54.27 -33.92 59.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.1 t80 -125.1 84.44 59.28 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' TYR . 52.0 Cg_exo -52.16 -140.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.111 2.54 . . . . 0.0 112.338 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 94.16 5.68 62.11 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -146.27 30.7 1.02 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -1.145 . . . . 0.0 109.578 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -110.4 149.45 40.22 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 109.588 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.996 2.464 . . . . 0.0 112.256 179.763 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.574 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.275 0.56 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -78.19 162.86 26.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.872 . . . . 0.0 109.537 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.527 HH21 HG23 ' A' ' 7' ' ' VAL . 23.9 ptt-85 -140.06 170.45 15.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.521 ' C ' ' H ' ' A' ' 6' ' ' TRP . 4.1 m -96.87 -155.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.88 -16.18 0.86 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.521 ' H ' ' C ' ' A' ' 4' ' ' CYS . 26.6 m95 44.46 37.8 2.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.183 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.5 m -64.91 126.74 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' GLN . 29.4 t -164.08 156.84 17.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' SER . 41.3 tt0 56.94 159.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 109.561 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.2 72.74 0.82 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.9 -28.78 13.83 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.844 2.363 . . . . 0.0 112.147 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.36 -39.32 94.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.72 -46.54 78.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.56 -48.78 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.383 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.77 -36.77 76.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.52 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.556 ' CE2' HD22 ' A' ' 50' ' ' LEU . 63.3 t80 -59.89 -44.11 94.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.484 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.15 -49.05 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -64.53 -40.28 95.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -64.42 -64.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.519 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.9 mm-40 -140.13 -151.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.628 ' CZ2' ' HB2' ' A' ' 168' ' ' ALA . 27.1 t-105 62.19 130.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.475 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.62 -17.69 58.51 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.8 m -78.11 149.69 76.72 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.416 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.01 119.41 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.858 2.372 . . . . 0.0 111.785 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.6 133.41 56.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.985 . . . . 0.0 109.809 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 p -134.46 9.09 3.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.033 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.73 141.49 31.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.711 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 14.9 m -68.63 -36.38 78.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -58.97 -52.43 65.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -40.29 96.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.685 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 2.3 mm? -58.66 -39.38 80.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.11 -0.994 . . . . 0.0 109.871 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -67.1 -54.24 23.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.873 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -71.11 -31.46 67.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.4 tpp -60.04 -53.75 54.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 109.676 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 36' ' ' CYS . 18.3 tt -82.76 -42.99 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.062 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.548 ' N ' HG23 ' A' ' 35' ' ' ILE . 33.7 t -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.944 . . . . 0.0 110.044 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.6 -40.42 76.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.867 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -59.91 -24.35 64.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.802 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.43 -28.72 3.5 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.18 -31.64 72.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.24 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -47.98 -34.41 9.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.78 111.33 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.727 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.61 -39.24 2.84 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -105.78 -138.15 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.7 t -141.73 155.26 45.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 22.7 p90 -55.54 -31.85 62.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.57 -39.64 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.7 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -73.28 -32.26 64.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.9 t -58.69 -37.68 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 16' ' ' TYR . 31.7 mt -53.83 -55.49 26.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -59.27 -42.19 90.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HB2' ' HZ2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.57 -21.59 60.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.376 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.57 ' HG2' HH11 ' A' ' 53' ' ' ARG . 7.9 ttt-85 -58.62 -47.64 83.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.209 -0.932 . . . . 0.0 108.99 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' A' ' 54' ' ' GLU . 10.1 pt-20 -69.63 -41.02 76.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -66.05 -50.72 63.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.269 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 28.0 t80 -60.45 -37.51 81.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.379 -0.826 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 40.8 ttp180 -55.83 -38.12 69.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.859 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.25 53.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.07 -11.69 35.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 110.286 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 56.4 m-85 -130.04 -51.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.97 -1.082 . . . . 0.0 110.193 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.2 t-80 -49.25 -38.3 26.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.083 -1.01 . . . . 0.0 109.909 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -55.45 -37.44 67.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.781 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.09 -16.79 52.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.866 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 63.99 132.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.064 -1.022 . . . . 0.0 109.578 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.33 -34.5 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.904 2.402 . . . . 0.0 112.688 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.2 t -55.16 -49.35 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mtpt -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -58.09 -42.17 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.595 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.83 -42.24 67.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.25 23.91 8.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.1 ttm -62.36 163.04 9.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -109.9 154.22 23.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -34.92 69.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.28 -37.38 85.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.456 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -60.13 -44.11 95.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 80' ' ' VAL . 92.5 t -56.41 -43.18 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.596 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.15 -33.46 74.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.315 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -58.89 -44.23 91.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.799 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 92.3 mt -73.32 -32.6 64.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 76' ' ' VAL . 51.3 t -51.78 -36.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.763 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -75.57 -62.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -99.89 107.84 19.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.423 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -175.62 75.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.397 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.66 10.4 1.51 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.521 HD12 ' CG ' ' A' ' 87' ' ' ARG . 5.1 pt -79.59 -175.92 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -1.146 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 86' ' ' ILE . 67.6 mt -83.34 -2.33 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 85' ' ' ILE . 3.6 mmp_? -66.88 145.58 55.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.427 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' O ' ' N ' ' A' ' 90' ' ' GLY . 53.0 m80 -141.96 70.52 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.133 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.424 HH11 ' HG3' ' A' ' 89' ' ' ARG . 27.2 ttm-85 59.02 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.397 -0.814 . . . . 0.0 109.927 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -56.57 -37.48 75.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -59.59 -45.47 91.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.73 -44.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.629 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.332 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.21 -36.31 79.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.419 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.9 mm -69.03 -44.52 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.96 -47.93 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 109.543 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.42 -42.92 99.88 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 23.9 m120 -58.86 -43.77 90.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -1.207 . . . . 0.0 109.42 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.71 92.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.57 -44.28 91.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.4 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.11 -53.74 7.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -56.99 -44.71 83.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -61.04 -33.87 73.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -62.33 -35.87 80.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' N ' ' A' ' 108' ' ' ASN . 84.3 tt0 -70.82 -30.77 67.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -51.89 -14.38 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.561 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 106' ' ' GLU . 77.7 m-20 -75.97 -14.98 60.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 36.6 18.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -138.75 152.17 70.09 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.76 119.12 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.612 2.208 . . . . 0.0 111.685 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -74.57 -43.51 55.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.0 110.465 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.42 -47.21 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.168 -0.958 . . . . 0.0 110.772 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.564 ' O ' ' OG ' ' A' ' 118' ' ' SER . 53.6 t0 -54.9 -37.7 66.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 111.056 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 -48.35 39.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.088 -1.008 . . . . 0.0 111.221 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 3.6 m -53.96 -49.35 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.058 -1.026 . . . . 0.0 111.679 -175.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 114' ' ' ASP . 21.9 p-90 -87.69 -24.94 23.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.729 -1.232 . . . . 0.0 111.09 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 6.8 m -56.02 -23.95 36.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.783 -1.198 . . . . 0.0 109.708 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -44.46 -15.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.166 -0.958 . . . . 0.0 110.076 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.3 m -88.15 24.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.001 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 1.6 m120 72.14 38.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 109.641 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 51.4 p-80 41.96 40.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.579 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.416 ' H ' HG23 ' A' ' 120' ' ' VAL . 81.5 mt-30 -147.52 148.09 30.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.542 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.42 135.58 36.99 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.671 2.247 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -100.08 148.41 24.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.776 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.6 ptm -133.27 156.68 47.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.447 -0.783 . . . . 0.0 109.155 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.3 t -124.03 163.3 21.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.921 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -137.69 54.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -89.99 -158.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.663 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.58 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 6.4 m -140.9 -29.6 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.34 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.405 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 14.2 m -135.06 161.17 36.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.469 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.431 HD11 ' CD1' ' A' ' 6' ' ' TRP . 50.4 mt -73.58 -16.73 61.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.84 -41.21 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.8 pt-20 -71.93 -26.04 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.174 -0.954 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.0 117.45 48.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.03 131.28 5.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.096 2.53 . . . . 0.0 112.563 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.464 ' H ' HG22 ' A' ' 137' ' ' THR . 0.7 OUTLIER -76.98 -13.38 59.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.259 179.585 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.2 m -94.73 101.87 13.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.91 154.62 49.64 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.05 -42.68 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.843 2.362 . . . . 0.0 112.009 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.73 -41.38 53.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -62.05 -42.53 99.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.412 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 44.1 t0 -62.87 -45.24 93.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.17 80.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 162' ' ' CYS . 23.6 tp -57.96 -50.9 71.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.3 p -58.6 -39.36 80.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.55 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 60.7 mttp -60.69 -32.72 71.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.06 -55.11 10.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.5 mp -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.626 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.63 -41.38 85.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.419 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.01 -35.45 80.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.498 HH11 ' HG3' ' A' ' 152' ' ' ARG . 26.6 ttm-85 -63.86 -21.75 66.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.8 21.47 8.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.69 136.76 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -1.112 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 1.8 mptm? -97.67 -169.64 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 16.5 p90 39.47 41.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 157' ' ' VAL . 5.5 m -96.38 25.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.54 154.58 1.21 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.7 m -55.87 -28.03 54.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.423 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -48.33 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.9 mp -58.74 -44.24 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 109.438 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' A' ' 145' ' ' LEU . 2.2 t -62.64 -49.04 76.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -62.74 -40.0 95.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.364 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -60.71 -38.65 85.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CZ ' HD11 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -61.12 -43.63 98.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.529 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.3 mtp -59.33 -40.2 85.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.75 -34.16 77.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.628 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -67.31 -63.2 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.685 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.8 t -63.26 -40.31 97.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.98 21.64 15.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 34.8 mt -54.17 -35.1 61.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.395 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.18 133.95 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.546 ' OD1' ' ND1' ' A' ' 175' ' ' HIS . 5.8 t-20 -81.48 100.96 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.45 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -86.26 118.46 25.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.546 ' ND1' ' OD1' ' A' ' 173' ' ' ASN . 15.0 m170 -147.62 162.22 39.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.519 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 130' ' ' THR . 38.9 t -110.82 132.71 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 129' ' ' ALA . 83.3 t -71.88 -39.25 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.495 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.91 28.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 29.7 t -91.03 167.29 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -1.138 . . . . 0.0 109.49 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.3 p -90.84 -37.87 13.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.503 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.479 ' HG ' ' HG ' ' A' ' 179' ' ' CYS . 17.0 p -53.31 -35.9 60.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.464 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 39.8 t80 -125.2 83.59 60.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -85.28 31.55 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.047 2.498 . . . . 0.0 112.441 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.42 14.68 79.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 57.8 37.82 27.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -1.15 . . . . 0.0 109.567 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.63 155.69 59.09 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 C-N-CA 122.998 2.465 . . . . 0.0 112.267 179.894 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -93.63 143.49 26.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.449 HH11 ' HG3' ' A' ' 3' ' ' ARG . 50.7 mtm-85 -143.75 148.4 35.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.08 -164.83 1.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.387 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.12 3.24 63.71 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.608 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 1.4 m0 47.83 42.89 16.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.477 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 8' ' ' SER . 33.2 m -66.29 127.99 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER 166.6 178.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.497 ' N ' ' OG ' ' A' ' 8' ' ' SER . 49.4 tp60 59.41 -127.86 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.12 150.74 91.66 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 -11.63 26.29 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.159 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.75 -33.08 74.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.555 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 42.3 m-85 -54.16 -46.47 72.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.444 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.93 -28.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.4 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.84 -47.14 81.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 1.3 p90 -75.76 -38.73 58.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.502 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.552 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 83.9 t60 -54.16 -46.27 72.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.498 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -71.38 -34.51 70.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.514 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -61.81 -62.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.545 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TRP . 10.3 pt-20 -174.04 -115.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.796 ' CZ2' ' HB2' ' A' ' 168' ' ' ALA . 34.5 t-105 60.07 130.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.524 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.81 60.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.7 OUTLIER -76.89 152.74 82.77 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.264 -1.139 . . . . 0.0 109.376 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 123.01 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.752 2.301 . . . . 0.0 111.857 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -108.57 135.22 50.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.858 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -134.94 5.32 3.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 109.038 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.91 128.45 35.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.277 -0.889 . . . . 0.0 109.296 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.536 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -61.71 -55.89 25.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.581 -178.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -62.73 -43.63 98.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.708 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.619 ' NZ ' ' NH2' ' A' ' 53' ' ' ARG . 15.9 tptp -64.63 -44.35 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.85 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 113' ' ' ALA . 5.3 tp -60.87 -42.07 97.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.85 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.9 m-30 -60.34 -35.89 76.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 0.0 109.892 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.76 -30.06 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.819 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.0 tpp -74.34 -56.23 5.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.837 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.445 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -61.69 -36.7 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 75.9 m -71.72 -44.72 63.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.6 tp -73.53 -39.8 64.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.977 . . . . 0.0 109.876 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -53.71 -34.56 59.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.775 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.72 -34.27 56.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -64.22 -29.14 70.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.161 . . . . 0.0 109.778 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.1 tt0 -49.04 -31.01 6.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.759 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.99 110.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -31.84 6.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 41' ' ' GLN . 19.4 mt -99.47 -150.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.8 m -145.98 161.34 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -52.39 -41.25 62.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -51.9 -40.99 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -75.65 -34.63 60.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.71 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.65 -44.21 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HZ2' HD12 ' A' ' 47' ' ' ILE . 46.5 mttp -59.36 -49.39 78.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -72.51 -22.5 61.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.334 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.619 ' NH2' ' NZ ' ' A' ' 30' ' ' LYS . 3.8 ttt-85 -57.57 -44.29 85.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.111 -0.993 . . . . 0.0 108.975 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.11 -44.56 65.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -66.38 -35.03 79.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.242 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 29.4 t80 -57.06 -49.25 76.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.468 -0.77 . . . . 0.0 109.379 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 80.4 mtm180 -59.67 -41.37 90.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.06 39.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.213 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.9 m -95.9 -33.97 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 30.1 m-85 -86.05 -32.85 21.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.047 -1.033 . . . . 0.0 110.233 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 85.5 t60 -47.47 -16.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 60' ' ' PHE . 7.2 pt20 -100.35 -22.07 15.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.818 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.467 ' O ' HG23 ' A' ' 68' ' ' VAL . 60.0 m-85 -99.94 68.79 1.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.077 -1.015 . . . . 0.0 109.871 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 63' ' ' PHE . 4.9 m-20 -41.42 154.3 0.24 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.995 . . . . 0.0 109.607 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -34.46 -53.97 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.948 2.432 . . . . 0.0 112.627 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.82 -44.76 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.125 -0.984 . . . . 0.0 109.632 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.7 -32.78 74.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 63' ' ' PHE . 49.0 t -57.34 -43.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.617 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.497 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.41 -3.1 58.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.6 mtp -55.74 146.68 20.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.2 tp60 -105.97 166.46 10.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 97.2 mt-10 -63.25 -29.31 70.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.442 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.41 -37.16 84.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 109.441 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.63 -39.28 80.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.421 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' VAL . 96.8 t -63.82 -44.14 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -56.98 -37.25 71.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.377 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -61.05 -44.09 97.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.416 -0.803 . . . . 0.0 109.81 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.8 mt -73.78 -33.07 64.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 76' ' ' VAL . 40.9 t -50.55 -35.63 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.953 . . . . 0.0 109.788 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -88.93 -50.19 6.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.089 -1.007 . . . . 0.0 109.568 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.5 m-20 -71.33 153.27 42.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.38 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.12 26.65 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -47.33 -34.74 9.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 85' ' ' ILE . 22.3 pt -148.61 -174.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.343 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.47 138.04 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -89.92 106.88 18.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 109.445 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 91' ' ' LYS . 1.1 t60 -176.34 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -45.02 -34.72 2.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.894 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.86 -44.52 88.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 15.1 ttmm -66.44 -43.12 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.491 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.94 -46.67 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -59.71 -33.22 71.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.42 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.99 90.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 80.5 mt -64.13 -44.79 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.05 -45.82 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.22 -38.06 95.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.508 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 22.0 t-20 -57.64 -40.87 80.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.356 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.71 95.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.57 -40.81 75.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.44 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.77 -31.97 73.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.451 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 22.6 t80 -62.1 -48.4 80.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.3 mm? -58.35 -37.4 75.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 109.488 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -61.28 -51.71 67.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.606 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 27.3 ttt -69.97 -39.45 75.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.36 -26.78 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 109.443 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -51.7 -25.11 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.14 -19.0 58.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.496 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.58 17.47 68.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.11 152.74 38.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.151 -1.205 . . . . 0.0 109.741 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.83 122.92 10.63 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.641 2.228 . . . . 0.0 111.669 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.606 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 26.3 t80 -76.73 -42.16 42.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -69.91 -50.68 39.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 118' ' ' SER . 43.8 t0 -53.01 -33.32 51.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.012 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 16.2 t80 -76.24 -52.28 10.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.036 -1.04 . . . . 0.0 111.223 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.471 HG23 ' N ' ' A' ' 117' ' ' TRP . 10.1 m -56.56 -50.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.972 -1.08 . . . . 0.0 111.683 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.521 ' HB2' HD11 ' A' ' 171' ' ' LEU . 7.6 p-90 -82.05 -31.12 31.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.709 -1.244 . . . . 0.0 111.163 -176.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 18.0 t -56.28 -24.01 40.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.871 -1.143 . . . . 0.0 109.785 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -43.11 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.279 -0.888 . . . . 0.0 110.083 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 118' ' ' SER . 19.5 m -83.11 24.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.973 -1.079 . . . . 0.0 110.003 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 67.35 36.23 4.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.2 m80 53.82 26.16 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.465 ' H ' HG23 ' A' ' 120' ' ' VAL . 31.7 mt-30 -142.89 103.67 5.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.75 147.61 4.46 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.685 2.257 . . . . 0.0 111.808 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -95.83 157.97 15.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.727 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -121.95 142.49 50.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.7 t -86.14 160.19 19.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.938 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -141.73 46.83 1.67 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.645 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -101.79 135.75 42.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.8 m -76.8 -30.22 56.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.353 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -133.39 175.75 9.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.582 HD22 ' HE1' ' A' ' 6' ' ' TRP . 34.6 mt -67.79 -31.92 72.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.556 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.1 p -63.51 -34.86 78.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.645 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.3 mt-10 -73.51 -21.6 60.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.125 -0.985 . . . . 0.0 109.435 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 132' ' ' LEU . 84.9 mt -66.96 120.02 68.55 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.28 136.53 7.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.11 2.54 . . . . 0.0 112.561 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -95.15 4.78 53.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.325 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.9 t -137.14 90.74 2.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.59 156.27 39.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.74 -40.08 24.18 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.777 2.318 . . . . 0.0 112.03 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.96 -38.38 66.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.307 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.6 t -62.54 -47.38 84.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.03 -45.45 92.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.88 75.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.53 -46.64 78.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.537 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.3 t -56.09 -43.73 78.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.22 -35.96 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.08 -52.41 35.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.4 mp -66.29 -37.13 84.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.38 -0.825 . . . . 0.0 109.546 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -62.45 -37.23 85.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.333 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.62 -37.58 86.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 0.0 109.441 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.608 ' NH2' ' CE1' ' A' ' 115' ' ' PHE . 99.3 mtt180 -63.77 -23.41 67.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.46 12.21 9.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.508 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 43.0 m-85 -78.41 135.01 37.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -1.108 . . . . 0.0 109.51 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 19.9 tptt -101.35 -166.19 1.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 14.6 p90 37.83 33.95 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.407 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -101.77 24.89 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.388 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.62 157.0 1.67 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.7 m -53.61 -31.01 45.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.0 m -63.53 -47.18 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -64.98 -40.53 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.4 -41.05 96.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.319 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.5 -46.41 90.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.288 -0.883 . . . . 0.0 109.306 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 95.5 p -60.74 -36.8 79.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.02 -49.42 76.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.8 mtp -59.95 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.97 -46.05 90.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.796 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -72.62 -43.61 63.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.671 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' VAL . 13.6 t -58.13 -29.56 65.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.986 . . . . 0.0 109.425 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 0.33 61.3 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 117' ' ' TRP . 3.7 mp -55.07 -43.29 73.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -1.17 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.99 135.97 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.53 ' O ' HG22 ' A' ' 127' ' ' THR . 16.2 m-20 -86.43 117.89 25.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 42.1 p-10 -91.86 93.43 8.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -149.23 130.98 15.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.55 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 26.3 m -100.02 139.75 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.23 -33.77 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.11 65.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 176' ' ' VAL . 12.6 p -79.09 129.63 34.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.548 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 71.2 m -63.1 -29.67 70.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.9 t -48.73 -28.74 3.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.2 t80 -124.63 84.42 57.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.619 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 182' ' ' TYR . 53.6 Cg_exo -51.39 -139.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.115 2.543 . . . . 0.0 112.343 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.5 1.94 58.94 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -153.71 33.42 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.375 -1.074 . . . . 0.0 109.607 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -125.58 79.66 67.19 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.532 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 123.012 2.475 . . . . 0.0 112.322 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.32 0.581 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -131.95 158.18 42.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -149.57 176.72 10.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.7 p -43.35 159.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -125.98 -17.93 2.44 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -65.58 5.16 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 5' ' ' GLY . 4.6 t -63.32 140.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 p -61.8 151.29 34.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 109.475 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.81 -31.69 68.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -49.14 143.49 9.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.444 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.08 -28.5 12.8 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.898 2.399 . . . . 0.0 112.161 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.4 tp -62.13 -39.97 94.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.71 -49.13 67.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.91 . . . . 0.0 109.427 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.59 -40.9 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.69 -36.66 84.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -62.12 -43.09 99.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -60.92 -42.89 98.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.463 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.99 -39.45 85.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -63.63 -55.37 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -175.84 130.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.95 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -173.92 122.14 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.75 -0.03 79.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 169' ' ' CYS . 6.6 m -80.42 148.62 66.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.291 -1.123 . . . . 0.0 109.33 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 119.7 6.68 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.754 2.303 . . . . 0.0 111.857 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.26 130.86 53.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.832 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -117.05 4.09 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.865 . . . . 0.0 109.006 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -78.53 116.84 19.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 76.1 p -61.58 -33.52 74.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.599 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -58.04 -47.15 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -70.28 -48.8 55.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.09 -39.77 93.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 61.5 t80 -60.3 -45.0 94.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.893 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.59 -31.67 72.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 109.88 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.52 -53.22 57.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.805 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.84 -42.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.025 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.589 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 12.1 m -62.27 -51.74 66.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 mt -76.07 -42.4 47.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 161' ' ' ILE . 44.2 tt0 -54.25 -36.49 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.797 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.46 -32.97 61.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.54 -27.56 69.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -1.22 . . . . 0.0 109.718 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -48.53 -36.9 16.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 109.624 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.47 114.71 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.659 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.59 -33.36 5.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 mt -97.44 -141.83 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -1.17 . . . . 0.0 109.43 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.0 p -147.3 154.49 41.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -50.88 -45.03 59.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.219 -0.925 . . . . 0.0 109.494 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 47' ' ' ILE . 7.8 tp -55.35 -34.77 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.684 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.1 m -72.02 -35.08 69.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.0 t -59.19 -49.06 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.49 -50.84 70.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -59.37 -48.45 81.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.304 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -69.36 -30.57 68.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HG2' HH11 ' A' ' 53' ' ' ARG . 20.2 ttt-85 -50.99 -46.27 61.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 108.943 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.33 -44.22 72.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.355 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.58 -41.51 98.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.479 ' CD2' ' CE2' ' A' ' 60' ' ' PHE . 3.3 m-85 -55.87 -49.68 72.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.393 -0.817 . . . . 0.0 109.369 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' HIS . 58.8 mtp180 -51.72 -45.04 63.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.782 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.75 -43.14 47.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.1 m -96.4 -27.55 14.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.278 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.479 ' CE2' ' CD2' ' A' ' 56' ' ' TYR . 38.9 m-85 -92.36 -34.38 14.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.093 . . . . 0.0 110.133 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 86.5 t60 -48.29 -38.92 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -68.4 -34.12 75.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.716 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 64' ' ' ASP . 40.2 m-85 -88.9 62.97 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.85 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -39.77 159.0 0.13 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 109.558 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -38.61 -53.45 1.82 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.923 2.415 . . . . 0.0 112.651 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.9 t -53.36 -44.63 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -66.71 -34.39 77.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 63' ' ' PHE . 48.5 t -58.23 -48.77 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 109.661 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.32 63.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.49 7.07 43.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.633 ' SD ' HD11 ' A' ' 96' ' ' ILE . 41.9 ttm -57.06 146.97 25.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' OE1' ' OE2' ' A' ' 74' ' ' GLU . 95.3 mt-30 -107.44 162.02 14.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.07 -28.51 70.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' OE1' ' A' ' 72' ' ' GLN . 24.9 pt-20 -72.29 -27.76 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.81 -47.71 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 80' ' ' VAL . 10.7 m -64.05 -36.85 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -54.82 -37.97 66.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -70.05 -43.74 70.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.367 -0.833 . . . . 0.0 109.803 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 79' ' ' LEU . 96.0 mt -70.04 -41.45 74.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.99 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 76' ' ' VAL . 54.3 t -50.86 -36.3 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.31 -62.41 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -99.84 114.14 27.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.92 79.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -25.95 7.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' GLY . 22.1 pt -57.85 -160.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.249 -1.147 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.98 132.67 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.52 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.0 ptm180 -102.48 136.33 42.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.16 100.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.152 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -47.51 -30.28 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.923 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.8 -48.82 15.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.61 -43.39 98.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -1.145 . . . . 0.0 109.489 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.436 ' CG2' HG12 ' A' ' 76' ' ' VAL . 61.1 mt -63.47 -55.33 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.628 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -58.17 -31.58 67.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.72 93.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 109.39 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.5 -41.7 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.633 HD11 ' SD ' ' A' ' 71' ' ' MET . 70.9 mt -55.4 -54.3 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.82 94.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.589 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -58.03 -40.29 80.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -70.75 -37.05 73.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.04 -43.42 98.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -70.0 -33.85 72.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 19.4 t80 -69.84 -46.66 65.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 109.527 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.87 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 28.1 ttt -61.71 -41.53 97.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.485 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.1 -27.09 63.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -52.07 -21.82 3.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.513 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.46 -13.71 60.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.7 4.55 72.74 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.46 167.25 16.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -1.213 . . . . 0.0 109.696 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.76 118.55 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.546 2.164 . . . . 0.0 111.704 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 36.4 t80 -66.35 -44.23 83.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.467 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.47 89.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.774 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 24.7 t70 -53.41 -54.43 36.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 111.082 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -39.06 68.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.998 -1.064 . . . . 0.0 111.313 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.02 -60.4 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.997 -1.064 . . . . 0.0 111.676 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.673 ' O ' HG22 ' A' ' 120' ' ' VAL . 63.0 p-90 -87.99 -20.99 25.1 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.759 -1.213 . . . . 0.0 111.151 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 58.3 m -56.93 -32.25 65.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.838 -1.164 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -45.89 -14.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.5 m -82.23 24.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.1 -1.0 . . . . 0.0 109.949 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 71.95 29.65 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 109.764 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.1 t60 53.9 31.98 14.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 0.0 109.59 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.508 ' H ' HG23 ' A' ' 120' ' ' VAL . 39.1 mt-30 -150.32 121.52 3.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.97 153.26 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.732 2.288 . . . . 0.0 111.809 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 91.9 mm-40 -110.89 148.22 32.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.731 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.595 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 31.5 tpp -120.85 135.06 55.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.103 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -85.94 164.17 17.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.801 HE22 ' CG ' ' A' ' 185' ' ' ASN . 15.8 mm100 -142.91 43.08 1.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.835 . . . . 0.0 109.364 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.18 -164.6 1.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.483 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 40.3 m -158.91 -26.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.61 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.3 m -115.36 158.13 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.92 -13.78 60.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -92.87 -32.87 14.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 131' ' ' THR . 6.5 pt-20 -77.36 3.56 12.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -0.964 . . . . 0.0 109.409 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.89 126.09 91.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.695 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.12 128.24 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.159 2.573 . . . . 0.0 112.512 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.0 t -101.07 7.86 43.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 t -144.34 88.98 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.396 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.95 160.98 32.71 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.43 -40.29 28.93 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.801 2.334 . . . . 0.0 112.01 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.85 75.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.347 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 t -61.39 -46.95 88.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 147' ' ' LYS . 24.4 t70 -61.49 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.88 83.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 149' ' ' LEU . 9.3 tt -65.82 -39.79 91.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 109.537 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -55.66 -48.95 74.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' NZ ' ' OD2' ' A' ' 143' ' ' ASP . 61.0 mttp -62.96 -28.8 70.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.52 -47.51 69.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 145' ' ' LEU . 91.0 mt -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -57.45 -37.88 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -61.33 -40.06 92.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.402 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -68.06 -19.99 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 109.377 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.05 26.25 19.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 1.9 m-85 -85.23 135.87 33.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -101.73 175.0 5.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 55.66 46.92 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' GLY . 25.8 m -120.18 25.93 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.62 164.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.2 m -53.84 -31.27 48.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -1.089 . . . . 0.0 109.386 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 -47.3 76.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.83 -36.32 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.5 m -67.99 -48.82 64.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.287 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.92 -41.56 98.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.416 -0.803 . . . . 0.0 109.316 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.0 m -59.13 -38.5 79.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -60.68 -45.68 93.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mmm -58.91 -41.83 88.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.611 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -71.02 -31.34 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' VAL . 2.5 p -80.74 -63.98 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 109.472 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.683 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 158.04 -98.78 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mt 61.52 -22.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.683 ' H ' ' C ' ' A' ' 170' ' ' GLY . 12.9 m -132.39 143.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.595 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 6.1 m-20 -92.53 102.18 14.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.407 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.39 97.34 11.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.496 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.53 141.08 32.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 m -94.63 136.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.77 138.19 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.62 2.95 62.95 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 180' ' ' CYS . 7.6 m -153.24 155.06 35.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -1.163 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 1.7 t 71.01 3.87 4.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 3.2 m 62.71 56.36 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.538 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.578 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 0.5 OUTLIER -115.53 97.23 48.2 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.578 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 91.5 Cg_endo -86.67 -161.5 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.108 2.539 . . . . 0.0 112.353 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 94.38 5.42 61.93 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.801 ' CG ' HE22 ' A' ' 128' ' ' GLN . 84.7 m-20 -143.41 34.93 1.31 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.563 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -135.21 78.74 51.64 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--N 1.306 -1.7 0 C-N-CA 123.011 2.474 . . . . 0.0 112.309 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -94.05 145.62 24.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.74 HH21 HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -97.81 151.28 20.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 m -52.59 166.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.62 -17.53 61.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.506 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -76.51 6.91 5.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.427 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.9 p -78.83 133.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -71.47 162.56 29.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.935 . . . . 0.0 109.447 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.647 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 0.7 OUTLIER -84.07 1.23 44.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.92 144.87 73.12 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.74 -17.15 26.17 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.893 2.395 . . . . 0.0 112.102 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.81 -46.71 14.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -66.42 -44.58 82.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.434 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.74 HD11 HH21 ' A' ' 3' ' ' ARG . 15.2 tt -59.78 -42.17 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 14' ' ' ILE . . . -72.43 -41.59 66.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.504 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.54 ' OH ' ' NE1' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -59.62 -37.53 78.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.47 -43.45 85.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.7 p30 -91.63 1.09 57.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ALA . 31.5 t30 -63.59 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -153.08 -16.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.54 ' NE1' ' OH ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -50.13 145.89 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.32 -5.51 62.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.61 119.06 65.75 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.243 -1.151 . . . . 0.0 109.335 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.15 121.01 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.806 2.337 . . . . 0.0 111.855 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -103.72 138.92 39.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -134.63 0.31 2.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.033 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -81.26 118.7 22.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -53.81 -37.85 63.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.22 -42.09 94.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -70.98 -48.81 51.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.2 mp -64.49 -36.69 85.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.817 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 35' ' ' ILE . 20.8 t80 -61.42 -50.81 71.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.11 -28.97 65.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.421 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 47.5 tpp -57.28 -52.6 64.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.795 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.457 HD12 ' OE2' ' A' ' 38' ' ' GLU . 2.8 tp -65.83 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.971 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 78.4 m -74.48 -38.87 62.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.096 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.07 -50.08 51.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 109.887 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE2' HD12 ' A' ' 35' ' ' ILE . 25.9 pt-20 -62.82 -27.89 69.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.8 -33.97 28.62 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -63.79 -27.54 69.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.263 . . . . 0.0 109.776 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 56.9 tt0 -50.37 -41.3 51.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.93 112.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.669 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.17 -37.16 3.63 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 86' ' ' ILE . 25.9 mt -100.88 -140.4 0.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.172 . . . . 0.0 109.41 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 p -141.59 159.92 41.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.512 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 74.9 t-105 -57.08 -44.62 83.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.484 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 48' ' ' THR . 9.9 tp -56.87 -34.61 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 47' ' ' ILE . 69.4 m -70.63 -34.62 72.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.96 . . . . 0.0 109.723 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.3 t -70.16 -44.3 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.1 mt -53.26 -53.97 43.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.8 -45.6 82.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.097 -1.002 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 85' ' ' ILE . 63.5 mttm -79.79 -11.55 59.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 49' ' ' VAL . 27.5 ttt-85 -64.65 -48.54 74.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.189 -0.944 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 19.7 pt-20 -72.61 -39.25 67.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.809 . . . . 0.0 109.307 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -70.07 -41.55 73.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.294 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 32.2 t80 -60.2 -44.75 94.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.407 -0.808 . . . . 0.0 109.375 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' HIS . 52.2 mtp180 -58.57 -38.49 78.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.849 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.06 80.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 1.9 p -93.4 -12.83 28.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 37.6 m-85 -117.0 -54.21 2.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.941 -1.1 . . . . 0.0 110.173 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ARG . 74.8 t60 -54.87 -42.15 71.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.112 -0.992 . . . . 0.0 109.882 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -57.37 -35.26 69.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 46.8 m-85 -72.57 -22.7 60.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 131.44 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.005 . . . . 0.0 109.608 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -40.52 -34.29 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.93 2.42 . . . . 0.0 112.701 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.7 t -56.34 -49.77 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' MET . 53.6 mtpt -73.24 -30.27 63.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.848 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.519 ' O ' ' SD ' ' A' ' 71' ' ' MET . 62.1 t -56.02 -44.15 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.41 42.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.65 34.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 9.6 ptm -61.64 144.91 53.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.701 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -95.22 171.36 8.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.578 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.67 -33.53 68.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.451 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 49.3 mp0 -56.07 -36.91 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.86 -38.28 90.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.3 t -59.47 -44.51 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.1 -34.94 79.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.187 -0.945 . . . . 0.0 109.338 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -58.8 -43.86 90.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.338 -0.852 . . . . 0.0 109.783 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.8 mt -69.58 -32.63 71.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.97 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.15 -32.95 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -92.93 -51.96 4.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 87.4 m-20 -90.89 155.65 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.361 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.73 84.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -70.42 25.99 0.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 83' ' ' ALA . 2.5 pt -47.18 -97.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -1.176 . . . . 0.0 109.312 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.48 HD11 HD11 ' A' ' 44' ' ' LEU . 14.4 tt -114.55 131.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.653 ' HG2' HH11 ' A' ' 87' ' ' ARG . 8.9 mtt-85 -86.36 94.11 9.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -173.44 80.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -47.16 -33.8 5.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.938 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.01 -42.7 97.06 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -63.5 -44.53 94.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -1.193 . . . . 0.0 109.489 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.85 -43.71 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -57.16 -37.24 71.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.91 88.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.384 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -57.56 -42.71 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.83 . . . . 0.0 109.44 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.561 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 26.9 mm -54.1 -50.17 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.91 -32.2 80.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 24.4 m120 -62.86 -46.91 85.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -1.177 . . . . 0.0 109.414 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.77 83.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -64.57 -39.59 94.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.4 61.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.535 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -68.8 -48.39 63.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.55 -41.48 90.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.59 -38.87 91.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.543 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -35.39 80.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.44 -29.46 68.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -51.77 -19.88 1.87 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.496 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -75.73 -17.85 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.54 63.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.39 151.13 42.48 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -1.154 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -68.43 119.35 6.35 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.636 2.224 . . . . 0.0 111.675 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -74.32 -40.19 62.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.504 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.93 -49.99 73.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 118' ' ' SER . 89.5 m-20 -57.84 -54.3 48.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 111.064 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 57.8 t80 -53.69 -42.46 68.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 111.256 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.38 -59.56 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.974 -1.079 . . . . 0.0 111.662 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.614 ' CB ' HD21 ' A' ' 171' ' ' LEU . 59.2 p-90 -88.22 -21.28 24.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.735 -1.228 . . . . 0.0 111.122 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' VAL . 72.7 p -58.94 -28.59 66.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.825 -1.172 . . . . 0.0 109.77 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.01 -14.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.01 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.4 m -84.17 24.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.041 -1.037 . . . . 0.0 109.974 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.3 t-20 72.52 31.35 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.682 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 81.9 t60 53.05 33.47 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.539 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.547 ' H ' HG23 ' A' ' 120' ' ' VAL . 69.3 mt-30 -142.52 106.5 5.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.558 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -46.61 151.58 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.611 2.207 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.79 143.53 29.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.723 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.3 ttm -126.76 130.38 50.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.843 . . . . 0.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.0 OUTLIER -94.18 164.75 12.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.875 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -164.03 41.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 109.3 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.37 -176.72 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 109.67 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -76.53 -41.48 46.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.398 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.415 HG23 ' OG ' ' A' ' 133' ' ' SER . 1.2 t -147.44 175.0 11.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.11 -32.18 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.415 ' OG ' HG23 ' A' ' 131' ' ' THR . 85.4 p -57.46 -38.03 73.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.444 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.54 -32.01 72.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.47 131.96 89.73 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.78 138.59 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.152 2.568 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -84.59 4.25 33.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -140.96 88.47 2.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -94.9 174.8 3.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 139' ' ' THR . 35.9 Cg_exo -56.9 -42.24 66.66 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.07 74.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 t -60.97 -48.84 79.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.14 -41.36 94.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.04 89.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.2 tp -60.45 -48.27 82.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -55.33 -43.67 75.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -59.29 -37.87 78.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.544 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.24 -51.67 28.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 109.593 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -59.12 -41.68 88.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.09 -37.38 86.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.564 ' HG2' HH11 ' A' ' 152' ' ' ARG . 28.2 mtt-85 -64.15 -21.4 66.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.342 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.02 6.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 10.0 m-85 -96.1 137.08 35.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -1.116 . . . . 0.0 109.475 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -94.59 -166.98 1.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 31.6 p90 40.03 37.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.52 24.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.21 158.93 3.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -57.82 -29.82 65.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.1 m -66.94 -44.85 79.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.28 -37.79 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.15 -41.14 92.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.56 -44.01 97.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.431 -0.793 . . . . 0.0 109.337 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 22.9 t -57.71 -38.02 74.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -59.25 -41.77 89.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.399 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 57.6 mtt -63.91 -38.39 90.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.632 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -59.19 -38.94 81.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.687 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -80.44 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.542 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 37.3 t -49.96 -43.38 50.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.495 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.83 15.66 26.0 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.614 HD21 ' CB ' ' A' ' 117' ' ' TRP . 6.0 mp -51.71 -51.1 58.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.4 m -90.88 136.31 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 127' ' ' THR . 62.1 t30 -85.6 103.39 14.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.932 . . . . 0.0 109.447 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 63.6 t0 -96.52 115.43 27.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.526 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 51.2 m80 -159.82 15.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 177' ' ' VAL . 9.4 t 52.49 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.684 ' H ' HG12 ' A' ' 176' ' ' VAL . 10.4 p -94.94 -8.86 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.03 47.6 0.71 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 181' ' ' CYS . 4.8 t -146.49 170.11 17.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 109.516 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 72.1 m 53.55 -86.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.539 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.1 p -166.05 36.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 183' ' ' PRO . 27.5 t80 -90.71 117.3 67.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.545 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 84.5 Cg_endo -84.9 -171.67 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.081 2.52 . . . . 0.0 112.323 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 101.28 -5.71 55.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -107.9 23.38 14.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -1.196 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -142.9 79.89 14.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.947 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.307 -1.643 0 C-N-CA 123.007 2.471 . . . . 0.0 112.289 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mmm . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.307 0.575 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 52.4 mp0 -94.17 154.76 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.629 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.9 OUTLIER -146.71 161.08 41.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.01 161.35 30.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.56 -5.79 86.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -54.39 -33.64 59.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.483 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 14' ' ' ILE . 9.1 p -105.03 137.08 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 17.4 p -157.53 -136.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.505 ' N ' ' OG ' ' A' ' 8' ' ' SER . 51.7 mt-30 -61.22 -147.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.533 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 53.61 74.62 0.73 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.36 -27.62 13.89 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.9 2.4 . . . . 0.0 112.108 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.5 tt -73.17 -39.1 65.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.465 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -65.82 -53.75 35.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 7' ' ' VAL . 4.4 pt -63.79 -33.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.355 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.28 -43.71 83.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -72.87 -44.57 61.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 109.478 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.599 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 30.0 t-80 -64.0 -49.42 72.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.84 -34.06 74.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -65.38 -69.62 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.526 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.83 119.13 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.599 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 77.7 t90 -172.65 128.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.42 83.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.2 114.91 64.83 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.4 120.48 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.75 2.3 . . . . 0.0 111.896 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HB2' HD21 ' A' ' 31' ' ' LEU . 79.2 mm-40 -101.65 128.91 47.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.85 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.6 p -103.09 -4.4 24.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -79.71 117.81 20.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 0.0 109.367 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.0 m -59.64 -34.08 72.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 109.628 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.02 -46.23 85.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.87 -44.17 73.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 25' ' ' GLU . 84.3 mt -63.67 -47.18 82.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.835 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -60.7 -42.17 96.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.837 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -73.46 -30.46 63.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.6 tpp -63.0 -54.63 35.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 109.803 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 36' ' ' CYS . 3.4 tp -65.01 -35.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.998 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 35' ' ' ILE . 75.0 m -71.92 -44.21 64.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.072 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.7 -43.32 72.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -0.994 . . . . 0.0 109.845 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.31 -31.18 70.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.788 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.3 -32.94 22.8 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.2 -29.34 70.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -1.215 . . . . 0.0 109.7 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -51.92 -23.4 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.662 -179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.14 109.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 0.0 109.684 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.05 -32.23 5.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 23.2 mt -105.79 160.98 14.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 p -89.06 157.09 18.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.425 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -56.32 -29.6 61.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.639 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.16 -38.05 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.686 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.5 m -74.46 -33.14 62.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -58.27 -35.01 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.44 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.2 mt -54.69 -51.4 65.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.34 -46.32 89.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 56' ' ' TYR . 68.0 mmtt -71.18 -22.74 61.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.37 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -59.17 -47.59 84.74 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 109.001 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 57' ' ' ARG . 78.0 mm-40 -66.6 -44.35 82.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.398 -0.814 . . . . 0.0 109.394 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.6 -32.72 71.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.245 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.643 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 60.4 t80 -64.27 -45.96 85.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.464 -0.773 . . . . 0.0 109.403 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 54' ' ' GLU . 58.4 mtm180 -58.27 -42.3 86.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.75 73.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 110.303 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.504 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 10.7 m -94.92 -12.38 26.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.065 -1.022 . . . . 0.0 110.232 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 54.6 m-85 -123.83 -43.18 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.877 -1.139 . . . . 0.0 110.218 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 57' ' ' ARG . 36.4 t-80 -49.39 -43.12 43.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -67.78 -34.43 76.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.735 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 38.5 m-85 -71.29 -44.95 64.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 5.0 t70 73.85 136.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.066 -1.021 . . . . 0.0 109.613 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -41.16 -25.67 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.864 2.376 . . . . 0.0 112.739 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.97 -47.78 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -67.25 -49.65 63.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.841 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 69' ' ' ALA . 8.3 m -55.16 -44.32 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 109.541 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.594 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -66.48 -21.49 66.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.95 . . . . 0.0 109.445 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.74 1.28 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.369 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.4 mtm -78.83 159.4 27.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -104.34 168.83 8.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.54 -34.04 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 109.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.52 -37.45 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.902 . . . . 0.0 109.469 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.64 -38.33 90.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.466 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 80' ' ' VAL . 77.6 t -56.73 -42.97 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.625 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.97 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.336 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.424 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.7 ttt-85 -60.91 -47.04 88.25 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.458 ' O ' ' CA ' ' A' ' 84' ' ' GLY . 96.0 mt -69.68 -39.07 77.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.7 t -50.71 -33.1 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.722 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -91.69 -56.87 2.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -95.06 122.4 37.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.438 ' HB1' ' SG ' ' A' ' 59' ' ' CYS . . . 55.49 47.0 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.425 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -86.87 31.89 4.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.72 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 20.01 -116.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -1.13 . . . . 0.0 109.32 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.89 140.54 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.626 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -77.14 94.56 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.7 m170 -164.22 88.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.157 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 80' ' ' VAL . 54.1 mtp180 -51.24 -28.71 12.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.828 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.96 -42.5 77.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -60.88 -52.44 65.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -1.135 . . . . 0.0 109.577 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 89.3 mt -57.49 -50.73 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -57.33 -32.69 66.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.407 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.97 -40.14 94.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CE1' ' A' ' 60' ' ' PHE . 23.6 mm -58.41 -50.95 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 109.352 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 68' ' ' VAL . 80.0 mt -53.99 -48.22 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.578 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.35 -33.94 83.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 24.7 m120 -62.67 -40.43 97.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.428 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.13 -40.76 86.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.426 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 48.1 ttm-85 -59.17 -41.44 88.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -37.05 67.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.594 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 17.8 t80 -73.52 -48.61 31.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 103' ' ' LEU . 25.5 tp -58.36 -45.91 87.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.895 . . . . 0.0 109.472 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -63.33 -36.12 82.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.8 ttt -61.17 -43.17 99.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.132 -0.98 . . . . 0.0 109.459 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -71.9 -27.3 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.19 -31.93 33.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.04 0.84 34.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.21 40.1 34.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.82 82.37 49.42 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -1.182 . . . . 0.0 109.634 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -37.29 127.99 0.63 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.626 2.218 . . . . 0.0 111.732 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -63.98 -48.18 77.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.09 -41.3 71.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 110.678 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -62.42 -33.72 75.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 111.008 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.541 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 84.1 t80 -63.92 -52.55 59.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.064 -1.022 . . . . 0.0 111.241 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 116' ' ' VAL . 8.4 m -58.1 -41.42 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.0 111.692 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.512 ' O ' ' N ' ' A' ' 122' ' ' HIS . 59.6 m95 -63.88 -33.55 75.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.775 -1.203 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.4 t -66.03 -34.61 78.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.81 -1.181 . . . . 0.0 109.746 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.83 -43.01 99.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.101 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.4 p -87.76 24.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.947 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.51 22.05 7.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.641 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 117' ' ' TRP . 84.7 t60 49.27 45.68 23.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -151.37 114.91 3.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 138.72 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.716 2.277 . . . . 0.0 111.836 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.528 ' NE2' HG23 ' A' ' 120' ' ' VAL . 40.2 mt-30 -97.58 149.7 21.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 109.762 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -135.68 148.11 48.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.121 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 13.5 t -133.51 154.93 50.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 109.82 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -110.8 44.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.86 163.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.643 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 134' ' ' GLU . 9.0 m -116.23 -28.58 6.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 109.361 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 132' ' ' LEU . 1.7 t -142.06 -179.9 6.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.412 ' N ' ' OG1' ' A' ' 131' ' ' THR . 39.5 mt -64.23 -35.95 82.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -67.27 -29.57 69.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 130' ' ' THR . 40.0 mm-40 -63.15 -20.14 65.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.445 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.6 mp -67.04 119.83 67.25 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 109.698 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.19 130.68 5.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.065 2.51 . . . . 0.0 112.472 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.24 11.12 40.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 109.324 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.1 p -138.52 88.41 2.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.86 154.8 37.21 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.09 -32.11 94.27 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.813 2.342 . . . . 0.0 112.08 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.51 -40.89 48.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.4 p -62.51 -41.25 98.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.86 -48.08 75.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.41 82.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -47.41 84.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.85 . . . . 0.0 109.51 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.5 m -55.92 -43.62 77.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.47 -35.9 78.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.513 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.65 -52.59 36.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.952 . . . . 0.0 109.531 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.8 mp -63.58 -38.11 89.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -61.35 -39.69 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.406 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.4 -37.05 85.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' A' ' 152' ' ' ARG . 44.9 mtt-85 -64.32 -23.24 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.404 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.74 10.51 16.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -74.68 137.74 42.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -1.115 . . . . 0.0 109.523 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.597 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -97.97 -168.4 1.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 21.8 p90 39.53 38.32 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.509 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 157' ' ' VAL . 3.1 m -97.68 24.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.52 155.18 3.98 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 57.0 m -54.91 -30.4 58.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.451 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.1 m -67.03 -47.91 69.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -64.95 -37.08 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.53 -42.16 92.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.31 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.99 -43.51 98.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.3 m -57.4 -37.32 72.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 109.265 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.92 -39.94 91.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.452 ' SD ' HD12 ' A' ' 171' ' ' LEU . 64.3 mmm -66.11 -49.24 68.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.656 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.511 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 28.3 mm100 -69.24 -41.93 76.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.715 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.54 84.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.98 -45.28 71.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.09 12.3 22.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.467 HD23 ' CH2' ' A' ' 117' ' ' TRP . 83.0 mt -58.64 -31.31 68.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.7 p -122.66 139.95 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.434 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -97.28 105.25 17.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 97.8 m-20 -94.76 97.58 10.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.506 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -139.7 150.23 44.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 m -68.75 -160.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.43 139.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.43 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 81.1 29.32 41.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.2 m -149.82 162.02 41.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.465 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 80.8 m 52.52 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.553 ' N ' ' O ' ' A' ' 179' ' ' CYS . 22.4 p -169.96 24.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' A' ' 183' ' ' PRO . 74.0 t80 -69.17 131.86 90.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.685 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.545 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 92.6 Cg_endo -80.28 -158.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 123.078 2.518 . . . . 0.0 112.397 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.514 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . 98.98 -9.84 61.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 184' ' ' GLY . 31.0 m120 -155.79 30.38 0.36 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.134 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -99.06 152.4 37.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 C-N-CA 123.123 2.549 . . . . 0.0 112.265 179.656 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.23 0.538 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -74.8 147.95 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.535 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -149.04 171.66 16.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 p -46.13 160.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.71 -0.78 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -78.26 8.69 4.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.6 p -130.14 130.87 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.922 . . . . 0.0 109.455 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.506 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 12.0 p -173.95 54.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 8' ' ' SER . 89.7 mm-40 -137.58 -135.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.34 153.91 4.75 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.335 -0.853 . . . . 0.0 109.448 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.7 -11.44 31.91 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.791 2.328 . . . . 0.0 112.174 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.48 -36.4 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.442 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 87.4 m-85 -73.67 -54.72 7.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.46 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.24 -48.9 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.342 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.96 87.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.59 -41.22 94.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 13' ' ' TYR . 28.1 m80 -62.99 -45.9 90.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.5 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.51 -37.26 51.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.479 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -57.94 -60.47 3.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -153.69 104.98 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.534 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -171.28 116.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.38 6.18 71.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' CYS . 2.3 t -110.68 104.12 55.5 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.245 -1.15 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.65 132.03 16.29 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.765 2.31 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.22 136.26 52.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.779 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.4 p -104.91 0.72 28.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.096 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -77.79 123.48 26.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.795 . . . . 0.0 109.35 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.3 p -66.84 -33.26 75.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 109.638 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -59.06 -43.54 91.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.152 -0.967 . . . . 0.0 109.771 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.57 -50.61 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.47 -38.51 77.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.16 -41.47 92.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 109.841 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' ' HG ' ' A' ' 36' ' ' CYS . 97.5 mt-10 -73.81 -31.06 63.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 109.84 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.48 -52.96 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.0 tp -55.1 -42.58 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.0 109.989 -178.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 30.7 p -72.81 -48.83 34.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.141 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 84.8 mt -65.75 -29.93 70.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.075 -1.016 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -51.77 -36.87 49.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.77 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.65 -29.29 61.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.04 -34.51 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.4 tt0 -57.68 -32.86 67.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.0 109.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 109.645 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.52 3.37 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.5 mm? -85.94 -160.01 0.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -1.192 . . . . 0.0 109.455 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 m -118.53 152.32 36.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -56.07 -33.24 64.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 0.0 109.513 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -29.56 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 109.611 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.2 m -64.78 -39.61 93.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.5 t -61.99 -38.91 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 mt -55.69 -55.13 35.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 51' ' ' LYS . 9.4 mtmp? -60.38 -45.12 94.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.325 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.476 ' NZ ' ' CG1' ' A' ' 86' ' ' ILE . 1.0 OUTLIER -68.91 -29.45 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.351 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.601 ' HG2' HH11 ' A' ' 53' ' ' ARG . 2.5 ttt-85 -54.27 -43.08 70.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.15 -0.968 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.99 -43.78 70.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.435 -0.791 . . . . 0.0 109.376 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -65.61 -43.87 88.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t80 -60.88 -44.72 96.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.389 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 42.9 ttp180 -59.68 -27.31 66.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 109.77 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.44 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.425 -0.797 . . . . 0.0 110.265 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.0 m -92.89 -20.85 20.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.133 -0.979 . . . . 0.0 110.262 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 27.9 m-85 -102.75 -52.43 3.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.976 -1.077 . . . . 0.0 110.16 -178.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t60 -54.0 -39.14 65.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.972 -1.08 . . . . 0.0 109.88 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -56.32 -37.92 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' ASP . 54.9 m-85 -91.36 3.85 53.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 0.0 109.956 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 57.45 162.57 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.604 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.52 -28.49 8.31 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.904 2.403 . . . . 0.0 112.746 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -62.95 -48.96 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.681 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 71' ' ' MET . 91.1 mttt -65.51 -34.58 78.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.846 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 64' ' ' ASP . 55.8 t -56.09 -39.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -72.05 -34.31 68.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.1 16.53 22.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.361 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' LYS . 20.7 ttp -79.65 159.87 26.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.7 159.86 16.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.79 -25.17 62.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.48 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -55.68 -44.02 76.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 63.6 m-20 -61.83 -38.37 87.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.08 -41.44 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.58 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.18 -38.76 84.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 75' ' ' ASP . 72.8 mtm180 -68.94 -39.93 79.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.392 -0.817 . . . . 0.0 109.799 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.57 -46.45 69.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.3 t -51.78 -31.59 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.751 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.01 -57.61 3.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.515 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.79 126.37 44.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 51.89 47.05 25.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -75.85 15.56 4.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.615 ' C ' ' O ' ' A' ' 84' ' ' GLY . 3.9 pt 28.88 90.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.107 . . . . 0.0 109.346 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 85' ' ' ILE . 79.0 mt 58.02 151.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.541 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 53.8 mtm-85 -89.01 105.39 17.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 16.8 m-70 -163.47 61.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.219 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -47.56 -35.86 9.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.33 88.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 2.6 tppt? -73.41 -41.93 62.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -1.173 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.67 -53.53 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.609 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -56.36 -33.32 65.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.977 . . . . 0.0 109.323 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -59.55 -37.79 79.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.38 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.19 -40.49 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.4 mt -54.41 -45.68 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.8 -37.93 93.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 59.3 m-20 -58.53 -42.73 88.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -1.187 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.8 77.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 43.0 ttm-85 -59.1 -39.56 82.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.73 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.579 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -59.39 -48.32 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.39 -41.5 98.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.432 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.2 -44.19 96.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 109.563 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.85 -43.18 75.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.943 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.64 -26.66 65.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -52.49 -27.34 15.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.546 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -75.95 -14.04 60.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.472 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.95 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -94.9 114.71 64.26 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.713 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -46.27 125.48 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.614 2.209 . . . . 0.0 111.698 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.89 -34.44 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.87 -49.31 59.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.176 -0.952 . . . . 0.0 110.685 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 118' ' ' SER . 86.2 m-20 -56.06 -55.63 30.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 111.079 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -56.11 -38.23 70.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 111.21 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 117' ' ' TRP . 2.4 t -55.93 -59.64 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 111.66 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.632 ' CB ' HD21 ' A' ' 171' ' ' LEU . 57.8 p-90 -88.97 -20.48 24.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.806 -1.184 . . . . 0.0 111.173 -178.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -60.41 -28.04 67.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.754 -1.216 . . . . 0.0 109.72 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.015 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 5.4 m -92.15 24.6 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 109.964 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 5.3 t-20 79.23 19.49 0.75 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 59.94 48.16 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.533 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.9 pt20 -154.15 147.97 18.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.92 154.78 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.652 2.234 . . . . 0.0 111.815 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 19.9 mp0 -122.83 152.85 40.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 0.0 109.725 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 61.1 mtt -136.49 155.01 50.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -135.25 158.81 43.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.924 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 128' ' ' GLN . 7.6 mp0 -117.27 47.35 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.324 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.15 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 m -83.98 -41.25 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 132' ' ' LEU . 29.6 m -131.85 164.55 25.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.522 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.5 mp -69.62 -11.0 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.1 m -85.12 -35.75 21.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -12.5 61.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -178.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.414 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 85.2 mt -68.52 118.0 55.69 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.767 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.01 128.63 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.63 -19.55 48.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.336 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 m -87.42 102.65 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.328 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.9 p -121.34 150.31 53.99 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.96 -40.71 33.16 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.746 2.297 . . . . 0.0 112.042 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.16 -38.75 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.4 m -61.33 -45.46 94.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.39 -44.57 94.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -41.3 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.515 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.31 -44.36 88.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.7 t -57.48 -42.32 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -62.62 -35.24 78.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.33 -51.91 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.03 -34.35 74.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -58.37 -36.43 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HB2' HH11 ' A' ' 152' ' ' ARG . 59.8 mttp -62.1 -39.28 91.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.421 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.7 mpt_? -63.79 -21.26 66.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.26 22.23 10.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.48 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 11.8 m-85 -83.27 133.4 34.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -101.67 170.33 8.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 53.35 47.88 23.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.617 HG22 ' SG ' ' A' ' 162' ' ' CYS . 10.7 p -122.32 26.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.417 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.76 170.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.9 t -59.0 -31.63 68.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -1.169 . . . . 0.0 109.427 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.465 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -62.98 -47.21 84.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 -179.877 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.96 -39.95 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.499 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 157' ' ' VAL . 79.9 m -67.21 -41.71 85.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.414 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 75.9 t80 -60.25 -45.39 93.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.467 -0.771 . . . . 0.0 109.348 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 m -58.85 -39.17 80.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.304 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -41.96 96.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.0 mtp -56.54 -41.7 77.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.81 -36.41 83.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.677 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.04 75.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.546 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 9.1 t -71.15 -62.89 1.23 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.466 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.17 15.32 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.632 HD21 ' CB ' ' A' ' 117' ' ' TRP . 8.4 mp -52.79 -52.36 57.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.39 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -102.24 135.66 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.94 101.73 14.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 11.3 p30 -91.76 115.63 28.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -142.23 162.15 36.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.472 ' CG2' ' SG ' ' A' ' 179' ' ' CYS . 19.5 m -115.74 144.19 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.05 -34.54 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.76 -29.1 57.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 176' ' ' VAL . 52.7 m -82.29 146.82 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -1.216 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.2 t -65.53 -29.29 69.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 182' ' ' TYR . 30.0 p -49.74 -45.0 48.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.62 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 183' ' ' PRO . 22.9 t80 -100.89 114.83 65.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 87.9 Cg_endo -86.16 -167.45 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.11 2.54 . . . . 0.0 112.333 178.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.61 63.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -85.78 9.15 17.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -1.133 . . . . 0.0 109.586 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -145.54 78.85 11.74 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.928 . . . . 0.0 109.489 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 123.027 2.485 . . . . 0.0 112.286 -179.77 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 2' ' ' GLU . 19.3 tmm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.252 0.548 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.49 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 79.4 mm-40 -84.32 152.24 24.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.433 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 7.4 tpt180 -132.64 143.68 49.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.3 m -47.07 138.25 6.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.15 22.49 12.24 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 6' ' ' TRP . 40.6 p-90 -147.09 52.85 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.0 109.475 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 p -152.07 -16.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.6 p -84.32 14.1 4.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -54.67 -39.97 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.39 159.59 1.38 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.35 -35.04 43.12 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.79 2.327 . . . . 0.0 112.14 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 12' ' ' LEU . 31.7 tp -61.04 -37.8 83.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.813 . . . . 0.0 109.48 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.47 -44.5 90.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.52 -43.96 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 109.383 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.39 98.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.34 -40.82 98.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -63.59 -48.0 79.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.58 -33.14 72.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -51.53 -51.11 57.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.22 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CD2' ' N ' ' A' ' 22' ' ' GLY . 46.4 t90 -144.77 147.92 33.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.518 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 21' ' ' TRP . . . 86.39 -29.28 4.88 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 169' ' ' CYS . 32.8 m -72.15 145.64 88.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.26 120.04 6.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.778 2.319 . . . . 0.0 111.893 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.495 ' OE1' ' SG ' ' A' ' 169' ' ' CYS . 74.3 mt-10 -95.33 128.04 41.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.952 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -133.98 -3.08 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.058 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -81.44 137.08 35.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 p -61.91 -38.12 87.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.585 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.94 -49.37 62.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -64.61 -38.68 91.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.845 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.499 HD11 ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -73.3 -33.97 65.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -65.17 -48.13 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.878 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -65.61 -30.41 71.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.821 -178.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.5 tpt -70.72 -53.37 15.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.19 -34.11 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.994 -178.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -72.18 -49.52 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 110.123 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.3 -39.5 78.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 50.4 mm-40 -57.08 -35.87 69.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.66 -31.25 57.55 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -63.75 -31.52 72.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.237 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 38' ' ' GLU . 5.1 pt20 -52.64 -23.44 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 -179.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.19 108.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.965 . . . . 0.0 109.665 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.9 -33.3 2.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.397 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -87.69 169.52 12.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.5 p -82.11 165.01 20.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -67.81 -35.29 78.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.506 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.19 -39.1 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.639 -179.7 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.476 ' N ' HG23 ' A' ' 47' ' ' ILE . 92.5 m -49.92 -35.76 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.645 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.45 -29.81 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.49 -56.47 9.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -60.92 -37.29 81.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.152 -0.967 . . . . 0.0 109.265 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' TYR . 53.1 tttm -73.91 -26.69 60.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -57.7 -48.9 78.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.242 -0.911 . . . . 0.0 108.989 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.32 -47.69 69.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.841 . . . . 0.0 109.284 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.61 -34.54 78.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 29.7 t80 -59.47 -47.43 85.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.321 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -57.1 -30.85 64.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.779 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.04 93.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.7 m -94.32 -13.1 26.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.072 -1.017 . . . . 0.0 110.262 -178.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 43.2 m-85 -111.26 -52.78 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.937 -1.102 . . . . 0.0 110.201 -178.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -52.94 -36.96 60.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 109.87 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -55.55 -33.7 64.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.3 m-85 -97.08 4.9 51.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 0.0 109.864 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.22 164.52 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.04 -1.038 . . . . 0.0 109.609 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.37 -34.06 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.869 2.379 . . . . 0.0 112.713 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.93 -49.12 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' MET . 46.4 mtpt -65.1 -35.17 80.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.84 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 64' ' ' ASP . 54.7 t -54.81 -40.3 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 109.557 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -35.49 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.913 . . . . 0.0 109.462 179.04 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.39 15.31 26.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.1 tmm? -83.86 149.64 26.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.406 ' O ' ' SD ' ' A' ' 71' ' ' MET . 14.9 pt20 -102.97 167.04 10.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.42 -28.12 69.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -56.54 -44.36 80.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.497 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.57 -38.72 81.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.612 ' O ' HG23 ' A' ' 80' ' ' VAL . 77.4 t -60.98 -45.64 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.02 -31.63 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -68.0 -48.47 65.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.336 -0.853 . . . . 0.0 109.795 -178.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.3 pp -80.5 -20.13 44.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.635 -178.12 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 76' ' ' VAL . 6.0 t -54.35 -45.14 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.908 . . . . 0.0 109.774 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -58.04 -50.54 73.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.498 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -99.67 107.05 19.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 178.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.09 74.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.41 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.41 -23.89 4.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' GLY . 21.2 pt -56.46 -164.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 109.352 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.28 136.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -92.44 96.52 10.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 10.9 m80 -165.69 87.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.595 ' HG2' HH11 ' A' ' 89' ' ' ARG . 1.4 ptt-85 -47.31 -29.34 2.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.992 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.03 97.89 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -62.61 -45.07 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.451 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.503 HG21 HG13 ' A' ' 76' ' ' VAL . 98.3 mt -56.8 -42.2 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 76' ' ' VAL . 98.0 mm-40 -60.27 -37.82 81.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.12 78.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mm -62.57 -40.92 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -57.04 -40.67 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.8 -40.68 99.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -57.38 -47.65 81.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.458 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.71 -42.84 85.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -63.88 -43.71 95.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.88 -38.1 58.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -66.63 -48.6 68.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.43 -42.49 87.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.46 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.55 -41.97 87.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.576 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -40.4 96.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.68 -27.07 64.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -51.99 -17.73 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.487 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 78.5 m-20 -74.88 -16.25 60.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.04 19.2 65.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.3 mp0 -115.87 151.93 46.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.188 -1.184 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.06 123.53 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.535 2.156 . . . . 0.0 111.696 179.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -76.18 -43.48 42.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 110.43 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -60.69 -49.85 75.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.095 -1.003 . . . . 0.0 110.704 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 92.1 m-20 -51.56 -36.36 44.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 111.019 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.39 -47.92 21.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 111.207 -177.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -56.34 -46.52 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.017 . . . . 0.0 111.653 -175.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' HG13 ' A' ' 116' ' ' VAL . 16.9 p-90 -88.18 -27.85 21.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.745 -1.222 . . . . 0.0 111.131 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 120' ' ' VAL . 10.2 t -56.08 -29.26 60.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.871 -1.143 . . . . 0.0 109.772 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.25 -13.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' SER . 14.1 m -82.54 24.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.051 -1.03 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.573 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 13.6 t-20 74.17 17.21 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 109.68 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER 66.68 -13.35 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 121' ' ' ASN . 77.5 mt-30 -86.37 150.61 52.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.72 149.59 73.4 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.631 2.221 . . . . 0.0 111.849 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -110.27 145.66 37.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.3 mtt -135.84 152.55 51.18 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.173 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 173' ' ' ASN . 10.6 t -94.73 160.65 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.29 49.63 1.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 109.317 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.99 135.05 42.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.682 -179.356 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.8 m -76.05 -34.29 59.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.32 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.3 m -127.34 159.22 35.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.7 mt -56.26 -30.89 63.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.7 p -71.81 -29.94 64.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.82 1.12 15.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.11 119.81 67.29 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.766 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.92 130.05 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.144 2.562 . . . . 0.0 112.544 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 t -104.63 12.58 32.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.268 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -139.0 92.41 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 161.64 22.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.9 -39.55 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.829 2.352 . . . . 0.0 111.975 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.59 73.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.2 m -59.95 -45.97 90.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.26 -42.2 99.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.38 -43.2 67.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -60.55 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -53.84 -43.27 69.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -62.45 -33.74 75.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.49 -51.19 38.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -33.16 72.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.589 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -58.36 -39.23 79.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.356 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.99 -40.48 97.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 109.443 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.45 -20.46 66.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.18 32.42 7.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.43 132.11 37.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.94 174.85 6.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 53.24 48.03 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLY . 5.4 m -115.2 26.22 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.07 167.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 159' ' ' THR . 1.0 OUTLIER -61.35 -28.31 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -1.158 . . . . 0.0 109.417 -179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -70.32 -41.26 73.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.425 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.43 -47.82 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.0 p -64.28 -38.81 92.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.263 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.542 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 53.7 t80 -62.26 -46.5 88.54 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -61.6 -37.86 85.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.275 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.499 ' CE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -61.71 -55.07 34.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 179.692 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.455 ' N ' ' CG ' ' A' ' 165' ' ' PHE . 48.0 mtm -63.72 -41.31 98.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.646 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -66.41 -42.92 87.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 -42.32 75.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 109.697 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' ' OE1' ' A' ' 25' ' ' GLU . 3.5 m -60.91 -61.1 2.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.413 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 144.31 1.78 0.89 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 171' ' ' LEU . 4.3 mm? -57.43 -43.12 83.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 109.396 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.75 136.57 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 127' ' ' THR . 86.7 m-20 -87.95 112.58 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.429 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -86.82 110.02 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.532 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -153.8 126.69 8.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.558 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.26 137.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.491 HG22 ' ND2' ' A' ' 185' ' ' ASN . 43.4 t -59.75 135.68 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.43 5.71 60.22 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 16.4 p -77.15 -150.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.491 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.53 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 71.9 m -57.85 -39.6 78.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 0.9 OUTLIER 173.15 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.979 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.3 OUTLIER -118.17 94.93 47.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.519 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 95.4 Cg_endo -87.28 -166.63 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 123.024 2.482 . . . . 0.0 112.416 178.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 93.78 8.23 60.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.491 ' ND2' HG22 ' A' ' 177' ' ' VAL . 11.5 p30 -142.92 32.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -1.161 . . . . 0.0 109.624 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -138.56 78.8 31.1 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--N 1.306 -1.707 0 C-N-CA 123.071 2.514 . . . . 0.0 112.237 -179.924 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -90.27 145.83 24.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -148.8 154.32 39.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.881 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' ARG . 14.2 m 55.76 167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.0 109.397 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.93 -29.13 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -72.85 -0.0 12.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' SER . 7.1 p -108.88 134.72 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 167.27 0.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -79.26 -130.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.877 . . . . 0.0 109.484 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 152.08 14.28 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.96 -11.47 32.33 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.863 2.376 . . . . 0.0 112.137 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.4 tt -63.28 -38.72 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -59.82 -47.93 83.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.7 mt -66.64 -41.6 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.359 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -46.84 87.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CD1' HD22 ' A' ' 50' ' ' LEU . 64.9 t80 -66.97 -41.46 86.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -59.97 -42.18 93.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.87 -10.71 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -78.29 -76.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.433 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.44 101.53 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -170.04 126.47 0.83 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.69 -29.15 8.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.5 m -72.17 149.33 91.85 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.23 -1.159 . . . . 0.0 109.32 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.43 119.29 6.3 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.776 2.317 . . . . 0.0 111.89 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -112.67 132.87 54.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.804 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 p -134.87 3.06 3.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.029 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -80.72 122.37 27.04 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.364 -0.835 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 t -58.69 -39.81 81.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.25 -43.22 82.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.723 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.35 -50.77 50.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -67.81 -35.72 79.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.88 -45.59 93.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -74.61 -31.27 61.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.77 -179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.7 ttm -71.67 -54.59 9.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.723 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 36' ' ' CYS . 2.9 tp -59.37 -40.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 0.0 110.035 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.52 ' N ' HG23 ' A' ' 35' ' ' ILE . 76.7 m -72.76 -46.43 53.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.123 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD2' ' NH1' ' A' ' 53' ' ' ARG . 9.6 tp -69.8 -33.71 72.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.01 . . . . 0.0 109.863 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -52.15 -34.94 46.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.803 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.455 ' HA3' ' HZ1' ' A' ' 91' ' ' LYS . . . -52.23 -27.0 22.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.15 -31.94 72.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -1.22 . . . . 0.0 109.777 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.62 -26.34 63.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.965 . . . . 0.0 109.728 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.59 109.08 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.694 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.91 -29.95 4.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.3 mt -100.45 163.73 12.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.429 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -87.39 164.86 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.384 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -59.38 -40.95 88.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 109.505 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 48' ' ' THR . 9.0 tp -54.53 -39.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.653 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 47' ' ' ILE . 88.8 m -61.37 -36.27 79.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -69.75 -40.1 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 16' ' ' TYR . 79.2 mt -57.12 -54.92 41.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -57.62 -47.41 82.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -68.66 -29.86 68.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttm-85 -50.74 -47.11 59.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 108.987 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.35 -43.68 73.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.515 -0.741 . . . . 0.0 109.406 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -67.12 -37.3 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 0.0 109.229 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 7.5 t80 -63.19 -43.89 96.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.374 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.533 ' HG2' HH11 ' A' ' 57' ' ' ARG . 43.7 mtt-85 -58.41 -39.2 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.31 77.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.458 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 85.6 m -92.39 -12.92 30.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 110.244 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 5.9 m-85 -115.97 -49.09 2.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.932 -1.105 . . . . 0.0 110.153 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.4 t60 -49.86 -42.48 47.72 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.066 -1.021 . . . . 0.0 109.877 -178.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -65.15 -30.14 71.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.789 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.434 ' O ' ' O ' ' A' ' 64' ' ' ASP . 50.2 m-85 -88.13 -0.2 56.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.833 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 56.14 165.65 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.049 -1.032 . . . . 0.0 109.596 -179.747 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.649 ' O ' HG22 ' A' ' 68' ' ' VAL . 72.6 Cg_endo -78.72 -54.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.832 2.355 . . . . 0.0 112.709 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 t -47.22 -33.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -68.7 -44.11 74.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.341 -0.849 . . . . 0.0 109.827 -177.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 65' ' ' PRO . 1.4 m -56.99 -39.92 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.616 -178.048 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -64.18 -39.37 93.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.473 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.93 23.54 7.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 109.373 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.407 ' HG3' ' H ' ' A' ' 72' ' ' GLN . 11.5 ttp -93.53 160.37 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 109.626 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.407 ' H ' ' HG3' ' A' ' 71' ' ' MET . 95.2 mt-30 -101.46 166.5 10.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.3 mt-10 -70.52 -21.93 62.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.13 -31.15 65.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.94 . . . . 0.0 109.468 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.05 -38.23 87.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.424 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 76' ' ' VAL . 10.5 m -73.57 -29.32 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 80' ' ' VAL . 44.5 tp10 -67.11 -36.38 81.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 -178.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 13.3 ptm180 -77.87 -41.9 35.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.897 ' O ' HD12 ' A' ' 79' ' ' LEU . 1.2 pp -81.46 -7.13 59.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.953 . . . . 0.0 109.637 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 81' ' ' GLN . 9.3 p -49.37 -42.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.688 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.537 ' N ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -90.42 20.91 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.006 . . . . 0.0 109.441 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.1 t0 -74.94 121.39 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.378 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.54 0.34 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 65.65 43.3 94.6 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -58.55 -165.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 86' ' ' ILE . 18.9 tt -56.02 127.89 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 87' ' ' ARG . 9.4 ptm180 -73.24 95.41 2.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -171.83 69.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -45.02 -36.15 3.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.904 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.03 98.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 33.8 tptt -62.43 -43.23 99.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.478 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 92' ' ' ILE . 18.2 mt -54.64 -50.56 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.62 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.89 -30.61 69.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.985 . . . . 0.0 109.384 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -58.78 -44.47 90.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.9 mp -56.28 -39.8 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 68' ' ' VAL . 87.9 mt -62.81 -29.23 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.77 -45.13 77.4 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -64.86 -38.02 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -1.185 . . . . 0.0 109.428 -178.548 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.59 80.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -59.53 -43.87 93.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.36 -30.41 66.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.93 -47.25 87.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.28 -44.77 86.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.94 -44.68 94.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.482 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.61 -41.61 79.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -71.45 -27.4 63.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.485 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -52.56 -23.26 6.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.425 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -75.35 -13.11 60.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.84 48.8 6.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -135.34 150.93 73.9 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.187 -1.184 . . . . 0.0 109.653 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.23 119.14 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.571 2.181 . . . . 0.0 111.677 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -75.28 -40.76 58.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.439 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 -48.17 69.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 110.725 -178.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 118' ' ' SER . 44.3 t0 -55.1 -55.28 32.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 111.096 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -55.66 -38.59 69.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 111.249 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.97 -59.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 0.0 111.646 -178.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.43 ' O ' HG22 ' A' ' 120' ' ' VAL . 61.1 p-90 -87.79 -28.1 21.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.663 -1.273 . . . . 0.0 111.125 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 120' ' ' VAL . 94.1 p -56.34 -26.03 51.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.816 -1.178 . . . . 0.0 109.769 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.47 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.056 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 118' ' ' SER . 10.7 m -89.56 25.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 23.8 t30 80.01 22.06 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.696 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 59.46 49.75 8.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.499 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.476 ' H ' HG23 ' A' ' 120' ' ' VAL . 2.6 pt20 -154.61 146.46 17.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.37 143.36 43.1 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.642 2.228 . . . . 0.0 111.778 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -100.25 151.35 21.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 109.746 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -136.03 156.89 48.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.176 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.4 t -129.82 164.12 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -133.16 50.88 2.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -94.23 142.2 27.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.704 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 m -92.43 -27.69 17.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 109.361 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -126.15 156.73 39.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -57.88 -34.76 70.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 m -62.35 -36.67 82.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.68 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.8 mt-10 -63.67 -28.84 70.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.1 mt -67.08 116.55 37.06 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.11 130.19 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.11 2.54 . . . . 0.0 112.503 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.75 -8.15 58.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.5 p -101.05 101.84 12.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.378 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.82 151.78 52.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.31 -33.84 97.81 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.75 2.3 . . . . 0.0 112.009 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.89 -35.2 57.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.359 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.9 p -62.8 -34.62 77.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.92 -51.01 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.43 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.429 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.617 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -55.68 -50.14 71.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.6 t -63.81 -42.49 97.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -60.7 -36.98 80.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.03 -51.63 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -32.94 74.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.536 ' HZ2' ' CG1' ' A' ' 157' ' ' VAL . 14.9 mmtm -59.84 -38.37 81.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.397 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -61.72 -36.93 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -69.04 -19.81 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.24 27.16 9.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -1.121 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -112.43 169.37 8.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 51.6 50.78 18.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.0 p -120.14 27.05 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.414 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.95 159.46 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 33.5 m -53.2 -29.63 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -1.195 . . . . 0.0 109.492 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.2 p -62.42 -42.26 99.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.5 mp -63.95 -47.61 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.84 -42.61 99.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.306 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.15 -45.13 91.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.461 -0.774 . . . . 0.0 109.357 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.5 m -62.72 -40.25 96.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.306 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -35.13 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -65.39 -52.47 53.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -38.22 84.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.31 -0.869 . . . . 0.0 109.681 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.96 85.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.694 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.522 ' O ' ' O ' ' A' ' 23' ' ' VAL . 64.5 m -81.45 -62.44 1.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.373 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.52 2.74 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.88 -47.51 43.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.26 136.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.404 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.464 ' O ' HG22 ' A' ' 127' ' ' THR . 40.3 m-20 -100.76 108.14 19.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 38.5 p30 -116.95 92.22 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -108.72 9.37 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 179' ' ' CYS . 4.2 t 56.59 101.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.3 p -54.99 -34.84 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.38 -44.1 97.34 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 181' ' ' CYS . 12.4 t -105.37 -178.85 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.55 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 12.1 t 55.09 5.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.875 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 8.7 p 42.22 25.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 1.4 t80 -67.02 117.38 45.22 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 109.572 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.567 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.4 Cg_endo -83.17 -155.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 123.121 2.547 . . . . 0.0 112.369 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.24 57.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -149.59 32.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -1.131 . . . . 0.0 109.586 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -83.61 153.12 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.306 -1.686 0 C-N-CA 123.021 2.48 . . . . 0.0 112.284 179.916 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mmt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.267 0.556 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' OE1' ' SG ' ' A' ' 179' ' ' CYS . 95.2 mt-10 -89.24 153.95 20.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 3' ' ' ARG . 4.4 ptm180 -148.44 171.79 15.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.8 m -47.93 112.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -71.39 -29.34 68.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -53.41 -7.97 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.466 -179.647 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.489 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 12.7 p -56.66 134.43 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 t -65.66 140.84 58.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -64.83 -31.45 72.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.38 143.82 6.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -32.3 9.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.829 2.353 . . . . 0.0 112.14 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.01 -41.95 99.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.23 -45.62 76.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.413 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.69 -43.97 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.92 97.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.447 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 74.0 t80 -62.41 -41.64 98.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.8 t-80 -61.92 -45.32 94.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -79.95 -47.43 15.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -56.55 -42.73 79.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.527 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' HIS . 77.4 mm-40 -138.62 -150.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.463 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 20' ' ' GLU . 11.0 t90 59.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.32 72.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.89 115.39 64.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.215 -1.168 . . . . 0.0 109.423 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.99 121.69 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.758 2.305 . . . . 0.0 111.851 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -117.95 136.17 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.854 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 p -121.26 6.47 10.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.9 . . . . 0.0 109.042 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.287 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.719 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 15.1 m -74.61 -32.61 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -59.11 -52.4 65.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 109.753 -178.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -64.17 -43.42 95.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.872 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 113' ' ' ALA . 9.1 mp -74.32 -31.88 62.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.816 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 28' ' ' SER . 47.7 t80 -62.81 -47.78 81.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.95 . . . . 0.0 109.854 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.1 pp20? -75.2 -30.19 60.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 8.1 tpt -66.78 -53.12 36.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -63.06 -33.21 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.566 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 83.5 m -71.2 -49.49 42.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.31 -35.93 66.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 32.3 mm-40 -53.93 -33.05 55.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.786 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.81 97.7 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 36' ' ' CYS . 2.2 mp0 -70.0 -24.79 63.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.807 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -45.28 -27.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -178.894 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.77 123.86 7.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.31 -29.77 4.68 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.34 -166.46 1.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -123.83 152.25 42.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -53.78 -39.88 65.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.671 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -63.58 -39.4 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.684 -179.182 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.511 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 88.2 m -66.46 -36.74 83.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.719 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.13 -44.85 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.395 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.5 mt -60.61 -46.62 89.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.62 -50.72 71.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.306 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -68.1 -32.65 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.337 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' NH1' ' CE1' ' A' ' 16' ' ' TYR . 43.3 ttm180 -50.42 -44.32 55.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 108.94 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.29 -43.63 63.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 109.394 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -64.69 -40.71 95.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -55.85 -47.15 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.366 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 4.0 mmp_? -59.78 -34.7 73.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.416 -0.802 . . . . 0.0 109.82 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.94 -35.66 73.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.1 -36.16 12.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.005 . . . . 0.0 110.266 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 -48.03 9.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.926 -1.109 . . . . 0.0 110.2 -178.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 56.9 t60 -50.23 -39.12 43.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.0 . . . . 0.0 109.848 -178.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -56.53 -35.09 67.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' ASP . 62.8 m-85 -95.78 1.89 53.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.913 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.12 162.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 0.0 109.632 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.06 -27.6 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.88 2.386 . . . . 0.0 112.64 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -49.25 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' MET . 7.2 mtpm? -67.29 -33.11 74.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 64' ' ' ASP . 57.5 t -55.78 -41.81 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -71.02 -34.64 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.61 17.62 20.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 16.2 ttp -77.79 157.75 29.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.654 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.72 159.96 15.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 48.0 mp0 -60.36 -25.87 66.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.493 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.53 -43.2 93.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 15.9 t70 -61.01 -38.69 86.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.36 -42.99 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.47 -38.35 80.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -63.29 -41.96 99.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.806 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 82' ' ' ASP . 96.4 mt -67.35 -34.34 77.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.69 -33.12 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -86.94 -57.24 3.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 84.1 m-20 -80.04 170.62 16.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.14 87.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -61.42 8.64 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.6 ' H ' ' C ' ' A' ' 83' ' ' ALA . 14.0 pt -57.57 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -1.184 . . . . 0.0 109.362 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 76.0 mt -68.02 133.58 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 109.457 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.556 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 38.6 ttm180 -97.79 108.9 21.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.8 m-70 -164.55 85.37 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' A' ' 89' ' ' ARG . 19.5 ttt-85 -48.71 -30.51 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.783 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.69 -47.37 68.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.95 -45.09 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -1.212 . . . . 0.0 109.526 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.7 mt -55.88 -44.79 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -58.29 -37.77 75.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.398 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.92 84.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -44.77 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.8 mt -56.81 -42.34 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.525 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.45 -37.43 94.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 43.9 m-20 -61.4 -43.07 99.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.84 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.418 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 47.9 ttm-85 -63.9 -46.64 83.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.22 77.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.555 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 24.9 t80 -62.95 -41.71 99.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.24 -39.63 87.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.75 -41.3 86.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 51.9 mmm -63.69 -39.56 94.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.11 -27.05 64.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 107' ' ' GLN . 1.1 tm0? -51.42 -35.31 38.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -83.46 -3.51 57.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.08 74.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.5 146.88 40.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.144 -1.21 . . . . 0.0 109.644 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.72 124.81 11.47 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.63 2.22 . . . . 0.0 111.713 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -78.33 -45.31 22.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.456 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -55.44 -44.4 76.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.74 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.505 ' O ' ' OG ' ' A' ' 118' ' ' SER . 91.2 m-20 -57.65 -45.55 85.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 111.055 -178.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -60.16 -49.33 78.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.014 -1.053 . . . . 0.0 111.23 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 116' ' ' VAL . 7.0 m -60.37 -46.65 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 111.731 -176.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.492 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 3.3 p-90 -88.7 -37.26 15.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.733 -1.23 . . . . 0.0 111.1 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 120' ' ' VAL . 41.4 m -56.96 -25.29 57.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.807 -1.183 . . . . 0.0 109.698 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.18 -14.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.022 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.8 m -85.04 23.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 58.27 40.27 24.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.752 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.24 14.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -114.65 120.52 37.5 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.59 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.22 153.32 31.6 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.648 2.232 . . . . 0.0 111.86 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -102.53 149.89 23.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.8 mtt -136.61 156.6 48.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.6 t -117.12 159.57 22.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.885 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -150.46 53.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.835 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.78 -143.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 m -141.76 -30.2 0.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.922 . . . . 0.0 109.353 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -123.48 156.31 35.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.16 -32.57 74.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.1 p -66.66 -33.18 75.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.41 -25.12 67.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 32.3 mm -66.51 116.99 39.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.728 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.25 133.54 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.068 2.512 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.59 -9.68 53.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.9 p -96.95 102.21 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.384 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -117.67 152.91 50.37 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.387 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.01 -41.82 25.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.741 2.294 . . . . 0.0 112.041 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.65 61.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.06 -43.3 92.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.61 -38.8 80.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.1 tt -61.63 -45.63 93.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.202 -0.936 . . . . 0.0 109.498 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.3 t -58.14 -41.75 84.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -61.79 -39.15 90.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.549 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -48.31 71.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.0 mt -59.68 -35.22 74.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.07 -41.1 82.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.396 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -64.38 -37.81 88.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.593 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 24.4 mmt180 -65.23 -20.62 66.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.346 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.76 29.2 10.97 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 4.0 m-85 -92.16 130.59 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HG2' ' H ' ' A' ' 156' ' ' PHE . 72.9 tttt -93.43 170.33 9.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.452 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 55.2 m-85 57.64 50.86 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.09 28.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.13 159.77 0.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.4 m -52.43 -32.41 39.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -1.172 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.5 m -66.37 -36.54 83.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.36 -44.14 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.513 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 85.7 m -61.04 -41.64 96.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.47 ' CD2' ' OE1' ' A' ' 167' ' ' GLN . 42.9 t80 -60.12 -50.59 73.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.306 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.8 m -60.99 -39.25 88.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -64.36 -44.83 90.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.469 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.504 ' SD ' HD22 ' A' ' 171' ' ' LEU . 40.1 mmm -64.69 -41.83 95.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.632 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.47 ' OE1' ' CD2' ' A' ' 163' ' ' TYR . 66.6 mt-30 -63.47 -43.67 96.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 -179.424 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.46 -45.0 92.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.674 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.7 t -61.65 -23.24 65.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.26 7.88 58.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.504 HD22 ' SD ' ' A' ' 166' ' ' MET . 5.1 mp -63.24 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.411 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.21 130.79 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.431 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.41 ' O ' HG22 ' A' ' 127' ' ' THR . 87.3 m-20 -94.03 108.54 20.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -88.28 112.06 22.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -138.18 134.93 35.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.88 136.91 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.15 134.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.21 -0.85 72.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.486 ' SG ' ' OE1' ' A' ' 2' ' ' GLU . 65.9 m -151.74 -178.14 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.565 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.5 t 54.3 6.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 179' ' ' CYS . 2.2 m 69.52 37.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.609 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 16.2 t80 -124.37 80.58 59.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.58 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.84 9.11 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.023 2.482 . . . . 0.0 112.351 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.34 10.24 78.52 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.05 38.06 28.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -145.47 79.63 11.33 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.985 . . . . 0.0 109.536 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 C-N-CA 123.122 2.548 . . . . 0.0 112.234 -179.88 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 14.1 tm-20 -148.21 145.31 28.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 73.5 mtm180 -126.24 145.8 50.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 p -47.63 163.5 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.619 ' H ' HD11 ' A' ' 132' ' ' LEU . . . -80.43 -7.24 88.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -55.59 -29.13 58.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -1.12 . . . . 0.0 109.392 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 8' ' ' SER . 6.3 p -98.66 126.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER 166.28 72.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.521 ' OE1' HD13 ' A' ' 47' ' ' ILE . 36.7 tt0 -156.36 -128.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -84.61 152.19 59.81 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.9 -26.72 3.54 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.8 2.333 . . . . 0.0 112.132 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.1 tp -63.18 -44.74 94.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.78 -46.76 71.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.7 -43.96 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.39 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.11 99.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -63.13 -37.46 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLU . 46.2 t-80 -58.0 -51.24 70.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.71 -37.93 85.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.527 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -60.22 -51.86 67.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.469 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.1 mm-40 -142.96 -132.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.478 ' CH2' ' OD2' ' A' ' 174' ' ' ASP . 27.8 t90 58.92 116.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.17 5.59 67.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -120.04 96.01 49.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.293 -1.122 . . . . 0.0 109.412 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.71 120.02 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.738 2.292 . . . . 0.0 111.853 -179.277 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -95.58 134.53 38.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.863 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.4 p -112.7 0.16 15.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.83 121.0 24.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.0 m -61.57 -38.64 88.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.907 . . . . 0.0 109.627 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -59.93 -55.38 34.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -69.39 -43.51 73.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.935 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' SG ' ' A' ' 169' ' ' CYS . 6.9 tp -62.95 -39.28 94.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.842 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.412 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 62.2 t80 -63.0 -34.92 78.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.911 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -74.17 -30.22 62.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.955 . . . . 0.0 109.874 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.552 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 55.0 ttm -64.94 -53.99 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.965 . . . . 0.0 109.785 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 36' ' ' CYS . 3.3 tp -65.19 -39.29 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.032 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 35' ' ' ILE . 5.7 t -72.89 -40.89 65.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.67 -40.07 94.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 109.822 -178.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' OE2' ' N ' ' A' ' 165' ' ' PHE . 82.5 mt-10 -54.21 -28.7 42.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.772 -179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.15 -39.1 19.43 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -67.79 -30.87 70.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -1.211 . . . . 0.0 109.711 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.9 tt0 -52.64 -35.94 55.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 109.721 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.54 116.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -31.4 6.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.81 -145.0 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -1.189 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 t -148.23 155.41 41.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -50.4 -41.91 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.908 . . . . 0.0 109.514 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.571 HG23 ' N ' ' A' ' 48' ' ' THR . 9.6 tp -52.1 -43.06 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.645 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.571 ' N ' HG23 ' A' ' 47' ' ' ILE . 63.1 m -71.64 -33.78 69.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.4 t -58.8 -39.37 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.47 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -53.92 -54.37 39.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.511 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.64 -40.14 82.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -77.28 -19.26 56.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.624 ' NH1' ' NH2' ' A' ' 57' ' ' ARG . 1.2 ttt-85 -60.97 -46.96 88.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.171 -0.956 . . . . 0.0 109.013 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -74.02 -41.33 62.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.363 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -67.44 -45.03 77.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.25 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 42.6 t80 -62.87 -38.13 89.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.42 -0.8 . . . . 0.0 109.284 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.624 ' NH2' ' NH1' ' A' ' 53' ' ' ARG . 48.6 ttm-85 -57.27 -38.49 73.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.31 -22.47 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.26 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.507 ' SG ' ' CB ' ' A' ' 83' ' ' ALA . 63.9 m -92.45 -13.55 29.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.222 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 55.8 m-85 -127.21 -53.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.935 -1.103 . . . . 0.0 110.173 -178.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -57.71 -42.46 83.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -178.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -53.8 -35.14 61.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' ASP . 92.7 m-85 -91.43 8.98 33.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.0 109.908 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER 56.42 156.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 -179.45 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.4 -28.15 39.41 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.853 2.369 . . . . 0.0 112.68 -178.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.35 -49.19 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -67.98 -31.46 71.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 64' ' ' ASP . 73.7 t -56.61 -41.12 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.586 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.27 64.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.62 14.63 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.417 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 7.7 mmm -54.83 -176.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.668 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 71' ' ' MET . 28.5 mm-40 -136.74 159.15 42.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.258 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.2 mt-10 -61.39 -34.97 76.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -72.1 -28.37 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.44 -47.96 65.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 -179.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 92' ' ' ILE . 6.9 m -60.35 -38.08 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.32 -36.99 81.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -65.38 -39.66 92.53 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 109.769 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.35 -31.84 72.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.603 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.5 t -56.25 -34.9 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.71 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -96.38 -33.94 11.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.602 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 93.1 m-20 -86.75 138.49 31.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.368 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.03 -21.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 47.07 27.49 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 86' ' ' ILE . 6.2 pt -56.35 83.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.334 179.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 85' ' ' ILE . 85.1 mt 57.04 145.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.489 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.621 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.1 OUTLIER -101.64 111.64 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.53 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.58 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.165 179.753 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 89' ' ' ARG . 35.0 ttt-85 -46.87 -36.81 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.39 95.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -67.3 -44.49 79.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.5 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.481 HG22 HG12 ' A' ' 76' ' ' VAL . 37.1 mt -58.52 -49.44 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.551 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -53.57 -34.82 59.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.419 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.548 HG21 ' CE2' ' A' ' 60' ' ' PHE . 30.4 mm -60.39 -45.37 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mm -55.55 -51.99 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.84 72.67 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.655 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.35 -37.34 77.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -1.188 . . . . 0.0 109.378 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.655 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -71.08 -35.68 71.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.65 -42.49 92.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -71.2 -32.11 68.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.412 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 32.4 t80 -66.24 -44.03 84.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.86 -40.25 96.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -60.5 -37.84 82.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.519 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.55 -34.25 77.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -68.76 -27.52 65.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -52.17 -27.84 15.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.16 -15.15 60.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.2 17.25 78.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -96.63 149.7 36.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.247 -1.149 . . . . 0.0 109.634 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.14 119.16 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.623 2.216 . . . . 0.0 111.69 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -71.29 -39.94 71.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.822 . . . . 0.0 110.446 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.72 -50.31 72.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.976 . . . . 0.0 110.771 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.509 ' O ' ' OG ' ' A' ' 118' ' ' SER . 29.1 t0 -55.57 -54.13 47.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -0.918 . . . . 0.0 111.081 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -53.85 -43.06 69.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 111.217 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.57 -60.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.097 . . . . 0.0 111.638 -177.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.683 ' CB ' HD21 ' A' ' 171' ' ' LEU . 67.1 p-90 -88.24 -19.28 27.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.787 -1.196 . . . . 0.0 111.141 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 120' ' ' VAL . 34.0 m -56.09 -30.09 61.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.763 -1.21 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.43 -11.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 110.049 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 117' ' ' TRP . 15.2 m -86.02 24.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 109.991 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.9 t-20 77.1 20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 62.38 29.64 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.903 . . . . 0.0 109.568 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.462 ' H ' HG23 ' A' ' 120' ' ' VAL . 12.4 pt20 -148.01 143.38 17.58 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.593 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.03 142.24 61.03 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.585 2.19 . . . . 0.0 111.833 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -110.93 155.66 22.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.0 ptp -135.28 156.49 48.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.155 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.0 t -118.36 155.67 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 109.872 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -115.95 45.04 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.304 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.15 135.12 47.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.872 . . . . 0.0 109.653 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.72 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 9.1 m -88.29 -32.98 18.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.432 HG22 ' OE1' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -133.57 166.31 22.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.619 HD11 ' H ' ' A' ' 5' ' ' GLY . 24.7 mt -74.27 -8.73 57.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.567 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -87.81 -31.98 19.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.527 -177.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.72 ' CD ' ' H ' ' A' ' 130' ' ' THR . 8.5 pt-20 -86.93 9.96 17.75 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -178.215 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.16 119.85 62.33 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.756 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.04 120.95 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.179 2.586 . . . . 0.0 112.482 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 t -97.29 21.65 9.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.318 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.6 p -129.61 66.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.375 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -87.62 153.39 52.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.463 179.642 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.85 -30.74 92.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.754 2.303 . . . . 0.0 112.04 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.26 -38.11 51.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.37 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -62.42 -48.6 78.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -64.96 -41.1 95.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.57 86.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.2 tp -59.14 -48.63 80.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.511 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -54.67 -45.61 73.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -60.3 -35.04 74.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.88 -50.55 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.451 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.92 -38.63 91.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.81 -26.5 68.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.78 -40.03 86.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -74.07 -20.17 60.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.22 29.46 7.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.441 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 1.4 m-85 -78.34 137.54 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.519 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -102.1 175.36 5.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 53.4 47.3 24.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.7 p -122.66 26.54 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.1 167.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.4 m -58.19 -30.41 66.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 0.0 109.435 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 62.9 p -62.26 -42.07 99.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.5 mp -65.64 -46.81 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.53 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 12.3 p -63.01 -39.61 95.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.282 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 34.1 t80 -62.67 -47.83 81.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.5 p -59.5 -41.85 90.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.286 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 1.1 t80 -61.83 -27.04 68.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 178.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -53.56 27.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.682 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -67.89 -36.28 79.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.686 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.649 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 41.7 m -78.59 -64.34 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.37 9.12 2.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.683 HD21 ' CB ' ' A' ' 117' ' ' TRP . 9.4 mp -50.96 -52.62 40.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -1.134 . . . . 0.0 109.414 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.3 m -98.2 134.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 175' ' ' HIS . 11.5 t-20 -81.15 105.13 12.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.478 ' OD2' ' CH2' ' A' ' 21' ' ' TRP . 11.7 p30 -91.62 107.33 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 109.484 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.726 ' N ' ' ND1' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -156.69 171.03 21.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.527 179.653 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.07 164.7 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 182' ' ' TYR . 14.7 t -80.29 140.05 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.467 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.7 -17.46 58.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 15.4 t -91.27 165.95 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -1.119 . . . . 0.0 109.466 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.0 p -76.06 92.63 3.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 180' ' ' CYS . 0.1 OUTLIER 160.6 -39.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.544 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 28.9 t80 -96.31 115.54 65.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.544 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.4 Cg_endo -85.53 179.4 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.141 2.56 . . . . 0.0 112.353 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 96.91 3.43 59.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -143.86 35.51 1.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -1.13 . . . . 0.0 109.601 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -83.87 132.37 48.82 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.993 2.462 . . . . 0.0 112.261 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.7 m 46.96 -162.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.65 -27.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -73.72 -16.69 61.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 0.0 109.447 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 7' ' ' VAL . 34.9 m -67.02 130.17 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLN . 33.4 t -162.68 137.19 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.51 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' SER . 93.2 mt-30 50.53 179.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.535 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' LEU . 5.1 m-20 48.31 77.12 0.48 Allowed Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.251 -0.905 . . . . 0.0 109.409 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -47.69 -10.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.886 2.391 . . . . 0.0 112.073 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.5 mt -62.78 -33.81 75.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 47' ' ' ILE . 54.0 m-85 -63.03 -58.13 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.67 -47.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.66 69.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -72.26 -43.51 64.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.489 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 60.5 t-80 -60.85 -43.53 98.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.62 -41.25 79.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.54 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -60.24 -48.11 83.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' HIS . 80.0 mm-40 -141.97 -131.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.489 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 5.7 t90 56.56 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.16 0.63 65.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 169' ' ' CYS . 10.0 t -118.08 96.61 49.91 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.217 -1.167 . . . . 0.0 109.416 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.25 122.59 5.65 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.778 2.318 . . . . 0.0 111.871 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 27.6 tp10 -110.67 139.31 46.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.885 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.4 p -115.56 3.96 14.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 93.6 m-20 -77.77 123.54 26.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.33 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 t -64.48 -37.81 88.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 9.5 mtmp? -62.88 -55.06 29.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -65.87 -43.91 86.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.803 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.6 -34.79 76.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.103 -0.998 . . . . 0.0 109.924 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.51 -39.45 83.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.885 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 3.6 mp0 -73.77 -31.05 63.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.885 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.565 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 55.9 ttm -59.06 -54.05 51.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.798 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.55 -33.16 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.983 . . . . 0.0 110.034 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 t -71.81 -45.88 60.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.4 mt -64.23 -44.26 92.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 41' ' ' GLN . 97.2 mt-10 -63.1 -33.28 75.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 109.829 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.27 -36.38 7.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 19.3 mp0 -75.47 -14.7 60.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -1.221 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLU . 4.0 pp0? -55.27 -23.77 24.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.62 108.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.92 -34.09 3.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.2 mm? -86.14 178.06 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -1.186 . . . . 0.0 109.489 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.6 m -108.69 149.93 28.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.348 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 p90 -53.79 -36.28 62.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.68 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -62.54 -40.51 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 93.4 m -64.31 -37.25 86.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.9 t -60.09 -39.42 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.44 -46.8 83.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -62.03 -50.99 69.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 109.349 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -66.96 -28.74 68.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' VAL . 64.6 ttt180 -53.37 -44.55 68.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.156 -0.965 . . . . 0.0 108.973 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.66 -43.58 79.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -66.15 -37.53 85.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 14.3 t80 -59.65 -49.06 79.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 21.9 mmm180 -61.24 -29.55 69.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.735 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.64 98.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.875 . . . . 0.0 110.241 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.0 m -93.9 -41.91 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 110.232 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 32.4 m-85 -70.73 -52.09 23.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.218 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 49.7 t60 -51.55 -38.07 52.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.055 -1.028 . . . . 0.0 109.865 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.03 -37.13 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.769 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 64' ' ' ASP . 70.2 m-85 -88.06 -9.0 54.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.007 . . . . 0.0 109.856 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 63' ' ' PHE . 7.2 t70 61.75 129.83 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.74 -31.76 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.841 2.36 . . . . 0.0 112.69 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.62 -50.66 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.632 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 71' ' ' MET . 40.7 mtpt -66.82 -34.5 77.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 109.797 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 96' ' ' ILE . 89.0 t -58.16 -28.9 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' CB ' HD12 ' A' ' 103' ' ' LEU . . . -87.6 -18.39 29.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.57 25.98 5.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.1 ptp -75.22 -160.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -129.58 160.56 32.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 49.2 mp0 -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -70.73 -24.34 62.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.443 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -67.0 -47.65 70.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 0.0 109.386 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 HG22 ' A' ' 92' ' ' ILE . 6.7 m -64.91 -38.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.57 -32.61 73.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.616 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.93 -41.99 81.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.775 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.93 -30.68 70.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.4 t -49.55 -33.8 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.952 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -91.36 -63.45 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -101.55 115.75 31.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.49 -46.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.64 15.07 64.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 pt -123.58 167.39 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -1.131 . . . . 0.0 109.304 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.9 mt -49.07 128.64 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 87' ' ' ARG . 14.0 ptm180 -108.29 128.08 54.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.693 ' O ' ' N ' ' A' ' 90' ' ' GLY . 58.4 t-80 -158.21 1.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.147 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 59.48 -60.65 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.07 -46.73 93.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -42.54 96.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -1.151 . . . . 0.0 109.499 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.495 HG22 HG12 ' A' ' 76' ' ' VAL . 38.6 mt -63.37 -49.41 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.624 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -54.47 -33.14 59.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.401 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.368 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.408 HD13 ' HE2' ' A' ' 56' ' ' TYR . 94.8 mt -58.41 -41.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.495 HD12 ' SD ' ' A' ' 71' ' ' MET . 16.9 mm -55.49 -47.28 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.82 93.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.27 -45.22 91.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.137 . . . . 0.0 109.386 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -70.04 -47.63 61.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.72 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -68.06 -46.17 71.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.439 HD12 ' CB ' ' A' ' 69' ' ' ALA . 96.9 mt -67.73 -38.95 84.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.62 -44.98 85.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.85 -41.19 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -71.7 -27.01 62.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -51.25 -32.1 23.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.31 1.81 39.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.9 9.38 86.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -79.04 129.23 73.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.11 -1.229 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.51 122.16 8.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.673 2.249 . . . . 0.0 111.692 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -76.44 -44.89 33.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.472 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.43 -49.69 76.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.792 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 85.4 m-20 -54.64 -35.1 63.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.949 . . . . 0.0 111.005 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 75.7 t80 -73.54 -48.42 33.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.032 -1.042 . . . . 0.0 111.219 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 117' ' ' TRP . 3.1 m -55.95 -50.34 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.052 -1.03 . . . . 0.0 111.655 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.583 ' O ' HG22 ' A' ' 120' ' ' VAL . 25.2 p-90 -86.66 -22.42 26.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.84 -1.162 . . . . 0.0 111.087 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 120' ' ' VAL . 8.0 t -59.48 -27.95 66.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.821 -1.175 . . . . 0.0 109.658 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.12 -15.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.075 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 117' ' ' TRP . 14.8 m -83.22 22.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 109.979 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.612 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 29.4 t30 61.05 48.27 6.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.046 . . . . 0.0 109.765 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 32.4 p80 41.91 32.99 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 8.6 tt0 -142.84 90.86 7.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -47.16 155.19 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.724 2.282 . . . . 0.0 111.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 16.7 mp0 -105.66 158.92 16.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 109.688 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.9 mtt -135.98 156.9 48.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.134 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.6 t -122.57 160.38 25.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.482 ' N ' ' OE1' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -141.28 43.72 1.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -86.73 169.72 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 m -87.69 -33.24 18.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.68 169.43 17.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.2 mt -67.85 -27.69 66.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.577 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.7 t -59.08 -41.22 87.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.579 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 69.3 mm-40 -64.19 -29.86 70.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.395 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.37 131.76 93.25 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.409 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 98.4 Cg_endo -80.03 141.45 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.141 2.561 . . . . 0.0 112.571 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 6.26 42.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 109.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.1 t -136.37 92.69 2.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.887 . . . . 0.0 109.35 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -98.06 154.53 37.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.74 -40.18 24.25 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.797 2.331 . . . . 0.0 112.061 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.86 70.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.0 m -62.39 -45.58 92.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.05 -43.77 86.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.59 73.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 109.513 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.729 ' C ' HD23 ' A' ' 145' ' ' LEU . 8.2 tt -66.88 -46.73 74.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 87.7 p -58.9 -39.03 80.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.962 . . . . 0.0 109.548 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -63.59 -34.68 78.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.4 -50.28 60.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.22 -32.49 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -57.92 -38.11 75.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.33 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.644 ' NZ ' HH12 ' A' ' 152' ' ' ARG . 7.0 ttpm? -61.55 -38.94 89.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.452 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.644 HH12 ' NZ ' ' A' ' 151' ' ' LYS . 12.7 mpt_? -63.55 -20.22 65.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.28 24.65 10.09 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -89.84 131.92 35.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -1.121 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.34 177.69 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.407 ' O ' HD13 ' A' ' 161' ' ' ILE . 93.6 m-85 54.07 57.19 6.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.9 m -121.78 25.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.412 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.49 166.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 159' ' ' THR . 1.1 p -66.36 -24.53 66.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.397 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 161' ' ' ILE . 15.0 t -72.04 -42.66 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 160' ' ' THR . 81.5 mt -65.65 -41.45 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.552 ' SG ' HD22 ' A' ' 145' ' ' LEU . 50.1 t -63.22 -40.43 97.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CE1' ' O ' ' A' ' 136' ' ' PRO . 68.0 t80 -60.75 -46.85 88.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.395 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -45.55 84.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.888 . . . . 0.0 109.354 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -62.66 -34.45 77.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 178.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 30.7 ttm -63.28 -45.0 93.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.645 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.419 ' NE2' HG21 ' A' ' 172' ' ' VAL . 63.4 mm-40 -70.08 -37.17 75.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.668 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.565 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -64.76 -46.98 79.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 14.4 m -64.66 -61.14 2.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.0 7.54 3.25 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.571 HD21 ' CB ' ' A' ' 117' ' ' TRP . 9.5 mp -50.07 -43.55 51.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 109.38 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.419 HG21 ' NE2' ' A' ' 167' ' ' GLN . 30.8 m -100.61 134.54 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.487 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.406 ' O ' HG22 ' A' ' 127' ' ' THR . 87.5 m-20 -87.19 103.41 15.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -91.92 121.99 34.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.593 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -160.9 100.28 1.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.96 148.17 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.68 129.9 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.23 7.98 63.35 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 52.3 t -79.65 94.2 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.507 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.2 t 65.63 -57.18 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 37.6 t -173.07 60.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.414 ' OH ' ' CB ' ' A' ' 128' ' ' GLN . 21.8 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 109.608 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.614 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 6' ' ' TRP . 14.1 m -150.91 26.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.407 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.98 -44.19 0.16 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . 94.1 m95 -54.63 -35.06 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.463 HG23 ' NE ' ' A' ' 3' ' ' ARG . 5.9 m -73.49 63.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -149.94 48.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -152.96 -125.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.1 150.17 98.07 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.859 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.63 -19.84 41.46 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.899 2.4 . . . . 0.0 112.095 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.29 -41.36 98.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.392 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -65.24 -49.6 69.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.443 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.0 -45.12 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.84 88.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -57.57 -42.39 83.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.536 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 48.7 t-80 -62.32 -41.76 98.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.8 -40.03 94.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -58.77 -53.04 62.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 21' ' ' TRP . 76.3 mm-40 -142.48 -131.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.536 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 24.2 t90 58.76 138.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.535 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.28 -29.0 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 23' ' ' VAL . 11.0 p -75.49 131.59 77.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.11 120.51 6.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.817 2.345 . . . . 0.0 111.885 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -111.5 137.19 49.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.845 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -132.61 4.87 3.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 28' ' ' SER . 63.3 t0 -94.22 142.96 26.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.284 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 60.3 p -64.33 -34.63 78.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.4 -47.64 75.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.91 -48.89 27.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -66.61 -35.37 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.845 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 28' ' ' SER . 48.9 t80 -60.63 -46.97 88.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.864 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.14 -30.11 62.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.83 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -58.47 -53.28 60.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.793 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.583 HD12 ' OE1' ' A' ' 38' ' ' GLU . 4.1 tp -69.77 -31.62 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 110.017 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 69.2 m -73.31 -46.58 48.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.902 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 35' ' ' ILE . 16.5 pt-20 -49.8 -43.5 48.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.778 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . 77.2 171.31 35.19 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.702 ' C ' ' H ' ' A' ' 42' ' ' ALA . 4.5 tt0 -66.35 -43.77 85.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.247 . . . . 0.0 109.737 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 58.34 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 109.704 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -70.84 117.88 12.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.11 -15.25 63.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.0 mp -116.87 -135.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -1.176 . . . . 0.0 109.461 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -153.27 154.8 35.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.434 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.519 ' NE1' HD21 ' A' ' 50' ' ' LEU . 74.4 t-105 -52.31 -35.64 51.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 48' ' ' THR . 10.4 tp -52.91 -40.99 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 47' ' ' ILE . 73.5 m -66.83 -35.65 80.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 0.0 109.701 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.9 t -60.97 -39.91 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.414 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.519 HD21 ' NE1' ' A' ' 46' ' ' TRP . 60.8 mt -59.95 -47.48 85.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.61 ' NZ ' ' NZ ' ' A' ' 52' ' ' LYS . 9.8 mtmp? -64.63 -53.06 53.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.262 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.61 ' NZ ' ' NZ ' ' A' ' 51' ' ' LYS . 13.0 mptt -64.51 -34.36 78.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' VAL . 7.9 tmm_? -50.45 -45.94 56.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.2 -0.938 . . . . 0.0 108.95 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG3' HH21 ' A' ' 57' ' ' ARG . 85.3 tt0 -63.38 -42.24 98.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -66.51 -36.33 82.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.223 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -61.95 -45.66 92.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.3 mtm180 -57.15 -42.1 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.828 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.6 66.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 m -92.34 -12.61 31.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 0.0 110.363 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.84 -43.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.906 -1.121 . . . . 0.0 110.239 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -51.41 -43.76 62.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.113 -0.992 . . . . 0.0 109.885 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -67.11 -39.98 86.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 93.5 m-85 -71.58 -24.17 61.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.854 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.4 t70 69.62 131.48 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.996 -1.065 . . . . 0.0 109.563 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -39.9 -37.24 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.834 2.356 . . . . 0.0 112.679 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.03 -48.38 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.14 -0.975 . . . . 0.0 109.647 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 71' ' ' MET . 60.5 mttp -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.15 -43.4 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 109.626 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.3 -30.3 54.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.68 58.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.407 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.8 mtp -65.08 136.65 56.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -94.37 171.98 8.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.93 -33.28 70.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -59.18 -42.57 91.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -59.26 -38.45 80.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 80' ' ' VAL . 79.4 t -58.85 -44.99 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.571 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.538 ' OE1' ' NH1' ' A' ' 89' ' ' ARG . 41.8 tp10 -56.44 -37.79 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -65.4 -43.74 89.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.718 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.01 -36.21 79.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.637 ' CG1' HH21 ' A' ' 87' ' ' ARG . 52.7 t -50.64 -35.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.723 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.15 -60.04 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 109.518 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -99.91 115.92 30.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.72 -45.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.11 33.38 40.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.42 172.17 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -1.111 . . . . 0.0 109.336 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.0 mt -48.53 135.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.637 HH21 ' CG1' ' A' ' 80' ' ' VAL . 1.3 tpt180 -75.46 122.62 24.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.44 91.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 109.141 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 77' ' ' GLU . 38.3 ttm-85 -48.57 -32.54 8.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.932 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.44 -38.48 93.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HZ1' ' H ' ' A' ' 40' ' ' GLN . 14.1 mmmt -60.04 -47.34 86.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.499 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.404 HG21 HG13 ' A' ' 76' ' ' VAL . 76.5 mt -60.26 -41.39 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -58.08 -39.08 77.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.0 81.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.505 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 33.3 mm -59.6 -43.74 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.434 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.28 -28.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.548 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.05 -45.65 80.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.679 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -63.12 -35.48 80.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -1.148 . . . . 0.0 109.416 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.679 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -62.78 -46.79 86.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 109.521 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -71.43 -45.77 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.93 81.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.529 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.41 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 64.8 t80 -63.6 -49.2 74.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.94 -42.71 80.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.483 ' NE2' ' OE1' ' A' ' 107' ' ' GLN . 69.7 tp60 -65.53 -41.64 92.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.6 ttt -65.31 -41.82 93.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.471 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.68 -27.33 65.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.483 ' OE1' ' NE2' ' A' ' 104' ' ' GLN . 61.4 tt0 -51.8 -31.13 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -76.74 -12.7 60.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.45 0.46 76.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.83 132.54 64.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.2 -1.177 . . . . 0.0 109.712 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.49 118.58 5.73 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.6 2.2 . . . . 0.0 111.7 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -77.22 -38.57 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.795 . . . . 0.0 110.455 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.709 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.14 -49.72 76.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 110.77 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 118' ' ' SER . 93.0 m-20 -61.27 -44.43 97.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.228 -0.92 . . . . 0.0 111.102 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.77 -53.47 57.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.94 -1.1 . . . . 0.0 111.224 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 117' ' ' TRP . 12.2 m -57.96 -49.71 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.934 -1.104 . . . . 0.0 111.666 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.511 ' CE3' ' O ' ' A' ' 117' ' ' TRP . 2.4 p-90 -86.89 -21.55 26.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.712 -1.242 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 120' ' ' VAL . 17.0 p -58.84 -33.84 70.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.799 -1.188 . . . . 0.0 109.721 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.07 -12.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.915 . . . . 0.0 110.076 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.685 ' O ' HG12 ' A' ' 120' ' ' VAL . 43.1 t -82.32 23.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.073 -1.017 . . . . 0.0 109.939 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 35.1 t30 68.95 18.75 8.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 53.58 50.08 18.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.0 tt0 -159.7 121.41 1.82 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.34 151.89 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.716 2.278 . . . . 0.0 111.794 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 87.9 mm-40 -118.44 146.96 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.975 . . . . 0.0 109.72 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -135.91 156.49 48.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.79 . . . . 0.0 109.097 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.7 t -119.4 163.22 17.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.86 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -149.06 43.41 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.26 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB1' ' OE1' ' A' ' 134' ' ' GLU . . . -82.05 -150.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 109.676 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.445 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 14.4 m -138.72 -33.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -121.9 154.34 37.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.13 -33.84 75.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.893 . . . . 0.0 109.618 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -63.03 -33.38 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 130' ' ' THR . 95.6 mt-10 -62.92 -30.87 71.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.8 mp -67.52 117.04 43.44 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.699 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.06 125.65 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.079 2.519 . . . . 0.0 112.537 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 10.2 t -76.65 -18.15 58.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 109.322 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.0 t -102.72 99.19 9.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.11 155.45 37.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -46.89 -40.67 25.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.749 2.299 . . . . 0.0 111.963 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.85 -35.18 67.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.389 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.8 m -60.66 -41.86 95.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -64.8 -45.82 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.49 81.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.761 ' C ' HD23 ' A' ' 145' ' ' LEU . 7.4 tt -66.52 -46.35 76.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -56.33 -47.54 78.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.93 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.59 -45.0 73.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 149' ' ' LEU . 68.0 mt -60.17 -33.85 72.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.606 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -57.37 -40.89 79.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.86 -37.07 85.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.43 -17.81 65.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.19 20.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 136.27 33.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.14 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -105.24 -179.22 3.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.541 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 54.37 56.92 6.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.49 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 m -122.56 26.59 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.87 161.39 0.16 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.1 t -55.66 -32.61 63.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.158 . . . . 0.0 109.425 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 46.7 m -68.57 -46.83 68.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.04 -33.82 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 145' ' ' LEU . 6.4 t -68.42 -41.77 79.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.299 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 137' ' ' THR . 43.4 t80 -62.23 -45.38 93.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.3 t -59.15 -36.9 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.54 -43.36 97.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.418 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.94 -39.74 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.638 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -61.63 -47.12 86.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.859 . . . . 0.0 109.689 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.65 -37.86 80.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.75 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' VAL . 15.6 m -59.59 -28.81 67.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.457 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.06 9.92 55.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.81 -40.65 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 109.483 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 t -96.36 129.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.575 ' ND2' ' NE2' ' A' ' 175' ' ' HIS . 45.7 t-20 -100.04 117.53 34.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.378 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -75.42 137.04 40.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.457 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.575 ' NE2' ' ND2' ' A' ' 173' ' ' ASN . 75.6 m-70 -146.22 48.68 1.2 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.95 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.54 144.88 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.9 t -81.69 134.19 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.952 . . . . 0.0 109.503 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.27 25.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 13.8 p -86.94 -160.53 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.527 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.9 t -84.41 -54.16 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 t -64.94 -11.17 35.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.609 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' CYS . 32.8 ptt180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' ARG . 20.2 m 53.94 171.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.07 12.69 1.44 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 2.9 p-90 -148.3 46.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 109.429 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.42 130.36 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.527 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 m -73.81 146.41 44.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 27.6 mp0 -65.29 -29.35 70.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.515 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -53.52 142.65 40.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.85 -23.81 18.54 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.874 2.383 . . . . 0.0 112.163 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.85 -39.79 95.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -79.45 -47.38 15.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.39 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.7 mt -55.41 -49.05 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.416 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -46.08 78.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -62.23 -40.41 96.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t-80 -58.68 -45.86 88.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.38 -46.23 12.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -57.98 -37.66 74.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 21' ' ' TRP . 93.7 mt-10 -144.54 -156.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.464 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.483 ' O ' ' O ' ' A' ' 20' ' ' GLU . 34.6 t90 59.76 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.64 -28.51 10.01 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.56 119.63 68.48 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.33 -1.1 . . . . 0.0 109.409 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.95 129.13 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.868 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -115.58 137.95 51.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.9 p -126.46 4.99 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.888 . . . . 0.0 109.104 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -72.18 119.47 16.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.6 p -60.55 -36.89 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -62.71 -46.98 85.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.828 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.16 -50.74 62.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.8 mp -64.55 -39.0 92.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.119 -0.988 . . . . 0.0 109.887 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 90.4 t80 -61.6 -52.91 62.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 109.864 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -33.11 75.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -56.72 -50.81 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.82 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.32 -40.16 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.995 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -72.24 -39.96 68.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.123 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 56' ' ' TYR . 18.4 mt -72.44 -40.64 66.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 109.848 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -53.63 -35.88 61.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.15 -31.56 26.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.463 ' HA ' ' HZ2' ' A' ' 91' ' ' LYS . 26.8 mt-30 -71.06 -29.83 65.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -1.202 . . . . 0.0 109.742 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' LEU . 6.0 pt20 -51.28 -31.26 20.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.695 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.43 109.75 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.656 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.82 -31.88 5.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLN . 27.1 mt -96.23 -179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.484 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.0 m -105.78 163.15 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.972 . . . . 0.0 109.415 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.2 -46.43 75.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 47' ' ' ILE . 10.3 tp -56.57 -34.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 47' ' ' ILE . 80.9 m -64.54 -33.99 77.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.8 t -63.18 -40.76 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -53.66 -51.38 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -56.91 -39.68 74.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HB3' HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -80.75 -17.87 49.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.375 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.8 ttm-85 -60.99 -49.25 78.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.157 -0.964 . . . . 0.0 108.992 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 19.6 pt-20 -73.95 -42.84 59.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.456 -0.778 . . . . 0.0 109.347 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -66.64 -43.11 85.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 60' ' ' PHE . 35.9 t80 -60.42 -46.14 91.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.364 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' HIS . 76.6 mtm180 -59.48 -37.13 77.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 15.1 p -94.14 -12.33 28.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.301 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.635 ' CD2' ' CZ ' ' A' ' 56' ' ' TYR . 52.4 m-85 -120.95 -54.22 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.967 -1.083 . . . . 0.0 110.2 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 57' ' ' ARG . 44.7 t-80 -55.6 -41.79 73.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -55.77 -32.93 63.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 81.5 m-85 -94.96 3.81 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.856 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 57.7 162.58 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 109.555 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.48 -14.49 22.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.876 2.384 . . . . 0.0 112.694 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.678 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.81 -46.61 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.908 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 69' ' ' ALA . 6.3 m -56.69 -41.9 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.007 . . . . 0.0 109.641 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.548 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -58.9 -40.93 85.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.96 27.98 2.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.6 ttm -71.21 147.83 47.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.689 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -100.08 149.23 23.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 55.7 mp0 -52.34 -31.81 35.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.99 -45.64 88.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.45 -39.13 79.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.428 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.5 t -55.29 -46.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.33 -34.14 70.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.58 -49.27 71.84 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.337 -0.852 . . . . 0.0 109.78 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 mt -63.88 -38.39 90.9 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.97 -30.72 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -89.42 -58.54 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -99.52 124.85 45.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.415 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -170.27 -61.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.442 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.98 75.12 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.502 HG12 ' HB1' ' A' ' 83' ' ' ALA . 22.1 pt -100.3 -169.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.337 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.11 138.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.28 122.27 31.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.468 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -177.6 81.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -48.37 -28.59 3.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.16 98.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HZ2' ' HA ' ' A' ' 40' ' ' GLN . 14.1 mtpt -69.13 -42.48 75.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -1.205 . . . . 0.0 109.571 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.95 -50.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -57.13 -33.48 67.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.443 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -62.21 -43.58 98.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 mm -55.75 -44.3 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -55.36 -50.15 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.69 -29.21 65.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.659 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.31 -40.3 85.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -1.195 . . . . 0.0 109.422 -178.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.659 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -67.8 -38.96 83.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -55.39 -44.83 76.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 109.541 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.33 69.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.442 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 37.0 t80 -60.75 -44.64 96.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.69 -36.31 83.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -57.68 -43.18 84.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.69 -43.86 71.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.62 -28.06 66.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -51.87 -33.04 34.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.5 -12.48 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.19 10.99 83.0 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -93.5 149.16 36.78 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.215 -1.168 . . . . 0.0 109.735 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.66 120.09 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.722 2.282 . . . . 0.0 111.697 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.466 ' O ' HG23 ' A' ' 116' ' ' VAL . 83.7 t80 -66.46 -43.25 86.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 0.0 110.408 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.11 72.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.183 -0.948 . . . . 0.0 110.713 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' O ' ' CB ' ' A' ' 118' ' ' SER . 18.2 t70 -55.11 -51.18 67.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 111.046 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.426 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 69.7 t80 -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 111.261 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -57.02 -58.37 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 111.706 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . 45.0 p-90 -88.19 -20.69 25.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.786 -1.196 . . . . 0.0 111.162 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 120' ' ' VAL . 71.7 p -61.23 -24.29 66.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.159 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.13 -11.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.052 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.6 m -90.23 24.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 109.987 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 0.2 OUTLIER 77.51 -50.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 109.719 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.3 p-80 162.48 -19.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.38 148.96 35.92 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.15 154.7 47.05 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.707 2.272 . . . . 0.0 111.779 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -87.44 153.01 21.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 126' ' ' MET . 2.4 mpp? -136.57 150.46 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.431 ' OG1' ' CD1' ' A' ' 135' ' ' ILE . 15.1 t -99.35 171.55 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.864 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -160.17 67.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.31 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.49 -121.46 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 109.676 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 m -158.72 -33.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 134' ' ' GLU . 1.2 t -124.0 170.27 10.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -73.79 -28.57 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.0 m -67.0 -38.1 85.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.525 ' H ' HG23 ' A' ' 131' ' ' THR . 63.1 mm-40 -67.25 -15.04 63.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.186 -0.946 . . . . 0.0 109.445 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CD1' ' OG1' ' A' ' 127' ' ' THR . 44.3 mm -65.68 116.69 34.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -42.53 136.23 4.35 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.071 2.514 . . . . 0.0 112.552 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -4.01 35.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -143.98 83.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.2 p -74.86 153.11 86.94 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.18 -29.97 68.91 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.76 2.307 . . . . 0.0 112.059 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.5 -33.44 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.386 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.5 p -64.27 -40.42 95.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.88 -50.12 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 109.527 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.62 82.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.03 -43.79 91.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.473 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.0 p -55.35 -43.86 75.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -62.58 -32.03 72.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.479 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.04 36.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.488 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.8 mm? -62.36 -37.88 87.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.635 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -59.23 -37.44 77.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.09 -39.89 91.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 152' ' ' ARG . 38.7 mtt-85 -64.65 -19.57 65.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.23 21.91 21.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.06 138.42 36.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -103.53 170.42 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 59.08 47.08 12.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 158' ' ' GLY . 17.2 m -118.92 25.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.71 168.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.3 m -55.8 -32.61 63.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.46 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.1 m -62.28 -48.6 79.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.577 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -65.7 -34.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.94 -47.07 69.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -64.95 -40.78 95.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 109.347 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -59.57 -36.72 76.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.24 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.595 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 81.8 t80 -61.61 -43.09 99.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.5 mtp -70.43 -36.85 74.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -64.59 -54.79 26.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.698 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.32 83.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.595 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 22.9 m -53.88 -38.3 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.6 5.97 47.62 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.69 -33.1 73.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.75 132.32 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -94.57 105.33 17.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -96.02 96.13 8.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.168 -0.957 . . . . 0.0 109.494 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' A' ' 176' ' ' VAL . 21.2 m80 -108.9 -6.88 15.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 177' ' ' VAL . 87.6 t 54.29 163.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.453 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.57 ' N ' HG12 ' A' ' 176' ' ' VAL . 81.8 t -108.08 133.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.83 61.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 181' ' ' CYS . 39.2 m -144.41 168.35 20.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.163 . . . . 0.0 109.525 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 98.5 m 50.09 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 179' ' ' CYS . 38.6 t -155.8 14.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 109.513 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.494 HH11 ' HG3' ' A' ' 3' ' ' ARG . 32.0 mtm-85 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.323 0.583 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -141.39 -142.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.562 ' H ' HD11 ' A' ' 132' ' ' LEU . . . -47.44 -11.99 0.1 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . 44.5 m95 -67.14 -9.48 40.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 6' ' ' TRP . 20.1 m 35.76 -154.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 8' ' ' SER . 10.3 t -178.08 47.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.411 ' N ' HD11 ' A' ' 14' ' ' ILE . 6.6 pt20 -130.63 -105.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 9' ' ' GLN . 58.2 m-20 -43.6 107.09 0.54 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -48.71 -34.84 28.55 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.799 2.333 . . . . 0.0 112.173 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.44 -44.22 95.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.473 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.46 ' CE1' ' CE1' ' A' ' 17' ' ' HIS . 40.0 t80 -68.15 -42.6 79.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.411 HD11 ' N ' ' A' ' 9' ' ' GLN . 61.2 mt -59.36 -42.61 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.424 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' ASN . . . -61.72 -39.12 90.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.88 -41.27 77.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CE1' ' CE1' ' A' ' 13' ' ' TYR . 3.5 m80 -77.39 -20.87 54.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.912 . . . . 0.0 109.461 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -104.15 -2.04 26.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.523 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . 13.0 m120 -77.27 -74.83 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -147.89 23.43 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -79.85 132.89 36.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.95 -28.35 13.03 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 169' ' ' CYS . 4.0 t -91.39 112.95 56.77 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.212 -1.169 . . . . 0.0 109.41 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.68 137.85 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.759 2.306 . . . . 0.0 111.865 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.7 141.34 51.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.809 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.9 p -90.44 12.4 18.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.376 -0.827 . . . . 0.0 109.107 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -81.36 129.51 34.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 109.317 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.671 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 95.2 p -71.28 -31.03 66.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -58.64 -42.57 88.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.681 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.88 -48.56 65.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 31' ' ' LEU . 11.1 mp -67.89 -42.07 81.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 31.8 t80 -61.5 -52.68 63.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.48 -30.65 71.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -67.97 -55.39 12.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.805 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.4 HG23 ' CG2' ' A' ' 161' ' ' ILE . 9.3 mt -65.75 -43.84 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -58.23 -49.26 77.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 0.0 110.105 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD11 ' CG ' ' A' ' 56' ' ' TYR . 4.2 mm? -76.86 -41.68 43.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.857 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -53.93 -37.97 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.792 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.63 -29.73 25.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.624 ' NE2' ' CZ ' ' A' ' 56' ' ' TYR . 72.3 mt-30 -66.79 -30.03 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.187 . . . . 0.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.699 HE22 ' N ' ' A' ' 46' ' ' TRP . 35.6 tp60 -45.79 -39.05 7.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.935 . . . . 0.0 109.702 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.84 107.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.63 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.28 -32.72 4.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 40' ' ' GLN . 2.5 mt -89.19 -165.11 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -1.126 . . . . 0.0 109.512 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.411 ' HA ' HE22 ' A' ' 41' ' ' GLN . 39.7 t -121.73 149.88 42.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.699 ' N ' HE22 ' A' ' 41' ' ' GLN . 36.2 p90 -57.61 -49.13 77.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 9.4 tp -48.34 -37.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.672 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.474 ' N ' HG23 ' A' ' 47' ' ' ILE . 58.0 m -71.71 -34.2 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.727 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.63 -48.35 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -60.45 -47.22 87.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -61.9 -51.49 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.982 . . . . 0.0 109.305 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.65 -36.2 83.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 109.403 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -48.26 -46.11 35.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.205 -0.934 . . . . 0.0 108.975 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -65.23 -42.32 93.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.362 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.86 -39.08 90.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.286 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.624 ' CZ ' ' NE2' ' A' ' 40' ' ' GLN . 3.6 m-85 -61.87 -44.13 97.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 109.342 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 53.4 mtp180 -54.77 -43.51 72.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.299 -0.875 . . . . 0.0 109.834 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.38 -23.54 65.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.792 . . . . 0.0 110.328 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 79' ' ' LEU . 3.8 t -92.31 -12.64 31.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.271 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -133.16 -46.68 0.84 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.892 -1.13 . . . . 0.0 110.231 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 53.3 t-80 -53.47 -41.55 66.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.037 -1.039 . . . . 0.0 109.901 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.08 -34.87 68.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.792 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' ASP . 88.1 m-85 -91.04 4.41 52.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.874 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.61 160.67 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.601 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.73 -24.22 25.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.856 2.371 . . . . 0.0 112.728 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.85 -48.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.1 mttm -66.09 -33.78 76.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.403 -0.811 . . . . 0.0 109.866 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 71' ' ' MET . 61.0 t -57.43 -43.14 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.058 -1.026 . . . . 0.0 109.576 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.17 -24.35 61.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.63 14.13 28.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.356 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 11.8 ptm -77.61 152.55 33.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -100.62 163.29 12.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.558 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.38 -28.71 60.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.459 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -57.07 -37.42 71.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.13 -38.37 86.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' VAL . 71.0 t -61.5 -38.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.83 -39.4 90.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.391 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 78' ' ' ARG . 53.5 mtm-85 -75.35 -47.85 25.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.318 -0.863 . . . . 0.0 109.767 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.54 HD22 ' SG ' ' A' ' 59' ' ' CYS . 93.1 mt -62.73 -41.85 99.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 76' ' ' VAL . 25.0 t -54.24 -34.28 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.713 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.62 -54.86 3.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.543 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -98.86 109.01 21.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 109.404 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.29 -38.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.87 36.84 46.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -124.5 173.42 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -1.139 . . . . 0.0 109.377 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 87.2 mt -47.71 138.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.593 ' HG2' HH11 ' A' ' 87' ' ' ARG . 9.9 ttt-85 -89.53 126.28 35.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 109.5 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.89 84.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -48.12 -32.09 6.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.935 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.88 93.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -65.13 -40.5 94.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.46 HG21 HG13 ' A' ' 76' ' ' VAL . 4.3 mm -57.82 -47.46 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.49 -38.31 63.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.28 75.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.398 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.514 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 63.2 mt -59.9 -40.74 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.573 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 41.2 mm -54.19 -43.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.96 64.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -65.61 -45.73 82.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.14 . . . . 0.0 109.407 -178.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.516 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.71 -44.97 84.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.71 -41.28 98.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -46.54 38.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.453 ' HH ' ' HG ' ' A' ' 28' ' ' SER . 49.8 t80 -55.45 -44.74 76.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.516 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.19 -32.99 74.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -54.85 -49.83 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.1 mtp -66.53 -38.55 87.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.73 -27.21 67.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -51.6 -34.03 35.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -81.11 -4.69 56.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.9 10.69 80.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -84.74 149.12 53.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.03 119.62 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.626 2.217 . . . . 0.0 111.704 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -73.85 -46.85 42.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -57.85 -47.36 82.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.716 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.473 ' O ' ' OG ' ' A' ' 118' ' ' SER . 19.6 t70 -55.27 -39.1 69.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.907 . . . . 0.0 111.017 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.449 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 92.2 t80 -66.5 -49.43 66.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 111.192 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 116' ' ' VAL . 5.7 m -60.46 -46.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 111.67 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.529 ' O ' HG22 ' A' ' 120' ' ' VAL . 5.1 p-90 -85.97 -33.72 21.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.726 -1.233 . . . . 0.0 111.163 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 120' ' ' VAL . 74.4 m -57.12 -27.5 61.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 109.754 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.4 m -83.78 26.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.056 -1.027 . . . . 0.0 109.988 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.0 m120 74.36 21.57 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 56.51 42.2 27.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.93 . . . . 0.0 109.487 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.455 ' H ' HG23 ' A' ' 120' ' ' VAL . 7.9 pt20 -138.8 146.09 48.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.519 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.67 154.76 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.683 2.255 . . . . 0.0 111.836 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -120.27 147.46 44.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.965 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.7 ptp -135.58 157.31 47.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.838 . . . . 0.0 109.104 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.3 t -127.49 161.2 29.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -147.12 57.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.518 ' HB1' ' OE1' ' A' ' 134' ' ' GLU . . . -98.91 -151.18 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.705 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.3 m -114.31 -28.16 7.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 0.0 109.382 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.3 m -139.18 154.11 48.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.453 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.661 ' H ' HD12 ' A' ' 132' ' ' LEU . 1.0 OUTLIER -62.13 -30.86 71.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -67.2 -32.63 73.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.953 . . . . 0.0 109.513 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.518 ' OE1' ' HB1' ' A' ' 129' ' ' ALA . 95.1 mt-10 -59.08 -26.27 64.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.421 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.7 mp -67.34 121.58 79.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.25 133.94 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.125 2.55 . . . . 0.0 112.504 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 137' ' ' THR . 1.0 OUTLIER -81.67 -17.32 48.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.373 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.1 p -73.05 102.4 3.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -134.8 151.65 76.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.36 -31.39 92.7 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.761 2.307 . . . . 0.0 112.049 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.85 73.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -63.57 -43.63 96.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.31 -44.5 97.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.83 60.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.681 ' C ' HD23 ' A' ' 145' ' ' LEU . 6.8 tt -65.05 -49.05 71.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -57.84 -39.64 78.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.907 . . . . 0.0 109.539 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -62.31 -35.3 78.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.8 -51.57 57.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.2 mt -59.17 -35.02 72.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -58.16 -37.18 74.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.402 ' HB3' HH11 ' A' ' 152' ' ' ARG . 84.3 tttt -62.48 -40.6 97.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.5 mpt_? -64.51 -20.01 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.79 20.82 20.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -84.51 128.04 34.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 156' ' ' PHE . 22.9 tptt -97.41 176.99 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.436 ' H ' ' HG3' ' A' ' 155' ' ' LYS . 67.9 m-85 55.05 47.38 22.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 158' ' ' GLY . 2.6 m -121.71 25.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.69 171.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.443 ' H ' HG23 ' A' ' 159' ' ' THR . 1.1 p -58.31 -32.36 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.455 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.9 m -64.75 -48.46 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -63.37 -39.8 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 109.521 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.527 ' SG ' HD22 ' A' ' 145' ' ' LEU . 31.9 t -68.93 -50.13 52.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.29 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.492 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 53.1 t80 -63.93 -35.63 81.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 109.35 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.3 m -59.41 -41.47 89.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.256 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -65.05 -42.33 94.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.6 mtp -57.38 -40.9 79.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 174' ' ' ASP . 24.1 mm100 -77.1 -36.4 55.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.41 -54.17 27.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.699 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.558 ' O ' ' O ' ' A' ' 23' ' ' VAL . 11.4 p -57.78 -61.14 2.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 144.22 2.76 0.81 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 117' ' ' TRP . 2.6 mp -48.5 -41.81 31.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.419 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.74 128.54 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 32.4 t-20 -81.12 101.29 9.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 109.404 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.526 ' O ' ' ND1' ' A' ' 175' ' ' HIS . 78.6 m-20 -83.87 121.35 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 174' ' ' ASP . 28.4 m-70 -158.57 127.36 5.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.53 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 4' ' ' CYS . 33.7 m -90.41 132.96 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.49 -20.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.78 -3.47 79.82 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 6.9 t -90.17 143.49 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -1.151 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.9 -36.73 80.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.11 -39.33 81.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.9 t80 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.607 -179.908 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 m -48.11 137.73 10.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.39 -11.87 55.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -67.59 -1.86 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -1.154 . . . . 0.0 109.422 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -62.32 137.1 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -58.06 144.9 38.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.26 -32.81 73.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 109.533 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 143.1 78.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.06 -15.34 25.96 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.871 2.381 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.0 -43.06 99.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.22 -47.86 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.6 -46.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.29 92.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.11 -39.19 92.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.514 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 54.4 t-80 -55.27 -47.04 76.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.425 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.09 -42.36 38.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -58.88 -43.36 90.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 21' ' ' TRP . 87.9 mt-10 -146.55 -143.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' O ' ' A' ' 20' ' ' GLU . 35.3 t90 60.06 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.77 67.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -118.38 94.19 46.68 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.272 -1.134 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.04 131.27 21.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.766 2.311 . . . . 0.0 111.834 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.4 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.862 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.1 p -106.28 0.32 25.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.38 134.76 36.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 10.2 p -72.93 -31.72 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -64.7 -54.78 26.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -73.36 -49.75 25.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 109.893 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.2 -44.62 75.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.02 -42.41 98.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.954 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -58.29 -31.51 67.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 109.78 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 tpp -63.67 -46.36 85.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.834 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.53 -47.21 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 110.01 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 14.2 p -60.04 -38.55 83.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.522 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 43.6 mt -66.08 -36.81 84.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.13 -0.981 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 65.3 mm-40 -60.18 -37.9 81.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.704 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.2 -36.05 7.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.443 ' OE1' HG21 ' A' ' 86' ' ' ILE . 74.5 mm-40 -66.09 -31.31 72.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -1.186 . . . . 0.0 109.794 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.533 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 7.9 tt0 -56.8 -31.73 64.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.736 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.72 109.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.98 -31.89 5.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.6 mp -104.73 -160.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -1.187 . . . . 0.0 109.422 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.2 m -125.44 152.96 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.542 ' CZ3' ' OE2' ' A' ' 38' ' ' GLU . 72.5 t-105 -54.19 -42.52 69.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.366 -0.833 . . . . 0.0 109.493 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.637 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -48.99 -39.74 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.68 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.52 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 52.9 m -71.92 -31.5 66.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 109.686 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ARG . 67.6 t -57.82 -30.8 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 109.438 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 50' ' ' LEU . 4.1 mm? -52.87 -54.68 30.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.419 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.09 -45.89 89.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.351 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.85 -24.62 65.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' VAL . 33.2 ttt-85 -62.23 -47.33 84.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.22 -0.925 . . . . 0.0 109.032 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -44.51 84.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 109.337 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.28 -43.95 69.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 22.9 t80 -63.4 -37.31 86.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.474 -0.766 . . . . 0.0 109.332 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.77 -41.95 92.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.383 -0.823 . . . . 0.0 109.783 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 -21.43 59.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 85' ' ' ILE . 25.8 m -89.46 -11.97 41.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 110.266 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 83.3 m-85 -133.51 -50.91 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.113 . . . . 0.0 110.2 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -49.91 -42.83 48.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.913 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -59.32 -28.52 66.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 64' ' ' ASP . 90.8 m-85 -85.52 17.55 3.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.052 -1.03 . . . . 0.0 109.901 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 55.52 162.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 109.576 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.52 -54.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.884 2.389 . . . . 0.0 112.755 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.9 p -48.48 -44.61 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.703 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.577 ' N ' HG13 ' A' ' 66' ' ' VAL . 80.6 tttt -58.12 -37.99 75.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 64' ' ' ASP . 58.9 t -57.46 -38.96 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.083 -1.01 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.06 -24.45 62.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.83 12.83 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.384 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.5 mtp -61.94 135.98 57.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -95.47 162.95 13.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' CD ' HE22 ' A' ' 93' ' ' GLN . 75.6 mm-40 -57.86 -27.75 63.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -71.82 -29.02 63.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.11 -49.4 70.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 92' ' ' ILE . 14.9 m -60.68 -37.64 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.58 -37.1 70.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.427 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.9 ttt-85 -65.25 -42.32 93.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.402 -0.811 . . . . 0.0 109.775 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.9 mt -67.12 -27.15 67.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.631 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.1 t -61.93 -28.42 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.712 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.79 -56.72 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 109.519 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.666 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 53.1 t0 -99.07 169.89 9.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.77 73.59 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 109.416 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -77.95 33.18 1.7 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.502 HG21 ' SG ' ' A' ' 59' ' ' CYS . 16.0 pt -55.87 -159.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -1.12 . . . . 0.0 109.372 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.714 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 2.9 tt -55.86 -165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 109.515 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.714 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 8.0 mtt-85 -47.65 153.3 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -142.65 -156.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.176 -179.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 57.88 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.933 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -66.13 -44.19 91.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -61.59 -42.58 99.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -1.227 . . . . 0.0 109.5 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.59 HG22 HG12 ' A' ' 76' ' ' VAL . 18.8 mt -57.06 -47.29 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.555 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.573 HE22 ' CD ' ' A' ' 73' ' ' GLU . 15.5 mm100 -53.22 -36.99 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.35 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.355 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.586 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 81.4 mt -59.47 -50.0 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.91 -38.5 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.518 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.33 99.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 97.4 m-20 -69.44 -44.68 70.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.423 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.06 95.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.546 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -63.63 -43.93 95.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 109.531 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.99 -34.18 66.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.895 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.64 -51.29 63.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.31 -39.01 91.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -60.13 -42.84 95.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -61.98 -41.43 98.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.65 -27.01 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.127 -0.983 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -51.67 -20.38 2.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.506 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 110' ' ' GLU . 64.3 t30 -75.53 -18.45 59.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.83 65.16 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.517 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 12.0 mp0 -103.48 151.07 38.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.163 -1.198 . . . . 0.0 109.653 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.97 119.65 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.67 2.247 . . . . 0.0 111.676 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -74.88 -45.74 40.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 0.0 110.467 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -62.09 -47.95 82.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 110.734 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.484 ' O ' ' OG ' ' A' ' 118' ' ' SER . 18.4 t70 -55.8 -40.36 72.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.937 . . . . 0.0 111.036 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -64.72 -51.22 63.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.029 -1.045 . . . . 0.0 111.225 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.3 m -56.78 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.98 -1.075 . . . . 0.0 111.716 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.477 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -86.99 -32.82 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.775 -1.203 . . . . 0.0 111.134 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 120' ' ' VAL . 57.1 p -55.65 -21.03 16.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -44.04 -15.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.007 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.9 m -91.77 24.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.044 -1.035 . . . . 0.0 109.982 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.525 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 1.3 m120 72.56 -48.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 3.0 p-80 165.13 -20.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -106.31 149.3 38.06 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.6 149.17 67.58 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.696 2.264 . . . . 0.0 111.805 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -75.38 146.81 40.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.745 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 88.1 mtp -126.44 144.93 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.117 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.09 175.49 6.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -164.86 71.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.279 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.12 -132.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.734 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.9 m -154.22 -35.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -113.13 155.21 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.76 -30.27 70.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.501 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.0 p -70.74 -33.37 70.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.5 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.69 -24.89 67.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.5 mm -66.33 116.77 37.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.686 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.85 126.3 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.187 2.592 . . . . 0.0 112.538 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.453 ' OG1' ' CB ' ' A' ' 163' ' ' TYR . 2.0 t -77.2 -18.26 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.266 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.4 p -89.25 66.61 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.356 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -77.27 152.31 81.59 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.37 -36.02 16.92 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.8 2.333 . . . . 0.0 112.035 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.46 -41.51 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.1 m -59.65 -39.82 85.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -62.17 -48.32 80.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.82 78.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -61.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.528 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.7 p -63.26 -39.43 94.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.918 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.54 43.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.71 -33.44 75.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.564 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.44 -39.67 84.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.422 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -61.16 -39.93 91.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.618 HH11 ' CG ' ' A' ' 152' ' ' ARG . 7.3 mtt-85 -64.43 -21.51 66.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.85 36.99 5.87 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.448 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 1.4 m-85 -84.79 133.51 34.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -1.112 . . . . 0.0 109.517 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.61 159.87 14.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.448 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 56.12 48.38 17.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.7 p -121.82 26.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.457 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.51 156.3 0.07 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -59.88 -14.02 13.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -1.133 . . . . 0.0 109.448 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.6 p -70.86 -44.97 65.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 38' ' ' GLU . 26.0 mt -65.07 -36.34 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.526 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 68.3 m -55.81 -40.81 73.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.321 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.453 ' CB ' ' OG1' ' A' ' 137' ' ' THR . 37.6 t80 -66.78 -47.26 72.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.405 -0.809 . . . . 0.0 109.314 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.7 m -66.05 -40.68 91.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.317 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.77 -49.38 77.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 92.6 mtp -68.94 -39.55 79.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.666 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.47 -41.89 99.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.734 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.58 97.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.678 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.4 m -66.06 -60.82 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 138.8 1.69 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.29 -33.34 72.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -1.167 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -99.74 130.1 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -98.76 105.06 17.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.29 114.23 26.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -135.51 143.18 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.44 142.5 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.441 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.435 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 89.05 15.63 58.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 178' ' ' GLY . 7.7 m -149.8 176.16 10.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 75.3 m 50.75 -97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 181' ' ' CYS . 52.7 t -156.17 15.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.8 t80 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.641 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.338 0.59 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -48.13 167.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.99 9.23 1.54 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.607 ' CD1' HD13 ' A' ' 132' ' ' LEU . 21.6 m95 -83.13 -1.22 52.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.94 132.8 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' GLN . 68.4 m -79.64 177.94 8.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.4 mm-40 -61.03 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 51.54 85.06 0.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.01 -25.76 4.32 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.852 2.368 . . . . 0.0 112.1 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.91 -39.31 93.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.481 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -71.16 -48.11 53.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.12 -44.84 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.376 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.92 81.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.459 ' CG ' HD21 ' A' ' 50' ' ' LEU . 85.5 t80 -61.64 -43.96 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.18 -49.45 77.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.48 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.483 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -56.95 -56.36 22.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -175.25 131.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -159.64 123.05 3.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 109.516 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.98 -5.29 75.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' CYS . 19.3 t -63.4 132.09 95.02 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.209 -1.171 . . . . 0.0 109.343 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.03 120.47 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.777 2.318 . . . . 0.0 111.849 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.46 132.79 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.854 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -115.08 3.5 14.43 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 109.083 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.1 126.02 32.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 m -64.52 -40.44 95.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -60.93 -45.28 95.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.61 -45.01 69.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.895 . . . . 0.0 109.846 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.2 -43.93 96.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.118 -0.989 . . . . 0.0 109.808 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.486 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 44.9 t80 -60.52 -37.03 79.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.919 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.93 -30.55 63.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.878 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.9 tpp -64.45 -54.98 24.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.794 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.3 tp -64.46 -33.32 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 110.045 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.5 m -64.44 -49.9 69.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 110.106 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.19 -28.38 59.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 109.805 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -52.82 -35.26 56.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 109.772 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.61 -33.88 74.03 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -59.05 -32.54 69.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -1.207 . . . . 0.0 109.763 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -52.87 -39.7 62.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.05 120.41 3.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -35.27 4.2 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.02 -138.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.137 . . . . 0.0 109.445 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -142.41 158.92 43.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -56.14 -39.36 72.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.474 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -59.12 -34.46 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.687 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 61.1 m -69.39 -33.47 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.0 t -57.63 -43.16 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.442 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 50' ' ' LEU . 9.8 mp -56.7 -52.15 66.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.57 -44.69 93.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 109.307 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -73.25 -21.61 60.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.193 -0.942 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.8 ttm-85 -60.35 -46.05 91.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -71.13 -45.95 62.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.403 -0.811 . . . . 0.0 109.439 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.99 -35.0 79.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.609 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 25.3 t80 -62.78 -44.61 95.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.563 ' HG2' HH11 ' A' ' 57' ' ' ARG . 27.9 mtt-85 -57.0 -41.81 79.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.828 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -29.9 71.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.258 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 97.9 m -93.49 -12.6 29.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.262 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 61.8 m-85 -125.68 -43.27 1.88 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 0.0 110.181 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 29.9 t-80 -49.89 -40.14 42.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -61.85 -31.73 72.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.739 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.7 m-85 -91.34 -0.85 57.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.077 -1.014 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.05 161.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.107 -0.995 . . . . 0.0 109.623 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.47 -27.11 16.17 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.867 2.378 . . . . 0.0 112.713 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.5 -47.87 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.13 -35.35 80.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 64' ' ' ASP . 46.3 t -58.11 -35.71 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 109.598 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.81 66.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.466 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 23.08 9.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 tpp -61.22 156.45 18.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.671 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -110.47 156.83 20.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.6 mt-10 -55.75 -35.06 65.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.94 -37.59 85.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 80' ' ' VAL . 59.9 t -54.71 -49.5 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.3 mp0 -64.25 -32.74 74.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.63 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.28 -49.2 67.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.806 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.0 -41.18 67.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.605 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 76' ' ' VAL . 38.9 t -51.1 -33.08 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -80.95 -59.79 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -98.96 117.11 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 77.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -22.91 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 84' ' ' GLY . 24.0 pt -62.29 -134.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.321 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.05 136.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -101.29 117.98 36.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.467 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -172.4 94.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.183 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -45.27 -35.43 3.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 109.967 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.33 -47.66 85.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -66.16 -38.12 87.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.25 -50.22 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.12 -32.99 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.326 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.26 99.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.388 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.06 -46.17 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.375 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.61 -36.45 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.63 94.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.623 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 13.9 m120 -60.17 -42.52 95.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.66 89.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.512 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -61.23 -44.33 97.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.29 72.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 30.1 t80 -66.93 -43.72 82.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.527 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -66.93 -50.51 62.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -59.9 -35.0 73.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ttt -59.16 -40.96 87.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.29 -27.75 66.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.482 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -51.66 -34.05 36.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -83.4 -1.19 52.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.39 35.92 40.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -116.84 82.16 12.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.657 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -41.67 131.31 3.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.634 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.06 -47.74 83.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -45.45 80.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 110.718 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -59.22 -33.21 70.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 111.034 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.3 t80 -65.26 -53.43 44.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.023 -1.048 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 116' ' ' VAL . 7.0 m -58.02 -40.99 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.719 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -68.56 -31.12 70.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.719 -1.238 . . . . 0.0 111.104 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -65.15 -34.78 79.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 109.676 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -58.72 -44.2 90.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.084 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 123' ' ' GLN . 3.2 p -89.71 20.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.079 -1.013 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.62 30.48 18.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 55.45 22.88 5.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.495 ' H ' HG13 ' A' ' 120' ' ' VAL . 65.8 mt-30 -123.39 100.98 38.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.626 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -47.38 139.45 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.728 2.286 . . . . 0.0 111.855 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -85.5 157.38 20.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -131.85 151.3 51.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 109.183 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -131.58 152.52 50.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -133.96 45.67 2.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.324 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.73 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -68.52 147.06 52.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.2 m -74.08 -36.26 64.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.4 m -132.56 157.58 44.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.884 ' H ' HD12 ' A' ' 132' ' ' LEU . 6.0 mp -54.29 -32.34 56.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.2 t -64.93 -33.83 76.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.73 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 71.3 mm-40 -69.34 -19.12 63.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 109.367 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -66.85 124.2 88.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 109.676 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.36 127.24 5.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.143 2.562 . . . . 0.0 112.552 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 -13.79 47.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.304 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -109.15 100.64 9.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 109.374 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -105.51 150.75 39.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.917 . . . . 0.0 109.462 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.96 -41.1 26.01 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.789 2.326 . . . . 0.0 111.982 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.65 -36.91 60.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.3 m -60.9 -43.24 98.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -61.96 -48.07 82.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.21 89.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.22 -41.39 99.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.2 p -57.88 -43.36 85.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.7 -27.68 68.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.502 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.48 -51.33 29.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.42 -36.17 73.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -57.62 -36.6 72.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.34 -40.1 92.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.62 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -67.51 -19.74 65.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.413 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.92 22.25 16.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.623 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 8.0 m-85 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -1.107 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -101.79 168.52 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.501 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 54.05 53.13 11.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.28 25.16 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.419 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.41 167.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -55.47 -32.18 62.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.436 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 65.9 p -64.38 -47.78 77.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -65.7 -35.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 5.9 t -68.7 -44.13 74.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.259 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -62.23 -44.97 95.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.7 m -57.99 -37.18 73.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.222 -0.924 . . . . 0.0 109.248 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.617 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 72.4 t80 -59.73 -41.36 90.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.398 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.12 -38.57 72.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.533 HE22 ' CG ' ' A' ' 174' ' ' ASP . 98.1 mm-40 -63.34 -46.45 86.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.7 -44.63 49.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.617 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 98.3 m -62.44 -36.13 81.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.462 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.28 8.8 56.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.8 mp -53.41 -26.82 21.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -1.152 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.06 138.61 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.449 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -82.12 102.37 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.533 ' CG ' HE22 ' A' ' 167' ' ' GLN . 34.4 m-20 -91.56 118.17 30.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.56 166.0 28.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.621 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.27 150.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.29 130.23 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 180' ' ' CYS . . . 91.2 4.71 68.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 181' ' ' CYS . 53.5 t -76.34 28.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.542 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.45 ' H ' ' C ' ' A' ' 178' ' ' GLY . 3.2 m 63.04 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 179' ' ' CYS . 73.3 m -59.47 -35.35 73.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.0 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.637 ' HG2' HH11 ' A' ' 3' ' ' ARG . 10.2 mtt-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' TRP . 26.6 p -47.23 127.29 10.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.94 -6.27 3.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' CYS . 16.9 m95 -54.53 -37.0 64.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.423 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 7' ' ' VAL . 17.9 m -88.76 127.15 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.564 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' GLN . 75.2 m -165.86 146.46 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.0 mm100 60.32 133.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.552 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' GLN . 1.1 m-20 63.0 125.11 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.26 -7.71 19.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.845 2.364 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.49 -32.86 72.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.55 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 30.8 m-85 -49.47 -44.23 45.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.78 -28.42 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.424 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -58.97 -48.23 82.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.429 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.559 ' CG ' ' N ' ' A' ' 17' ' ' HIS . 2.2 p90 -75.52 -39.09 58.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.559 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 48.3 t-80 -60.85 -48.21 82.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.42 -44.86 67.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 98.4 m-20 -55.28 -45.45 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.3 pt-20 -173.52 -143.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.595 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 11.0 t-105 60.6 125.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.03 -20.28 46.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 169' ' ' CYS . 26.3 m -84.66 141.36 38.64 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.17 -1.194 . . . . 0.0 109.33 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.87 122.85 4.48 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.758 2.306 . . . . 0.0 111.905 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -119.6 131.98 55.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.02 . . . . 0.0 109.857 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -123.21 5.5 9.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.88 135.01 33.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.439 ' CA ' ' HB2' ' A' ' 113' ' ' ALA . 14.5 m -69.63 -39.36 77.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.603 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.47 -43.59 88.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 109.717 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -65.94 -49.64 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.86 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 ' SG ' ' A' ' 169' ' ' CYS . 43.9 mt -72.91 -29.96 63.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.873 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' ' N ' ' A' ' 33' ' ' GLU . 9.2 t80 -59.98 -56.39 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.0 pp20? -68.58 -29.72 68.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.595 ' SD ' ' CH2' ' A' ' 21' ' ' TRP . 55.2 tpp -63.61 -53.36 52.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.88 -46.78 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 110.05 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.9 t -70.34 -39.17 74.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.4 tp -73.34 -38.37 65.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 35.0 mm-40 -52.76 -34.54 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.24 -23.66 41.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.2 -38.01 86.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.176 . . . . 0.0 109.783 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -48.75 -38.93 23.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.786 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.53 106.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.662 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -31.26 6.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -86.03 -165.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -1.192 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 48' ' ' THR . 15.6 p -117.36 150.64 38.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -56.21 -36.65 68.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -79.52 -30.77 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.707 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 45' ' ' SER . 52.4 m -67.64 -40.46 84.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.679 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' ARG . 70.4 t -68.91 -40.89 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 16' ' ' TYR . 85.7 mt -57.05 -47.25 81.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -60.79 -51.45 69.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 109.297 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.48 -26.31 67.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.7 tmm_? -54.47 -46.63 73.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.38 -34.48 76.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.259 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -63.76 -45.8 88.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -0.789 . . . . 0.0 109.327 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 79.3 mtm180 -62.29 -30.63 71.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.864 . . . . 0.0 109.732 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.66 82.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.881 . . . . 0.0 110.276 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -93.77 -13.33 27.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.27 -178.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -113.76 -52.33 2.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.913 -1.117 . . . . 0.0 110.175 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.424 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.9 t-80 -51.94 -40.0 60.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 109.91 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -56.55 -32.5 65.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-85 -88.67 -2.83 58.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 109.883 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER 56.2 158.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.08 -24.04 20.85 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.893 2.396 . . . . 0.0 112.728 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.39 -48.24 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' MET . 12.2 mptt -67.88 -33.7 75.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 64' ' ' ASP . 94.1 t -56.16 -41.22 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.029 . . . . 0.0 109.551 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.11 68.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.46 17.7 20.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.399 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ttp -75.81 155.43 35.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.68 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 18.5 pt20 -105.48 162.53 13.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.96 -30.07 70.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.32 -41.32 84.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.425 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.5 m-20 -60.93 -39.83 90.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.36 -42.51 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -60.15 -34.06 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.635 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.41 -44.55 82.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 13.9 mt -65.04 -33.4 75.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.932 . . . . 0.0 109.626 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.79 -31.99 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -84.88 -60.89 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.552 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.23 123.73 43.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.371 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . . . -166.11 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.78 27.18 57.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ARG . 9.9 pt -133.0 167.38 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.138 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.71 58.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.634 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -106.69 139.79 40.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.471 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' GLY . 14.3 p80 -128.8 44.19 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.146 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HG2' HH11 ' A' ' 89' ' ' ARG . 3.9 ttt-85 65.67 -58.54 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -60.82 -35.35 89.94 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -61.27 -50.98 70.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -1.167 . . . . 0.0 109.461 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -52.39 -39.51 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.691 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.53 -36.63 76.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.0 109.32 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.14 95.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.7 mp -55.54 -47.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -58.46 -30.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.551 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.23 94.83 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.728 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 29.0 p30 -68.63 -33.35 73.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 109.358 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.728 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -67.4 -42.25 83.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -65.23 -45.95 82.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.585 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.72 63.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 29.8 t80 -68.83 -43.44 75.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.549 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -66.57 -47.96 71.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.474 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -57.97 -39.58 78.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 17.2 ttt -66.74 -41.24 88.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.85 -25.94 68.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -51.28 -29.28 14.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 105' ' ' MET . 51.0 p30 -80.16 -1.48 40.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.489 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.66 79.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HB3' HD21 ' A' ' 108' ' ' ASN . 32.4 tt0 -80.76 132.98 56.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.158 -1.201 . . . . 0.0 109.627 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.47 121.27 8.03 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.614 2.21 . . . . 0.0 111.726 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -74.72 -43.86 52.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.393 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' ' CA ' ' A' ' 28' ' ' SER . . . -56.06 -49.99 72.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -0.967 . . . . 0.0 110.708 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 86.5 m-20 -61.23 -42.7 99.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 27.5 t80 -55.31 -48.62 73.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 111.213 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.7 m -63.82 -48.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 0.0 111.721 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.488 ' CD2' ' N ' ' A' ' 118' ' ' SER . 4.3 p-90 -89.32 -37.49 14.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.769 -1.207 . . . . 0.0 111.117 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.4 m -56.18 -26.88 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.781 -1.199 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -13.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.04 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 118' ' ' SER . 18.7 m -82.8 21.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t30 60.36 36.22 20.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.061 -1.024 . . . . 0.0 109.703 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.2 m80 53.54 27.08 6.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.47 87.91 21.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.72 151.78 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.695 2.263 . . . . 0.0 111.842 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -93.44 155.16 17.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.719 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 71.6 mtm -137.15 147.17 45.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.198 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.5 t -142.18 155.82 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.801 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -123.61 45.61 2.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.289 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.2 139.5 35.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.2 m -74.56 -35.52 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.8 t -139.45 178.92 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -68.84 -33.4 73.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.543 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m -63.12 -36.42 83.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.81 -24.44 64.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.161 -0.962 . . . . 0.0 109.404 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 132' ' ' LEU . 87.4 mt -67.28 119.95 68.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.728 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.76 129.22 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.088 2.526 . . . . 0.0 112.487 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 137' ' ' THR . 1.2 t -80.62 -19.19 45.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.4 m -98.05 98.54 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.858 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.5 p -106.23 154.61 39.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.32 -40.12 52.85 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.839 2.36 . . . . 0.0 111.999 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.16 -36.48 58.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.407 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -61.19 -41.3 96.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 -53.13 57.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.27 -35.26 79.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.435 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.01 -50.19 74.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 80.5 p -58.5 -37.69 76.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.91 -36.08 82.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.549 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.31 -50.56 45.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.467 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.603 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.88 -38.82 79.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.355 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -61.92 -39.37 91.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -63.84 -20.54 65.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.92 31.01 8.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.47 137.95 32.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.132 . . . . 0.0 109.454 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -101.19 173.58 6.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.485 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 52.82 50.79 17.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 157' ' ' VAL . 11.3 p -123.68 28.79 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.21 159.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.8 t -52.46 -29.81 26.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.373 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.5 m -65.9 -36.84 84.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.446 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.9 mm -62.24 -44.09 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.22 -48.7 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.411 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 42.9 t80 -60.21 -47.01 87.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.811 . . . . 0.0 109.352 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 22.6 t -61.64 -43.35 99.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.857 . . . . 0.0 109.27 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.411 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -63.08 -32.63 74.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.47 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 31.5 ttm -64.29 -45.13 89.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.609 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.81 -34.1 77.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.672 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.659 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.557 ' SG ' HD22 ' A' ' 31' ' ' LEU . 1.2 m -77.2 -42.5 37.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.65 28.77 5.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.72 -34.33 77.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.41 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.69 132.15 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -84.64 100.95 11.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p-10 -120.64 92.62 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 176' ' ' VAL . 75.5 m80 -132.99 36.35 3.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.67 HG12 ' N ' ' A' ' 177' ' ' VAL . 86.3 t 54.39 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.452 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.67 ' N ' HG12 ' A' ' 176' ' ' VAL . 8.1 p -110.61 136.23 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.75 24.13 75.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 181' ' ' CYS . 66.4 m -143.73 169.9 16.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 109.523 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 84.5 m 48.3 -93.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 179' ' ' CYS . 50.0 m -157.92 33.09 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 7.9 p -47.39 146.02 2.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.66 2.87 46.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' HE1' HD22 ' A' ' 132' ' ' LEU . 8.8 m95 -54.22 -36.56 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -1.135 . . . . 0.0 109.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -97.01 131.14 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 13.0 t -177.31 -168.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.547 ' N ' ' OG ' ' A' ' 8' ' ' SER . 94.9 mt-30 49.38 -117.93 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.85 153.44 91.17 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.352 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.46 -6.14 18.28 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.804 2.336 . . . . 0.0 112.139 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.5 tt -59.82 -39.52 85.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.633 ' CZ ' HD13 ' A' ' 47' ' ' ILE . 88.7 m-85 -56.47 -43.73 79.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.43 -43.95 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.51 76.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.39 -40.15 93.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -63.42 -37.42 87.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -88.41 -4.41 58.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.513 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.561 HD22 HH22 ' A' ' 53' ' ' ARG . 48.0 t30 -74.09 -73.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -150.93 38.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.479 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -92.77 138.83 31.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.02 -21.39 44.18 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.58 132.44 72.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.247 -1.149 . . . . 0.0 109.366 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.48 119.69 6.28 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.724 2.282 . . . . 0.0 111.87 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.67 137.25 41.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -134.54 2.59 3.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.071 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -89.66 135.19 33.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.375 -0.828 . . . . 0.0 109.303 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.739 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 96.2 p -59.94 -38.28 81.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.632 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -57.02 -43.82 82.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.766 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.37 -53.31 24.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.0 mp -69.03 -27.89 66.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.783 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 56.1 t80 -60.36 -50.53 73.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.928 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -74.44 -31.11 62.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.813 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.89 -54.39 22.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -64.4 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.032 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' N ' HG23 ' A' ' 35' ' ' ILE . 36.1 t -73.36 -46.6 48.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.16 -0.962 . . . . 0.0 110.088 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.1 -41.67 97.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.877 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.22 -28.59 64.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.296 -0.878 . . . . 0.0 109.788 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.75 -37.07 27.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -66.07 -29.0 69.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -1.184 . . . . 0.0 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.4 tt0 -48.11 -34.22 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.72 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.42 111.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -33.12 5.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.0 mt -96.06 -145.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -1.14 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 m -144.68 155.97 43.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -51.17 -38.95 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.374 -0.829 . . . . 0.0 109.461 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.633 HD13 ' CZ ' ' A' ' 13' ' ' TYR . 9.7 tp -61.94 -40.44 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 109.672 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 47' ' ' ILE . 96.1 m -63.91 -35.87 82.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 53' ' ' ARG . 72.9 t -62.06 -42.82 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.473 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.43 -51.06 69.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -60.37 -44.08 95.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 109.348 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -75.78 -19.35 59.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.975 . . . . 0.0 109.361 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.561 HH22 HD22 ' A' ' 19' ' ' ASN . 43.8 ttp180 -61.22 -45.65 93.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 108.994 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 10.2 pt-20 -72.15 -43.0 65.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.34 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.95 -35.29 79.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.229 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 52.7 t80 -57.39 -49.27 76.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.427 -0.795 . . . . 0.0 109.308 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.4 mtp180 -58.42 -43.12 88.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.741 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.97 -39.81 42.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.793 . . . . 0.0 110.305 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -96.78 -28.63 14.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 35.4 m-85 -95.71 -27.75 15.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.977 -1.077 . . . . 0.0 110.231 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.7 t60 -48.77 -21.66 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -90.87 -25.61 19.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.81 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 68' ' ' VAL . 61.9 m-85 -92.03 66.09 4.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 109.925 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' PHE . 3.7 m-20 -41.33 153.77 0.24 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 109.604 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -35.92 -53.66 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.852 2.368 . . . . 0.0 112.722 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.31 -45.11 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.64 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -67.35 -31.67 72.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.853 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 63' ' ' PHE . 93.9 t -56.45 -46.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.572 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.81 58.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.48 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 -3.58 58.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 mtp -70.97 141.1 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 31.1 tp60 -99.85 169.15 9.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 78.7 mm-40 -61.84 -33.87 74.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 46.7 mp0 -60.84 -40.89 94.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.437 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -62.74 -37.76 87.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.41 -43.29 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.48 -33.47 75.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.97 -44.76 91.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.314 -0.866 . . . . 0.0 109.792 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -70.07 -35.48 74.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 109.591 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.1 t -51.19 -34.94 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.739 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -87.83 -60.13 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.614 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -100.17 109.23 21.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.903 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.47 -60.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.47 4.61 70.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 85' ' ' ILE . 12.9 pt -90.02 -155.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.32 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.2 mt -68.62 136.79 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.478 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 87' ' ' ARG . 19.7 mmm-85 -88.6 95.89 10.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -172.41 88.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.13 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -49.96 -29.12 7.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.04 96.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -63.05 -48.19 79.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -1.186 . . . . 0.0 109.479 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.83 -44.13 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.598 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -54.51 -38.62 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.327 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.02 79.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 60' ' ' PHE . 44.1 mm -57.69 -46.66 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.432 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -55.18 -43.74 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.06 -36.23 85.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.602 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 16.5 t30 -56.87 -48.16 78.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.72 93.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.416 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 46.2 ttm-85 -66.56 -45.16 80.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.525 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.73 -36.06 67.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -71.08 -47.6 57.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.61 -37.79 85.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.865 . . . . 0.0 109.534 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.53 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.601 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 28.2 ttt -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.529 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.35 -27.19 67.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -52.11 -24.08 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.49 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -75.54 -18.12 59.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.8 7.43 68.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.59 150.28 38.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.205 -1.174 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.99 119.17 6.18 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.621 2.214 . . . . 0.0 111.693 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -74.57 -44.91 48.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.803 . . . . 0.0 110.404 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.26 -48.58 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.201 -0.937 . . . . 0.0 110.732 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 83.2 m-20 -56.23 -43.59 78.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.204 -0.935 . . . . 0.0 111.081 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -61.93 -51.31 68.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 111.227 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 117' ' ' TRP . 6.7 m -57.97 -47.37 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 111.722 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -87.6 -28.04 22.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.696 -1.253 . . . . 0.0 111.178 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -59.61 -23.9 63.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 109.709 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -43.85 -19.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.08 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.7 m -82.9 22.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.087 -1.008 . . . . 0.0 109.954 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 58.22 36.92 26.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.0 109.67 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.1 m80 60.27 15.23 5.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.531 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -111.83 128.1 25.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.628 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.57 147.89 41.42 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.672 2.248 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -98.5 144.5 27.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 109.751 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.4 ttp -132.07 135.06 46.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.784 . . . . 0.0 109.097 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.7 t -85.5 156.08 20.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.897 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -151.06 48.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.855 . . . . 0.0 109.3 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB1' ' OE2' ' A' ' 134' ' ' GLU . . . -100.82 -155.81 0.53 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.662 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.587 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.2 m -130.88 -54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.0 m -98.04 161.11 13.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.429 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.513 HD22 ' HE1' ' A' ' 6' ' ' TRP . 20.9 mt -75.53 -11.16 59.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 t -89.72 -39.04 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 130' ' ' THR . 11.2 pt-20 -68.66 -13.31 62.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 132' ' ' LEU . 79.1 mt -67.43 118.41 56.44 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.52 131.29 5.49 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.047 2.498 . . . . 0.0 112.536 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -91.39 -11.85 36.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.9 t -92.88 99.04 11.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.3 p -110.18 151.56 42.63 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -45.71 -40.79 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.815 2.343 . . . . 0.0 112.011 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.24 76.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -61.66 -42.2 98.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.863 . . . . 0.0 109.494 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -61.06 -44.46 97.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.65 -43.61 68.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.4 -49.56 77.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.7 m -54.12 -43.61 70.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.76 -38.14 84.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.11 -49.87 66.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.5 -34.94 74.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.878 . . . . 0.0 109.564 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -60.55 -36.79 79.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -60.76 -37.88 83.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.24 -21.32 63.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.283 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.77 4.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -97.51 129.92 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -92.97 167.16 11.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 51.54 48.31 23.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.7 p -121.63 25.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.45 165.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.8 t -56.87 -29.88 63.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -1.156 . . . . 0.0 109.442 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 m -59.77 -47.56 85.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 73.3 m -61.04 -42.89 99.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -60.31 -44.58 95.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.46 -0.775 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.5 p -61.98 -36.71 82.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -42.45 83.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 56.8 mtp -61.36 -39.24 89.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -61.69 -47.12 86.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.17 -38.98 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.98 -14.18 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.42 0.04 77.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.3 mp -63.04 -39.92 96.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.07 131.56 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.501 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' THR . 84.2 m-20 -95.66 117.98 31.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.443 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.15 105.15 17.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -145.89 144.5 30.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.67 137.08 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 177' ' ' VAL . 14.9 p -75.13 134.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.22 3.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.507 ' C ' ' H ' ' A' ' 181' ' ' CYS . 34.8 m -98.66 173.72 6.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -1.152 . . . . 0.0 109.534 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 54.1 m 54.45 5.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.443 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.507 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.3 m 62.8 50.19 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.602 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 23.9 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 45.1 mtm-85 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 6' ' ' TRP . 16.3 p -96.39 -176.14 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.39 -24.83 0.9 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.659 ' CD2' HD21 ' A' ' 132' ' ' LEU . 11.4 m0 53.13 55.68 8.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -59.84 -5.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 6' ' ' TRP . 52.6 m -47.22 114.33 0.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 109.418 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -167.84 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -151.55 150.89 27.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.0 -36.97 16.75 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.896 2.397 . . . . 0.0 112.145 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 47' ' ' ILE . 52.3 tp -63.44 -51.25 66.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -70.08 -45.12 67.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 109.379 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.9 mt -59.81 -42.37 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.347 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.94 -47.1 69.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.417 ' CE1' HD22 ' A' ' 50' ' ' LEU . 87.7 t80 -59.85 -44.7 93.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CE1' ' CE3' ' A' ' 21' ' ' TRP . 19.9 t60 -62.6 -45.54 92.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.27 -22.25 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.19 -75.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -145.15 113.8 6.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.873 . . . . 0.0 109.52 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CE3' ' CE1' ' A' ' 17' ' ' HIS . 62.3 t90 -172.99 139.61 0.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -29.84 3.1 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 169' ' ' CYS . 3.7 m -68.02 149.19 98.27 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.232 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.99 128.25 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.805 2.337 . . . . 0.0 111.891 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -124.99 130.67 52.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.78 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -123.13 12.21 9.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.072 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.3 136.8 35.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 92.0 p -73.16 -33.61 65.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.07 -51.57 60.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HZ3' ' HB3' ' A' ' 30' ' ' LYS . 8.9 mtpm? -62.79 -46.39 88.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 109.861 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.42 -37.21 80.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 109.834 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -65.15 -51.32 61.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.12 -32.55 73.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.1 tpt -59.36 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.806 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.29 -39.06 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.7 m -65.7 -45.29 83.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.54 -41.23 66.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.13 -34.17 73.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.38 -36.18 88.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.83 -26.63 64.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -1.191 . . . . 0.0 109.748 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -51.47 -26.07 7.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.698 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.09 109.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.95 -33.42 5.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 mt -97.36 175.18 6.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -1.175 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.8 m -100.94 161.79 13.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 45.2 p90 -55.48 -41.29 72.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.862 . . . . 0.0 109.446 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 8.7 tp -57.97 -38.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.724 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.469 ' N ' HG23 ' A' ' 47' ' ' ILE . 90.3 m -64.69 -37.95 89.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.694 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.43 -42.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.466 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 16' ' ' TYR . 74.5 mt -57.99 -42.49 85.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -61.72 -51.5 68.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 11.5 mptt -65.75 -36.58 83.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -47.15 -42.65 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.194 -0.941 . . . . 0.0 109.006 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -70.17 -42.48 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -63.43 -47.46 81.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.266 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CD2' ' CE1' ' A' ' 60' ' ' PHE . 12.3 m-85 -58.68 -49.27 78.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 17.9 mmm180 -53.3 -27.75 24.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.35 -29.43 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 56' ' ' TYR . 16.7 m-85 -81.73 -51.75 7.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.945 -1.097 . . . . 0.0 110.205 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 53.1 t60 -51.62 -42.3 61.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.829 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -73.67 -14.58 61.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CE2' ' SD ' ' A' ' 71' ' ' MET . 16.3 t80 -93.3 2.83 56.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.007 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.93 159.2 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.024 . . . . 0.0 109.598 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.2 -53.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.886 2.391 . . . . 0.0 112.707 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.1 t -48.17 -41.95 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.717 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -64.74 -34.57 78.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.382 -0.824 . . . . 0.0 109.883 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 64' ' ' ASP . 54.5 t -56.93 -40.55 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.614 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -70.68 -32.94 70.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 109.452 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.04 18.57 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.603 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -75.36 155.2 36.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.689 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.8 tp60 -102.63 167.54 9.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 96.4 mt-10 -70.05 -25.92 63.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.2 -30.99 67.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.465 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.27 -49.7 68.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 76' ' ' VAL . 8.5 m -59.65 -37.88 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.9 mt-10 -58.99 -35.98 74.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.3 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -65.72 -40.2 91.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.16 -34.28 77.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.9 -35.49 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -87.06 -62.03 1.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -101.34 107.08 18.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.61 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.85 14.38 65.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 pt -104.09 178.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.391 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.51 140.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HG3' HH11 ' A' ' 87' ' ' ARG . 44.0 mtm-85 -87.81 101.81 14.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.52 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.464 ' CD2' ' HZ2' ' A' ' 91' ' ' LYS . 49.2 t-80 -171.54 82.04 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.218 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 15.3 ptm180 -46.84 -30.46 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.83 93.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HZ2' ' CD2' ' A' ' 88' ' ' HIS . 62.3 mttp -66.11 -42.62 88.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.6 mt -63.64 -49.55 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.37 -35.6 67.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.375 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.3 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.98 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.06 -39.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.539 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.69 95.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.481 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 3.0 m120 -63.26 -43.83 96.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -1.204 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.06 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 47.6 ttm-85 -58.46 -41.75 85.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.21 70.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.87 -48.46 81.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -61.75 -44.72 96.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.6 -44.26 93.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.604 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 23.7 ttt -67.11 -32.54 73.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.48 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.91 -29.25 69.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -52.29 -24.75 7.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.15 -18.7 59.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.492 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.8 55.11 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -116.85 150.8 46.46 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -1.181 . . . . 0.0 109.691 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.21 130.86 26.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.618 2.212 . . . . 0.0 111.659 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -79.25 -49.21 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.475 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -55.77 -48.92 74.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.53 ' O ' ' OG ' ' A' ' 118' ' ' SER . 85.3 m-20 -60.0 -43.63 95.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 111.053 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.59 -50.92 70.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.067 -1.021 . . . . 0.0 111.188 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.6 m -59.31 -48.45 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.096 -1.003 . . . . 0.0 111.64 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.474 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 5.0 p-90 -88.88 -33.38 17.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 0.0 111.147 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 120' ' ' VAL . 66.8 m -55.08 -26.44 37.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.793 -1.192 . . . . 0.0 109.752 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.32 -14.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 118' ' ' SER . 12.9 m -85.07 27.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.046 -1.034 . . . . 0.0 109.983 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 75.78 19.0 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.747 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 58.72 39.65 24.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.438 ' H ' HG23 ' A' ' 120' ' ' VAL . 8.3 pt20 -146.05 146.77 29.56 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.636 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.86 147.56 44.35 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.691 2.261 . . . . 0.0 111.814 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -111.21 153.72 25.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 58.2 ttm -133.26 148.83 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -122.52 164.84 17.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -133.41 49.68 2.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.308 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.52 -158.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 11.7 m -145.34 -27.48 0.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.57 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 8.9 m -127.73 157.98 38.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -75.22 -12.79 60.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.2 m -93.0 -32.53 14.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 131' ' ' THR . 5.6 pt-20 -74.11 -1.42 20.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.925 . . . . 0.0 109.428 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 28.9 mm -66.9 130.85 93.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.77 126.24 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.096 2.531 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 137' ' ' THR . 3.1 m -89.77 -10.57 45.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.9 . . . . 0.0 109.342 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 72.2 p -94.13 102.26 14.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 p -119.11 149.9 47.92 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.53 -31.84 87.67 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.17 58.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 42.9 t -62.08 -46.33 89.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.469 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -61.67 -46.23 90.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.57 84.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.67 -47.11 82.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.0 t -54.5 -45.09 73.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -60.62 -33.33 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.547 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.24 16.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 149' ' ' LEU . 10.7 mp -60.15 -34.75 73.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.575 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -58.15 -34.97 70.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.43 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -62.66 -36.31 82.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.637 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -72.14 -19.88 61.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.357 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.56 30.11 7.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.481 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 5.1 m-85 -86.29 132.67 33.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -1.108 . . . . 0.0 109.474 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -104.79 177.86 4.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 52.8 47.94 23.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 158' ' ' GLY . 26.9 m -116.32 25.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.58 166.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.0 m -54.01 -32.54 54.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.3 p -65.09 -48.04 75.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -66.31 -39.29 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 7.9 t -68.58 -44.31 74.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.5 -42.03 98.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -59.27 -33.47 71.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.245 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 79.4 t80 -65.77 -35.45 80.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.397 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.2 mmm -63.32 -52.2 62.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.85 -38.0 85.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.45 -54.19 49.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.675 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 8.7 m -66.29 -33.23 75.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.01 35.38 6.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -74.05 -41.39 61.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.425 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 172' ' ' VAL . 3.0 m -96.56 134.27 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -88.66 110.04 20.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -84.57 122.42 29.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -142.38 165.55 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.601 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 4.8 m -122.65 164.11 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 0.0 109.414 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.427 HG22 ' CE2' ' A' ' 182' ' ' TYR . 59.3 t -96.21 133.38 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 72.2 29.48 66.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 178' ' ' GLY . 3.3 m -164.64 178.74 7.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.46 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 43.6 t 51.03 -98.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 7.7 m -162.91 27.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.645 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.605 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.598 HH12 HG23 ' A' ' 14' ' ' ILE . 70.9 mtm180 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.332 0.587 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 m -140.94 71.37 1.36 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 7' ' ' VAL . . . -139.88 -5.67 1.19 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 19.8 m95 49.53 11.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.411 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.8 m -62.25 140.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -168.32 36.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.349 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 70.0 tp60 -142.76 110.03 5.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 6.3 t70 61.71 134.51 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.28 -10.17 23.87 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.819 2.346 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.34 -41.58 98.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -69.65 -41.57 75.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.8 mp -60.8 -51.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.424 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -46.97 65.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.429 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' OH ' ' CZ3' ' A' ' 21' ' ' TRP . 60.5 t80 -61.55 -43.83 98.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.0 -39.96 94.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -88.16 -0.11 56.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -75.19 -78.91 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.835 . . . . 0.0 109.407 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -147.06 40.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CZ3' ' OH ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -103.89 145.47 30.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.57 62.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 23' ' ' VAL . 1.2 m -84.67 152.26 59.72 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.226 -1.161 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 121.13 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.727 2.285 . . . . 0.0 111.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 78.4 mm-40 -123.8 135.92 54.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.9 p -126.75 12.33 7.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.281 -0.887 . . . . 0.0 109.055 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.88 134.44 47.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.385 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 83.4 p -72.44 -37.9 68.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -67.8 -34.57 77.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 0.0 109.804 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' HZ1' ' CD ' ' A' ' 25' ' ' GLU . 30.6 ttmt -75.23 -54.29 7.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD22 ' HB1' ' A' ' 113' ' ' ALA . 8.5 mp -66.57 -37.28 84.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.856 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 51.0 t80 -61.17 -42.73 99.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.938 . . . . 0.0 109.904 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.2 -29.51 64.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.599 ' SD ' ' CH2' ' A' ' 46' ' ' TRP . 49.9 tpp -74.46 -54.28 7.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.783 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 36' ' ' CYS . 9.3 tp -57.18 -37.74 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.043 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 15.0 p -73.16 -46.28 51.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 61.9 tp -73.28 -34.99 66.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -0.99 . . . . 0.0 109.932 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 43.2 tp10 -52.13 -28.66 18.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.69 51.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -62.36 -32.41 73.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 109.754 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.426 HE21 ' H ' ' A' ' 46' ' ' TRP . 50.2 tt0 -50.21 -35.07 24.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.705 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.43 116.84 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.42 -20.2 49.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.48 -144.34 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -1.205 . . . . 0.0 109.414 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.7 t -146.4 151.22 37.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 72.6 t-105 -55.35 -28.47 54.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.609 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -54.05 -37.89 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.727 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 18.8 m -85.26 -33.84 22.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 109.657 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -61.06 -36.99 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.45 HD21 ' HE1' ' A' ' 46' ' ' TRP . 19.8 mt -54.63 -54.05 46.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.1 -49.96 75.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.262 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -65.51 -33.33 75.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HG2' HH11 ' A' ' 53' ' ' ARG . 28.0 ttt-85 -48.97 -43.71 40.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.14 -40.62 86.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -66.36 -40.84 90.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.288 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD1' HD12 ' A' ' 85' ' ' ILE . 4.5 m-85 -56.22 -48.61 76.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 84.7 mtm180 -64.74 -27.08 68.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 0.0 109.81 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.1 94.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 83' ' ' ALA . 86.9 m -94.45 -40.79 9.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.3 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.74 -52.01 16.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 0.0 110.224 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 39.2 t60 -50.94 -38.28 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.899 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -54.32 -36.98 64.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.12 -0.988 . . . . 0.0 109.811 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' ASP . 86.9 m-85 -97.54 3.71 50.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.883 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.92 161.44 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.096 -1.003 . . . . 0.0 109.569 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.12 -26.37 21.42 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.885 2.39 . . . . 0.0 112.694 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.6 t -62.68 -48.81 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.734 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' MET . 89.2 mttt -67.17 -31.79 72.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 64' ' ' ASP . 75.1 t -56.32 -41.37 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 109.606 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.96 62.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.507 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.24 3.06 51.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.3 mtp -66.2 136.67 56.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.617 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -92.12 168.12 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 57.4 mp0 -59.23 -29.7 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.462 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.4 -44.35 88.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.5 -37.52 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.82 -44.02 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -35.72 76.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -60.56 -41.5 94.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 109.736 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 82' ' ' ASP . 92.1 mt -72.73 -31.92 65.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.175 -0.953 . . . . 0.0 109.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.83 -31.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.938 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -84.29 -59.27 2.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.978 . . . . 0.0 109.568 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 21.3 t70 -96.33 148.27 22.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.897 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.09 71.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.406 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -89.24 30.59 5.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' O ' ' A' ' 86' ' ' ILE . 4.9 pt -45.75 117.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.31 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.715 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 3.5 tt 38.63 -168.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.504 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.715 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -52.16 152.56 3.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.504 ' ND1' HD11 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -141.91 -162.9 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 109.184 -178.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.684 ' H ' ' CD1' ' A' ' 92' ' ' ILE . 56.7 ttt180 62.37 -77.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 109.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -71.86 -48.07 29.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.21 -38.6 87.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.684 ' CD1' ' H ' ' A' ' 89' ' ' ARG . 52.5 mt -55.07 -46.64 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 109.648 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.428 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.57 82.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.8 -38.79 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.5 mt -54.22 -46.59 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.18 -36.1 92.49 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.541 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -60.96 -49.08 78.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -1.23 . . . . 0.0 109.422 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.89 89.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -64.62 -46.83 80.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.25 69.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.421 ' CD1' ' CE1' ' A' ' 32' ' ' PHE . 77.2 t80 -64.64 -46.81 80.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 109.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.05 -40.65 98.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -57.45 -42.51 82.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 25.5 ttt -71.09 -33.26 70.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.548 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.69 -30.77 71.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -51.4 -25.91 6.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 109.548 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -76.47 -16.65 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.01 41.65 47.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -129.79 151.11 77.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.186 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.2 125.7 15.06 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.592 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 23.9 t80 -72.99 -44.1 61.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.42 -0.8 . . . . 0.0 110.417 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -54.98 -48.85 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.742 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 118' ' ' SER . 87.2 m-20 -52.16 -38.38 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 111.102 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -72.7 -49.87 28.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 111.244 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.45 -49.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.01 -1.056 . . . . 0.0 111.696 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.452 ' HB2' HD11 ' A' ' 171' ' ' LEU . 15.8 p-90 -87.01 -24.38 24.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.709 -1.244 . . . . 0.0 111.147 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' VAL . 7.7 t -57.63 -32.99 67.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.61 -12.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 7.3 p -83.09 23.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 12.0 t-20 79.33 16.63 0.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 7.1 m80 57.74 43.54 21.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -155.31 148.44 18.29 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.0 151.34 73.42 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.655 2.237 . . . . 0.0 111.833 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -120.35 146.49 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 109.801 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.6 mtp -129.59 156.26 44.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 109.184 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 173' ' ' ASN . 6.6 t -128.9 147.59 50.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.908 . . . . 0.0 109.797 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -113.24 43.02 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 109.302 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.437 ' HB1' ' CG ' ' A' ' 134' ' ' GLU . . . -75.58 152.1 37.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 m -92.48 -34.41 14.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.79 30.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.481 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -74.06 -9.11 58.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.6 p -83.4 -31.53 26.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.437 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -78.19 -18.47 55.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.51 116.88 41.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.765 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.11 136.83 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.146 2.564 . . . . 0.0 112.5 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 t -85.05 -4.25 59.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.2 t -98.39 103.66 15.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.367 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -126.89 152.68 75.69 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.13 -42.53 26.34 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.758 2.305 . . . . 0.0 112.043 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.36 -37.85 63.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -49.73 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.32 -39.41 93.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.04 77.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.0 OUTLIER -62.68 -44.25 96.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.4 p -62.16 -38.07 87.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.52 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -65.05 -36.47 84.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.86 -50.51 56.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.75 -34.32 76.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -60.24 -41.69 93.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -63.89 -38.19 90.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.55 HH22 ' CE ' ' A' ' 105' ' ' MET . 11.7 tpp180 -64.4 -21.47 66.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.34 24.18 6.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -95.39 130.65 42.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -1.111 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 63.2 mttp -98.06 -167.12 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 19.0 p90 40.31 38.86 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.5 OUTLIER -102.34 25.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -45.38 163.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 2.5 t -63.43 -23.99 67.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -1.161 . . . . 0.0 109.478 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.5 p -70.07 -38.45 75.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -69.74 -41.24 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.3 p -64.88 -33.72 76.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.457 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 51.9 t80 -65.61 -50.97 63.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.374 -0.829 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 18.9 t -58.69 -33.11 69.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 109.28 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.84 -42.18 88.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.444 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 52.0 mtt -62.96 -37.43 87.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -55.07 -40.26 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.76 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.91 11.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.504 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 10.5 t -59.29 -37.27 77.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.94 14.28 52.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.504 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mp -54.83 -56.81 15.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.16 134.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.457 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.667 HD21 ' CE1' ' A' ' 175' ' ' HIS . 17.2 t-20 -100.56 103.78 15.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.435 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 32.4 p30 -103.47 91.47 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.536 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.667 ' CE1' HD21 ' A' ' 173' ' ' ASN . 44.6 m170 -102.81 0.3 32.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.592 ' O ' ' O ' ' A' ' 175' ' ' HIS . 6.2 t 56.61 139.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.55 123.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.98 -50.15 0.71 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 7.8 t -150.46 -132.67 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -1.157 . . . . 0.0 109.519 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 8.5 t 52.95 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 35.9 t -162.49 32.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.3 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.643 -179.47 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 44.3 mtm-85 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 180' ' ' CYS . 8.0 m -59.8 151.83 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.419 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.22 -20.68 16.27 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -52.64 -34.96 53.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.436 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.34 128.81 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.555 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 9' ' ' GLN . 22.6 t -169.68 129.97 1.02 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 8' ' ' SER . 92.8 mm-40 44.8 -156.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 109.526 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 52.38 64.09 7.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -45.64 -34.94 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.771 2.314 . . . . 0.0 112.185 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' CD2' ' HZ3' ' A' ' 51' ' ' LYS . 60.1 tp -63.87 -38.63 91.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 17' ' ' HIS . 86.6 t80 -66.65 -43.61 84.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.44 -43.65 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.23 83.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -59.94 -42.83 94.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.365 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 13' ' ' TYR . 2.4 m-70 -62.24 -39.47 92.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -60.63 -27.45 67.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.61 -77.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.506 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -143.64 116.24 8.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -172.17 140.09 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.59 -28.22 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.538 HG23 ' OE2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -67.9 154.4 93.69 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.184 -1.186 . . . . 0.0 109.412 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.07 120.09 4.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.762 2.308 . . . . 0.0 111.959 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.538 ' OE2' HG23 ' A' ' 23' ' ' VAL . 18.8 mp0 -103.15 133.86 47.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.812 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -134.77 4.1 3.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.93 133.2 35.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 p -61.35 -34.44 75.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.86 -52.3 57.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -68.74 -45.9 70.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.884 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.29 -46.55 89.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.868 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.475 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 93.8 t80 -68.05 -47.29 68.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -64.08 -30.72 71.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.854 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.671 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 55.7 ttm -64.71 -51.83 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -58.28 -47.41 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 12.4 p -62.55 -37.89 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.052 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.525 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 6.2 tp -66.69 -39.81 88.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.12 -27.81 69.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.5 -36.51 11.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.522 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 1.7 mp0 -59.9 -33.79 72.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.2 tt0 -57.18 -29.74 63.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.715 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.03 109.83 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.626 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.67 -32.3 5.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.0 mt -103.67 -155.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -1.153 . . . . 0.0 109.464 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 m -121.97 149.67 43.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 47' ' ' ILE . 23.7 p90 -49.05 -36.51 18.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.642 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -60.9 -37.2 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.659 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.463 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 57.2 m -64.46 -33.69 76.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.95 -38.96 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.1 mp -54.3 -52.06 62.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HZ3' ' CD2' ' A' ' 12' ' ' LEU . 61.0 mttm -59.67 -49.21 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.325 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.22 -34.13 77.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.62 ' NH1' HH21 ' A' ' 57' ' ' ARG . 3.1 ttt-85 -49.5 -45.44 47.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.118 -0.989 . . . . 0.0 108.937 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -66.84 -40.6 88.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.376 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.565 HD21 ' C ' ' A' ' 84' ' ' GLY . 36.5 t-20 -64.51 -40.98 96.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.851 . . . . 0.0 109.249 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' PHE . 4.4 m-85 -56.59 -43.34 79.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 109.304 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.62 HH21 ' NH1' ' A' ' 53' ' ' ARG . 96.7 mtt180 -58.61 -36.22 73.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -49.29 76.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.198 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' CE2' ' A' ' 60' ' ' PHE . 3.2 p -94.68 -13.2 26.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.285 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' TYR . 63.6 m-85 -133.27 32.16 3.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.913 -1.117 . . . . 0.0 110.192 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 p80 -46.91 -42.94 18.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' PHE . 40.6 tt0 -79.64 -42.9 23.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.806 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 69.5 t80 44.07 36.64 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -56.57 113.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 109.558 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.07 -45.12 7.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.944 2.429 . . . . 0.0 112.678 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.8 p -66.27 -45.33 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 66' ' ' VAL . 55.3 tttp -61.94 -45.24 94.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.82 -39.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.095 . . . . 0.0 109.628 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.31 64.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.494 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 12.77 23.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.6 tpp -50.41 161.05 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.625 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.82 156.99 19.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.81 -33.38 74.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.5 -39.22 86.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' VAL . 91.3 t -71.84 -28.54 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -68.34 -43.57 77.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.341 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 30.9 ptt180 -76.42 -34.63 58.8 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.838 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 mt -61.84 -39.05 90.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.678 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 76' ' ' VAL . 53.5 t -58.56 -28.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.988 . . . . 0.0 109.736 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.55 -53.79 3.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 78' ' ' ARG . 1.9 p30 -99.77 106.52 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.72 -64.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.565 ' C ' HD21 ' A' ' 55' ' ' ASN . . . 91.34 -1.48 76.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 85' ' ' ILE . 15.5 pt -77.11 -159.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 109.36 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.42 136.56 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 96.6 mtt180 -79.35 95.68 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.6 m-70 -166.47 82.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 109.214 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -46.56 -35.25 5.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.984 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.83 -34.37 82.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -72.45 -41.69 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.509 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.6 -56.29 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.29 -30.95 63.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.7 99.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.39 -43.11 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.6 mm -54.59 -48.1 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.28 -34.28 89.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 32' ' ' PHE . 15.8 t-20 -56.65 -45.8 81.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.184 . . . . 0.0 109.337 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.76 73.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.542 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.29 -43.4 98.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.434 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.38 -33.38 75.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.579 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.34 -46.42 83.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.21 -42.65 99.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -59.12 -53.87 53.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.543 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 26.0 ttt -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.73 -27.41 65.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -52.05 -26.42 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -75.69 -19.09 59.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.44 18.86 65.46 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.34 151.65 37.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.9 119.18 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.618 2.212 . . . . 0.0 111.668 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -75.42 -43.33 50.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -59.79 -47.62 84.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 118' ' ' SER . 92.2 m-20 -51.1 -54.93 20.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 0.0 111.029 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.25 -43.35 82.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' O ' HD11 ' A' ' 145' ' ' LEU . 62.3 t -54.39 -60.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.679 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.708 ' O ' HG22 ' A' ' 120' ' ' VAL . 67.8 p-90 -86.03 -17.86 34.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.727 -1.233 . . . . 0.0 111.153 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.508 ' OG ' ' NE2' ' A' ' 122' ' ' HIS . 9.2 t -54.98 -30.61 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.872 -1.142 . . . . 0.0 109.744 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -43.43 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 178.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.9 m -82.84 24.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.945 . . . . 0.0 110.004 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.87 29.28 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.508 ' NE2' ' OG ' ' A' ' 118' ' ' SER . 26.1 m80 55.62 34.48 23.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.592 ' H ' HG23 ' A' ' 120' ' ' VAL . 72.6 mt-30 -141.91 114.53 6.52 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.45 154.49 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.648 2.232 . . . . 0.0 111.861 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.493 HE22 ' CB ' ' A' ' 141' ' ' ALA . 94.4 mt-30 -106.59 144.4 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.586 ' CE ' HD22 ' A' ' 173' ' ' ASN . 80.1 mtp -137.61 151.73 48.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.797 . . . . 0.0 109.187 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.1 t -129.65 160.09 34.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.904 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.04 46.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 0.0 109.26 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.45 -135.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.73 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 m -143.34 -33.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.378 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 t -137.96 170.77 15.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.757 ' H ' HD12 ' A' ' 132' ' ' LEU . 5.5 mp -68.31 -32.29 72.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.4 m -54.21 -37.3 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.184 -0.947 . . . . 0.0 109.478 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.7 -35.04 78.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.917 . . . . 0.0 109.427 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.767 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.8 mp -81.36 117.82 69.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.663 ' C ' ' H ' ' A' ' 138' ' ' SER . 89.0 Cg_endo -82.59 2.49 8.47 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.133 2.556 . . . . 0.0 112.555 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.531 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER 56.08 -4.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 136' ' ' PRO . 65.2 p -123.41 80.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.319 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -83.74 153.78 64.53 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.49 -37.01 19.22 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.773 2.315 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.493 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -71.97 -36.83 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.311 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.2 m -61.38 -49.07 78.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.462 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 49.8 t0 -62.93 -45.91 90.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.42 86.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 116' ' ' VAL . 6.5 tt -66.0 -43.52 87.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -54.64 -44.99 73.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.462 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 61.1 mttp -63.81 -30.74 71.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.573 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.56 -52.03 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.8 mm? -62.91 -39.09 93.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.78 -37.54 87.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -60.8 -38.14 84.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.359 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.583 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -63.8 -22.7 67.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.378 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 116.53 9.51 11.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.434 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 46.8 m-85 -82.53 133.74 35.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -1.143 . . . . 0.0 109.494 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 60.6 mttp -99.97 -169.39 1.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 14.5 p90 39.43 40.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 158' ' ' GLY . 0.3 OUTLIER -110.57 25.44 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.364 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.49 170.7 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.5 t -62.77 -28.13 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -1.097 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 68.3 p -64.59 -48.17 75.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -63.92 -35.9 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.88 -48.54 73.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.312 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.54 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 58.3 t80 -60.11 -43.21 95.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -59.63 -39.19 83.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -68.03 -41.01 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.437 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.441 ' SD ' HD22 ' A' ' 171' ' ' LEU . 35.4 mmm -59.74 -41.2 90.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.0 109.573 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 163' ' ' TYR . 49.4 mt-30 -69.8 -46.14 66.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.671 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -63.8 -34.34 77.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.504 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 17.2 t -81.41 -4.35 55.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 65.77 24.13 71.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.441 HD22 ' SD ' ' A' ' 166' ' ' MET . 1.8 tp -68.8 -47.16 66.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 109.422 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 172' ' ' VAL . 8.2 p -103.45 131.98 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.586 HD22 ' CE ' ' A' ' 126' ' ' MET . 79.9 m-20 -90.54 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -98.27 119.05 36.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.498 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.652 ' ND1' ' CD2' ' A' ' 182' ' ' TYR . 2.5 p80 -164.33 127.28 2.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.55 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.81 150.98 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.413 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 140.72 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.131 -0.981 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.75 1.62 70.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.476 ' C ' ' H ' ' A' ' 181' ' ' CYS . 49.9 m -155.01 179.5 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 5.2 t 60.4 1.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.4 t 65.82 50.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.902 . . . . 0.0 109.614 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.652 ' CD2' ' ND1' ' A' ' 175' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -46.52 159.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -109.87 -21.76 6.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -66.08 -11.83 51.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG12 ' H ' ' A' ' 8' ' ' SER . 43.6 t -82.39 -123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.765 ' H ' HG12 ' A' ' 7' ' ' VAL . 23.8 t 53.5 170.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 8' ' ' SER . 52.3 tt0 59.5 135.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' LEU . 13.4 m-20 50.45 82.05 0.25 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.3 -10.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.828 2.352 . . . . 0.0 112.108 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 47' ' ' ILE . 18.3 tp -62.7 -34.01 76.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 33.2 m-85 -54.26 -41.97 69.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 109.504 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.8 mt -80.0 -33.14 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.435 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.32 -48.19 71.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 109.509 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 13' ' ' TYR . 1.5 p90 -76.51 -34.27 58.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.482 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 57.3 t-80 -55.77 -50.01 71.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.26 -38.44 65.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.419 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -56.02 -46.59 78.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.9 pt-20 -173.28 -146.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' A' ' 20' ' ' GLU . 27.9 t-105 58.94 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.14 -9.0 59.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.2 154.43 37.68 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.94 119.9 7.02 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.786 2.324 . . . . 0.0 111.899 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -127.47 136.69 52.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.975 . . . . 0.0 109.826 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.0 p -131.55 9.46 4.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 0.0 109.075 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -90.68 135.17 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 0.0 109.299 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.744 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 89.4 p -61.67 -39.31 90.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.9 -41.09 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 0.0 109.774 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -77.23 -53.89 7.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.905 . . . . 0.0 109.863 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD22 ' HB1' ' A' ' 113' ' ' ALA . 10.9 mp -64.6 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 80.0 t80 -62.33 -56.45 18.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 109.854 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.84 -31.14 70.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.902 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.501 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.56 -51.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.866 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -62.43 -43.3 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -60.86 -48.38 82.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 110.086 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 8.2 mp -73.69 -44.68 55.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.929 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.89 -37.13 75.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.69 -25.1 34.88 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -82.64 -18.39 41.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.234 . . . . 0.0 109.773 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.6 pp0? -61.95 -21.44 64.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.71 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.07 110.22 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.695 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.03 -32.9 5.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.05 164.37 12.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -1.142 . . . . 0.0 109.448 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -86.26 167.06 15.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 47' ' ' ILE . 5.4 p90 -61.07 -43.78 98.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 48' ' ' THR . 10.4 tp -43.52 -42.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.553 ' N ' HG23 ' A' ' 47' ' ' ILE . 95.1 m -61.13 -34.21 74.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 46' ' ' TRP . 16.4 t -66.56 -46.7 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.33 -53.06 61.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -61.64 -46.21 90.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.351 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 56' ' ' TYR . 43.6 tttm -65.44 -30.18 70.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.383 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.2 ttm180 -55.72 -48.37 75.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.267 -0.895 . . . . 0.0 108.952 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.47 -46.64 87.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.45 -0.781 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 94.4 m-20 -69.07 -32.42 71.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.251 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.7 t80 -62.28 -44.61 96.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.405 -0.809 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 61' ' ' HIS . 14.5 mtm180 -60.08 -42.22 94.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 109.764 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.52 69.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -0.815 . . . . 0.0 110.301 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.6 m -92.98 -12.1 31.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 110.281 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 65.6 m-85 -129.47 -48.11 1.17 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.882 -1.137 . . . . 0.0 110.155 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' ARG . 62.3 t60 -50.14 -43.46 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.085 -1.009 . . . . 0.0 109.904 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -66.56 -25.92 66.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 93.4 m-85 -91.88 16.48 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 109.889 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 55.12 167.05 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.94 -55.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.832 2.355 . . . . 0.0 112.68 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -48.93 -44.29 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.557 ' N ' HG13 ' A' ' 66' ' ' VAL . 48.3 tttp -58.28 -36.91 74.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.845 . . . . 0.0 109.82 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 64' ' ' ASP . 56.5 t -57.18 -37.92 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 109.575 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.53 -29.82 68.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.81 22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.342 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.42 ' SD ' ' CB ' ' A' ' 75' ' ' ASP . 3.4 mmm -60.48 173.76 0.66 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.638 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 71' ' ' MET . 13.9 mm100 -131.8 158.29 41.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.35 -29.76 71.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -72.57 -31.55 65.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.478 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' CB ' ' SD ' ' A' ' 71' ' ' MET . 85.6 m-20 -65.06 -48.14 74.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 80' ' ' VAL . 11.2 m -61.75 -40.19 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.537 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -62.28 -30.62 71.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.309 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.21 -46.42 77.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.379 -0.826 . . . . 0.0 109.803 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.3 pp -78.58 -22.78 46.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 109.572 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 76' ' ' VAL . 3.6 t -51.17 -36.71 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.801 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -50.61 -42.41 56.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -89.86 115.02 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -80.28 26.12 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.432 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.439 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . -45.06 -23.49 0.65 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.3 pt -124.19 177.19 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -1.136 . . . . 0.0 109.322 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.4 mt -45.28 137.31 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 59.8 mtp180 -80.05 95.36 6.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 11.7 m-70 -168.37 83.66 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.134 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.301 -0.874 . . . . 0.0 109.97 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.16 97.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -62.19 -38.47 89.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -1.215 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.436 HG22 HG12 ' A' ' 76' ' ' VAL . 23.3 mt -57.23 -48.66 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.573 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.45 -38.72 69.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 0.0 109.402 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -36.66 71.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.26 -40.43 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.368 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.4 mt -56.16 -50.29 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.534 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.79 -36.68 92.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.598 ' ND2' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -56.67 -41.84 77.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -1.157 . . . . 0.0 109.38 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.3 74.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.08 -41.83 93.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 -29.92 70.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 35.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.0 -36.37 83.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.41 -38.71 84.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.577 ' SD ' ' NH2' ' A' ' 152' ' ' ARG . 2.0 tpt -67.79 -38.79 83.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -61.67 -30.09 70.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.437 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -52.52 -31.51 35.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.475 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -87.0 -5.59 59.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.77 69.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -105.28 119.42 53.02 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -1.183 . . . . 0.0 109.654 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.72 119.43 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.548 2.166 . . . . 0.0 111.714 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.48 -35.98 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.828 . . . . 0.0 110.427 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -67.95 -50.07 58.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.182 -0.949 . . . . 0.0 110.707 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 118' ' ' SER . 40.8 t0 -60.5 -46.76 88.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -56.92 -52.77 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.089 -1.007 . . . . 0.0 111.209 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 117' ' ' TRP . 15.4 m -56.74 -48.94 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.03 -1.044 . . . . 0.0 111.677 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.495 ' HB2' HD11 ' A' ' 171' ' ' LEU . 3.4 p-90 -88.35 -27.7 21.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.819 -1.176 . . . . 0.0 111.121 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 120' ' ' VAL . 28.3 t -55.92 -27.21 51.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.717 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.57 -14.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.718 ' O ' HG12 ' A' ' 120' ' ' VAL . 59.9 t -83.9 23.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.06 -1.025 . . . . 0.0 109.911 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 14.6 t-20 72.82 22.66 3.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.2 t60 60.26 49.65 6.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.94 149.13 22.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.03 155.16 29.79 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.676 2.251 . . . . 0.0 111.816 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -119.2 145.51 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.744 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.9 ttm -136.34 149.81 48.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.16 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 t -134.81 156.76 48.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.37 48.53 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -69.81 128.98 38.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.636 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.413 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.4 m -71.07 -33.43 70.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 t -136.84 174.5 10.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.27 -31.05 71.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -60.36 -39.34 86.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.511 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.1 mt-10 -65.39 -29.44 70.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.44 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.25 116.18 33.78 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.693 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -86.95 117.49 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.14 2.56 . . . . 0.0 112.511 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.8 m -74.04 -17.66 60.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 138' ' ' SER . 24.6 p -94.72 100.67 12.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.89 151.54 44.86 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 -32.1 92.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.854 2.369 . . . . 0.0 112.036 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.83 -38.69 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 m -56.52 -44.41 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.83 -45.58 88.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.14 81.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -63.46 -43.91 95.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -56.83 -44.45 82.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.21 -36.2 81.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.77 73.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.438 HD11 HD22 ' A' ' 145' ' ' LEU . 50.8 mt -60.77 -40.57 93.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.393 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -60.93 -40.59 93.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.577 ' NH2' ' SD ' ' A' ' 105' ' ' MET . 5.8 tpp180 -65.72 -22.63 66.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.335 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.33 9.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.84 133.15 34.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -1.165 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -97.68 175.5 6.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 54.3 51.81 13.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 158' ' ' GLY . 15.4 m -119.89 26.2 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.24 167.62 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.9 t -59.58 -28.28 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -1.147 . . . . 0.0 109.477 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 p -63.56 -43.08 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -66.21 -39.77 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.73 -40.25 96.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.286 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -60.57 -48.93 79.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 m -61.97 -37.97 86.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.28 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.68 -46.01 91.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 75.2 mtp -65.78 -39.7 91.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.0 109.594 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.76 -41.24 97.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.501 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -74.16 -54.7 7.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.609 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.1 t -47.84 -24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.24 7.46 67.61 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 120' ' ' VAL . 4.0 mp -54.68 -52.0 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 172' ' ' VAL . 25.6 m -98.81 130.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.515 ' ND2' ' ND1' ' A' ' 175' ' ' HIS . 19.6 t30 -94.26 101.95 13.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 90.5 m-20 -94.09 119.88 33.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.515 ' ND1' ' ND2' ' A' ' 173' ' ' ASN . 73.0 m80 -157.72 128.9 6.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 179' ' ' CYS . 29.0 m -78.27 144.41 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.83 -38.33 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.86 -23.97 47.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.41 ' H ' HG23 ' A' ' 176' ' ' VAL . 48.8 t -79.94 139.16 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.505 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.95 -37.17 83.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.461 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.84 -28.82 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.568 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.9 t80 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.951 . . . . 0.0 109.574 -179.864 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.265 0.555 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.67 132.3 53.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.884 . . . . 0.0 109.408 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -74.44 -39.13 43.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -63.27 1.75 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 109.449 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 5' ' ' GLY . 8.3 p -59.01 -14.89 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.505 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.0 m 60.79 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 10' ' ' ASP . 23.5 pt20 -82.78 -17.49 43.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLN . 9.5 m-20 -43.34 106.39 0.49 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.384 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.5 -38.24 35.1 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.824 2.35 . . . . 0.0 112.156 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.4 tp -62.89 -41.2 99.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.466 ' CE2' ' CE1' ' A' ' 17' ' ' HIS . 40.9 t80 -68.13 -42.57 79.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.83 -44.25 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.06 89.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -59.27 -43.54 92.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.466 ' CE1' ' CE2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.64 -49.35 68.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.65 -39.94 95.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.31 -54.56 44.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -177.37 124.93 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 59.1 t90 -171.22 124.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.457 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.7 1.04 83.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.96 120.16 71.43 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -45.98 120.83 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -128.17 135.62 49.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.962 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 56.9 p -115.41 9.05 15.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.076 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.65 132.47 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.302 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.574 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 77.5 p -73.7 -38.13 64.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.605 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.58 -42.64 98.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -70.37 -51.94 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 109.869 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.553 HD22 ' HB1' ' A' ' 113' ' ' ALA . 7.8 mp -66.77 -38.37 86.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.798 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 67.2 t80 -61.55 -38.96 89.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.76 -30.63 64.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.9 tpp -73.21 -54.45 8.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.853 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.31 -32.72 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 110.007 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.6 m -72.13 -49.99 31.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.139 -0.976 . . . . 0.0 110.057 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 56' ' ' TYR . 4.5 mt -75.2 -28.99 60.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 109.888 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 39.0 tp10 -52.08 -31.94 32.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.792 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.47 -21.81 69.02 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.43 -27.42 62.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -1.204 . . . . 0.0 109.733 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -60.27 -33.06 71.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.771 -178.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 41' ' ' GLN . . . -46.02 110.85 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.47 -6.71 68.27 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.16 -169.94 2.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -1.183 . . . . 0.0 109.406 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -108.97 153.0 24.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.526 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 6.0 t-105 -54.86 -46.22 74.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.65 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.96 -38.97 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.692 -178.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 98.4 m -63.02 -35.22 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.714 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.5 t -60.19 -44.74 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -55.13 -44.29 74.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.487 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.43 -52.84 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.354 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 10.9 mptt -69.55 -25.79 64.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 49' ' ' VAL . 37.0 ttp180 -54.23 -44.6 71.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 109.004 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -72.74 -43.97 62.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -64.08 -49.61 71.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.239 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 21.7 t80 -58.48 -39.94 81.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.309 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -55.76 -37.91 69.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.844 . . . . 0.0 109.77 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.0 -23.46 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.256 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.7 m -91.77 -12.14 34.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.146 -0.971 . . . . 0.0 110.251 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 43.9 m-85 -125.46 -51.68 1.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.135 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -53.44 -41.68 66.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 109.835 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.06 -38.85 73.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 96.9 m-85 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 130.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.002 . . . . 0.0 109.611 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -40.6 -36.05 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.68 -49.29 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.9 mttm -72.25 -31.2 65.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.869 . . . . 0.0 109.862 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.93 -44.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 109.605 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.54 -34.21 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.539 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.01 18.18 17.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.309 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.7 tpp -63.69 157.6 23.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -103.63 167.36 9.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.47 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 96.7 mt-10 -71.19 -24.17 62.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -72.04 -31.82 66.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.59 -47.14 79.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.418 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.451 HG12 ' CG2' ' A' ' 92' ' ' ILE . 14.4 m -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.12 -33.66 71.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 78' ' ' ARG . 42.0 ttm-85 -66.67 -46.08 76.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.774 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.4 mt -66.47 -34.38 77.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 76' ' ' VAL . 52.1 t -51.79 -35.82 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -81.26 -60.33 2.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 62.7 t0 -100.06 139.69 35.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.72 76.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -74.22 -31.99 58.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.613 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.3 pt 28.96 41.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.348 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 84' ' ' GLY . 54.9 mt 52.12 4.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.607 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -97.85 109.49 22.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 89' ' ' ARG . 84.0 t60 -96.99 172.17 8.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.165 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' N ' ' CG ' ' A' ' 88' ' ' HIS . 38.4 ttm180 -48.63 -41.91 32.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.74 -47.39 61.6 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 29.2 mmtm -64.72 -51.81 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 109.524 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.451 ' CG2' HG12 ' A' ' 76' ' ' VAL . 91.6 mt -54.77 -47.39 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.625 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -53.02 -33.45 51.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -61.29 -42.09 98.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.354 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.607 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.8 mp -60.77 -48.13 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.383 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.11 -50.0 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.43 84.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.66 -36.98 79.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -1.194 . . . . 0.0 109.465 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -65.97 -37.41 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.38 -45.19 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.541 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -71.84 -31.25 66.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 16.7 t80 -69.29 -50.53 45.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.73 -37.53 86.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.29 -42.02 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.8 ttt -64.22 -41.3 97.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.54 -27.41 69.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -51.97 -29.15 19.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.552 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -76.26 -17.23 59.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.08 3.55 67.67 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.75 115.6 65.34 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.65 124.64 7.01 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.619 2.213 . . . . 0.0 111.714 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.63 ' CZ ' ' NH1' ' A' ' 152' ' ' ARG . 49.6 t80 -61.1 -37.47 82.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -68.11 -49.83 58.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.126 -0.984 . . . . 0.0 110.745 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' O ' ' OG ' ' A' ' 118' ' ' SER . 56.5 t0 -52.07 -35.39 47.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 111.032 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.577 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 14.7 t80 -76.41 -46.24 28.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 2.6 p -56.49 -45.87 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.974 -1.079 . . . . 0.0 111.729 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 18.2 p-90 -88.92 -26.9 21.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.735 -1.228 . . . . 0.0 111.114 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.7 m -58.06 -27.52 63.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.875 -1.141 . . . . 0.0 109.719 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.76 -13.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.084 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.9 m -82.51 22.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.025 . . . . 0.0 109.947 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 59.64 35.0 22.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -0.942 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.4 m80 54.84 26.88 8.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.403 ' H ' HG23 ' A' ' 120' ' ' VAL . 50.3 tt0 -137.07 89.63 16.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.558 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.03 155.03 1.96 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.673 2.248 . . . . 0.0 111.779 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.5 156.15 16.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.729 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 48.3 ttp -127.62 136.15 51.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.4 t -95.57 169.14 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.906 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -168.99 44.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.543 ' HB1' ' CG ' ' A' ' 134' ' ' GLU . . . -83.9 -174.23 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.63 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.5 m -114.34 -29.81 6.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -128.63 157.86 40.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.7 mt -74.66 -10.97 60.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.8 m -87.64 -31.49 19.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.9 pt-20 -80.14 -7.81 59.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.72 118.38 57.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.718 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.68 130.27 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.095 2.53 . . . . 0.0 112.544 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.0 t -86.91 -15.11 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.267 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.5 t -85.52 102.18 13.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.4 p -118.71 152.69 51.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.93 . . . . 0.0 109.508 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.66 -35.15 92.47 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.093 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -41.13 52.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.2 p -61.4 -37.46 83.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.23 -46.46 86.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 0.0 109.568 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.89 -30.42 65.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -66.09 -46.68 76.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -63.19 -42.63 99.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -61.28 -35.41 77.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.562 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.79 42.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.68 -32.42 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.858 . . . . 0.0 109.583 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -60.48 -40.73 92.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.429 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -61.0 -37.02 81.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.63 ' NH1' ' CZ ' ' A' ' 112' ' ' PHE . 98.8 mtt180 -64.87 -20.03 66.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.49 22.92 13.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 2.6 m-85 -84.65 141.03 30.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -1.107 . . . . 0.0 109.535 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -109.1 175.29 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 53.91 44.18 29.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.584 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.5 p -122.66 26.02 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.82 166.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.1 m -54.58 -33.6 60.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.3 m -61.02 -46.49 90.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.4 mp -64.67 -41.57 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 157' ' ' VAL . 83.1 m -64.37 -40.4 95.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 109.264 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.26 -47.63 85.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.271 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.526 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 29.7 t -59.63 -37.15 77.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.288 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.69 -37.66 79.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.8 mtp -65.25 -47.29 77.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.617 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.41 -35.88 80.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.713 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.74 -44.18 93.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.7 m -83.02 -59.13 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.45 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.85 18.04 1.01 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 mt -58.95 -32.82 69.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -1.095 . . . . 0.0 109.427 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.09 141.83 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' HG22 ' A' ' 127' ' ' THR . 23.5 t30 -76.02 102.56 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 22.9 t70 -94.03 101.35 13.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 81.7 m-70 -160.05 123.39 3.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.54 HG22 ' H ' ' A' ' 178' ' ' GLY . 8.0 p -74.79 134.5 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.3 p -54.99 -25.76 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.423 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.54 ' H ' HG22 ' A' ' 176' ' ' VAL . . . -64.08 -24.27 68.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.521 ' H ' HG13 ' A' ' 176' ' ' VAL . 3.7 m -77.67 140.86 39.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.193 . . . . 0.0 109.535 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 182' ' ' TYR . 83.3 m -62.9 -38.61 91.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.91 . . . . 0.0 109.438 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 95.1 m -51.29 -7.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 180' ' ' CYS . 20.9 t80 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -92.82 -153.52 0.35 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.427 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.2 -5.11 56.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 28.6 m95 45.73 38.41 4.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.405 ' H ' HG12 ' A' ' 7' ' ' VAL . 1.3 p -60.99 131.19 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -171.47 29.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.81 -130.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.91 153.08 45.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.48 -27.51 3.44 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.862 2.375 . . . . 0.0 112.184 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.33 -39.68 95.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.404 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -66.11 -45.36 81.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.425 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.92 -39.82 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.72 92.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -66.87 -40.12 87.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' GLU . 59.1 t-80 -56.38 -48.53 76.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.77 -39.11 70.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -44.49 91.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.502 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 39.9 mt-10 -149.1 -137.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.496 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.482 ' O ' ' O ' ' A' ' 20' ' ' GLU . 23.5 t90 59.82 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.547 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.41 82.94 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.9 t -119.71 94.74 48.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 0.0 109.34 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -46.87 121.96 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.764 2.309 . . . . 0.0 111.878 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.48 140.71 37.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -128.28 -2.02 5.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.0 109.109 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -81.33 130.7 35.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.4 t -57.17 -34.42 68.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.204 -0.935 . . . . 0.0 109.608 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -67.21 -55.55 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.763 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -66.92 -43.73 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.923 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.33 -44.14 95.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.835 -179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.96 -36.71 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 109.903 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.25 -32.05 71.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 43.3 tpp -63.84 -53.31 52.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.785 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 3.2 tp -72.11 -32.12 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.75 -50.35 30.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.132 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 6.7 mp -74.08 -16.38 61.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -52.24 -42.1 63.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.953 . . . . 0.0 109.841 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.583 ' N ' ' OE1' ' A' ' 38' ' ' GLU . . . 61.69 171.97 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.687 ' C ' ' H ' ' A' ' 42' ' ' ALA . 31.4 tp60 -60.07 -45.15 93.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -1.193 . . . . 0.0 109.77 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.642 HE21 ' N ' ' A' ' 46' ' ' TRP . 52.9 tt0 60.13 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.671 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -58.28 143.27 45.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 -24.03 0.62 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 42' ' ' ALA . 17.4 mt -104.04 -141.23 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 109.476 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -153.43 155.0 35.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.642 ' N ' HE21 ' A' ' 41' ' ' GLN . 76.0 t-105 -48.08 -39.05 19.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 48' ' ' THR . 9.7 tp -54.41 -40.59 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' HG23 ' A' ' 47' ' ' ILE . 85.5 m -63.83 -38.73 92.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.735 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.18 -40.75 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.422 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.26 -44.78 92.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -65.64 -49.49 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.394 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' CD ' HD23 ' A' ' 37' ' ' LEU . 37.1 ttp180 -52.39 -45.39 65.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.158 -0.964 . . . . 0.0 109.038 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.4 -44.87 96.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 24.0 m120 -66.2 -38.45 88.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.254 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CG ' ' A' ' 60' ' ' PHE . 25.3 t80 -62.8 -50.43 71.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.348 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 20.7 mmm180 -60.8 -21.37 63.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.798 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -48.58 62.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.6 m -95.65 -43.34 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 110.254 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CG ' ' CE2' ' A' ' 56' ' ' TYR . 53.9 m-85 -66.91 -50.79 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 57.5 t60 -48.78 -41.67 33.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -61.6 -37.37 83.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.734 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.573 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 48.0 m-85 -78.5 -48.24 15.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 109.832 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.1 t70 79.87 136.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.534 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -40.05 -22.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.909 2.406 . . . . 0.0 112.745 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' ASP . 91.9 t -75.97 -44.55 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.653 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' LYS . 3.2 mptp? -72.61 -45.07 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.845 . . . . 0.0 109.895 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.1 m -56.05 -42.84 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.612 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.547 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -62.19 -38.0 87.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.53 13.13 32.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.373 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.502 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 27.3 ttp -83.26 158.14 22.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -103.98 160.52 14.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.5 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.56 -30.29 69.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.69 -43.72 72.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 55.1 t0 -61.58 -38.33 87.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.444 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.08 -44.13 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -56.2 -37.18 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.44 -38.66 90.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.341 -0.849 . . . . 0.0 109.782 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.2 mt -70.99 -29.32 65.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.77 -36.38 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.04 -62.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.0 109.514 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -100.01 116.13 31.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.431 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.66 -46.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 55' ' ' ASN . . . 78.74 26.36 58.85 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 pt -116.43 171.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.0 mt -47.22 135.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.628 ' HG2' HH11 ' A' ' 87' ' ' ARG . 9.0 mtt-85 -74.9 102.49 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.42 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -171.73 80.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.208 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG2' HH11 ' A' ' 89' ' ' ARG . 11.9 ptt-85 -47.67 -32.97 6.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.908 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.75 95.47 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.08 -45.24 95.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.52 -41.56 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -60.67 -37.63 82.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.26 96.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.355 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 ' HE2' ' A' ' 56' ' ' TYR . 97.3 mt -57.99 -46.41 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 68' ' ' VAL . 78.5 mt -54.66 -39.23 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.74 -33.39 87.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 88.1 m-20 -61.6 -41.83 98.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 109.423 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.74 86.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 109.51 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -57.71 -45.03 86.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.71 -33.5 68.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -64.5 -45.5 87.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 103' ' ' LEU . 3.5 mm? -59.78 -39.18 84.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -60.54 -37.01 79.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.525 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.5 mmm -63.35 -37.08 85.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.73 -29.42 69.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -51.72 -35.35 42.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -91.8 -1.34 57.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.8 66.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -97.05 149.15 35.38 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.154 -1.203 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.82 124.57 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.662 2.241 . . . . 0.0 111.698 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.409 ' CE1' ' NH1' ' A' ' 152' ' ' ARG . 72.3 t80 -79.11 -45.47 19.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.49 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.711 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 20.0 t70 -52.65 -36.5 56.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 111.043 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.66 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 48.3 t80 -73.09 -49.6 27.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.081 -1.012 . . . . 0.0 111.221 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 116' ' ' VAL . 3.0 m -56.12 -49.35 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.023 -1.048 . . . . 0.0 111.675 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.569 ' O ' HG22 ' A' ' 120' ' ' VAL . 20.0 p-90 -86.88 -28.06 23.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.742 -1.224 . . . . 0.0 111.09 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 21.7 p -56.75 -28.41 61.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.874 -1.142 . . . . 0.0 109.725 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -46.63 -11.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 117' ' ' TRP . 18.5 m -84.7 24.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 123' ' ' GLN . 3.5 m-20 72.51 17.62 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.023 . . . . 0.0 109.701 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 16.8 t60 73.58 -23.14 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.544 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 121' ' ' ASN . 2.3 pt20 -86.52 145.76 40.28 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.532 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 154.06 72.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.666 2.244 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.642 HE22 ' CB ' ' A' ' 141' ' ' ALA . 94.4 mt-30 -104.68 149.0 25.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.771 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.575 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 71.2 mmm -135.78 145.95 47.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 109.172 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.2 t -115.7 164.79 13.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.929 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -139.15 47.12 1.91 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.299 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -86.57 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.7 m -72.15 -37.8 69.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.1 t -133.95 177.93 7.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.454 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.09 -34.11 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.604 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -59.11 -35.23 73.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.55 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 93.1 mt-10 -72.72 -23.25 60.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.483 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 5.7 mm -65.57 120.47 68.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.749 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.473 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 85.1 Cg_endo -83.72 135.72 6.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.072 2.514 . . . . 0.0 112.525 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 137' ' ' THR . 1.7 t -91.52 6.72 44.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.33 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.9 m -138.81 90.23 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.28 160.61 29.38 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -47.88 -41.78 31.89 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.874 2.382 . . . . 0.0 112.035 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.642 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -71.38 -38.45 71.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -58.45 -43.92 88.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -61.84 -45.16 95.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.511 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.04 73.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.1 tt -60.05 -48.68 80.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.486 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.6 t -61.23 -37.18 82.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.58 ' HZ3' ' HZ3' ' A' ' 151' ' ' LYS . 63.4 tttm -62.0 -42.04 98.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.18 71.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.7 -34.53 74.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.593 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -59.78 -40.91 89.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 109.4 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.58 ' HZ3' ' HZ3' ' A' ' 147' ' ' LYS . 38.7 mmtm -61.17 -40.38 93.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.447 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.66 ' NH2' ' CD1' ' A' ' 115' ' ' PHE . 98.6 mtt180 -67.98 -19.89 64.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.23 13.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.482 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 2.1 m-85 -86.29 127.34 34.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -1.118 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -97.23 -176.85 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 40' ' ' GLN . 76.4 m-85 53.2 48.32 22.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.73 24.17 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.1 162.67 0.21 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 159' ' ' THR . 1.0 OUTLIER -55.62 -31.49 62.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -1.167 . . . . 0.0 109.446 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.6 m -66.77 -47.77 71.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.81 -44.42 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.1 m -60.29 -43.9 95.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.325 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.483 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 73.4 t80 -60.53 -43.26 97.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 0.0 109.334 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -57.08 -38.97 74.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 31' ' ' LEU . 16.2 t80 -61.75 -31.18 71.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.418 ' SD ' HD12 ' A' ' 171' ' ' LEU . 63.0 mmm -68.12 -54.18 19.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.623 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.19 -42.49 65.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.708 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.52 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -60.96 -34.7 75.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 26.2 t -83.31 -61.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.424 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.04 14.43 1.83 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.486 HD11 ' CE2' ' A' ' 165' ' ' PHE . 27.7 mt -65.55 -34.23 77.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.56 140.59 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.575 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 1.7 m-80 -88.88 115.09 26.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -98.63 113.02 24.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -152.18 143.06 23.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.522 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 m -97.04 145.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.1 m -54.75 142.82 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.09 -83.01 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 73.8 m -74.25 -171.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -1.158 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.601 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 33.3 m 52.4 17.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.468 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.601 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 13.7 p 42.46 43.63 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 30.4 t80 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 109.621 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' TRP . 63.5 m 45.91 31.25 1.04 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.97 -46.01 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.664 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -149.84 -91.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -1.201 . . . . 0.0 109.452 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 7' ' ' VAL . 38.6 t 54.39 -0.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.608 ' H ' ' C ' ' A' ' 6' ' ' TRP . 72.1 m -79.87 28.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.424 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' SER . 35.1 tt0 -61.27 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 5.6 p30 -94.77 152.23 39.62 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.35 -34.09 13.53 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.819 2.346 . . . . 0.0 112.098 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.68 -43.3 99.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.476 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.55 -46.61 75.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 109.393 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.0 mt -62.14 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.373 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.12 98.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -62.01 -40.77 96.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 20.6 t60 -60.65 -48.9 79.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.81 -39.31 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.551 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.85 -47.33 83.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 89.5 mt-10 -151.82 -125.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.497 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.523 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 37.7 t90 57.99 114.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.52 -6.31 67.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.669 ' O ' HG13 ' A' ' 23' ' ' VAL . 8.3 p -105.78 109.92 63.65 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.183 -1.186 . . . . 0.0 109.429 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.1 121.12 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.742 2.294 . . . . 0.0 111.896 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -92.94 134.73 34.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.141 -0.974 . . . . 0.0 109.887 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -132.59 -2.25 3.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 109.042 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.14 147.53 46.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.649 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -71.0 -60.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -178.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.86 -37.02 82.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.72 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.04 -42.81 84.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.871 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -66.7 -40.8 88.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.215 -0.928 . . . . 0.0 109.862 -176.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.3 m-30 -60.51 -41.42 94.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.896 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 37' ' ' LEU . 98.6 mt-10 -64.4 -32.81 74.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 ttm -68.42 -53.7 21.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.801 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 36' ' ' CYS . 8.4 tp -70.6 -39.18 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 110.027 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.486 ' N ' HG23 ' A' ' 35' ' ' ILE . 77.0 m -71.31 -47.19 58.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 17.2 tp -64.84 -41.5 95.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 109.811 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 44.2 tp10 -56.22 -29.74 61.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.85 -38.38 59.64 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 40' ' ' GLN . 18.9 mp0 -60.3 -30.75 69.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -1.233 . . . . 0.0 109.724 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.7 tt0 -48.09 -29.7 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 109.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.66 109.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.23 -32.11 5.36 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.9 mp -98.21 -160.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -1.209 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.9 m -131.99 152.55 51.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.362 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 43.6 p90 -55.63 -33.49 64.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -57.99 -40.68 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 54.6 m -73.5 -32.52 64.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.692 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 73.0 t -57.4 -36.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -54.38 -54.93 33.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.57 -45.97 90.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.123 -0.986 . . . . 0.0 109.35 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -68.86 -28.47 66.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.582 ' HG2' HH11 ' A' ' 53' ' ' ARG . 6.4 ttt-85 -52.82 -45.95 67.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -0.986 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -70.47 -43.77 69.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -65.48 -38.16 88.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.325 -0.859 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.13 -49.75 76.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' HIS . 73.8 mtm180 -54.75 -43.39 72.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.41 71.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.29 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.86 -20.19 19.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.201 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -104.33 -38.96 6.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.849 -1.157 . . . . 0.0 110.238 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.5 t60 -49.77 -41.91 45.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 109.898 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.44 -31.39 72.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.722 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 53.7 m-85 -91.31 62.79 4.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -39.31 153.6 0.18 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.618 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -35.34 -53.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.856 2.371 . . . . 0.0 112.757 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -54.44 -44.93 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.647 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 71' ' ' MET . 20.3 tptp -65.73 -37.1 85.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.388 -0.82 . . . . 0.0 109.876 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 63' ' ' PHE . 21.4 t -56.98 -49.89 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.076 -1.015 . . . . 0.0 109.594 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.63 70.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.511 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.06 -0.83 57.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.398 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 63' ' ' PHE . 8.9 ttp -71.52 158.35 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -104.67 156.8 17.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.57 -31.28 69.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.51 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -60.49 -39.2 86.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.86 -40.85 94.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.05 -44.03 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.579 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.79 -36.67 81.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.308 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 78' ' ' ARG . 33.2 ttm-85 -63.22 -42.29 99.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -36.13 82.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.2 t -51.29 -33.44 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -93.64 -60.28 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.523 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -101.3 108.1 19.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.92 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.418 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.94 27.94 57.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 pt -121.03 171.78 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -1.15 . . . . 0.0 109.38 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -46.69 141.62 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -94.0 97.6 10.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.431 -179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 15.6 m-70 -162.71 86.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.176 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 89' ' ' ARG . 24.9 ttt-85 -48.65 -29.88 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.38 -47.05 92.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -63.85 -48.81 75.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.27 -41.08 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.9 -36.63 72.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.399 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.318 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 98.9 mt -57.59 -41.66 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 mm -56.29 -50.76 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.12 95.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.614 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 17.9 m120 -57.85 -35.94 71.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.14 68.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.88 -42.61 99.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.47 -35.12 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 10.3 t80 -63.98 -48.13 77.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 tp -63.29 -39.27 94.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -60.75 -38.3 84.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -64.13 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.242 -0.912 . . . . 0.0 109.468 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.75 -29.12 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -52.39 -24.45 7.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.514 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.92 -16.88 59.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.512 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.77 9.6 74.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.58 114.42 63.1 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.246 -1.15 . . . . 0.0 109.677 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.02 120.53 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.578 2.185 . . . . 0.0 111.692 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -58.47 -35.03 71.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 0.0 110.504 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.21 -50.87 68.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.0 110.742 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 118' ' ' SER . 90.2 m-20 -62.67 -43.56 98.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 111.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.88 -49.33 73.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.991 -1.068 . . . . 0.0 111.155 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -63.8 -48.9 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.034 -1.041 . . . . 0.0 111.632 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.509 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 2.7 p-90 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.775 -1.203 . . . . 0.0 111.207 -177.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 33.1 m -55.41 -28.57 55.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.861 -1.149 . . . . 0.0 109.766 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.23 -14.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.1 p -83.24 26.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.901 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 120' ' ' VAL . 2.4 m-80 76.03 17.61 2.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.706 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 59.94 39.34 20.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.492 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.474 ' H ' HG13 ' A' ' 120' ' ' VAL . 77.3 mt-30 -151.13 144.84 17.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.59 146.95 50.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.694 2.262 . . . . 0.0 111.872 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.2 134.58 46.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.982 . . . . 0.0 109.741 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 38.7 ttp -109.36 125.41 52.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.4 t -94.28 166.56 12.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 109.868 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -147.43 53.3 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.403 -0.811 . . . . 0.0 109.252 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.688 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -91.21 142.88 27.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -80.48 -33.47 36.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.0 m -128.91 159.29 36.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.417 ' CD1' ' NE1' ' A' ' 6' ' ' TRP . 31.5 mt -55.94 -35.56 66.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.9 p -66.85 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.688 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.9 mm-40 -65.92 -23.1 66.55 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.142 -0.974 . . . . 0.0 109.411 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.26 116.98 42.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -84.18 132.1 5.19 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.132 2.555 . . . . 0.0 112.516 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.1 t -92.44 -12.46 32.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.309 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 80.0 p -92.57 100.93 13.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.36 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -116.74 151.45 47.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.07 -31.87 93.99 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.844 2.362 . . . . 0.0 111.966 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.92 -41.47 51.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.1 m -60.74 -41.15 94.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.56 -48.93 77.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.522 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.41 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.692 ' C ' HD23 ' A' ' 145' ' ' LEU . 7.5 tt -59.56 -48.29 82.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.47 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -59.97 -41.77 92.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.21 -33.15 74.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.76 -51.38 49.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.548 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 145' ' ' LEU . 76.6 mt -60.89 -34.63 74.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -58.03 -40.33 80.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.382 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.6 -37.13 82.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -63.91 -20.11 65.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.09 19.39 19.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.614 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 6.0 m-85 -88.51 133.6 34.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.52 177.75 5.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 55.05 53.67 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.86 24.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.45 167.51 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 159' ' ' THR . 1.1 p -66.05 -25.27 66.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 109.37 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.9 p -70.9 -46.17 63.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.01 -34.52 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.536 ' SG ' HD22 ' A' ' 145' ' ' LEU . 43.1 t -68.12 -46.0 72.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.317 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.07 -42.49 99.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.1 m -57.57 -32.6 67.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.28 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.43 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.61 -31.25 69.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.446 178.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 25.5 mtt -68.5 -53.95 19.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.523 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 1.9 pp0? -62.39 -36.46 82.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.704 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.478 ' N ' ' CD ' ' A' ' 167' ' ' GLN . . . -74.71 -38.96 62.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.744 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 23' ' ' VAL . 10.3 t -74.54 -29.05 61.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.444 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.14 56.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.446 HD13 ' SG ' ' A' ' 169' ' ' CYS . 1.1 mp -52.69 -52.88 54.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 0.0 109.39 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.1 m -91.9 135.84 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' THR . 22.5 m-20 -82.67 105.03 13.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 109.46 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -93.71 123.92 37.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CD2' ' CD2' ' A' ' 182' ' ' TYR . 1.9 p-80 -164.06 159.23 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -111.39 122.73 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 178' ' ' GLY . 8.6 p -70.19 -40.02 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.507 ' N ' HG13 ' A' ' 177' ' ' VAL . . . -60.03 -18.94 49.6 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 96.5 m -86.37 -176.67 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.503 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.6 t -106.12 -21.77 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.523 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.7 t -54.27 -33.92 59.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.1 t80 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.527 HH21 HG23 ' A' ' 7' ' ' VAL . 23.9 ptt-85 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.521 ' C ' ' H ' ' A' ' 6' ' ' TRP . 4.1 m -96.87 -155.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.88 -16.18 0.86 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.521 ' H ' ' C ' ' A' ' 4' ' ' CYS . 26.6 m95 44.46 37.8 2.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.183 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.5 m -64.91 126.74 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' GLN . 29.4 t -164.08 156.84 17.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' SER . 41.3 tt0 56.94 159.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 109.561 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.2 72.74 0.82 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.9 -28.78 13.83 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.844 2.363 . . . . 0.0 112.147 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.36 -39.32 94.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.72 -46.54 78.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.56 -48.78 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.383 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.77 -36.77 76.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.52 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.556 ' CE2' HD22 ' A' ' 50' ' ' LEU . 63.3 t80 -59.89 -44.11 94.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.484 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.15 -49.05 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -64.53 -40.28 95.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -64.42 -64.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.519 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.9 mm-40 -140.13 -151.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.628 ' CZ2' ' HB2' ' A' ' 168' ' ' ALA . 27.1 t-105 62.19 130.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.475 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.62 -17.69 58.51 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.8 m -78.11 149.69 76.72 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.416 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.01 119.41 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.858 2.372 . . . . 0.0 111.785 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.6 133.41 56.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.985 . . . . 0.0 109.809 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 p -134.46 9.09 3.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.033 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.73 141.49 31.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.711 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 14.9 m -68.63 -36.38 78.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -58.97 -52.43 65.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -40.29 96.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.685 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 2.3 mm? -58.66 -39.38 80.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.11 -0.994 . . . . 0.0 109.871 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -67.1 -54.24 23.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.873 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -71.11 -31.46 67.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.4 tpp -60.04 -53.75 54.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 109.676 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 36' ' ' CYS . 18.3 tt -82.76 -42.99 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.062 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.548 ' N ' HG23 ' A' ' 35' ' ' ILE . 33.7 t -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.944 . . . . 0.0 110.044 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.6 -40.42 76.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.867 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -59.91 -24.35 64.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.802 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.43 -28.72 3.5 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.18 -31.64 72.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.24 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -47.98 -34.41 9.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.78 111.33 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.727 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.61 -39.24 2.84 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -105.78 -138.15 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.7 t -141.73 155.26 45.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 22.7 p90 -55.54 -31.85 62.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.57 -39.64 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.7 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -73.28 -32.26 64.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.9 t -58.69 -37.68 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 16' ' ' TYR . 31.7 mt -53.83 -55.49 26.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -59.27 -42.19 90.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HB2' ' HZ2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.57 -21.59 60.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.376 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.57 ' HG2' HH11 ' A' ' 53' ' ' ARG . 7.9 ttt-85 -58.62 -47.64 83.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.209 -0.932 . . . . 0.0 108.99 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' A' ' 54' ' ' GLU . 10.1 pt-20 -69.63 -41.02 76.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -66.05 -50.72 63.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.269 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 28.0 t80 -60.45 -37.51 81.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.379 -0.826 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 40.8 ttp180 -55.83 -38.12 69.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.859 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.25 53.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.07 -11.69 35.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 110.286 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 56.4 m-85 -130.04 -51.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.97 -1.082 . . . . 0.0 110.193 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.2 t-80 -49.25 -38.3 26.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.083 -1.01 . . . . 0.0 109.909 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -55.45 -37.44 67.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.781 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.09 -16.79 52.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.866 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 63.99 132.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.064 -1.022 . . . . 0.0 109.578 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.33 -34.5 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.904 2.402 . . . . 0.0 112.688 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.2 t -55.16 -49.35 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mtpt -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -58.09 -42.17 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.595 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.83 -42.24 67.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.25 23.91 8.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.1 ttm -62.36 163.04 9.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -109.9 154.22 23.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -34.92 69.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.28 -37.38 85.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.456 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -60.13 -44.11 95.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG11 HE21 ' A' ' 93' ' ' GLN . 92.5 t -56.41 -43.18 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.596 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.15 -33.46 74.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.315 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -58.89 -44.23 91.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.799 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 92.3 mt -73.32 -32.6 64.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 76' ' ' VAL . 51.3 t -51.78 -36.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.763 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -75.57 -62.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -99.89 107.84 19.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.423 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -175.62 75.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.397 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.66 10.4 1.51 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.521 HD12 ' CG ' ' A' ' 87' ' ' ARG . 5.1 pt -79.59 -175.92 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -1.146 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 86' ' ' ILE . 67.6 mt -83.34 -2.33 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 85' ' ' ILE . 3.6 mmp_? -66.88 145.58 55.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.427 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' O ' ' N ' ' A' ' 90' ' ' GLY . 53.0 m80 -141.96 70.52 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.133 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.424 HH11 ' HG3' ' A' ' 89' ' ' ARG . 27.2 ttm-85 59.02 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.397 -0.814 . . . . 0.0 109.927 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -56.57 -37.48 75.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -59.59 -45.47 91.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.73 -44.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.629 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.432 HE21 HG11 ' A' ' 76' ' ' VAL . 93.8 mm-40 -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.332 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.21 -36.31 79.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.419 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.9 mm -69.03 -44.52 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.96 -47.93 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 109.543 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.42 -42.92 99.88 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 23.9 m120 -58.86 -43.77 90.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -1.207 . . . . 0.0 109.42 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.71 92.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.57 -44.28 91.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.4 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.11 -53.74 7.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -56.99 -44.71 83.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -61.04 -33.87 73.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -62.33 -35.87 80.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' N ' ' A' ' 108' ' ' ASN . 84.3 tt0 -70.82 -30.77 67.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -51.89 -14.38 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.561 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 106' ' ' GLU . 77.7 m-20 -75.97 -14.98 60.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 36.6 18.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -138.75 152.17 70.09 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.76 119.12 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.612 2.208 . . . . 0.0 111.685 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -74.57 -43.51 55.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.0 110.465 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.42 -47.21 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.168 -0.958 . . . . 0.0 110.772 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.564 ' O ' ' OG ' ' A' ' 118' ' ' SER . 53.6 t0 -54.9 -37.7 66.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 111.056 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 -48.35 39.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.088 -1.008 . . . . 0.0 111.221 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 3.6 m -53.96 -49.35 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.058 -1.026 . . . . 0.0 111.679 -175.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 114' ' ' ASP . 21.9 p-90 -87.69 -24.94 23.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.729 -1.232 . . . . 0.0 111.09 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 6.8 m -56.02 -23.95 36.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.783 -1.198 . . . . 0.0 109.708 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -44.46 -15.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.166 -0.958 . . . . 0.0 110.076 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.3 m -88.15 24.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.001 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 1.6 m120 72.14 38.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 109.641 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 51.4 p-80 41.96 40.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.579 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.416 ' H ' HG23 ' A' ' 120' ' ' VAL . 81.5 mt-30 -147.52 148.09 30.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.542 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.42 135.58 36.99 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.671 2.247 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.488 HE22 ' CB ' ' A' ' 141' ' ' ALA . 86.3 mt-30 -100.08 148.41 24.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.776 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.6 ptm -133.27 156.68 47.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.447 -0.783 . . . . 0.0 109.155 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.3 t -124.03 163.3 21.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.921 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -137.69 54.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -89.99 -158.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.663 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.58 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 6.4 m -140.9 -29.6 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.34 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.405 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 14.2 m -135.06 161.17 36.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.469 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.431 HD11 ' CD1' ' A' ' 6' ' ' TRP . 50.4 mt -73.58 -16.73 61.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.84 -41.21 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.8 pt-20 -71.93 -26.04 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.174 -0.954 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.0 117.45 48.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.03 131.28 5.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.096 2.53 . . . . 0.0 112.563 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.464 ' H ' HG22 ' A' ' 137' ' ' THR . 0.7 OUTLIER -76.98 -13.38 59.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.259 179.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.2 m -94.73 101.87 13.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.91 154.62 49.64 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.05 -42.68 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.843 2.362 . . . . 0.0 112.009 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.488 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -75.73 -41.38 53.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -62.05 -42.53 99.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.412 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 44.1 t0 -62.87 -45.24 93.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.17 80.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 162' ' ' CYS . 23.6 tp -57.96 -50.9 71.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.3 p -58.6 -39.36 80.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.55 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 60.7 mttp -60.69 -32.72 71.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.06 -55.11 10.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.5 mp -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.626 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.63 -41.38 85.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.419 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.01 -35.45 80.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.498 HH11 ' HG3' ' A' ' 152' ' ' ARG . 26.6 ttm-85 -63.86 -21.75 66.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.8 21.47 8.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.69 136.76 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -1.112 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 1.8 mptm? -97.67 -169.64 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 16.5 p90 39.47 41.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 157' ' ' VAL . 5.5 m -96.38 25.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.54 154.58 1.21 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.7 m -55.87 -28.03 54.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.423 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -48.33 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.9 mp -58.74 -44.24 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 109.438 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' A' ' 145' ' ' LEU . 2.2 t -62.64 -49.04 76.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -62.74 -40.0 95.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.364 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -60.71 -38.65 85.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CZ ' HD11 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -61.12 -43.63 98.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.529 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.3 mtp -59.33 -40.2 85.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.75 -34.16 77.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.628 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -67.31 -63.2 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.685 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.8 t -63.26 -40.31 97.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.98 21.64 15.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 34.8 mt -54.17 -35.1 61.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.395 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.18 133.95 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.546 ' OD1' ' ND1' ' A' ' 175' ' ' HIS . 5.8 t-20 -81.48 100.96 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.45 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -86.26 118.46 25.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.546 ' ND1' ' OD1' ' A' ' 173' ' ' ASN . 15.0 m170 -147.62 162.22 39.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.519 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 130' ' ' THR . 38.9 t -110.82 132.71 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 129' ' ' ALA . 83.3 t -71.88 -39.25 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.495 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.91 28.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 29.7 t -91.03 167.29 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -1.138 . . . . 0.0 109.49 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.3 p -90.84 -37.87 13.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.503 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.479 ' HG ' ' HG ' ' A' ' 179' ' ' CYS . 17.0 p -53.31 -35.9 60.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.464 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 39.8 t80 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.449 HH11 ' HG3' ' A' ' 3' ' ' ARG . 50.7 mtm-85 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.08 -164.83 1.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.387 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.12 3.24 63.71 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.608 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 1.4 m0 47.83 42.89 16.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.477 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 8' ' ' SER . 33.2 m -66.29 127.99 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER 166.6 178.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.497 ' N ' ' OG ' ' A' ' 8' ' ' SER . 49.4 tp60 59.41 -127.86 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.12 150.74 91.66 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 -11.63 26.29 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.159 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.75 -33.08 74.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.555 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 42.3 m-85 -54.16 -46.47 72.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.444 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.93 -28.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.4 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -56.84 -47.14 81.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 1.3 p90 -75.76 -38.73 58.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.502 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.552 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 83.9 t60 -54.16 -46.27 72.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.498 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -71.38 -34.51 70.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.514 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 3.1 m120 -61.81 -62.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.545 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TRP . 10.3 pt-20 -174.04 -115.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.796 ' CZ2' ' HB2' ' A' ' 168' ' ' ALA . 34.5 t-105 60.07 130.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.524 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.81 60.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.7 OUTLIER -76.89 152.74 82.77 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.264 -1.139 . . . . 0.0 109.376 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 123.01 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.752 2.301 . . . . 0.0 111.857 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -108.57 135.22 50.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.858 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -134.94 5.32 3.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 109.038 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.91 128.45 35.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.277 -0.889 . . . . 0.0 109.296 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.536 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -61.71 -55.89 25.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.581 -178.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -62.73 -43.63 98.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.708 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.619 ' NZ ' ' NH2' ' A' ' 53' ' ' ARG . 15.9 tptp -64.63 -44.35 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.85 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 113' ' ' ALA . 5.3 tp -60.87 -42.07 97.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.85 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.9 m-30 -60.34 -35.89 76.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 0.0 109.892 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.76 -30.06 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.819 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.0 tpp -74.34 -56.23 5.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.837 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.445 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -61.69 -36.7 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.59 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 75.9 m -71.72 -44.72 63.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.6 tp -73.53 -39.8 64.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.977 . . . . 0.0 109.876 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -53.71 -34.56 59.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.775 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.72 -34.27 56.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -64.22 -29.14 70.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.161 . . . . 0.0 109.778 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.1 tt0 -49.04 -31.01 6.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.759 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.99 110.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -31.84 6.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 41' ' ' GLN . 19.4 mt -99.47 -150.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.8 m -145.98 161.34 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -52.39 -41.25 62.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -51.9 -40.99 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -75.65 -34.63 60.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.71 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.65 -44.21 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HZ2' HD12 ' A' ' 47' ' ' ILE . 46.5 mttp -59.36 -49.39 78.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -72.51 -22.5 61.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.334 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.619 ' NH2' ' NZ ' ' A' ' 30' ' ' LYS . 3.8 ttt-85 -57.57 -44.29 85.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.111 -0.993 . . . . 0.0 108.975 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.11 -44.56 65.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -66.38 -35.03 79.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.242 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 29.4 t80 -57.06 -49.25 76.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.468 -0.77 . . . . 0.0 109.379 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 80.4 mtm180 -59.67 -41.37 90.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.06 39.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.213 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.9 m -95.9 -33.97 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 30.1 m-85 -86.05 -32.85 21.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.047 -1.033 . . . . 0.0 110.233 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 85.5 t60 -47.47 -16.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 60' ' ' PHE . 7.2 pt20 -100.35 -22.07 15.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.818 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.467 ' O ' HG23 ' A' ' 68' ' ' VAL . 60.0 m-85 -99.94 68.79 1.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.077 -1.015 . . . . 0.0 109.871 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 63' ' ' PHE . 4.9 m-20 -41.42 154.3 0.24 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.995 . . . . 0.0 109.607 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -34.46 -53.97 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.948 2.432 . . . . 0.0 112.627 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.82 -44.76 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.125 -0.984 . . . . 0.0 109.632 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.7 -32.78 74.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 63' ' ' PHE . 49.0 t -57.34 -43.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.617 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.497 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.41 -3.1 58.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.6 mtp -55.74 146.68 20.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.2 tp60 -105.97 166.46 10.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 97.2 mt-10 -63.25 -29.31 70.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.442 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.41 -37.16 84.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 109.441 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.63 -39.28 80.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.421 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' VAL . 96.8 t -63.82 -44.14 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -56.98 -37.25 71.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.377 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -61.05 -44.09 97.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.416 -0.803 . . . . 0.0 109.81 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.8 mt -73.78 -33.07 64.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 76' ' ' VAL . 40.9 t -50.55 -35.63 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.953 . . . . 0.0 109.788 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -88.93 -50.19 6.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.089 -1.007 . . . . 0.0 109.568 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.5 m-20 -71.33 153.27 42.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.38 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.12 26.65 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -47.33 -34.74 9.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 85' ' ' ILE . 22.3 pt -148.61 -174.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.343 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.47 138.04 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -89.92 106.88 18.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 109.445 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CD2' ' H ' ' A' ' 90' ' ' GLY . 20.2 t-160 -176.34 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -45.02 -34.72 2.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.894 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.548 ' H ' ' CD2' ' A' ' 88' ' ' HIS . . . -66.86 -44.52 88.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -66.44 -43.12 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.491 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.94 -46.67 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -59.71 -33.22 71.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.42 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.99 90.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 80.5 mt -64.13 -44.79 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.05 -45.82 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.22 -38.06 95.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 6.9 t30 -57.64 -40.87 80.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.356 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.71 95.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.57 -40.81 75.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.44 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.77 -31.97 73.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.451 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 22.6 t80 -62.1 -48.4 80.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.3 mm? -58.35 -37.4 75.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 109.488 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -61.28 -51.71 67.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.606 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 27.3 ttt -69.97 -39.45 75.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.36 -26.78 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 109.443 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -51.7 -25.11 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.14 -19.0 58.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.496 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.58 17.47 68.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.11 152.74 38.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.151 -1.205 . . . . 0.0 109.741 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.83 122.92 10.63 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.641 2.228 . . . . 0.0 111.669 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.606 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 26.3 t80 -76.73 -42.16 42.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -69.91 -50.68 39.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 118' ' ' SER . 43.8 t0 -53.01 -33.32 51.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.012 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 16.2 t80 -76.24 -52.28 10.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.036 -1.04 . . . . 0.0 111.223 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.471 HG23 ' N ' ' A' ' 117' ' ' TRP . 10.1 m -56.56 -50.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.972 -1.08 . . . . 0.0 111.683 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.521 ' HB2' HD11 ' A' ' 171' ' ' LEU . 7.6 p-90 -82.05 -31.12 31.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.709 -1.244 . . . . 0.0 111.163 -176.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 18.0 t -56.28 -24.01 40.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.871 -1.143 . . . . 0.0 109.785 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -43.11 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.279 -0.888 . . . . 0.0 110.083 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 118' ' ' SER . 19.5 m -83.11 24.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.973 -1.079 . . . . 0.0 110.003 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 67.35 36.23 4.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 118' ' ' SER . 74.0 m-70 53.82 26.16 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.465 ' H ' HG23 ' A' ' 120' ' ' VAL . 31.7 mt-30 -142.89 103.67 5.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.75 147.61 4.46 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.685 2.257 . . . . 0.0 111.808 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -95.83 157.97 15.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.727 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -121.95 142.49 50.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.7 t -86.14 160.19 19.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.938 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -141.73 46.83 1.67 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.645 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -101.79 135.75 42.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.8 m -76.8 -30.22 56.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.353 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -133.39 175.75 9.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.582 HD22 ' HE1' ' A' ' 6' ' ' TRP . 34.6 mt -67.79 -31.92 72.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.556 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.1 p -63.51 -34.86 78.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.645 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.3 mt-10 -73.51 -21.6 60.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.125 -0.985 . . . . 0.0 109.435 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 132' ' ' LEU . 84.9 mt -66.96 120.02 68.55 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.28 136.53 7.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.11 2.54 . . . . 0.0 112.561 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -95.15 4.78 53.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.325 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.9 t -137.14 90.74 2.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.59 156.27 39.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.74 -40.08 24.18 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.777 2.318 . . . . 0.0 112.03 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.96 -38.38 66.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.307 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.6 t -62.54 -47.38 84.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.03 -45.45 92.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.88 75.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.53 -46.64 78.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.537 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.3 t -56.09 -43.73 78.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.22 -35.96 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.08 -52.41 35.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.4 mp -66.29 -37.13 84.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.38 -0.825 . . . . 0.0 109.546 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -62.45 -37.23 85.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.333 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.62 -37.58 86.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 0.0 109.441 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.608 ' NH2' ' CE1' ' A' ' 115' ' ' PHE . 99.3 mtt180 -63.77 -23.41 67.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.46 12.21 9.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 43.0 m-85 -78.41 135.01 37.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -1.108 . . . . 0.0 109.51 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 19.9 tptt -101.35 -166.19 1.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 14.6 p90 37.83 33.95 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.407 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -101.77 24.89 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.388 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.62 157.0 1.67 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.7 m -53.61 -31.01 45.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.0 m -63.53 -47.18 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -64.98 -40.53 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.4 -41.05 96.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.319 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.5 -46.41 90.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.288 -0.883 . . . . 0.0 109.306 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 95.5 p -60.74 -36.8 79.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.02 -49.42 76.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.8 mtp -59.95 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.97 -46.05 90.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.796 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -72.62 -43.61 63.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.671 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' VAL . 13.6 t -58.13 -29.56 65.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.986 . . . . 0.0 109.425 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 0.33 61.3 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 117' ' ' TRP . 3.7 mp -55.07 -43.29 73.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -1.17 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.99 135.97 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.572 ' N ' HD22 ' A' ' 173' ' ' ASN . 1.8 m120 -86.43 117.89 25.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 42.1 p-10 -91.86 93.43 8.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -149.23 130.98 15.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.55 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 26.3 m -100.02 139.75 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.23 -33.77 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.11 65.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 176' ' ' VAL . 12.6 p -79.09 129.63 34.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.548 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 71.2 m -63.1 -29.67 70.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.9 t -48.73 -28.74 3.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.2 t80 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.619 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.7 p -43.35 159.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -125.98 -17.93 2.44 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -65.58 5.16 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 5' ' ' GLY . 4.6 t -63.32 140.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 p -61.8 151.29 34.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 109.475 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.81 -31.69 68.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -49.14 143.49 9.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.444 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.08 -28.5 12.8 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.898 2.399 . . . . 0.0 112.161 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.4 tp -62.13 -39.97 94.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.71 -49.13 67.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.91 . . . . 0.0 109.427 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.59 -40.9 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.69 -36.66 84.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -62.12 -43.09 99.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -60.92 -42.89 98.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.463 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.99 -39.45 85.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -63.63 -55.37 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -175.84 130.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.95 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -173.92 122.14 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.75 -0.03 79.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 169' ' ' CYS . 6.6 m -80.42 148.62 66.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.291 -1.123 . . . . 0.0 109.33 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 119.7 6.68 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.754 2.303 . . . . 0.0 111.857 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.26 130.86 53.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.832 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -117.05 4.09 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.865 . . . . 0.0 109.006 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -78.53 116.84 19.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 76.1 p -61.58 -33.52 74.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.599 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -58.04 -47.15 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -70.28 -48.8 55.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.09 -39.77 93.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 61.5 t80 -60.3 -45.0 94.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.893 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.59 -31.67 72.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 109.88 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.52 -53.22 57.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.805 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.84 -42.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.025 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.589 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 12.1 m -62.27 -51.74 66.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 mt -76.07 -42.4 47.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 161' ' ' ILE . 44.2 tt0 -54.25 -36.49 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.797 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.46 -32.97 61.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.54 -27.56 69.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -1.22 . . . . 0.0 109.718 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -48.53 -36.9 16.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 109.624 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.47 114.71 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.659 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.59 -33.36 5.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 mt -97.44 -141.83 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -1.17 . . . . 0.0 109.43 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.0 p -147.3 154.49 41.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -50.88 -45.03 59.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.219 -0.925 . . . . 0.0 109.494 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 47' ' ' ILE . 7.8 tp -55.35 -34.77 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.684 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.1 m -72.02 -35.08 69.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.0 t -59.19 -49.06 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.49 -50.84 70.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -59.37 -48.45 81.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.304 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -69.36 -30.57 68.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HG2' HH11 ' A' ' 53' ' ' ARG . 20.2 ttt-85 -50.99 -46.27 61.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 108.943 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.33 -44.22 72.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.355 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.58 -41.51 98.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.479 ' CD2' ' CE2' ' A' ' 60' ' ' PHE . 3.3 m-85 -55.87 -49.68 72.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.393 -0.817 . . . . 0.0 109.369 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' HIS . 58.8 mtp180 -51.72 -45.04 63.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.782 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.75 -43.14 47.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.1 m -96.4 -27.55 14.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.278 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.479 ' CE2' ' CD2' ' A' ' 56' ' ' TYR . 38.9 m-85 -92.36 -34.38 14.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.093 . . . . 0.0 110.133 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 86.5 t60 -48.29 -38.92 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -68.4 -34.12 75.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.716 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 64' ' ' ASP . 40.2 m-85 -88.9 62.97 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.85 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -39.77 159.0 0.13 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 109.558 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -38.61 -53.45 1.82 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.923 2.415 . . . . 0.0 112.651 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.9 t -53.36 -44.63 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -66.71 -34.39 77.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 63' ' ' PHE . 48.5 t -58.23 -48.77 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 109.661 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.32 63.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.49 7.07 43.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.633 ' SD ' HD11 ' A' ' 96' ' ' ILE . 41.9 ttm -57.06 146.97 25.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' OE1' ' OE2' ' A' ' 74' ' ' GLU . 95.3 mt-30 -107.44 162.02 14.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.07 -28.51 70.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' OE1' ' A' ' 72' ' ' GLN . 24.9 pt-20 -72.29 -27.76 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.81 -47.71 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 80' ' ' VAL . 10.7 m -64.05 -36.85 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -54.82 -37.97 66.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -70.05 -43.74 70.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.367 -0.833 . . . . 0.0 109.803 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 79' ' ' LEU . 96.0 mt -70.04 -41.45 74.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.99 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 76' ' ' VAL . 54.3 t -50.86 -36.3 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.31 -62.41 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -99.84 114.14 27.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.92 79.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -25.95 7.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' GLY . 22.1 pt -57.85 -160.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.249 -1.147 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.98 132.67 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.52 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.0 ptm180 -102.48 136.33 42.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.16 100.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.152 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -47.51 -30.28 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.923 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.8 -48.82 15.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.61 -43.39 98.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -1.145 . . . . 0.0 109.489 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.436 ' CG2' HG12 ' A' ' 76' ' ' VAL . 61.1 mt -63.47 -55.33 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.628 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -58.17 -31.58 67.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.72 93.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 109.39 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.5 -41.7 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.633 HD11 ' SD ' ' A' ' 71' ' ' MET . 70.9 mt -55.4 -54.3 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.82 94.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.589 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -58.03 -40.29 80.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -70.75 -37.05 73.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.04 -43.42 98.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -70.0 -33.85 72.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 19.4 t80 -69.84 -46.66 65.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 109.527 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.87 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 28.1 ttt -61.71 -41.53 97.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.485 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.1 -27.09 63.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -52.07 -21.82 3.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.513 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.46 -13.71 60.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.7 4.55 72.74 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.46 167.25 16.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -1.213 . . . . 0.0 109.696 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.76 118.55 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.546 2.164 . . . . 0.0 111.704 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 36.4 t80 -66.35 -44.23 83.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.467 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.47 89.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.774 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 24.7 t70 -53.41 -54.43 36.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 111.082 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -39.06 68.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.998 -1.064 . . . . 0.0 111.313 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.02 -60.4 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.997 -1.064 . . . . 0.0 111.676 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.673 ' O ' HG22 ' A' ' 120' ' ' VAL . 63.0 p-90 -87.99 -20.99 25.1 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.759 -1.213 . . . . 0.0 111.151 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 58.3 m -56.93 -32.25 65.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.838 -1.164 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -45.89 -14.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.5 m -82.23 24.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.1 -1.0 . . . . 0.0 109.949 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 71.95 29.65 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 109.764 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.1 t60 53.9 31.98 14.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 0.0 109.59 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.508 ' H ' HG23 ' A' ' 120' ' ' VAL . 39.1 mt-30 -150.32 121.52 3.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.97 153.26 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.732 2.288 . . . . 0.0 111.809 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 91.9 mm-40 -110.89 148.22 32.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.731 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.595 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 31.5 tpp -120.85 135.06 55.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.103 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -85.94 164.17 17.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.449 ' NE2' ' OH ' ' A' ' 182' ' ' TYR . 76.1 mm-40 -142.91 43.08 1.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.835 . . . . 0.0 109.364 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.18 -164.6 1.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.483 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 40.3 m -158.91 -26.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.61 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.3 m -115.36 158.13 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.92 -13.78 60.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -92.87 -32.87 14.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 131' ' ' THR . 6.5 pt-20 -77.36 3.56 12.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -0.964 . . . . 0.0 109.409 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.89 126.09 91.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.695 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.12 128.24 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.159 2.573 . . . . 0.0 112.512 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.0 t -101.07 7.86 43.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 t -144.34 88.98 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.396 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.95 160.98 32.71 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.43 -40.29 28.93 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.801 2.334 . . . . 0.0 112.01 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.85 75.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.347 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 t -61.39 -46.95 88.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 147' ' ' LYS . 24.4 t70 -61.49 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.88 83.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 149' ' ' LEU . 9.3 tt -65.82 -39.79 91.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 109.537 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -55.66 -48.95 74.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' NZ ' ' OD2' ' A' ' 143' ' ' ASP . 61.0 mttp -62.96 -28.8 70.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.52 -47.51 69.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 145' ' ' LEU . 91.0 mt -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -57.45 -37.88 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -61.33 -40.06 92.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.402 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -68.06 -19.99 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 109.377 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.05 26.25 19.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 1.9 m-85 -85.23 135.87 33.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -101.73 175.0 5.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 55.66 46.92 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' GLY . 25.8 m -120.18 25.93 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.62 164.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.2 m -53.84 -31.27 48.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -1.089 . . . . 0.0 109.386 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 -47.3 76.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.83 -36.32 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.5 m -67.99 -48.82 64.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.287 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.92 -41.56 98.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.416 -0.803 . . . . 0.0 109.316 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.0 m -59.13 -38.5 79.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -60.68 -45.68 93.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mmm -58.91 -41.83 88.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.611 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.02 -31.34 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' VAL . 2.5 p -80.74 -63.98 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 109.472 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.683 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 158.04 -98.78 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mt 61.52 -22.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.683 ' H ' ' C ' ' A' ' 170' ' ' GLY . 12.9 m -132.39 143.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.595 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 6.1 m-20 -92.53 102.18 14.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.407 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.39 97.34 11.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.496 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.53 141.08 32.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 m -94.63 136.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.77 138.19 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.62 2.95 62.95 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 180' ' ' CYS . 7.6 m -153.24 155.06 35.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -1.163 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 1.7 t 71.01 3.87 4.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 3.2 m 62.71 56.36 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.538 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.55 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.74 HH21 HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.261 0.553 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 m -52.59 166.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.62 -17.53 61.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.506 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -76.51 6.91 5.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.427 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.9 p -78.83 133.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -71.47 162.56 29.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.935 . . . . 0.0 109.447 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.647 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 0.7 OUTLIER -84.07 1.23 44.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.92 144.87 73.12 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.74 -17.15 26.17 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.893 2.395 . . . . 0.0 112.102 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.81 -46.71 14.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -66.42 -44.58 82.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.434 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.74 HD11 HH21 ' A' ' 3' ' ' ARG . 15.2 tt -59.78 -42.17 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 14' ' ' ILE . . . -72.43 -41.59 66.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.504 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.54 ' OH ' ' NE1' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -59.62 -37.53 78.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.47 -43.45 85.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.7 p30 -91.63 1.09 57.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ALA . 31.5 t30 -63.59 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -153.08 -16.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.54 ' NE1' ' OH ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -50.13 145.89 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.32 -5.51 62.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.61 119.06 65.75 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.243 -1.151 . . . . 0.0 109.335 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.15 121.01 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.806 2.337 . . . . 0.0 111.855 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -103.72 138.92 39.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -134.63 0.31 2.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.033 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -81.26 118.7 22.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -53.81 -37.85 63.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.22 -42.09 94.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -70.98 -48.81 51.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.2 mp -64.49 -36.69 85.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.817 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 35' ' ' ILE . 20.8 t80 -61.42 -50.81 71.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.11 -28.97 65.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.421 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 47.5 tpp -57.28 -52.6 64.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.795 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.457 HD12 ' OE2' ' A' ' 38' ' ' GLU . 2.8 tp -65.83 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.971 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 78.4 m -74.48 -38.87 62.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.096 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.07 -50.08 51.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 109.887 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE2' HD12 ' A' ' 35' ' ' ILE . 25.9 pt-20 -62.82 -27.89 69.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.8 -33.97 28.62 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.79 -27.54 69.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.263 . . . . 0.0 109.776 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 7.1 tt0 -50.37 -41.3 51.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.93 112.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.669 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.17 -37.16 3.63 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 86' ' ' ILE . 25.9 mt -100.88 -140.4 0.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.172 . . . . 0.0 109.41 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 p -141.59 159.92 41.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.512 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 74.9 t-105 -57.08 -44.62 83.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.484 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 48' ' ' THR . 9.9 tp -56.87 -34.61 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 47' ' ' ILE . 69.4 m -70.63 -34.62 72.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.96 . . . . 0.0 109.723 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.3 t -70.16 -44.3 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.1 mt -53.26 -53.97 43.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.8 -45.6 82.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.097 -1.002 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 85' ' ' ILE . 63.5 mttm -79.79 -11.55 59.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 49' ' ' VAL . 27.5 ttt-85 -64.65 -48.54 74.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.189 -0.944 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 19.7 pt-20 -72.61 -39.25 67.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.809 . . . . 0.0 109.307 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -70.07 -41.55 73.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.294 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 32.2 t80 -60.2 -44.75 94.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.407 -0.808 . . . . 0.0 109.375 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' HIS . 52.2 mtp180 -58.57 -38.49 78.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.849 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.06 80.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 1.9 p -93.4 -12.83 28.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 37.6 m-85 -117.0 -54.21 2.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.941 -1.1 . . . . 0.0 110.173 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ARG . 74.8 t60 -54.87 -42.15 71.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.112 -0.992 . . . . 0.0 109.882 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -57.37 -35.26 69.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 46.8 m-85 -72.57 -22.7 60.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 131.44 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.005 . . . . 0.0 109.608 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -40.52 -34.29 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.93 2.42 . . . . 0.0 112.701 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.7 t -56.34 -49.77 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' MET . 53.6 mtpt -73.24 -30.27 63.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.848 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.519 ' O ' ' SD ' ' A' ' 71' ' ' MET . 62.1 t -56.02 -44.15 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.41 42.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.65 34.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 9.6 ptm -61.64 144.91 53.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.701 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -95.22 171.36 8.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.578 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.67 -33.53 68.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.451 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 49.3 mp0 -56.07 -36.91 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.86 -38.28 90.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.3 t -59.47 -44.51 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.1 -34.94 79.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.187 -0.945 . . . . 0.0 109.338 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -58.8 -43.86 90.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.338 -0.852 . . . . 0.0 109.783 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.8 mt -69.58 -32.63 71.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.97 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.15 -32.95 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -92.93 -51.96 4.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 87.4 m-20 -90.89 155.65 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.361 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.73 84.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -70.42 25.99 0.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 83' ' ' ALA . 2.5 pt -47.18 -97.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -1.176 . . . . 0.0 109.312 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.48 HD11 HD11 ' A' ' 44' ' ' LEU . 14.4 tt -114.55 131.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.653 ' HG2' HH11 ' A' ' 87' ' ' ARG . 8.9 mtt-85 -86.36 94.11 9.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -173.44 80.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -47.16 -33.8 5.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.938 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.01 -42.7 97.06 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -63.5 -44.53 94.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -1.193 . . . . 0.0 109.489 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.85 -43.71 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -57.16 -37.24 71.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.91 88.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.384 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -57.56 -42.71 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.83 . . . . 0.0 109.44 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.561 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 26.9 mm -54.1 -50.17 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.91 -32.2 80.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 24.4 m120 -62.86 -46.91 85.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -1.177 . . . . 0.0 109.414 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.77 83.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -64.57 -39.59 94.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.4 61.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.535 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -68.8 -48.39 63.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.55 -41.48 90.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.59 -38.87 91.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.543 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -35.39 80.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.44 -29.46 68.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -51.77 -19.88 1.87 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.496 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -75.73 -17.85 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.54 63.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.39 151.13 42.48 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -1.154 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -68.43 119.35 6.35 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.636 2.224 . . . . 0.0 111.675 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -74.32 -40.19 62.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.504 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.93 -49.99 73.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 118' ' ' SER . 89.5 m-20 -57.84 -54.3 48.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 111.064 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 57.8 t80 -53.69 -42.46 68.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 111.256 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.38 -59.56 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.974 -1.079 . . . . 0.0 111.662 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.614 ' CB ' HD21 ' A' ' 171' ' ' LEU . 59.2 p-90 -88.22 -21.28 24.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.735 -1.228 . . . . 0.0 111.122 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' VAL . 72.7 p -58.94 -28.59 66.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.825 -1.172 . . . . 0.0 109.77 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.01 -14.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.01 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.4 m -84.17 24.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.041 -1.037 . . . . 0.0 109.974 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.3 t-20 72.52 31.35 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.682 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 81.9 t60 53.05 33.47 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.539 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.547 ' H ' HG23 ' A' ' 120' ' ' VAL . 20.2 mt-30 -142.52 106.5 5.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.558 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -46.61 151.58 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.611 2.207 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.79 143.53 29.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.723 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.3 ttm -126.76 130.38 50.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.843 . . . . 0.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.0 OUTLIER -94.18 164.75 12.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.875 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -164.03 41.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 109.3 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.37 -176.72 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 109.67 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -76.53 -41.48 46.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.398 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.415 HG23 ' OG ' ' A' ' 133' ' ' SER . 1.2 t -147.44 175.0 11.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.11 -32.18 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.415 ' OG ' HG23 ' A' ' 131' ' ' THR . 85.4 p -57.46 -38.03 73.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.444 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.54 -32.01 72.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.47 131.96 89.73 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.78 138.59 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.152 2.568 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -84.59 4.25 33.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -140.96 88.47 2.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -94.9 174.8 3.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 139' ' ' THR . 35.9 Cg_exo -56.9 -42.24 66.66 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.07 74.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 t -60.97 -48.84 79.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.14 -41.36 94.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.04 89.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.2 tp -60.45 -48.27 82.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -55.33 -43.67 75.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -59.29 -37.87 78.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.544 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.24 -51.67 28.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 109.593 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -59.12 -41.68 88.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.09 -37.38 86.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.564 ' HG2' HH11 ' A' ' 152' ' ' ARG . 28.2 mtt-85 -64.15 -21.4 66.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.342 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.02 6.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 10.0 m-85 -96.1 137.08 35.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -1.116 . . . . 0.0 109.475 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -94.59 -166.98 1.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 31.6 p90 40.03 37.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.52 24.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.21 158.93 3.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -57.82 -29.82 65.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.1 m -66.94 -44.85 79.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.28 -37.79 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.15 -41.14 92.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.56 -44.01 97.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.431 -0.793 . . . . 0.0 109.337 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 22.9 t -57.71 -38.02 74.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -59.25 -41.77 89.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.399 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 57.6 mtt -63.91 -38.39 90.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.632 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -59.19 -38.94 81.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.687 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -80.44 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.542 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 37.3 t -49.96 -43.38 50.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.495 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.83 15.66 26.0 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.614 HD21 ' CB ' ' A' ' 117' ' ' TRP . 6.0 mp -51.71 -51.1 58.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.4 m -90.88 136.31 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 127' ' ' THR . 62.1 t30 -85.6 103.39 14.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.932 . . . . 0.0 109.447 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 63.6 t0 -96.52 115.43 27.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.526 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 51.2 m80 -159.82 15.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 177' ' ' VAL . 9.4 t 52.49 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.684 ' H ' HG12 ' A' ' 176' ' ' VAL . 10.4 p -94.94 -8.86 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.03 47.6 0.71 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 181' ' ' CYS . 4.8 t -146.49 170.11 17.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 109.516 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 72.1 m 53.55 -86.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.539 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.1 p -166.05 36.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.596 179.913 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.629 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.01 161.35 30.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.56 -5.79 86.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -54.39 -33.64 59.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.483 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 14' ' ' ILE . 9.1 p -105.03 137.08 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 17.4 p -157.53 -136.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.505 ' N ' ' OG ' ' A' ' 8' ' ' SER . 51.7 mt-30 -61.22 -147.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.533 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 53.61 74.62 0.73 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.36 -27.62 13.89 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.9 2.4 . . . . 0.0 112.108 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.5 tt -73.17 -39.1 65.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.465 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -65.82 -53.75 35.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 7' ' ' VAL . 4.4 pt -63.79 -33.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.355 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.28 -43.71 83.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -72.87 -44.57 61.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 109.478 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.599 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 30.0 t-80 -64.0 -49.42 72.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.84 -34.06 74.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -65.38 -69.62 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.526 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.83 119.13 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.599 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 77.7 t90 -172.65 128.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.42 83.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.2 114.91 64.83 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.4 120.48 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.75 2.3 . . . . 0.0 111.896 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HB2' HD21 ' A' ' 31' ' ' LEU . 79.2 mm-40 -101.65 128.91 47.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.85 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.6 p -103.09 -4.4 24.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -79.71 117.81 20.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 0.0 109.367 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.0 m -59.64 -34.08 72.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 109.628 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.02 -46.23 85.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.87 -44.17 73.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 25' ' ' GLU . 84.3 mt -63.67 -47.18 82.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.835 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -60.7 -42.17 96.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.837 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -73.46 -30.46 63.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.6 tpp -63.0 -54.63 35.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 109.803 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 36' ' ' CYS . 3.4 tp -65.01 -35.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.998 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 35' ' ' ILE . 75.0 m -71.92 -44.21 64.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.072 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.7 -43.32 72.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -0.994 . . . . 0.0 109.845 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.31 -31.18 70.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.788 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.3 -32.94 22.8 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.2 -29.34 70.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -1.215 . . . . 0.0 109.7 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.719 HE21 HD11 ' A' ' 161' ' ' ILE . 3.5 pp0? -51.92 -23.4 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.662 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.14 109.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 0.0 109.684 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.05 -32.23 5.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 23.2 mt -105.79 160.98 14.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 p -89.06 157.09 18.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.425 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -56.32 -29.6 61.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.639 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.16 -38.05 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.686 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.5 m -74.46 -33.14 62.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -58.27 -35.01 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.44 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.2 mt -54.69 -51.4 65.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.34 -46.32 89.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 56' ' ' TYR . 68.0 mmtt -71.18 -22.74 61.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.37 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -59.17 -47.59 84.74 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 109.001 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 57' ' ' ARG . 78.0 mm-40 -66.6 -44.35 82.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.398 -0.814 . . . . 0.0 109.394 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.6 -32.72 71.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.245 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.643 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 60.4 t80 -64.27 -45.96 85.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.464 -0.773 . . . . 0.0 109.403 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 54' ' ' GLU . 58.4 mtm180 -58.27 -42.3 86.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.75 73.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 110.303 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.504 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 10.7 m -94.92 -12.38 26.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.065 -1.022 . . . . 0.0 110.232 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 54.6 m-85 -123.83 -43.18 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.877 -1.139 . . . . 0.0 110.218 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 57' ' ' ARG . 36.4 t-80 -49.39 -43.12 43.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -67.78 -34.43 76.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.735 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 38.5 m-85 -71.29 -44.95 64.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 5.0 t70 73.85 136.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.066 -1.021 . . . . 0.0 109.613 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -41.16 -25.67 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.864 2.376 . . . . 0.0 112.739 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.97 -47.78 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -67.25 -49.65 63.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.841 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 69' ' ' ALA . 8.3 m -55.16 -44.32 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 109.541 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.594 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -66.48 -21.49 66.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.95 . . . . 0.0 109.445 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.74 1.28 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.369 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.4 mtm -78.83 159.4 27.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.34 168.83 8.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.54 -34.04 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 109.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.52 -37.45 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.902 . . . . 0.0 109.469 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.64 -38.33 90.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.466 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 80' ' ' VAL . 77.6 t -56.73 -42.97 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.625 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.97 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.336 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.424 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.7 ttt-85 -60.91 -47.04 88.25 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.458 ' O ' ' CA ' ' A' ' 84' ' ' GLY . 96.0 mt -69.68 -39.07 77.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.7 t -50.71 -33.1 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.722 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -91.69 -56.87 2.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -95.06 122.4 37.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.438 ' HB1' ' SG ' ' A' ' 59' ' ' CYS . . . 55.49 47.0 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.425 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -86.87 31.89 4.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.72 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 20.01 -116.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -1.13 . . . . 0.0 109.32 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.89 140.54 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.626 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -77.14 94.56 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.7 m170 -164.22 88.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.157 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 80' ' ' VAL . 54.1 mtp180 -51.24 -28.71 12.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.828 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.96 -42.5 77.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -60.88 -52.44 65.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -1.135 . . . . 0.0 109.577 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 89.3 mt -57.49 -50.73 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -57.33 -32.69 66.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.407 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.97 -40.14 94.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CE1' ' A' ' 60' ' ' PHE . 23.6 mm -58.41 -50.95 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 109.352 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 68' ' ' VAL . 80.0 mt -53.99 -48.22 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.578 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.35 -33.94 83.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 24.7 m120 -62.67 -40.43 97.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.428 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.13 -40.76 86.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.426 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 48.1 ttm-85 -59.17 -41.44 88.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -37.05 67.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.594 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 17.8 t80 -73.52 -48.61 31.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 103' ' ' LEU . 25.5 tp -58.36 -45.91 87.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.895 . . . . 0.0 109.472 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -63.33 -36.12 82.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.8 ttt -61.17 -43.17 99.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.132 -0.98 . . . . 0.0 109.459 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -71.9 -27.3 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.19 -31.93 33.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.04 0.84 34.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.21 40.1 34.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.82 82.37 49.42 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -1.182 . . . . 0.0 109.634 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -37.29 127.99 0.63 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.626 2.218 . . . . 0.0 111.732 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -63.98 -48.18 77.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.09 -41.3 71.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 110.678 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -62.42 -33.72 75.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 111.008 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.541 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 84.1 t80 -63.92 -52.55 59.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.064 -1.022 . . . . 0.0 111.241 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 116' ' ' VAL . 8.4 m -58.1 -41.42 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.0 111.692 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.512 ' O ' ' N ' ' A' ' 122' ' ' HIS . 59.6 m95 -63.88 -33.55 75.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.775 -1.203 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.4 t -66.03 -34.61 78.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.81 -1.181 . . . . 0.0 109.746 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.83 -43.01 99.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.101 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.4 p -87.76 24.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.947 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.51 22.05 7.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.641 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 117' ' ' TRP . 84.7 t60 49.27 45.68 23.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -151.37 114.91 3.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 138.72 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.716 2.277 . . . . 0.0 111.836 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.528 ' NE2' HG23 ' A' ' 120' ' ' VAL . 40.2 mt-30 -97.58 149.7 21.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 109.762 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -135.68 148.11 48.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.121 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 13.5 t -133.51 154.93 50.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 109.82 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -110.8 44.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.86 163.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.643 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 134' ' ' GLU . 9.0 m -116.23 -28.58 6.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 109.361 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 132' ' ' LEU . 1.7 t -142.06 -179.9 6.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.412 ' N ' ' OG1' ' A' ' 131' ' ' THR . 39.5 mt -64.23 -35.95 82.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -67.27 -29.57 69.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 130' ' ' THR . 40.0 mm-40 -63.15 -20.14 65.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.445 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.6 mp -67.04 119.83 67.25 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 109.698 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.19 130.68 5.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.065 2.51 . . . . 0.0 112.472 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.24 11.12 40.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 109.324 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.1 p -138.52 88.41 2.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.86 154.8 37.21 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.09 -32.11 94.27 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.813 2.342 . . . . 0.0 112.08 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.51 -40.89 48.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.4 p -62.51 -41.25 98.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.86 -48.08 75.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.41 82.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -47.41 84.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.85 . . . . 0.0 109.51 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.5 m -55.92 -43.62 77.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.47 -35.9 78.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.513 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.65 -52.59 36.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.952 . . . . 0.0 109.531 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.8 mp -63.58 -38.11 89.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -61.35 -39.69 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.406 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.4 -37.05 85.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' A' ' 152' ' ' ARG . 44.9 mtt-85 -64.32 -23.24 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.404 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.74 10.51 16.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -74.68 137.74 42.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -1.115 . . . . 0.0 109.523 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.597 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -97.97 -168.4 1.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 21.8 p90 39.53 38.32 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.509 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 157' ' ' VAL . 3.1 m -97.68 24.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.52 155.18 3.98 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 57.0 m -54.91 -30.4 58.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.451 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.1 m -67.03 -47.91 69.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.719 HD11 HE21 ' A' ' 41' ' ' GLN . 1.8 mp -64.95 -37.08 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.53 -42.16 92.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.31 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.99 -43.51 98.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.3 m -57.4 -37.32 72.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 109.265 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.92 -39.94 91.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.452 ' SD ' HD12 ' A' ' 171' ' ' LEU . 64.3 mmm -66.11 -49.24 68.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.656 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.536 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 96.0 mm-40 -69.24 -41.93 76.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.715 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.54 84.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.98 -45.28 71.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.09 12.3 22.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.467 HD23 ' CH2' ' A' ' 117' ' ' TRP . 83.0 mt -58.64 -31.31 68.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.7 p -122.66 139.95 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.434 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -97.28 105.25 17.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.536 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 97.8 m-20 -94.76 97.58 10.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.506 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -139.7 150.23 44.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 m -68.75 -160.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.43 139.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.43 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 81.1 29.32 41.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.2 m -149.82 162.02 41.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.465 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 80.8 m 52.52 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.553 ' N ' ' O ' ' A' ' 179' ' ' CYS . 22.4 p -169.96 24.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.478 ' CZ ' ' O ' ' A' ' 127' ' ' THR . 74.0 t80 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.685 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 p -46.13 160.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.71 -0.78 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -78.26 8.69 4.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.6 p -130.14 130.87 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.922 . . . . 0.0 109.455 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.506 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 12.0 p -173.95 54.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 8' ' ' SER . 89.7 mm-40 -137.58 -135.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.34 153.91 4.75 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.335 -0.853 . . . . 0.0 109.448 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.7 -11.44 31.91 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.791 2.328 . . . . 0.0 112.174 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.48 -36.4 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.442 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 87.4 m-85 -73.67 -54.72 7.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.46 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.24 -48.9 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.342 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.96 87.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.59 -41.22 94.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 13' ' ' TYR . 28.1 m80 -62.99 -45.9 90.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.5 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.51 -37.26 51.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.479 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -57.94 -60.47 3.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -153.69 104.98 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.534 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -171.28 116.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.38 6.18 71.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' CYS . 2.3 t -110.68 104.12 55.5 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.245 -1.15 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.65 132.03 16.29 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.765 2.31 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.22 136.26 52.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.779 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.4 p -104.91 0.72 28.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.096 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -77.79 123.48 26.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.795 . . . . 0.0 109.35 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.3 p -66.84 -33.26 75.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 109.638 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -59.06 -43.54 91.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.152 -0.967 . . . . 0.0 109.771 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.57 -50.61 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.47 -38.51 77.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.16 -41.47 92.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 109.841 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' ' HG ' ' A' ' 36' ' ' CYS . 97.5 mt-10 -73.81 -31.06 63.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 109.84 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.48 -52.96 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.0 tp -55.1 -42.58 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.0 109.989 -178.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 30.7 p -72.81 -48.83 34.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.141 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 84.8 mt -65.75 -29.93 70.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.075 -1.016 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -51.77 -36.87 49.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.77 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.65 -29.29 61.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -59.04 -34.51 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.4 tt0 -57.68 -32.86 67.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.0 109.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 109.645 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.52 3.37 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.5 mm? -85.94 -160.01 0.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -1.192 . . . . 0.0 109.455 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 m -118.53 152.32 36.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -56.07 -33.24 64.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 0.0 109.513 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -29.56 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 109.611 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.2 m -64.78 -39.61 93.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.5 t -61.99 -38.91 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 mt -55.69 -55.13 35.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 51' ' ' LYS . 9.4 mtmp? -60.38 -45.12 94.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.325 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.476 ' NZ ' ' CG1' ' A' ' 86' ' ' ILE . 1.0 OUTLIER -68.91 -29.45 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.351 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.601 ' HG2' HH11 ' A' ' 53' ' ' ARG . 2.5 ttt-85 -54.27 -43.08 70.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.15 -0.968 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.99 -43.78 70.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.435 -0.791 . . . . 0.0 109.376 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -43.87 88.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t80 -60.88 -44.72 96.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.389 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 42.9 ttp180 -59.68 -27.31 66.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 109.77 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.44 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.425 -0.797 . . . . 0.0 110.265 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.0 m -92.89 -20.85 20.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.133 -0.979 . . . . 0.0 110.262 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 27.9 m-85 -102.75 -52.43 3.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.976 -1.077 . . . . 0.0 110.16 -178.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t60 -54.0 -39.14 65.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.972 -1.08 . . . . 0.0 109.88 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -56.32 -37.92 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' ASP . 54.9 m-85 -91.36 3.85 53.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 0.0 109.956 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 57.45 162.57 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.604 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.52 -28.49 8.31 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.904 2.403 . . . . 0.0 112.746 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -62.95 -48.96 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.681 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 71' ' ' MET . 91.1 mttt -65.51 -34.58 78.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.846 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 64' ' ' ASP . 55.8 t -56.09 -39.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -72.05 -34.31 68.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.1 16.53 22.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.361 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' LYS . 20.7 ttp -79.65 159.87 26.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.7 159.86 16.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.79 -25.17 62.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.48 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -55.68 -44.02 76.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 63.6 m-20 -61.83 -38.37 87.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.08 -41.44 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.58 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.18 -38.76 84.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 75' ' ' ASP . 72.8 mtm180 -68.94 -39.93 79.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.392 -0.817 . . . . 0.0 109.799 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.57 -46.45 69.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.3 t -51.78 -31.59 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.751 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.01 -57.61 3.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.515 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.79 126.37 44.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 51.89 47.05 25.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -75.85 15.56 4.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.615 ' C ' ' O ' ' A' ' 84' ' ' GLY . 3.9 pt 28.88 90.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.107 . . . . 0.0 109.346 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 85' ' ' ILE . 79.0 mt 58.02 151.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.541 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 53.8 mtm-85 -89.01 105.39 17.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 16.8 m-70 -163.47 61.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.219 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -47.56 -35.86 9.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.33 88.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 2.6 tppt? -73.41 -41.93 62.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -1.173 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.67 -53.53 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.609 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -56.36 -33.32 65.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.977 . . . . 0.0 109.323 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -59.55 -37.79 79.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.38 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.19 -40.49 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.4 mt -54.41 -45.68 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.8 -37.93 93.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 4.0 m120 -58.53 -42.73 88.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -1.187 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.8 77.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 43.0 ttm-85 -59.1 -39.56 82.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.73 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.579 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -59.39 -48.32 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.39 -41.5 98.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.432 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.2 -44.19 96.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 109.563 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.85 -43.18 75.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.943 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.64 -26.66 65.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -52.49 -27.34 15.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.546 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -75.95 -14.04 60.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.472 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.95 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -94.9 114.71 64.26 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.713 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -46.27 125.48 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.614 2.209 . . . . 0.0 111.698 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.89 -34.44 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.87 -49.31 59.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.176 -0.952 . . . . 0.0 110.685 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 118' ' ' SER . 86.2 m-20 -56.06 -55.63 30.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 111.079 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -56.11 -38.23 70.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 111.21 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 117' ' ' TRP . 2.4 t -55.93 -59.64 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 111.66 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.632 ' CB ' HD21 ' A' ' 171' ' ' LEU . 57.8 p-90 -88.97 -20.48 24.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.806 -1.184 . . . . 0.0 111.173 -178.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -60.41 -28.04 67.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.754 -1.216 . . . . 0.0 109.72 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.015 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 5.4 m -92.15 24.6 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 109.964 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 5.3 t-20 79.23 19.49 0.75 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 59.94 48.16 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.533 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.9 pt20 -154.15 147.97 18.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.92 154.78 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.652 2.234 . . . . 0.0 111.815 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 19.9 mp0 -122.83 152.85 40.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 0.0 109.725 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 61.1 mtt -136.49 155.01 50.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -135.25 158.81 43.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.924 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 128' ' ' GLN . 7.6 mp0 -117.27 47.35 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.324 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.15 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 m -83.98 -41.25 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 132' ' ' LEU . 29.6 m -131.85 164.55 25.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.522 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.5 mp -69.62 -11.0 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.1 m -85.12 -35.75 21.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -12.5 61.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -178.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.414 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 85.2 mt -68.52 118.0 55.69 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.767 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.01 128.63 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.63 -19.55 48.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.336 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 m -87.42 102.65 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.328 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.9 p -121.34 150.31 53.99 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.96 -40.71 33.16 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.746 2.297 . . . . 0.0 112.042 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.16 -38.75 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.4 m -61.33 -45.46 94.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.39 -44.57 94.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -41.3 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.515 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.31 -44.36 88.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.7 t -57.48 -42.32 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -62.62 -35.24 78.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.33 -51.91 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.03 -34.35 74.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -58.37 -36.43 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HB2' HH11 ' A' ' 152' ' ' ARG . 59.8 mttp -62.1 -39.28 91.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.421 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.7 mpt_? -63.79 -21.26 66.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.26 22.23 10.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.48 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 11.8 m-85 -83.27 133.4 34.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -101.67 170.33 8.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 53.35 47.88 23.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.617 HG22 ' SG ' ' A' ' 162' ' ' CYS . 10.7 p -122.32 26.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.417 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.76 170.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.9 t -59.0 -31.63 68.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -1.169 . . . . 0.0 109.427 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.465 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -62.98 -47.21 84.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 -179.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.96 -39.95 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.499 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 157' ' ' VAL . 79.9 m -67.21 -41.71 85.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.414 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 75.9 t80 -60.25 -45.39 93.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.467 -0.771 . . . . 0.0 109.348 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 m -58.85 -39.17 80.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.304 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -41.96 96.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.0 mtp -56.54 -41.7 77.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.81 -36.41 83.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.677 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.04 75.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.546 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 9.1 t -71.15 -62.89 1.23 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.466 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.17 15.32 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.632 HD21 ' CB ' ' A' ' 117' ' ' TRP . 8.4 mp -52.79 -52.36 57.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.39 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -102.24 135.66 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.94 101.73 14.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 11.3 p30 -91.76 115.63 28.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -142.23 162.15 36.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.472 ' CG2' ' SG ' ' A' ' 179' ' ' CYS . 19.5 m -115.74 144.19 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.05 -34.54 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.76 -29.1 57.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 176' ' ' VAL . 52.7 m -82.29 146.82 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -1.216 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.2 t -65.53 -29.29 69.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 182' ' ' TYR . 30.0 p -49.74 -45.0 48.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.62 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 22.9 t80 . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 7.4 tpt180 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.3 m -47.07 138.25 6.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.15 22.49 12.24 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 6' ' ' TRP . 40.6 p-90 -147.09 52.85 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.0 109.475 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 p -152.07 -16.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.6 p -84.32 14.1 4.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -54.67 -39.97 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.39 159.59 1.38 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.35 -35.04 43.12 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.79 2.327 . . . . 0.0 112.14 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 12' ' ' LEU . 31.7 tp -61.04 -37.8 83.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.813 . . . . 0.0 109.48 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.47 -44.5 90.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.52 -43.96 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 109.383 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.39 98.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.34 -40.82 98.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -63.59 -48.0 79.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.58 -33.14 72.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -51.53 -51.11 57.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.22 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CD2' ' N ' ' A' ' 22' ' ' GLY . 46.4 t90 -144.77 147.92 33.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.518 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 21' ' ' TRP . . . 86.39 -29.28 4.88 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 169' ' ' CYS . 32.8 m -72.15 145.64 88.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.26 120.04 6.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.778 2.319 . . . . 0.0 111.893 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.495 ' OE1' ' SG ' ' A' ' 169' ' ' CYS . 74.3 mt-10 -95.33 128.04 41.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.952 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -133.98 -3.08 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.058 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -81.44 137.08 35.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 p -61.91 -38.12 87.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.585 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.94 -49.37 62.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -64.61 -38.68 91.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.845 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.499 HD11 ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -73.3 -33.97 65.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -65.17 -48.13 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.878 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -65.61 -30.41 71.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.821 -178.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.5 tpt -70.72 -53.37 15.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.19 -34.11 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.994 -178.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -72.18 -49.52 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 110.123 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.3 -39.5 78.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 50.4 mm-40 -57.08 -35.87 69.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.66 -31.25 57.55 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.402 HE22 ' HB3' ' A' ' 91' ' ' LYS . 14.7 mm100 -63.75 -31.52 72.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.237 . . . . 0.0 109.757 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 38' ' ' GLU . 5.1 pt20 -52.64 -23.44 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 -179.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.19 108.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.965 . . . . 0.0 109.665 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.9 -33.3 2.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -87.69 169.52 12.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.5 p -82.11 165.01 20.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -67.81 -35.29 78.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.506 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.19 -39.1 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.639 -179.7 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.476 ' N ' HG23 ' A' ' 47' ' ' ILE . 92.5 m -49.92 -35.76 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.645 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.45 -29.81 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.49 -56.47 9.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -60.92 -37.29 81.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.152 -0.967 . . . . 0.0 109.265 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' TYR . 53.1 tttm -73.91 -26.69 60.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -57.7 -48.9 78.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.242 -0.911 . . . . 0.0 108.989 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.32 -47.69 69.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.841 . . . . 0.0 109.284 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.61 -34.54 78.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 29.7 t80 -59.47 -47.43 85.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.321 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -57.1 -30.85 64.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.779 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.04 93.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.7 m -94.32 -13.1 26.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.072 -1.017 . . . . 0.0 110.262 -178.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 43.2 m-85 -111.26 -52.78 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.937 -1.102 . . . . 0.0 110.201 -178.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -52.94 -36.96 60.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 109.87 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -55.55 -33.7 64.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.3 m-85 -97.08 4.9 51.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 0.0 109.864 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.22 164.52 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.04 -1.038 . . . . 0.0 109.609 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.37 -34.06 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.869 2.379 . . . . 0.0 112.713 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.93 -49.12 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' MET . 46.4 mtpt -65.1 -35.17 80.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.84 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 64' ' ' ASP . 54.7 t -54.81 -40.3 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 109.557 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -35.49 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.913 . . . . 0.0 109.462 179.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.39 15.31 26.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.1 tmm? -83.86 149.64 26.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.406 ' O ' ' SD ' ' A' ' 71' ' ' MET . 14.9 pt20 -102.97 167.04 10.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.42 -28.12 69.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -56.54 -44.36 80.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.497 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.57 -38.72 81.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.612 ' O ' HG23 ' A' ' 80' ' ' VAL . 77.4 t -60.98 -45.64 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.02 -31.63 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -68.0 -48.47 65.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.336 -0.853 . . . . 0.0 109.795 -178.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.3 pp -80.5 -20.13 44.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.635 -178.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 76' ' ' VAL . 6.0 t -54.35 -45.14 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.908 . . . . 0.0 109.774 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -58.04 -50.54 73.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.498 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -99.67 107.05 19.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 178.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.09 74.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.41 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.41 -23.89 4.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' GLY . 21.2 pt -56.46 -164.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 109.352 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.28 136.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -92.44 96.52 10.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 29.4 m-70 -165.69 87.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.595 ' HG2' HH11 ' A' ' 89' ' ' ARG . 1.4 ptt-85 -47.31 -29.34 2.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.992 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.03 97.89 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' NZ ' ' CD2' ' A' ' 88' ' ' HIS . 62.3 mttp -62.61 -45.07 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.451 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.503 HG21 HG13 ' A' ' 76' ' ' VAL . 98.3 mt -56.8 -42.2 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 76' ' ' VAL . 98.0 mm-40 -60.27 -37.82 81.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.12 78.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mm -62.57 -40.92 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -57.04 -40.67 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.8 -40.68 99.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -57.38 -47.65 81.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.458 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.71 -42.84 85.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -63.88 -43.71 95.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.88 -38.1 58.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -66.63 -48.6 68.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.43 -42.49 87.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.46 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.55 -41.97 87.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.576 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -40.4 96.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.68 -27.07 64.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -51.99 -17.73 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.487 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 78.5 m-20 -74.88 -16.25 60.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.04 19.2 65.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.3 mp0 -115.87 151.93 46.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.188 -1.184 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.06 123.53 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.535 2.156 . . . . 0.0 111.696 179.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -76.18 -43.48 42.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 110.43 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -60.69 -49.85 75.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.095 -1.003 . . . . 0.0 110.704 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 92.1 m-20 -51.56 -36.36 44.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 111.019 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.39 -47.92 21.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 111.207 -177.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -56.34 -46.52 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.017 . . . . 0.0 111.653 -175.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' HG13 ' A' ' 116' ' ' VAL . 16.9 p-90 -88.18 -27.85 21.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.745 -1.222 . . . . 0.0 111.131 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 120' ' ' VAL . 10.2 t -56.08 -29.26 60.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.871 -1.143 . . . . 0.0 109.772 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.25 -13.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' SER . 14.1 m -82.54 24.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.051 -1.03 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.573 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 13.6 t-20 74.17 17.21 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 109.68 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER 66.68 -13.35 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 121' ' ' ASN . 23.2 mt-30 -86.37 150.61 52.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.72 149.59 73.4 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.631 2.221 . . . . 0.0 111.849 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -110.27 145.66 37.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.3 mtt -135.84 152.55 51.18 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.173 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 173' ' ' ASN . 10.6 t -94.73 160.65 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.29 49.63 1.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 109.317 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.99 135.05 42.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.682 -179.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.8 m -76.05 -34.29 59.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.32 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.3 m -127.34 159.22 35.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.7 mt -56.26 -30.89 63.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.7 p -71.81 -29.94 64.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.82 1.12 15.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.11 119.81 67.29 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.766 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.92 130.05 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.144 2.562 . . . . 0.0 112.544 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 t -104.63 12.58 32.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.268 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -139.0 92.41 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 161.64 22.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.9 -39.55 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.829 2.352 . . . . 0.0 111.975 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.59 73.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.2 m -59.95 -45.97 90.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.26 -42.2 99.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.38 -43.2 67.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -60.55 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -53.84 -43.27 69.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -62.45 -33.74 75.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.49 -51.19 38.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -33.16 72.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.589 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -58.36 -39.23 79.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.356 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.99 -40.48 97.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 109.443 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.45 -20.46 66.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.18 32.42 7.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.43 132.11 37.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.94 174.85 6.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 53.24 48.03 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLY . 5.4 m -115.2 26.22 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.07 167.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 159' ' ' THR . 1.0 OUTLIER -61.35 -28.31 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -1.158 . . . . 0.0 109.417 -179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -70.32 -41.26 73.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.425 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.43 -47.82 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.0 p -64.28 -38.81 92.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.263 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.542 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 53.7 t80 -62.26 -46.5 88.54 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -61.6 -37.86 85.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.275 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.499 ' CE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -61.71 -55.07 34.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 179.692 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.455 ' N ' ' CG ' ' A' ' 165' ' ' PHE . 48.0 mtm -63.72 -41.31 98.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.646 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -66.41 -42.92 87.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 -42.32 75.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 109.697 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' ' OE1' ' A' ' 25' ' ' GLU . 3.5 m -60.91 -61.1 2.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.413 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 144.31 1.78 0.89 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 171' ' ' LEU . 4.3 mm? -57.43 -43.12 83.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 109.396 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.75 136.57 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 127' ' ' THR . 86.7 m-20 -87.95 112.58 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.429 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 80.7 m-20 -86.82 110.02 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.532 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 58.8 m-70 -153.8 126.69 8.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.558 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.26 137.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.75 135.68 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.43 5.71 60.22 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 16.4 p -77.15 -150.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.491 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.53 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 71.9 m -57.85 -39.6 78.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 0.9 OUTLIER 173.15 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.979 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' ARG . 14.2 m 55.76 167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.0 109.397 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.93 -29.13 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -72.85 -0.0 12.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' SER . 7.1 p -108.88 134.72 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 167.27 0.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -79.26 -130.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.877 . . . . 0.0 109.484 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 152.08 14.28 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.96 -11.47 32.33 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.863 2.376 . . . . 0.0 112.137 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.4 tt -63.28 -38.72 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -59.82 -47.93 83.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.7 mt -66.64 -41.6 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.359 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -46.84 87.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CD1' HD22 ' A' ' 50' ' ' LEU . 64.9 t80 -66.97 -41.46 86.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -59.97 -42.18 93.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.87 -10.71 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -78.29 -76.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.433 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.44 101.53 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -170.04 126.47 0.83 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.69 -29.15 8.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.5 m -72.17 149.33 91.85 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.23 -1.159 . . . . 0.0 109.32 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.43 119.29 6.3 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.776 2.317 . . . . 0.0 111.89 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -112.67 132.87 54.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.804 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 p -134.87 3.06 3.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.029 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -80.72 122.37 27.04 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.364 -0.835 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 t -58.69 -39.81 81.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.25 -43.22 82.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.723 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.35 -50.77 50.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -67.81 -35.72 79.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.88 -45.59 93.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -74.61 -31.27 61.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.77 -179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.7 ttm -71.67 -54.59 9.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.723 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 36' ' ' CYS . 2.9 tp -59.37 -40.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 0.0 110.035 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.52 ' N ' HG23 ' A' ' 35' ' ' ILE . 76.7 m -72.76 -46.43 53.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.123 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD2' ' NH1' ' A' ' 53' ' ' ARG . 9.6 tp -69.8 -33.71 72.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.01 . . . . 0.0 109.863 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -52.15 -34.94 46.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.803 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.455 ' HA3' ' HZ1' ' A' ' 91' ' ' LYS . . . -52.23 -27.0 22.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.15 -31.94 72.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -1.22 . . . . 0.0 109.777 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.62 -26.34 63.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.965 . . . . 0.0 109.728 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.59 109.08 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.694 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.91 -29.95 4.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.3 mt -100.45 163.73 12.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.429 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -87.39 164.86 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.384 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -59.38 -40.95 88.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 109.505 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 48' ' ' THR . 9.0 tp -54.53 -39.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.653 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 47' ' ' ILE . 88.8 m -61.37 -36.27 79.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -69.75 -40.1 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 16' ' ' TYR . 79.2 mt -57.12 -54.92 41.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -57.62 -47.41 82.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -68.66 -29.86 68.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttm-85 -50.74 -47.11 59.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 108.987 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.35 -43.68 73.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.515 -0.741 . . . . 0.0 109.406 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -67.12 -37.3 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 0.0 109.229 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 7.5 t80 -63.19 -43.89 96.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.374 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.533 ' HG2' HH11 ' A' ' 57' ' ' ARG . 43.7 mtt-85 -58.41 -39.2 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.31 77.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.458 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 85.6 m -92.39 -12.92 30.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 110.244 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 5.9 m-85 -115.97 -49.09 2.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.932 -1.105 . . . . 0.0 110.153 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.4 t60 -49.86 -42.48 47.72 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.066 -1.021 . . . . 0.0 109.877 -178.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -65.15 -30.14 71.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.789 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.434 ' O ' ' O ' ' A' ' 64' ' ' ASP . 50.2 m-85 -88.13 -0.2 56.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.833 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 56.14 165.65 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.049 -1.032 . . . . 0.0 109.596 -179.747 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.649 ' O ' HG22 ' A' ' 68' ' ' VAL . 72.6 Cg_endo -78.72 -54.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.832 2.355 . . . . 0.0 112.709 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 t -47.22 -33.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -68.7 -44.11 74.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.341 -0.849 . . . . 0.0 109.827 -177.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 65' ' ' PRO . 1.4 m -56.99 -39.92 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.616 -178.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -64.18 -39.37 93.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.473 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.93 23.54 7.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 109.373 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.407 ' HG3' ' H ' ' A' ' 72' ' ' GLN . 11.5 ttp -93.53 160.37 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 109.626 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.407 ' H ' ' HG3' ' A' ' 71' ' ' MET . 95.2 mt-30 -101.46 166.5 10.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.3 mt-10 -70.52 -21.93 62.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.13 -31.15 65.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.94 . . . . 0.0 109.468 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.05 -38.23 87.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.424 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 76' ' ' VAL . 10.5 m -73.57 -29.32 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 80' ' ' VAL . 44.5 tp10 -67.11 -36.38 81.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 -178.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 13.3 ptm180 -77.87 -41.9 35.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.897 ' O ' HD12 ' A' ' 79' ' ' LEU . 1.2 pp -81.46 -7.13 59.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.953 . . . . 0.0 109.637 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 81' ' ' GLN . 9.3 p -49.37 -42.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.688 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.537 ' N ' HG13 ' A' ' 80' ' ' VAL . 2.8 pp0? -90.42 20.91 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.006 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.1 t0 -74.94 121.39 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.378 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.54 0.34 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 65.65 43.3 94.6 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -58.55 -165.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 86' ' ' ILE . 18.9 tt -56.02 127.89 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 87' ' ' ARG . 9.4 ptm180 -73.24 95.41 2.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -171.83 69.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -45.02 -36.15 3.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.904 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.03 98.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 33.8 tptt -62.43 -43.23 99.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.478 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 92' ' ' ILE . 18.2 mt -54.64 -50.56 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.62 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.89 -30.61 69.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.985 . . . . 0.0 109.384 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -58.78 -44.47 90.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.9 mp -56.28 -39.8 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 68' ' ' VAL . 87.9 mt -62.81 -29.23 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.77 -45.13 77.4 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -64.86 -38.02 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -1.185 . . . . 0.0 109.428 -178.548 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.59 80.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -59.53 -43.87 93.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.36 -30.41 66.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.93 -47.25 87.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.28 -44.77 86.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.94 -44.68 94.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.482 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.61 -41.61 79.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -71.45 -27.4 63.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.485 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -52.56 -23.26 6.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.425 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -75.35 -13.11 60.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.84 48.8 6.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -135.34 150.93 73.9 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.187 -1.184 . . . . 0.0 109.653 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.23 119.14 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.571 2.181 . . . . 0.0 111.677 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -75.28 -40.76 58.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.439 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 -48.17 69.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 110.725 -178.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 118' ' ' SER . 44.3 t0 -55.1 -55.28 32.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 111.096 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -55.66 -38.59 69.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 111.249 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.97 -59.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 0.0 111.646 -178.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.43 ' O ' HG22 ' A' ' 120' ' ' VAL . 61.1 p-90 -87.79 -28.1 21.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.663 -1.273 . . . . 0.0 111.125 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 120' ' ' VAL . 94.1 p -56.34 -26.03 51.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.816 -1.178 . . . . 0.0 109.769 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.47 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.056 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 118' ' ' SER . 10.7 m -89.56 25.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 23.8 t30 80.01 22.06 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.696 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 59.46 49.75 8.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.499 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.476 ' H ' HG23 ' A' ' 120' ' ' VAL . 2.6 pt20 -154.61 146.46 17.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.37 143.36 43.1 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.642 2.228 . . . . 0.0 111.778 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -100.25 151.35 21.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 109.746 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -136.03 156.89 48.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.176 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.4 t -129.82 164.12 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -133.16 50.88 2.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -94.23 142.2 27.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.704 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 m -92.43 -27.69 17.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 109.361 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -126.15 156.73 39.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -57.88 -34.76 70.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 m -62.35 -36.67 82.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.68 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.8 mt-10 -63.67 -28.84 70.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.1 mt -67.08 116.55 37.06 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.11 130.19 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.11 2.54 . . . . 0.0 112.503 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.75 -8.15 58.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.5 p -101.05 101.84 12.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.378 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.82 151.78 52.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.31 -33.84 97.81 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.75 2.3 . . . . 0.0 112.009 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.89 -35.2 57.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.359 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.9 p -62.8 -34.62 77.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.92 -51.01 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.43 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.429 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.617 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -55.68 -50.14 71.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.6 t -63.81 -42.49 97.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -60.7 -36.98 80.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.03 -51.63 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -32.94 74.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.536 ' HZ2' ' CG1' ' A' ' 157' ' ' VAL . 14.9 mmtm -59.84 -38.37 81.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.397 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -61.72 -36.93 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -69.04 -19.81 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.24 27.16 9.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -1.121 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -112.43 169.37 8.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 51.6 50.78 18.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.0 p -120.14 27.05 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.414 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.95 159.46 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 33.5 m -53.2 -29.63 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -1.195 . . . . 0.0 109.492 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.2 p -62.42 -42.26 99.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.5 mp -63.95 -47.61 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.84 -42.61 99.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.306 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.15 -45.13 91.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.461 -0.774 . . . . 0.0 109.357 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.5 m -62.72 -40.25 96.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.306 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -35.13 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -65.39 -52.47 53.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -38.22 84.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.31 -0.869 . . . . 0.0 109.681 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.96 85.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.694 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.522 ' O ' ' O ' ' A' ' 23' ' ' VAL . 64.5 m -81.45 -62.44 1.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.373 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.52 2.74 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.88 -47.51 43.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.26 136.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.404 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.464 ' O ' HG22 ' A' ' 127' ' ' THR . 2.7 m120 -100.76 108.14 19.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 38.5 p30 -116.95 92.22 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -108.72 9.37 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 179' ' ' CYS . 4.2 t 56.59 101.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.3 p -54.99 -34.84 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.38 -44.1 97.34 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 181' ' ' CYS . 12.4 t -105.37 -178.85 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.55 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 12.1 t 55.09 5.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.875 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 8.7 p 42.22 25.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 180' ' ' CYS . 1.4 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 109.572 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 3' ' ' ARG . 4.4 ptm180 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.287 0.565 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.8 m -47.93 112.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -71.39 -29.34 68.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -53.41 -7.97 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.466 -179.647 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.489 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 12.7 p -56.66 134.43 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 t -65.66 140.84 58.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -64.83 -31.45 72.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.38 143.82 6.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -32.3 9.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.829 2.353 . . . . 0.0 112.14 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.01 -41.95 99.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.23 -45.62 76.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.413 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.69 -43.97 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.92 97.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.447 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 74.0 t80 -62.41 -41.64 98.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.8 t-80 -61.92 -45.32 94.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -79.95 -47.43 15.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -56.55 -42.73 79.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.527 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' HIS . 77.4 mm-40 -138.62 -150.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.463 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 20' ' ' GLU . 11.0 t90 59.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.32 72.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.89 115.39 64.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.215 -1.168 . . . . 0.0 109.423 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.99 121.69 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.758 2.305 . . . . 0.0 111.851 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -117.95 136.17 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.854 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 p -121.26 6.47 10.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.9 . . . . 0.0 109.042 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.287 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.719 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 15.1 m -74.61 -32.61 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -59.11 -52.4 65.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 109.753 -178.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -64.17 -43.42 95.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.872 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 113' ' ' ALA . 9.1 mp -74.32 -31.88 62.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.816 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 28' ' ' SER . 47.7 t80 -62.81 -47.78 81.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.95 . . . . 0.0 109.854 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.1 pp20? -75.2 -30.19 60.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 8.1 tpt -66.78 -53.12 36.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -63.06 -33.21 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 83.5 m -71.2 -49.49 42.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.31 -35.93 66.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 32.3 mm-40 -53.93 -33.05 55.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.786 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.81 97.7 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 36' ' ' CYS . 2.8 mp0 -70.0 -24.79 63.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.807 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -45.28 -27.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -178.894 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.77 123.86 7.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.31 -29.77 4.68 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.34 -166.46 1.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -123.83 152.25 42.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -53.78 -39.88 65.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.671 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -63.58 -39.4 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.684 -179.182 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.511 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 88.2 m -66.46 -36.74 83.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.719 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.13 -44.85 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.395 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.5 mt -60.61 -46.62 89.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.62 -50.72 71.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.306 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -68.1 -32.65 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.337 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' NH1' ' CE1' ' A' ' 16' ' ' TYR . 43.3 ttm180 -50.42 -44.32 55.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 108.94 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.29 -43.63 63.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 109.394 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -64.69 -40.71 95.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -55.85 -47.15 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.366 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 4.0 mmp_? -59.78 -34.7 73.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.416 -0.802 . . . . 0.0 109.82 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.94 -35.66 73.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.1 -36.16 12.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.005 . . . . 0.0 110.266 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 -48.03 9.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.926 -1.109 . . . . 0.0 110.2 -178.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 56.9 t60 -50.23 -39.12 43.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.0 . . . . 0.0 109.848 -178.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -56.53 -35.09 67.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' ASP . 62.8 m-85 -95.78 1.89 53.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.913 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.12 162.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 0.0 109.632 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.06 -27.6 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.88 2.386 . . . . 0.0 112.64 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -49.25 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' MET . 7.2 mtpm? -67.29 -33.11 74.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 64' ' ' ASP . 57.5 t -55.78 -41.81 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -71.02 -34.64 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.61 17.62 20.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 16.2 ttp -77.79 157.75 29.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.654 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.72 159.96 15.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 48.0 mp0 -60.36 -25.87 66.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.493 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.53 -43.2 93.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 15.9 t70 -61.01 -38.69 86.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.36 -42.99 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.47 -38.35 80.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -63.29 -41.96 99.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.806 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 82' ' ' ASP . 96.4 mt -67.35 -34.34 77.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.69 -33.12 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -86.94 -57.24 3.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 84.1 m-20 -80.04 170.62 16.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.14 87.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -61.42 8.64 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.6 ' H ' ' C ' ' A' ' 83' ' ' ALA . 14.0 pt -57.57 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -1.184 . . . . 0.0 109.362 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 76.0 mt -68.02 133.58 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 109.457 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.556 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 38.6 ttm180 -97.79 108.9 21.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.8 m-70 -164.55 85.37 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' A' ' 89' ' ' ARG . 19.5 ttt-85 -48.71 -30.51 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.783 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.69 -47.37 68.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.95 -45.09 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -1.212 . . . . 0.0 109.526 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.7 mt -55.88 -44.79 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -58.29 -37.77 75.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.398 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.92 84.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -44.77 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.8 mt -56.81 -42.34 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.525 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.45 -37.43 94.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.476 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 2.9 m120 -61.4 -43.07 99.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.84 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.418 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 47.9 ttm-85 -63.9 -46.64 83.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.22 77.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.555 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 24.9 t80 -62.95 -41.71 99.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.24 -39.63 87.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.75 -41.3 86.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 51.9 mmm -63.69 -39.56 94.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.11 -27.05 64.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 107' ' ' GLN . 1.1 tm0? -51.42 -35.31 38.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -83.46 -3.51 57.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.08 74.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.5 146.88 40.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.144 -1.21 . . . . 0.0 109.644 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.72 124.81 11.47 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.63 2.22 . . . . 0.0 111.713 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -78.33 -45.31 22.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.456 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -55.44 -44.4 76.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.74 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.505 ' O ' ' OG ' ' A' ' 118' ' ' SER . 91.2 m-20 -57.65 -45.55 85.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 111.055 -178.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -60.16 -49.33 78.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.014 -1.053 . . . . 0.0 111.23 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 116' ' ' VAL . 7.0 m -60.37 -46.65 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 111.731 -176.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.492 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 3.3 p-90 -88.7 -37.26 15.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.733 -1.23 . . . . 0.0 111.1 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 120' ' ' VAL . 41.4 m -56.96 -25.29 57.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.807 -1.183 . . . . 0.0 109.698 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.18 -14.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.022 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.8 m -85.04 23.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m120 58.27 40.27 24.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.752 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.24 14.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -114.65 120.52 37.5 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.59 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.22 153.32 31.6 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.648 2.232 . . . . 0.0 111.86 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -102.53 149.89 23.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.8 mtt -136.61 156.6 48.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.6 t -117.12 159.57 22.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.885 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.46 53.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.78 -143.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 m -141.76 -30.2 0.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.922 . . . . 0.0 109.353 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -123.48 156.31 35.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.16 -32.57 74.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.1 p -66.66 -33.18 75.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.41 -25.12 67.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 32.3 mm -66.51 116.99 39.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.728 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.25 133.54 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.068 2.512 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.59 -9.68 53.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.9 p -96.95 102.21 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.384 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -117.67 152.91 50.37 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.387 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.01 -41.82 25.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.741 2.294 . . . . 0.0 112.041 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.65 61.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.06 -43.3 92.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.61 -38.8 80.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.1 tt -61.63 -45.63 93.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.202 -0.936 . . . . 0.0 109.498 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.3 t -58.14 -41.75 84.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -61.79 -39.15 90.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.549 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -48.31 71.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.0 mt -59.68 -35.22 74.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.07 -41.1 82.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.396 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -64.38 -37.81 88.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.593 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 24.4 mmt180 -65.23 -20.62 66.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.346 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.76 29.2 10.97 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 4.0 m-85 -92.16 130.59 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HG2' ' H ' ' A' ' 156' ' ' PHE . 72.9 tttt -93.43 170.33 9.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.452 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 55.2 m-85 57.64 50.86 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.09 28.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.13 159.77 0.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.4 m -52.43 -32.41 39.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -1.172 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.5 m -66.37 -36.54 83.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.36 -44.14 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.513 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 85.7 m -61.04 -41.64 96.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.618 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 42.9 t80 -60.12 -50.59 73.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.306 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.8 m -60.99 -39.25 88.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -64.36 -44.83 90.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.469 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.504 ' SD ' HD22 ' A' ' 171' ' ' LEU . 40.1 mmm -64.69 -41.83 95.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.632 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CE2' ' A' ' 163' ' ' TYR . 42.0 mt-30 -63.47 -43.67 96.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 -179.424 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.46 -45.0 92.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.674 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.7 t -61.65 -23.24 65.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.26 7.88 58.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.504 HD22 ' SD ' ' A' ' 166' ' ' MET . 5.1 mp -63.24 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.411 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.21 130.79 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.431 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.41 ' O ' HG22 ' A' ' 127' ' ' THR . 87.3 m-20 -94.03 108.54 20.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -88.28 112.06 22.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -138.18 134.93 35.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.88 136.91 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.15 134.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.21 -0.85 72.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 181' ' ' CYS . 65.9 m -151.74 -178.14 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.565 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.5 t 54.3 6.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 179' ' ' CYS . 2.2 m 69.52 37.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.609 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 16.2 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.58 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.374 0.606 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 p -47.63 163.5 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.619 ' H ' HD11 ' A' ' 132' ' ' LEU . . . -80.43 -7.24 88.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -55.59 -29.13 58.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -1.12 . . . . 0.0 109.392 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 8' ' ' SER . 6.3 p -98.66 126.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER 166.28 72.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.521 ' OE1' HD13 ' A' ' 47' ' ' ILE . 36.7 tt0 -156.36 -128.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -84.61 152.19 59.81 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.9 -26.72 3.54 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.8 2.333 . . . . 0.0 112.132 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.1 tp -63.18 -44.74 94.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.78 -46.76 71.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.7 -43.96 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.39 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.11 99.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -63.13 -37.46 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLU . 83.7 t60 -58.0 -51.24 70.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.71 -37.93 85.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.527 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 19' ' ' ASN . 2.6 m120 -60.22 -51.86 67.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.469 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.1 mm-40 -142.96 -132.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.478 ' CH2' ' OD2' ' A' ' 174' ' ' ASP . 27.8 t90 58.92 116.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.17 5.59 67.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -120.04 96.01 49.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.293 -1.122 . . . . 0.0 109.412 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.71 120.02 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.738 2.292 . . . . 0.0 111.853 -179.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -95.58 134.53 38.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.863 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.4 p -112.7 0.16 15.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.83 121.0 24.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.0 m -61.57 -38.64 88.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.907 . . . . 0.0 109.627 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -59.93 -55.38 34.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -69.39 -43.51 73.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.935 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' SG ' ' A' ' 169' ' ' CYS . 6.9 tp -62.95 -39.28 94.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.842 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.412 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 62.2 t80 -63.0 -34.92 78.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.911 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -74.17 -30.22 62.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.955 . . . . 0.0 109.874 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.552 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 55.0 ttm -64.94 -53.99 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.965 . . . . 0.0 109.785 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 36' ' ' CYS . 3.3 tp -65.19 -39.29 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.032 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 35' ' ' ILE . 5.7 t -72.89 -40.89 65.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.67 -40.07 94.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 109.822 -178.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.44 ' OE2' ' N ' ' A' ' 165' ' ' PHE . 82.5 mt-10 -54.21 -28.7 42.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.772 -179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.15 -39.1 19.43 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -67.79 -30.87 70.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -1.211 . . . . 0.0 109.711 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.9 tt0 -52.64 -35.94 55.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 109.721 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.54 116.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -31.4 6.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.81 -145.0 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -1.189 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 t -148.23 155.41 41.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -50.4 -41.91 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.908 . . . . 0.0 109.514 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.571 HG23 ' N ' ' A' ' 48' ' ' THR . 9.6 tp -52.1 -43.06 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.645 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.571 ' N ' HG23 ' A' ' 47' ' ' ILE . 63.1 m -71.64 -33.78 69.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.4 t -58.8 -39.37 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.47 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -53.92 -54.37 39.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.511 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.64 -40.14 82.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -77.28 -19.26 56.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.624 ' NH1' ' NH2' ' A' ' 57' ' ' ARG . 1.2 ttt-85 -60.97 -46.96 88.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.171 -0.956 . . . . 0.0 109.013 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -74.02 -41.33 62.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.363 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -67.44 -45.03 77.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.25 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 42.6 t80 -62.87 -38.13 89.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.42 -0.8 . . . . 0.0 109.284 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.624 ' NH2' ' NH1' ' A' ' 53' ' ' ARG . 48.6 ttm-85 -57.27 -38.49 73.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.31 -22.47 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.26 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.507 ' SG ' ' CB ' ' A' ' 83' ' ' ALA . 63.9 m -92.45 -13.55 29.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.222 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 55.8 m-85 -127.21 -53.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.935 -1.103 . . . . 0.0 110.173 -178.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -57.71 -42.46 83.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -178.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -53.8 -35.14 61.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' ASP . 92.7 m-85 -91.43 8.98 33.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.0 109.908 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER 56.42 156.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 -179.45 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.4 -28.15 39.41 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.853 2.369 . . . . 0.0 112.68 -178.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.35 -49.19 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -67.98 -31.46 71.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 64' ' ' ASP . 73.7 t -56.61 -41.12 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.586 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.27 64.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.62 14.63 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.426 ' O ' ' OE1' ' A' ' 72' ' ' GLN . 7.7 mmm -54.83 -176.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.668 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 71' ' ' MET . 15.8 mm100 -136.74 159.15 42.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.2 mt-10 -61.39 -34.97 76.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -72.1 -28.37 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.44 -47.96 65.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 -179.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 92' ' ' ILE . 6.9 m -60.35 -38.08 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.32 -36.99 81.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -65.38 -39.66 92.53 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 109.769 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.35 -31.84 72.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.603 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.5 t -56.25 -34.9 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.71 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -96.38 -33.94 11.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.602 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 93.1 m-20 -86.75 138.49 31.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.368 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.03 -21.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 47.07 27.49 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 86' ' ' ILE . 6.2 pt -56.35 83.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.334 179.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 85' ' ' ILE . 85.1 mt 57.04 145.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.489 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.621 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.1 OUTLIER -101.64 111.64 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.53 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.58 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.165 179.753 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 89' ' ' ARG . 35.0 ttt-85 -46.87 -36.81 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.39 95.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -67.3 -44.49 79.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.5 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.481 HG22 HG12 ' A' ' 76' ' ' VAL . 37.1 mt -58.52 -49.44 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.551 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -53.57 -34.82 59.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.419 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.548 HG21 ' CE2' ' A' ' 60' ' ' PHE . 30.4 mm -60.39 -45.37 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mm -55.55 -51.99 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.84 72.67 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.655 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.35 -37.34 77.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -1.188 . . . . 0.0 109.378 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.655 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -71.08 -35.68 71.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.65 -42.49 92.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -71.2 -32.11 68.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.412 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 32.4 t80 -66.24 -44.03 84.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.86 -40.25 96.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -60.5 -37.84 82.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.519 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.55 -34.25 77.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -68.76 -27.52 65.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -52.17 -27.84 15.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.16 -15.15 60.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.2 17.25 78.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -96.63 149.7 36.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.247 -1.149 . . . . 0.0 109.634 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.14 119.16 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.623 2.216 . . . . 0.0 111.69 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -71.29 -39.94 71.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.822 . . . . 0.0 110.446 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.72 -50.31 72.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.976 . . . . 0.0 110.771 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.509 ' O ' ' OG ' ' A' ' 118' ' ' SER . 29.1 t0 -55.57 -54.13 47.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -0.918 . . . . 0.0 111.081 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -53.85 -43.06 69.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 111.217 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.57 -60.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.097 . . . . 0.0 111.638 -177.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.683 ' CB ' HD21 ' A' ' 171' ' ' LEU . 67.1 p-90 -88.24 -19.28 27.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.787 -1.196 . . . . 0.0 111.141 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 120' ' ' VAL . 34.0 m -56.09 -30.09 61.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.763 -1.21 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.43 -11.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 110.049 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 117' ' ' TRP . 15.2 m -86.02 24.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 109.991 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 17.3 t30 77.1 20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 62.38 29.64 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.903 . . . . 0.0 109.568 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.462 ' H ' HG23 ' A' ' 120' ' ' VAL . 12.4 pt20 -148.01 143.38 17.58 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.593 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.03 142.24 61.03 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.585 2.19 . . . . 0.0 111.833 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.93 155.66 22.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.0 ptp -135.28 156.49 48.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.155 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.0 t -118.36 155.67 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 109.872 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -115.95 45.04 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.304 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.15 135.12 47.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.872 . . . . 0.0 109.653 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.72 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 9.1 m -88.29 -32.98 18.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.432 HG22 ' OE1' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -133.57 166.31 22.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.619 HD11 ' H ' ' A' ' 5' ' ' GLY . 24.7 mt -74.27 -8.73 57.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.567 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -87.81 -31.98 19.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.527 -177.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.72 ' CD ' ' H ' ' A' ' 130' ' ' THR . 8.5 pt-20 -86.93 9.96 17.75 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -178.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.16 119.85 62.33 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.756 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.04 120.95 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.179 2.586 . . . . 0.0 112.482 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 t -97.29 21.65 9.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.318 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.6 p -129.61 66.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.375 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -87.62 153.39 52.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.463 179.642 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.85 -30.74 92.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.754 2.303 . . . . 0.0 112.04 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.26 -38.11 51.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.37 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -62.42 -48.6 78.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -64.96 -41.1 95.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.57 86.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.2 tp -59.14 -48.63 80.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.511 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -54.67 -45.61 73.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -60.3 -35.04 74.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.88 -50.55 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.451 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.92 -38.63 91.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.81 -26.5 68.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.78 -40.03 86.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -74.07 -20.17 60.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.22 29.46 7.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.441 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 1.4 m-85 -78.34 137.54 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.519 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -102.1 175.36 5.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 53.4 47.3 24.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.7 p -122.66 26.54 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.1 167.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.4 m -58.19 -30.41 66.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 0.0 109.435 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 62.9 p -62.26 -42.07 99.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.5 mp -65.64 -46.81 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.53 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 12.3 p -63.01 -39.61 95.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.282 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 34.1 t80 -62.67 -47.83 81.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.5 p -59.5 -41.85 90.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.286 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 1.1 t80 -61.83 -27.04 68.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 178.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -53.56 27.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.682 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -67.89 -36.28 79.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.686 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.649 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 41.7 m -78.59 -64.34 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.37 9.12 2.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.683 HD21 ' CB ' ' A' ' 117' ' ' TRP . 9.4 mp -50.96 -52.62 40.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -1.134 . . . . 0.0 109.414 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.3 m -98.2 134.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 175' ' ' HIS . 11.5 t-20 -81.15 105.13 12.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.478 ' OD2' ' CH2' ' A' ' 21' ' ' TRP . 11.7 p30 -91.62 107.33 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 109.484 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.726 ' N ' ' ND1' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -156.69 171.03 21.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.527 179.653 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.07 164.7 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 182' ' ' TYR . 14.7 t -80.29 140.05 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.467 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.7 -17.46 58.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 15.4 t -91.27 165.95 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -1.119 . . . . 0.0 109.466 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.0 p -76.06 92.63 3.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 180' ' ' CYS . 0.1 OUTLIER 160.6 -39.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' A' ' 177' ' ' VAL . 28.9 t80 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' SG ' ' A' ' 180' ' ' CYS . 1.8 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -129.34 144.93 51.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -144.93 140.07 28.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.7 m 46.96 -162.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.65 -27.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -73.72 -16.69 61.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 0.0 109.447 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 7' ' ' VAL . 34.9 m -67.02 130.17 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLN . 33.4 t -162.68 137.19 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.51 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' SER . 93.2 mt-30 50.53 179.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.535 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' LEU . 5.1 m-20 48.31 77.12 0.48 Allowed Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.251 -0.905 . . . . 0.0 109.409 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -47.69 -10.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.886 2.391 . . . . 0.0 112.073 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.5 mt -62.78 -33.81 75.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 47' ' ' ILE . 54.0 m-85 -63.03 -58.13 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.67 -47.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.66 69.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -72.26 -43.51 64.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.489 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 60.5 t-80 -60.85 -43.53 98.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.62 -41.25 79.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.54 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -60.24 -48.11 83.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' HIS . 80.0 mm-40 -141.97 -131.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.489 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 5.7 t90 56.56 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.16 0.63 65.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 169' ' ' CYS . 10.0 t -118.08 96.61 49.91 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.217 -1.167 . . . . 0.0 109.416 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.25 122.59 5.65 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.778 2.318 . . . . 0.0 111.871 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 27.6 tp10 -110.67 139.31 46.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.885 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.4 p -115.56 3.96 14.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 93.6 m-20 -77.77 123.54 26.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.33 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 t -64.48 -37.81 88.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.6 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 9.5 mtmp? -62.88 -55.06 29.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -65.87 -43.91 86.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.803 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.6 -34.79 76.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.103 -0.998 . . . . 0.0 109.924 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.51 -39.45 83.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.885 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 3.6 mp0 -73.77 -31.05 63.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.885 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.565 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 55.9 ttm -59.06 -54.05 51.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.798 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.55 -33.16 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.983 . . . . 0.0 110.034 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 t -71.81 -45.88 60.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.4 mt -64.23 -44.26 92.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.875 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 41' ' ' GLN . 97.2 mt-10 -63.1 -33.28 75.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 109.829 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.27 -36.38 7.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 19.3 mp0 -75.47 -14.7 60.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -1.221 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLU . 4.0 pp0? -55.27 -23.77 24.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.62 108.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.92 -34.09 3.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.2 mm? -86.14 178.06 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -1.186 . . . . 0.0 109.489 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.6 m -108.69 149.93 28.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.348 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 p90 -53.79 -36.28 62.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.68 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -62.54 -40.51 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 93.4 m -64.31 -37.25 86.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.9 t -60.09 -39.42 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.44 -46.8 83.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -62.03 -50.99 69.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 109.349 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -66.96 -28.74 68.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' VAL . 64.6 ttt180 -53.37 -44.55 68.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.156 -0.965 . . . . 0.0 108.973 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.66 -43.58 79.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -66.15 -37.53 85.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 14.3 t80 -59.65 -49.06 79.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 21.9 mmm180 -61.24 -29.55 69.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.398 -0.814 . . . . 0.0 109.735 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.64 98.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.875 . . . . 0.0 110.241 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.0 m -93.9 -41.91 9.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 110.232 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 32.4 m-85 -70.73 -52.09 23.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.218 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 49.7 t60 -51.55 -38.07 52.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.055 -1.028 . . . . 0.0 109.865 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.03 -37.13 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.769 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 64' ' ' ASP . 70.2 m-85 -88.06 -9.0 54.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.007 . . . . 0.0 109.856 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 63' ' ' PHE . 7.2 t70 61.75 129.83 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.74 -31.76 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.841 2.36 . . . . 0.0 112.69 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.62 -50.66 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.632 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 71' ' ' MET . 40.7 mtpt -66.82 -34.5 77.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 109.797 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 96' ' ' ILE . 89.0 t -58.16 -28.9 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' CB ' HD12 ' A' ' 103' ' ' LEU . . . -87.6 -18.39 29.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.57 25.98 5.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.1 ptp -75.22 -160.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -129.58 160.56 32.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 49.2 mp0 -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -70.73 -24.34 62.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.443 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -67.0 -47.65 70.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 0.0 109.386 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 HG22 ' A' ' 92' ' ' ILE . 6.7 m -64.91 -38.1 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.57 -32.61 73.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.616 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -67.93 -41.99 81.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.775 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.93 -30.68 70.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.4 t -49.55 -33.8 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.952 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -91.36 -63.45 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -101.55 115.75 31.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.49 -46.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.64 15.07 64.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 pt -123.58 167.39 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -1.131 . . . . 0.0 109.304 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.9 mt -49.07 128.64 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 87' ' ' ARG . 14.0 ptm180 -108.29 128.08 54.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.693 ' O ' ' N ' ' A' ' 90' ' ' GLY . 58.4 t-80 -158.21 1.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.147 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 59.48 -60.65 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -59.07 -46.73 93.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.49 -42.54 96.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -1.151 . . . . 0.0 109.499 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.495 HG22 HG12 ' A' ' 76' ' ' VAL . 38.6 mt -63.37 -49.41 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.624 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -54.47 -33.14 59.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.401 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.368 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.408 HD13 ' HE2' ' A' ' 56' ' ' TYR . 94.8 mt -58.41 -41.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.495 HD12 ' SD ' ' A' ' 71' ' ' MET . 16.9 mm -55.49 -47.28 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.82 93.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.27 -45.22 91.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.137 . . . . 0.0 109.386 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -70.04 -47.63 61.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.23 -29.72 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -68.06 -46.17 71.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.439 HD12 ' CB ' ' A' ' 69' ' ' ALA . 96.9 mt -67.73 -38.95 84.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.62 -44.98 85.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.85 -41.19 71.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -71.7 -27.01 62.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -51.25 -32.1 23.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.31 1.81 39.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.9 9.38 86.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -79.04 129.23 73.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.11 -1.229 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.51 122.16 8.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.673 2.249 . . . . 0.0 111.692 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -76.44 -44.89 33.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.472 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.43 -49.69 76.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.792 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 85.4 m-20 -54.64 -35.1 63.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.949 . . . . 0.0 111.005 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 75.7 t80 -73.54 -48.42 33.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.032 -1.042 . . . . 0.0 111.219 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 117' ' ' TRP . 3.1 m -55.95 -50.34 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.052 -1.03 . . . . 0.0 111.655 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.583 ' O ' HG22 ' A' ' 120' ' ' VAL . 25.2 p-90 -86.66 -22.42 26.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.84 -1.162 . . . . 0.0 111.087 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 120' ' ' VAL . 8.0 t -59.48 -27.95 66.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.821 -1.175 . . . . 0.0 109.658 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.12 -15.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.075 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 117' ' ' TRP . 14.8 m -83.22 22.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 109.979 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.612 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 29.4 t30 61.05 48.27 6.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.046 . . . . 0.0 109.765 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 32.4 p80 41.91 32.99 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 8.6 tt0 -142.84 90.86 7.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -47.16 155.19 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.724 2.282 . . . . 0.0 111.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 16.7 mp0 -105.66 158.92 16.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 109.688 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.9 mtt -135.98 156.9 48.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.134 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.6 t -122.57 160.38 25.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.482 ' N ' ' OE1' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -141.28 43.72 1.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -86.73 169.72 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 m -87.69 -33.24 18.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.68 169.43 17.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.2 mt -67.85 -27.69 66.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.577 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.7 t -59.08 -41.22 87.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.579 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 69.3 mm-40 -64.19 -29.86 70.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 109.395 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.37 131.76 93.25 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.409 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 98.4 Cg_endo -80.03 141.45 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.141 2.561 . . . . 0.0 112.571 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 6.26 42.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 109.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.1 t -136.37 92.69 2.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.887 . . . . 0.0 109.35 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.1 p -98.06 154.53 37.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.74 -40.18 24.25 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.797 2.331 . . . . 0.0 112.061 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.86 70.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.0 m -62.39 -45.58 92.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.05 -43.77 86.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.59 73.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 109.513 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.729 ' C ' HD23 ' A' ' 145' ' ' LEU . 8.2 tt -66.88 -46.73 74.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 87.7 p -58.9 -39.03 80.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.962 . . . . 0.0 109.548 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -63.59 -34.68 78.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.4 -50.28 60.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.22 -32.49 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -57.92 -38.11 75.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.33 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.644 ' NZ ' HH12 ' A' ' 152' ' ' ARG . 7.0 ttpm? -61.55 -38.94 89.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 109.452 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.644 HH12 ' NZ ' ' A' ' 151' ' ' LYS . 12.7 mpt_? -63.55 -20.22 65.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.28 24.65 10.09 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -89.84 131.92 35.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -1.121 . . . . 0.0 109.458 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.34 177.69 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.407 ' O ' HD13 ' A' ' 161' ' ' ILE . 93.6 m-85 54.07 57.19 6.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.9 m -121.78 25.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.412 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.49 166.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 159' ' ' THR . 1.1 p -66.36 -24.53 66.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.397 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 161' ' ' ILE . 15.0 t -72.04 -42.66 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 160' ' ' THR . 81.5 mt -65.65 -41.45 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.552 ' SG ' HD22 ' A' ' 145' ' ' LEU . 50.1 t -63.22 -40.43 97.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CE1' ' O ' ' A' ' 136' ' ' PRO . 68.0 t80 -60.75 -46.85 88.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.395 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -57.36 -45.55 84.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.888 . . . . 0.0 109.354 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -62.66 -34.45 77.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 178.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 30.7 ttm -63.28 -45.0 93.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.645 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.419 ' NE2' HG21 ' A' ' 172' ' ' VAL . 63.4 mm-40 -70.08 -37.17 75.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.668 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.565 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -64.76 -46.98 79.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 14.4 m -64.66 -61.14 2.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.0 7.54 3.25 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.571 HD21 ' CB ' ' A' ' 117' ' ' TRP . 9.5 mp -50.07 -43.55 51.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 109.38 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.419 HG21 ' NE2' ' A' ' 167' ' ' GLN . 30.8 m -100.61 134.54 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.487 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.406 ' O ' HG22 ' A' ' 127' ' ' THR . 87.5 m-20 -87.19 103.41 15.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -91.92 121.99 34.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.593 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -160.9 100.28 1.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.96 148.17 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.68 129.9 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.23 7.98 63.35 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 52.3 t -79.65 94.2 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.507 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.512 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 3.2 t 65.63 -57.18 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 37.6 t -173.07 60.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 21.8 t80 -83.27 118.41 71.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.528 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 88.0 Cg_endo -85.72 176.26 5.54 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.017 2.478 . . . . 0.0 112.331 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.71 -10.92 64.68 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -90.12 18.38 5.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -1.122 . . . . 0.0 109.668 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -83.42 151.32 62.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.306 -1.673 0 C-N-CA 123.086 2.524 . . . . 0.0 112.216 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.295 0.569 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -141.29 157.52 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.614 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -137.18 140.0 41.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 6' ' ' TRP . 14.1 m -150.91 26.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.407 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.98 -44.19 0.16 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . 94.1 m95 -54.63 -35.06 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.463 HG23 ' NE ' ' A' ' 3' ' ' ARG . 5.9 m -73.49 63.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -149.94 48.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -152.96 -125.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.1 150.17 98.07 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.859 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.63 -19.84 41.46 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.899 2.4 . . . . 0.0 112.095 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.29 -41.36 98.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.392 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -65.24 -49.6 69.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.443 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.0 -45.12 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.84 88.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -57.57 -42.39 83.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.503 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.536 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 48.7 t-80 -62.32 -41.76 98.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.8 -40.03 94.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -58.77 -53.04 62.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 21' ' ' TRP . 76.3 mm-40 -142.48 -131.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.536 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 24.2 t90 58.76 138.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.535 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.28 -29.0 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 23' ' ' VAL . 11.0 p -75.49 131.59 77.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.11 120.51 6.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.817 2.345 . . . . 0.0 111.885 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -111.5 137.19 49.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.845 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -132.61 4.87 3.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 28' ' ' SER . 63.3 t0 -94.22 142.96 26.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.284 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 60.3 p -64.33 -34.63 78.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.4 -47.64 75.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.91 -48.89 27.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -66.61 -35.37 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.845 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 28' ' ' SER . 48.9 t80 -60.63 -46.97 88.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.864 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.14 -30.11 62.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.83 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -58.47 -53.28 60.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.793 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.583 HD12 ' OE1' ' A' ' 38' ' ' GLU . 4.1 tp -69.77 -31.62 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 110.017 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 69.2 m -73.31 -46.58 48.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.902 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 35' ' ' ILE . 16.5 pt-20 -49.8 -43.5 48.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.778 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . 77.2 171.31 35.19 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.702 ' C ' ' H ' ' A' ' 42' ' ' ALA . 4.5 tt0 -66.35 -43.77 85.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.247 . . . . 0.0 109.737 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 58.34 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 109.704 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -70.84 117.88 12.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 109.621 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.11 -15.25 63.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.0 mp -116.87 -135.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -1.176 . . . . 0.0 109.461 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -153.27 154.8 35.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.434 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.519 ' NE1' HD21 ' A' ' 50' ' ' LEU . 74.4 t-105 -52.31 -35.64 51.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 48' ' ' THR . 10.4 tp -52.91 -40.99 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 47' ' ' ILE . 73.5 m -66.83 -35.65 80.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 0.0 109.701 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.9 t -60.97 -39.91 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.414 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.519 HD21 ' NE1' ' A' ' 46' ' ' TRP . 60.8 mt -59.95 -47.48 85.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.61 ' NZ ' ' NZ ' ' A' ' 52' ' ' LYS . 9.8 mtmp? -64.63 -53.06 53.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.262 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.61 ' NZ ' ' NZ ' ' A' ' 51' ' ' LYS . 13.0 mptt -64.51 -34.36 78.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' VAL . 7.9 tmm_? -50.45 -45.94 56.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.2 -0.938 . . . . 0.0 108.95 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG3' HH21 ' A' ' 57' ' ' ARG . 85.3 tt0 -63.38 -42.24 98.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -66.51 -36.33 82.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.223 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -61.95 -45.66 92.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.3 mtm180 -57.15 -42.1 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.828 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.6 66.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 m -92.34 -12.61 31.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 0.0 110.363 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.84 -43.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.906 -1.121 . . . . 0.0 110.239 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -51.41 -43.76 62.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.113 -0.992 . . . . 0.0 109.885 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -67.11 -39.98 86.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 93.5 m-85 -71.58 -24.17 61.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.854 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.4 t70 69.62 131.48 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.996 -1.065 . . . . 0.0 109.563 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -39.9 -37.24 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.834 2.356 . . . . 0.0 112.679 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.03 -48.38 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.14 -0.975 . . . . 0.0 109.647 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 71' ' ' MET . 60.5 mttp -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.84 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.15 -43.4 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.977 . . . . 0.0 109.626 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.3 -30.3 54.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.68 58.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.407 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' LYS . 6.8 mtp -65.08 136.65 56.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -94.37 171.98 8.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.93 -33.28 70.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -59.18 -42.57 91.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -59.26 -38.45 80.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 80' ' ' VAL . 79.4 t -58.85 -44.99 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.571 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.538 ' OE1' ' NH1' ' A' ' 89' ' ' ARG . 41.8 tp10 -56.44 -37.79 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -65.4 -43.74 89.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.718 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.01 -36.21 79.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.637 ' CG1' HH21 ' A' ' 87' ' ' ARG . 52.7 t -50.64 -35.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.723 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.15 -60.04 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 109.518 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -99.91 115.92 30.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.72 -45.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.11 33.38 40.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.42 172.17 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -1.111 . . . . 0.0 109.336 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.0 mt -48.53 135.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.637 HH21 ' CG1' ' A' ' 80' ' ' VAL . 1.3 tpt180 -75.46 122.62 24.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.44 91.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 109.141 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 77' ' ' GLU . 38.3 ttm-85 -48.57 -32.54 8.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.932 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.44 -38.48 93.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HZ1' ' H ' ' A' ' 40' ' ' GLN . 14.1 mmmt -60.04 -47.34 86.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.499 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.404 HG21 HG13 ' A' ' 76' ' ' VAL . 76.5 mt -60.26 -41.39 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -58.08 -39.08 77.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.0 81.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.505 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 33.3 mm -59.6 -43.74 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.434 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.28 -28.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.548 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.05 -45.65 80.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.679 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -63.12 -35.48 80.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -1.148 . . . . 0.0 109.416 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.679 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -62.78 -46.79 86.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 109.521 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -71.43 -45.77 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.93 81.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.529 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.41 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 64.8 t80 -63.6 -49.2 74.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.94 -42.71 80.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.483 ' NE2' ' OE1' ' A' ' 107' ' ' GLN . 69.7 tp60 -65.53 -41.64 92.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.6 ttt -65.31 -41.82 93.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.471 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.68 -27.33 65.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.483 ' OE1' ' NE2' ' A' ' 104' ' ' GLN . 61.4 tt0 -51.8 -31.13 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -76.74 -12.7 60.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.45 0.46 76.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.83 132.54 64.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.2 -1.177 . . . . 0.0 109.712 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.49 118.58 5.73 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.6 2.2 . . . . 0.0 111.7 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -77.22 -38.57 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.795 . . . . 0.0 110.455 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.709 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -58.14 -49.72 76.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 110.77 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 118' ' ' SER . 93.0 m-20 -61.27 -44.43 97.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.228 -0.92 . . . . 0.0 111.102 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.77 -53.47 57.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.94 -1.1 . . . . 0.0 111.224 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 117' ' ' TRP . 12.2 m -57.96 -49.71 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.934 -1.104 . . . . 0.0 111.666 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.511 ' CE3' ' O ' ' A' ' 117' ' ' TRP . 2.4 p-90 -86.89 -21.55 26.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.712 -1.242 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 120' ' ' VAL . 17.0 p -58.84 -33.84 70.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.799 -1.188 . . . . 0.0 109.721 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.07 -12.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.915 . . . . 0.0 110.076 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.685 ' O ' HG12 ' A' ' 120' ' ' VAL . 43.1 t -82.32 23.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.073 -1.017 . . . . 0.0 109.939 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 35.1 t30 68.95 18.75 8.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 53.58 50.08 18.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.0 tt0 -159.7 121.41 1.82 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.34 151.89 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.716 2.278 . . . . 0.0 111.794 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 87.9 mm-40 -118.44 146.96 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.975 . . . . 0.0 109.72 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -135.91 156.49 48.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.79 . . . . 0.0 109.097 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.7 t -119.4 163.22 17.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.86 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -149.06 43.41 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.26 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB1' ' OE1' ' A' ' 134' ' ' GLU . . . -82.05 -150.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 109.676 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.445 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 14.4 m -138.72 -33.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -121.9 154.34 37.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.13 -33.84 75.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.893 . . . . 0.0 109.618 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -63.03 -33.38 75.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 130' ' ' THR . 95.6 mt-10 -62.92 -30.87 71.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.8 mp -67.52 117.04 43.44 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.699 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.06 125.65 3.64 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.079 2.519 . . . . 0.0 112.537 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 10.2 t -76.65 -18.15 58.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 109.322 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.0 t -102.72 99.19 9.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.11 155.45 37.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -46.89 -40.67 25.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.749 2.299 . . . . 0.0 111.963 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.85 -35.18 67.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 0.0 109.389 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.8 m -60.66 -41.86 95.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.438 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -64.8 -45.82 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.49 81.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.761 ' C ' HD23 ' A' ' 145' ' ' LEU . 7.4 tt -66.52 -46.35 76.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -56.33 -47.54 78.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.492 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.93 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.59 -45.0 73.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 149' ' ' LEU . 68.0 mt -60.17 -33.85 72.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.606 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -57.37 -40.89 79.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.86 -37.07 85.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.43 -17.81 65.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.19 20.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 136.27 33.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.14 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -105.24 -179.22 3.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.541 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 54.37 56.92 6.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.49 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 m -122.56 26.59 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.394 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.87 161.39 0.16 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.1 t -55.66 -32.61 63.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.158 . . . . 0.0 109.425 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 46.7 m -68.57 -46.83 68.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.04 -33.82 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 145' ' ' LEU . 6.4 t -68.42 -41.77 79.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.299 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 137' ' ' THR . 43.4 t80 -62.23 -45.38 93.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.3 t -59.15 -36.9 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.54 -43.36 97.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.418 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.94 -39.74 61.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.638 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -61.63 -47.12 86.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.859 . . . . 0.0 109.689 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.65 -37.86 80.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.75 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' VAL . 15.6 m -59.59 -28.81 67.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.166 -0.959 . . . . 0.0 109.457 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.06 9.92 55.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.81 -40.65 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 109.483 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 t -96.36 129.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.575 ' ND2' ' NE2' ' A' ' 175' ' ' HIS . 45.7 t-20 -100.04 117.53 34.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.378 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -75.42 137.04 40.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.457 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.575 ' NE2' ' ND2' ' A' ' 173' ' ' ASN . 75.6 m-70 -146.22 48.68 1.2 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.95 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.54 144.88 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.9 t -81.69 134.19 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.952 . . . . 0.0 109.503 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.27 25.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 13.8 p -86.94 -160.53 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.527 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.9 t -84.41 -54.16 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 t -64.94 -11.17 35.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.53 83.01 47.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.609 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.58 41.43 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 123.142 2.561 . . . . 0.0 112.367 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.68 25.72 66.84 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.34 43.38 20.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -1.147 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -129.45 79.63 73.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.955 . . . . 0.0 109.563 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 C--N 1.306 -1.698 0 C-N-CA 123.072 2.515 . . . . 0.0 112.173 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -98.78 158.87 15.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.59 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' CYS . 32.8 ptt180 -146.66 158.96 44.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 3' ' ' ARG . 20.2 m 53.94 171.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.07 12.69 1.44 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 2.9 p-90 -148.3 46.05 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 109.429 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.42 130.36 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.527 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 m -73.81 146.41 44.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 27.6 mp0 -65.29 -29.35 70.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.515 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -53.52 142.65 40.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.85 -23.81 18.54 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.874 2.383 . . . . 0.0 112.163 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.85 -39.79 95.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -79.45 -47.38 15.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.39 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.7 mt -55.41 -49.05 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.416 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -46.08 78.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -62.23 -40.41 96.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t-80 -58.68 -45.86 88.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.38 -46.23 12.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -57.98 -37.66 74.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 21' ' ' TRP . 93.7 mt-10 -144.54 -156.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.464 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.483 ' O ' ' O ' ' A' ' 20' ' ' GLU . 34.6 t90 59.76 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.64 -28.51 10.01 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.56 119.63 68.48 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.33 -1.1 . . . . 0.0 109.409 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.95 129.13 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.868 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -115.58 137.95 51.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.9 p -126.46 4.99 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.888 . . . . 0.0 109.104 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -72.18 119.47 16.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.6 p -60.55 -36.89 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -62.71 -46.98 85.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.828 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -66.16 -50.74 62.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.8 mp -64.55 -39.0 92.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.119 -0.988 . . . . 0.0 109.887 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 90.4 t80 -61.6 -52.91 62.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 109.864 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -33.11 75.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -56.72 -50.81 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.82 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.32 -40.16 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.995 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.6 m -72.24 -39.96 68.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.123 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 56' ' ' TYR . 18.4 mt -72.44 -40.64 66.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 109.848 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -53.63 -35.88 61.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.15 -31.56 26.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.463 ' HA ' ' HZ2' ' A' ' 91' ' ' LYS . 26.8 mt-30 -71.06 -29.83 65.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -1.202 . . . . 0.0 109.742 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' LEU . 6.0 pt20 -51.28 -31.26 20.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.695 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.43 109.75 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.656 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.82 -31.88 5.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLN . 27.1 mt -96.23 -179.38 4.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.484 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.0 m -105.78 163.15 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.972 . . . . 0.0 109.415 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.2 -46.43 75.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 47' ' ' ILE . 10.3 tp -56.57 -34.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 47' ' ' ILE . 80.9 m -64.54 -33.99 77.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.8 t -63.18 -40.76 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -53.66 -51.38 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -56.91 -39.68 74.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HB3' HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -80.75 -17.87 49.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.375 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.8 ttm-85 -60.99 -49.25 78.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.157 -0.964 . . . . 0.0 108.992 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 19.6 pt-20 -73.95 -42.84 59.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.456 -0.778 . . . . 0.0 109.347 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -66.64 -43.11 85.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.635 ' CZ ' ' CD2' ' A' ' 60' ' ' PHE . 35.9 t80 -60.42 -46.14 91.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.364 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' HIS . 76.6 mtm180 -59.48 -37.13 77.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 15.1 p -94.14 -12.33 28.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.301 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.635 ' CD2' ' CZ ' ' A' ' 56' ' ' TYR . 52.4 m-85 -120.95 -54.22 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.967 -1.083 . . . . 0.0 110.2 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 57' ' ' ARG . 44.7 t-80 -55.6 -41.79 73.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -55.77 -32.93 63.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' ASP . 81.5 m-85 -94.96 3.81 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.856 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 57.7 162.58 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 109.555 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.48 -14.49 22.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.876 2.384 . . . . 0.0 112.694 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.678 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.81 -46.61 65.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.908 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 69' ' ' ALA . 6.3 m -56.69 -41.9 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.007 . . . . 0.0 109.641 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.548 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . . . -58.9 -40.93 85.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.96 27.98 2.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.6 ttm -71.21 147.83 47.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.689 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -100.08 149.23 23.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 55.7 mp0 -52.34 -31.81 35.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.99 -45.64 88.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.45 -39.13 79.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.428 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.5 t -55.29 -46.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.33 -34.14 70.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -64.58 -49.27 71.84 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.337 -0.852 . . . . 0.0 109.78 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 mt -63.88 -38.39 90.9 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.97 -30.72 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -89.42 -58.54 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -99.52 124.85 45.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.415 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -170.27 -61.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.442 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.98 75.12 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.502 HG12 ' HB1' ' A' ' 83' ' ' ALA . 22.1 pt -100.3 -169.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -1.11 . . . . 0.0 109.337 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.11 138.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -88.28 122.27 31.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.468 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -177.6 81.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -48.37 -28.59 3.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.16 98.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HZ2' ' HA ' ' A' ' 40' ' ' GLN . 14.1 mtpt -69.13 -42.48 75.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -1.205 . . . . 0.0 109.571 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.95 -50.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -57.13 -33.48 67.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.443 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -62.21 -43.58 98.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 mm -55.75 -44.3 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -55.36 -50.15 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.69 -29.21 65.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.659 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.31 -40.3 85.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -1.195 . . . . 0.0 109.422 -178.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.659 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -67.8 -38.96 83.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.538 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -55.39 -44.83 76.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 109.541 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.33 69.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.442 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 37.0 t80 -60.75 -44.64 96.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.69 -36.31 83.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -57.68 -43.18 84.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.69 -43.86 71.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.62 -28.06 66.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -51.87 -33.04 34.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.5 -12.48 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.19 10.99 83.0 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -93.5 149.16 36.78 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.215 -1.168 . . . . 0.0 109.735 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.66 120.09 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.722 2.282 . . . . 0.0 111.697 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.466 ' O ' HG23 ' A' ' 116' ' ' VAL . 83.7 t80 -66.46 -43.25 86.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 0.0 110.408 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.27 -47.11 72.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.183 -0.948 . . . . 0.0 110.713 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' O ' ' CB ' ' A' ' 118' ' ' SER . 18.2 t70 -55.11 -51.18 67.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 111.046 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.426 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 69.7 t80 -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 111.261 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -57.02 -58.37 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 111.706 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . 45.0 p-90 -88.19 -20.69 25.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.786 -1.196 . . . . 0.0 111.162 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 120' ' ' VAL . 71.7 p -61.23 -24.29 66.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.159 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.13 -11.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.052 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.6 m -90.23 24.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.07 -1.019 . . . . 0.0 109.987 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 0.2 OUTLIER 77.51 -50.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 109.719 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.3 p-80 162.48 -19.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.38 148.96 35.92 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.15 154.7 47.05 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.707 2.272 . . . . 0.0 111.779 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -87.44 153.01 21.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 126' ' ' MET . 2.4 mpp? -136.57 150.46 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.431 ' OG1' ' CD1' ' A' ' 135' ' ' ILE . 15.1 t -99.35 171.55 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.864 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -160.17 67.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.31 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.49 -121.46 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 109.676 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 m -158.72 -33.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 134' ' ' GLU . 1.2 t -124.0 170.27 10.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.3 mt -73.79 -28.57 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.608 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.0 m -67.0 -38.1 85.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.525 ' H ' HG23 ' A' ' 131' ' ' THR . 63.1 mm-40 -67.25 -15.04 63.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.186 -0.946 . . . . 0.0 109.445 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.431 ' CD1' ' OG1' ' A' ' 127' ' ' THR . 44.3 mm -65.68 116.69 34.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -42.53 136.23 4.35 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.071 2.514 . . . . 0.0 112.552 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -4.01 35.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -143.98 83.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.2 p -74.86 153.11 86.94 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.18 -29.97 68.91 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.76 2.307 . . . . 0.0 112.059 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.5 -33.44 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.386 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.5 p -64.27 -40.42 95.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.88 -50.12 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 109.527 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.62 82.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.03 -43.79 91.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.473 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.0 p -55.35 -43.86 75.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -62.58 -32.03 72.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.479 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.04 36.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.488 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 3.8 mm? -62.36 -37.88 87.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.635 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -59.23 -37.44 77.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.09 -39.89 91.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 152' ' ' ARG . 38.7 mtt-85 -64.65 -19.57 65.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.23 21.91 21.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.06 138.42 36.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -103.53 170.42 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 59.08 47.08 12.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 158' ' ' GLY . 17.2 m -118.92 25.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.71 168.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 52.3 m -55.8 -32.61 63.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.46 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.1 m -62.28 -48.6 79.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.577 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -65.7 -34.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.94 -47.07 69.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -64.95 -40.78 95.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 109.347 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -59.57 -36.72 76.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.24 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.595 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 81.8 t80 -61.61 -43.09 99.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.5 mtp -70.43 -36.85 74.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -64.59 -54.79 26.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.698 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.32 83.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.595 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 22.9 m -53.88 -38.3 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.6 5.97 47.62 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.69 -33.1 73.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.75 132.32 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -94.57 105.33 17.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -96.02 96.13 8.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.168 -0.957 . . . . 0.0 109.494 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' A' ' 176' ' ' VAL . 21.2 m80 -108.9 -6.88 15.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 177' ' ' VAL . 87.6 t 54.29 163.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.453 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.57 ' N ' HG12 ' A' ' 176' ' ' VAL . 81.8 t -108.08 133.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.83 61.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 181' ' ' CYS . 39.2 m -144.41 168.35 20.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.163 . . . . 0.0 109.525 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 98.5 m 50.09 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 179' ' ' CYS . 38.6 t -155.8 14.3 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.623 ' O ' ' O ' ' A' ' 183' ' ' PRO . 30.0 t80 -71.42 139.46 84.17 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 109.513 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.623 ' O ' ' O ' ' A' ' 182' ' ' TYR . 89.8 Cg_exo -40.07 -175.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 123.156 2.571 . . . . 0.0 112.375 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.21 -14.1 63.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.37 21.92 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.099 . . . . 0.0 109.593 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.13 80.15 48.32 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 109.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--N 1.305 -1.736 0 C-N-CA 123.065 2.51 . . . . 0.0 112.288 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.37 151.83 25.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.494 HH11 ' HG3' ' A' ' 3' ' ' ARG . 32.0 mtm-85 -139.88 -174.05 3.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.442 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -141.39 -142.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.562 ' H ' HD11 ' A' ' 132' ' ' LEU . . . -47.44 -11.99 0.1 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . 44.5 m95 -67.14 -9.48 40.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 6' ' ' TRP . 20.1 m 35.76 -154.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 8' ' ' SER . 10.3 t -178.08 47.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.411 ' N ' HD11 ' A' ' 14' ' ' ILE . 6.6 pt20 -130.63 -105.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 9' ' ' GLN . 58.2 m-20 -43.6 107.09 0.54 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -48.71 -34.84 28.55 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.799 2.333 . . . . 0.0 112.173 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.44 -44.22 95.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.473 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.46 ' CE1' ' CE1' ' A' ' 17' ' ' HIS . 40.0 t80 -68.15 -42.6 79.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.411 HD11 ' N ' ' A' ' 9' ' ' GLN . 61.2 mt -59.36 -42.61 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.424 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' ASN . . . -61.72 -39.12 90.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.88 -41.27 77.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CE1' ' CE1' ' A' ' 13' ' ' TYR . 3.5 m80 -77.39 -20.87 54.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.912 . . . . 0.0 109.461 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -104.15 -2.04 26.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.523 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . 13.0 m120 -77.27 -74.83 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -147.89 23.43 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -79.85 132.89 36.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.95 -28.35 13.03 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 169' ' ' CYS . 4.0 t -91.39 112.95 56.77 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.212 -1.169 . . . . 0.0 109.41 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.68 137.85 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.759 2.306 . . . . 0.0 111.865 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.7 141.34 51.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.809 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.9 p -90.44 12.4 18.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.376 -0.827 . . . . 0.0 109.107 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -81.36 129.51 34.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 109.317 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.671 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 95.2 p -71.28 -31.03 66.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -58.64 -42.57 88.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.681 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.88 -48.56 65.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 31' ' ' LEU . 11.1 mp -67.89 -42.07 81.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 31.8 t80 -61.5 -52.68 63.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.896 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.48 -30.65 71.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 109.85 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.8 tpt -67.97 -55.39 12.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.805 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.4 HG23 ' CG2' ' A' ' 161' ' ' ILE . 9.3 mt -65.75 -43.84 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -58.23 -49.26 77.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 0.0 110.105 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD11 ' CG ' ' A' ' 56' ' ' TYR . 4.2 mm? -76.86 -41.68 43.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.857 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -53.93 -37.97 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.792 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.63 -29.73 25.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.624 ' NE2' ' CZ ' ' A' ' 56' ' ' TYR . 72.3 mt-30 -66.79 -30.03 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -1.187 . . . . 0.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.699 HE22 ' N ' ' A' ' 46' ' ' TRP . 35.6 tp60 -45.79 -39.05 7.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.935 . . . . 0.0 109.702 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.84 107.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.63 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.28 -32.72 4.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 40' ' ' GLN . 2.5 mt -89.19 -165.11 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -1.126 . . . . 0.0 109.512 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.411 ' HA ' HE22 ' A' ' 41' ' ' GLN . 39.7 t -121.73 149.88 42.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.699 ' N ' HE22 ' A' ' 41' ' ' GLN . 36.2 p90 -57.61 -49.13 77.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 9.4 tp -48.34 -37.88 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.672 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.474 ' N ' HG23 ' A' ' 47' ' ' ILE . 58.0 m -71.71 -34.2 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.727 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.63 -48.35 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -60.45 -47.22 87.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -61.9 -51.49 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.982 . . . . 0.0 109.305 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -64.65 -36.2 83.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.177 -0.952 . . . . 0.0 109.403 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -48.26 -46.11 35.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.205 -0.934 . . . . 0.0 108.975 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -65.23 -42.32 93.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.362 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.86 -39.08 90.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.286 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.624 ' CZ ' ' NE2' ' A' ' 40' ' ' GLN . 3.6 m-85 -61.87 -44.13 97.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 109.342 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 53.4 mtp180 -54.77 -43.51 72.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.299 -0.875 . . . . 0.0 109.834 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.38 -23.54 65.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.432 -0.792 . . . . 0.0 110.328 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 79' ' ' LEU . 3.8 t -92.31 -12.64 31.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.271 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -133.16 -46.68 0.84 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.892 -1.13 . . . . 0.0 110.231 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 53.3 t-80 -53.47 -41.55 66.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.037 -1.039 . . . . 0.0 109.901 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.08 -34.87 68.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.792 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 64' ' ' ASP . 88.1 m-85 -91.04 4.41 52.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.874 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.61 160.67 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.601 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.73 -24.22 25.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.856 2.371 . . . . 0.0 112.728 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.85 -48.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.1 mttm -66.09 -33.78 76.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.403 -0.811 . . . . 0.0 109.866 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 71' ' ' MET . 61.0 t -57.43 -43.14 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.058 -1.026 . . . . 0.0 109.576 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.17 -24.35 61.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.63 14.13 28.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.356 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 11.8 ptm -77.61 152.55 33.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -100.62 163.29 12.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.558 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.38 -28.71 60.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.459 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -57.07 -37.42 71.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.13 -38.37 86.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' VAL . 71.0 t -61.5 -38.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.83 -39.4 90.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.391 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 78' ' ' ARG . 53.5 mtm-85 -75.35 -47.85 25.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.318 -0.863 . . . . 0.0 109.767 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD22 ' SG ' ' A' ' 59' ' ' CYS . 93.1 mt -62.73 -41.85 99.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 76' ' ' VAL . 25.0 t -54.24 -34.28 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.713 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.62 -54.86 3.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.543 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -98.86 109.01 21.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 109.404 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.29 -38.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.87 36.84 46.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -124.5 173.42 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -1.139 . . . . 0.0 109.377 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 87.2 mt -47.71 138.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.593 ' HG2' HH11 ' A' ' 87' ' ' ARG . 9.9 ttt-85 -89.53 126.28 35.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 109.5 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.89 84.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -48.12 -32.09 6.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.935 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.88 93.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -65.13 -40.5 94.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.546 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.46 HG21 HG13 ' A' ' 76' ' ' VAL . 4.3 mm -57.82 -47.46 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.49 -38.31 63.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.28 75.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.398 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.514 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 63.2 mt -59.9 -40.74 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.573 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 41.2 mm -54.19 -43.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.96 64.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -65.61 -45.73 82.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.14 . . . . 0.0 109.407 -178.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.516 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -65.71 -44.97 84.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.71 -41.28 98.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.58 -46.54 38.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.453 ' HH ' ' HG ' ' A' ' 28' ' ' SER . 49.8 t80 -55.45 -44.74 76.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.516 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.19 -32.99 74.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -54.85 -49.83 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.1 mtp -66.53 -38.55 87.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.73 -27.21 67.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -51.6 -34.03 35.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -81.11 -4.69 56.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.9 10.69 80.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -84.74 149.12 53.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.03 119.62 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.626 2.217 . . . . 0.0 111.704 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -73.85 -46.85 42.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -57.85 -47.36 82.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.716 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.473 ' O ' ' OG ' ' A' ' 118' ' ' SER . 19.6 t70 -55.27 -39.1 69.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.907 . . . . 0.0 111.017 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.449 ' CE2' ' NH2' ' A' ' 152' ' ' ARG . 92.2 t80 -66.5 -49.43 66.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 111.192 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 116' ' ' VAL . 5.7 m -60.46 -46.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 111.67 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.529 ' O ' HG22 ' A' ' 120' ' ' VAL . 5.1 p-90 -85.97 -33.72 21.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.726 -1.233 . . . . 0.0 111.163 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 120' ' ' VAL . 74.4 m -57.12 -27.5 61.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 109.754 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 110.128 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.4 m -83.78 26.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.056 -1.027 . . . . 0.0 109.988 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.0 m120 74.36 21.57 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 56.51 42.2 27.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.93 . . . . 0.0 109.487 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.455 ' H ' HG23 ' A' ' 120' ' ' VAL . 7.9 pt20 -138.8 146.09 48.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.519 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.67 154.76 30.97 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.683 2.255 . . . . 0.0 111.836 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -120.27 147.46 44.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.965 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.7 ptp -135.58 157.31 47.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.838 . . . . 0.0 109.104 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.3 t -127.49 161.2 29.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -147.12 57.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.518 ' HB1' ' OE1' ' A' ' 134' ' ' GLU . . . -98.91 -151.18 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.705 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.3 m -114.31 -28.16 7.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 0.0 109.382 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.3 m -139.18 154.11 48.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.453 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.661 ' H ' HD12 ' A' ' 132' ' ' LEU . 1.0 OUTLIER -62.13 -30.86 71.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.578 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -67.2 -32.63 73.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.953 . . . . 0.0 109.513 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.518 ' OE1' ' HB1' ' A' ' 129' ' ' ALA . 95.1 mt-10 -59.08 -26.27 64.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.421 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.7 mp -67.34 121.58 79.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.25 133.94 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.125 2.55 . . . . 0.0 112.504 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 137' ' ' THR . 1.0 OUTLIER -81.67 -17.32 48.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.373 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.1 p -73.05 102.4 3.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.385 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -134.8 151.65 76.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.36 -31.39 92.7 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.761 2.307 . . . . 0.0 112.049 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.85 73.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -63.57 -43.63 96.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.31 -44.5 97.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.83 60.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.681 ' C ' HD23 ' A' ' 145' ' ' LEU . 6.8 tt -65.05 -49.05 71.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -57.84 -39.64 78.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.907 . . . . 0.0 109.539 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -62.31 -35.3 78.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.8 -51.57 57.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.2 mt -59.17 -35.02 72.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -58.16 -37.18 74.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.402 ' HB3' HH11 ' A' ' 152' ' ' ARG . 84.3 tttt -62.48 -40.6 97.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.449 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.5 mpt_? -64.51 -20.01 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.79 20.82 20.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -84.51 128.04 34.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 156' ' ' PHE . 22.9 tptt -97.41 176.99 5.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.436 ' H ' ' HG3' ' A' ' 155' ' ' LYS . 67.9 m-85 55.05 47.38 22.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 158' ' ' GLY . 2.6 m -121.71 25.93 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.69 171.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.443 ' H ' HG23 ' A' ' 159' ' ' THR . 1.1 p -58.31 -32.36 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.455 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.9 m -64.75 -48.46 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -63.37 -39.8 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 109.521 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.527 ' SG ' HD22 ' A' ' 145' ' ' LEU . 31.9 t -68.93 -50.13 52.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.29 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.492 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 53.1 t80 -63.93 -35.63 81.31 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 109.35 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.3 m -59.41 -41.47 89.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.256 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -65.05 -42.33 94.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.6 mtp -57.38 -40.9 79.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 174' ' ' ASP . 24.1 mm100 -77.1 -36.4 55.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.41 -54.17 27.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.699 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.558 ' O ' ' O ' ' A' ' 23' ' ' VAL . 11.4 p -57.78 -61.14 2.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 144.22 2.76 0.81 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 117' ' ' TRP . 2.6 mp -48.5 -41.81 31.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.419 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.74 128.54 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 32.4 t-20 -81.12 101.29 9.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 109.404 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.526 ' O ' ' ND1' ' A' ' 175' ' ' HIS . 78.6 m-20 -83.87 121.35 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 174' ' ' ASP . 28.4 m-70 -158.57 127.36 5.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.53 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 4' ' ' CYS . 33.7 m -90.41 132.96 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.49 -20.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.78 -3.47 79.82 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 6.9 t -90.17 143.49 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -1.151 . . . . 0.0 109.555 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.9 -36.73 80.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.11 -39.33 81.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -124.69 81.12 61.21 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.607 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -86.16 28.62 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.086 2.524 . . . . 0.0 112.332 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.03 23.46 76.12 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.3 t30 56.74 40.09 29.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.091 . . . . 0.0 109.605 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -100.91 131.86 22.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo . . . . . 0 C--N 1.306 -1.702 0 C-N-CA 123.021 2.481 . . . . 0.0 112.308 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.254 0.549 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -75.1 147.32 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -148.52 164.74 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 m -48.11 137.73 10.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.39 -11.87 55.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -67.59 -1.86 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -1.154 . . . . 0.0 109.422 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -62.32 137.1 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -58.06 144.9 38.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.26 -32.81 73.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 109.533 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 143.1 78.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.06 -15.34 25.96 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.871 2.381 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.0 -43.06 99.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.22 -47.86 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.6 -46.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.29 92.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.11 -39.19 92.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.514 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 54.4 t-80 -55.27 -47.04 76.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.425 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.09 -42.36 38.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -58.88 -43.36 90.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 21' ' ' TRP . 87.9 mt-10 -146.55 -143.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' O ' ' A' ' 20' ' ' GLU . 35.3 t90 60.06 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 109.542 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.77 67.77 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -118.38 94.19 46.68 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.272 -1.134 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.04 131.27 21.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.766 2.311 . . . . 0.0 111.834 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.4 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.862 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.1 p -106.28 0.32 25.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.07 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.38 134.76 36.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 10.2 p -72.93 -31.72 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -64.7 -54.78 26.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -73.36 -49.75 25.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 109.893 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.2 -44.62 75.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.02 -42.41 98.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.954 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -58.29 -31.51 67.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 109.78 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 tpp -63.67 -46.36 85.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.834 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.53 -47.21 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 110.01 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 14.2 p -60.04 -38.55 83.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.522 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 43.6 mt -66.08 -36.81 84.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.13 -0.981 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' OE2' ' CZ3' ' A' ' 46' ' ' TRP . 65.3 mm-40 -60.18 -37.9 81.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.704 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.2 -36.05 7.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.443 ' OE1' HG21 ' A' ' 86' ' ' ILE . 74.5 mm-40 -66.09 -31.31 72.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -1.186 . . . . 0.0 109.794 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.533 ' NE2' ' OE1' ' A' ' 38' ' ' GLU . 7.9 tt0 -56.8 -31.73 64.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.736 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.72 109.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.98 -31.89 5.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.6 mp -104.73 -160.55 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -1.187 . . . . 0.0 109.422 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.2 m -125.44 152.96 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.542 ' CZ3' ' OE2' ' A' ' 38' ' ' GLU . 72.5 t-105 -54.19 -42.52 69.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.366 -0.833 . . . . 0.0 109.493 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.637 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -48.99 -39.74 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.68 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.52 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 52.9 m -71.92 -31.5 66.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 109.686 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ARG . 67.6 t -57.82 -30.8 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 109.438 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 50' ' ' LEU . 4.1 mm? -52.87 -54.68 30.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.419 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.09 -45.89 89.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.351 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.85 -24.62 65.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' VAL . 33.2 ttt-85 -62.23 -47.33 84.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.22 -0.925 . . . . 0.0 109.032 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -44.51 84.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 109.337 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.28 -43.95 69.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 22.9 t80 -63.4 -37.31 86.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.474 -0.766 . . . . 0.0 109.332 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.77 -41.95 92.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.383 -0.823 . . . . 0.0 109.783 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 -21.43 59.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 110.242 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 85' ' ' ILE . 25.8 m -89.46 -11.97 41.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 110.266 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 83.3 m-85 -133.51 -50.91 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.113 . . . . 0.0 110.2 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -49.91 -42.83 48.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.913 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -59.32 -28.52 66.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 64' ' ' ASP . 90.8 m-85 -85.52 17.55 3.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.052 -1.03 . . . . 0.0 109.901 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 55.52 162.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 109.576 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.52 -54.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.884 2.389 . . . . 0.0 112.755 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.9 p -48.48 -44.61 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 109.703 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.577 ' N ' HG13 ' A' ' 66' ' ' VAL . 80.6 tttt -58.12 -37.99 75.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 64' ' ' ASP . 58.9 t -57.46 -38.96 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.083 -1.01 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.06 -24.45 62.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.83 12.83 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.384 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.5 mtp -61.94 135.98 57.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -95.47 162.95 13.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' CD ' HE22 ' A' ' 93' ' ' GLN . 75.6 mm-40 -57.86 -27.75 63.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -71.82 -29.02 63.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.11 -49.4 70.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 92' ' ' ILE . 14.9 m -60.68 -37.64 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -56.58 -37.1 70.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.427 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.9 ttt-85 -65.25 -42.32 93.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.402 -0.811 . . . . 0.0 109.775 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.9 mt -67.12 -27.15 67.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 0.0 109.631 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.1 t -61.93 -28.42 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.712 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.79 -56.72 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 109.519 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.666 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 53.1 t0 -99.07 169.89 9.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.77 73.59 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 109.416 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -77.95 33.18 1.7 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.502 HG21 ' SG ' ' A' ' 59' ' ' CYS . 16.0 pt -55.87 -159.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -1.12 . . . . 0.0 109.372 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.714 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 2.9 tt -55.86 -165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 109.515 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.714 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 8.0 mtt-85 -47.65 153.3 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -142.65 -156.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.176 -179.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 57.88 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.933 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -66.13 -44.19 91.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -61.59 -42.58 99.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -1.227 . . . . 0.0 109.5 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.59 HG22 HG12 ' A' ' 76' ' ' VAL . 18.8 mt -57.06 -47.29 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.555 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.573 HE22 ' CD ' ' A' ' 73' ' ' GLU . 15.5 mm100 -53.22 -36.99 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.35 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.355 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.586 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 81.4 mt -59.47 -50.0 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.91 -38.5 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.518 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.33 99.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 97.4 m-20 -69.44 -44.68 70.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.423 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.06 95.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.546 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -63.63 -43.93 95.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 109.531 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.99 -34.18 66.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.895 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.64 -51.29 63.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.31 -39.01 91.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -60.13 -42.84 95.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -61.98 -41.43 98.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.65 -27.01 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.127 -0.983 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -51.67 -20.38 2.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.506 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 110' ' ' GLU . 64.3 t30 -75.53 -18.45 59.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.83 65.16 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.517 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 12.0 mp0 -103.48 151.07 38.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.163 -1.198 . . . . 0.0 109.653 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.97 119.65 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.67 2.247 . . . . 0.0 111.676 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -74.88 -45.74 40.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 0.0 110.467 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -62.09 -47.95 82.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 110.734 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.484 ' O ' ' OG ' ' A' ' 118' ' ' SER . 18.4 t70 -55.8 -40.36 72.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.937 . . . . 0.0 111.036 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -64.72 -51.22 63.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.029 -1.045 . . . . 0.0 111.225 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.3 m -56.78 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.98 -1.075 . . . . 0.0 111.716 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.477 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -86.99 -32.82 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.775 -1.203 . . . . 0.0 111.134 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 120' ' ' VAL . 57.1 p -55.65 -21.03 16.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -44.04 -15.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.007 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.9 m -91.77 24.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.044 -1.035 . . . . 0.0 109.982 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.525 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 1.3 m120 72.56 -48.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 3.0 p-80 165.13 -20.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -106.31 149.3 38.06 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.6 149.17 67.58 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.696 2.264 . . . . 0.0 111.805 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -75.38 146.81 40.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.745 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 88.1 mtp -126.44 144.93 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.117 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.09 175.49 6.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -164.86 71.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.279 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.12 -132.45 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.734 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.9 m -154.22 -35.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -113.13 155.21 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.76 -30.27 70.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.501 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.0 p -70.74 -33.37 70.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.5 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.69 -24.89 67.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.5 mm -66.33 116.77 37.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.686 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.85 126.3 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.187 2.592 . . . . 0.0 112.538 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.453 ' OG1' ' CB ' ' A' ' 163' ' ' TYR . 2.0 t -77.2 -18.26 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.266 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.4 p -89.25 66.61 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.356 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -77.27 152.31 81.59 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.37 -36.02 16.92 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.8 2.333 . . . . 0.0 112.035 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.46 -41.51 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.1 m -59.65 -39.82 85.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -62.17 -48.32 80.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.82 78.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -61.92 -43.8 98.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.528 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.7 p -63.26 -39.43 94.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.918 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.54 43.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.71 -33.44 75.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.564 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.44 -39.67 84.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.422 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -61.16 -39.93 91.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.618 HH11 ' CG ' ' A' ' 152' ' ' ARG . 7.3 mtt-85 -64.43 -21.51 66.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.85 36.99 5.87 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.448 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 1.4 m-85 -84.79 133.51 34.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -1.112 . . . . 0.0 109.517 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.61 159.87 14.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.448 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 56.12 48.38 17.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 157' ' ' VAL . 10.7 p -121.82 26.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.457 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.51 156.3 0.07 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -59.88 -14.02 13.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -1.133 . . . . 0.0 109.448 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.6 p -70.86 -44.97 65.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 38' ' ' GLU . 26.0 mt -65.07 -36.34 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.526 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 68.3 m -55.81 -40.81 73.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.321 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.453 ' CB ' ' OG1' ' A' ' 137' ' ' THR . 37.6 t80 -66.78 -47.26 72.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.405 -0.809 . . . . 0.0 109.314 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.7 m -66.05 -40.68 91.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.317 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.77 -49.38 77.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 92.6 mtp -68.94 -39.55 79.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.666 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.47 -41.89 99.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.734 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.58 97.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.678 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.4 m -66.06 -60.82 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 138.8 1.69 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.29 -33.34 72.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -1.167 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -99.74 130.1 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -98.76 105.06 17.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.29 114.23 26.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -135.51 143.18 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.44 142.5 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.441 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.435 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 89.05 15.63 58.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 178' ' ' GLY . 7.7 m -149.8 176.16 10.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 75.3 m 50.75 -97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 181' ' ' CYS . 52.7 t -156.17 15.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 29.8 t80 -66.46 117.09 40.56 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.641 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.569 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 84.9 Cg_endo -83.55 -163.74 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.074 2.516 . . . . 0.0 112.397 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.23 67.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.46 40.74 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -1.155 . . . . 0.0 109.605 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -130.8 79.63 71.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.144 -0.973 . . . . 0.0 109.491 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.307 -1.648 0 C-N-CA 123.004 2.469 . . . . 0.0 112.259 -179.916 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.5 tpp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 13.8 pt-20 -87.35 143.53 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -149.45 174.16 12.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -48.13 167.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.99 9.23 1.54 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.607 ' CD1' HD13 ' A' ' 132' ' ' LEU . 21.6 m95 -83.13 -1.22 52.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.94 132.8 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' GLN . 68.4 m -79.64 177.94 8.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.4 mm-40 -61.03 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 51.54 85.06 0.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.01 -25.76 4.32 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.852 2.368 . . . . 0.0 112.1 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.91 -39.31 93.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.481 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -71.16 -48.11 53.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.12 -44.84 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.376 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.92 81.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.44 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.459 ' CG ' HD21 ' A' ' 50' ' ' LEU . 85.5 t80 -61.64 -43.96 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.18 -49.45 77.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.48 -36.72 79.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.483 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -56.95 -56.36 22.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -175.25 131.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -159.64 123.05 3.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 109.516 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.98 -5.29 75.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' CYS . 19.3 t -63.4 132.09 95.02 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.209 -1.171 . . . . 0.0 109.343 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.03 120.47 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.777 2.318 . . . . 0.0 111.849 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.46 132.79 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.854 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -115.08 3.5 14.43 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 109.083 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.1 126.02 32.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 m -64.52 -40.44 95.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -60.93 -45.28 95.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.61 -45.01 69.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.895 . . . . 0.0 109.846 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.2 -43.93 96.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.118 -0.989 . . . . 0.0 109.808 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 44.9 t80 -60.52 -37.03 79.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.919 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.93 -30.55 63.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.878 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.9 tpp -64.45 -54.98 24.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.794 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 35' ' ' ILE . 10.3 tp -64.46 -33.32 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 110.045 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.5 m -64.44 -49.9 69.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 110.106 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.19 -28.38 59.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 109.805 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -52.82 -35.26 56.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 109.772 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.61 -33.88 74.03 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -59.05 -32.54 69.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -1.207 . . . . 0.0 109.763 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -52.87 -39.7 62.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.05 120.41 3.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -35.27 4.2 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.02 -138.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.137 . . . . 0.0 109.445 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -142.41 158.92 43.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -56.14 -39.36 72.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.474 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -59.12 -34.46 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.687 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 61.1 m -69.39 -33.47 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.0 t -57.63 -43.16 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.442 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 50' ' ' LEU . 9.8 mp -56.7 -52.15 66.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.57 -44.69 93.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 109.307 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -73.25 -21.61 60.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.193 -0.942 . . . . 0.0 109.417 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.8 ttm-85 -60.35 -46.05 91.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -71.13 -45.95 62.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.403 -0.811 . . . . 0.0 109.439 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.99 -35.0 79.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.609 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 25.3 t80 -62.78 -44.61 95.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.563 ' HG2' HH11 ' A' ' 57' ' ' ARG . 27.9 mtt-85 -57.0 -41.81 79.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.828 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -29.9 71.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.258 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 97.9 m -93.49 -12.6 29.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.262 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 61.8 m-85 -125.68 -43.27 1.88 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 0.0 110.181 -178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 29.9 t-80 -49.89 -40.14 42.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -61.85 -31.73 72.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.739 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASP . 97.7 m-85 -91.34 -0.85 57.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.077 -1.014 . . . . 0.0 109.86 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 56.05 161.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.107 -0.995 . . . . 0.0 109.623 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.47 -27.11 16.17 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.867 2.378 . . . . 0.0 112.713 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.5 -47.87 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.13 -35.35 80.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 64' ' ' ASP . 46.3 t -58.11 -35.71 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 109.598 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.81 66.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.466 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 23.08 9.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.246 -0.909 . . . . 0.0 109.374 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 tpp -61.22 156.45 18.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.671 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -110.47 156.83 20.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 96.6 mt-10 -55.75 -35.06 65.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.94 -37.59 85.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 80' ' ' VAL . 59.9 t -54.71 -49.5 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 73' ' ' GLU . 26.3 mp0 -64.25 -32.74 74.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.63 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.28 -49.2 67.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.806 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.0 -41.18 67.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.605 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 76' ' ' VAL . 38.9 t -51.1 -33.08 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -80.95 -59.79 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -98.96 117.11 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 77.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -22.91 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 84' ' ' GLY . 24.0 pt -62.29 -134.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.321 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.05 136.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -101.29 117.98 36.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.467 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -172.4 94.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.183 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -45.27 -35.43 3.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 109.967 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.33 -47.66 85.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -66.16 -38.12 87.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.25 -50.22 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.12 -32.99 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 109.326 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.26 99.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.388 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.06 -46.17 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.375 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.61 -36.45 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.63 94.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.623 ' ND2' ' CD2' ' A' ' 154' ' ' PHE . 13.9 m120 -60.17 -42.52 95.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.66 89.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.512 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -61.23 -44.33 97.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.29 72.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 30.1 t80 -66.93 -43.72 82.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.527 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -66.93 -50.51 62.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -59.9 -35.0 73.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.477 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ttt -59.16 -40.96 87.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -68.29 -27.75 66.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.482 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -51.66 -34.05 36.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -83.4 -1.19 52.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.39 35.92 40.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -116.84 82.16 12.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.657 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -41.67 131.31 3.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.634 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.06 -47.74 83.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -45.45 80.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 110.718 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -59.22 -33.21 70.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 111.034 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 68.3 t80 -65.26 -53.43 44.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.023 -1.048 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 116' ' ' VAL . 7.0 m -58.02 -40.99 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.719 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -68.56 -31.12 70.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.719 -1.238 . . . . 0.0 111.104 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 m -65.15 -34.78 79.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 109.676 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -58.72 -44.2 90.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.084 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 123' ' ' GLN . 3.2 p -89.71 20.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.079 -1.013 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.62 30.48 18.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 55.45 22.88 5.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.495 ' H ' HG13 ' A' ' 120' ' ' VAL . 65.8 mt-30 -123.39 100.98 38.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.626 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -47.38 139.45 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.728 2.286 . . . . 0.0 111.855 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -85.5 157.38 20.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -131.85 151.3 51.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 109.183 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -131.58 152.52 50.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -133.96 45.67 2.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.324 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.73 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -68.52 147.06 52.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 62.2 m -74.08 -36.26 64.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.4 m -132.56 157.58 44.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.884 ' H ' HD12 ' A' ' 132' ' ' LEU . 6.0 mp -54.29 -32.34 56.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.2 t -64.93 -33.83 76.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.73 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 71.3 mm-40 -69.34 -19.12 63.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 109.367 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -66.85 124.2 88.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 109.676 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.36 127.24 5.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.143 2.562 . . . . 0.0 112.552 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 -13.79 47.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.304 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -109.15 100.64 9.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.0 109.374 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -105.51 150.75 39.37 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.917 . . . . 0.0 109.462 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.96 -41.1 26.01 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.789 2.326 . . . . 0.0 111.982 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.65 -36.91 60.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.3 m -60.9 -43.24 98.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -61.96 -48.07 82.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.21 89.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.22 -41.39 99.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.2 p -57.88 -43.36 85.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -65.7 -27.68 68.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.502 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.48 -51.33 29.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.2 mt -58.42 -36.17 73.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -57.62 -36.6 72.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.34 -40.1 92.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.62 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -67.51 -19.74 65.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.413 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.92 22.25 16.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.623 ' CD2' ' ND2' ' A' ' 98' ' ' ASN . 8.0 m-85 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -1.107 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -101.79 168.52 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.501 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 54.05 53.13 11.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.28 25.16 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.419 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.41 167.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -55.47 -32.18 62.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.436 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 65.9 p -64.38 -47.78 77.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -65.7 -35.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 5.9 t -68.7 -44.13 74.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.259 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -62.23 -44.97 95.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.7 m -57.99 -37.18 73.77 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.222 -0.924 . . . . 0.0 109.248 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.617 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 72.4 t80 -59.73 -41.36 90.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.398 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.12 -38.57 72.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.533 HE22 ' CG ' ' A' ' 174' ' ' ASP . 98.1 mm-40 -63.34 -46.45 86.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.7 -44.63 49.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.617 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 98.3 m -62.44 -36.13 81.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.462 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.28 8.8 56.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.8 mp -53.41 -26.82 21.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -1.152 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.06 138.61 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.965 . . . . 0.0 109.449 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -82.12 102.37 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.533 ' CG ' HE22 ' A' ' 167' ' ' GLN . 34.4 m-20 -91.56 118.17 30.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.56 166.0 28.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.621 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.27 150.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.4 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.29 130.23 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.531 ' H ' ' HA ' ' A' ' 183' ' ' PRO . . . 91.2 4.71 68.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 181' ' ' CYS . 53.5 t -76.34 28.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.542 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 3.2 m 63.04 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 179' ' ' CYS . 73.3 m -59.47 -35.35 73.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 7.0 t80 -125.47 80.67 65.43 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.531 ' HA ' ' H ' ' A' ' 178' ' ' GLY . 85.3 Cg_endo -85.88 47.97 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.028 2.485 . . . . 0.0 112.359 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.07 64.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 57.87 42.79 22.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 109.535 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -134.78 78.72 54.31 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.518 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 C--N 1.306 -1.702 0 C-N-CA 123.097 2.531 . . . . 0.0 112.211 -179.89 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.318 0.58 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' OE2' ' SG ' ' A' ' 179' ' ' CYS . 22.3 pt-20 -83.71 145.58 28.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.637 ' HG2' HH11 ' A' ' 3' ' ' ARG . 10.2 mtt-85 -108.32 160.53 15.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' TRP . 26.6 p -47.23 127.29 10.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.94 -6.27 3.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' CYS . 16.9 m95 -54.53 -37.0 64.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.423 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 7' ' ' VAL . 17.9 m -88.76 127.15 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.564 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 9' ' ' GLN . 75.2 m -165.86 146.46 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.0 mm100 60.32 133.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.552 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' GLN . 1.1 m-20 63.0 125.11 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.26 -7.71 19.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.845 2.364 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.49 -32.86 72.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.55 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 30.8 m-85 -49.47 -44.23 45.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.78 -28.42 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.424 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 19' ' ' ASN . . . -58.97 -48.23 82.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.429 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.559 ' CG ' ' N ' ' A' ' 17' ' ' HIS . 2.2 p90 -75.52 -39.09 58.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.559 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 48.3 t-80 -60.85 -48.21 82.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.42 -44.86 67.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 98.4 m-20 -55.28 -45.45 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.3 pt-20 -173.52 -143.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.595 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 11.0 t-105 60.6 125.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.03 -20.28 46.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 169' ' ' CYS . 26.3 m -84.66 141.36 38.64 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.17 -1.194 . . . . 0.0 109.33 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.87 122.85 4.48 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.758 2.306 . . . . 0.0 111.905 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -119.6 131.98 55.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.02 . . . . 0.0 109.857 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -123.21 5.5 9.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.88 135.01 33.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.439 ' CA ' ' HB2' ' A' ' 113' ' ' ALA . 14.5 m -69.63 -39.36 77.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.603 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.47 -43.59 88.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 109.717 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -65.94 -49.64 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.86 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 ' SG ' ' A' ' 169' ' ' CYS . 43.9 mt -72.91 -29.96 63.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.873 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' ' N ' ' A' ' 33' ' ' GLU . 9.2 t80 -59.98 -56.39 22.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.0 pp20? -68.58 -29.72 68.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.595 ' SD ' ' CH2' ' A' ' 21' ' ' TRP . 55.2 tpp -63.61 -53.36 52.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.88 -46.78 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 110.05 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.9 t -70.34 -39.17 74.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.4 tp -73.34 -38.37 65.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 35.0 mm-40 -52.76 -34.54 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.24 -23.66 41.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.2 -38.01 86.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.176 . . . . 0.0 109.783 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -48.75 -38.93 23.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.786 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.53 106.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.662 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -31.26 6.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -86.03 -165.52 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -1.192 . . . . 0.0 109.422 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 48' ' ' THR . 15.6 p -117.36 150.64 38.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.428 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -56.21 -36.65 68.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -79.52 -30.77 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.707 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 45' ' ' SER . 52.4 m -67.64 -40.46 84.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.679 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' ARG . 70.4 t -68.91 -40.89 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 16' ' ' TYR . 85.7 mt -57.05 -47.25 81.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -60.79 -51.45 69.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 109.297 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.48 -26.31 67.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' VAL . 9.7 tmm_? -54.47 -46.63 73.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.52 -42.65 91.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -68.38 -34.48 76.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.259 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -63.76 -45.8 88.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -0.789 . . . . 0.0 109.327 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 79.3 mtm180 -62.29 -30.63 71.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -0.864 . . . . 0.0 109.732 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.66 82.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.881 . . . . 0.0 110.276 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -93.77 -13.33 27.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.27 -178.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -113.76 -52.33 2.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.913 -1.117 . . . . 0.0 110.175 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.424 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.9 t-80 -51.94 -40.0 60.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 109.91 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -56.55 -32.5 65.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 64' ' ' ASP . 82.4 m-85 -88.67 -2.83 58.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 109.883 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER 56.2 158.99 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.08 -24.04 20.85 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.893 2.396 . . . . 0.0 112.728 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.39 -48.24 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' MET . 12.2 mptt -67.88 -33.7 75.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 64' ' ' ASP . 94.1 t -56.16 -41.22 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.029 . . . . 0.0 109.551 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.11 68.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.46 17.7 20.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.399 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 67' ' ' LYS . 2.8 ttp -75.81 155.43 35.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.68 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 18.5 pt20 -105.48 162.53 13.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.96 -30.07 70.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -58.32 -41.32 84.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.425 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.5 m-20 -60.93 -39.83 90.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.36 -42.51 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -60.15 -34.06 73.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.635 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.41 -44.55 82.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 13.9 mt -65.04 -33.4 75.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.932 . . . . 0.0 109.626 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.79 -31.99 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -84.88 -60.89 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.552 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.23 123.73 43.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.371 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . . . -166.11 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.78 27.18 57.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ARG . 9.9 pt -133.0 167.38 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.138 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.71 58.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.634 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -106.69 139.79 40.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.471 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' GLY . 14.3 p80 -128.8 44.19 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.146 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HG2' HH11 ' A' ' 89' ' ' ARG . 3.9 ttt-85 65.67 -58.54 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -60.82 -35.35 89.94 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -61.27 -50.98 70.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -1.167 . . . . 0.0 109.461 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -52.39 -39.51 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.691 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.53 -36.63 76.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.0 109.32 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.14 95.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 1.7 mp -55.54 -47.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -58.46 -30.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.551 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.23 94.83 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.728 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 29.0 p30 -68.63 -33.35 73.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 109.358 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.728 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -67.4 -42.25 83.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -65.23 -45.95 82.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.585 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.72 63.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 29.8 t80 -68.83 -43.44 75.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.549 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -66.57 -47.96 71.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.474 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -57.97 -39.58 78.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 109.545 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 17.2 ttt -66.74 -41.24 88.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.85 -25.94 68.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -51.28 -29.28 14.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 105' ' ' MET . 51.0 p30 -80.16 -1.48 40.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.489 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.94 6.66 79.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HB3' HD21 ' A' ' 108' ' ' ASN . 32.4 tt0 -80.76 132.98 56.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.158 -1.201 . . . . 0.0 109.627 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.47 121.27 8.03 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.614 2.21 . . . . 0.0 111.726 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -74.72 -43.86 52.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.393 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' ' CA ' ' A' ' 28' ' ' SER . . . -56.06 -49.99 72.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -0.967 . . . . 0.0 110.708 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 86.5 m-20 -61.23 -42.7 99.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 27.5 t80 -55.31 -48.62 73.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 111.213 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.7 m -63.82 -48.5 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 0.0 111.721 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.488 ' CD2' ' N ' ' A' ' 118' ' ' SER . 4.3 p-90 -89.32 -37.49 14.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.769 -1.207 . . . . 0.0 111.117 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.4 m -56.18 -26.88 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.781 -1.199 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -13.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.04 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 118' ' ' SER . 18.7 m -82.8 21.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.071 -1.018 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t30 60.36 36.22 20.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.061 -1.024 . . . . 0.0 109.703 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.2 m80 53.54 27.08 6.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.47 87.91 21.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.72 151.78 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.695 2.263 . . . . 0.0 111.842 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -93.44 155.16 17.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.719 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 71.6 mtm -137.15 147.17 45.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.198 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.5 t -142.18 155.82 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.801 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -123.61 45.61 2.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.289 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.2 139.5 35.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 109.677 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.2 m -74.56 -35.52 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.8 t -139.45 178.92 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -68.84 -33.4 73.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.543 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m -63.12 -36.42 83.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.81 -24.44 64.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.161 -0.962 . . . . 0.0 109.404 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 132' ' ' LEU . 87.4 mt -67.28 119.95 68.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.728 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.76 129.22 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.088 2.526 . . . . 0.0 112.487 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 137' ' ' THR . 1.2 t -80.62 -19.19 45.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.4 m -98.05 98.54 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.858 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.5 p -106.23 154.61 39.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.32 -40.12 52.85 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.839 2.36 . . . . 0.0 111.999 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.16 -36.48 58.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.407 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -61.19 -41.3 96.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 -53.13 57.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.27 -35.26 79.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.435 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.01 -50.19 74.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 80.5 p -58.5 -37.69 76.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.91 -36.08 82.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.549 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.31 -50.56 45.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.467 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.603 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.88 -38.82 79.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.355 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -61.92 -39.37 91.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -63.84 -20.54 65.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.92 31.01 8.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.47 137.95 32.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.132 . . . . 0.0 109.454 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -101.19 173.58 6.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.485 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 52.82 50.79 17.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 157' ' ' VAL . 11.3 p -123.68 28.79 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -43.21 159.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.8 t -52.46 -29.81 26.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.373 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 55.5 m -65.9 -36.84 84.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.446 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.9 mm -62.24 -44.09 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.22 -48.7 80.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.411 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 42.9 t80 -60.21 -47.01 87.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.811 . . . . 0.0 109.352 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' A' ' 38' ' ' GLU . 22.6 t -61.64 -43.35 99.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.857 . . . . 0.0 109.27 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.411 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.0 OUTLIER -63.08 -32.63 74.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.47 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 31.5 ttm -64.29 -45.13 89.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.609 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.81 -34.1 77.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.672 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.659 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.557 ' SG ' HD22 ' A' ' 31' ' ' LEU . 1.2 m -77.2 -42.5 37.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.65 28.77 5.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.72 -34.33 77.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.41 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.69 132.15 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -84.64 100.95 11.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 45.6 p-10 -120.64 92.62 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 176' ' ' VAL . 75.5 m80 -132.99 36.35 3.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.67 HG12 ' N ' ' A' ' 177' ' ' VAL . 86.3 t 54.39 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.452 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.67 ' N ' HG12 ' A' ' 176' ' ' VAL . 8.1 p -110.61 136.23 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.75 24.13 75.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 181' ' ' CYS . 66.4 m -143.73 169.9 16.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 109.523 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 84.5 m 48.3 -93.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 179' ' ' CYS . 50.0 m -157.92 33.09 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 30.8 t80 -88.27 117.06 67.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.552 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 87.8 Cg_endo -84.1 -159.61 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.15 2.567 . . . . 0.0 112.374 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 90.53 7.87 66.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -143.67 33.64 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -127.34 80.15 72.15 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 123.077 2.518 . . . . 0.0 112.226 -179.836 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.4 161.85 40.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -88.55 148.64 24.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.965 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 7.9 p -47.39 146.02 2.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.66 2.87 46.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' HE1' HD22 ' A' ' 132' ' ' LEU . 8.8 m95 -54.22 -36.56 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -1.135 . . . . 0.0 109.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -97.01 131.14 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 13.0 t -177.31 -168.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.547 ' N ' ' OG ' ' A' ' 8' ' ' SER . 94.9 mt-30 49.38 -117.93 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.85 153.44 91.17 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.352 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.46 -6.14 18.28 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.804 2.336 . . . . 0.0 112.139 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.5 tt -59.82 -39.52 85.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.633 ' CZ ' HD13 ' A' ' 47' ' ' ILE . 88.7 m-85 -56.47 -43.73 79.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.43 -43.95 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.51 76.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.5 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.39 -40.15 93.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -63.42 -37.42 87.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -88.41 -4.41 58.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.513 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.561 HD22 HH22 ' A' ' 53' ' ' ARG . 48.0 t30 -74.09 -73.09 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -150.93 38.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.479 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -92.77 138.83 31.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.02 -21.39 44.18 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.58 132.44 72.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.247 -1.149 . . . . 0.0 109.366 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.48 119.69 6.28 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.724 2.282 . . . . 0.0 111.87 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.67 137.25 41.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -134.54 2.59 3.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.071 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -89.66 135.19 33.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.375 -0.828 . . . . 0.0 109.303 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.739 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 96.2 p -59.94 -38.28 81.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.632 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -57.02 -43.82 82.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.766 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.37 -53.31 24.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.0 mp -69.03 -27.89 66.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.783 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 56.1 t80 -60.36 -50.53 73.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.928 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -74.44 -31.11 62.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.813 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.89 -54.39 22.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -64.4 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.032 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' N ' HG23 ' A' ' 35' ' ' ILE . 36.1 t -73.36 -46.6 48.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.16 -0.962 . . . . 0.0 110.088 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.1 -41.67 97.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.877 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.22 -28.59 64.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.296 -0.878 . . . . 0.0 109.788 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.75 -37.07 27.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -66.07 -29.0 69.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -1.184 . . . . 0.0 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.4 tt0 -48.11 -34.22 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.72 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.42 111.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -33.12 5.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.0 mt -96.06 -145.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -1.14 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 m -144.68 155.97 43.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -51.17 -38.95 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.374 -0.829 . . . . 0.0 109.461 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.633 HD13 ' CZ ' ' A' ' 13' ' ' TYR . 9.7 tp -61.94 -40.44 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 109.672 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 47' ' ' ILE . 96.1 m -63.91 -35.87 82.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 53' ' ' ARG . 72.9 t -62.06 -42.82 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.473 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.43 -51.06 69.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -60.37 -44.08 95.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 109.348 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -75.78 -19.35 59.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.975 . . . . 0.0 109.361 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.561 HH22 HD22 ' A' ' 19' ' ' ASN . 43.8 ttp180 -61.22 -45.65 93.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 108.994 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 10.2 pt-20 -72.15 -43.0 65.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.34 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.95 -35.29 79.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.229 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 52.7 t80 -57.39 -49.27 76.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.427 -0.795 . . . . 0.0 109.308 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 61' ' ' HIS . 59.4 mtp180 -58.42 -43.12 88.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.741 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.97 -39.81 42.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.793 . . . . 0.0 110.305 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.5 m -96.78 -28.63 14.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 35.4 m-85 -95.71 -27.75 15.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.977 -1.077 . . . . 0.0 110.231 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.7 t60 -48.77 -21.66 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -90.87 -25.61 19.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.81 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 68' ' ' VAL . 61.9 m-85 -92.03 66.09 4.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 109.925 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' PHE . 3.7 m-20 -41.33 153.77 0.24 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 109.604 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -35.92 -53.66 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.852 2.368 . . . . 0.0 112.722 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.31 -45.11 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.64 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -67.35 -31.67 72.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.853 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 63' ' ' PHE . 93.9 t -56.45 -46.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.572 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.81 58.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.48 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 -3.58 58.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 mtp -70.97 141.1 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 109.646 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 31.1 tp60 -99.85 169.15 9.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 78.7 mm-40 -61.84 -33.87 74.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 46.7 mp0 -60.84 -40.89 94.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.437 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -62.74 -37.76 87.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.41 -43.29 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.48 -33.47 75.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.97 -44.76 91.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.314 -0.866 . . . . 0.0 109.792 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -70.07 -35.48 74.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 109.591 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.1 t -51.19 -34.94 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.739 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -87.83 -60.13 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.614 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -100.17 109.23 21.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.903 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.47 -60.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.47 4.61 70.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 85' ' ' ILE . 12.9 pt -90.02 -155.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.32 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.2 mt -68.62 136.79 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.478 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 87' ' ' ARG . 19.7 mmm-85 -88.6 95.89 10.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -172.41 88.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.13 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -49.96 -29.12 7.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.04 96.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -63.05 -48.19 79.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -1.186 . . . . 0.0 109.479 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.83 -44.13 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.598 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -54.51 -38.62 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.327 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.02 79.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 60' ' ' PHE . 44.1 mm -57.69 -46.66 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.432 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -55.18 -43.74 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.06 -36.23 85.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.602 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 16.5 t30 -56.87 -48.16 78.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.72 93.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.416 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 46.2 ttm-85 -66.56 -45.16 80.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.525 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.73 -36.06 67.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -71.08 -47.6 57.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.61 -37.79 85.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.865 . . . . 0.0 109.534 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.53 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.601 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 28.2 ttt -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.529 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.35 -27.19 67.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -52.11 -24.08 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.49 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -75.54 -18.12 59.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.8 7.43 68.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.59 150.28 38.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.205 -1.174 . . . . 0.0 109.728 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.99 119.17 6.18 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.621 2.214 . . . . 0.0 111.693 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -74.57 -44.91 48.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.803 . . . . 0.0 110.404 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -59.26 -48.58 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.201 -0.937 . . . . 0.0 110.732 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 83.2 m-20 -56.23 -43.59 78.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.204 -0.935 . . . . 0.0 111.081 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -61.93 -51.31 68.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 111.227 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 117' ' ' TRP . 6.7 m -57.97 -47.37 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.98 -1.075 . . . . 0.0 111.722 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD2' ' C ' ' A' ' 117' ' ' TRP . 5.3 p-90 -87.6 -28.04 22.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.696 -1.253 . . . . 0.0 111.178 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -59.61 -23.9 63.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 109.709 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.9 OUTLIER -43.85 -19.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.08 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.7 m -82.9 22.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.087 -1.008 . . . . 0.0 109.954 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 58.22 36.92 26.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -0.982 . . . . 0.0 109.67 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.1 m80 60.27 15.23 5.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.531 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -111.83 128.1 25.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.628 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.57 147.89 41.42 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.672 2.248 . . . . 0.0 111.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -98.5 144.5 27.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 109.751 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.4 ttp -132.07 135.06 46.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.784 . . . . 0.0 109.097 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.7 t -85.5 156.08 20.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.897 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -151.06 48.73 0.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.855 . . . . 0.0 109.3 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB1' ' OE2' ' A' ' 134' ' ' GLU . . . -100.82 -155.81 0.53 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.662 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.587 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.2 m -130.88 -54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 4.0 m -98.04 161.11 13.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.429 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.513 HD22 ' HE1' ' A' ' 6' ' ' TRP . 20.9 mt -75.53 -11.16 59.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 t -89.72 -39.04 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 130' ' ' THR . 11.2 pt-20 -68.66 -13.31 62.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 132' ' ' LEU . 79.1 mt -67.43 118.41 56.44 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.52 131.29 5.49 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.047 2.498 . . . . 0.0 112.536 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -91.39 -11.85 36.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.9 t -92.88 99.04 11.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.3 p -110.18 151.56 42.63 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -45.71 -40.79 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.815 2.343 . . . . 0.0 112.011 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.24 76.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -61.66 -42.2 98.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.863 . . . . 0.0 109.494 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -61.06 -44.46 97.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.65 -43.61 68.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.4 -49.56 77.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.7 m -54.12 -43.61 70.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.76 -38.14 84.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.11 -49.87 66.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.5 -34.94 74.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.878 . . . . 0.0 109.564 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -60.55 -36.79 79.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -60.76 -37.88 83.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -69.24 -21.32 63.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.283 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.77 4.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -97.51 129.92 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -92.97 167.16 11.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 51.54 48.31 23.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.7 p -121.63 25.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.45 165.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.8 t -56.87 -29.88 63.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -1.156 . . . . 0.0 109.442 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 m -59.77 -47.56 85.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 73.3 m -61.04 -42.89 99.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -60.31 -44.58 95.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.46 -0.775 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.5 p -61.98 -36.71 82.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.269 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -42.45 83.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 56.8 mtp -61.36 -39.24 89.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -61.69 -47.12 86.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.17 -38.98 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.696 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.98 -14.18 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.42 0.04 77.02 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.3 mp -63.04 -39.92 96.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.07 131.56 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.501 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' THR . 84.2 m-20 -95.66 117.98 31.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.443 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.15 105.15 17.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -145.89 144.5 30.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.67 137.08 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 177' ' ' VAL . 14.9 p -75.13 134.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.22 3.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.507 ' C ' ' H ' ' A' ' 181' ' ' CYS . 34.8 m -98.66 173.72 6.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -1.152 . . . . 0.0 109.534 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 54.1 m 54.45 5.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.443 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.507 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.3 m 62.8 50.19 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.602 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 23.9 t80 -124.6 80.33 61.45 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.59 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -84.99 30.79 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.067 2.511 . . . . 0.0 112.358 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.21 20.28 79.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 53.48 39.97 30.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -1.131 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 187' ' ' PRO . 16.6 pttp -83.16 147.42 53.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 186' ' ' LYS . 88.8 Cg_exo . . . . . 0 C--N 1.306 -1.659 0 C-N-CA 123.017 2.478 . . . . 0.0 112.238 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 2.3 pm0 -98.7 149.37 22.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 45.1 mtm-85 -107.98 149.84 27.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.487 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 6' ' ' TRP . 16.3 p -96.39 -176.14 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.39 -24.83 0.9 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.659 ' CD2' HD21 ' A' ' 132' ' ' LEU . 11.4 m0 53.13 55.68 8.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -59.84 -5.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 6' ' ' TRP . 52.6 m -47.22 114.33 0.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 109.418 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -167.84 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -151.55 150.89 27.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.427 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.0 -36.97 16.75 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.896 2.397 . . . . 0.0 112.145 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 47' ' ' ILE . 52.3 tp -63.44 -51.25 66.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -70.08 -45.12 67.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 109.379 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.9 mt -59.81 -42.37 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.347 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.94 -47.1 69.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.935 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.417 ' CE1' HD22 ' A' ' 50' ' ' LEU . 87.7 t80 -59.85 -44.7 93.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.496 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.412 ' CE1' ' CE3' ' A' ' 21' ' ' TRP . 19.9 t60 -62.6 -45.54 92.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.27 -22.25 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.19 -75.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -145.15 113.8 6.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.873 . . . . 0.0 109.52 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CE3' ' CE1' ' A' ' 17' ' ' HIS . 62.3 t90 -172.99 139.61 0.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -29.84 3.1 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 169' ' ' CYS . 3.7 m -68.02 149.19 98.27 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.232 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.99 128.25 17.4 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.805 2.337 . . . . 0.0 111.891 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -124.99 130.67 52.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.78 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -123.13 12.21 9.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.072 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.3 136.8 35.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 92.0 p -73.16 -33.61 65.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.07 -51.57 60.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HZ3' ' HB3' ' A' ' 30' ' ' LYS . 8.9 mtpm? -62.79 -46.39 88.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 109.861 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.42 -37.21 80.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 109.834 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -65.15 -51.32 61.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.12 -32.55 73.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.1 tpt -59.36 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.806 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -61.29 -39.06 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.7 m -65.7 -45.29 83.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.54 -41.23 66.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.13 -34.17 73.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.38 -36.18 88.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.83 -26.63 64.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -1.191 . . . . 0.0 109.748 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 44' ' ' LEU . 5.2 pt20 -51.47 -26.07 7.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.698 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.09 109.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.95 -33.42 5.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 mt -97.36 175.18 6.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -1.175 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.8 m -100.94 161.79 13.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 45.2 p90 -55.48 -41.29 72.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.862 . . . . 0.0 109.446 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 8.7 tp -57.97 -38.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.724 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.469 ' N ' HG23 ' A' ' 47' ' ' ILE . 90.3 m -64.69 -37.95 89.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.694 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.43 -42.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.466 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 16' ' ' TYR . 74.5 mt -57.99 -42.49 85.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -61.72 -51.5 68.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 11.5 mptt -65.75 -36.58 83.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -47.15 -42.65 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.194 -0.941 . . . . 0.0 109.006 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -70.17 -42.48 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -63.43 -47.46 81.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.266 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CD2' ' CE1' ' A' ' 60' ' ' PHE . 12.3 m-85 -58.68 -49.27 78.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 17.9 mmm180 -53.3 -27.75 24.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.35 -29.43 15.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 56' ' ' TYR . 16.7 m-85 -81.73 -51.75 7.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.945 -1.097 . . . . 0.0 110.205 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 53.1 t60 -51.62 -42.3 61.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.829 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -73.67 -14.58 61.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CE2' ' SD ' ' A' ' 71' ' ' MET . 16.3 t80 -93.3 2.83 56.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.007 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER 57.93 159.2 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.024 . . . . 0.0 109.598 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.2 -53.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.886 2.391 . . . . 0.0 112.707 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.1 t -48.17 -41.95 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.717 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -64.74 -34.57 78.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.382 -0.824 . . . . 0.0 109.883 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 64' ' ' ASP . 54.5 t -56.93 -40.55 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.614 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -70.68 -32.94 70.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 109.452 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.04 18.57 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.603 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -75.36 155.2 36.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.689 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.8 tp60 -102.63 167.54 9.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 96.4 mt-10 -70.05 -25.92 63.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.2 -30.99 67.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.465 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.27 -49.7 68.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 76' ' ' VAL . 8.5 m -59.65 -37.88 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.9 mt-10 -58.99 -35.98 74.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.3 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -65.72 -40.2 91.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.16 -34.28 77.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.9 -35.49 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -87.06 -62.03 1.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -101.34 107.08 18.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.61 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.85 14.38 65.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.6 pt -104.09 178.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -1.154 . . . . 0.0 109.391 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.51 140.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HG3' HH11 ' A' ' 87' ' ' ARG . 44.0 mtm-85 -87.81 101.81 14.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.52 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.464 ' CD2' ' HZ2' ' A' ' 91' ' ' LYS . 49.2 t-80 -171.54 82.04 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.218 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 15.3 ptm180 -46.84 -30.46 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.961 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.83 93.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HZ2' ' CD2' ' A' ' 88' ' ' HIS . 62.3 mttp -66.11 -42.62 88.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.6 mt -63.64 -49.55 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.37 -35.6 67.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.375 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.3 86.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.98 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.06 -39.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.539 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.69 95.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.481 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 3.0 m120 -63.26 -43.83 96.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.153 -1.204 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.06 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.536 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 47.6 ttm-85 -58.46 -41.75 85.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.21 70.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.87 -48.46 81.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -61.75 -44.72 96.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.6 -44.26 93.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.531 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.604 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 23.7 ttt -67.11 -32.54 73.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.48 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.91 -29.25 69.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -52.29 -24.75 7.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.15 -18.7 59.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.492 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.8 55.11 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -116.85 150.8 46.46 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -1.181 . . . . 0.0 109.691 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.21 130.86 26.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.618 2.212 . . . . 0.0 111.659 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -79.25 -49.21 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.475 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -55.77 -48.92 74.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.53 ' O ' ' OG ' ' A' ' 118' ' ' SER . 85.3 m-20 -60.0 -43.63 95.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 111.053 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.59 -50.92 70.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.067 -1.021 . . . . 0.0 111.188 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 4.6 m -59.31 -48.45 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.096 -1.003 . . . . 0.0 111.64 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.474 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 5.0 p-90 -88.88 -33.38 17.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 0.0 111.147 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 120' ' ' VAL . 66.8 m -55.08 -26.44 37.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.793 -1.192 . . . . 0.0 109.752 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.32 -14.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 118' ' ' SER . 12.9 m -85.07 27.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.046 -1.034 . . . . 0.0 109.983 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 75.78 19.0 2.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.747 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 58.72 39.65 24.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.438 ' H ' HG23 ' A' ' 120' ' ' VAL . 8.3 pt20 -146.05 146.77 29.56 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.636 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.86 147.56 44.35 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.691 2.261 . . . . 0.0 111.814 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -111.21 153.72 25.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 58.2 ttm -133.26 148.83 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.1 t -122.52 164.84 17.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -133.41 49.68 2.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.308 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.52 -158.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 11.7 m -145.34 -27.48 0.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.57 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 8.9 m -127.73 157.98 38.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.1 OUTLIER -75.22 -12.79 60.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.2 m -93.0 -32.53 14.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 131' ' ' THR . 5.6 pt-20 -74.11 -1.42 20.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.925 . . . . 0.0 109.428 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 28.9 mm -66.9 130.85 93.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.77 126.24 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.096 2.531 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 137' ' ' THR . 3.1 m -89.77 -10.57 45.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.9 . . . . 0.0 109.342 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 72.2 p -94.13 102.26 14.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 p -119.11 149.9 47.92 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.53 -31.84 87.67 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.801 2.334 . . . . 0.0 111.973 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.17 58.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 42.9 t -62.08 -46.33 89.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.469 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -61.67 -46.23 90.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.57 84.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.67 -47.11 82.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.0 t -54.5 -45.09 73.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -60.62 -33.33 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.547 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.24 16.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 149' ' ' LEU . 10.7 mp -60.15 -34.75 73.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.575 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -58.15 -34.97 70.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.43 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -62.66 -36.31 82.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.637 HH11 ' CG ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -72.14 -19.88 61.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.357 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.56 30.11 7.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.481 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 5.1 m-85 -86.29 132.67 33.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -1.108 . . . . 0.0 109.474 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -104.79 177.86 4.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 52.8 47.94 23.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 158' ' ' GLY . 26.9 m -116.32 25.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.58 166.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.0 m -54.01 -32.54 54.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.3 p -65.09 -48.04 75.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -66.31 -39.29 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 7.9 t -68.58 -44.31 74.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.5 -42.03 98.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -59.27 -33.47 71.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.245 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.587 ' CZ ' ' SG ' ' A' ' 169' ' ' CYS . 79.4 t80 -65.77 -35.45 80.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.397 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 65.2 mmm -63.32 -52.2 62.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.85 -38.0 85.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.45 -54.19 49.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.675 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.587 ' SG ' ' CZ ' ' A' ' 165' ' ' PHE . 8.7 m -66.29 -33.23 75.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.01 35.38 6.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.4 mt -74.05 -41.39 61.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.425 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 172' ' ' VAL . 3.0 m -96.56 134.27 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -88.66 110.04 20.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -84.57 122.42 29.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -142.38 165.55 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.601 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 4.8 m -122.65 164.11 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.89 . . . . 0.0 109.414 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.427 HG22 ' CE2' ' A' ' 182' ' ' TYR . 59.3 t -96.21 133.38 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 72.2 29.48 66.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 178' ' ' GLY . 3.3 m -164.64 178.74 7.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.46 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 43.6 t 51.03 -98.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 7.7 m -162.91 27.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.645 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -116.01 97.03 48.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.605 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.543 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 90.7 Cg_endo -86.56 -153.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.02 2.48 . . . . 0.0 112.378 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.82 9.32 37.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -151.67 32.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.54 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -83.68 154.22 65.0 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.555 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 123.034 2.49 . . . . 0.0 112.223 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 tpp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.256 0.55 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -88.81 146.11 25.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.598 HH12 HG23 ' A' ' 14' ' ' ILE . 70.9 mtm180 -101.94 174.59 5.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 m -140.94 71.37 1.36 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 7' ' ' VAL . . . -139.88 -5.67 1.19 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 19.8 m95 49.53 11.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.411 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.8 m -62.25 140.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -168.32 36.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.965 . . . . 0.0 109.349 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 10' ' ' ASP . 70.0 tp60 -142.76 110.03 5.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLN . 6.3 t70 61.71 134.51 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.28 -10.17 23.87 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.819 2.346 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.34 -41.58 98.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -69.65 -41.57 75.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.8 mp -60.8 -51.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.424 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -46.97 65.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.429 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' OH ' ' CZ3' ' A' ' 21' ' ' TRP . 60.5 t80 -61.55 -43.83 98.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.491 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.0 -39.96 94.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -88.16 -0.11 56.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -75.19 -78.91 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.835 . . . . 0.0 109.407 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -147.06 40.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CZ3' ' OH ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -103.89 145.47 30.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.57 62.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 23' ' ' VAL . 1.2 m -84.67 152.26 59.72 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.226 -1.161 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 121.13 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.727 2.285 . . . . 0.0 111.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 78.4 mm-40 -123.8 135.92 54.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.9 p -126.75 12.33 7.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.281 -0.887 . . . . 0.0 109.055 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.88 134.44 47.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.385 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 83.4 p -72.44 -37.9 68.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -67.8 -34.57 77.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.27 -0.894 . . . . 0.0 109.804 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' HZ1' ' CD ' ' A' ' 25' ' ' GLU . 30.6 ttmt -75.23 -54.29 7.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD22 ' HB1' ' A' ' 113' ' ' ALA . 8.5 mp -66.57 -37.28 84.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.856 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 51.0 t80 -61.17 -42.73 99.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.938 . . . . 0.0 109.904 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.2 -29.51 64.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.599 ' SD ' ' CH2' ' A' ' 46' ' ' TRP . 49.9 tpp -74.46 -54.28 7.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.783 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 36' ' ' CYS . 9.3 tp -57.18 -37.74 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.043 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 15.0 p -73.16 -46.28 51.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 61.9 tp -73.28 -34.99 66.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -0.99 . . . . 0.0 109.932 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 43.2 tp10 -52.13 -28.66 18.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.69 51.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -62.36 -32.41 73.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 109.754 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.426 HE21 ' H ' ' A' ' 46' ' ' TRP . 50.2 tt0 -50.21 -35.07 24.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.705 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.43 116.84 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.42 -20.2 49.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.48 -144.34 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -1.205 . . . . 0.0 109.414 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.7 t -146.4 151.22 37.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CH2' ' SD ' ' A' ' 34' ' ' MET . 72.6 t-105 -55.35 -28.47 54.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.609 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -54.05 -37.89 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.727 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 18.8 m -85.26 -33.84 22.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 109.657 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -61.06 -36.99 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.45 HD21 ' HE1' ' A' ' 46' ' ' TRP . 19.8 mt -54.63 -54.05 46.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.1 -49.96 75.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.262 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -65.51 -33.33 75.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HG2' HH11 ' A' ' 53' ' ' ARG . 28.0 ttt-85 -48.97 -43.71 40.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.14 -40.62 86.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -66.36 -40.84 90.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.288 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD1' HD12 ' A' ' 85' ' ' ILE . 4.5 m-85 -56.22 -48.61 76.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 84.7 mtm180 -64.74 -27.08 68.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 0.0 109.81 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.1 94.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 83' ' ' ALA . 86.9 m -94.45 -40.79 9.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.3 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.74 -52.01 16.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 0.0 110.224 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 39.2 t60 -50.94 -38.28 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.899 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -54.32 -36.98 64.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.12 -0.988 . . . . 0.0 109.811 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' ASP . 86.9 m-85 -97.54 3.71 50.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.883 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.92 161.44 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.096 -1.003 . . . . 0.0 109.569 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.12 -26.37 21.42 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.885 2.39 . . . . 0.0 112.694 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.6 t -62.68 -48.81 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.734 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' MET . 89.2 mttt -67.17 -31.79 72.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 64' ' ' ASP . 75.1 t -56.32 -41.37 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 109.606 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.96 62.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.507 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.24 3.06 51.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.3 mtp -66.2 136.67 56.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.617 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -92.12 168.12 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 57.4 mp0 -59.23 -29.7 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.462 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.4 -44.35 88.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.5 -37.52 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.82 -44.02 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -35.72 76.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -60.56 -41.5 94.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 109.736 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 82' ' ' ASP . 92.1 mt -72.73 -31.92 65.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.175 -0.953 . . . . 0.0 109.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.83 -31.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.938 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -84.29 -59.27 2.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.978 . . . . 0.0 109.568 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 21.3 t70 -96.33 148.27 22.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.897 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.09 71.68 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.406 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -89.24 30.59 5.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' O ' ' A' ' 86' ' ' ILE . 4.9 pt -45.75 117.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.31 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.715 ' CG1' ' H ' ' A' ' 87' ' ' ARG . 3.5 tt 38.63 -168.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.504 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.715 ' H ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -52.16 152.56 3.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.504 ' ND1' HD11 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -141.91 -162.9 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 109.184 -178.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.684 ' H ' ' CD1' ' A' ' 92' ' ' ILE . 56.7 ttt180 62.37 -77.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 109.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -71.86 -48.07 29.3 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.21 -38.6 87.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.684 ' CD1' ' H ' ' A' ' 89' ' ' ARG . 52.5 mt -55.07 -46.64 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 109.648 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.428 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.57 82.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.8 -38.79 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.5 mt -54.22 -46.59 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.18 -36.1 92.49 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.541 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -60.96 -49.08 78.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -1.23 . . . . 0.0 109.422 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.89 89.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -64.62 -46.83 80.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.25 69.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.421 ' CD1' ' CE1' ' A' ' 32' ' ' PHE . 77.2 t80 -64.64 -46.81 80.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 109.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.05 -40.65 98.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -57.45 -42.51 82.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 25.5 ttt -71.09 -33.26 70.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.548 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.69 -30.77 71.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -51.4 -25.91 6.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 109.548 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -76.47 -16.65 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.01 41.65 47.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -129.79 151.11 77.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.186 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.2 125.7 15.06 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.592 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 23.9 t80 -72.99 -44.1 61.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.42 -0.8 . . . . 0.0 110.417 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -54.98 -48.85 72.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.742 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 118' ' ' SER . 87.2 m-20 -52.16 -38.38 57.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 111.102 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -72.7 -49.87 28.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 111.244 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.45 -49.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.01 -1.056 . . . . 0.0 111.696 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.452 ' HB2' HD11 ' A' ' 171' ' ' LEU . 15.8 p-90 -87.01 -24.38 24.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.709 -1.244 . . . . 0.0 111.147 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' VAL . 7.7 t -57.63 -32.99 67.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.61 -12.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 7.3 p -83.09 23.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 12.0 t-20 79.33 16.63 0.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 109.73 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CD2' ' OG ' ' A' ' 118' ' ' SER . 7.1 m80 57.74 43.54 21.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -155.31 148.44 18.29 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.0 151.34 73.42 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.655 2.237 . . . . 0.0 111.833 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -120.35 146.49 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 109.801 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 80.6 mtp -129.59 156.26 44.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 109.184 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 173' ' ' ASN . 6.6 t -128.9 147.59 50.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.908 . . . . 0.0 109.797 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -113.24 43.02 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 109.302 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.437 ' HB1' ' CG ' ' A' ' 134' ' ' GLU . . . -75.58 152.1 37.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 m -92.48 -34.41 14.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.79 30.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.481 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -74.06 -9.11 58.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 75.6 p -83.4 -31.53 26.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.437 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -78.19 -18.47 55.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 31.4 mt -67.51 116.88 41.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.765 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.11 136.83 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.146 2.564 . . . . 0.0 112.5 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.8 t -85.05 -4.25 59.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.353 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.2 t -98.39 103.66 15.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.367 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 p -126.89 152.68 75.69 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.13 -42.53 26.34 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.758 2.305 . . . . 0.0 112.043 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.36 -37.85 63.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -49.73 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 109.506 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.32 -39.41 93.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.04 77.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.0 OUTLIER -62.68 -44.25 96.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.4 p -62.16 -38.07 87.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.52 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -65.05 -36.47 84.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.86 -50.51 56.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.75 -34.32 76.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -60.24 -41.69 93.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -63.89 -38.19 90.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.55 HH22 ' CE ' ' A' ' 105' ' ' MET . 11.7 tpp180 -64.4 -21.47 66.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.34 24.18 6.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -95.39 130.65 42.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -1.111 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 63.2 mttp -98.06 -167.12 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 19.0 p90 40.31 38.86 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.5 OUTLIER -102.34 25.96 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -45.38 163.83 0.08 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.445 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 2.5 t -63.43 -23.99 67.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -1.161 . . . . 0.0 109.478 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.5 p -70.07 -38.45 75.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -69.74 -41.24 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.3 p -64.88 -33.72 76.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.457 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 51.9 t80 -65.61 -50.97 63.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.374 -0.829 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 18.9 t -58.69 -33.11 69.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 109.28 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.84 -42.18 88.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.444 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 52.0 mtt -62.96 -37.43 87.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -55.07 -40.26 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.76 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.91 11.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.504 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 10.5 t -59.29 -37.27 77.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.94 14.28 52.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.504 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 4.4 mp -54.83 -56.81 15.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.7 m -84.16 134.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.457 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.667 HD21 ' CE1' ' A' ' 175' ' ' HIS . 17.2 t-20 -100.56 103.78 15.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.435 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 32.4 p30 -103.47 91.47 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.536 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.667 ' CE1' HD21 ' A' ' 173' ' ' ASN . 44.6 m170 -102.81 0.3 32.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.592 ' O ' ' O ' ' A' ' 175' ' ' HIS . 6.2 t 56.61 139.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.55 123.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.98 -50.15 0.71 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 181' ' ' CYS . 7.8 t -150.46 -132.67 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -1.157 . . . . 0.0 109.519 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 8.5 t 52.95 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 179' ' ' CYS . 35.9 t -162.49 32.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 183' ' ' PRO . 26.3 t80 -124.25 97.76 39.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.643 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 182' ' ' TYR . 68.6 Cg_exo -51.38 -135.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.037 2.491 . . . . 0.0 112.368 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 91.74 3.78 68.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -169.58 37.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.607 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.426 ' CB ' ' NZ ' ' A' ' 186' ' ' LYS . 7.3 ttpm? -140.02 79.5 22.33 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.209 -0.932 . . . . 0.0 109.566 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--N 1.306 -1.662 0 C-N-CA 123.06 2.506 . . . . 0.0 112.264 -179.766 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.414 ' OE1' ' SG ' ' A' ' 179' ' ' CYS . 95.1 mt-10 -86.47 148.37 25.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 3' ' ' ARG . 44.3 mtm-85 -139.39 150.03 44.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 180' ' ' CYS . 8.0 m -59.8 151.83 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.419 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.22 -20.68 16.27 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -52.64 -34.96 53.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 109.436 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.34 128.81 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.555 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 9' ' ' GLN . 22.6 t -169.68 129.97 1.02 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 8' ' ' SER . 92.8 mm-40 44.8 -156.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.371 -0.83 . . . . 0.0 109.526 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 52.38 64.09 7.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -45.64 -34.94 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.771 2.314 . . . . 0.0 112.185 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' CD2' ' HZ3' ' A' ' 51' ' ' LYS . 60.1 tp -63.87 -38.63 91.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 17' ' ' HIS . 86.6 t80 -66.65 -43.61 84.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.44 -43.65 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.23 83.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -59.94 -42.83 94.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.365 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 13' ' ' TYR . 2.4 m-70 -62.24 -39.47 92.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -60.63 -27.45 67.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.61 -77.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.506 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -143.64 116.24 8.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -172.17 140.09 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.59 -28.22 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.538 HG23 ' OE2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -67.9 154.4 93.69 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.184 -1.186 . . . . 0.0 109.412 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.07 120.09 4.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.762 2.308 . . . . 0.0 111.959 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.538 ' OE2' HG23 ' A' ' 23' ' ' VAL . 18.8 mp0 -103.15 133.86 47.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.812 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -134.77 4.1 3.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -80.93 133.2 35.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 p -61.35 -34.44 75.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.86 -52.3 57.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -68.74 -45.9 70.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.884 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.29 -46.55 89.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.868 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.475 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 93.8 t80 -68.05 -47.29 68.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -64.08 -30.72 71.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.854 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.671 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 55.7 ttm -64.71 -51.83 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mm -58.28 -47.41 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 12.4 p -62.55 -37.89 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.052 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.525 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 6.2 tp -66.69 -39.81 88.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.852 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.12 -27.81 69.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.5 -36.51 11.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.522 ' N ' ' OE1' ' A' ' 40' ' ' GLN . 1.7 mp0 -59.9 -33.79 72.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.2 tt0 -57.18 -29.74 63.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.715 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -45.03 109.83 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.626 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.67 -32.3 5.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.0 mt -103.67 -155.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -1.153 . . . . 0.0 109.464 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 m -121.97 149.67 43.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 47' ' ' ILE . 23.7 p90 -49.05 -36.51 18.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.642 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -60.9 -37.2 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.659 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.463 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 57.2 m -64.46 -33.69 76.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.95 -38.96 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.1 mp -54.3 -52.06 62.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HZ3' ' CD2' ' A' ' 12' ' ' LEU . 61.0 mttm -59.67 -49.21 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.325 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.22 -34.13 77.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.62 ' NH1' HH21 ' A' ' 57' ' ' ARG . 3.1 ttt-85 -49.5 -45.44 47.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.118 -0.989 . . . . 0.0 108.937 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -66.84 -40.6 88.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.412 -0.805 . . . . 0.0 109.376 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.565 HD21 ' C ' ' A' ' 84' ' ' GLY . 36.5 t-20 -64.51 -40.98 96.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.851 . . . . 0.0 109.249 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' PHE . 4.4 m-85 -56.59 -43.34 79.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.779 . . . . 0.0 109.304 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.62 HH21 ' NH1' ' A' ' 53' ' ' ARG . 96.7 mtt180 -58.61 -36.22 73.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -49.29 76.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.198 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' ' CE2' ' A' ' 60' ' ' PHE . 3.2 p -94.68 -13.2 26.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.285 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' TYR . 63.6 m-85 -133.27 32.16 3.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.913 -1.117 . . . . 0.0 110.192 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 p80 -46.91 -42.94 18.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' PHE . 40.6 tt0 -79.64 -42.9 23.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.806 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 69.5 t80 44.07 36.64 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -56.57 113.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 109.558 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.07 -45.12 7.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.944 2.429 . . . . 0.0 112.678 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.8 p -66.27 -45.33 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 66' ' ' VAL . 55.3 tttp -61.94 -45.24 94.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.82 -39.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.095 . . . . 0.0 109.628 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.31 64.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.494 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 12.77 23.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.6 tpp -50.41 161.05 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.625 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.82 156.99 19.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.81 -33.38 74.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.5 -39.22 86.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' VAL . 91.3 t -71.84 -28.54 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -68.34 -43.57 77.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.341 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 30.9 ptt180 -76.42 -34.63 58.8 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.838 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 mt -61.84 -39.05 90.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.678 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 76' ' ' VAL . 53.5 t -58.56 -28.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.118 -0.988 . . . . 0.0 109.736 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.55 -53.79 3.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 78' ' ' ARG . 1.9 p30 -99.77 106.52 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.72 -64.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.565 ' C ' HD21 ' A' ' 55' ' ' ASN . . . 91.34 -1.48 76.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 85' ' ' ILE . 15.5 pt -77.11 -159.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 109.36 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.42 136.56 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 96.6 mtt180 -79.35 95.68 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 9.6 m-70 -166.47 82.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 109.214 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -46.56 -35.25 5.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.984 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.83 -34.37 82.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -72.45 -41.69 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.509 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.6 -56.29 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.29 -30.95 63.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.7 99.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.39 -43.11 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.6 mm -54.59 -48.1 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.28 -34.28 89.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 32' ' ' PHE . 15.8 t-20 -56.65 -45.8 81.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.184 . . . . 0.0 109.337 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.76 73.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.542 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -61.29 -43.4 98.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.434 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.38 -33.38 75.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.579 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.34 -46.42 83.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.21 -42.65 99.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -59.12 -53.87 53.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.543 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 26.0 ttt -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.73 -27.41 65.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -52.05 -26.42 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -75.69 -19.09 59.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.44 18.86 65.46 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.34 151.65 37.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.9 119.18 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.618 2.212 . . . . 0.0 111.668 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -75.42 -43.33 50.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -59.79 -47.62 84.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 118' ' ' SER . 92.2 m-20 -51.1 -54.93 20.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 0.0 111.029 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.25 -43.35 82.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' O ' HD11 ' A' ' 145' ' ' LEU . 62.3 t -54.39 -60.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.018 -1.051 . . . . 0.0 111.679 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.708 ' O ' HG22 ' A' ' 120' ' ' VAL . 67.8 p-90 -86.03 -17.86 34.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.727 -1.233 . . . . 0.0 111.153 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.508 ' OG ' ' NE2' ' A' ' 122' ' ' HIS . 9.2 t -54.98 -30.61 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.872 -1.142 . . . . 0.0 109.744 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER -43.43 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 178.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.9 m -82.84 24.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.945 . . . . 0.0 110.004 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.87 29.28 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.683 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.508 ' NE2' ' OG ' ' A' ' 118' ' ' SER . 26.1 m80 55.62 34.48 23.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.592 ' H ' HG23 ' A' ' 120' ' ' VAL . 72.6 mt-30 -141.91 114.53 6.52 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.45 154.49 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.648 2.232 . . . . 0.0 111.861 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.493 HE22 ' CB ' ' A' ' 141' ' ' ALA . 94.4 mt-30 -106.59 144.4 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.586 ' CE ' HD22 ' A' ' 173' ' ' ASN . 80.1 mtp -137.61 151.73 48.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.797 . . . . 0.0 109.187 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.1 t -129.65 160.09 34.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.904 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.04 46.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 0.0 109.26 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.45 -135.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.73 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 m -143.34 -33.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.378 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 t -137.96 170.77 15.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.757 ' H ' HD12 ' A' ' 132' ' ' LEU . 5.5 mp -68.31 -32.29 72.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.4 m -54.21 -37.3 64.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.184 -0.947 . . . . 0.0 109.478 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.7 -35.04 78.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.917 . . . . 0.0 109.427 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.767 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.8 mp -81.36 117.82 69.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.692 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.663 ' C ' ' H ' ' A' ' 138' ' ' SER . 89.0 Cg_endo -82.59 2.49 8.47 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.133 2.556 . . . . 0.0 112.555 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.531 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER 56.08 -4.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 136' ' ' PRO . 65.2 p -123.41 80.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.319 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -83.74 153.78 64.53 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.49 -37.01 19.22 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.773 2.315 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.493 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -71.97 -36.83 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.311 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.2 m -61.38 -49.07 78.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.462 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 49.8 t0 -62.93 -45.91 90.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.42 86.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 116' ' ' VAL . 6.5 tt -66.0 -43.52 87.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -54.64 -44.99 73.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.462 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 61.1 mttp -63.81 -30.74 71.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.573 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.56 -52.03 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 149' ' ' LEU . 3.8 mm? -62.91 -39.09 93.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.78 -37.54 87.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -60.8 -38.14 84.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.359 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.583 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -63.8 -22.7 67.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.378 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 116.53 9.51 11.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.434 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 46.8 m-85 -82.53 133.74 35.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -1.143 . . . . 0.0 109.494 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 60.6 mttp -99.97 -169.39 1.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.439 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 14.5 p90 39.43 40.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 158' ' ' GLY . 0.3 OUTLIER -110.57 25.44 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.364 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.49 170.7 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.5 t -62.77 -28.13 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -1.097 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 68.3 p -64.59 -48.17 75.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.8 mp -63.92 -35.9 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.88 -48.54 73.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.312 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.54 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 58.3 t80 -60.11 -43.21 95.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -59.63 -39.19 83.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -68.03 -41.01 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.437 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.441 ' SD ' HD22 ' A' ' 171' ' ' LEU . 35.4 mmm -59.74 -41.2 90.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.0 109.573 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 163' ' ' TYR . 49.4 mt-30 -69.8 -46.14 66.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.671 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -63.8 -34.34 77.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.504 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 17.2 t -81.41 -4.35 55.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 65.77 24.13 71.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.441 HD22 ' SD ' ' A' ' 166' ' ' MET . 1.8 tp -68.8 -47.16 66.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 109.422 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 172' ' ' VAL . 8.2 p -103.45 131.98 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.586 HD22 ' CE ' ' A' ' 126' ' ' MET . 79.9 m-20 -90.54 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -98.27 119.05 36.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.498 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.652 ' ND1' ' CD2' ' A' ' 182' ' ' TYR . 2.5 p80 -164.33 127.28 2.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.55 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.81 150.98 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.413 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 140.72 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.131 -0.981 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 179' ' ' CYS . . . 91.75 1.62 70.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.476 ' C ' ' H ' ' A' ' 181' ' ' CYS . 49.9 m -155.01 179.5 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 5.2 t 60.4 1.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 179' ' ' CYS . 3.4 t 65.82 50.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.902 . . . . 0.0 109.614 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.652 ' CD2' ' ND1' ' A' ' 175' ' ' HIS . 0.4 OUTLIER -116.49 95.91 46.8 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.538 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 93.4 Cg_endo -86.91 -168.42 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.101 2.534 . . . . 0.0 112.35 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 94.87 -14.32 65.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.25 19.33 5.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -1.157 . . . . 0.0 109.638 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -83.27 151.47 62.88 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.307 -1.626 0 C-N-CA 122.997 2.465 . . . . 0.0 112.242 179.937 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.607 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.265 0.555 . . . . 0.0 109.525 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.607 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.8 pm0 -134.67 162.58 31.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -143.6 172.52 12.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -46.52 159.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -109.87 -21.76 6.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -66.08 -11.83 51.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG12 ' H ' ' A' ' 8' ' ' SER . 43.6 t -82.39 -123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.765 ' H ' HG12 ' A' ' 7' ' ' VAL . 23.8 t 53.5 170.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 8' ' ' SER . 52.3 tt0 59.5 135.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' LEU . 13.4 m-20 50.45 82.05 0.25 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.3 -10.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.828 2.352 . . . . 0.0 112.108 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 47' ' ' ILE . 18.3 tp -62.7 -34.01 76.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 33.2 m-85 -54.26 -41.97 69.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.365 -0.835 . . . . 0.0 109.504 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.8 mt -80.0 -33.14 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.435 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.32 -48.19 71.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 109.509 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 13' ' ' TYR . 1.5 p90 -76.51 -34.27 58.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.482 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 57.3 t-80 -55.77 -50.01 71.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.26 -38.44 65.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.419 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -56.02 -46.59 78.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 21' ' ' TRP . 22.9 pt-20 -173.28 -146.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.468 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.486 ' O ' ' O ' ' A' ' 20' ' ' GLU . 27.9 t-105 58.94 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.14 -9.0 59.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.2 154.43 37.68 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.94 119.9 7.02 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.786 2.324 . . . . 0.0 111.899 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -127.47 136.69 52.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.975 . . . . 0.0 109.826 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.0 p -131.55 9.46 4.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 0.0 109.075 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -90.68 135.17 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 0.0 109.299 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.744 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 89.4 p -61.67 -39.31 90.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.9 -41.09 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 0.0 109.774 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -77.23 -53.89 7.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.905 . . . . 0.0 109.863 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD22 ' HB1' ' A' ' 113' ' ' ALA . 10.9 mp -64.6 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 80.0 t80 -62.33 -56.45 18.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 109.854 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.84 -31.14 70.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.902 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.501 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.56 -51.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.866 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mm -62.43 -43.3 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -60.86 -48.38 82.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 110.086 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 8.2 mp -73.69 -44.68 55.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 109.929 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -58.89 -37.13 75.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.69 -25.1 34.88 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -82.64 -18.39 41.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.234 . . . . 0.0 109.773 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 44' ' ' LEU . 3.6 pp0? -61.95 -21.44 64.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.71 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.07 110.22 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.695 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.03 -32.9 5.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.05 164.37 12.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -1.142 . . . . 0.0 109.448 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -86.26 167.06 15.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 47' ' ' ILE . 5.4 p90 -61.07 -43.78 98.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.444 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 48' ' ' THR . 10.4 tp -43.52 -42.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.691 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.553 ' N ' HG23 ' A' ' 47' ' ' ILE . 95.1 m -61.13 -34.21 74.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 46' ' ' TRP . 16.4 t -66.56 -46.7 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.33 -53.06 61.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -61.64 -46.21 90.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.351 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 56' ' ' TYR . 43.6 tttm -65.44 -30.18 70.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.383 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.2 ttm180 -55.72 -48.37 75.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.267 -0.895 . . . . 0.0 108.952 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.47 -46.64 87.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.45 -0.781 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 94.4 m-20 -69.07 -32.42 71.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.251 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.7 t80 -62.28 -44.61 96.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.405 -0.809 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 61' ' ' HIS . 14.5 mtm180 -60.08 -42.22 94.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 109.764 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.52 69.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -0.815 . . . . 0.0 110.301 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.6 m -92.98 -12.1 31.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 110.281 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 65.6 m-85 -129.47 -48.11 1.17 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.882 -1.137 . . . . 0.0 110.155 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' ARG . 62.3 t60 -50.14 -43.46 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.085 -1.009 . . . . 0.0 109.904 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -66.56 -25.92 66.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 93.4 m-85 -91.88 16.48 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 109.889 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 55.12 167.05 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.94 -55.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.832 2.355 . . . . 0.0 112.68 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -48.93 -44.29 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.678 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.557 ' N ' HG13 ' A' ' 66' ' ' VAL . 48.3 tttp -58.28 -36.91 74.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.845 . . . . 0.0 109.82 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 64' ' ' ASP . 56.5 t -57.18 -37.92 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 109.575 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.53 -29.82 68.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.81 22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.342 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.42 ' SD ' ' CB ' ' A' ' 75' ' ' ASP . 3.4 mmm -60.48 173.76 0.66 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.638 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 71' ' ' MET . 13.9 mm100 -131.8 158.29 41.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.35 -29.76 71.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -72.57 -31.55 65.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.478 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' CB ' ' SD ' ' A' ' 71' ' ' MET . 85.6 m-20 -65.06 -48.14 74.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 80' ' ' VAL . 11.2 m -61.75 -40.19 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.537 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -62.28 -30.62 71.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.309 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.21 -46.42 77.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.379 -0.826 . . . . 0.0 109.803 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.3 pp -78.58 -22.78 46.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 109.572 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 76' ' ' VAL . 3.6 t -51.17 -36.71 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.801 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -50.61 -42.41 56.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -89.86 115.02 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -80.28 26.12 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.432 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.439 ' O ' ' ND2' ' A' ' 55' ' ' ASN . . . -45.06 -23.49 0.65 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.3 pt -124.19 177.19 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -1.136 . . . . 0.0 109.322 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.4 mt -45.28 137.31 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 59.8 mtp180 -80.05 95.36 6.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 11.7 m-70 -168.37 83.66 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.134 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.301 -0.874 . . . . 0.0 109.97 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.16 97.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -62.19 -38.47 89.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -1.215 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.436 HG22 HG12 ' A' ' 76' ' ' VAL . 23.3 mt -57.23 -48.66 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.573 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.45 -38.72 69.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 0.0 109.402 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -36.66 71.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.26 -40.43 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.368 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.4 mt -56.16 -50.29 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.534 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.79 -36.68 92.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.598 ' ND2' ' CZ ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -56.67 -41.84 77.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -1.157 . . . . 0.0 109.38 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.3 74.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.08 -41.83 93.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 -29.92 70.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' CD1' ' A' ' 32' ' ' PHE . 35.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.1 mm? -63.0 -36.37 83.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.391 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.41 -38.71 84.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.577 ' SD ' ' NH2' ' A' ' 152' ' ' ARG . 2.0 tpt -67.79 -38.79 83.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -61.67 -30.09 70.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.437 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -52.52 -31.51 35.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.475 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -87.0 -5.59 59.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.77 69.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -105.28 119.42 53.02 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -1.183 . . . . 0.0 109.654 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.72 119.43 2.77 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.548 2.166 . . . . 0.0 111.714 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.48 -35.98 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.828 . . . . 0.0 110.427 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -67.95 -50.07 58.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.182 -0.949 . . . . 0.0 110.707 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 118' ' ' SER . 40.8 t0 -60.5 -46.76 88.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -56.92 -52.77 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.089 -1.007 . . . . 0.0 111.209 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 117' ' ' TRP . 15.4 m -56.74 -48.94 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.03 -1.044 . . . . 0.0 111.677 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.495 ' HB2' HD11 ' A' ' 171' ' ' LEU . 3.4 p-90 -88.35 -27.7 21.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.819 -1.176 . . . . 0.0 111.121 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 120' ' ' VAL . 28.3 t -55.92 -27.21 51.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.717 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.57 -14.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.718 ' O ' HG12 ' A' ' 120' ' ' VAL . 59.9 t -83.9 23.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.06 -1.025 . . . . 0.0 109.911 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 14.6 t-20 72.82 22.66 3.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.2 t60 60.26 49.65 6.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.94 149.13 22.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.03 155.16 29.79 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.676 2.251 . . . . 0.0 111.816 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -119.2 145.51 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.744 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.9 ttm -136.34 149.81 48.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.16 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 t -134.81 156.76 48.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.37 48.53 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -69.81 128.98 38.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.636 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.413 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 20.4 m -71.07 -33.43 70.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 t -136.84 174.5 10.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.27 -31.05 71.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.9 t -60.36 -39.34 86.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.511 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.1 mt-10 -65.39 -29.44 70.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.44 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.25 116.18 33.78 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.693 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -86.95 117.49 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.14 2.56 . . . . 0.0 112.511 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.8 m -74.04 -17.66 60.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 138' ' ' SER . 24.6 p -94.72 100.67 12.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.89 151.54 44.86 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 -32.1 92.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.854 2.369 . . . . 0.0 112.036 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.83 -38.69 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.2 m -56.52 -44.41 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.83 -45.58 88.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.14 81.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -63.46 -43.91 95.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -56.83 -44.45 82.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.566 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.21 -36.2 81.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.77 73.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.438 HD11 HD22 ' A' ' 145' ' ' LEU . 50.8 mt -60.77 -40.57 93.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.393 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -60.93 -40.59 93.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.577 ' NH2' ' SD ' ' A' ' 105' ' ' MET . 5.8 tpp180 -65.72 -22.63 66.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.335 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.33 9.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.84 133.15 34.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -1.165 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -97.68 175.5 6.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 54.3 51.81 13.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 158' ' ' GLY . 15.4 m -119.89 26.2 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.24 167.62 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.9 t -59.58 -28.28 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -1.147 . . . . 0.0 109.477 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.6 p -63.56 -43.08 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -66.21 -39.77 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.73 -40.25 96.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.286 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -60.57 -48.93 79.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 m -61.97 -37.97 86.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.28 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.68 -46.01 91.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 75.2 mtp -65.78 -39.7 91.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.0 109.594 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.76 -41.24 97.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.501 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -74.16 -54.7 7.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.609 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.1 t -47.84 -24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.24 7.46 67.61 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 120' ' ' VAL . 4.0 mp -54.68 -52.0 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 172' ' ' VAL . 25.6 m -98.81 130.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.515 ' ND2' ' ND1' ' A' ' 175' ' ' HIS . 19.6 t30 -94.26 101.95 13.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 90.5 m-20 -94.09 119.88 33.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.515 ' ND1' ' ND2' ' A' ' 173' ' ' ASN . 73.0 m80 -157.72 128.9 6.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 179' ' ' CYS . 29.0 m -78.27 144.41 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.83 -38.33 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.86 -23.97 47.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.41 ' H ' HG23 ' A' ' 176' ' ' VAL . 48.8 t -79.94 139.16 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.505 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.95 -37.17 83.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.461 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.6 t -47.84 -28.82 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.568 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.535 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 30.9 t80 -97.35 115.2 65.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.951 . . . . 0.0 109.574 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.535 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.2 Cg_endo -85.47 177.41 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.111 2.541 . . . . 0.0 112.368 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.44 60.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -149.04 44.32 0.98 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.59 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -83.2 148.88 57.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo . . . . . 0 C--N 1.307 -1.624 0 C-N-CA 123.016 2.478 . . . . 0.0 112.279 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -135.6 150.1 49.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -141.99 158.17 44.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.67 132.3 53.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.884 . . . . 0.0 109.408 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -74.44 -39.13 43.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -63.27 1.75 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 109.449 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 5' ' ' GLY . 8.3 p -59.01 -14.89 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.505 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.0 m 60.79 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 10' ' ' ASP . 23.5 pt20 -82.78 -17.49 43.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLN . 9.5 m-20 -43.34 106.39 0.49 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.384 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.5 -38.24 35.1 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 122.824 2.35 . . . . 0.0 112.156 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.4 tp -62.89 -41.2 99.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.466 ' CE2' ' CE1' ' A' ' 17' ' ' HIS . 40.9 t80 -68.13 -42.57 79.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.83 -44.25 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.06 89.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -59.27 -43.54 92.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.466 ' CE1' ' CE2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.64 -49.35 68.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.65 -39.94 95.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.31 -54.56 44.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -177.37 124.93 0.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 59.1 t90 -171.22 124.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.457 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.7 1.04 83.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.96 120.16 71.43 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -45.98 120.83 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.682 2.255 . . . . 0.0 111.943 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -128.17 135.62 49.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.962 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 56.9 p -115.41 9.05 15.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.076 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.65 132.47 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.302 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.574 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 77.5 p -73.7 -38.13 64.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.605 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.58 -42.64 98.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -70.37 -51.94 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 109.869 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.553 HD22 ' HB1' ' A' ' 113' ' ' ALA . 7.8 mp -66.77 -38.37 86.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.798 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 67.2 t80 -61.55 -38.96 89.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.76 -30.63 64.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.9 tpp -73.21 -54.45 8.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.853 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.31 -32.72 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 110.007 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 91.6 m -72.13 -49.99 31.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.139 -0.976 . . . . 0.0 110.057 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 56' ' ' TYR . 4.5 mt -75.2 -28.99 60.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 109.888 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 39.0 tp10 -52.08 -31.94 32.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.792 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.47 -21.81 69.02 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.43 -27.42 62.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -1.204 . . . . 0.0 109.733 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -60.27 -33.06 71.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.771 -178.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 41' ' ' GLN . . . -46.02 110.85 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.47 -6.71 68.27 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.16 -169.94 2.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -1.183 . . . . 0.0 109.406 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -108.97 153.0 24.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.526 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 6.0 t-105 -54.86 -46.22 74.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.65 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.96 -38.97 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.692 -178.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 98.4 m -63.02 -35.22 79.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.714 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.5 t -60.19 -44.74 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.9 mm? -55.13 -44.29 74.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.487 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.43 -52.84 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.354 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 52' ' ' LYS . 10.9 mptt -69.55 -25.79 64.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 49' ' ' VAL . 37.0 ttp180 -54.23 -44.6 71.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 109.004 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -72.74 -43.97 62.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -64.08 -49.61 71.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.239 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 21.7 t80 -58.48 -39.94 81.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.309 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -55.76 -37.91 69.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.844 . . . . 0.0 109.77 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.0 -23.46 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.256 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.7 m -91.77 -12.14 34.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.146 -0.971 . . . . 0.0 110.251 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 43.9 m-85 -125.46 -51.68 1.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.135 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -53.44 -41.68 66.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 109.835 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.06 -38.85 73.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 96.9 m-85 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 130.05 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.002 . . . . 0.0 109.611 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -40.6 -36.05 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.68 -49.29 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' MET . 65.9 mttm -72.25 -31.2 65.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.869 . . . . 0.0 109.862 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.93 -44.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 109.605 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.54 -34.21 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.539 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.01 18.18 17.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.309 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.7 tpp -63.69 157.6 23.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.669 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -103.63 167.36 9.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.47 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 96.7 mt-10 -71.19 -24.17 62.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -72.04 -31.82 66.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.59 -47.14 79.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.418 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG12 ' CG2' ' A' ' 92' ' ' ILE . 14.4 m -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.12 -33.66 71.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 78' ' ' ARG . 42.0 ttm-85 -66.67 -46.08 76.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.774 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.4 mt -66.47 -34.38 77.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.557 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 76' ' ' VAL . 52.1 t -51.79 -35.82 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -81.26 -60.33 2.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 62.7 t0 -100.06 139.69 35.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.72 76.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -74.22 -31.99 58.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.613 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.3 pt 28.96 41.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.348 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 84' ' ' GLY . 54.9 mt 52.12 4.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.607 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -97.85 109.49 22.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 89' ' ' ARG . 84.0 t60 -96.99 172.17 8.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.165 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' N ' ' CG ' ' A' ' 88' ' ' HIS . 38.4 ttm180 -48.63 -41.91 32.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.74 -47.39 61.6 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 29.2 mmtm -64.72 -51.81 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 109.524 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.451 ' CG2' HG12 ' A' ' 76' ' ' VAL . 91.6 mt -54.77 -47.39 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.625 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -53.02 -33.45 51.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -61.29 -42.09 98.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.354 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.607 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.8 mp -60.77 -48.13 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.383 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.4 mt -53.11 -50.0 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.01 -32.43 84.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.66 -36.98 79.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -1.194 . . . . 0.0 109.465 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -65.97 -37.41 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.38 -45.19 95.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.541 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -71.84 -31.25 66.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 16.7 t80 -69.29 -50.53 45.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.73 -37.53 86.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.428 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.29 -42.02 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.8 ttt -64.22 -41.3 97.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.54 -27.41 69.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -51.97 -29.15 19.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.552 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -76.26 -17.23 59.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.08 3.55 67.67 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.75 115.6 65.34 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.251 -1.147 . . . . 0.0 109.634 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.65 124.64 7.01 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.619 2.213 . . . . 0.0 111.714 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.63 ' CZ ' ' NH1' ' A' ' 152' ' ' ARG . 49.6 t80 -61.1 -37.47 82.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -68.11 -49.83 58.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.126 -0.984 . . . . 0.0 110.745 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' O ' ' OG ' ' A' ' 118' ' ' SER . 56.5 t0 -52.07 -35.39 47.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 111.032 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.577 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 14.7 t80 -76.41 -46.24 28.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 117' ' ' TRP . 2.6 p -56.49 -45.87 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.974 -1.079 . . . . 0.0 111.729 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 18.2 p-90 -88.92 -26.9 21.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.735 -1.228 . . . . 0.0 111.114 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 16.7 m -58.06 -27.52 63.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.875 -1.141 . . . . 0.0 109.719 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.76 -13.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.084 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' SER . 16.9 m -82.51 22.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.025 . . . . 0.0 109.947 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 59.64 35.0 22.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -0.942 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 35.4 m80 54.84 26.88 8.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.403 ' H ' HG23 ' A' ' 120' ' ' VAL . 50.3 tt0 -137.07 89.63 16.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.558 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.03 155.03 1.96 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.673 2.248 . . . . 0.0 111.779 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.5 156.15 16.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.729 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 48.3 ttp -127.62 136.15 51.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.4 t -95.57 169.14 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.906 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -168.99 44.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.543 ' HB1' ' CG ' ' A' ' 134' ' ' GLU . . . -83.9 -174.23 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.63 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.5 m -114.34 -29.81 6.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 m -128.63 157.86 40.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.7 mt -74.66 -10.97 60.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.8 m -87.64 -31.49 19.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.9 pt-20 -80.14 -7.81 59.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.72 118.38 57.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.718 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.68 130.27 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.095 2.53 . . . . 0.0 112.544 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.0 t -86.91 -15.11 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.267 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.5 t -85.52 102.18 13.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.367 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.4 p -118.71 152.69 51.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.93 . . . . 0.0 109.508 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.66 -35.15 92.47 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.093 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -41.13 52.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.2 p -61.4 -37.46 83.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.23 -46.46 86.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 0.0 109.568 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.89 -30.42 65.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.2 tt -66.09 -46.68 76.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.494 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -63.19 -42.63 99.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -61.28 -35.41 77.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.562 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.01 -51.79 42.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.68 -32.42 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.858 . . . . 0.0 109.583 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -60.48 -40.73 92.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.429 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -61.0 -37.02 81.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.63 ' NH1' ' CZ ' ' A' ' 112' ' ' PHE . 98.8 mtt180 -64.87 -20.03 66.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 98.49 22.92 13.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 2.6 m-85 -84.65 141.03 30.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -1.107 . . . . 0.0 109.535 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -109.1 175.29 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 53.91 44.18 29.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.584 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.5 p -122.66 26.02 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.82 166.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.1 m -54.58 -33.6 60.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.3 m -61.02 -46.49 90.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.4 mp -64.67 -41.57 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 157' ' ' VAL . 83.1 m -64.37 -40.4 95.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 109.264 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.26 -47.63 85.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.271 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.526 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 29.7 t -59.63 -37.15 77.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.288 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.69 -37.66 79.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.8 mtp -65.25 -47.29 77.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.617 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.41 -35.88 80.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.713 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.74 -44.18 93.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 7.7 m -83.02 -59.13 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.45 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.85 18.04 1.01 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.2 mt -58.95 -32.82 69.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -1.095 . . . . 0.0 109.427 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.09 141.83 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' HG22 ' A' ' 127' ' ' THR . 23.5 t30 -76.02 102.56 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 22.9 t70 -94.03 101.35 13.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 81.7 m-70 -160.05 123.39 3.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.54 HG22 ' H ' ' A' ' 178' ' ' GLY . 8.0 p -74.79 134.5 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.3 p -54.99 -25.76 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.423 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.54 ' H ' HG22 ' A' ' 176' ' ' VAL . . . -64.08 -24.27 68.55 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.521 ' H ' HG13 ' A' ' 176' ' ' VAL . 3.7 m -77.67 140.86 39.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.193 . . . . 0.0 109.535 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 182' ' ' TYR . 83.3 m -62.9 -38.61 91.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.91 . . . . 0.0 109.438 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 95.1 m -51.29 -7.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.551 ' C ' ' H ' ' A' ' 184' ' ' GLY . 20.9 t80 -124.59 80.65 61.06 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 109.576 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -50.43 0.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.044 2.496 . . . . 0.0 112.356 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 182' ' ' TYR . . . 75.08 9.29 83.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 57.5 42.15 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -1.107 . . . . 0.0 109.603 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.55 147.66 53.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 123.043 2.495 . . . . 0.0 112.266 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -125.81 160.69 29.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -85.47 138.99 31.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -92.82 -153.52 0.35 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.427 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.2 -5.11 56.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 28.6 m95 45.73 38.41 4.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.405 ' H ' HG12 ' A' ' 7' ' ' VAL . 1.3 p -60.99 131.19 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.6 p -171.47 29.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.81 -130.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.91 153.08 45.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.48 -27.51 3.44 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.862 2.375 . . . . 0.0 112.184 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.33 -39.68 95.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.404 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -66.11 -45.36 81.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.425 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.92 -39.82 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.72 92.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -66.87 -40.12 87.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' GLU . 59.1 t-80 -56.38 -48.53 76.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.77 -39.11 70.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -44.49 91.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.502 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 39.9 mt-10 -149.1 -137.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.496 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.482 ' O ' ' O ' ' A' ' 20' ' ' GLU . 23.5 t90 59.82 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.547 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.41 82.94 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.9 t -119.71 94.74 48.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 0.0 109.34 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -46.87 121.96 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.764 2.309 . . . . 0.0 111.878 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.48 140.71 37.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -128.28 -2.02 5.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.0 109.109 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -81.33 130.7 35.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.4 t -57.17 -34.42 68.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.204 -0.935 . . . . 0.0 109.608 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -67.21 -55.55 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.763 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -66.92 -43.73 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.923 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.33 -44.14 95.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.835 -179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.96 -36.71 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 109.903 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.25 -32.05 71.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 43.3 tpp -63.84 -53.31 52.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.785 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 3.2 tp -72.11 -32.12 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.5 t -71.75 -50.35 30.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.132 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 6.7 mp -74.08 -16.38 61.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -52.24 -42.1 63.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.953 . . . . 0.0 109.841 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.583 ' N ' ' OE1' ' A' ' 38' ' ' GLU . . . 61.69 171.97 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.687 ' C ' ' H ' ' A' ' 42' ' ' ALA . 31.4 tp60 -60.07 -45.15 93.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -1.193 . . . . 0.0 109.77 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.642 HE21 ' N ' ' A' ' 46' ' ' TRP . 52.9 tt0 60.13 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.671 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -58.28 143.27 45.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 -24.03 0.62 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 42' ' ' ALA . 17.4 mt -104.04 -141.23 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 109.476 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -153.43 155.0 35.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.642 ' N ' HE21 ' A' ' 41' ' ' GLN . 76.0 t-105 -48.08 -39.05 19.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 48' ' ' THR . 9.7 tp -54.41 -40.59 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' HG23 ' A' ' 47' ' ' ILE . 85.5 m -63.83 -38.73 92.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.735 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.18 -40.75 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 109.422 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.26 -44.78 92.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -65.64 -49.49 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.394 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' CD ' HD23 ' A' ' 37' ' ' LEU . 37.1 ttp180 -52.39 -45.39 65.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.158 -0.964 . . . . 0.0 109.038 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.4 -44.87 96.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 24.0 m120 -66.2 -38.45 88.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.254 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CG ' ' A' ' 60' ' ' PHE . 25.3 t80 -62.8 -50.43 71.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.348 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 20.7 mmm180 -60.8 -21.37 63.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.798 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -48.58 62.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 90.6 m -95.65 -43.34 7.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 110.254 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CG ' ' CE2' ' A' ' 56' ' ' TYR . 53.9 m-85 -66.91 -50.79 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 57.5 t60 -48.78 -41.67 33.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -61.6 -37.37 83.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.734 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.573 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 48.0 m-85 -78.5 -48.24 15.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 109.832 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.1 t70 79.87 136.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.534 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -40.05 -22.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.909 2.406 . . . . 0.0 112.745 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' ASP . 91.9 t -75.97 -44.55 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.653 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' LYS . 3.2 mptp? -72.61 -45.07 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.845 . . . . 0.0 109.895 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.1 m -56.05 -42.84 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.612 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.547 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -62.19 -38.0 87.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.53 13.13 32.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.373 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.502 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 27.3 ttp -83.26 158.14 22.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -103.98 160.52 14.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.5 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.56 -30.29 69.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.69 -43.72 72.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 55.1 t0 -61.58 -38.33 87.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.444 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.08 -44.13 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -56.2 -37.18 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.44 -38.66 90.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.341 -0.849 . . . . 0.0 109.782 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.2 mt -70.99 -29.32 65.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.77 -36.38 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.04 -62.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.0 109.514 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -100.01 116.13 31.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.431 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.66 -46.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 55' ' ' ASN . . . 78.74 26.36 58.85 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 pt -116.43 171.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.0 mt -47.22 135.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.628 ' HG2' HH11 ' A' ' 87' ' ' ARG . 9.0 mtt-85 -74.9 102.49 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 109.42 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -171.73 80.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.208 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG2' HH11 ' A' ' 89' ' ' ARG . 11.9 ptt-85 -47.67 -32.97 6.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.908 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.75 95.47 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.08 -45.24 95.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.52 -41.56 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -60.67 -37.63 82.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.26 96.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.355 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 ' HE2' ' A' ' 56' ' ' TYR . 97.3 mt -57.99 -46.41 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 68' ' ' VAL . 78.5 mt -54.66 -39.23 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.74 -33.39 87.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 88.1 m-20 -61.6 -41.83 98.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 109.423 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.74 86.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 109.51 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -57.71 -45.03 86.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.71 -33.5 68.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -64.5 -45.5 87.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 103' ' ' LEU . 3.5 mm? -59.78 -39.18 84.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -60.54 -37.01 79.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.525 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.5 mmm -63.35 -37.08 85.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.73 -29.42 69.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -51.72 -35.35 42.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -91.8 -1.34 57.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.8 66.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -97.05 149.15 35.38 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.154 -1.203 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.82 124.57 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.662 2.241 . . . . 0.0 111.698 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.409 ' CE1' ' NH1' ' A' ' 152' ' ' ARG . 72.3 t80 -79.11 -45.47 19.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.49 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.711 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 118' ' ' SER . 20.0 t70 -52.65 -36.5 56.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.914 . . . . 0.0 111.043 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.66 ' CD1' ' NH2' ' A' ' 152' ' ' ARG . 48.3 t80 -73.09 -49.6 27.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.081 -1.012 . . . . 0.0 111.221 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 116' ' ' VAL . 3.0 m -56.12 -49.35 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.023 -1.048 . . . . 0.0 111.675 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.569 ' O ' HG22 ' A' ' 120' ' ' VAL . 20.0 p-90 -86.88 -28.06 23.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.742 -1.224 . . . . 0.0 111.09 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 21.7 p -56.75 -28.41 61.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.874 -1.142 . . . . 0.0 109.725 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -46.63 -11.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 117' ' ' TRP . 18.5 m -84.7 24.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 123' ' ' GLN . 3.5 m-20 72.51 17.62 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.023 . . . . 0.0 109.701 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 16.8 t60 73.58 -23.14 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.544 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 121' ' ' ASN . 2.3 pt20 -86.52 145.76 40.28 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.532 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 154.06 72.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.666 2.244 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.642 HE22 ' CB ' ' A' ' 141' ' ' ALA . 94.4 mt-30 -104.68 149.0 25.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.771 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.575 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 71.2 mmm -135.78 145.95 47.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 109.172 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 173' ' ' ASN . 3.2 t -115.7 164.79 13.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.929 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -139.15 47.12 1.91 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.299 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -86.57 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.7 m -72.15 -37.8 69.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.1 t -133.95 177.93 7.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.454 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.09 -34.11 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.604 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.4 t -59.11 -35.23 73.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.55 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 93.1 mt-10 -72.72 -23.25 60.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.483 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 5.7 mm -65.57 120.47 68.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.749 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.473 ' O ' ' CE1' ' A' ' 163' ' ' TYR . 85.1 Cg_endo -83.72 135.72 6.95 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.072 2.514 . . . . 0.0 112.525 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 137' ' ' THR . 1.7 t -91.52 6.72 44.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.33 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.9 m -138.81 90.23 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.28 160.61 29.38 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -47.88 -41.78 31.89 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.874 2.382 . . . . 0.0 112.035 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.642 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -71.38 -38.45 71.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -58.45 -43.92 88.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -61.84 -45.16 95.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.511 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.04 73.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.1 tt -60.05 -48.68 80.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.486 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.6 t -61.23 -37.18 82.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.58 ' HZ3' ' HZ3' ' A' ' 151' ' ' LYS . 63.4 tttm -62.0 -42.04 98.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.18 71.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.7 -34.53 74.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.593 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -59.78 -40.91 89.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 109.4 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.58 ' HZ3' ' HZ3' ' A' ' 147' ' ' LYS . 38.7 mmtm -61.17 -40.38 93.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.447 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.66 ' NH2' ' CD1' ' A' ' 115' ' ' PHE . 98.6 mtt180 -67.98 -19.89 64.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.23 13.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.482 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 2.1 m-85 -86.29 127.34 34.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -1.118 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -97.23 -176.85 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 40' ' ' GLN . 76.4 m-85 53.2 48.32 22.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.73 24.17 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.1 162.67 0.21 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 159' ' ' THR . 1.0 OUTLIER -55.62 -31.49 62.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -1.167 . . . . 0.0 109.446 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.6 m -66.77 -47.77 71.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.81 -44.42 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 91.1 m -60.29 -43.9 95.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.325 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.483 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 73.4 t80 -60.53 -43.26 97.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 0.0 109.334 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -57.08 -38.97 74.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 31' ' ' LEU . 16.2 t80 -61.75 -31.18 71.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.418 ' SD ' HD12 ' A' ' 171' ' ' LEU . 63.0 mmm -68.12 -54.18 19.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.623 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.19 -42.49 65.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.708 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.52 ' HB1' ' SD ' ' A' ' 34' ' ' MET . . . -60.96 -34.7 75.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 26.2 t -83.31 -61.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.424 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 131.04 14.43 1.83 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.486 HD11 ' CE2' ' A' ' 165' ' ' PHE . 27.7 mt -65.55 -34.23 77.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.56 140.59 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.575 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 1.7 m-80 -88.88 115.09 26.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -98.63 113.02 24.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -152.18 143.06 23.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.522 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.8 m -97.04 145.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.1 m -54.75 142.82 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.09 -83.01 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 73.8 m -74.25 -171.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -1.158 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.601 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 33.3 m 52.4 17.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.468 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.601 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 13.7 p 42.46 43.63 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 30.4 t80 -121.59 82.83 40.96 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 109.621 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.75 36.47 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.131 2.554 . . . . 0.0 112.378 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.46 26.12 66.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.7 t30 57.56 43.27 22.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.546 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -134.77 78.83 54.1 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 122.969 2.446 . . . . 0.0 112.293 -179.794 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.288 0.566 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -84.01 152.54 24.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.594 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -146.44 148.2 32.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' TRP . 63.5 m 45.91 31.25 1.04 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.97 -46.01 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.664 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -149.84 -91.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -1.201 . . . . 0.0 109.452 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 7' ' ' VAL . 38.6 t 54.39 -0.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.608 ' H ' ' C ' ' A' ' 6' ' ' TRP . 72.1 m -79.87 28.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.424 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' SER . 35.1 tt0 -61.27 -131.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 5.6 p30 -94.77 152.23 39.62 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.35 -34.09 13.53 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.819 2.346 . . . . 0.0 112.098 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.68 -43.3 99.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.476 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.55 -46.61 75.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 109.393 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 99.0 mt -62.14 -37.41 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.373 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.12 98.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.466 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -62.01 -40.77 96.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 20' ' ' GLU . 20.6 t60 -60.65 -48.9 79.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.81 -39.31 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.551 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.85 -47.33 83.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' TRP . 89.5 mt-10 -151.82 -125.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.497 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.523 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 37.7 t90 57.99 114.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.52 -6.31 67.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.669 ' O ' HG13 ' A' ' 23' ' ' VAL . 8.3 p -105.78 109.92 63.65 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.183 -1.186 . . . . 0.0 109.429 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.1 121.12 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.742 2.294 . . . . 0.0 111.896 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -92.94 134.73 34.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.141 -0.974 . . . . 0.0 109.887 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -132.59 -2.25 3.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 109.042 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.14 147.53 46.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.649 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -71.0 -60.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -178.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.86 -37.02 82.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.72 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.04 -42.81 84.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.871 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -66.7 -40.8 88.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.215 -0.928 . . . . 0.0 109.862 -176.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.3 m-30 -60.51 -41.42 94.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.896 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 37' ' ' LEU . 98.6 mt-10 -64.4 -32.81 74.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 ttm -68.42 -53.7 21.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.801 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 36' ' ' CYS . 8.4 tp -70.6 -39.18 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 110.027 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.486 ' N ' HG23 ' A' ' 35' ' ' ILE . 77.0 m -71.31 -47.19 58.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 17.2 tp -64.84 -41.5 95.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 109.811 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 44.2 tp10 -56.22 -29.74 61.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.85 -38.38 59.64 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 40' ' ' GLN . 18.9 mp0 -60.3 -30.75 69.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -1.233 . . . . 0.0 109.724 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 33.7 tt0 -48.09 -29.7 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 109.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -43.66 109.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.23 -32.11 5.36 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 41' ' ' GLN . 5.9 mp -98.21 -160.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -1.209 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.9 m -131.99 152.55 51.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.362 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 43.6 p90 -55.63 -33.49 64.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -57.99 -40.68 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 54.6 m -73.5 -32.52 64.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.692 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 73.0 t -57.4 -36.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -54.38 -54.93 33.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.57 -45.97 90.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.123 -0.986 . . . . 0.0 109.35 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -68.86 -28.47 66.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.582 ' HG2' HH11 ' A' ' 53' ' ' ARG . 6.4 ttt-85 -52.82 -45.95 67.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -0.986 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -70.47 -43.77 69.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -65.48 -38.16 88.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.325 -0.859 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.13 -49.75 76.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' HIS . 73.8 mtm180 -54.75 -43.39 72.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.41 71.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.29 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.86 -20.19 19.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.201 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -104.33 -38.96 6.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.849 -1.157 . . . . 0.0 110.238 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . 79.5 t60 -49.77 -41.91 45.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 109.898 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.44 -31.39 72.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.722 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 53.7 m-85 -91.31 62.79 4.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -39.31 153.6 0.18 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.618 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -35.34 -53.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.856 2.371 . . . . 0.0 112.757 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -54.44 -44.93 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.647 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 71' ' ' MET . 20.3 tptp -65.73 -37.1 85.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.388 -0.82 . . . . 0.0 109.876 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 63' ' ' PHE . 21.4 t -56.98 -49.89 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.076 -1.015 . . . . 0.0 109.594 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.63 70.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.511 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.06 -0.83 57.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.398 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 63' ' ' PHE . 8.9 ttp -71.52 158.35 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -104.67 156.8 17.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.57 -31.28 69.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.51 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -60.49 -39.2 86.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.86 -40.85 94.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.05 -44.03 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.579 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.79 -36.67 81.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.308 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 78' ' ' ARG . 33.2 ttm-85 -63.22 -42.29 99.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.22 -36.13 82.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.2 t -51.29 -33.44 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -93.64 -60.28 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.938 . . . . 0.0 109.523 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -101.3 108.1 19.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -174.92 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.418 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.94 27.94 57.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 pt -121.03 171.78 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -1.15 . . . . 0.0 109.38 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -46.69 141.62 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -94.0 97.6 10.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.431 -179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 15.6 m-70 -162.71 86.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.176 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 89' ' ' ARG . 24.9 ttt-85 -48.65 -29.88 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.38 -47.05 92.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -63.85 -48.81 75.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.27 -41.08 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.9 -36.63 72.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.399 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.318 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 98.9 mt -57.59 -41.66 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 mm -56.29 -50.76 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.12 95.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.614 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 17.9 m120 -57.85 -35.94 71.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.14 68.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.88 -42.61 99.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.47 -35.12 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 10.3 t80 -63.98 -48.13 77.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 tp -63.29 -39.27 94.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -60.75 -38.3 84.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -64.13 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.242 -0.912 . . . . 0.0 109.468 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.75 -29.12 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -52.39 -24.45 7.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.514 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -76.92 -16.88 59.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.512 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.77 9.6 74.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.58 114.42 63.1 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.246 -1.15 . . . . 0.0 109.677 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.02 120.53 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.578 2.185 . . . . 0.0 111.692 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -58.47 -35.03 71.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 0.0 110.504 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.21 -50.87 68.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.0 110.742 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 118' ' ' SER . 90.2 m-20 -62.67 -43.56 98.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 111.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -55.88 -49.33 73.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.991 -1.068 . . . . 0.0 111.155 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -63.8 -48.9 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.034 -1.041 . . . . 0.0 111.632 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.509 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 2.7 p-90 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.775 -1.203 . . . . 0.0 111.207 -177.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' VAL . 33.1 m -55.41 -28.57 55.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.861 -1.149 . . . . 0.0 109.766 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.23 -14.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.1 p -83.24 26.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.901 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 120' ' ' VAL . 2.4 m-80 76.03 17.61 2.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.706 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 59.94 39.34 20.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.492 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.474 ' H ' HG13 ' A' ' 120' ' ' VAL . 77.3 mt-30 -151.13 144.84 17.47 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.59 146.95 50.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.694 2.262 . . . . 0.0 111.872 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.2 134.58 46.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.982 . . . . 0.0 109.741 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 38.7 ttp -109.36 125.41 52.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.255 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.4 t -94.28 166.56 12.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 109.868 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -147.43 53.3 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.403 -0.811 . . . . 0.0 109.252 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.688 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -91.21 142.88 27.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -80.48 -33.47 36.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.0 m -128.91 159.29 36.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.417 ' CD1' ' NE1' ' A' ' 6' ' ' TRP . 31.5 mt -55.94 -35.56 66.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 86.9 p -66.85 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.688 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 78.9 mm-40 -65.92 -23.1 66.55 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.142 -0.974 . . . . 0.0 109.411 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.26 116.98 42.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -84.18 132.1 5.19 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.132 2.555 . . . . 0.0 112.516 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.1 t -92.44 -12.46 32.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.309 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 80.0 p -92.57 100.93 13.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.36 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.1 p -116.74 151.45 47.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.488 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.07 -31.87 93.99 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.844 2.362 . . . . 0.0 111.966 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.92 -41.47 51.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.1 m -60.74 -41.15 94.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.56 -48.93 77.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.522 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.41 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.692 ' C ' HD23 ' A' ' 145' ' ' LEU . 7.5 tt -59.56 -48.29 82.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.47 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -59.97 -41.77 92.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -62.21 -33.15 74.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.76 -51.38 49.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.548 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 145' ' ' LEU . 76.6 mt -60.89 -34.63 74.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -58.03 -40.33 80.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.382 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.6 -37.13 82.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -63.91 -20.11 65.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.09 19.39 19.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.614 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 6.0 m-85 -88.51 133.6 34.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.52 177.75 5.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 55.05 53.67 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.86 24.53 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.45 167.51 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 159' ' ' THR . 1.1 p -66.05 -25.27 66.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 109.37 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.9 p -70.9 -46.17 63.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.01 -34.52 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.536 ' SG ' HD22 ' A' ' 145' ' ' LEU . 43.1 t -68.12 -46.0 72.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.317 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.07 -42.49 99.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.1 m -57.57 -32.6 67.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.28 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.43 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.61 -31.25 69.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.446 178.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 25.5 mtt -68.5 -53.95 19.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.523 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 1.9 pp0? -62.39 -36.46 82.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.704 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.478 ' N ' ' CD ' ' A' ' 167' ' ' GLN . . . -74.71 -38.96 62.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.744 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 23' ' ' VAL . 10.3 t -74.54 -29.05 61.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.444 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.14 56.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.446 HD13 ' SG ' ' A' ' 169' ' ' CYS . 1.1 mp -52.69 -52.88 54.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 0.0 109.39 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.1 m -91.9 135.84 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' THR . 22.5 m-20 -82.67 105.03 13.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 109.46 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -93.71 123.92 37.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CD2' ' CD2' ' A' ' 182' ' ' TYR . 1.9 p-80 -164.06 159.23 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.598 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -111.39 122.73 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 178' ' ' GLY . 8.6 p -70.19 -40.02 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.507 ' N ' HG13 ' A' ' 177' ' ' VAL . . . -60.03 -18.94 49.6 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 96.5 m -86.37 -176.67 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.503 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.6 t -106.12 -21.77 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.523 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.7 t -54.27 -33.92 59.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.1 t80 -125.1 84.44 59.28 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' TYR . 52.0 Cg_exo -52.16 -140.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.111 2.54 . . . . 0.0 112.338 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 94.16 5.68 62.11 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -146.27 30.7 1.02 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -1.145 . . . . 0.0 109.578 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -110.4 149.45 40.22 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 109.588 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 C-N-CA 122.996 2.464 . . . . 0.0 112.256 179.763 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.574 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.275 0.56 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -78.19 162.86 26.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.872 . . . . 0.0 109.537 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.527 HH21 HG23 ' A' ' 7' ' ' VAL . 23.9 ptt-85 -140.06 170.45 15.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.521 ' C ' ' H ' ' A' ' 6' ' ' TRP . 4.1 m -96.87 -155.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.88 -16.18 0.86 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.521 ' H ' ' C ' ' A' ' 4' ' ' CYS . 26.6 m95 44.46 37.8 2.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.183 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.5 m -64.91 126.74 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' GLN . 29.4 t -164.08 156.84 17.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' SER . 41.3 tt0 56.94 159.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 109.561 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.2 72.74 0.82 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.9 -28.78 13.83 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.844 2.363 . . . . 0.0 112.147 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.36 -39.32 94.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.72 -46.54 78.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.56 -48.78 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.383 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.77 -36.77 76.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.52 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.556 ' CE2' HD22 ' A' ' 50' ' ' LEU . 63.3 t80 -59.89 -44.11 94.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.484 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.15 -49.05 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -64.53 -40.28 95.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -64.42 -64.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.519 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.9 mm-40 -140.13 -151.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.628 ' CZ2' ' HB2' ' A' ' 168' ' ' ALA . 27.1 t-105 62.19 130.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.475 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.62 -17.69 58.51 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.8 m -78.11 149.69 76.72 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.416 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.01 119.41 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.858 2.372 . . . . 0.0 111.785 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.6 133.41 56.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.985 . . . . 0.0 109.809 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 p -134.46 9.09 3.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.033 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.73 141.49 31.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.711 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 14.9 m -68.63 -36.38 78.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -58.97 -52.43 65.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.716 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -40.29 96.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.685 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 2.3 mm? -58.66 -39.38 80.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.11 -0.994 . . . . 0.0 109.871 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -67.1 -54.24 23.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.873 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -71.11 -31.46 67.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.4 tpp -60.04 -53.75 54.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 109.676 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 36' ' ' CYS . 18.3 tt -82.76 -42.99 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.062 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.548 ' N ' HG23 ' A' ' 35' ' ' ILE . 33.7 t -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.944 . . . . 0.0 110.044 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.6 -40.42 76.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.867 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -59.91 -24.35 64.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.802 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.43 -28.72 3.5 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.18 -31.64 72.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.24 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -47.98 -34.41 9.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.78 111.33 0.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.727 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.61 -39.24 2.84 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -105.78 -138.15 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.7 t -141.73 155.26 45.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 22.7 p90 -55.54 -31.85 62.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -58.57 -39.64 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.7 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -73.28 -32.26 64.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.9 t -58.69 -37.68 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 16' ' ' TYR . 31.7 mt -53.83 -55.49 26.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -59.27 -42.19 90.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HB2' ' HZ2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -73.57 -21.59 60.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.376 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.57 ' HG2' HH11 ' A' ' 53' ' ' ARG . 7.9 ttt-85 -58.62 -47.64 83.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.209 -0.932 . . . . 0.0 108.99 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' A' ' 54' ' ' GLU . 10.1 pt-20 -69.63 -41.02 76.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -66.05 -50.72 63.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.269 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 28.0 t80 -60.45 -37.51 81.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.379 -0.826 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 40.8 ttp180 -55.83 -38.12 69.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.859 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.25 53.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 110.304 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.07 -11.69 35.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 110.286 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 56.4 m-85 -130.04 -51.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.97 -1.082 . . . . 0.0 110.193 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 14.2 t-80 -49.25 -38.3 26.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.083 -1.01 . . . . 0.0 109.909 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -55.45 -37.44 67.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.781 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.09 -16.79 52.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.866 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 63.99 132.0 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.064 -1.022 . . . . 0.0 109.578 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.33 -34.5 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.904 2.402 . . . . 0.0 112.688 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.2 t -55.16 -49.35 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.103 -0.998 . . . . 0.0 109.633 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 71' ' ' MET . 51.3 mtpt -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -58.09 -42.17 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.068 -1.02 . . . . 0.0 109.595 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.83 -42.24 67.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.25 23.91 8.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 67' ' ' LYS . 1.1 ttm -62.36 163.04 9.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -109.9 154.22 23.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -34.92 69.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.28 -37.38 85.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.456 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -60.13 -44.11 95.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG11 HE21 ' A' ' 93' ' ' GLN . 92.5 t -56.41 -43.18 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.596 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.15 -33.46 74.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.315 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -58.89 -44.23 91.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.799 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 92.3 mt -73.32 -32.6 64.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 76' ' ' VAL . 51.3 t -51.78 -36.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.763 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -75.57 -62.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -99.89 107.84 19.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.423 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -175.62 75.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.397 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.66 10.4 1.51 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.521 HD12 ' CG ' ' A' ' 87' ' ' ARG . 5.1 pt -79.59 -175.92 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -1.146 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 86' ' ' ILE . 67.6 mt -83.34 -2.33 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 85' ' ' ILE . 3.6 mmp_? -66.88 145.58 55.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.427 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' O ' ' N ' ' A' ' 90' ' ' GLY . 53.0 m80 -141.96 70.52 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.133 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.424 HH11 ' HG3' ' A' ' 89' ' ' ARG . 27.2 ttm-85 59.02 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.397 -0.814 . . . . 0.0 109.927 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 88' ' ' HIS . . . -56.57 -37.48 75.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -59.59 -45.47 91.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.73 -44.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.629 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.432 HE21 HG11 ' A' ' 76' ' ' VAL . 93.8 mm-40 -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.332 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.21 -36.31 79.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.419 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.9 mm -69.03 -44.52 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.96 -47.93 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 109.543 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.42 -42.92 99.88 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 23.9 m120 -58.86 -43.77 90.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -1.207 . . . . 0.0 109.42 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.71 92.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.57 -44.28 91.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.4 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.11 -53.74 7.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tp -56.99 -44.71 83.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -61.04 -33.87 73.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -62.33 -35.87 80.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.415 ' C ' ' N ' ' A' ' 108' ' ' ASN . 84.3 tt0 -70.82 -30.77 67.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -51.89 -14.38 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.561 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 106' ' ' GLU . 77.7 m-20 -75.97 -14.98 60.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 36.6 18.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -138.75 152.17 70.09 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.76 119.12 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.612 2.208 . . . . 0.0 111.685 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -74.57 -43.51 55.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.0 110.465 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -63.42 -47.21 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.168 -0.958 . . . . 0.0 110.772 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.564 ' O ' ' OG ' ' A' ' 118' ' ' SER . 53.6 t0 -54.9 -37.7 66.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 111.056 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 -48.35 39.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.088 -1.008 . . . . 0.0 111.221 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 113' ' ' ALA . 3.6 m -53.96 -49.35 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.058 -1.026 . . . . 0.0 111.679 -175.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 114' ' ' ASP . 21.9 p-90 -87.69 -24.94 23.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.729 -1.232 . . . . 0.0 111.09 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 6.8 m -56.02 -23.95 36.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.783 -1.198 . . . . 0.0 109.708 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -44.46 -15.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.166 -0.958 . . . . 0.0 110.076 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.3 m -88.15 24.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.001 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 1.6 m120 72.14 38.63 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 109.641 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 51.4 p-80 41.96 40.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.579 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.416 ' H ' HG23 ' A' ' 120' ' ' VAL . 81.5 mt-30 -147.52 148.09 30.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.542 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.42 135.58 36.99 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.671 2.247 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.488 HE22 ' CB ' ' A' ' 141' ' ' ALA . 86.3 mt-30 -100.08 148.41 24.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.776 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.6 ptm -133.27 156.68 47.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.447 -0.783 . . . . 0.0 109.155 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.3 t -124.03 163.3 21.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.921 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -137.69 54.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -89.99 -158.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.663 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.58 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 6.4 m -140.9 -29.6 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.34 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.405 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 14.2 m -135.06 161.17 36.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.469 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.431 HD11 ' CD1' ' A' ' 6' ' ' TRP . 50.4 mt -73.58 -16.73 61.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -79.84 -41.21 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 130' ' ' THR . 5.8 pt-20 -71.93 -26.04 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.174 -0.954 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.0 117.45 48.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.03 131.28 5.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.096 2.53 . . . . 0.0 112.563 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.464 ' H ' HG22 ' A' ' 137' ' ' THR . 0.7 OUTLIER -76.98 -13.38 59.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.259 179.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.2 m -94.73 101.87 13.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.406 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.91 154.62 49.64 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.05 -42.68 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.843 2.362 . . . . 0.0 112.009 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.488 ' CB ' HE22 ' A' ' 125' ' ' GLN . . . -75.73 -41.38 53.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.219 -0.925 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -62.05 -42.53 99.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.412 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 147' ' ' LYS . 44.1 t0 -62.87 -45.24 93.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.17 80.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 109.497 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 162' ' ' CYS . 23.6 tp -57.96 -50.9 71.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 92.3 p -58.6 -39.36 80.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.55 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 143' ' ' ASP . 60.7 mttp -60.69 -32.72 71.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.06 -55.11 10.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.5 mp -65.99 -34.8 78.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.626 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.63 -41.38 85.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.419 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -66.01 -35.45 80.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.498 HH11 ' HG3' ' A' ' 152' ' ' ARG . 26.6 ttm-85 -63.86 -21.75 66.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.8 21.47 8.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.69 136.76 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -1.112 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 1.8 mptm? -97.67 -169.64 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 16.5 p90 39.47 41.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 157' ' ' VAL . 5.5 m -96.38 25.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.54 154.58 1.21 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.7 m -55.87 -28.03 54.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.423 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -48.33 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.9 mp -58.74 -44.24 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 109.438 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' A' ' 145' ' ' LEU . 2.2 t -62.64 -49.04 76.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -62.74 -40.0 95.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.364 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -60.71 -38.65 85.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CZ ' HD11 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -61.12 -43.63 98.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.529 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.3 mtp -59.33 -40.2 85.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.75 -34.16 77.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.628 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -67.31 -63.2 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.685 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.8 t -63.26 -40.31 97.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.98 21.64 15.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 34.8 mt -54.17 -35.1 61.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.395 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.18 133.95 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.546 ' OD1' ' ND1' ' A' ' 175' ' ' HIS . 5.8 t-20 -81.48 100.96 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.45 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -86.26 118.46 25.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.546 ' ND1' ' OD1' ' A' ' 173' ' ' ASN . 15.0 m170 -147.62 162.22 39.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.519 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 130' ' ' THR . 38.9 t -110.82 132.71 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 129' ' ' ALA . 83.3 t -71.88 -39.25 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.495 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.91 28.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 29.7 t -91.03 167.29 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -1.138 . . . . 0.0 109.49 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.3 p -90.84 -37.87 13.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.503 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.479 ' HG ' ' HG ' ' A' ' 179' ' ' CYS . 17.0 p -53.31 -35.9 60.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.464 ' N ' ' SG ' ' A' ' 181' ' ' CYS . 39.8 t80 -125.2 83.59 60.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -85.28 31.55 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.047 2.498 . . . . 0.0 112.441 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.42 14.68 79.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.8 37.82 27.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -1.15 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.63 155.69 59.09 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 C-N-CA 122.998 2.465 . . . . 0.0 112.267 179.894 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -93.63 143.49 26.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.449 HH11 ' HG3' ' A' ' 3' ' ' ARG . 50.7 mtm-85 -143.75 148.4 35.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.08 -164.83 1.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.387 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.12 3.24 63.71 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.608 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 1.4 m0 47.83 42.89 16.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.477 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 8' ' ' SER . 33.2 m -66.29 127.99 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER 166.6 178.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.497 ' N ' ' OG ' ' A' ' 8' ' ' SER . 49.4 tp60 59.41 -127.86 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.12 150.74 91.66 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 -11.63 26.29 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.821 2.348 . . . . 0.0 112.159 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.75 -33.08 74.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.555 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 42.3 m-85 -54.16 -46.47 72.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.444 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.93 -28.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.4 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -56.84 -47.14 81.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 1.3 p90 -75.76 -38.73 58.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.502 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.552 ' N ' ' CG ' ' A' ' 16' ' ' TYR . 83.9 t60 -54.16 -46.27 72.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.498 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -71.38 -34.51 70.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.514 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 3.1 m120 -61.81 -62.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.545 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TRP . 10.3 pt-20 -174.04 -115.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.796 ' CZ2' ' HB2' ' A' ' 168' ' ' ALA . 34.5 t-105 60.07 130.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.524 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.81 60.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 169' ' ' CYS . 0.7 OUTLIER -76.89 152.74 82.77 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.264 -1.139 . . . . 0.0 109.376 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 123.01 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.752 2.301 . . . . 0.0 111.857 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -108.57 135.22 50.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.858 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -134.94 5.32 3.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 109.038 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.91 128.45 35.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.277 -0.889 . . . . 0.0 109.296 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.536 ' O ' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -61.71 -55.89 25.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.581 -178.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -62.73 -43.63 98.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.708 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.619 ' NZ ' ' NH2' ' A' ' 53' ' ' ARG . 15.9 tptp -64.63 -44.35 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.85 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 113' ' ' ALA . 5.3 tp -60.87 -42.07 97.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.85 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 1.9 m-30 -60.34 -35.89 76.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 0.0 109.892 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.76 -30.06 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.819 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.0 tpp -74.34 -56.23 5.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.837 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.445 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.2 tp -61.69 -36.7 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.59 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 75.9 m -71.72 -44.72 63.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.6 tp -73.53 -39.8 64.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.977 . . . . 0.0 109.876 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -53.71 -34.56 59.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.775 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.72 -34.27 56.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -64.22 -29.14 70.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.161 . . . . 0.0 109.778 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.1 tt0 -49.04 -31.01 6.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.759 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.99 110.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -31.84 6.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 41' ' ' GLN . 19.4 mt -99.47 -150.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.8 m -145.98 161.34 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -52.39 -41.25 62.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.67 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -51.9 -40.99 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.711 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 53.9 m -75.65 -34.63 60.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.71 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.65 -44.21 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HZ2' HD12 ' A' ' 47' ' ' ILE . 46.5 mttp -59.36 -49.39 78.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -72.51 -22.5 61.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.334 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.619 ' NH2' ' NZ ' ' A' ' 30' ' ' LYS . 3.8 ttt-85 -57.57 -44.29 85.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.111 -0.993 . . . . 0.0 108.975 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.11 -44.56 65.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -66.38 -35.03 79.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.242 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 29.4 t80 -57.06 -49.25 76.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.468 -0.77 . . . . 0.0 109.379 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 80.4 mtm180 -59.67 -41.37 90.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.06 39.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.213 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.9 m -95.9 -33.97 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 30.1 m-85 -86.05 -32.85 21.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.047 -1.033 . . . . 0.0 110.233 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 85.5 t60 -47.47 -16.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 109.919 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 60' ' ' PHE . 7.2 pt20 -100.35 -22.07 15.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.818 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.467 ' O ' HG23 ' A' ' 68' ' ' VAL . 60.0 m-85 -99.94 68.79 1.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.077 -1.015 . . . . 0.0 109.871 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 63' ' ' PHE . 4.9 m-20 -41.42 154.3 0.24 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.995 . . . . 0.0 109.607 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -34.46 -53.97 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.948 2.432 . . . . 0.0 112.627 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.82 -44.76 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.125 -0.984 . . . . 0.0 109.632 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.7 -32.78 74.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 63' ' ' PHE . 49.0 t -57.34 -43.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.617 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.86 -24.61 60.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.497 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.41 -3.1 58.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.6 mtp -55.74 146.68 20.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 29.2 tp60 -105.97 166.46 10.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 97.2 mt-10 -63.25 -29.31 70.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.442 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.41 -37.16 84.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 109.441 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.63 -39.28 80.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.421 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' VAL . 96.8 t -63.82 -44.14 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -56.98 -37.25 71.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.377 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -61.05 -44.09 97.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.416 -0.803 . . . . 0.0 109.81 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 82' ' ' ASP . 47.8 mt -73.78 -33.07 64.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 76' ' ' VAL . 40.9 t -50.55 -35.63 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.953 . . . . 0.0 109.788 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -88.93 -50.19 6.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.089 -1.007 . . . . 0.0 109.568 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 79' ' ' LEU . 86.5 m-20 -71.33 153.27 42.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.38 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.12 26.65 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -47.33 -34.74 9.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 85' ' ' ILE . 22.3 pt -148.61 -174.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.343 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.47 138.04 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -89.92 106.88 18.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 109.445 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CD2' ' H ' ' A' ' 90' ' ' GLY . 20.2 t-160 -176.34 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -45.02 -34.72 2.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.894 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.548 ' H ' ' CD2' ' A' ' 88' ' ' HIS . . . -66.86 -44.52 88.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -66.44 -43.12 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.491 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.94 -46.67 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -59.71 -33.22 71.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.42 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.99 90.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 80.5 mt -64.13 -44.79 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.05 -45.82 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.22 -38.06 95.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 6.9 t30 -57.64 -40.87 80.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.356 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.71 95.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.57 -40.81 75.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.44 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.77 -31.97 73.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.451 ' OH ' ' CE2' ' A' ' 32' ' ' PHE . 22.6 t80 -62.1 -48.4 80.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.3 mm? -58.35 -37.4 75.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 109.488 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -61.28 -51.71 67.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.606 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 27.3 ttt -69.97 -39.45 75.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.36 -26.78 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 109.443 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -51.7 -25.11 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.14 -19.0 58.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.496 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.58 17.47 68.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.11 152.74 38.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.151 -1.205 . . . . 0.0 109.741 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.83 122.92 10.63 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.641 2.228 . . . . 0.0 111.669 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.606 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 26.3 t80 -76.73 -42.16 42.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -69.91 -50.68 39.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 118' ' ' SER . 43.8 t0 -53.01 -33.32 51.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.012 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 16.2 t80 -76.24 -52.28 10.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.036 -1.04 . . . . 0.0 111.223 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.471 HG23 ' N ' ' A' ' 117' ' ' TRP . 10.1 m -56.56 -50.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.972 -1.08 . . . . 0.0 111.683 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.521 ' HB2' HD11 ' A' ' 171' ' ' LEU . 7.6 p-90 -82.05 -31.12 31.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.709 -1.244 . . . . 0.0 111.163 -176.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 18.0 t -56.28 -24.01 40.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.871 -1.143 . . . . 0.0 109.785 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -43.11 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.279 -0.888 . . . . 0.0 110.083 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 118' ' ' SER . 19.5 m -83.11 24.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.973 -1.079 . . . . 0.0 110.003 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 67.35 36.23 4.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 118' ' ' SER . 74.0 m-70 53.82 26.16 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.465 ' H ' HG23 ' A' ' 120' ' ' VAL . 31.7 mt-30 -142.89 103.67 5.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.75 147.61 4.46 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.685 2.257 . . . . 0.0 111.808 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -95.83 157.97 15.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.727 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -121.95 142.49 50.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 173' ' ' ASN . 2.7 t -86.14 160.19 19.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.938 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -141.73 46.83 1.67 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.645 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -101.79 135.75 42.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.8 m -76.8 -30.22 56.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.353 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -133.39 175.75 9.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.582 HD22 ' HE1' ' A' ' 6' ' ' TRP . 34.6 mt -67.79 -31.92 72.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.556 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.1 p -63.51 -34.86 78.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.645 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 96.3 mt-10 -73.51 -21.6 60.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.125 -0.985 . . . . 0.0 109.435 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 132' ' ' LEU . 84.9 mt -66.96 120.02 68.55 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.28 136.53 7.79 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.11 2.54 . . . . 0.0 112.561 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -95.15 4.78 53.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.325 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.9 t -137.14 90.74 2.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.59 156.27 39.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.74 -40.08 24.18 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.777 2.318 . . . . 0.0 112.03 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.96 -38.38 66.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.307 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.6 t -62.54 -47.38 84.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.03 -45.45 92.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.88 75.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.53 -46.64 78.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.537 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.3 t -56.09 -43.73 78.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.22 -35.96 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.08 -52.41 35.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 149' ' ' LEU . 8.4 mp -66.29 -37.13 84.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.38 -0.825 . . . . 0.0 109.546 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -62.45 -37.23 85.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.333 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.62 -37.58 86.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 0.0 109.441 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.608 ' NH2' ' CE1' ' A' ' 115' ' ' PHE . 99.3 mtt180 -63.77 -23.41 67.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 109.337 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.46 12.21 9.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 43.0 m-85 -78.41 135.01 37.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -1.108 . . . . 0.0 109.51 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.616 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 19.9 tptt -101.35 -166.19 1.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 14.6 p90 37.83 33.95 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.407 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -101.77 24.89 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.388 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.62 157.0 1.67 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.7 m -53.61 -31.01 45.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.0 m -63.53 -47.18 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -64.98 -40.53 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.4 -41.05 96.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.319 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.5 -46.41 90.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.288 -0.883 . . . . 0.0 109.306 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 95.5 p -60.74 -36.8 79.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.02 -49.42 76.09 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.8 mtp -59.95 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.97 -46.05 90.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.796 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -72.62 -43.61 63.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.671 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' VAL . 13.6 t -58.13 -29.56 65.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.986 . . . . 0.0 109.425 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.37 0.33 61.3 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 117' ' ' TRP . 3.7 mp -55.07 -43.29 73.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -1.17 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.99 135.97 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.572 ' N ' HD22 ' A' ' 173' ' ' ASN . 1.8 m120 -86.43 117.89 25.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 42.1 p-10 -91.86 93.43 8.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -149.23 130.98 15.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.55 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 26.3 m -100.02 139.75 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.23 -33.77 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.11 65.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 176' ' ' VAL . 12.6 p -79.09 129.63 34.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.548 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 71.2 m -63.1 -29.67 70.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.9 t -48.73 -28.74 3.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 1.2 t80 -124.63 84.42 57.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.619 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 182' ' ' TYR . 53.6 Cg_exo -51.39 -139.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.115 2.543 . . . . 0.0 112.343 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.5 1.94 58.94 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -153.71 33.42 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.375 -1.074 . . . . 0.0 109.607 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -125.58 79.66 67.19 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.532 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 123.012 2.475 . . . . 0.0 112.322 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.32 0.581 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -131.95 158.18 42.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -149.57 176.72 10.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 3' ' ' ARG . 1.7 p -43.35 159.39 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -125.98 -17.93 2.44 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -65.58 5.16 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 5' ' ' GLY . 4.6 t -63.32 140.37 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 p -61.8 151.29 34.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 109.475 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.81 -31.69 68.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -49.14 143.49 9.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.444 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.08 -28.5 12.8 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.898 2.399 . . . . 0.0 112.161 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.4 tp -62.13 -39.97 94.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.71 -49.13 67.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.91 . . . . 0.0 109.427 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.59 -40.9 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.69 -36.66 84.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -62.12 -43.09 99.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -60.92 -42.89 98.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.463 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.99 -39.45 85.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -63.63 -55.37 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -175.84 130.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.95 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -173.92 122.14 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.512 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.75 -0.03 79.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 169' ' ' CYS . 6.6 m -80.42 148.62 66.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.291 -1.123 . . . . 0.0 109.33 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 119.7 6.68 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.754 2.303 . . . . 0.0 111.857 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.26 130.86 53.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.832 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -117.05 4.09 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.865 . . . . 0.0 109.006 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -78.53 116.84 19.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 76.1 p -61.58 -33.52 74.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.599 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -58.04 -47.15 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -70.28 -48.8 55.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.09 -39.77 93.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE1' ' ND2' ' A' ' 98' ' ' ASN . 61.5 t80 -60.3 -45.0 94.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.893 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.59 -31.67 72.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 109.88 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 tpt -62.52 -53.22 57.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.805 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.84 -42.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.025 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.589 ' SG ' ' ND2' ' A' ' 98' ' ' ASN . 12.1 m -62.27 -51.74 66.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 mt -76.07 -42.4 47.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.976 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 161' ' ' ILE . 44.2 tt0 -54.25 -36.49 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.797 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.46 -32.97 61.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.54 -27.56 69.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -1.22 . . . . 0.0 109.718 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -48.53 -36.9 16.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 109.624 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.47 114.71 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.659 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.59 -33.36 5.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 mt -97.44 -141.83 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -1.17 . . . . 0.0 109.43 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.0 p -147.3 154.49 41.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -50.88 -45.03 59.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.219 -0.925 . . . . 0.0 109.494 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 47' ' ' ILE . 7.8 tp -55.35 -34.77 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 109.684 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.1 m -72.02 -35.08 69.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.0 t -59.19 -49.06 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.8 mm? -56.49 -50.84 70.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -59.37 -48.45 81.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.304 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -69.36 -30.57 68.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HG2' HH11 ' A' ' 53' ' ' ARG . 20.2 ttt-85 -50.99 -46.27 61.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 108.943 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.33 -44.22 72.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.355 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.58 -41.51 98.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.479 ' CD2' ' CE2' ' A' ' 60' ' ' PHE . 3.3 m-85 -55.87 -49.68 72.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.393 -0.817 . . . . 0.0 109.369 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' HIS . 58.8 mtp180 -51.72 -45.04 63.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.782 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.75 -43.14 47.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.1 m -96.4 -27.55 14.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.278 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.479 ' CE2' ' CD2' ' A' ' 56' ' ' TYR . 38.9 m-85 -92.36 -34.38 14.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.093 . . . . 0.0 110.133 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . 86.5 t60 -48.29 -38.92 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -68.4 -34.12 75.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.716 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 64' ' ' ASP . 40.2 m-85 -88.9 62.97 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.85 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -39.77 159.0 0.13 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 109.558 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -38.61 -53.45 1.82 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.923 2.415 . . . . 0.0 112.651 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.9 t -53.36 -44.63 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -66.71 -34.39 77.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 63' ' ' PHE . 48.5 t -58.23 -48.77 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 109.661 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.32 63.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.49 7.07 43.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.633 ' SD ' HD11 ' A' ' 96' ' ' ILE . 41.9 ttm -57.06 146.97 25.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' OE1' ' OE2' ' A' ' 74' ' ' GLU . 95.3 mt-30 -107.44 162.02 14.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.07 -28.51 70.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' OE1' ' A' ' 72' ' ' GLN . 24.9 pt-20 -72.29 -27.76 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.81 -47.71 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 80' ' ' VAL . 10.7 m -64.05 -36.85 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -54.82 -37.97 66.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -70.05 -43.74 70.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.367 -0.833 . . . . 0.0 109.803 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 79' ' ' LEU . 96.0 mt -70.04 -41.45 74.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.99 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 76' ' ' VAL . 54.3 t -50.86 -36.3 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -77.31 -62.41 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -99.84 114.14 27.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.92 79.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.61 -25.95 7.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' GLY . 22.1 pt -57.85 -160.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.249 -1.147 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.98 132.67 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.52 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.0 ptm180 -102.48 136.33 42.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER 170.16 100.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.152 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -47.51 -30.28 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.923 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.8 -48.82 15.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.61 -43.39 98.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -1.145 . . . . 0.0 109.489 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.436 ' CG2' HG12 ' A' ' 76' ' ' VAL . 61.1 mt -63.47 -55.33 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.628 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -58.17 -31.58 67.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.72 93.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 109.39 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.5 -41.7 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.633 HD11 ' SD ' ' A' ' 71' ' ' MET . 70.9 mt -55.4 -54.3 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.82 94.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.589 ' ND2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -58.03 -40.29 80.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 98' ' ' ASN . . . -70.75 -37.05 73.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.04 -43.42 98.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -70.0 -33.85 72.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 19.4 t80 -69.84 -46.66 65.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 109.527 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.87 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 28.1 ttt -61.71 -41.53 97.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.485 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.1 -27.09 63.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -52.07 -21.82 3.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.513 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.46 -13.71 60.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.7 4.55 72.74 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.46 167.25 16.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -1.213 . . . . 0.0 109.696 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.76 118.55 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.546 2.164 . . . . 0.0 111.704 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 36.4 t80 -66.35 -44.23 83.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.467 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.47 89.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.774 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 24.7 t70 -53.41 -54.43 36.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 111.082 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -39.06 68.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.998 -1.064 . . . . 0.0 111.313 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.02 -60.4 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.997 -1.064 . . . . 0.0 111.676 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.673 ' O ' HG22 ' A' ' 120' ' ' VAL . 63.0 p-90 -87.99 -20.99 25.1 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.759 -1.213 . . . . 0.0 111.151 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 120' ' ' VAL . 58.3 m -56.93 -32.25 65.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.838 -1.164 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -45.89 -14.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.5 m -82.23 24.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.1 -1.0 . . . . 0.0 109.949 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 1.7 m120 71.95 29.65 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 109.764 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.1 t60 53.9 31.98 14.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 0.0 109.59 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.508 ' H ' HG23 ' A' ' 120' ' ' VAL . 39.1 mt-30 -150.32 121.52 3.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.97 153.26 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.732 2.288 . . . . 0.0 111.809 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 91.9 mm-40 -110.89 148.22 32.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.731 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.595 ' SD ' ' ND2' ' A' ' 173' ' ' ASN . 31.5 tpp -120.85 135.06 55.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.103 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -85.94 164.17 17.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.62 ' NE2' HD21 ' A' ' 185' ' ' ASN . 76.1 mm-40 -142.91 43.08 1.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.835 . . . . 0.0 109.364 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.18 -164.6 1.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.672 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.483 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 40.3 m -158.91 -26.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.61 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 7.3 m -115.36 158.13 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.92 -13.78 60.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -92.87 -32.87 14.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 131' ' ' THR . 6.5 pt-20 -77.36 3.56 12.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -0.964 . . . . 0.0 109.409 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.89 126.09 91.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.695 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.12 128.24 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.159 2.573 . . . . 0.0 112.512 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.0 t -101.07 7.86 43.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 t -144.34 88.98 1.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.396 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.95 160.98 32.71 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.43 -40.29 28.93 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.801 2.334 . . . . 0.0 112.01 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.85 75.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.347 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 t -61.39 -46.95 88.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 147' ' ' LYS . 24.4 t70 -61.49 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.88 83.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 149' ' ' LEU . 9.3 tt -65.82 -39.79 91.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 109.537 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.2 t -55.66 -48.95 74.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' NZ ' ' OD2' ' A' ' 143' ' ' ASP . 61.0 mttp -62.96 -28.8 70.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.52 -47.51 69.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 145' ' ' LEU . 91.0 mt -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -57.45 -37.88 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -61.33 -40.06 92.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.402 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -68.06 -19.99 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 109.377 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.05 26.25 19.63 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 1.9 m-85 -85.23 135.87 33.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -101.73 175.0 5.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.499 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 55.66 46.92 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' GLY . 25.8 m -120.18 25.93 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.62 164.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.2 m -53.84 -31.27 48.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -1.089 . . . . 0.0 109.386 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 -47.3 76.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.83 -36.32 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 74.5 m -67.99 -48.82 64.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.287 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.92 -41.56 98.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.416 -0.803 . . . . 0.0 109.316 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.0 m -59.13 -38.5 79.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -60.68 -45.68 93.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mmm -58.91 -41.83 88.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.611 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.02 -31.34 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 0.0 109.628 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' VAL . 2.5 p -80.74 -63.98 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 109.472 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.683 ' C ' ' H ' ' A' ' 172' ' ' VAL . . . 158.04 -98.78 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 mt 61.52 -22.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.683 ' H ' ' C ' ' A' ' 170' ' ' GLY . 12.9 m -132.39 143.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.481 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.595 ' ND2' ' SD ' ' A' ' 126' ' ' MET . 6.1 m-20 -92.53 102.18 14.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.407 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.39 97.34 11.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.496 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.53 141.08 32.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 m -94.63 136.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.77 138.19 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.62 2.95 62.95 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 180' ' ' CYS . 7.6 m -153.24 155.06 35.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -1.163 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 1.7 t 71.01 3.87 4.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 3.2 m 62.71 56.36 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.538 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.578 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 0.5 OUTLIER -115.53 97.23 48.2 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.578 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 91.5 Cg_endo -86.67 -161.5 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.108 2.539 . . . . 0.0 112.353 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . 94.38 5.42 61.93 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.62 HD21 ' NE2' ' A' ' 128' ' ' GLN . 27.4 m120 -143.41 34.93 1.31 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.563 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -135.21 78.74 51.64 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--N 1.306 -1.7 0 C-N-CA 123.011 2.474 . . . . 0.0 112.309 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -94.05 145.62 24.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.74 HH21 HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -97.81 151.28 20.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 m -52.59 166.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.62 -17.53 61.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.506 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -76.51 6.91 5.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.427 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.9 p -78.83 133.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -71.47 162.56 29.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.935 . . . . 0.0 109.447 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.647 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 0.7 OUTLIER -84.07 1.23 44.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.92 144.87 73.12 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.74 -17.15 26.17 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.893 2.395 . . . . 0.0 112.102 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.81 -46.71 14.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -66.42 -44.58 82.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.434 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.74 HD11 HH21 ' A' ' 3' ' ' ARG . 15.2 tt -59.78 -42.17 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 14' ' ' ILE . . . -72.43 -41.59 66.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.504 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.54 ' OH ' ' NE1' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -59.62 -37.53 78.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -66.47 -43.45 85.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.7 p30 -91.63 1.09 57.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ALA . 31.5 t30 -63.59 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -153.08 -16.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.54 ' NE1' ' OH ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -50.13 145.89 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.32 -5.51 62.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.61 119.06 65.75 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.243 -1.151 . . . . 0.0 109.335 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.15 121.01 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.806 2.337 . . . . 0.0 111.855 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -103.72 138.92 39.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -134.63 0.31 2.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.033 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -81.26 118.7 22.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -53.81 -37.85 63.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.22 -42.09 94.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -70.98 -48.81 51.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.2 mp -64.49 -36.69 85.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.817 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 35' ' ' ILE . 20.8 t80 -61.42 -50.81 71.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.11 -28.97 65.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.421 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 47.5 tpp -57.28 -52.6 64.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.795 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.457 HD12 ' OE2' ' A' ' 38' ' ' GLU . 2.8 tp -65.83 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.971 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 78.4 m -74.48 -38.87 62.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.096 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.07 -50.08 51.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 109.887 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE2' HD12 ' A' ' 35' ' ' ILE . 25.9 pt-20 -62.82 -27.89 69.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.8 -33.97 28.62 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.79 -27.54 69.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.263 . . . . 0.0 109.776 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 7.1 tt0 -50.37 -41.3 51.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -44.93 112.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.669 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.17 -37.16 3.63 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 86' ' ' ILE . 25.9 mt -100.88 -140.4 0.34 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.172 . . . . 0.0 109.41 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 p -141.59 159.92 41.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.512 ' CZ3' ' OG ' ' A' ' 164' ' ' SER . 74.9 t-105 -57.08 -44.62 83.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.484 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 48' ' ' THR . 9.9 tp -56.87 -34.61 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.722 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 47' ' ' ILE . 69.4 m -70.63 -34.62 72.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.96 . . . . 0.0 109.723 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' ARG . 77.3 t -70.16 -44.3 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.1 mt -53.26 -53.97 43.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.8 -45.6 82.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.097 -1.002 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 85' ' ' ILE . 63.5 mttm -79.79 -11.55 59.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 49' ' ' VAL . 27.5 ttt-85 -64.65 -48.54 74.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.189 -0.944 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 19.7 pt-20 -72.61 -39.25 67.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.809 . . . . 0.0 109.307 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -70.07 -41.55 73.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.294 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 32.2 t80 -60.2 -44.75 94.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.407 -0.808 . . . . 0.0 109.375 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' HIS . 52.2 mtp180 -58.57 -38.49 78.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.849 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.06 80.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 1.9 p -93.4 -12.83 28.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 37.6 m-85 -117.0 -54.21 2.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.941 -1.1 . . . . 0.0 110.173 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ARG . 74.8 t60 -54.87 -42.15 71.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.112 -0.992 . . . . 0.0 109.882 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -57.37 -35.26 69.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.768 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 46.8 m-85 -72.57 -22.7 60.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 1.9 t70 70.47 131.44 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.005 . . . . 0.0 109.608 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -40.52 -34.29 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.93 2.42 . . . . 0.0 112.701 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.7 t -56.34 -49.77 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' MET . 53.6 mtpt -73.24 -30.27 63.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.848 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.519 ' O ' ' SD ' ' A' ' 71' ' ' MET . 62.1 t -56.02 -44.15 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.41 42.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.65 34.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' ' CD1' ' A' ' 96' ' ' ILE . 9.6 ptm -61.64 144.91 53.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.701 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -95.22 171.36 8.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.578 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.67 -33.53 68.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 109.451 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 49.3 mp0 -56.07 -36.91 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.86 -38.28 90.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.3 t -59.47 -44.51 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.1 -34.94 79.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.187 -0.945 . . . . 0.0 109.338 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -58.8 -43.86 90.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.338 -0.852 . . . . 0.0 109.783 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 82' ' ' ASP . 81.8 mt -69.58 -32.63 71.49 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.149 -0.97 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.15 -32.95 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -92.93 -51.96 4.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 87.4 m-20 -90.89 155.65 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.361 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.73 84.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -70.42 25.99 0.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 83' ' ' ALA . 2.5 pt -47.18 -97.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -1.176 . . . . 0.0 109.312 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.48 HD11 HD11 ' A' ' 44' ' ' LEU . 14.4 tt -114.55 131.03 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.482 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.653 ' HG2' HH11 ' A' ' 87' ' ' ARG . 8.9 mtt-85 -86.36 94.11 9.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -173.44 80.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -47.16 -33.8 5.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.938 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.01 -42.7 97.06 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -63.5 -44.53 94.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -1.193 . . . . 0.0 109.489 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.85 -43.71 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -57.16 -37.24 71.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.91 88.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.384 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -57.56 -42.71 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.83 . . . . 0.0 109.44 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.561 ' CD1' ' SD ' ' A' ' 71' ' ' MET . 26.9 mm -54.1 -50.17 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.91 -32.2 80.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' ND2' ' CE2' ' A' ' 154' ' ' PHE . 24.4 m120 -62.86 -46.91 85.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -1.177 . . . . 0.0 109.414 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.77 83.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -64.57 -39.59 94.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.4 61.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.535 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -68.8 -48.39 63.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.55 -41.48 90.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.59 -38.87 91.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.543 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -35.39 80.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.44 -29.46 68.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -51.77 -19.88 1.87 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.496 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -75.73 -17.85 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.76 21.54 63.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.39 151.13 42.48 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.238 -1.154 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -68.43 119.35 6.35 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.636 2.224 . . . . 0.0 111.675 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -74.32 -40.19 62.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.504 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.93 -49.99 73.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 118' ' ' SER . 89.5 m-20 -57.84 -54.3 48.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 111.064 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE1' ' NH2' ' A' ' 152' ' ' ARG . 57.8 t80 -53.69 -42.46 68.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 111.256 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.38 -59.56 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.974 -1.079 . . . . 0.0 111.662 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.614 ' CB ' HD21 ' A' ' 171' ' ' LEU . 59.2 p-90 -88.22 -21.28 24.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.735 -1.228 . . . . 0.0 111.122 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' VAL . 72.7 p -58.94 -28.59 66.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.825 -1.172 . . . . 0.0 109.77 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.01 -14.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.01 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 117' ' ' TRP . 13.4 m -84.17 24.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.041 -1.037 . . . . 0.0 109.974 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 2.3 t-20 72.52 31.35 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.682 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 81.9 t60 53.05 33.47 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.539 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.547 ' H ' HG23 ' A' ' 120' ' ' VAL . 20.2 mt-30 -142.52 106.5 5.51 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.558 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -46.61 151.58 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.611 2.207 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.79 143.53 29.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.723 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 45.3 ttm -126.76 130.38 50.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.843 . . . . 0.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 173' ' ' ASN . 1.0 OUTLIER -94.18 164.75 12.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.875 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -164.03 41.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 109.3 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.37 -176.72 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 109.67 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -76.53 -41.48 46.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.398 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.415 HG23 ' OG ' ' A' ' 133' ' ' SER . 1.2 t -147.44 175.0 11.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.11 -32.18 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.415 ' OG ' HG23 ' A' ' 131' ' ' THR . 85.4 p -57.46 -38.03 73.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.444 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.54 -32.01 72.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.47 131.96 89.73 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.78 138.59 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.152 2.568 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -84.59 4.25 33.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -140.96 88.47 2.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -94.9 174.8 3.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 139' ' ' THR . 35.9 Cg_exo -56.9 -42.24 66.66 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.07 74.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 t -60.97 -48.84 79.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.14 -41.36 94.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.04 89.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.2 tp -60.45 -48.27 82.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -55.33 -43.67 75.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -59.29 -37.87 78.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.544 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.24 -51.67 28.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 109.593 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -59.12 -41.68 88.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.09 -37.38 86.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.564 ' HG2' HH11 ' A' ' 152' ' ' ARG . 28.2 mtt-85 -64.15 -21.4 66.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.342 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.02 6.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 98' ' ' ASN . 10.0 m-85 -96.1 137.08 35.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -1.116 . . . . 0.0 109.475 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -94.59 -166.98 1.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 31.6 p90 40.03 37.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.52 24.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.21 158.93 3.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -57.82 -29.82 65.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.1 m -66.94 -44.85 79.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.7 mp -63.28 -37.79 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.15 -41.14 92.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.56 -44.01 97.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.431 -0.793 . . . . 0.0 109.337 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CZ3' ' A' ' 46' ' ' TRP . 22.9 t -57.71 -38.02 74.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -59.25 -41.77 89.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.399 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 57.6 mtt -63.91 -38.39 90.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.632 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -59.19 -38.94 81.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.687 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -80.44 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.542 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 37.3 t -49.96 -43.38 50.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.495 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.83 15.66 26.0 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.614 HD21 ' CB ' ' A' ' 117' ' ' TRP . 6.0 mp -51.71 -51.1 58.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.4 m -90.88 136.31 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 127' ' ' THR . 62.1 t30 -85.6 103.39 14.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.932 . . . . 0.0 109.447 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.515 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 63.6 t0 -96.52 115.43 27.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.526 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 51.2 m80 -159.82 15.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 177' ' ' VAL . 9.4 t 52.49 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.684 ' H ' HG12 ' A' ' 176' ' ' VAL . 10.4 p -94.94 -8.86 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.03 47.6 0.71 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 181' ' ' CYS . 4.8 t -146.49 170.11 17.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 109.516 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 72.1 m 53.55 -86.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.539 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.1 p -166.05 36.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 183' ' ' PRO . 27.5 t80 -90.71 117.3 67.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.545 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 84.5 Cg_endo -84.9 -171.67 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.081 2.52 . . . . 0.0 112.323 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 101.28 -5.71 55.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -107.9 23.38 14.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -1.196 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -142.9 79.89 14.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.947 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.307 -1.643 0 C-N-CA 123.007 2.471 . . . . 0.0 112.289 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mmm . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.307 0.575 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 52.4 mp0 -94.17 154.76 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.629 ' HG2' HH11 ' A' ' 3' ' ' ARG . 0.9 OUTLIER -146.71 161.08 41.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.01 161.35 30.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.56 -5.79 86.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -54.39 -33.64 59.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.483 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 14' ' ' ILE . 9.1 p -105.03 137.08 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 9' ' ' GLN . 17.4 p -157.53 -136.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.46 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.505 ' N ' ' OG ' ' A' ' 8' ' ' SER . 51.7 mt-30 -61.22 -147.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.533 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 53.61 74.62 0.73 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.36 -27.62 13.89 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.9 2.4 . . . . 0.0 112.108 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.5 tt -73.17 -39.1 65.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.465 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -65.82 -53.75 35.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 7' ' ' VAL . 4.4 pt -63.79 -33.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.355 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.28 -43.71 83.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -72.87 -44.57 61.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 109.478 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.599 ' NE2' ' CE3' ' A' ' 21' ' ' TRP . 30.0 t-80 -64.0 -49.42 72.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.84 -34.06 74.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -65.38 -69.62 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.526 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.83 119.13 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.599 ' CE3' ' NE2' ' A' ' 17' ' ' HIS . 77.7 t90 -172.65 128.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.29 -2.42 83.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.2 114.91 64.83 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.4 120.48 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.75 2.3 . . . . 0.0 111.896 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HB2' HD21 ' A' ' 31' ' ' LEU . 79.2 mm-40 -101.65 128.91 47.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.85 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.6 p -103.09 -4.4 24.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -79.71 117.81 20.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 0.0 109.367 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.0 m -59.64 -34.08 72.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 109.628 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.02 -46.23 85.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.87 -44.17 73.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 25' ' ' GLU . 84.3 mt -63.67 -47.18 82.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.835 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -60.7 -42.17 96.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.837 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -73.46 -30.46 63.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.6 tpp -63.0 -54.63 35.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 109.803 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 36' ' ' CYS . 3.4 tp -65.01 -35.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.998 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 35' ' ' ILE . 75.0 m -71.92 -44.21 64.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.072 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.7 -43.32 72.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -0.994 . . . . 0.0 109.845 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.31 -31.18 70.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.788 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.3 -32.94 22.8 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.2 -29.34 70.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -1.215 . . . . 0.0 109.7 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.719 HE21 HD11 ' A' ' 161' ' ' ILE . 3.5 pp0? -51.92 -23.4 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.662 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.14 109.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 0.0 109.684 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.05 -32.23 5.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 23.2 mt -105.79 160.98 14.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 p -89.06 157.09 18.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.425 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -56.32 -29.6 61.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.639 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -56.16 -38.05 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.686 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 55.5 m -74.46 -33.14 62.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -58.27 -35.01 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 0.0 109.44 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.2 mt -54.69 -51.4 65.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.34 -46.32 89.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.367 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 56' ' ' TYR . 68.0 mmtt -71.18 -22.74 61.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.37 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -59.17 -47.59 84.74 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 109.001 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 57' ' ' ARG . 78.0 mm-40 -66.6 -44.35 82.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.398 -0.814 . . . . 0.0 109.394 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.6 -32.72 71.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.245 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.643 ' CE2' ' CD2' ' A' ' 60' ' ' PHE . 60.4 t80 -64.27 -45.96 85.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.464 -0.773 . . . . 0.0 109.403 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 54' ' ' GLU . 58.4 mtm180 -58.27 -42.3 86.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.75 73.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 110.303 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.504 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 10.7 m -94.92 -12.38 26.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.065 -1.022 . . . . 0.0 110.232 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD2' ' CE2' ' A' ' 56' ' ' TYR . 54.6 m-85 -123.83 -43.18 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.877 -1.139 . . . . 0.0 110.218 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 57' ' ' ARG . 36.4 t-80 -49.39 -43.12 43.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -67.78 -34.43 76.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.735 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CD1' ' O ' ' A' ' 59' ' ' CYS . 38.5 m-85 -71.29 -44.95 64.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 5.0 t70 73.85 136.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.066 -1.021 . . . . 0.0 109.613 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -41.16 -25.67 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.864 2.376 . . . . 0.0 112.739 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.97 -47.78 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -67.25 -49.65 63.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.841 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 69' ' ' ALA . 8.3 m -55.16 -44.32 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 109.541 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.594 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -66.48 -21.49 66.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.95 . . . . 0.0 109.445 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.74 1.28 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.369 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.4 mtm -78.83 159.4 27.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.34 168.83 8.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.54 -34.04 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 109.485 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.52 -37.45 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.902 . . . . 0.0 109.469 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.64 -38.33 90.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.466 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 80' ' ' VAL . 77.6 t -56.73 -42.97 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.625 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.97 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.336 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.424 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.7 ttt-85 -60.91 -47.04 88.25 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.458 ' O ' ' CA ' ' A' ' 84' ' ' GLY . 96.0 mt -69.68 -39.07 77.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.7 t -50.71 -33.1 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.722 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -91.69 -56.87 2.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -95.06 122.4 37.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.438 ' HB1' ' SG ' ' A' ' 59' ' ' CYS . . . 55.49 47.0 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.425 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -86.87 31.89 4.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.72 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 20.01 -116.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -1.13 . . . . 0.0 109.32 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.89 140.54 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.626 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -77.14 94.56 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.7 m170 -164.22 88.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.157 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 80' ' ' VAL . 54.1 mtp180 -51.24 -28.71 12.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.828 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.96 -42.5 77.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -60.88 -52.44 65.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -1.135 . . . . 0.0 109.577 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 89.3 mt -57.49 -50.73 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -57.33 -32.69 66.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.407 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -61.97 -40.14 94.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CE1' ' A' ' 60' ' ' PHE . 23.6 mm -58.41 -50.95 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 109.352 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 68' ' ' VAL . 80.0 mt -53.99 -48.22 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.578 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.35 -33.94 83.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 94' ' ' ALA . 24.7 m120 -62.67 -40.43 97.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -1.205 . . . . 0.0 109.428 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.13 -40.76 86.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.426 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 48.1 ttm-85 -59.17 -41.44 88.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.78 -37.05 67.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.594 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 17.8 t80 -73.52 -48.61 31.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 103' ' ' LEU . 25.5 tp -58.36 -45.91 87.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.895 . . . . 0.0 109.472 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -63.33 -36.12 82.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.8 ttt -61.17 -43.17 99.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.132 -0.98 . . . . 0.0 109.459 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -71.9 -27.3 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.977 . . . . 0.0 109.476 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -52.19 -31.93 33.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.04 0.84 34.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.21 40.1 34.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.82 82.37 49.42 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -1.182 . . . . 0.0 109.634 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -37.29 127.99 0.63 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.626 2.218 . . . . 0.0 111.732 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -63.98 -48.18 77.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 110.453 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.09 -41.3 71.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 110.678 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -62.42 -33.72 75.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 111.008 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.541 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 84.1 t80 -63.92 -52.55 59.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.064 -1.022 . . . . 0.0 111.241 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 116' ' ' VAL . 8.4 m -58.1 -41.42 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.0 111.692 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.512 ' O ' ' N ' ' A' ' 122' ' ' HIS . 59.6 m95 -63.88 -33.55 75.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.775 -1.203 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.4 t -66.03 -34.61 78.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.81 -1.181 . . . . 0.0 109.746 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.1 m-85 -61.83 -43.01 99.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.101 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.4 p -87.76 24.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.947 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.51 22.05 7.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.641 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 117' ' ' TRP . 84.7 t60 49.27 45.68 23.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -151.37 114.91 3.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 138.72 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.716 2.277 . . . . 0.0 111.836 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.528 ' NE2' HG23 ' A' ' 120' ' ' VAL . 40.2 mt-30 -97.58 149.7 21.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 109.762 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.2 mtt -135.68 148.11 48.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.121 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 13.5 t -133.51 154.93 50.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 109.82 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -110.8 44.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.86 163.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.643 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 134' ' ' GLU . 9.0 m -116.23 -28.58 6.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 109.361 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 132' ' ' LEU . 1.7 t -142.06 -179.9 6.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.412 ' N ' ' OG1' ' A' ' 131' ' ' THR . 39.5 mt -64.23 -35.95 82.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -67.27 -29.57 69.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 130' ' ' THR . 40.0 mm-40 -63.15 -20.14 65.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.445 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.6 mp -67.04 119.83 67.25 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 109.698 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.19 130.68 5.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.065 2.51 . . . . 0.0 112.472 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.24 11.12 40.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 109.324 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.1 p -138.52 88.41 2.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.86 154.8 37.21 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.09 -32.11 94.27 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.813 2.342 . . . . 0.0 112.08 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.51 -40.89 48.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.4 p -62.51 -41.25 98.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.86 -48.08 75.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.41 82.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -47.41 84.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.339 -0.85 . . . . 0.0 109.51 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.5 m -55.92 -43.62 77.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.47 -35.9 78.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.513 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.65 -52.59 36.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.952 . . . . 0.0 109.531 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.8 mp -63.58 -38.11 89.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -61.35 -39.69 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.406 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.4 -37.05 85.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' A' ' 152' ' ' ARG . 44.9 mtt-85 -64.32 -23.24 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.404 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.74 10.51 16.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -74.68 137.74 42.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -1.115 . . . . 0.0 109.523 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.597 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 68.5 mttm -97.97 -168.4 1.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 21.8 p90 39.53 38.32 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.509 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 157' ' ' VAL . 3.1 m -97.68 24.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.52 155.18 3.98 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 57.0 m -54.91 -30.4 58.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.451 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.1 m -67.03 -47.91 69.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.719 HD11 HE21 ' A' ' 41' ' ' GLN . 1.8 mp -64.95 -37.08 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.53 -42.16 92.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.31 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.99 -43.51 98.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.3 m -57.4 -37.32 72.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 109.265 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.92 -39.94 91.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.452 ' SD ' HD12 ' A' ' 171' ' ' LEU . 64.3 mmm -66.11 -49.24 68.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.656 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.536 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 96.0 mm-40 -69.24 -41.93 76.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.715 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.54 84.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.98 -45.28 71.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 109.45 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.09 12.3 22.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.467 HD23 ' CH2' ' A' ' 117' ' ' TRP . 83.0 mt -58.64 -31.31 68.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.7 p -122.66 139.95 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.434 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -97.28 105.25 17.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.536 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 97.8 m-20 -94.76 97.58 10.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.506 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -139.7 150.23 44.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 m -68.75 -160.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.43 139.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.43 ' C ' ' SG ' ' A' ' 179' ' ' CYS . . . 81.1 29.32 41.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.2 m -149.82 162.02 41.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.465 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 80.8 m 52.52 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.553 ' N ' ' O ' ' A' ' 179' ' ' CYS . 22.4 p -169.96 24.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' A' ' 183' ' ' PRO . 74.0 t80 -69.17 131.86 90.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.685 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.545 ' O ' ' CD2' ' A' ' 182' ' ' TYR . 92.6 Cg_endo -80.28 -158.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 123.078 2.518 . . . . 0.0 112.397 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.514 ' O ' ' ND2' ' A' ' 185' ' ' ASN . . . 98.98 -9.84 61.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 184' ' ' GLY . 31.0 m120 -155.79 30.38 0.36 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.134 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -99.06 152.4 37.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 C-N-CA 123.123 2.549 . . . . 0.0 112.265 179.656 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.23 0.538 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -74.8 147.95 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.535 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -149.04 171.66 16.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 p -46.13 160.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.863 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.71 -0.78 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -78.26 8.69 4.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.6 p -130.14 130.87 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.922 . . . . 0.0 109.455 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.506 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 12.0 p -173.95 54.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 8' ' ' SER . 89.7 mm-40 -137.58 -135.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.34 153.91 4.75 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.335 -0.853 . . . . 0.0 109.448 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.7 -11.44 31.91 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.791 2.328 . . . . 0.0 112.174 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.48 -36.4 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.442 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' ND1' ' A' ' 17' ' ' HIS . 87.4 m-85 -73.67 -54.72 7.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.46 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.24 -48.9 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.342 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.96 87.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -60.59 -41.22 94.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 13' ' ' TYR . 28.1 m80 -62.99 -45.9 90.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.5 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.51 -37.26 51.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.479 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -57.94 -60.47 3.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -153.69 104.98 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 109.534 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -171.28 116.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.38 6.18 71.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' CYS . 2.3 t -110.68 104.12 55.5 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.245 -1.15 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.65 132.03 16.29 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.765 2.31 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.22 136.26 52.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.779 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.4 p -104.91 0.72 28.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.096 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -77.79 123.48 26.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.795 . . . . 0.0 109.35 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.3 p -66.84 -33.26 75.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 109.638 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -59.06 -43.54 91.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.152 -0.967 . . . . 0.0 109.771 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.57 -50.61 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 mt -69.47 -38.51 77.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.16 -41.47 92.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 109.841 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' ' HG ' ' A' ' 36' ' ' CYS . 97.5 mt-10 -73.81 -31.06 63.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -0.952 . . . . 0.0 109.84 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.48 -52.96 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 36' ' ' CYS . 10.0 tp -55.1 -42.58 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.0 109.989 -178.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 37' ' ' LEU . 30.7 p -72.81 -48.83 34.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.141 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 84.8 mt -65.75 -29.93 70.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.075 -1.016 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -51.77 -36.87 49.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.77 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.65 -29.29 61.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -59.04 -34.51 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' LEU . 63.4 tt0 -57.68 -32.86 67.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.0 109.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 109.645 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.92 -36.52 3.37 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.5 mm? -85.94 -160.01 0.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -1.192 . . . . 0.0 109.455 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 m -118.53 152.32 36.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -56.07 -33.24 64.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 0.0 109.513 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -29.56 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.195 -0.941 . . . . 0.0 109.611 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.2 m -64.78 -39.61 93.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.5 t -61.99 -38.91 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 mt -55.69 -55.13 35.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 51' ' ' LYS . 9.4 mtmp? -60.38 -45.12 94.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.325 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.476 ' NZ ' ' CG1' ' A' ' 86' ' ' ILE . 1.0 OUTLIER -68.91 -29.45 67.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.351 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.601 ' HG2' HH11 ' A' ' 53' ' ' ARG . 2.5 ttt-85 -54.27 -43.08 70.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.15 -0.968 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.99 -43.78 70.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.435 -0.791 . . . . 0.0 109.376 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -43.87 88.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CZ ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t80 -60.88 -44.72 96.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.389 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 42.9 ttp180 -59.68 -27.31 66.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 109.77 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.44 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.425 -0.797 . . . . 0.0 110.265 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.0 m -92.89 -20.85 20.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.133 -0.979 . . . . 0.0 110.262 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' CZ ' ' A' ' 56' ' ' TYR . 27.9 m-85 -102.75 -52.43 3.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.976 -1.077 . . . . 0.0 110.16 -178.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 31.8 t60 -54.0 -39.14 65.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.972 -1.08 . . . . 0.0 109.88 -179.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -56.32 -37.92 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' ASP . 54.9 m-85 -91.36 3.85 53.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 0.0 109.956 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 57.45 162.57 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.068 -1.02 . . . . 0.0 109.604 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.52 -28.49 8.31 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.904 2.403 . . . . 0.0 112.746 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -62.95 -48.96 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.681 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 71' ' ' MET . 91.1 mttt -65.51 -34.58 78.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.846 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 64' ' ' ASP . 55.8 t -56.09 -39.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -72.05 -34.31 68.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.1 16.53 22.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.361 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' LYS . 20.7 ttp -79.65 159.87 26.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.7 159.86 16.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.79 -25.17 62.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.48 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -55.68 -44.02 76.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 63.6 m-20 -61.83 -38.37 87.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.08 -41.44 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.58 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.18 -38.76 84.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 75' ' ' ASP . 72.8 mtm180 -68.94 -39.93 79.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.392 -0.817 . . . . 0.0 109.799 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.57 -46.45 69.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.3 t -51.78 -31.59 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.751 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.01 -57.61 3.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.515 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.79 126.37 44.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . 51.89 47.05 25.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -75.85 15.56 4.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.615 ' C ' ' O ' ' A' ' 84' ' ' GLY . 3.9 pt 28.88 90.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.107 . . . . 0.0 109.346 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 85' ' ' ILE . 79.0 mt 58.02 151.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.541 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 53.8 mtm-85 -89.01 105.39 17.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 16.8 m-70 -163.47 61.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.219 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -47.56 -35.86 9.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.33 88.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 2.6 tppt? -73.41 -41.93 62.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -1.173 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.67 -53.53 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.609 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -56.36 -33.32 65.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.977 . . . . 0.0 109.323 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -59.55 -37.79 79.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.38 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.19 -40.49 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 87.4 mt -54.41 -45.68 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.8 -37.93 93.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 4.0 m120 -58.53 -42.73 88.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -1.187 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.8 77.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 43.0 ttm-85 -59.1 -39.56 82.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.73 71.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.579 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -59.39 -48.32 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 103' ' ' LEU . 4.2 mm? -63.39 -41.5 98.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.432 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.2 -44.19 96.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 109.563 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.85 -43.18 75.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.943 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.64 -26.66 65.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.511 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -52.49 -27.34 15.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.546 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -75.95 -14.04 60.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.472 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.95 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -94.9 114.71 64.26 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.713 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -46.27 125.48 8.88 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.614 2.209 . . . . 0.0 111.698 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.89 -34.44 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.87 -49.31 59.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.176 -0.952 . . . . 0.0 110.685 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 118' ' ' SER . 86.2 m-20 -56.06 -55.63 30.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 111.079 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -56.11 -38.23 70.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 111.21 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 117' ' ' TRP . 2.4 t -55.93 -59.64 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 111.66 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.632 ' CB ' HD21 ' A' ' 171' ' ' LEU . 57.8 p-90 -88.97 -20.48 24.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.806 -1.184 . . . . 0.0 111.173 -178.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 120' ' ' VAL . 31.2 t -60.41 -28.04 67.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.754 -1.216 . . . . 0.0 109.72 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.015 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.571 ' O ' ' CB ' ' A' ' 121' ' ' ASN . 5.4 m -92.15 24.6 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 109.964 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 5.3 t-20 79.23 19.49 0.75 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 59.94 48.16 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.533 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 7.9 pt20 -154.15 147.97 18.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.92 154.78 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.652 2.234 . . . . 0.0 111.815 178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 123' ' ' GLN . 19.9 mp0 -122.83 152.85 40.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 0.0 109.725 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 61.1 mtt -136.49 155.01 50.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -135.25 158.81 43.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.924 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 128' ' ' GLN . 7.6 mp0 -117.27 47.35 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.324 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.15 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.0 m -83.98 -41.25 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 132' ' ' LEU . 29.6 m -131.85 164.55 25.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.522 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.5 mp -69.62 -11.0 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.1 m -85.12 -35.75 21.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -12.5 61.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -178.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.414 ' CG2' ' OH ' ' A' ' 163' ' ' TYR . 85.2 mt -68.52 118.0 55.69 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.767 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.01 128.63 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.63 -19.55 48.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.336 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 m -87.42 102.65 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.328 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.9 p -121.34 150.31 53.99 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.96 -40.71 33.16 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.746 2.297 . . . . 0.0 112.042 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.16 -38.75 75.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.4 m -61.33 -45.46 94.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.39 -44.57 94.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -41.3 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.515 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.31 -44.36 88.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.7 t -57.48 -42.32 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -62.62 -35.24 78.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.33 -51.91 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.03 -34.35 74.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -58.37 -36.43 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HB2' HH11 ' A' ' 152' ' ' ARG . 59.8 mttp -62.1 -39.28 91.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.421 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 12.7 mpt_? -63.79 -21.26 66.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 102.26 22.23 10.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.48 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 11.8 m-85 -83.27 133.4 34.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -101.67 170.33 8.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 53.35 47.88 23.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.617 HG22 ' SG ' ' A' ' 162' ' ' CYS . 10.7 p -122.32 26.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.417 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -46.76 170.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.9 t -59.0 -31.63 68.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -1.169 . . . . 0.0 109.427 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.465 ' H ' HG22 ' A' ' 160' ' ' THR . 0.1 OUTLIER -62.98 -47.21 84.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 -179.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.96 -39.95 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.499 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 157' ' ' VAL . 79.9 m -67.21 -41.71 85.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.414 ' OH ' ' CG2' ' A' ' 135' ' ' ILE . 75.9 t80 -60.25 -45.39 93.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.467 -0.771 . . . . 0.0 109.348 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 m -58.85 -39.17 80.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.304 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -41.96 96.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 62.0 mtp -56.54 -41.7 77.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.81 -36.41 83.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.677 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.04 75.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.546 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 9.1 t -71.15 -62.89 1.23 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.466 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.17 15.32 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.632 HD21 ' CB ' ' A' ' 117' ' ' TRP . 8.4 mp -52.79 -52.36 57.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.39 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -102.24 135.66 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.94 101.73 14.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 11.3 p30 -91.76 115.63 28.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.546 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -142.23 162.15 36.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.502 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.472 ' CG2' ' SG ' ' A' ' 179' ' ' CYS . 19.5 m -115.74 144.19 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.05 -34.54 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.76 -29.1 57.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 176' ' ' VAL . 52.7 m -82.29 146.82 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -1.216 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.2 t -65.53 -29.29 69.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 182' ' ' TYR . 30.0 p -49.74 -45.0 48.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.62 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 183' ' ' PRO . 22.9 t80 -100.89 114.83 65.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 87.9 Cg_endo -86.16 -167.45 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.11 2.54 . . . . 0.0 112.333 178.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.61 63.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -85.78 9.15 17.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -1.133 . . . . 0.0 109.586 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -145.54 78.85 11.74 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.928 . . . . 0.0 109.489 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 123.027 2.485 . . . . 0.0 112.286 -179.77 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 2' ' ' GLU . 19.3 tmm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.252 0.548 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.49 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 79.4 mm-40 -84.32 152.24 24.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.433 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 3' ' ' ARG . 7.4 tpt180 -132.64 143.68 49.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.3 m -47.07 138.25 6.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.15 22.49 12.24 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 6' ' ' TRP . 40.6 p-90 -147.09 52.85 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.0 109.475 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 p -152.07 -16.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.6 p -84.32 14.1 4.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -54.67 -39.97 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.39 159.59 1.38 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.35 -35.04 43.12 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.79 2.327 . . . . 0.0 112.14 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 12' ' ' LEU . 31.7 tp -61.04 -37.8 83.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.813 . . . . 0.0 109.48 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.47 -44.5 90.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.52 -43.96 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 109.383 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.39 98.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.34 -40.82 98.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -63.59 -48.0 79.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.58 -33.14 72.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -51.53 -51.11 57.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.22 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CD2' ' N ' ' A' ' 22' ' ' GLY . 46.4 t90 -144.77 147.92 33.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.518 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 21' ' ' TRP . . . 86.39 -29.28 4.88 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 169' ' ' CYS . 32.8 m -72.15 145.64 88.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.26 120.04 6.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.778 2.319 . . . . 0.0 111.893 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.495 ' OE1' ' SG ' ' A' ' 169' ' ' CYS . 74.3 mt-10 -95.33 128.04 41.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.952 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -133.98 -3.08 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.058 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -81.44 137.08 35.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 p -61.91 -38.12 87.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.585 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.94 -49.37 62.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -64.61 -38.68 91.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.845 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.499 HD11 ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -73.3 -33.97 65.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -65.17 -48.13 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.878 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -65.61 -30.41 71.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.821 -178.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.5 tpt -70.72 -53.37 15.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.19 -34.11 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.994 -178.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -72.18 -49.52 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 110.123 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.3 -39.5 78.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 50.4 mm-40 -57.08 -35.87 69.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.66 -31.25 57.55 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.402 HE22 ' HB3' ' A' ' 91' ' ' LYS . 14.7 mm100 -63.75 -31.52 72.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.237 . . . . 0.0 109.757 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 38' ' ' GLU . 5.1 pt20 -52.64 -23.44 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 -179.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.19 108.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.965 . . . . 0.0 109.665 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.9 -33.3 2.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -87.69 169.52 12.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.5 p -82.11 165.01 20.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -67.81 -35.29 78.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.506 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.19 -39.1 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.639 -179.7 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.476 ' N ' HG23 ' A' ' 47' ' ' ILE . 92.5 m -49.92 -35.76 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.645 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.45 -29.81 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.49 -56.47 9.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -60.92 -37.29 81.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.152 -0.967 . . . . 0.0 109.265 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' TYR . 53.1 tttm -73.91 -26.69 60.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -57.7 -48.9 78.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.242 -0.911 . . . . 0.0 108.989 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.32 -47.69 69.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.841 . . . . 0.0 109.284 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.61 -34.54 78.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 29.7 t80 -59.47 -47.43 85.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.321 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -57.1 -30.85 64.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.779 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.04 93.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.7 m -94.32 -13.1 26.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.072 -1.017 . . . . 0.0 110.262 -178.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 43.2 m-85 -111.26 -52.78 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.937 -1.102 . . . . 0.0 110.201 -178.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -52.94 -36.96 60.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 109.87 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -55.55 -33.7 64.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 64' ' ' ASP . 99.3 m-85 -97.08 4.9 51.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 0.0 109.864 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.22 164.52 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.04 -1.038 . . . . 0.0 109.609 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.37 -34.06 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.869 2.379 . . . . 0.0 112.713 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.93 -49.12 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' MET . 46.4 mtpt -65.1 -35.17 80.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.84 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 64' ' ' ASP . 54.7 t -54.81 -40.3 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 109.557 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.25 -35.49 76.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.913 . . . . 0.0 109.462 179.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.39 15.31 26.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.1 tmm? -83.86 149.64 26.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.406 ' O ' ' SD ' ' A' ' 71' ' ' MET . 14.9 pt20 -102.97 167.04 10.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.42 -28.12 69.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -56.54 -44.36 80.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.497 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.57 -38.72 81.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.399 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.612 ' O ' HG23 ' A' ' 80' ' ' VAL . 77.4 t -60.98 -45.64 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.02 -31.63 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -68.0 -48.47 65.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.336 -0.853 . . . . 0.0 109.795 -178.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.3 pp -80.5 -20.13 44.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.635 -178.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 76' ' ' VAL . 6.0 t -54.35 -45.14 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.908 . . . . 0.0 109.774 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -58.04 -50.54 73.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.498 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -99.67 107.05 19.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.439 178.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.09 74.6 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.41 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -49.41 -23.89 4.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' GLY . 21.2 pt -56.46 -164.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 109.352 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.28 136.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -92.44 96.52 10.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 29.4 m-70 -165.69 87.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.595 ' HG2' HH11 ' A' ' 89' ' ' ARG . 1.4 ptt-85 -47.31 -29.34 2.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.992 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.1 -41.03 97.89 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' NZ ' ' CD2' ' A' ' 88' ' ' HIS . 62.3 mttp -62.61 -45.07 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.451 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.503 HG21 HG13 ' A' ' 76' ' ' VAL . 98.3 mt -56.8 -42.2 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 76' ' ' VAL . 98.0 mm-40 -60.27 -37.82 81.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.12 78.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mm -62.57 -40.92 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -57.04 -40.67 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.8 -40.68 99.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -57.38 -47.65 81.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.458 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.71 -42.84 85.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -63.88 -43.71 95.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.88 -38.1 58.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -66.63 -48.6 68.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.43 -42.49 87.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.46 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.55 -41.97 87.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.576 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -40.4 96.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.68 -27.07 64.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -51.99 -17.73 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.487 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' ' OE1' ' A' ' 110' ' ' GLU . 78.5 m-20 -74.88 -16.25 60.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.04 19.2 65.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 108' ' ' ASN . 2.3 mp0 -115.87 151.93 46.94 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.188 -1.184 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.06 123.53 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.535 2.156 . . . . 0.0 111.696 179.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -76.18 -43.48 42.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 110.43 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -60.69 -49.85 75.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.095 -1.003 . . . . 0.0 110.704 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' HA ' ' NE1' ' A' ' 117' ' ' TRP . 92.1 m-20 -51.56 -36.36 44.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 111.019 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.39 -47.92 21.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 111.207 -177.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -56.34 -46.52 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.017 . . . . 0.0 111.653 -175.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.554 ' N ' HG13 ' A' ' 116' ' ' VAL . 16.9 p-90 -88.18 -27.85 21.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.745 -1.222 . . . . 0.0 111.131 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 120' ' ' VAL . 10.2 t -56.08 -29.26 60.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.871 -1.143 . . . . 0.0 109.772 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.25 -13.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' SER . 14.1 m -82.54 24.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.051 -1.03 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.573 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 13.6 t-20 74.17 17.21 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 109.68 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER 66.68 -13.35 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 121' ' ' ASN . 23.2 mt-30 -86.37 150.61 52.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.72 149.59 73.4 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.631 2.221 . . . . 0.0 111.849 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -110.27 145.66 37.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.3 mtt -135.84 152.55 51.18 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.173 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 173' ' ' ASN . 10.6 t -94.73 160.65 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.29 49.63 1.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 109.317 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.99 135.05 42.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.682 -179.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.8 m -76.05 -34.29 59.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.32 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.3 m -127.34 159.22 35.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.7 mt -56.26 -30.89 63.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.7 p -71.81 -29.94 64.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.82 1.12 15.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.173 -0.954 . . . . 0.0 109.396 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.11 119.81 67.29 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.766 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.92 130.05 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.144 2.562 . . . . 0.0 112.544 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.3 t -104.63 12.58 32.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.268 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -139.0 92.41 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 161.64 22.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -47.9 -39.55 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.829 2.352 . . . . 0.0 111.975 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.59 73.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.2 m -59.95 -45.97 90.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.26 -42.2 99.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.38 -43.2 67.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 tp -60.55 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.3 t -53.84 -43.27 69.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -62.45 -33.74 75.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.49 -51.19 38.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -33.16 72.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.589 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -58.36 -39.23 79.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.356 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.99 -40.48 97.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 109.443 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.45 -20.46 66.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 93.18 32.42 7.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.43 132.11 37.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.94 174.85 6.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 53.24 48.03 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLY . 5.4 m -115.2 26.22 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.07 167.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 159' ' ' THR . 1.0 OUTLIER -61.35 -28.31 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -1.158 . . . . 0.0 109.417 -179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -70.32 -41.26 73.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.425 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.6 mp -65.43 -47.82 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 14.0 p -64.28 -38.81 92.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.263 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.542 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 53.7 t80 -62.26 -46.5 88.54 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.7 t -61.6 -37.86 85.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.275 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.499 ' CE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -61.71 -55.07 34.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 179.692 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.455 ' N ' ' CG ' ' A' ' 165' ' ' PHE . 48.0 mtm -63.72 -41.31 98.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.646 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -66.41 -42.92 87.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 -42.32 75.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 109.697 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' ' OE1' ' A' ' 25' ' ' GLU . 3.5 m -60.91 -61.1 2.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.413 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 144.31 1.78 0.89 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 171' ' ' LEU . 4.3 mm? -57.43 -43.12 83.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 109.396 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.75 136.57 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 127' ' ' THR . 86.7 m-20 -87.95 112.58 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.429 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.516 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 80.7 m-20 -86.82 110.02 19.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.532 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' A' ' 174' ' ' ASP . 58.8 m-70 -153.8 126.69 8.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.558 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.26 137.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.491 HG22 ' ND2' ' A' ' 185' ' ' ASN . 43.4 t -59.75 135.68 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.43 5.71 60.22 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 16.4 p -77.15 -150.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.491 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.53 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 71.9 m -57.85 -39.6 78.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 0.9 OUTLIER 173.15 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.979 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.3 OUTLIER -118.17 94.93 47.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.519 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 95.4 Cg_endo -87.28 -166.63 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 123.024 2.482 . . . . 0.0 112.416 178.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 93.78 8.23 60.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.491 ' ND2' HG22 ' A' ' 177' ' ' VAL . 11.5 p30 -142.92 32.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -1.161 . . . . 0.0 109.624 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -138.56 78.8 31.1 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--N 1.306 -1.707 0 C-N-CA 123.071 2.514 . . . . 0.0 112.237 -179.924 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -90.27 145.83 24.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -148.8 154.32 39.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.881 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 3' ' ' ARG . 14.2 m 55.76 167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.0 109.397 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.93 -29.13 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -72.85 -0.0 12.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.464 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 8' ' ' SER . 7.1 p -108.88 134.72 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 167.27 0.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -79.26 -130.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.877 . . . . 0.0 109.484 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 152.08 14.28 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.96 -11.47 32.33 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.863 2.376 . . . . 0.0 112.137 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 12' ' ' LEU . 1.4 tt -63.28 -38.72 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -59.82 -47.93 83.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.7 mt -66.64 -41.6 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.359 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -46.84 87.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CD1' HD22 ' A' ' 50' ' ' LEU . 64.9 t80 -66.97 -41.46 86.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -59.97 -42.18 93.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.87 -10.71 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -78.29 -76.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.433 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.44 101.53 3.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -170.04 126.47 0.83 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.69 -29.15 8.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' O ' ' A' ' 169' ' ' CYS . 2.5 m -72.17 149.33 91.85 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.23 -1.159 . . . . 0.0 109.32 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.43 119.29 6.3 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.776 2.317 . . . . 0.0 111.89 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -112.67 132.87 54.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.804 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 p -134.87 3.06 3.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.029 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -80.72 122.37 27.04 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.364 -0.835 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 t -58.69 -39.81 81.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.25 -43.22 82.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.723 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.35 -50.77 50.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -67.81 -35.72 79.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.881 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.88 -45.59 93.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -74.61 -31.27 61.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.77 -179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.7 ttm -71.67 -54.59 9.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.723 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 36' ' ' CYS . 2.9 tp -59.37 -40.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 0.0 110.035 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.52 ' N ' HG23 ' A' ' 35' ' ' ILE . 76.7 m -72.76 -46.43 53.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.123 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD2' ' NH1' ' A' ' 53' ' ' ARG . 9.6 tp -69.8 -33.71 72.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.01 . . . . 0.0 109.863 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -52.15 -34.94 46.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.803 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.455 ' HA3' ' HZ1' ' A' ' 91' ' ' LYS . . . -52.23 -27.0 22.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.15 -31.94 72.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -1.22 . . . . 0.0 109.777 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.62 -26.34 63.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.965 . . . . 0.0 109.728 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . -42.59 109.08 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.694 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.91 -29.95 4.45 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.3 mt -100.45 163.73 12.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.429 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -87.39 164.86 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 0.0 109.384 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -59.38 -40.95 88.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 109.505 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 48' ' ' THR . 9.0 tp -54.53 -39.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.653 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 47' ' ' ILE . 88.8 m -61.37 -36.27 79.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 97.7 t -69.75 -40.1 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.512 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 16' ' ' TYR . 79.2 mt -57.12 -54.92 41.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -57.62 -47.41 82.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -68.66 -29.86 68.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 41.5 ttm-85 -50.74 -47.11 59.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 108.987 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.35 -43.68 73.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.515 -0.741 . . . . 0.0 109.406 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -67.12 -37.3 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 0.0 109.229 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 7.5 t80 -63.19 -43.89 96.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.374 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.533 ' HG2' HH11 ' A' ' 57' ' ' ARG . 43.7 mtt-85 -58.41 -39.2 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.31 77.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.458 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 85.6 m -92.39 -12.92 30.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 110.244 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 5.9 m-85 -115.97 -49.09 2.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.932 -1.105 . . . . 0.0 110.153 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.4 t60 -49.86 -42.48 47.72 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.066 -1.021 . . . . 0.0 109.877 -178.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -65.15 -30.14 71.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.789 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.434 ' O ' ' O ' ' A' ' 64' ' ' ASP . 50.2 m-85 -88.13 -0.2 56.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.833 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER 56.14 165.65 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.049 -1.032 . . . . 0.0 109.596 -179.747 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.649 ' O ' HG22 ' A' ' 68' ' ' VAL . 72.6 Cg_endo -78.72 -54.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.832 2.355 . . . . 0.0 112.709 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 t -47.22 -33.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.645 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -68.7 -44.11 74.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.341 -0.849 . . . . 0.0 109.827 -177.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 65' ' ' PRO . 1.4 m -56.99 -39.92 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.616 -178.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 68' ' ' VAL . . . -64.18 -39.37 93.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.473 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.93 23.54 7.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 109.373 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.407 ' HG3' ' H ' ' A' ' 72' ' ' GLN . 11.5 ttp -93.53 160.37 14.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 0.0 109.626 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.407 ' H ' ' HG3' ' A' ' 71' ' ' MET . 95.2 mt-30 -101.46 166.5 10.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.3 mt-10 -70.52 -21.93 62.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.13 -31.15 65.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.94 . . . . 0.0 109.468 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.05 -38.23 87.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.424 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 76' ' ' VAL . 10.5 m -73.57 -29.32 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 80' ' ' VAL . 44.5 tp10 -67.11 -36.38 81.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 -178.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 13.3 ptm180 -77.87 -41.9 35.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.897 ' O ' HD12 ' A' ' 79' ' ' LEU . 1.2 pp -81.46 -7.13 59.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.953 . . . . 0.0 109.637 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 81' ' ' GLN . 9.3 p -49.37 -42.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.688 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.537 ' N ' HG13 ' A' ' 80' ' ' VAL . 2.8 pp0? -90.42 20.91 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.006 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 84' ' ' GLY . 60.1 t0 -74.94 121.39 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.378 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.54 0.34 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 65.65 43.3 94.6 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -58.55 -165.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 86' ' ' ILE . 18.9 tt -56.02 127.89 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 87' ' ' ARG . 9.4 ptm180 -73.24 95.41 2.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -171.83 69.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -45.02 -36.15 3.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.904 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.03 98.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 33.8 tptt -62.43 -43.23 99.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.478 179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 92' ' ' ILE . 18.2 mt -54.64 -50.56 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.62 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.89 -30.61 69.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.985 . . . . 0.0 109.384 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' O ' ' OD1' ' A' ' 98' ' ' ASN . . . -58.78 -44.47 90.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.9 mp -56.28 -39.8 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 68' ' ' VAL . 87.9 mt -62.81 -29.23 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.77 -45.13 77.4 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -64.86 -38.02 89.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -1.185 . . . . 0.0 109.428 -178.548 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.59 80.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -59.53 -43.87 93.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.36 -30.41 66.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.93 -47.25 87.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.28 -44.77 86.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.94 -44.68 94.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -0.887 . . . . 0.0 109.482 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -68.61 -41.61 79.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -71.45 -27.4 63.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.485 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -52.56 -23.26 6.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.425 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -75.35 -13.11 60.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.84 48.8 6.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -135.34 150.93 73.9 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.187 -1.184 . . . . 0.0 109.653 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.23 119.14 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.571 2.181 . . . . 0.0 111.677 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -75.28 -40.76 58.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.439 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 -48.17 69.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 110.725 -178.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 118' ' ' SER . 44.3 t0 -55.1 -55.28 32.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 111.096 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -55.66 -38.59 69.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 111.249 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.97 -59.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.035 -1.041 . . . . 0.0 111.646 -178.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.43 ' O ' HG22 ' A' ' 120' ' ' VAL . 61.1 p-90 -87.79 -28.1 21.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.663 -1.273 . . . . 0.0 111.125 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 120' ' ' VAL . 94.1 p -56.34 -26.03 51.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.816 -1.178 . . . . 0.0 109.769 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.47 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.056 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 118' ' ' SER . 10.7 m -89.56 25.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 23.8 t30 80.01 22.06 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.696 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 59.46 49.75 8.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.499 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.476 ' H ' HG23 ' A' ' 120' ' ' VAL . 2.6 pt20 -154.61 146.46 17.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.37 143.36 43.1 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.642 2.228 . . . . 0.0 111.778 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -100.25 151.35 21.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 109.746 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 70.8 mtm -136.03 156.89 48.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.176 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.4 t -129.82 164.12 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.497 ' OE1' ' ND2' ' A' ' 185' ' ' ASN . 94.2 mt-30 -133.16 50.88 2.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -94.23 142.2 27.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.704 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 m -92.43 -27.69 17.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 109.361 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.2 m -126.15 156.73 39.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.1 mt -57.88 -34.76 70.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.3 m -62.35 -36.67 82.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.68 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 95.8 mt-10 -63.67 -28.84 70.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.1 mt -67.08 116.55 37.06 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.11 130.19 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.11 2.54 . . . . 0.0 112.503 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.75 -8.15 58.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.5 p -101.05 101.84 12.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 109.378 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.82 151.78 52.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.31 -33.84 97.81 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.75 2.3 . . . . 0.0 112.009 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.89 -35.2 57.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.359 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.9 p -62.8 -34.62 77.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.92 -51.01 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.43 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.429 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.617 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -55.68 -50.14 71.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.6 t -63.81 -42.49 97.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -60.7 -36.98 80.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.03 -51.63 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.02 -32.94 74.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.536 ' HZ2' ' CG1' ' A' ' 157' ' ' VAL . 14.9 mmtm -59.84 -38.37 81.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.397 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -61.72 -36.93 82.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -69.04 -19.81 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.24 27.16 9.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -1.121 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -112.43 169.37 8.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 51.6 50.78 18.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.0 p -120.14 27.05 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.414 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -41.95 159.46 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 33.5 m -53.2 -29.63 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -1.195 . . . . 0.0 109.492 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.2 p -62.42 -42.26 99.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.5 mp -63.95 -47.61 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.84 -42.61 99.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.306 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.15 -45.13 91.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.461 -0.774 . . . . 0.0 109.357 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.5 m -62.72 -40.25 96.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.306 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -35.13 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.7 mtt -65.39 -52.47 53.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -38.22 84.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.31 -0.869 . . . . 0.0 109.681 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.96 85.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.694 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.522 ' O ' ' O ' ' A' ' 23' ' ' VAL . 64.5 m -81.45 -62.44 1.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.373 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.52 2.74 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.88 -47.51 43.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.26 136.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.404 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.464 ' O ' HG22 ' A' ' 127' ' ' THR . 2.7 m120 -100.76 108.14 19.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 38.5 p30 -116.95 92.22 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -108.72 9.37 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 179' ' ' CYS . 4.2 t 56.59 101.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.3 p -54.99 -34.84 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.38 -44.1 97.34 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 181' ' ' CYS . 12.4 t -105.37 -178.85 3.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.55 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 12.1 t 55.09 5.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.875 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 180' ' ' CYS . 8.7 p 42.22 25.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 1.4 t80 -67.02 117.38 45.22 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 109.572 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.567 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.4 Cg_endo -83.17 -155.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 123.121 2.547 . . . . 0.0 112.369 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.24 57.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' ND2' ' OE1' ' A' ' 128' ' ' GLN . 21.2 t-20 -149.59 32.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -1.131 . . . . 0.0 109.586 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -83.61 153.12 64.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.306 -1.686 0 C-N-CA 123.021 2.48 . . . . 0.0 112.284 179.916 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mmt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.267 0.556 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' OE1' ' SG ' ' A' ' 179' ' ' CYS . 95.2 mt-10 -89.24 153.95 20.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 3' ' ' ARG . 4.4 ptm180 -148.44 171.79 15.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.8 m -47.93 112.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -71.39 -29.34 68.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -53.41 -7.97 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.466 -179.647 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.489 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 12.7 p -56.66 134.43 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 t -65.66 140.84 58.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -64.83 -31.45 72.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.38 143.82 6.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -32.3 9.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.829 2.353 . . . . 0.0 112.14 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.01 -41.95 99.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.23 -45.62 76.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.413 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.69 -43.97 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.92 97.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.447 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 74.0 t80 -62.41 -41.64 98.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' GLU . 58.8 t-80 -61.92 -45.32 94.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -79.95 -47.43 15.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -56.55 -42.73 79.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.527 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' HIS . 77.4 mm-40 -138.62 -150.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.463 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 20' ' ' GLU . 11.0 t90 59.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.32 72.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.89 115.39 64.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.215 -1.168 . . . . 0.0 109.423 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.99 121.69 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.758 2.305 . . . . 0.0 111.851 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -117.95 136.17 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.854 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 p -121.26 6.47 10.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.9 . . . . 0.0 109.042 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.287 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.719 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 15.1 m -74.61 -32.61 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.626 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -59.11 -52.4 65.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 109.753 -178.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -64.17 -43.42 95.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.872 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 113' ' ' ALA . 9.1 mp -74.32 -31.88 62.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.816 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 28' ' ' SER . 47.7 t80 -62.81 -47.78 81.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.95 . . . . 0.0 109.854 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 34' ' ' MET . 3.1 pp20? -75.2 -30.19 60.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 8.1 tpt -66.78 -53.12 36.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tp -63.06 -33.21 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 83.5 m -71.2 -49.49 42.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.31 -35.93 66.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 32.3 mm-40 -53.93 -33.05 55.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.786 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.81 97.7 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 36' ' ' CYS . 2.8 mp0 -70.0 -24.79 63.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.807 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -45.28 -27.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -178.894 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.77 123.86 7.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.31 -29.77 4.68 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.34 -166.46 1.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -123.83 152.25 42.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -53.78 -39.88 65.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.671 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -63.58 -39.4 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.684 -179.182 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.511 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 88.2 m -66.46 -36.74 83.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.719 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.13 -44.85 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.395 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.5 mt -60.61 -46.62 89.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.62 -50.72 71.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.306 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -68.1 -32.65 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.337 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' NH1' ' CE1' ' A' ' 16' ' ' TYR . 43.3 ttm180 -50.42 -44.32 55.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 108.94 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.29 -43.63 63.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 109.394 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -64.69 -40.71 95.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -55.85 -47.15 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.366 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 4.0 mmp_? -59.78 -34.7 73.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.416 -0.802 . . . . 0.0 109.82 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.94 -35.66 73.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.1 -36.16 12.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.005 . . . . 0.0 110.266 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 -48.03 9.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.926 -1.109 . . . . 0.0 110.2 -178.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 56.9 t60 -50.23 -39.12 43.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.0 . . . . 0.0 109.848 -178.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -56.53 -35.09 67.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' ASP . 62.8 m-85 -95.78 1.89 53.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.913 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER 56.12 162.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 0.0 109.632 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.06 -27.6 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.88 2.386 . . . . 0.0 112.64 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -49.25 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' MET . 7.2 mtpm? -67.29 -33.11 74.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.861 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 64' ' ' ASP . 57.5 t -55.78 -41.81 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -71.02 -34.64 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.61 17.62 20.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 75' ' ' ASP . 16.2 ttp -77.79 157.75 29.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.654 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.72 159.96 15.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 48.0 mp0 -60.36 -25.87 66.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.493 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.53 -43.2 93.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 71' ' ' MET . 15.9 t70 -61.01 -38.69 86.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.36 -42.99 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.47 -38.35 80.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -63.29 -41.96 99.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.806 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 82' ' ' ASP . 96.4 mt -67.35 -34.34 77.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.69 -33.12 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -86.94 -57.24 3.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 84.1 m-20 -80.04 170.62 16.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 74.14 87.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -61.42 8.64 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.6 ' H ' ' C ' ' A' ' 83' ' ' ALA . 14.0 pt -57.57 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -1.184 . . . . 0.0 109.362 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 76.0 mt -68.02 133.58 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 109.457 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.556 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 38.6 ttm180 -97.79 108.9 21.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 13.8 m-70 -164.55 85.37 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' A' ' 89' ' ' ARG . 19.5 ttt-85 -48.71 -30.51 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.783 . . . . 0.0 109.888 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.69 -47.37 68.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.95 -45.09 75.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -1.212 . . . . 0.0 109.526 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.7 mt -55.88 -44.79 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -58.29 -37.77 75.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.398 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.92 84.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -44.77 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.8 mt -56.81 -42.34 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.525 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.45 -37.43 94.1 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' CG ' ' CE2' ' A' ' 154' ' ' PHE . 2.9 m120 -61.4 -43.07 99.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.84 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.418 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 47.9 ttm-85 -63.9 -46.64 83.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.22 77.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.555 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 24.9 t80 -62.95 -41.71 99.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.24 -39.63 87.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.75 -41.3 86.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' NH1' ' A' ' 152' ' ' ARG . 51.9 mmm -63.69 -39.56 94.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.11 -27.05 64.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 107' ' ' GLN . 1.1 tm0? -51.42 -35.31 38.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -83.46 -3.51 57.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.08 74.12 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.5 146.88 40.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.144 -1.21 . . . . 0.0 109.644 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.72 124.81 11.47 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.63 2.22 . . . . 0.0 111.713 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -78.33 -45.31 22.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.456 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 28' ' ' SER . . . -55.44 -44.4 76.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.74 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.505 ' O ' ' OG ' ' A' ' 118' ' ' SER . 91.2 m-20 -57.65 -45.55 85.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 111.055 -178.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -60.16 -49.33 78.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.014 -1.053 . . . . 0.0 111.23 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 116' ' ' VAL . 7.0 m -60.37 -46.65 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 111.731 -176.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.492 ' C ' ' CD2' ' A' ' 117' ' ' TRP . 3.3 p-90 -88.7 -37.26 15.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.733 -1.23 . . . . 0.0 111.1 -177.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 120' ' ' VAL . 41.4 m -56.96 -25.29 57.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.807 -1.183 . . . . 0.0 109.698 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.18 -14.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.022 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 118' ' ' SER . 15.8 m -85.04 23.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.071 -1.018 . . . . 0.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m120 58.27 40.27 24.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.752 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.24 14.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -114.65 120.52 37.5 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.59 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.22 153.32 31.6 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.648 2.232 . . . . 0.0 111.86 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -102.53 149.89 23.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 59.8 mtt -136.61 156.6 48.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.6 t -117.12 159.57 22.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.885 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.46 53.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.78 -143.63 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 m -141.76 -30.2 0.59 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.922 . . . . 0.0 109.353 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.1 m -123.48 156.31 35.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.16 -32.57 74.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.1 p -66.66 -33.18 75.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.548 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.41 -25.12 67.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 32.3 mm -66.51 116.99 39.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.728 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.25 133.54 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.068 2.512 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.59 -9.68 53.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.9 p -96.95 102.21 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.384 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -117.67 152.91 50.37 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.387 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.01 -41.82 25.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.741 2.294 . . . . 0.0 112.041 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.65 61.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.368 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.06 -43.3 92.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.61 -38.8 80.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.1 tt -61.63 -45.63 93.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.202 -0.936 . . . . 0.0 109.498 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.3 t -58.14 -41.75 84.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -61.79 -39.15 90.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 109.549 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.12 -48.31 71.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.0 mt -59.68 -35.22 74.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.07 -41.1 82.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.396 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -64.38 -37.81 88.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.593 ' NH1' ' SD ' ' A' ' 105' ' ' MET . 24.4 mmt180 -65.23 -20.62 66.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.346 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.76 29.2 10.97 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CE2' ' CG ' ' A' ' 98' ' ' ASN . 4.0 m-85 -92.16 130.59 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HG2' ' H ' ' A' ' 156' ' ' PHE . 72.9 tttt -93.43 170.33 9.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.452 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 55.2 m-85 57.64 50.86 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.09 28.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -45.13 159.77 0.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.4 m -52.43 -32.41 39.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -1.172 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.5 m -66.37 -36.54 83.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.36 -44.14 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.513 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 85.7 m -61.04 -41.64 96.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.618 ' CE2' ' NE2' ' A' ' 167' ' ' GLN . 42.9 t80 -60.12 -50.59 73.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.306 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.8 m -60.99 -39.25 88.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.268 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -64.36 -44.83 90.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.469 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.504 ' SD ' HD22 ' A' ' 171' ' ' LEU . 40.1 mmm -64.69 -41.83 95.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.632 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.618 ' NE2' ' CE2' ' A' ' 163' ' ' TYR . 42.0 mt-30 -63.47 -43.67 96.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 -179.424 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.46 -45.0 92.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.674 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.7 t -61.65 -23.24 65.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.26 7.88 58.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.504 HD22 ' SD ' ' A' ' 166' ' ' MET . 5.1 mp -63.24 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.411 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.21 130.79 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.431 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.41 ' O ' HG22 ' A' ' 127' ' ' THR . 87.3 m-20 -94.03 108.54 20.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -88.28 112.06 22.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -138.18 134.93 35.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.88 136.91 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.15 134.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.21 -0.85 72.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.486 ' SG ' ' OE1' ' A' ' 2' ' ' GLU . 65.9 m -151.74 -178.14 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.565 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.5 t 54.3 6.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 179' ' ' CYS . 2.2 m 69.52 37.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.609 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 16.2 t80 -124.37 80.58 59.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.58 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.84 9.11 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.023 2.482 . . . . 0.0 112.351 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.34 10.24 78.52 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.05 38.06 28.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -145.47 79.63 11.33 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.985 . . . . 0.0 109.536 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 C-N-CA 123.122 2.548 . . . . 0.0 112.234 -179.88 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 14.1 tm-20 -148.21 145.31 28.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 73.5 mtm180 -126.24 145.8 50.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 p -47.63 163.5 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.619 ' H ' HD11 ' A' ' 132' ' ' LEU . . . -80.43 -7.24 88.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -55.59 -29.13 58.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -1.12 . . . . 0.0 109.392 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 8' ' ' SER . 6.3 p -98.66 126.72 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER 166.28 72.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.521 ' OE1' HD13 ' A' ' 47' ' ' ILE . 36.7 tt0 -156.36 -128.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.905 . . . . 0.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -84.61 152.19 59.81 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.9 -26.72 3.54 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.8 2.333 . . . . 0.0 112.132 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.1 tp -63.18 -44.74 94.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.78 -46.76 71.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.7 -43.96 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.39 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.11 99.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -63.13 -37.46 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.474 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLU . 83.7 t60 -58.0 -51.24 70.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.71 -37.93 85.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.843 . . . . 0.0 109.527 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 19' ' ' ASN . 2.6 m120 -60.22 -51.86 67.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.469 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' TRP . 79.1 mm-40 -142.96 -132.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.478 ' CH2' ' OD2' ' A' ' 174' ' ' ASP . 27.8 t90 58.92 116.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.17 5.59 67.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -120.04 96.01 49.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.293 -1.122 . . . . 0.0 109.412 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.71 120.02 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.738 2.292 . . . . 0.0 111.853 -179.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -95.58 134.53 38.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.863 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.4 p -112.7 0.16 15.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.83 121.0 24.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.899 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.0 m -61.57 -38.64 88.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.907 . . . . 0.0 109.627 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -59.93 -55.38 34.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -69.39 -43.51 73.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.935 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' SG ' ' A' ' 169' ' ' CYS . 6.9 tp -62.95 -39.28 94.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.842 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.412 ' CD1' ' CD2' ' A' ' 102' ' ' TYR . 62.2 t80 -63.0 -34.92 78.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.911 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -74.17 -30.22 62.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.955 . . . . 0.0 109.874 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.552 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 55.0 ttm -64.94 -53.99 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.965 . . . . 0.0 109.785 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 36' ' ' CYS . 3.3 tp -65.19 -39.29 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.032 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 35' ' ' ILE . 5.7 t -72.89 -40.89 65.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.67 -40.07 94.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 109.822 -178.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' OE2' ' N ' ' A' ' 165' ' ' PHE . 82.5 mt-10 -54.21 -28.7 42.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.772 -179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.15 -39.1 19.43 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -67.79 -30.87 70.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -1.211 . . . . 0.0 109.711 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.9 tt0 -52.64 -35.94 55.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 109.721 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.54 116.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.42 -31.4 6.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' GLN . 24.0 mt -99.81 -145.0 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -1.189 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 t -148.23 155.41 41.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.447 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -50.4 -41.91 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.908 . . . . 0.0 109.514 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.571 HG23 ' N ' ' A' ' 48' ' ' THR . 9.6 tp -52.1 -43.06 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.645 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.571 ' N ' HG23 ' A' ' 47' ' ' ILE . 63.1 m -71.64 -33.78 69.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.4 t -58.8 -39.37 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.47 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -53.92 -54.37 39.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.511 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.64 -40.14 82.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -77.28 -19.26 56.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.624 ' NH1' ' NH2' ' A' ' 57' ' ' ARG . 1.2 ttt-85 -60.97 -46.96 88.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.171 -0.956 . . . . 0.0 109.013 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -74.02 -41.33 62.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.363 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -67.44 -45.03 77.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.25 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 42.6 t80 -62.87 -38.13 89.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.42 -0.8 . . . . 0.0 109.284 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.624 ' NH2' ' NH1' ' A' ' 53' ' ' ARG . 48.6 ttm-85 -57.27 -38.49 73.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.31 -22.47 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.26 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.507 ' SG ' ' CB ' ' A' ' 83' ' ' ALA . 63.9 m -92.45 -13.55 29.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.222 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 55.8 m-85 -127.21 -53.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.935 -1.103 . . . . 0.0 110.173 -178.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -57.71 -42.46 83.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -178.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -53.8 -35.14 61.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' ASP . 92.7 m-85 -91.43 8.98 33.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.0 109.908 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER 56.42 156.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 -179.45 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.4 -28.15 39.41 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.853 2.369 . . . . 0.0 112.68 -178.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.35 -49.19 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.672 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -67.98 -31.46 71.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 64' ' ' ASP . 73.7 t -56.61 -41.12 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.586 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.27 64.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.62 14.63 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.374 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.426 ' O ' ' OE1' ' A' ' 72' ' ' GLN . 7.7 mmm -54.83 -176.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.668 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 71' ' ' MET . 15.8 mm100 -136.74 159.15 42.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 97.2 mt-10 -61.39 -34.97 76.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -72.1 -28.37 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.44 -47.96 65.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 -179.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 92' ' ' ILE . 6.9 m -60.35 -38.08 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.32 -36.99 81.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -65.38 -39.66 92.53 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.411 -0.805 . . . . 0.0 109.769 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.35 -31.84 72.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.603 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.5 t -56.25 -34.9 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.71 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -96.38 -33.94 11.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.602 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 93.1 m-20 -86.75 138.49 31.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.368 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.03 -21.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 47.07 27.49 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 86' ' ' ILE . 6.2 pt -56.35 83.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.334 179.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 85' ' ' ILE . 85.1 mt 57.04 145.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.489 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.621 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.1 OUTLIER -101.64 111.64 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.53 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -178.58 73.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.165 179.753 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 89' ' ' ARG . 35.0 ttt-85 -46.87 -36.81 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.39 95.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -67.3 -44.49 79.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.5 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.481 HG22 HG12 ' A' ' 76' ' ' VAL . 37.1 mt -58.52 -49.44 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.551 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -53.57 -34.82 59.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.419 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.548 HG21 ' CE2' ' A' ' 60' ' ' PHE . 30.4 mm -60.39 -45.37 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mm -55.55 -51.99 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.96 -28.84 72.67 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.655 ' ND2' ' N ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.35 -37.34 77.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -1.188 . . . . 0.0 109.378 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.655 ' N ' ' ND2' ' A' ' 98' ' ' ASN . . . -71.08 -35.68 71.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.65 -42.49 92.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB3' ' HE1' ' A' ' 154' ' ' PHE . . . -71.2 -32.11 68.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.412 ' CD2' ' CD1' ' A' ' 32' ' ' PHE . 32.4 t80 -66.24 -44.03 84.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.86 -40.25 96.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -60.5 -37.84 82.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.519 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.55 -34.25 77.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -68.76 -27.52 65.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -52.17 -27.84 15.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.16 -15.15 60.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.2 17.25 78.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -96.63 149.7 36.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.247 -1.149 . . . . 0.0 109.634 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.14 119.16 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.623 2.216 . . . . 0.0 111.69 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -71.29 -39.94 71.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.822 . . . . 0.0 110.446 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' CD1' ' A' ' 117' ' ' TRP . . . -61.72 -50.31 72.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.976 . . . . 0.0 110.771 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.509 ' O ' ' OG ' ' A' ' 118' ' ' SER . 29.1 t0 -55.57 -54.13 47.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -0.918 . . . . 0.0 111.081 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -53.85 -43.06 69.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 111.217 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.57 -60.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.097 . . . . 0.0 111.638 -177.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.683 ' CB ' HD21 ' A' ' 171' ' ' LEU . 67.1 p-90 -88.24 -19.28 27.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.787 -1.196 . . . . 0.0 111.141 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 120' ' ' VAL . 34.0 m -56.09 -30.09 61.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.763 -1.21 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.43 -11.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 110.049 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 117' ' ' TRP . 15.2 m -86.02 24.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 109.991 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 120' ' ' VAL . 17.3 t30 77.1 20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 62.38 29.64 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.903 . . . . 0.0 109.568 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.462 ' H ' HG23 ' A' ' 120' ' ' VAL . 12.4 pt20 -148.01 143.38 17.58 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.593 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.03 142.24 61.03 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.585 2.19 . . . . 0.0 111.833 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.93 155.66 22.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.0 ptp -135.28 156.49 48.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.155 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 173' ' ' ASN . 5.0 t -118.36 155.67 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 109.872 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -115.95 45.04 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.304 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.15 135.12 47.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.872 . . . . 0.0 109.653 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.72 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 9.1 m -88.29 -32.98 18.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.432 HG22 ' OE1' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -133.57 166.31 22.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.619 HD11 ' H ' ' A' ' 5' ' ' GLY . 24.7 mt -74.27 -8.73 57.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.567 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.6 p -87.81 -31.98 19.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.527 -177.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.72 ' CD ' ' H ' ' A' ' 130' ' ' THR . 8.5 pt-20 -86.93 9.96 17.75 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -178.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.16 119.85 62.33 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.756 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.04 120.95 3.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.179 2.586 . . . . 0.0 112.482 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 t -97.29 21.65 9.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.318 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.6 p -129.61 66.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.375 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -87.62 153.39 52.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.463 179.642 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.85 -30.74 92.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.754 2.303 . . . . 0.0 112.04 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.26 -38.11 51.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.912 . . . . 0.0 109.37 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -62.42 -48.6 78.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -64.96 -41.1 95.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.57 86.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.2 tp -59.14 -48.63 80.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.511 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -54.67 -45.61 73.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -60.3 -35.04 74.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.88 -50.55 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.451 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.92 -38.63 91.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.81 -26.5 68.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.78 -40.03 86.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -74.07 -20.17 60.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.369 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 99.22 29.46 7.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.441 ' HE1' ' HB3' ' A' ' 101' ' ' ALA . 1.4 m-85 -78.34 137.54 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.519 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -102.1 175.36 5.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 53.4 47.3 24.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.7 p -122.66 26.54 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -45.1 167.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.4 m -58.19 -30.41 66.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 0.0 109.435 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 62.9 p -62.26 -42.07 99.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 161' ' ' ILE . 1.5 mp -65.64 -46.81 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.53 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 163' ' ' TYR . 12.3 p -63.01 -39.61 95.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.282 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 34.1 t80 -62.67 -47.83 81.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 94.5 p -59.5 -41.85 90.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.286 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 1.1 t80 -61.83 -27.04 68.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 178.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -53.56 27.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.682 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -67.89 -36.28 79.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.686 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.04 99.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.649 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 41.7 m -78.59 -64.34 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 133.37 9.12 2.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.683 HD21 ' CB ' ' A' ' 117' ' ' TRP . 9.4 mp -50.96 -52.62 40.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -1.134 . . . . 0.0 109.414 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.3 m -98.2 134.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 175' ' ' HIS . 11.5 t-20 -81.15 105.13 12.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.478 ' OD2' ' CH2' ' A' ' 21' ' ' TRP . 11.7 p30 -91.62 107.33 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 109.484 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.726 ' N ' ' ND1' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -156.69 171.03 21.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.527 179.653 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.07 164.7 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 182' ' ' TYR . 14.7 t -80.29 140.05 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.467 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.7 -17.46 58.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 15.4 t -91.27 165.95 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -1.119 . . . . 0.0 109.466 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 179' ' ' CYS . 2.0 p -76.06 92.63 3.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 180' ' ' CYS . 0.1 OUTLIER 160.6 -39.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.544 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 28.9 t80 -96.31 115.54 65.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.544 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 85.4 Cg_endo -85.53 179.4 3.96 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.141 2.56 . . . . 0.0 112.353 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 96.91 3.43 59.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -143.86 35.51 1.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -1.13 . . . . 0.0 109.601 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -83.87 132.37 48.82 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.993 2.462 . . . . 0.0 112.261 -179.804 . . . . . . . . 0 0 . 1 stop_ save_